-DOCSTART- -X- O O

The DT O
TOM NNP B-INTV
test NN I-INTV
: : I-INTV
a DT O
new JJ O
instrument NN O
for IN O
assessing VBG B-POPU
theory NN I-POPU
of IN I-POPU
mind NN I-POPU
in IN I-POPU
normal JJ I-POPU
children NNS I-POPU
and CC I-POPU
children NNS I-POPU
with IN I-POPU
pervasive JJ I-POPU
developmental NN I-POPU
disorders NNS I-POPU
. . O

This DT O
article NN O
describes VBZ O
a DT O
first JJ O
attempt NN O
to TO O
investigate VB O
the DT O
reliability NN O
and CC O
validity NN O
of IN O
the DT O
TOM NNP B-INTV
test NN I-INTV
, , O
a DT O
new JJ O
instrument NN O
for IN O
assessing VBG O
theory NN O
of IN O
mind NN O
ability NN O
in IN O
normal JJ B-POPU
children NNS I-POPU
and CC I-POPU
children NNS I-POPU
with IN I-POPU
pervasive JJ I-POPU
developmental NN I-POPU
disorders NNS I-POPU
( ( I-POPU
PDDs NNP I-POPU
) ) I-POPU
. . O

In IN O
Study NNP O
1 CD O
, , O
TOM NNP B-INTV
test NN I-INTV
scores NNS O
of IN O
normal JJ B-POPU
children NNS I-POPU
( ( I-POPU
n JJ I-POPU
= NNP I-POPU
70 CD I-POPU
) ) I-POPU
correlated VBD O
positively RB O
with IN O
their PRP$ O
performance NN O
on IN O
other JJ O
theory NN O
of IN O
mind NN O
tasks NNS O
. . O

Furthermore NNP O
, , O
young JJ B-POPU
children NNS I-POPU
only RB O
succeeded VBD O
on IN O
TOM NNP O
items NNS O
that WDT O
tap VBP O
the DT O
basic JJ O
domains NNS O
of IN O
theory NN O
of IN O
mind NN O
( ( O
e.g. JJ O
, , O
emotion JJ O
recognition NN O
) ) O
, , O
whereas JJ O
older JJR B-POPU
children NNS I-POPU
also RB O
passed VBD O
items NNS O
that WDT O
measure VBP O
the DT O
more JJR O
mature JJ O
areas NNS O
of IN O
theory NN O
of IN O
mind NN O
( ( O
e.g. JJ O
, , O
understanding NN O
of IN O
humor NN O
, , O
understanding VBG O
of IN O
second-order JJ O
beliefs NNS O
) ) O
. . O

Taken VBN O
together RB O
, , O
the DT O
findings NNS O
of IN O
Study NNP O
1 CD O
suggest NN O
that IN O
the DT O
TOM NNP B-INTV
test NN I-INTV
is VBZ O
a DT O
valid JJ O
measure NN O
. . O

Study NNP O
2 CD O
showed VBD O
for IN O
a DT O
separate JJ O
sample NN O
of IN O
normal JJ B-POPU
children NNS I-POPU
( ( I-POPU
n JJ I-POPU
= NNP I-POPU
12 CD I-POPU
) ) I-POPU
that IN O
the DT O
TOM NNP B-INTV
test NN I-INTV
possesses VBZ O
sufficient JJ O
test-retest JJ O
stability NN O
. . O

Study NNP O
3 CD O
demonstrated VBD O
for IN O
a DT O
sample NN B-POPU
of IN I-POPU
children NNS I-POPU
with IN I-POPU
PDDs NNP I-POPU
( ( I-POPU
n JJ I-POPU
= NNP I-POPU
10 CD I-POPU
) ) I-POPU
that IN O
the DT O
interrater NN B-OC
reliability NN I-OC
of IN O
the DT O
TOM NNP B-INTV
test NN I-INTV
is VBZ O
good JJ O
. . O

Study VB O
4 CD O
found NN O
that IN O
children NNS B-POPU
with IN I-POPU
PDDs NNP I-POPU
( ( I-POPU
n JJ I-POPU
= NNP I-POPU
20 CD I-POPU
) ) I-POPU
had VBD O
significantly RB O
lower JJR O
TOM NNP B-INTV
test NN I-INTV
scores NNS B-OC
than IN O
children NNS B-POPU
with IN I-POPU
other JJ I-POPU
psychiatric JJ I-POPU
disorders NNS I-POPU
( ( I-POPU
e.g. NN I-POPU
, , O
children NNS B-POPU
with IN I-POPU
Attention-deficit NNP I-POPU
Hyperactivity NNP I-POPU
Disorder NNP I-POPU
; : I-POPU
n CC I-POPU
= VB I-POPU
32 CD I-POPU
) ) I-POPU
, , O
a DT O
finding NN O
that WDT O
underlines VBZ O
the DT O
discriminant JJ O
validity NN O
of IN O
the DT O
TOM NNP B-INTV
test NN I-INTV
. . O

Furthermore RB O
, , O
Study NNP O
4 CD O
showed VBD O
that DT O
intelligence NN B-OC
as IN O
indexed VBN O
by IN O
the DT O
Wechsler NNP B-OC
Intelligence NNP I-OC
Scale NNP I-OC
for IN I-OC
Children NNP I-OC
was VBD O
positively RB O
associated VBN O
with IN O
TOM NNP B-INTV
test NN I-INTV
scores NNS B-OC
. . O

Finally RB O
, , O
in IN O
all DT O
studies NNS O
, , O
the DT O
TOM NNP B-INTV
test NN I-INTV
was VBD O
found VBN O
to TO O
be VB O
reliable JJ O
in IN O
terms NNS O
of IN O
internal JJ O
consistency NN O
. . O

Altogether RB O
, , O
results NNS O
indicate VBP O
that IN O
the DT O
TOM NNP B-INTV
test NN I-INTV
is VBZ O
a DT O
reliable JJ O
and CC O
valid JJ O
instrument NN O
that WDT O
can MD O
be VB O
employed VBN O
to TO O
measure VB O
various JJ O
aspects NNS O
of IN O
theory NN O
of IN O
mind NN O
. . O

-DOCSTART- -X- O O

Behavioral NNP O
and CC O
physiological JJ O
effects NNS O
of IN O
deep JJ B-INTV
pressure NN I-INTV
on IN O
children NNS B-POPU
with IN I-POPU
autism NN I-POPU
: : I-POPU
a DT O
pilot NN O
study NN O
evaluating VBG O
the DT O
efficacy NN O
of IN O
Grandin NNP B-INTV
's POS I-INTV
Hug NNP I-INTV
Machine NNP I-INTV
. . O

OBJECTIVE NNP O
One CD O
symptom NN O
common JJ O
to TO O
many JJ O
persons NNS B-POPU
with IN I-POPU
autism NN I-POPU
is VBZ O
a DT O
high JJ O
arousal NN O
or CC O
anxiety NN O
level NN O
. . O

This DT O
study NN O
investigated VBD O
the DT O
effects NNS O
of IN O
deep JJ B-INTV
pressure NN I-INTV
on IN O
arousal NN O
and CC O
anxiety NN O
reduction NN O
in IN O
autism NN O
with IN O
Grandin NNP B-INTV
's POS I-INTV
Hug NNP I-INTV
Machine NNP I-INTV
, , O
a DT O
device NN O
that WDT O
allows VBZ O
self-administration NN O
of IN O
lateral JJ O
body NN O
pressure NN O
. . O

METHOD NNP O
Twelve NNP B-POPU
children NNS I-POPU
with IN I-POPU
autism NN I-POPU
were VBD O
randomly RB O
assigned VBN O
to TO O
either DT O
an DT O
experimental JJ O
group NN O
( ( B-INTV
receiving VBG I-INTV
deep JJ I-INTV
pressure NN I-INTV
) ) I-INTV
or CC O
a DT O
placebo NN B-INTV
group NN O
( ( B-INTV
not RB I-INTV
receiving VBG I-INTV
deep JJ I-INTV
pressure NN I-INTV
but CC I-INTV
in IN I-INTV
the DT I-INTV
disengaged JJ I-INTV
Hug NNP I-INTV
Machine NNP I-INTV
) ) I-INTV
. . O

All DT O
children NNS O
received VBD O
two CD O
20-min JJ O
sessions NNS O
a DT O
week NN O
over IN O
a DT O
6-week JJ O
period NN O
. . O

Arousal NNP B-OC
was VBD O
measured VBN O
behaviorally RB O
with IN O
the DT O
Conners NNPS B-OC
Parent NNP I-OC
Rating NNP I-OC
Scale NNP I-OC
and CC I-OC
physiologically RB I-OC
with IN I-OC
galvanic JJ I-OC
skin NN I-OC
response NN I-OC
( ( I-OC
GSR NNP I-OC
) ) I-OC
readings NNS I-OC
. . O

RESULTS NNP O
Behavioral NNP O
results NNS O
indicated VBD O
a DT O
significant JJ B-OC
reduction NN I-OC
in IN I-OC
tension NN I-OC
and CC I-OC
a DT I-OC
marginally RB I-OC
significant JJ I-OC
reduction NN I-OC
in IN I-OC
anxiety NN I-OC
for IN O
children NNS O
who WP O
received VBD O
the DT O
deep JJ B-INTV
pressure NN I-INTV
compared VBN O
with IN O
the DT O
children NNS O
who WP O
did VBD O
not RB O
. . O

Additionally RB O
, , O
children NNS O
in IN O
the DT O
experimental JJ O
group NN O
, , O
whose WP$ O
GSR NNP B-OC
measures NNS I-OC
decreased VBD O
, , O
on IN O
average NN O
, , O
after IN O
deep JJ O
pressure NN O
, , O
were VBD O
somewhat RB O
more RBR O
likely JJ O
to TO O
have VB O
higher JJR O
GSR NNP B-OC
arousal VBZ I-OC
a DT O
priori NN O
. . O

CONCLUSION NNP O
These DT O
preliminary JJ O
findings NNS O
support VBP O
the DT O
hypothesis NN O
that WDT O
deep JJ B-INTV
pressure NN I-INTV
may MD O
have VB O
a DT O
calming JJ O
effect NN O
for IN O
persons NNS O
with IN O
autism NN O
, , O
especially RB O
those DT O
with IN O
high JJ O
levels NNS O
of IN O
arousal NN O
or CC O
anxiety NN O
. . O

-DOCSTART- -X- O O

Naltrexone NN B-INTV
and CC O
communication NN O
skills NNS O
in IN O
young JJ B-POPU
children NNS I-POPU
with IN I-POPU
autism NN I-POPU
. . O

OBJECTIVE UH O
To TO O
evaluate VB O
the DT O
effect NN O
of IN O
naltrexone NN B-INTV
on IN O
communication NN O
skills NNS O
of IN O
young JJ B-POPU
children NNS I-POPU
with IN I-POPU
autism NN I-POPU
. . O

METHOD NNP O
Twenty-four JJ B-POPU
children NNS I-POPU
with IN I-POPU
autism NN I-POPU
, , I-POPU
3.0 CD I-POPU
to TO I-POPU
8.3 CD I-POPU
years NNS I-POPU
old JJ I-POPU
( ( I-POPU
mean JJ I-POPU
5.1 CD I-POPU
) ) I-POPU
who WP I-POPU
were VBD I-POPU
living VBG I-POPU
at IN I-POPU
home NN I-POPU
and CC I-POPU
attending VBG I-POPU
appropriate JJ I-POPU
school NN I-POPU
programs NNS I-POPU
, , O
participated VBN O
in IN O
a DT O
randomized JJ O
, , O
double-blind JJ O
, , O
placebo-controlled JJ O
, , O
crossover JJ O
trial NN O
. . O

Naltrexone NNP B-INTV
, , I-INTV
1.0 CD I-INTV
mg/kg NN I-INTV
, , I-INTV
or CC I-INTV
placebo NN I-INTV
was VBD I-INTV
administered VBN I-INTV
daily RB I-INTV
for IN I-INTV
2 CD I-INTV
weeks NNS I-INTV
. . O

Communication NN O
was VBD O
evaluated VBN O
from IN O
videotaped JJ B-INTV
samples NNS I-INTV
of IN I-INTV
seminaturalistic JJ I-INTV
parent-child JJ I-INTV
interaction NN I-INTV
. . O

Child NN O
and CC O
parent NN O
language NN O
were VBD O
assessed VBN O
using VBG O
similar JJ O
measures NNS O
. . O

RESULTS NNP O
In IN O
this DT O
heterogeneous JJ O
sample NN O
, , O
the DT O
median JJ B-OC
number NN I-OC
of IN I-OC
words NNS I-OC
the DT I-OC
child NN I-OC
produced VBN I-OC
on IN O
placebo NN O
was VBD O
9.5 CD O
( ( O
range VB O
0-124 NN O
) ) O
. . O

The DT O
median JJ B-OC
proportion NN I-OC
of IN I-OC
utterances NNS I-OC
with IN I-OC
echolalia NN I-OC
was VBD O
0.16 CD O
. . O

No DT O
differences NNS O
were VBD O
found VBN O
between IN O
the DT O
naltrexone NN B-INTV
and CC O
placebo NN B-INTV
conditions NNS O
in IN O
any DT O
of IN O
the DT O
measures NNS O
of IN O
children NNS B-OC
or CC I-OC
parents NNS I-OC
' POS I-OC
communication NN I-OC
. . O

Significant JJ O
correlations NNS O
were VBD O
found VBN O
between IN O
the DT O
child NN B-OC
's POS I-OC
number NN I-OC
of IN I-OC
words NNS I-OC
and CC I-OC
developmental JJ I-OC
quotient NN I-OC
( ( O
Spearman NNP O
rho VBZ O
= JJ O
0.58 CD O
, , O
p NN O
= NNP O
.003 NNP O
) ) O
and CC O
between IN O
the DT O
child NN O
's POS O
and CC O
parent NN O
's POS O
number NN O
of IN O
words NNS O
( ( O
rho VB O
= RB O
0.55 CD O
, , O
p NN O
= NNP O
.005 NNP O
) ) O
. . O

CONCLUSIONS NNP O
Previous NNP O
studies NNS O
showed VBD O
that IN O
naltrexone NN B-INTV
was VBD O
associated VBN O
with IN O
modest JJ O
reduction NN O
in IN O
hyperactivity NN O
and CC O
restlessness NN O
in IN O
this DT O
group NN O
of IN O
children NNS O
with IN O
autism NN O
. . O

In IN O
this DT O
short-term JJ O
study NN O
, , O
the DT O
medication NN O
did VBD O
not RB O
lead VB O
to TO O
improvement NN O
in IN O
communication NN O
, , O
a DT O
core NN O
deficit NN O
of IN O
autism NN O
. . O

-DOCSTART- -X- O O

Sleep NNP B-OC
patterns NNS I-OC
in IN O
autistic JJ B-POPU
children NNS I-POPU
. . O

Sleep JJ B-OC
disturbances NNS I-OC
are VBP O
regarded VBN O
as IN O
a DT O
common JJ O
clinical JJ O
feature NN O
in IN O
autistic JJ B-POPU
children NNS I-POPU
. . O

This DT O
concept NN O
is VBZ O
based VBN O
primarily RB O
on IN O
informal JJ O
observations NNS O
or CC O
studies NNS O
conducted VBN O
with IN O
questionnaires NNS B-INTV
. . O

In IN O
this DT O
study NN O
we PRP O
compared VBN O
data NNS O
obtained VBN O
by IN O
questionnaires NNS B-INTV
to TO O
that DT O
obtained VBN O
with IN O
actigraphy NN B-INTV
. . O

Among IN O
22 CD B-POPU
autistic JJ I-POPU
children NNS I-POPU
, , I-POPU
12 CD I-POPU
were VBD I-POPU
reported VBN I-POPU
as IN I-POPU
having VBG I-POPU
sleep JJ I-POPU
problems NNS I-POPU
and CC O
8 CD B-POPU
patients NNS I-POPU
completed VBD I-POPU
72 CD I-POPU
hours NNS I-POPU
actigraphy RB I-POPU
. . O

While IN O
the DT O
employment NN O
of IN O
questionnaires NNS B-INTV
disclosed VBN O
that IN O
autistic JJ O
children NNS O
had VBD O
an DT O
earlier JJR B-OC
morning NN I-OC
awakening NN I-OC
time NN I-OC
and CC I-OC
multiple NN I-OC
and CC I-OC
early JJ I-OC
night NN I-OC
arousals NNS I-OC
, , O
actigraphic JJ B-INTV
monitoring NN O
showed VBD O
that IN O
with IN O
the DT O
exception NN O
of IN O
an DT O
earlier JJR B-OC
morning NN I-OC
arousal NN I-OC
time NN I-OC
( ( O
p JJ O
= NNP O
.045 NNP O
) ) O
, , O
sleep JJ B-OC
patterns NNS I-OC
of IN O
autistic JJ B-POPU
children NNS I-POPU
were VBD O
similar JJ O
to TO O
that DT O
of IN O
normal JJ O
children NNS O
. . O

Parental JJ O
oversensitivity NN O
to TO O
sleep VB B-OC
disturbances NNS I-OC
of IN O
the DT O
autistic JJ B-POPU
children NNS I-POPU
may MD O
explain VB O
this DT O
phenomenon NN O
. . O

-DOCSTART- -X- O O

Lack NN O
of IN O
benefit NN O
of IN O
a DT O
single JJ O
dose NN O
of IN O
synthetic JJ B-INTV
human JJ I-INTV
secretin NN I-INTV
in IN O
the DT O
treatment NN O
of IN O
autism NN B-POPU
and CC I-POPU
pervasive JJ I-POPU
developmental JJ I-POPU
disorder NN I-POPU
. . O

BACKGROUND NNP O
Secretin NNP B-INTV
is VBZ O
a DT O
peptide JJ O
hormone NN O
that WDT O
stimulates VBZ O
pancreatic JJ O
secretion NN O
. . O

After IN O
recent JJ O
publicity NN O
about IN O
a DT O
child NN O
with IN O
autism NN O
whose WP$ O
condition NN O
markedly RB O
improved VBN O
after IN O
a DT O
single JJ O
dose NN O
of IN O
secretin NN B-INTV
, , O
thousands NNS B-POPU
of IN I-POPU
children NNS I-POPU
with IN I-POPU
autistic JJ I-POPU
disorders NNS I-POPU
may MD O
have VB O
received VBN O
secretin JJ B-INTV
injections NNS I-INTV
. . O

METHODS NNP O
We PRP O
conducted VBD O
a DT O
double-blind JJ O
, , O
placebo-controlled JJ B-INTV
trial NN O
of IN O
a DT O
single JJ O
intravenous JJ O
dose NN O
of IN O
synthetic JJ B-INTV
human JJ I-INTV
secretin NN I-INTV
in IN O
60 CD B-POPU
children NNS I-POPU
( ( I-POPU
age NN I-POPU
, , I-POPU
3 CD I-POPU
to TO I-POPU
14 CD I-POPU
years NNS I-POPU
) ) I-POPU
with IN I-POPU
autism NN I-POPU
or CC I-POPU
pervasive JJ I-POPU
developmental JJ I-POPU
disorder NN I-POPU
. . O

The DT O
children NNS O
were VBD O
randomly RB O
assigned VBN O
to TO O
treatment NN O
with IN O
an DT O
intravenous JJ O
infusion NN O
of IN O
synthetic JJ B-INTV
human JJ I-INTV
secretin NN I-INTV
( ( O
0.4 CD O
microg NN O
per IN O
kilogram NN O
of IN O
body NN O
weight NN O
) ) O
or CC O
saline JJ B-INTV
placebo NN I-INTV
. . O

We PRP O
used VBD O
standardized JJ O
behavioral JJ O
measures NNS O
of IN O
the DT O
primary JJ O
and CC O
secondary JJ O
features NNS O
of IN O
autism NN O
, , O
including VBG O
the DT O
Autism NNP O
Behavior NNP O
Checklist NNP O
, , O
to TO O
assess VB O
the DT O
degree NN O
of IN O
impairment NN O
at IN O
base NN O
line NN O
and CC O
over IN O
the DT O
course NN O
of IN O
a DT O
four-week JJ O
period NN O
after IN O
treatment NN O
. . O

RESULTS NNP O
Of IN O
the DT O
60 CD B-POPU
children NNS I-POPU
, , I-POPU
4 CD I-POPU
could MD I-POPU
not RB I-POPU
be VB I-POPU
evaluated VBN I-POPU
- : O
2 CD O
received VBD O
secretin NN B-INTV
outside IN O
the DT O
study NN O
, , O
and CC O
2 CD O
did VBD O
not RB O
return VB O
for IN O
follow-up JJ O
. . O

Thus NNP O
, , O
56 CD B-POPU
children NNS I-POPU
( ( I-POPU
28 CD I-POPU
in IN I-POPU
each DT I-POPU
group NN I-POPU
) ) I-POPU
completed VBD I-POPU
the DT I-POPU
study NN I-POPU
. . O

As IN O
compared VBN O
with IN O
placebo NN B-INTV
, , I-INTV
secretin FW I-INTV
treatment NN O
was VBD O
not RB O
associated VBN O
with IN O
significant JJ B-OC
improvements NNS I-OC
in IN I-OC
any DT I-OC
of IN I-OC
the DT I-OC
outcome NN I-OC
measures NNS I-OC
. . O

Among IN O
the DT O
children NNS O
in IN O
the DT O
secretin NN B-INTV
group NN O
, , O
the DT O
mean JJ B-OC
total NN I-OC
score NN I-OC
on IN I-OC
the DT I-OC
Autism NNP I-OC
Behavior NNP I-OC
Checklist NNP I-OC
at IN O
base NN O
line NN O
was VBD O
59.0 CD O
( ( O
range NN O
of IN O
possible JJ O
values NNS O
, , O
0 CD O
to TO O
158 CD O
, , O
with IN O
a DT O
larger JJR O
value NN O
corresponding VBG O
to TO O
greater JJR O
impairment NN O
) ) O
, , O
and CC O
among IN O
those DT O
in IN O
the DT O
placebo NN B-INTV
group NN O
it PRP O
was VBD O
63.2 CD O
. . O

The DT O
mean JJ B-OC
decreases NNS I-OC
in IN I-OC
scores NNS I-OC
over IN O
the DT O
four-week JJ O
period NN O
were VBD O
8.9 CD O
in IN O
the DT O
secretin NN B-INTV
group NN O
and CC O
17.8 CD O
in IN O
the DT O
placebo NN B-INTV
group NN O
( ( O
mean JJ O
difference NN O
, , O
-8.9 NNP O
; : O
95 CD O
percent NN O
confidence NN O
interval NN O
, , O
-19.4 VBP O
to TO O
1.6 CD O
; : O
P=0.11 NNP O
) ) O
. . O

None NN O
of IN O
the DT O
children NNS B-POPU
had VBD O
treatment-limiting JJ B-OC
adverse JJ I-OC
effects NNS I-OC
. . O

After IN O
they PRP O
were VBD O
told VBN O
the DT O
results NNS O
, , O
69 CD O
percent NN O
of IN O
the DT O
parents NNS O
of IN O
the DT O
children NNS O
in IN O
this DT O
study NN O
said VBD O
they PRP O
remained VBD O
interested JJ O
in IN O
secretin NN B-INTV
as IN O
a DT O
treatment NN O
for IN O
their PRP$ O
children NNS O
. . O

CONCLUSIONS VB O
A DT O
single JJ O
dose NN O
of IN O
synthetic JJ O
human JJ B-INTV
secretin NN I-INTV
is VBZ O
not RB B-OC
an DT I-OC
effective JJ I-OC
treatment NN I-OC
for IN O
autism NN O
or CC O
pervasive JJ O
developmental JJ O
disorder NN O
. . O

-DOCSTART- -X- O O

The DT O
relationship NN O
between IN O
repetitive JJ B-OC
behaviors NNS I-OC
and CC I-OC
growth NN I-OC
hormone NN I-OC
response NN I-OC
to TO O
sumatriptan VB B-INTV
challenge NN O
in IN O
adult NN B-POPU
autistic JJ I-POPU
disorder NN I-POPU
. . O

Autism NNP O
is VBZ O
heterogeneous JJ O
with IN O
respect NN O
to TO O
clinical JJ O
symptoms NNS O
and CC O
etiology NN O
. . O

To TO O
sort VB O
out RP O
this DT O
heterogeneity NN O
in IN O
autism NN O
, , O
we PRP O
investigated VBD O
whether IN O
specific JJ B-OC
neurobiological JJ I-OC
markers NNS I-OC
vary VBP O
in IN O
parallel NN O
to TO O
core VB B-OC
symptomatology NN I-OC
. . O

Specifically RB O
, , O
we PRP O
assessed VBD O
growth NN B-OC
hormone NN I-OC
response NN I-OC
to TO O
the DT O
5-HT JJ B-INTV
1d CD I-INTV
agonist NN I-INTV
, , I-INTV
sumatriptan NN I-INTV
, , O
and CC O
linked VBD B-OC
this DT I-OC
measure NN I-OC
of IN I-OC
serotonergic JJ I-OC
function NN I-OC
to TO O
the DT B-OC
severity NN I-OC
of IN I-OC
repetitive JJ B-POPU
behaviors NNS I-POPU
in IN I-POPU
adult NN I-POPU
autistic JJ I-POPU
patients NNS I-POPU
. . O

Eleven NNP B-POPU
adult NN I-POPU
patients NNS I-POPU
with IN I-POPU
autism NN I-POPU
or CC I-POPU
Asperger NNP I-POPU
's POS I-POPU
disorder NN I-POPU
were VBD I-POPU
randomized VBN I-POPU
to TO O
single JJ O
dose JJ O
sumatriptan NN B-INTV
( ( O
6 CD O
mg RB O
SQ NNP O
) ) O
and CC O
placebo NN B-INTV
challenges NNS O
, , O
separated VBN O
by IN O
a DT O
one-week JJ O
interval NN O
. . O

In IN O
adult JJ O
autistic JJ O
disorders NNS O
, , O
severity NN B-OC
of IN I-OC
repetitive JJ I-OC
behaviors NNS I-OC
at IN I-OC
baseline NN I-OC
, , O
as IN O
measured VBN B-OC
by IN I-OC
YBOCS-compulsion NNP I-OC
score NN I-OC
, , I-OC
significantly RB I-OC
positively RB I-OC
correlated VBN I-OC
with IN O
both DT O
peak JJ B-OC
delta NN I-OC
growth NN I-OC
hormone NN I-OC
response NN I-OC
and CC I-OC
area NN I-OC
under IN I-OC
the DT I-OC
curve NN I-OC
growth NN I-OC
hormone NN I-OC
response NN I-OC
to TO O
sumatriptan VB B-INTV
. . O

Thus RB O
, , O
the DT O
severity NN B-OC
of IN I-OC
a DT I-OC
specific JJ I-OC
behavioral JJ I-OC
dimension NN I-OC
in IN O
autism NN O
( ( B-OC
repetitive JJ I-OC
behaviors NNS I-OC
) ) I-OC
parallels VBP I-OC
the DT I-OC
sensitivity NN I-OC
of IN O
the DT O
5-HT JJ B-INTV
1d CD I-INTV
receptor NN I-INTV
, , O
as IN O
manifest NN O
by IN O
sumatriptan NN B-INTV
elicited VBN B-OC
GH NNP I-OC
response NN I-OC
. . O

-DOCSTART- -X- O O

Auditory NNP B-INTV
integration NN I-INTV
training NN I-INTV
for IN O
children NNS B-POPU
with IN I-POPU
autism NN I-POPU
: : I-POPU
no DT O
behavioral JJ O
benefits NNS O
detected VBN O
. . O

Auditory NNP B-INTV
integration NN I-INTV
training NN I-INTV
and CC I-INTV
a DT I-INTV
control NN I-INTV
treatment NN I-INTV
were VBD O
provided VBN O
for IN O
16 CD B-POPU
children NNS I-POPU
with IN I-POPU
autism NN I-POPU
in IN O
a DT O
crossover NN O
experimental JJ O
design NN O
. . O

Measures NNS O
, , O
blind NN O
to TO O
treatment NN O
order NN O
, , O
included VBD O
parent NN B-OC
and CC I-OC
teacher JJ I-OC
ratings NNS I-OC
of IN I-OC
behavior NN I-OC
, , I-OC
direct JJ I-OC
observational JJ I-OC
recordings NNS I-OC
, , I-OC
IQ NNP I-OC
, , I-OC
language NN I-OC
, , I-OC
and CC I-OC
social/adaptive JJ I-OC
tests NNS I-OC
. . O

Significant JJ B-OC
differences NNS I-OC
tended VBD O
to TO O
show VB O
that IN O
the DT O
control NN O
condition NN O
was VBD O
superior JJ B-OC
on IN I-OC
parent-rated JJ I-OC
measures NNS I-OC
of IN I-OC
hyperactivity NN I-OC
and CC I-OC
on IN I-OC
direct JJ I-OC
observational JJ I-OC
measures NNS I-OC
of IN I-OC
ear-occlusion NN I-OC
. . O

No DT B-OC
differences NNS I-OC
were VBD O
detected VBN O
on IN O
teacher-rated JJ B-OC
measures NNS I-OC
. . O

Children NNP B-OC
's POS I-OC
IQs NNP I-OC
and CC I-OC
language NN I-OC
comprehension NN I-OC
did VBD I-OC
not RB I-OC
increase VB I-OC
, , O
but CC O
adaptive/social JJ B-OC
behavior NN I-OC
scores NNS I-OC
and CC I-OC
expressive JJ I-OC
language NN I-OC
quotients NNS I-OC
decreased VBN I-OC
. . O

The DT O
majority NN O
of IN O
parents NNS B-POPU
( ( O
56 CD O
% NN O
) ) O
were VBD O
unable JJ B-OC
to TO I-OC
report VB I-OC
in IN I-OC
retrospect NN I-OC
when WRB O
their PRP$ O
child NN O
had VBD O
received VBN O
auditory JJ B-INTV
integration NN I-INTV
training NN I-INTV
. . O

No DT B-OC
individual JJ O
child NN B-POPU
was VBD O
identified VBN O
as IN O
benefiting VBG B-OC
clinically RB I-OC
or CC I-OC
educationally RB I-OC
from IN O
the DT O
treatment NN O
. . O

-DOCSTART- -X- O O

Increased VBN B-OC
growth NN I-OC
hormone NN I-OC
response NN O
to TO O
sumatriptan VB B-INTV
challenge NN O
in IN O
adult NN B-POPU
autistic JJ I-POPU
disorders NNS I-POPU
. . O

Serotonergic NNP O
( ( O
5-HT JJ O
) ) O
abnormalities NNS O
have VBP O
been VBN O
documented VBN O
in IN O
autism NN O
. . O

To TO O
assess JJ O
sensitivity NN O
of IN O
the DT O
5-HT1d JJ O
receptor NN O
, , O
growth NN B-OC
hormone NN I-OC
response NN I-OC
to TO O
the DT O
5-HT1d JJ B-INTV
receptor NN I-INTV
agonist NN I-INTV
sumatriptan NN I-INTV
was VBD O
studied VBN O
in IN O
adult NN B-POPU
autistic JJ I-POPU
patients NNS I-POPU
and CC I-POPU
matched VBD I-POPU
normal JJ I-POPU
controls NNS I-POPU
. . O

In IN O
this DT O
study NN O
, , O
11 CD B-POPU
adult NN I-POPU
patients NNS I-POPU
with IN I-POPU
autism NN I-POPU
or CC I-POPU
Asperger NNP I-POPU
's POS I-POPU
disorder NN I-POPU
were VBD I-POPU
compared VBN I-POPU
with IN I-POPU
nine CD I-POPU
matched JJ I-POPU
controls NNS I-POPU
. . O

All DT O
subjects NNS O
were VBD O
randomized VBN O
to TO O
single JJ B-INTV
dose JJ I-INTV
sumatriptan NN I-INTV
( ( I-INTV
6 CD I-INTV
mg RB I-INTV
SQ NNP I-INTV
) ) I-INTV
and CC I-INTV
placebo NN I-INTV
challenges NNS I-INTV
, , I-INTV
separated VBN I-INTV
by IN I-INTV
a DT I-INTV
1-week JJ I-INTV
interval NN I-INTV
, , I-INTV
and CC I-INTV
growth NN I-INTV
hormone NN I-INTV
was VBD I-INTV
measured VBN I-INTV
before IN I-INTV
and CC I-INTV
during IN I-INTV
the DT I-INTV
challenges NNS I-INTV
. . O

The DT O
results NNS O
showed VBD O
a DT O
highly RB O
significant JJ O
diagnosisxdrugxtime JJ B-OC
interaction NN I-OC
on IN O
repeated JJ O
measure NN O
analysis NN O
covaried VBD O
for IN O
baseline NN O
. . O

This DT O
suggests VBZ O
that IN O
autistic JJ B-POPU
patients NNS I-POPU
had VBD O
significantly RB O
greater JJR O
growth NN B-OC
hormone NN I-OC
response NN I-OC
to TO O
sumatriptan VB B-INTV
than IN O
normal JJ O
controls NNS O
, , O
independent JJ O
of IN O
placebo JJ O
effects NNS O
. . O

Therefore RB O
, , O
abnormalities NNS O
in IN O
5-HT JJ O
regulation NN O
in IN O
autism NN O
may MD O
be VB O
related VBN O
to TO O
increased VBN O
sensitivity NN O
of IN O
the DT O
5-HT1d JJ O
inhibitory NN O
receptor NN O
in IN O
autism NN O
. . O

-DOCSTART- -X- O O

Secretin NNP O
and CC O
autism NN O
: : O
a DT O
two-part JJ O
clinical JJ O
investigation NN O
. . O

Recent JJ O
anecdotal JJ O
reports NNS O
have VBP O
touted VBN O
the DT O
gastrointestinal NN O
( ( O
GI NNP O
) ) O
hormone NN O
secretin NN B-INTV
as IN O
a DT O
treatment NN O
modality NN O
for IN O
autism NN O
, , O
though IN O
there EX O
is VBZ O
little JJ O
clinical JJ O
evidence NN O
or CC O
literature NN O
to TO O
support VB O
its PRP$ O
viability NN O
. . O

We PRP O
undertook VBD O
a DT O
two-part JJ O
clinical JJ O
trial NN O
to TO O
investigate VB O
these DT O
claims NNS O
. . O

Fifty-six JJ B-POPU
patients NNS I-POPU
( ( I-POPU
49 CD I-POPU
boys NNS I-POPU
, , I-POPU
7 CD I-POPU
girls NNS I-POPU
, , I-POPU
mean JJ I-POPU
age NN I-POPU
= VBD I-POPU
6.4 CD I-POPU
years NNS I-POPU
, , I-POPU
SD NNP I-POPU
= NNP I-POPU
2.7 CD I-POPU
) ) I-POPU
enrolled VBN I-POPU
in IN I-POPU
an DT I-POPU
open-label JJ I-POPU
trial NN I-POPU
of IN I-POPU
secretin NN I-POPU
, , I-POPU
during IN I-POPU
which WDT I-POPU
they PRP I-POPU
received VBD I-POPU
one CD I-POPU
injection NN I-POPU
of IN I-POPU
the DT I-POPU
hormone NN I-POPU
( ( I-POPU
2 CD I-POPU
IU/kg NNP I-POPU
) ) I-POPU
. . O

All DT O
subjects NNS O
were VBD O
evaluated VBN O
by IN O
their PRP$ O
parents NNS O
at IN O
baseline NN O
and CC O
follow-up JJ O
visits NNS O
( ( O
3-6 JJ O
weeks NNS O
later RB O
, , O
M NNP O
= NNP O
3.7 CD O
, , O
SD NNP O
= VBZ O
1.4 CD O
weeks NNS O
) ) O
with IN O
Childhood NNP B-OC
Autism NNP I-OC
Rating NNP I-OC
Scales NNP I-OC
( ( I-OC
CARS NNP I-OC
) ) I-OC
. . O

Thirty-four JJ B-POPU
patients NNS I-POPU
were VBD I-POPU
labeled VBN I-POPU
with IN I-POPU
Pervasive NNP I-POPU
Developmental NNP I-POPU
Disorder NNP I-POPU
Not RB I-POPU
Otherwise NNP I-POPU
Specified NNP I-POPU
, , I-POPU
and CC I-POPU
22 CD I-POPU
met VBD I-POPU
diagnostic JJ I-POPU
criteria NNS I-POPU
for IN I-POPU
Autistic JJ I-POPU
Disorder NNP I-POPU
. . O

Forty-five JJ B-POPU
patients NNS I-POPU
were VBD I-POPU
concurrently RB I-POPU
on IN I-POPU
other JJ I-POPU
drug NN I-POPU
treatments NNS I-POPU
. . O

At IN O
follow-up NN O
, , O
some DT O
reported VBD O
minimal JJ O
but CC O
potentially RB O
significant JJ O
improvements NNS O
including VBG O
changes NNS B-OC
in IN I-OC
GI NNP I-OC
symptoms NNS I-OC
, , I-OC
expressive JJ I-OC
and/or NN I-OC
receptive JJ I-OC
language NN I-OC
function NN I-OC
, , I-OC
and CC I-OC
improved JJ I-OC
awareness NN I-OC
and CC I-OC
social JJ I-OC
interactions NNS I-OC
. . O

No DT O
adverse JJ B-OC
effects NNS I-OC
were VBD O
reported VBN O
or CC O
observed VBN O
. . O

Subsequently NNP O
, , O
17 CD O
of IN O
the DT O
most RBS O
responsive JJ O
patients NNS O
from IN O
Study NNP O
1 CD O
began VBD O
a DT O
double-blind JJ O
trial NN O
that WDT O
also RB O
included VBD O
8 CD O
newly RB O
enrolled VBN O
patients NNS O
. . O

Patients NNS O
in IN O
this DT O
second JJ O
study NN O
were VBD O
alternatively RB O
entered VBN O
into IN O
one CD O
of IN O
two CD O
groups NNS O
and CC O
received VBD O
injections NNS O
of IN O
secretin NN B-INTV
or CC I-INTV
placebo NN I-INTV
with IN O
crossover NN O
at IN O
4 CD O
weeks NNS O
. . O

Patients NNS B-POPU
from IN I-POPU
Study NNP I-POPU
1 CD I-POPU
entered VBD I-POPU
into IN I-POPU
Study NNP I-POPU
2 CD I-POPU
at IN I-POPU
an DT I-POPU
average NN I-POPU
of IN I-POPU
6.5 CD I-POPU
( ( I-POPU
SD NNP I-POPU
= NNP I-POPU
0.8 CD I-POPU
) ) I-POPU
weeks NNS I-POPU
after IN I-POPU
beginning VBG I-POPU
Study NNP I-POPU
1 CD I-POPU
. . O

Results NNS O
of IN O
both DT O
inquiries NNS O
indicate VBP O
that IN O
although IN O
treatment NN O
with IN O
secretin NN B-INTV
was VBD O
reported VBN O
to TO O
cause VB O
transient JJ B-OC
changes NNS I-OC
in IN I-OC
speech NN I-OC
and CC I-OC
behavior NN I-OC
in IN O
some DT O
children NNS O
, , O
overall JJ O
it PRP O
produced VBD O
few JJ O
clinically RB O
meaningful JJ O
changes NNS O
when WRB O
compared VBN O
to TO O
children NNS O
given VBN O
placebo JJ B-INTV
injections NNS O
. . O

-DOCSTART- -X- O O

Comments NNS O
on IN O
" NNP B-INTV
Secretin NNP I-INTV
and CC O
autism NN B-POPU
: : I-POPU
a DT O
two-part JJ O
clinical JJ O
investigation NN O
" NN O
by IN O
M.G NNP O
. . O

Chez NNP O
et CC O
al NN O
. . O

-DOCSTART- -X- O O

Assessment NN O
in IN O
multisite JJ O
randomized JJ O
clinical JJ O
trials NNS O
of IN O
patients NNS B-POPU
with IN I-POPU
autistic JJ I-POPU
disorder NN I-POPU
: : I-POPU
the DT I-POPU
Autism NNP I-POPU
RUPP NNP I-POPU
Network NNP I-POPU
. . O

Research NNP O
Units VBZ O
on IN O
Pediatric NNP O
Psychopharmacology NNP O
. . O

Assessment NNP O
of IN O
autistic JJ B-OC
disorder NN I-OC
( ( I-OC
autism NN I-OC
) ) I-OC
symptoms NNS I-OC
, , I-OC
primary JJ I-OC
and CC I-OC
secondary JJ I-OC
, , O
poses VBZ O
more RBR O
challenging JJ O
problems NNS O
than IN O
ordinarily RB O
found VBN O
in IN O
multisite JJ O
randomized JJ O
clinical JJ O
trial NN O
( ( O
RCT NNP O
) ) O
assessments NNS O
. . O

For IN O
example NN O
, , O
subjects NNS O
may MD O
be VB O
uncommunicative JJ B-POPU
and CC I-POPU
extremely RB I-POPU
heterogeneous JJ I-POPU
in IN I-POPU
problem NN I-POPU
presentation NN I-POPU
, , O
and CC O
current JJ O
pharmacological JJ O
treatments NNS O
are VBP O
not RB O
likely JJ O
to TO O
alter VB O
most JJS O
core NN O
features NNS O
of IN O
autism NN O
. . O

The DT O
Autism NNP O
Research NNP O
Units NNP O
on IN O
Pediatric NNP O
Psychopharmacology NNP O
( ( O
RUPP NNP O
Autism NNP O
Network NNP O
) ) O
resolved VBD O
some DT O
of IN O
these DT O
problems NNS O
during IN O
the DT O
design NN O
of IN O
a DT O
risperidone NN B-INTV
RCT NNP I-INTV
in IN O
children/adolescents NNS B-POPU
. . O

The DT O
inappropriateness NN O
of IN O
the DT O
usual JJ O
anchors NNS O
for IN O
a DT O
Clinical JJ O
Global NNP O
Impression NNP O
of IN O
Severity NNP O
( ( O
CGI-S NNP O
) ) O
was VBD O
resolved VBN O
by IN O
defining VBG O
uncomplicated JJ B-POPU
autism NN I-POPU
without IN I-POPU
secondary JJ I-POPU
symptoms NNS I-POPU
as IN I-POPU
a DT I-POPU
CGI-S NNP I-POPU
of IN I-POPU
3 CD I-POPU
, , I-POPU
mildly RB I-POPU
ill JJ I-POPU
. . O

The DT O
communication NN B-OC
problems NNS I-OC
, , O
compromising VBG O
use NN O
of IN O
the DT O
patient NN O
as IN O
an DT O
informant NN O
, , O
were VBD O
addressed VBN O
by IN O
several JJ O
strategies NNS O
, , O
including VBG O
careful JJ B-INTV
questioning NN I-INTV
of IN I-INTV
care NN I-INTV
providers NNS I-INTV
, , I-INTV
rating NN I-INTV
scales NNS I-INTV
, , I-INTV
laboratory NN I-INTV
tests NNS I-INTV
, , I-INTV
and CC I-INTV
physical JJ I-INTV
exams NN I-INTV
. . O

The DT O
broad JJ O
subject JJ O
heterogeneity NN O
requires VBZ O
outcome JJ O
measures NNS O
sensitive JJ O
to TO O
individual JJ O
change NN O
over IN O
a DT O
wide JJ O
spectrum NN O
of IN O
treatment NN O
response NN B-OC
and CC O
side NN B-OC
effects NNS I-OC
. . O

The DT O
problems NNS O
of IN O
neuropsychologically RB O
testing VBG O
nonverbal JJ B-POPU
, , I-POPU
lower JJR I-POPU
functioning NN I-POPU
, , I-POPU
sometimes RB I-POPU
noncompliant JJ I-POPU
subjects NNS I-POPU
requires VBZ O
careful JJ O
instrument JJ O
selection/adaptation NN O
and CC O
flexible JJ O
administration NN O
techniques NNS O
. . O

The DT O
problems NNS O
of IN O
assessing VBG O
low-end JJ B-POPU
IQs NNP I-POPU
, , O
neglected VBN O
by IN O
most JJS O
standardized JJ O
test NN O
developers NNS O
, , O
was VBD O
resolved VBN O
by IN O
an DT O
algorithm NN O
of IN O
test NN O
hierarchy NN O
. . O

Scarcity NN O
of IN O
other JJ O
autism-adapted JJ O
cognitive NN O
and CC O
neuropsychological JJ O
tests NNS O
and CC O
lack NN O
of IN O
standardization NN O
required VBN O
development NN O
of IN O
a DT O
new JJ O
, , O
specially RB O
adapted VBN O
battery NN O
. . O

Reliability NN O
on IN O
the DT O
Autism NNP B-OC
Diagnostic NNP I-OC
Interview NNP I-OC
( ( O
currently RB O
the DT O
most RBS O
valid JJ O
diagnostic JJ O
instrument NN O
) ) O
and CC O
other JJ O
clinician JJ O
instruments NNS O
required VBN O
extensive JJ O
cross-site JJ O
training NN O
( ( O
in-person JJ O
, , O
videotape NN O
, , O
and CC O
teleconference NN O
sessions NNS O
) ) O
. . O

Definition NN O
of IN O
a DT O
treatment NN O
responder NN O
required VBN O
focus NN O
on IN O
individually RB O
relevant JJ O
target NN O
symptoms NNS O
, , O
synthesis NN O
of IN O
possible JJ O
modest JJ O
improvements NNS O
in IN O
many JJ O
domains NNS O
, , O
and CC O
acceptance NN O
of IN O
attainable JJ O
though IN O
imperfect JJ O
goals NNS O
. . O

The DT O
assessment NN B-INTV
strategy NN I-INTV
developed VBD O
is VBZ O
implemented VBN O
in IN O
a DT O
RCT NNP O
of IN O
risperidone NN B-INTV
( ( O
McDougle NNP O
et RB O
al. RB O
, , O
2000 CD O
) ) O
for IN O
which WDT O
the DT O
design NN O
and CC O
other JJ O
methodological JJ O
challenges NNS O
are VBP O
described VBN O
elsewhere RB O
( ( O
Scahill NNP O
et VBZ O
al. RB O
, , O
2000 CD O
) ) O
. . O

Some DT O
of IN O
these DT O
problems NNS O
and CC O
solutions NNS O
are VBP O
partially RB O
shared VBN O
with IN O
RCTs NNP O
of IN O
other JJ O
treatments NNS O
and CC O
other JJ O
disorders NNS O
. . O

-DOCSTART- -X- O O

Superior JJ O
modulation NN O
of IN O
activation NN O
levels NNS O
of IN O
stimulus JJ O
representations NNS O
does VBZ O
not RB O
underlie JJ O
superior JJ O
discrimination NN O
in IN O
autism NN B-POPU
. . O

The DT O
performance NN O
of IN O
children NNS B-POPU
with IN I-POPU
and CC I-POPU
without IN I-POPU
autism NN I-POPU
was VBD O
compared VBN O
in IN O
object-based JJ B-INTV
positive JJ I-INTV
and CC I-INTV
negative JJ I-INTV
priming NN I-INTV
tasks NNS I-INTV
within IN O
a DT O
visual JJ B-INTV
search NN I-INTV
procedure NN I-INTV
. . O

Object-based JJ O
positive JJ B-OC
and CC I-OC
negative JJ I-OC
priming NN I-OC
effects NNS I-OC
were VBD O
found VBN O
in IN O
both DT O
groups NNS O
of IN O
children NNS O
. . O

This DT O
result NN O
provides VBZ O
the DT O
first JJ O
evidence NN O
for IN O
the DT O
activation NN O
of IN O
object-based JJ B-OC
representations NNS I-OC
during IN O
visual JJ B-INTV
search NN I-INTV
task NN I-INTV
performance NN I-INTV
and CC O
further JJ O
supports NNS O
the DT O
notion NN O
that IN O
both DT O
excitatory NN B-OC
and CC I-OC
inhibitory JJ I-OC
guidance NN I-OC
mechanisms NNS I-OC
are VBP O
involved VBN O
in IN O
target NN O
location NN O
in IN O
visual JJ O
search NN O
. . O

The DT B-POPU
children NNS I-POPU
with IN I-POPU
autism NN I-POPU
were VBD O
overall JJ O
better JJR O
than IN O
the DT O
typically RB O
developing VBG O
children NNS O
at IN O
visual JJ B-OC
search NN I-OC
, , O
thus RB O
replicating VBG O
demonstrations NNS O
of IN O
superior JJ O
discrimination NN O
in IN O
autism NN O
. . O

Furthermore RB O
, , O
there EX O
was VBD O
no DT O
difference NN O
between IN O
the DT O
magnitude NN O
of IN O
the DT O
positive JJ O
nor CC O
the DT O
negative JJ O
priming NN B-OC
effects NNS I-OC
of IN O
the DT O
groups NNS O
. . O

This DT O
finding NN O
suggests VBZ O
that IN O
excitatory NN B-OC
and CC I-OC
inhibitory NN I-OC
control NN I-OC
operate NN I-OC
comparably RB I-OC
in IN O
autism NN O
and CC O
normal JJ B-OC
development NN I-OC
. . O

These DT O
results NNS O
are VBP O
discussed VBN O
in IN O
the DT O
light NN O
of IN O
the DT O
superior JJ O
ability NN O
of IN O
individuals NNS B-POPU
with IN I-POPU
autism NN I-POPU
to TO O
discriminate VB O
between IN O
items NNS O
. . O

More RBR O
specifically RB O
, , O
it PRP O
is VBZ O
argued VBN O
that IN O
superior JJ O
discrimination NN O
in IN O
autism NN O
does VBZ O
not RB O
result VB O
from IN O
enhanced VBN O
top-down JJ O
excitatory NN O
and CC O
inhibitory NN O
control NN O
. . O

-DOCSTART- -X- O O

Effect NN O
of IN O
secretin NN B-INTV
on IN O
children NNS B-POPU
with IN I-POPU
autism NN I-POPU
: : I-POPU
a DT O
randomized NN O
controlled VBN O
trial NN O
. . O

To TO O
determine VB O
the DT O
effect NN O
of IN O
intravenous JJ B-INTV
porcine NN I-INTV
secretin NN I-INTV
on IN O
autistic JJ O
behaviours NNS O
in IN O
children NNS B-POPU
aged VBD I-POPU
2 CD I-POPU
to TO I-POPU
7 CD I-POPU
years NNS I-POPU
, , O
the DT O
effects NNS O
of IN O
secretin NN O
on IN O
( ( O
1 CD O
) ) O
performance NN O
on IN O
a DT O
standardized JJ O
language NN O
measure NN O
, , O
and CC O
( ( O
2 CD O
) ) O
autistic JJ O
behaviours NN O
, , O
as IN O
rated VBN O
by IN O
parents NNS O
and CC O
child NN O
development NN O
professionals NNS O
was VBD O
examined VBN O
. . O

Employing VBG O
a DT O
randomized VBN O
, , O
double-blind JJ O
, , O
placebo-controlled JJ O
design NN O
, , O
95 CD B-POPU
participants NNS I-POPU
were VBD O
assigned VBN O
to TO O
one CD O
of IN O
two CD O
groups NNS O
and CC O
administered VBD O
a DT O
single JJ O
dose NN O
of IN O
either DT O
secretin NN B-INTV
or CC I-INTV
placebo NN I-INTV
. . O

A DT O
follow-up JJ O
assessment NN O
was VBD O
conducted VBN O
3 CD O
weeks NNS O
after IN O
the DT O
injection NN O
. . O

No DT O
significant JJ O
differences NNS O
in IN O
language NN B-OC
or CC I-OC
autistic JJ I-OC
behaviour NN I-OC
measures NNS I-OC
were VBD O
observed VBN O
at IN O
the DT O
3-week JJ O
follow-up NN O
between IN O
the DT O
groups NNS O
. . O

Also RB O
, , O
there EX O
was VBD O
no DT O
significant JJ O
difference NN O
in IN O
the DT O
proportion NN O
of IN O
individuals NNS O
who WP O
improved VBN O
by IN O
> NN B-OC
or CC I-OC
= $ I-OC
6 CD I-OC
points NNS I-OC
on IN I-OC
the DT I-OC
language NN I-OC
measure NN I-OC
at IN O
follow-up NN O
. . O

This DT O
study NN O
showed VBD O
no DT O
significant JJ O
effects NNS O
of IN O
secretin NN O
on IN O
children NNS B-POPU
with IN I-POPU
autism NN I-POPU
. . O

Our PRP$ O
results NNS O
are VBP O
consistent JJ O
with IN O
a DT O
systematic JJ O
review NN O
of IN O
randomized VBN O
controlled JJ O
trials NNS O
evaluating VBG O
the DT O
effect NN O
of IN O
secretin NN O
in IN O
children NNS B-POPU
with IN I-POPU
autism NN I-POPU
. . O

-DOCSTART- -X- O O

Spatial JJ B-INTV
orientation NN I-INTV
adjustments NNS I-INTV
in IN O
children NNS B-POPU
with IN I-POPU
autism NN I-POPU
in IN I-POPU
Hong NNP I-POPU
Kong NNP I-POPU
. . O

Abnormal NNP O
spatial JJ B-OC
orientation NN I-OC
and CC I-OC
body NN I-OC
postures NNS I-OC
in IN O
children NNS B-POPU
with IN I-POPU
autism NN I-POPU
often RB O
interfere RB O
with IN O
visual JJ O
abilities NNS O
to TO O
attend VB O
tasks NNS O
and CC O
social JJ O
interactions NNS O
. . O

Twenty-four JJ B-POPU
children NNS I-POPU
diagnosed VBN I-POPU
with IN I-POPU
autism NN I-POPU
from IN I-POPU
Kowloon NNP I-POPU
, , I-POPU
Hong NNP I-POPU
Kong NNP I-POPU
were VBD O
assessed VBN O
for IN O
spatial JJ B-OC
orientation NN I-OC
and CC O
spatial JJ B-OC
management NN I-OC
abilities NNS O
. . O

Positive JJ B-OC
changes NNS I-OC
in IN O
spatial JJ B-OC
orientation NN I-OC
were VBD O
evident JJ O
when WRB O
the DT O
children NNS O
wore VBD B-INTV
ambient JJ I-INTV
prism NN I-INTV
lenses NNS I-INTV
and CC O
included VBD O
changes NNS B-OC
in IN I-OC
posture NN I-OC
from IN O
slanted VBN O
to TO O
erect VB O
. . O

Adjustments NNS O
in IN O
spatial JJ B-OC
management NN I-OC
were VBD O
evident JJ O
in IN O
improved JJ O
ball NN O
catching VBG B-OC
ability NN I-OC
, , O
a DT O
task NN O
requiring VBG O
visual JJ O
tracking NN O
and CC O
eye-hand JJ O
coordination NN O
. . O

The DT O
findings NNS O
suggest VBP O
that IN O
alterations NNS B-INTV
to TO I-INTV
the DT I-INTV
sensory JJ I-INTV
systems NNS I-INTV
may MD O
lead VB O
to TO O
behavioral JJ O
change NN O
in IN O
some DT O
children NNS O
. . O

-DOCSTART- -X- O O

Effectiveness NN B-OC
of IN O
N NNP O
, , O
N-dimethylglycine NNP O
in IN O
autism NN B-POPU
and CC I-POPU
pervasive JJ I-POPU
developmental JJ I-POPU
disorder NN I-POPU
. . O

N NNP B-INTV
, , I-INTV
N-dimethylglycine NNP I-INTV
, , O
a DT O
dietary JJ O
supplement NN O
, , O
has VBZ O
been VBN O
reported VBN O
to TO O
be VB O
beneficial JJ O
in IN O
children NNS B-POPU
with IN I-POPU
autism NN I-POPU
and CC I-POPU
pervasive JJ I-POPU
developmental JJ I-POPU
disorder NN I-POPU
. . O

We PRP O
examined VBD O
the DT O
effectiveness NN O
of IN O
dimethylglycine NN O
in IN O
children NNS B-POPU
with IN I-POPU
autism NN I-POPU
and CC I-POPU
pervasive JJ I-POPU
developmental NN I-POPU
disorder NN I-POPU
in IN O
a DT O
double-blind JJ O
, , O
placebo-controlled JJ O
study NN O
. . O

Thirty-seven JJ B-POPU
children NNS I-POPU
between IN I-POPU
3 CD I-POPU
and CC I-POPU
11 CD I-POPU
years NNS I-POPU
of IN I-POPU
age NN I-POPU
with IN I-POPU
a DT I-POPU
diagnosis NN I-POPU
of IN I-POPU
autism NN I-POPU
and/or JJ I-POPU
pervasive JJ I-POPU
developmental NN I-POPU
disorder NN I-POPU
were VBD O
gender JJR O
and CC O
age NN O
matched VBN O
and CC O
randomly RB O
assigned VBN O
to TO O
receive VB B-INTV
either DT I-INTV
placebo NN I-INTV
or CC I-INTV
dimethylglycine NN I-INTV
for IN I-INTV
4 CD I-INTV
weeks NNS I-INTV
. . O

All DT O
children NNS O
were VBD O
assessed VBN O
before IN O
and CC O
after IN O
treatment NN O
on IN O
two CD B-INTV
behavioral JJ I-INTV
measures NNS I-INTV
, , I-INTV
the DT I-INTV
Vineland NNP I-INTV
Maladaptive NNP I-INTV
Behavior NNP I-INTV
Domain NNP I-INTV
and CC I-INTV
the DT I-INTV
Aberrant NNP I-INTV
Behavior NNP I-INTV
Checklist NNP I-INTV
. . O

Standardized NNP B-OC
neurologic JJ I-OC
examinations NNS I-OC
before IN I-OC
and CC I-OC
after IN I-OC
treatment NN I-OC
on IN O
33 CD O
children NNS O
showed VBD O
no DT O
change NN O
. . O

An DT O
overall JJ O
improvement NN O
on IN O
all DT B-OC
behavioral JJ I-OC
measures NNS I-OC
was VBD O
observed VBN O
for IN O
both DT O
the DT O
placebo NN O
and CC O
the DT O
dimethylglycine NN O
groups NNS O
. . O

However RB O
, , O
the DT O
improvement NN O
among IN O
the DT O
children NNS O
who WP O
received VBD O
dimethylglycine NN O
was VBD O
not RB O
statistically RB O
different JJ O
from IN O
the DT O
improvement NN O
observed VBD O
among IN O
the DT O
children NNS O
who WP O
received VBD O
the DT O
placebo NN O
. . O

The DT O
children NNS B-POPU
who WP I-POPU
participated VBD I-POPU
in IN I-POPU
this DT I-POPU
study NN I-POPU
were VBD I-POPU
a DT I-POPU
heterogeneous JJ I-POPU
group NN I-POPU
, , O
and CC O
their PRP$ O
apparent JJ O
responses NNS O
to TO O
the DT O
dimethylglycine NN O
varied VBN O
. . O

Some DT O
children NNS O
appeared VBD O
to TO O
respond VB O
positively RB O
to TO O
the DT O
dimethylglycine NN O
, , O
and CC O
there RB O
was VBD O
a DT O
smaller JJR O
proportion NN O
of IN O
negative JJ O
changes NNS O
in IN O
the DT O
dimethylglycine NN O
group NN O
, , O
but CC O
the DT O
quantitative JJ O
changes NNS O
in IN O
the DT O
dimethylglycine JJ O
behavioral JJ O
assessments NNS O
were VBD O
not RB O
significantly RB O
different JJ O
from IN O
what WP O
was VBD O
observed VBN O
among IN O
children NNS O
who WP O
received VBD O
placebo NN O
. . O

-DOCSTART- -X- O O

Repeated VBN O
doses NNS O
of IN O
porcine NN B-INTV
secretin NN I-INTV
in IN O
the DT O
treatment NN O
of IN O
autism NN B-POPU
: : I-POPU
a DT O
randomized JJ O
, , O
placebo-controlled JJ O
trial NN O
. . O

BACKGROUND NNP O
AND CC O
OBJECTIVES NNP O
Anecdotal NNP O
reports NNS O
on IN O
the DT O
efficacy NN O
of IN O
secretin NN B-INTV
in IN O
autism NN O
raised VBN O
great JJ O
hopes NNS O
for IN O
the DT O
treatment NN O
of IN O
children NNS B-POPU
with IN O
this DT O
disorder NN O
. . O

Initial JJ O
single-dose JJ O
, , O
randomized VBN O
, , O
controlled VBN O
trials NNS O
failed VBD O
to TO O
demonstrate VB O
any DT O
therapeutic JJ O
effects NNS O
of IN O
secretin NN B-INTV
. . O

The DT O
present JJ O
study NN O
is VBZ O
the DT O
first JJ O
to TO O
test VB O
the DT O
outcome NN O
of IN O
repeated VBN O
doses NNS O
and CC O
to TO O
examine VB O
whether IN O
there EX O
is VBZ O
a DT O
subgroup NN O
of IN O
children NNS O
who WP O
are VBP O
more RBR O
likely JJ O
to TO O
achieve VB O
positive JJ O
effects NNS O
. . O

METHOD NNP O
Sixty-four JJ B-POPU
children NNS I-POPU
with IN I-POPU
autism NN I-POPU
( ( I-POPU
ages VBZ I-POPU
2-7 CD I-POPU
years NNS I-POPU
; : I-POPU
55 CD I-POPU
boys NNS I-POPU
and CC I-POPU
9 CD I-POPU
girls NNS I-POPU
) ) I-POPU
with IN I-POPU
a DT I-POPU
range NN I-POPU
of IN I-POPU
intelligence NN I-POPU
quotient NN I-POPU
and CC I-POPU
verbal JJ I-POPU
ability NN I-POPU
were VBD O
randomly RB O
assigned VBN O
, , O
in IN O
a DT O
double-blind JJ O
manner NN O
, , O
to TO O
secretin VB B-INTV
or CC I-INTV
placebo VB I-INTV
groups NNS O
. . O

Children NNP O
received VBD O
2 CD O
doses NNS O
of IN O
placebo NN B-INTV
or CC I-INTV
porcine NN I-INTV
secretin NN I-INTV
, , O
6 CD O
weeks NNS O
apart RB O
. . O

Assessments NNS O
were VBD O
performed VBN O
at IN O
baseline NN O
and CC O
3 CD O
weeks NNS O
after IN O
each DT O
injection NN O
using VBG O
several JJ O
outcome JJ O
measures NNS O
. . O

RESULTS NNP O
There EX O
were VBD O
no DT O
group NN O
differences VBZ O
on IN O
formal JJ B-OC
measures NNS I-OC
of IN I-OC
language NN I-OC
, , I-OC
cognition NN I-OC
, , I-OC
or CC I-OC
autistic JJ I-OC
symptomatology NN I-OC
. . O

Subgroupings NNS O
based VBN O
on IN O
cognitive JJ B-OC
level NN I-OC
, , I-OC
the DT I-OC
presence NN I-OC
or CC I-OC
absence NN I-OC
of IN I-OC
diarrhea NN I-OC
, , O
or CC O
a DT O
history NN O
of IN O
regression NN B-OC
failed VBD O
to TO O
show VB O
any DT O
significant JJ O
therapeutic JJ O
effects NNS O
of IN O
secretin NN B-INTV
. . O

CONCLUSION NNP O
No DT O
evidence NN O
is VBZ O
provided VBN O
for IN O
the DT O
efficacy NN B-OC
of IN O
repeated JJ O
doses NNS O
of IN O
porcine NN B-INTV
secretin NN I-INTV
in IN O
the DT O
treatment NN O
of IN O
children NNS B-POPU
with IN I-POPU
autism NN I-POPU
. . O

The DT O
possible JJ O
relationship NN O
between IN O
relief NN O
of IN O
biological JJ B-OC
symptoms NNS I-OC
and CC O
enhanced VBD O
skill JJ B-OC
performance NN I-OC
is VBZ O
discussed VBN O
. . O

-DOCSTART- -X- O O

A DT O
randomized JJ O
, , O
double-blind JJ O
, , O
placebo-controlled JJ O
trial NN O
of IN O
single-dose JJ O
intravenous JJ O
secretin NN B-INTV
as IN O
treatment NN O
for IN O
children NNS B-POPU
with IN I-POPU
autism NN I-POPU
. . O

OBJECTIVE UH O
To TO O
determine VB O
whether IN O
a DT O
single JJ O
injection NN O
of IN O
intravenous JJ O
secretin NN B-INTV
results NNS O
in IN O
measurable JJ O
improvements NNS O
in IN O
socialization NN O
and/or NN O
communication NN O
skills NNS O
in IN O
children NNS B-POPU
with IN I-POPU
autism NN I-POPU
. . O

STUDY NNP O
DESIGN NNP O
Sixty NNP B-POPU
subjects VBZ I-POPU
with IN I-POPU
autism NN I-POPU
were VBD O
randomly RB O
selected VBN O
and CC O
assigned VBN O
to TO O
either DT O
treatment NN O
or CC O
placebo NN B-INTV
group NN O
. . O

Subjects VBZ O
in IN O
the DT O
treatment NN O
group NN O
received VBD O
2.0 CD B-INTV
clinical JJ I-INTV
units NNS I-INTV
of IN I-INTV
secretin NN I-INTV
per IN I-INTV
kilogram NN I-INTV
of IN I-INTV
body NN I-INTV
weight NN I-INTV
as IN O
a DT O
single JJ O
intravenous JJ O
dose NN O
. . O

Subjects NNS O
in IN O
the DT O
placebo NN B-INTV
group NN O
received VBD O
normal JJ B-INTV
saline JJ I-INTV
solution NN I-INTV
. . O

Neurodevelopmental NNP O
and CC O
behavioral JJ O
assessments NNS O
were VBD O
performed VBN O
for IN O
all DT O
subjects NNS O
before IN O
injection NN O
and CC O
at IN O
3 CD O
and CC O
6 CD O
weeks NNS O
after IN O
injection NN O
. . O

RESULTS NNP O
Assessment NNP B-OC
of IN I-OC
language NN I-OC
skills NNS I-OC
and CC I-OC
parents NNS I-OC
' POS I-OC
behavioral JJ I-OC
assessments NNS I-OC
revealed VBD O
no DT O
significant JJ O
differences NNS O
between IN O
the DT O
treatment NN O
and CC O
placebo NN O
groups NNS O
. . O

Raters NNS B-OC
' POS I-OC
assessments NNS I-OC
of IN I-OC
severity NN I-OC
of IN I-OC
autistic JJ I-OC
symptoms NNS I-OC
did VBD O
not RB O
differ VB O
for IN O
the DT O
2 CD O
groups NNS O
at IN O
6 CD O
weeks NNS O
after IN O
injection NN O
. . O

A DT O
marginally RB O
statistically RB O
significant JJ O
improvement NN O
in IN O
autistic JJ O
behaviors NNS O
was VBD O
seen VBN O
in IN O
the DT O
treatment NN O
group NN O
at IN O
3 CD O
weeks NNS O
after IN O
injection NN O
( ( O
P NNP O
=.051 NNP O
) ) O
. . O

CONCLUSIONS VB O
A DT O
single JJ O
dose NN O
of IN O
intravenous JJ O
secretin NN B-INTV
does VBZ O
not RB O
appear VB O
to TO O
have VB O
significant JJ O
effects NNS O
on IN O
either DT O
parents NNS O
' POS O
perception NN O
of IN O
autistic JJ O
behaviors NNS O
or CC O
language NN O
skills NNS O
at IN O
6 CD O
weeks NNS O
after IN O
injection NN O
. . O

Transient NNP O
, , O
marginally RB O
significant JJ O
improvements NNS O
in IN O
autistic JJ O
behaviors NNS O
may MD O
occur VB O
in IN O
some DT O
children NNS O
. . O

-DOCSTART- -X- O O

Double-blind NNP O
, , O
placebo-controlled JJ B-INTV
study NN O
of IN O
amantadine JJ B-INTV
hydrochloride NN I-INTV
in IN O
the DT O
treatment NN O
of IN O
children NNS B-POPU
with IN I-POPU
autistic JJ I-POPU
disorder NN I-POPU
. . O

OBJECTIVE UH O
To TO O
test VB O
the DT O
hypothesis NN O
that WDT O
amantadine JJ B-INTV
hydrochloride NN O
is VBZ O
a DT O
safe JJ O
and CC O
effective JJ O
treatment NN O
for IN O
behavioral JJ B-OC
disturbances NNS I-OC
-- : I-OC
for IN I-OC
example NN O
, , O
hyperactivity NN B-OC
and CC I-OC
irritability NN I-OC
-- : I-OC
in IN I-OC
children NNS B-POPU
with IN I-POPU
autism NN I-POPU
. . O

METHOD NNP O
Thirty-nine JJ B-POPU
subjects NNS I-POPU
( ( I-POPU
intent NN I-POPU
to TO I-POPU
treat VB I-POPU
; : I-POPU
5-19 CD I-POPU
years NNS I-POPU
old JJ I-POPU
; : I-POPU
IQ NNP I-POPU
> NNP I-POPU
35 CD I-POPU
) ) I-POPU
had VBD I-POPU
autism NN I-POPU
diagnosed VBN I-POPU
according VBG I-POPU
to TO I-POPU
DSM-IV NNP I-POPU
and CC I-POPU
ICD-10 NNP I-POPU
criteria NNS I-POPU
using VBG I-POPU
the DT I-POPU
Autism NNP I-POPU
Diagnostic NNP I-POPU
Interview-Revised JJ I-POPU
and CC I-POPU
the DT I-POPU
Autism NNP I-POPU
Diagnostic NNP I-POPU
Observation NNP I-POPU
Schedule-Generic NNP I-POPU
. . O

The DT O
Aberrant JJ B-OC
Behavior NNP I-OC
Checklist-Community NNP I-OC
Version NNP I-OC
( ( I-OC
ABC-CV NNP I-OC
) ) I-OC
and CC I-OC
Clinical JJ I-OC
Global NNP I-OC
Impressions NNP I-OC
( ( I-OC
CGI NNP I-OC
) ) I-OC
scale NN O
were VBD O
used VBN O
as IN O
outcome JJ O
variables NNS O
. . O

After IN O
a DT O
1-week JJ O
, , O
single-blind JJ O
placebo NN O
run-in NN O
, , O
patients NNS O
received VBD O
a DT O
single JJ B-INTV
daily JJ I-INTV
dose NN I-INTV
of IN I-INTV
amantadine NN I-INTV
( ( I-INTV
2.5 CD I-INTV
mg/kg NNS I-INTV
per IN I-INTV
day NN I-INTV
) ) I-INTV
or CC I-INTV
placebo NN I-INTV
for IN I-INTV
the DT I-INTV
next JJ I-INTV
week NN I-INTV
, , I-INTV
and CC I-INTV
then RB I-INTV
bid VB I-INTV
dosing VBG I-INTV
( ( I-INTV
5.0 CD I-INTV
mg/kg NNS I-INTV
per IN I-INTV
day NN I-INTV
) ) I-INTV
for IN I-INTV
the DT I-INTV
subsequent JJ I-INTV
3 CD I-INTV
weeks NNS I-INTV
. . O

RESULTS VB O
When WRB O
assessed VBN O
on IN O
the DT O
basis NN O
of IN O
parent-rated JJ B-OC
ABC-CV NNP I-OC
ratings NNS I-OC
of IN I-OC
irritability NN I-OC
and CC I-OC
hyperactivity NN I-OC
, , O
the DT O
mean JJ O
placebo NN O
response NN O
rate NN O
was VBD O
37 CD O
% NN O
versus NN O
amantadine NN O
at IN O
47 CD O
% NN O
( ( O
not RB O
significant JJ O
) ) O
. . O

However RB O
, , O
in IN O
the DT O
amantadine-treated JJ B-INTV
group NN O
there EX O
were VBD O
statistically RB O
significant JJ O
improvements NNS O
in IN O
absolute JJ O
changes NNS O
in IN O
clinician-rated JJ O
ABC-CVs NNP B-OC
for IN I-OC
hyperactivity NN I-OC
( ( O
amantadine JJ O
-6.4 NNP O
versus NN O
placebo NN O
-2.1 NNP O
; : O
p CC O
= NNP O
.046 NNP O
) ) O
and CC O
inappropriate JJ B-OC
speech NN I-OC
( ( O
-1.9 JJ O
versus NN O
0.4 CD O
; : O
p NN O
= NNP O
.008 NNP O
) ) O
. . O

CGI NNP B-OC
scale JJ I-OC
ratings NNS I-OC
were VBD O
higher JJR O
in IN O
the DT O
amantadine NN O
group NN O
: : O
53 CD O
% NN O
improved JJ O
versus NN O
25 CD O
% NN O
( ( O
p JJ O
= NNP O
.076 NNP O
) ) O
. . O

Amantadine NNP B-INTV
was VBD O
well RB O
tolerated VBN O
. . O

CONCLUSIONS NNP O
Parents NNPS O
did VBD O
not RB O
report VB O
statistically RB O
significant JJ O
behavioral JJ B-OC
change NN I-OC
with IN O
amantadine NN O
. . O

However RB O
, , O
clinician-rated JJ B-OC
improvements NNS I-OC
in IN I-OC
behavioral JJ I-OC
ratings NNS I-OC
following VBG O
treatment NN O
with IN O
amantadine JJ B-INTV
suggest VBP O
that IN O
further JJ O
studies NNS O
with IN O
this DT O
or CC O
other JJ O
drugs NNS O
acting VBG O
on IN O
the DT O
glutamatergic NN O
system NN O
are VBP O
warranted VBN O
. . O

The DT O
design NN O
of IN O
these DT O
and CC O
similar JJ O
drug NN O
trials NNS O
in IN O
children NNS B-POPU
with IN I-POPU
autistic JJ I-POPU
disorder NN I-POPU
must MD O
take VB O
into IN O
account NN O
the DT O
possibility NN O
of IN O
a DT O
large JJ O
placebo NN O
response NN O
. . O

-DOCSTART- -X- O O

Brief JJ O
report NN O
: : O
case NN O
reports NNS O
on IN O
naltrexone NN B-INTV
use NN O
in IN O
children NNS B-POPU
with IN I-POPU
autism NN I-POPU
: : I-POPU
controlled VBN O
observations NNS O
regarding VBG O
benefits NNS B-OC
and CC O
practical JJ B-OC
issues NNS I-OC
of IN O
medication NN O
management NN O
. . O

-DOCSTART- -X- O O

Lamotrigine NNP B-INTV
therapy NN I-INTV
for IN O
autistic JJ B-POPU
disorder NN I-POPU
: : I-POPU
a DT O
randomized JJ O
, , O
double-blind JJ O
, , O
placebo-controlled JJ O
trial NN O
. . O

In IN O
autism NN O
, , O
glutamate NN O
may MD O
be VB O
increased VBN O
or CC O
its PRP$ O
receptors NNS O
up-regulated JJ O
as IN O
part NN O
of IN O
an DT O
excitotoxic JJ O
process NN O
that WDT O
damages NNS O
neural JJ O
networks NNS O
and CC O
subsequently RB O
contributes VBZ O
to TO O
behavioral VB O
and CC O
cognitive VB O
deficits NNS O
seen VBN O
in IN O
the DT O
disorder NN O
. . O

This DT O
was VBD O
a DT O
double-blind JJ O
, , O
placebo-controlled JJ O
, , O
parallel JJ O
group NN O
study NN O
of IN O
lamotrigine NN B-INTV
, , O
an DT O
agent NN O
that WDT O
modulates VBZ O
glutamate JJ O
release NN O
. . O

Twenty-eight JJ B-POPU
children NNS I-POPU
( ( I-POPU
27 CD I-POPU
boys NNS I-POPU
) ) I-POPU
ages VBZ I-POPU
3 CD I-POPU
to TO I-POPU
11 CD I-POPU
years NNS I-POPU
( ( I-POPU
M NNP I-POPU
= NNP I-POPU
5.8 CD I-POPU
) ) I-POPU
with IN I-POPU
a DT I-POPU
primary JJ I-POPU
diagnosis NN I-POPU
of IN I-POPU
autistic JJ I-POPU
disorder NN I-POPU
received VBD I-POPU
either CC I-POPU
placebo NN I-POPU
or CC I-POPU
lamotrigine JJ I-POPU
twice JJ I-POPU
daily RB I-POPU
. . O

In IN O
children NNS O
on IN O
lamotrigine NN B-INTV
, , I-INTV
the DT I-INTV
drug NN I-INTV
was VBD I-INTV
titrated VBN I-INTV
upward RB I-INTV
over IN I-INTV
8 CD I-INTV
weeks NNS I-INTV
to TO I-INTV
reach VB I-INTV
a DT I-INTV
mean JJ I-INTV
maintenance NN I-INTV
dose NN I-INTV
of IN I-INTV
5.0 CD I-INTV
mg/kg NNS I-INTV
per IN I-INTV
day NN I-INTV
. . O

This DT B-INTV
dose NN I-INTV
was VBD I-INTV
then RB I-INTV
maintained VBN I-INTV
for IN I-INTV
4 CD I-INTV
weeks NNS I-INTV
. . O

Following VBG B-INTV
maintenance NN I-INTV
evaluations NNS I-INTV
, , I-INTV
the DT I-INTV
drug NN I-INTV
was VBD I-INTV
tapered VBN I-INTV
down RB I-INTV
over RB I-INTV
2 CD I-INTV
weeks NNS I-INTV
. . O

The DT B-INTV
trial NN I-INTV
ended VBD I-INTV
with IN I-INTV
a DT I-INTV
4-week JJ I-INTV
drug-free JJ I-INTV
period NN I-INTV
. . O

Outcome NNP O
measures VBZ O
included VBD O
improvements NNS B-OC
in IN I-OC
severity NN I-OC
and CC I-OC
behavioral JJ I-OC
features NNS I-OC
of IN I-OC
autistic JJ I-OC
disorder NN I-OC
( ( I-OC
stereotypies NNS I-OC
, , I-OC
lethargy NN I-OC
, , I-OC
irritability NN I-OC
, , I-OC
hyperactivity NN I-OC
, , I-OC
emotional JJ I-OC
reciprocity NN I-OC
, , I-OC
sharing VBG I-OC
pleasures NNS I-OC
) ) I-OC
and CC I-OC
improvements NNS I-OC
in IN I-OC
language NN I-OC
and CC I-OC
communication NN I-OC
, , I-OC
socialization NN I-OC
, , I-OC
and CC I-OC
daily RB I-OC
living VBG I-OC
skills NNS I-OC
noted VBD O
after IN O
12 CD O
weeks NNS O
( ( O
the DT O
end NN O
of IN O
a DT O
4-week JJ O
maintenance NN O
phase NN O
) ) O
. . O

We PRP O
did VBD O
not RB O
find VB O
any DT O
significant JJ O
differences NNS O
in IN O
improvements NNS O
between IN O
lamotrigine NN B-INTV
or CC I-INTV
placebo NN I-INTV
groups NNS O
on IN O
the DT O
Autism NNP B-OC
Behavior NNP I-OC
Checklist NNP I-OC
, , I-OC
the DT I-OC
Aberrant NNP I-OC
Behavior NNP I-OC
Checklist NNP I-OC
, , I-OC
the DT I-OC
Vineland NNP I-OC
Adaptive NNP I-OC
Behavior NNP I-OC
scales NNS I-OC
, , I-OC
the DT I-OC
PL-ADOS NNP I-OC
, , I-OC
or CC I-OC
the DT I-OC
CARS NNPS I-OC
. . O

Parent NN B-OC
rating NN I-OC
scales NNS I-OC
showed VBD O
marked JJ O
improvements NNS O
, , O
presumably RB O
due JJ O
to TO O
expectations NNS O
of IN O
benefits NNS O
. . O

-DOCSTART- -X- O O

Children NNP B-POPU
's POS I-POPU
attitudes NNS I-POPU
and CC I-POPU
behavioral JJ I-POPU
intentions NNS I-POPU
toward IN I-POPU
a DT I-POPU
peer NN I-POPU
with IN I-POPU
autistic JJ I-POPU
behaviors NNS I-POPU
: : I-POPU
does VBZ O
a DT O
brief JJ O
educational JJ B-INTV
intervention NN I-INTV
have VBP O
an DT O
effect NN O
? . O
This DT O
study NN O
examined VBD O
children NNS B-POPU
's POS I-POPU
ratings NNS I-POPU
of IN I-POPU
attitudes NNS I-POPU
and CC I-POPU
behavioral JJ I-POPU
intentions NNS I-POPU
toward IN I-POPU
a DT I-POPU
peer NN I-POPU
presented VBN I-POPU
with IN I-POPU
or CC I-POPU
without IN I-POPU
autistic JJ I-POPU
behaviors NNS I-POPU
. . O

The DT O
impact NN O
of IN O
information NN O
about IN O
autism NN O
on IN O
these DT O
ratings NNS O
was VBD O
investigated VBN O
as RB O
well RB O
as IN O
age NN O
and CC O
gender NN O
effects NNS O
. . O

Third- CD B-POPU
and CC I-POPU
sixth-grade JJ I-POPU
children NNS I-POPU
( ( I-POPU
N NNP I-POPU
= NNP I-POPU
233 CD I-POPU
) ) I-POPU
were VBD O
randomly RB O
assigned VBN O
to TO O
view VB B-INTV
a DT I-INTV
video NN I-INTV
of IN I-INTV
the DT I-INTV
same JJ I-INTV
boy NN I-INTV
in IN I-INTV
one CD I-INTV
of IN I-INTV
three CD I-INTV
conditions NNS I-INTV
: : I-INTV
No DT I-INTV
Autism NNP I-INTV
, , I-INTV
Autism NNP I-INTV
, , I-INTV
or CC I-INTV
Autism/Information NNP I-INTV
. . O

Children NNP O
at IN O
both DT O
grade NN O
levels NNS O
showed VBD O
less RBR B-OC
positive JJ I-OC
attitudes NNS I-OC
toward IN O
the DT O
child NN O
in IN O
the DT O
two CD O
autism NN O
conditions NNS O
. . O

In IN O
rating NN O
their PRP$ O
own JJ O
behavioral JJ B-OC
intentions NNS I-OC
, , O
children NNS O
showed VBD O
no DT O
differences NNS O
between IN O
conditions NNS O
. . O

However RB O
, , O
in IN O
attributing VBG O
intentions NNS O
to TO O
their PRP$ O
classmates NNS O
, , O
older JJR O
children NNS O
and CC O
girls NNS O
gave VBD O
lower JJR B-OC
ratings NNS I-OC
to TO O
the DT O
child NN O
in IN O
the DT O
autism NN O
conditions NNS O
. . O

Information NN O
about IN O
autism NN O
did VBD O
not RB O
affect JJ O
ratings NNS O
of IN O
either DT O
attitudes NNS B-OC
or CC I-OC
behavioral JJ I-OC
intentions NNS I-OC
as IN O
ascribed NN O
to TO O
self VB O
or CC O
others NNS O
. . O

-DOCSTART- -X- O O

Famotidine NNP B-INTV
treatment NN O
of IN O
children NNS B-POPU
with IN I-POPU
autistic JJ I-POPU
spectrum NN I-POPU
disorders NNS I-POPU
: : I-POPU
pilot NN O
research NN O
using VBG O
single JJ O
subject JJ O
research NN O
design NN O
. . O

Using VBG O
single JJ O
subject JJ O
research NN O
design NN O
, , O
we PRP O
performed VBD O
pilot JJ O
research NN O
to TO O
evaluate VB O
the DT O
safety NN O
and CC O
efficacy NN O
of IN O
famotidine NN B-INTV
for IN O
the DT O
treatment NN O
of IN O
children NNS B-POPU
with IN I-POPU
autistic JJ I-POPU
spectrum NN I-POPU
disorders NNS I-POPU
. . O

We PRP O
studied VBD O
9 CD B-POPU
Caucasian JJ I-POPU
boys NNS I-POPU
, , I-POPU
3.8-8.1 CD I-POPU
years NNS I-POPU
old JJ I-POPU
, , I-POPU
with IN I-POPU
a DT I-POPU
DSM-IV JJ I-POPU
diagnosis NN I-POPU
of IN I-POPU
a DT I-POPU
pervasive JJ I-POPU
developmental NN I-POPU
disorder NN I-POPU
, , I-POPU
living VBG I-POPU
with IN I-POPU
their PRP$ I-POPU
families NNS I-POPU
, , I-POPU
receiving VBG I-POPU
no DT I-POPU
chronic JJ I-POPU
medications NNS I-POPU
, , I-POPU
and CC I-POPU
without IN I-POPU
significant JJ I-POPU
gastrointestinal JJ I-POPU
symptoms NNS I-POPU
. . O

The DT O
dose NN O
of IN O
oral JJ B-INTV
famotidine NN I-INTV
was VBD I-INTV
2 CD I-INTV
mg/kg/day NN I-INTV
( ( I-INTV
given VBN I-INTV
in IN I-INTV
two CD I-INTV
divided JJ I-INTV
doses NNS I-INTV
) ) I-INTV
; : I-INTV
the DT I-INTV
maximum JJ I-INTV
total JJ I-INTV
daily JJ I-INTV
dose NN I-INTV
was VBD I-INTV
100 CD I-INTV
mg NN I-INTV
. . O

Using VBG O
single-subject JJ O
research NN O
analysis NN O
and CC O
medication NN O
given VBN O
in IN O
a DT O
randomized JJ O
, , O
double-blind JJ O
, , O
placebo-controlled JJ O
, , O
cross-over JJ O
design NN O
, , O
4 CD O
of IN O
9 CD O
children NNS O
randomized VBN O
( ( O
44 CD O
% NN O
) ) O
had VBD O
evidence NN O
of IN O
behavioral JJ B-OC
improvement NN I-OC
. . O

Primary JJ O
efficacy NN O
was VBD O
based VBN O
on IN O
data NNS O
kept VBN O
by IN O
primary JJ O
caregivers NNS O
, , O
including VBG O
a DT O
daily JJ B-OC
diary NN I-OC
; : I-OC
daily JJ I-OC
visual JJ I-OC
analogue NN I-OC
scales NNS I-OC
of IN I-OC
affection NN I-OC
, , I-OC
reciting VBG I-OC
, , I-OC
or CC I-OC
aspects NNS I-OC
of IN I-OC
social JJ I-OC
interaction NN I-OC
; : I-OC
Aberrant NNP I-OC
Behavior NNP I-OC
Checklists NNP I-OC
( ( I-OC
ABC NNP I-OC
, , I-OC
Aman NNP I-OC
) ) I-OC
; : I-OC
and CC I-OC
Clinical NNP I-OC
Global NNP I-OC
Improvement NNP I-OC
scales NNS I-OC
. . O

Children NNP B-POPU
with IN I-POPU
marked VBN I-POPU
stereotypy NN I-POPU
( ( I-POPU
meaningless NN I-POPU
, , I-POPU
repetitive JJ I-POPU
behaviors NNS I-POPU
) ) I-POPU
did VBD O
not RB O
respond VB O
. . O

Our PRP$ B-POPU
subjects NNS I-POPU
did VBD I-POPU
not RB I-POPU
have VB I-POPU
prominent JJ I-POPU
gastrointestinal JJ I-POPU
symptoms NNS I-POPU
and CC O
endoscopy NN O
was VBD O
not RB O
part NN O
of IN O
our PRP$ O
protocol NN O
; : O
thus RB O
, , O
we PRP O
can MD O
not RB O
exclude VB O
the DT O
possibility NN O
that IN O
our PRP$ O
subjects NNS O
improved VBN O
due JJ O
to TO O
the DT O
effective JJ O
treatment NN O
of IN O
asymptomatic JJ O
esophagitis NN O
. . O

The DT O
use NN O
of IN O
famotidine NN B-INTV
for IN O
the DT O
treatment NN O
of IN O
children NNS B-POPU
with IN I-POPU
autistic JJ I-POPU
spectrum NN I-POPU
disorders NNS I-POPU
warrants NNS O
further JJ O
investigation NN O
. . O

-DOCSTART- -X- O O

Clomipramine NNP B-INTV
versus NN I-INTV
haloperidol NN I-INTV
in IN O
the DT O
treatment NN O
of IN O
autistic JJ B-POPU
disorder NN I-POPU
: : I-POPU
a DT O
double-blind NN O
, , O
placebo-controlled JJ B-INTV
, , O
crossover NN O
study NN O
. . O

Clomipramine NNP B-INTV
, , I-INTV
haloperidol NN I-INTV
, , I-INTV
and CC I-INTV
placebo NN I-INTV
were VBD O
compared VBN O
with IN O
baseline NN O
in IN O
the DT O
treatment NN O
of IN O
autism NN B-POPU
, , O
and CC O
overall JJ B-OC
outcome NN I-OC
, , I-OC
specific JJ I-OC
symptoms NNS I-OC
, , I-OC
and CC I-OC
side JJ I-OC
effects NNS I-OC
were VBD O
examined VBN O
. . O

It PRP O
was VBD O
hypothesized VBN O
that IN O
clomipramine NN B-INTV
would MD O
be VB O
better RB O
tolerated VBN O
than IN O
haloperidol NN B-INTV
and CC O
prove VB O
superior JJ O
on IN O
a DT O
measure NN O
of IN O
stereotypy NN O
. . O

Individuals NNS B-POPU
with IN I-POPU
a DT I-POPU
DSM-IV JJ I-POPU
diagnosis NN I-POPU
of IN I-POPU
autistic JJ I-POPU
disorder NN I-POPU
( ( I-POPU
mean JJ I-POPU
age NN I-POPU
, , I-POPU
16.3 CD I-POPU
years NNS I-POPU
; : I-POPU
range NN I-POPU
, , I-POPU
10-36 JJ I-POPU
years NNS I-POPU
) ) I-POPU
were VBD I-POPU
randomly RB I-POPU
assigned VBN I-POPU
, , I-POPU
by IN I-POPU
using VBG I-POPU
a DT I-POPU
Latin NNP I-POPU
square NN I-POPU
design NN I-POPU
, , I-POPU
to TO I-POPU
the DT I-POPU
following JJ I-POPU
7-week JJ I-POPU
trials NNS I-POPU
: : I-POPU
placebo NN I-POPU
, , I-POPU
clomipramine NN I-POPU
( ( I-POPU
mean JJ I-POPU
daily RB I-POPU
dose RB I-POPU
, , I-POPU
128.4 CD I-POPU
mg NN I-POPU
; : I-POPU
range NN I-POPU
, , I-POPU
100-150 JJ I-POPU
mg NN I-POPU
) ) I-POPU
, , I-POPU
or CC I-POPU
haloperidol NN I-POPU
( ( I-POPU
mean JJ I-POPU
daily RB I-POPU
dose RB I-POPU
, , I-POPU
1.3 CD I-POPU
mg NN I-POPU
; : I-POPU
range NN I-POPU
, , I-POPU
1-1.5 JJ I-POPU
mg NN I-POPU
) ) I-POPU
. . O

Data NNP B-POPU
on IN I-POPU
36 CD I-POPU
subjects NNS I-POPU
were VBD I-POPU
analyzed VBN I-POPU
and CC O
taken VBN O
together RB O
; : O
the DT O
results NNS O
favored VBD O
haloperidol NN B-INTV
. . O

In IN O
those DT O
patients NNS O
who WP O
were VBD O
able JJ O
to TO O
complete VB O
a DT O
full JJ O
therapeutic JJ O
trial NN O
, , O
clomipramine NN B-INTV
proved VBD O
comparable JJ O
to TO O
haloperidol VB B-INTV
in IN O
terms NNS O
of IN O
improvement NN B-OC
compared VBN O
with IN O
baseline NN O
. . O

However RB O
, , O
significantly RB O
fewer JJR O
individuals NNS O
receiving VBG O
clomipramine NN B-INTV
versus NN O
haloperidol NN B-INTV
were VBD O
able JJ O
to TO O
complete VB O
the DT O
trial NN O
( ( O
37.5 CD O
% NN O
vs. FW O
69.7 CD O
% NN O
, , O
respectively RB O
) ) O
for IN O
reasons NNS O
related VBN O
to TO O
both DT O
side NN B-OC
effects NNS I-OC
and CC I-OC
efficacy NN I-OC
or CC I-OC
behavior NN I-OC
problems NNS I-OC
. . O

In IN O
the DT O
intent-to-treat JJ O
sample NN O
, , O
which WDT O
is VBZ O
perhaps RB O
more RBR O
clinically RB O
relevant JJ O
, , O
only RB O
haloperidol VBZ B-INTV
proved VBN O
superior JJ O
to TO O
baseline VB O
on IN O
a DT O
global JJ O
measure NN O
of IN O
autistic JJ B-OC
symptom NN I-OC
severity NN I-OC
, , O
as RB O
well RB O
as IN O
specific JJ O
measures NNS O
for IN O
irritability NN B-OC
and CC I-OC
hyperactivity NN I-OC
. . O

Clomipramine NNP B-INTV
did VBD O
not RB O
seem VB O
more RBR O
effective JJ O
on IN O
a DT O
measure NN O
of IN O
stereotypy NN O
, , O
nor CC O
was VBD O
it PRP O
better RBR O
tolerated VBN O
. . O

-DOCSTART- -X- O O

Olanzapine NNP B-INTV
versus NN I-INTV
haloperidol NN I-INTV
in IN O
children NNS B-POPU
with IN I-POPU
autistic JJ I-POPU
disorder NN I-POPU
: : I-POPU
an DT O
open JJ O
pilot NN O
study NN O
. . O

OBJECTIVES NNP O
Conventional NNP O
neuroleptics NNS B-INTV
ameliorate VBP O
symptoms NNS O
in IN O
children NNS B-POPU
with IN I-POPU
autistic JJ I-POPU
disorder NN I-POPU
; : I-POPU
however RB O
, , O
they PRP O
are VBP O
known VBN O
to TO O
cause VB O
dyskinesias NN O
. . O

Atypical JJ B-INTV
neuroleptics NNS I-INTV
, , O
including VBG O
olanzapine NN O
, , O
may MD O
have VB O
less JJR O
risk NN O
for IN O
dyskinesia NN O
, , O
but CC O
their PRP$ O
efficacy NN O
in IN O
autistic JJ O
disorder NN O
is VBZ O
not RB O
established VBN O
. . O

This DT O
study NN O
was VBD O
designed VBN O
to TO O
investigate VB O
the DT O
safety NN O
and CC O
effectiveness NN O
of IN O
open-label JJ O
olanzapine NN B-INTV
as IN O
a DT O
treatment NN O
for IN O
children NNS B-POPU
with IN I-POPU
autistic JJ I-POPU
disorder NN I-POPU
by IN O
using VBG O
haloperidol NN B-INTV
as IN O
a DT O
standard JJ O
comparator NN O
treatment NN O
. . O

METHOD NNP O
In IN O
a DT O
parallel JJ B-POPU
groups NNS I-POPU
design NN I-POPU
, , I-POPU
12 CD I-POPU
children NNS I-POPU
with IN I-POPU
DSM-IV NNP I-POPU
autistic JJ I-POPU
disorder NN I-POPU
( ( I-POPU
mean JJ I-POPU
age NN I-POPU
7.8+/-2.1 CD I-POPU
years NNS I-POPU
) ) I-POPU
were VBD I-POPU
randomized VBN I-POPU
to TO O
6 CD O
weeks NNS O
of IN O
open JJ B-INTV
treatment NN I-INTV
with IN I-INTV
olanzapine NN I-INTV
or CC I-INTV
haloperidol NN I-INTV
. . O

Mean NNP O
final JJ O
dosages NNS O
were VBD O
7.9+/-2.5 JJ O
mg/day NN O
for IN O
olanzapine NN B-INTV
and CC O
1.4+/-0.7 JJ O
mg/day NN O
for IN O
haloperidol NN B-INTV
. . O

Outcome NNP O
measures NNS O
included VBD O
the DT O
Clinical NNP B-OC
Global NNP I-OC
Impressions NNP I-OC
( ( I-OC
CGI NNP I-OC
) ) I-OC
and CC I-OC
the DT I-OC
Children NNP I-OC
's POS I-OC
Psychiatric NNP I-OC
Rating NNP I-OC
Scale NNP I-OC
( ( I-OC
CPRS NNP I-OC
) ) I-OC
. . O

RESULTS NNP O
Both NNP O
groups NNS O
had VBD O
symptom VBN B-OC
reduction NN I-OC
. . O

Five CD O
of IN O
six CD O
in IN O
the DT O
olanzapine NN B-INTV
group NN O
and CC O
three CD O
of IN O
six CD O
in IN O
the DT O
haloperidol NN B-INTV
group NN O
were VBD O
rated VBN O
as IN O
responders NNS O
according VBG O
to TO O
the DT O
CGI NNP B-OC
Improvement NNP O
item NN O
. . O

Subjects NNS O
showed VBD O
improvement NN O
on IN O
the DT O
CPRS NNP B-OC
Autism NNP I-OC
Factor NNP I-OC
( ( O
F1,9 NNP O
= NNP O
24.4 CD O
, , O
p NN O
= NNP O
.0008 NNP O
) ) O
. . O

Side JJ O
effects NNS O
included VBD O
drowsiness NN B-OC
and CC I-OC
weight JJ I-OC
gain NN I-OC
. . O

CONCLUSIONS VB O
The DT O
findings NNS O
suggest VBP O
that IN O
olanzapine NN B-INTV
is VBZ O
a DT O
promising JJ O
treatment NN B-OC
for IN O
children NNS B-POPU
with IN I-POPU
autistic JJ I-POPU
disorder NN I-POPU
. . O

Further JJ O
placebo-controlled JJ O
and CC O
long-term JJ O
studies NNS O
of IN O
olanzapine NN B-INTV
in IN O
autistic JJ O
disorder NN O
are VBP O
required VBN O
. . O

-DOCSTART- -X- O O

Multisite NNP O
, , O
double-blind NN O
, , O
placebo-controlled JJ B-INTV
trial NN O
of IN O
porcine NN B-INTV
secretin NN I-INTV
in IN O
autism NN B-POPU
. . O

OBJECTIVE UH O
To TO O
examine VB O
the DT O
efficacy NN B-OC
of IN O
intravenous JJ O
porcine NN B-INTV
secretin NN I-INTV
for IN O
the DT O
treatment NN B-OC
of IN O
autistic JJ B-POPU
disorder NN I-POPU
. . O

METHOD NNP O
Randomized NNP O
, , O
double-blind NN O
, , O
placebo-controlled JJ B-INTV
, , O
crossover JJ O
design NN O
. . O

Fifty-six JJ B-POPU
subjects NNS I-POPU
with IN I-POPU
autistic JJ I-POPU
disorder NN I-POPU
received VBD O
either CC O
a DT O
secretin NN B-INTV
or CC I-INTV
placebo NN I-INTV
infusion NN I-INTV
at IN O
baseline NN O
and CC O
the DT O
other JJ O
substance NN O
at IN O
week NN O
4 CD O
. . O

Subjects NNS O
were VBD O
given VBN O
the DT O
Autism NNP B-OC
Diagnostic NNP I-OC
Observation NNP I-OC
Schedule NNP I-OC
( ( I-OC
ADOS NNP I-OC
) ) I-OC
and CC O
other JJ O
pertinent JJ B-OC
developmental JJ I-OC
measures NNS I-OC
at IN O
baseline NN O
and CC O
at IN O
weeks NNS O
4 CD O
and CC O
8 CD O
to TO O
assess VB O
drug NN O
effects NNS O
. . O

RESULTS NNP O
For IN O
the DT O
primary JJ O
efficacy NN O
analysis NN O
, , O
change NN O
of IN O
ADOS NNP B-OC
social-communication NN I-OC
total JJ I-OC
score NN I-OC
from IN O
week NN O
0 CD O
to TO O
week NN O
4 CD O
, , O
no DT O
statistically RB O
significant JJ O
difference NN O
was VBD O
obtained VBN O
between IN O
placebo NN B-INTV
( ( O
-0.8 JJ O
+/- JJ O
2.9 CD O
) ) O
and CC O
secretin JJ B-INTV
groups NNS O
( ( O
-0.6 JJ O
+/- JJ O
1.4 CD O
; : O
t54 NN O
= VBZ O
0.346 CD O
, , O
p NN O
< NNP O
.73 NNP O
) ) O
. . O

The DT O
other JJ O
measures NNS O
showed VBD O
no DT O
treatment NN B-OC
effect NN I-OC
for IN O
secretin NN B-INTV
compared VBN O
with IN O
placebo NN B-INTV
. . O

CONCLUSION NNP O
There EX O
was VBD O
no DT O
evidence NN O
for IN O
efficacy NN B-OC
of IN O
secretin NN O
in IN O
this DT O
randomized JJ O
, , O
placebo-controlled JJ O
, , O
double-blind JJ O
trial NN O
. . O

-DOCSTART- -X- O O

Evaluation NN O
of IN O
a DT O
new JJ B-INTV
computer NN I-INTV
intervention NN I-INTV
to TO O
teach VB O
people NNS B-POPU
with IN I-POPU
autism NN I-POPU
or CC I-POPU
Asperger NNP I-POPU
syndrome VBP I-POPU
to TO O
recognize VB O
and CC O
predict VB O
emotions NNS O
in IN O
others NNS O
. . O

This DT O
randomized VBD O
controlled JJ O
trial NN O
looked VBD O
at IN O
the DT O
effect NN O
of IN O
a DT O
new JJ B-INTV
computer NN I-INTV
program NN I-INTV
designed VBN O
to TO O
teach VB O
people NNS B-POPU
with IN I-POPU
autistic JJ I-POPU
spectrum NN I-POPU
disorders NNS I-POPU
to TO O
better JJR O
recognize VB O
and CC O
predict VBP O
emotional JJ O
responses NNS O
in IN O
others NNS O
. . O

Two CD B-POPU
groups NNS I-POPU
of IN I-POPU
11 CD I-POPU
children NNS I-POPU
( ( I-POPU
age NN I-POPU
12-18 CD I-POPU
) ) I-POPU
with IN I-POPU
autism NN I-POPU
or CC I-POPU
Asperger NNP I-POPU
syndrome VBP I-POPU
at IN I-POPU
two CD I-POPU
special JJ I-POPU
schools NNS I-POPU
participated VBD I-POPU
: : I-POPU
one CD B-INTV
group NN I-INTV
used VBD I-INTV
the DT I-INTV
computer NN I-INTV
program NN I-INTV
for IN I-INTV
10 CD I-INTV
half-hour JJ I-INTV
sessions NNS I-INTV
over IN I-INTV
2 CD I-INTV
weeks NNS I-INTV
. . O

Within-program NNP O
data NN O
showed VBD O
a DT O
significant JJ O
reduction NN O
in IN O
errors NNS O
made VBN O
from IN O
first JJ O
to TO O
last JJ O
use NN O
. . O

Students NNS O
were VBD O
assessed VBN O
pre- JJ O
and CC O
post-intervention NN O
using VBG O
facial JJ B-OC
expression NN I-OC
photographs NN I-OC
, , I-OC
cartoons NNS I-OC
depicting VBG I-OC
emotion-laden JJ I-OC
situations NNS I-OC
, , I-OC
and CC I-OC
non-literal JJ I-OC
stories NNS I-OC
. . O

Scores NNS O
were VBD O
not RB O
related VBN O
to TO O
age NN O
or CC O
verbal JJ O
ability NN O
. . O

The DT O
experimental JJ O
group NN O
made VBD O
gains NNS O
relative JJ O
to TO O
the DT O
control NN O
group NN O
on IN O
all DT O
three CD O
measures NNS O
. . O

Gains NNP O
correlated VBD O
significantly RB O
with IN O
the DT O
number NN O
of IN O
times NNS O
the DT O
computer NN B-INTV
program NN I-INTV
was VBD O
used VBN O
and CC O
results NNS O
suggest VBP O
positive JJ O
effects NNS O
. . O

Further NNP O
research NN O
could MD O
assess VB O
whether IN O
these DT O
gains NNS O
generalized VBD O
into IN O
real JJ O
life NN O
or CC O
improved VBN O
performance NN O
on IN O
theory NN O
of IN O
mind NN O
measures NNS O
. . O

-DOCSTART- -X- O O

A DT O
double-blind JJ O
, , O
placebo-controlled JJ B-INTV
crossover NN O
study NN O
investigating VBG O
the DT O
effect NN O
of IN O
porcine NN B-INTV
secretin NN I-INTV
in IN O
children NNS B-POPU
with IN I-POPU
autism NN I-POPU
. . O

OBJECTIVES CC O
A DT O
recent JJ O
patient NN O
series NN O
reported VBD O
the DT O
incidental JJ O
findings NNS O
of IN O
improved VBN O
social JJ O
and CC O
language NN O
skills NNS O
in IN O
3 CD B-POPU
children NNS I-POPU
with IN I-POPU
autistic JJ I-POPU
spectrum NN I-POPU
disorders NNS I-POPU
after IN I-POPU
the DT I-POPU
administration NN I-POPU
of IN I-POPU
secretin NN I-POPU
, , I-POPU
a DT I-POPU
peptide NN I-POPU
hormone NN I-POPU
. . O

However RB O
, , O
a DT O
subsequent JJ O
study NN O
did VBD O
not RB O
find VB O
evidence NN O
for IN O
a DT O
drug NN O
effect NN O
. . O

Parents NNS O
are VBP O
seeking VBG O
treatment NN O
with IN O
secretin JJ B-INTV
despite IN O
the DT O
absence NN O
of IN O
empirical JJ O
investigations NNS O
demonstrating VBG O
amelioration NN O
in IN O
autism NN O
symptomology NN O
. . O

In IN O
order NN O
to TO O
more RBR O
precisely RB O
measure VB O
the DT O
effects NNS O
of IN O
secretin NN B-INTV
, , O
this DT O
study NN O
investigated VBD O
the DT O
effect NN O
of IN O
a DT O
single JJ O
intravenous JJ B-INTV
dose NN I-INTV
of IN I-INTV
porcine NN I-INTV
secretin NN I-INTV
on IN O
12 CD B-POPU
autistic JJ I-POPU
children NNS I-POPU
through IN O
a DT O
randomized VBN O
, , O
double-blind JJ O
, , O
placebo-controlled JJ B-INTV
, , O
crossover NN O
study NN O
. . O

Children NNP O
were VBD O
assessed VBN O
on IN O
objective JJ B-OC
language NN I-OC
and CC I-OC
on IN I-OC
social JJ I-OC
, , I-OC
neuropsychological JJ I-OC
, , I-OC
and CC I-OC
gastrointestinal JJ I-OC
measures NNS I-OC
to TO O
evaluate VB O
drug NN O
effects NNS O
. . O

The DT O
study NN O
was VBD O
conducted VBN O
over IN O
a DT O
16-week JJ O
trial NN O
. . O

The DT O
results NNS O
indicated VBD O
that IN O
significant JJ O
differences NNS O
were VBD O
not RB O
observed VBN O
on IN O
the DT O
majority NN O
of IN O
the DT O
dependent JJ O
variables NNS O
. . O

Statistically NNP O
significant JJ O
differences NNS O
were VBD O
observed VBN O
on IN O
measures NNS B-OC
of IN I-OC
positive JJ I-OC
affect NN I-OC
and CC I-OC
activity NN I-OC
level NN I-OC
following VBG O
secretin JJ B-INTV
infusion NN O
. . O

In IN O
general JJ O
, , O
the DT O
autistic JJ B-POPU
children NNS I-POPU
did VBD O
not RB O
demonstrate VB O
the DT O
improvements NNS O
described VBN O
in IN O
the DT O
initial JJ O
retrospective JJ O
report NN O
. . O

-DOCSTART- -X- O O

Methodological JJ O
issues NNS O
in IN O
designing VBG O
a DT O
multisite JJ O
trial NN O
of IN O
risperidone NN B-INTV
in IN O
children NNS B-POPU
and CC I-POPU
adolescents NNS I-POPU
with IN I-POPU
autism NN I-POPU
. . O

OBJECTIVE UH O
To TO O
describe VB O
the DT O
methodological JJ O
challenges NNS O
and CC O
decisions NNS O
made VBN O
in IN O
developing VBG O
a DT O
multisite NN O
, , O
controlled VBD O
study NN O
of IN O
risperidone NN B-INTV
in IN O
children NNS B-POPU
and CC I-POPU
adolescents NNS I-POPU
with IN I-POPU
autism NN I-POPU
. . O

METHODS NNP O
Review NNP O
the DT O
design NN O
considerations NNS O
for IN O
clinical JJ O
trials NNS O
in IN O
children NNS B-POPU
with IN I-POPU
autistic JJ I-POPU
disorder NN I-POPU
accompanied VBN I-POPU
by IN I-POPU
severe JJ I-POPU
tantrums NNS I-POPU
, , I-POPU
aggressive JJ I-POPU
and/or NN I-POPU
self-injurious JJ I-POPU
behaviors NNS I-POPU
. . O

These DT O
design JJ O
considerations NNS O
include VBP O
the DT O
definition NN O
of IN O
inclusion NN O
criteria NNS O
that WDT O
are VBP O
relevant JJ O
to TO O
clinical JJ O
practice NN O
and CC O
matching VBG O
study NN O
design NN O
to TO O
the DT O
goal NN O
of IN O
evaluating VBG O
short- JJ O
and CC O
long-term JJ O
effects NNS O
. . O

Additional NNP O
ethical JJ O
and CC O
scientific JJ O
issues NNS O
concern NN O
the DT O
length NN O
of IN O
trial NN O
and CC O
sample NN O
size NN O
. . O

RESULTS NNP O
We PRP O
undertook VBD O
a DT O
short-term JJ O
, , O
placebo-controlled JJ B-INTV
study NN O
to TO O
evaluate VB O
the DT O
efficacy NN B-OC
and CC I-OC
safety NN I-OC
of IN O
risperidone NN B-INTV
in IN O
children NNS B-POPU
and CC I-POPU
adolescents NNS I-POPU
with IN I-POPU
autistic JJ I-POPU
disorder NN I-POPU
. . O

This DT O
trial NN O
design NN O
was VBD O
followed VBN O
by IN O
an DT O
extended JJ O
open-label JJ O
maintenance NN O
on IN O
risperidone NN B-INTV
to TO O
confirm VB O
durability NN B-OC
of IN O
treatment NN O
effects NNS O
and CC O
to TO O
monitor VB O
safety NN B-OC
. . O

Finally RB O
, , O
a DT O
placebo-controlled JJ O
discontinuation NN O
study NN O
tested VBD O
the DT O
need NN O
for IN O
continuous JJ O
treatment NN O
. . O

CONCLUSIONS NNP O
In IN O
the DT O
absence NN O
of IN O
standard JJ O
pharmacological JJ O
treatment NN O
for IN O
children NNS O
with IN O
autistic JJ O
disorder NN O
, , O
a DT O
placebo-controlled JJ O
study NN O
remains VBZ O
the DT O
most RBS O
appropriate JJ O
method NN O
of IN O
testing VBG O
efficacy NN O
and CC O
safety NN O
. . O

The DT O
clinical JJ O
relevance NN O
of IN O
this DT O
study NN O
is VBZ O
enhanced VBN O
by IN O
the DT O
addition NN O
of IN O
an DT O
extended JJ O
maintenance NN O
phase NN O
followed VBN O
by IN O
a DT O
placebo NN B-INTV
discontinuation NN O
. . O

-DOCSTART- -X- O O

Brief JJ O
report NN O
: : O
imitation NN B-INTV
effects NNS O
on IN O
children NNS B-POPU
with IN I-POPU
autism NN I-POPU
. . O

Twenty NNP B-POPU
children NNS I-POPU
with IN I-POPU
autism NN I-POPU
( ( I-POPU
mean JJ I-POPU
age NN I-POPU
, , I-POPU
5 CD I-POPU
years NNS I-POPU
) ) I-POPU
were VBD I-POPU
recruited VBN I-POPU
for IN I-POPU
the DT I-POPU
study NN I-POPU
from IN I-POPU
a DT I-POPU
school NN I-POPU
for IN I-POPU
children NNS I-POPU
with IN I-POPU
autism NN I-POPU
. . O

The DT O
children NNS O
were VBD O
randomly RB O
assigned VBN O
to TO O
an DT O
imitation NN B-POPU
( ( I-POPU
n JJ I-POPU
= NNP I-POPU
10 CD I-POPU
) ) I-POPU
or CC I-POPU
contingently RB I-POPU
responsive JJ I-POPU
( ( I-POPU
n JJ I-POPU
= NNP I-POPU
10 CD I-POPU
) ) I-POPU
interaction NN O
group NN O
based VBN O
on IN O
a DT O
stratification NN O
table NN O
for IN O
gender NN O
and CC O
developmental NN O
and CC O
chronological JJ O
age NN O
. . O

The DT O
sessions NNS O
consisted VBD O
of IN O
four CD O
phases NNS O
, , O
with IN O
each DT O
phase NN O
lasting VBG O
3 CD O
minutes NNS O
. . O

In IN O
the DT O
first JJ O
phase NN O
, , O
the DT O
child NN O
walked VBD O
into IN O
a DT O
room NN O
that WDT O
was VBD O
furnished VBN O
with IN O
a DT O
sofa NN O
, , O
a DT O
table NN O
, , O
chairs NNS O
, , O
and CC O
two CD O
sets NNS O
of IN O
identical JJ O
toys NN O
. . O

An DT O
adult NN O
was VBD O
in IN O
the DT O
room NN O
sitting VBG O
very RB O
still RB O
like IN O
a DT O
statue NN O
( ( O
first JJ O
still-face JJ O
condition NN O
) ) O
. . O

In IN O
the DT O
second JJ O
phase NN O
, , O
the DT O
adult NN O
either RB O
imitated VBD O
the DT O
child NN O
or CC O
was VBD O
contingently RB B-INTV
responsive JJ I-INTV
to TO O
the DT O
child NN O
. . O

In IN O
the DT O
third JJ O
phase NN O
, , O
the DT O
adult NN O
sat VBD O
still RB O
again RB O
( ( O
second JJ O
still-face JJ O
condition NN O
) ) O
, , O
and CC O
in IN O
the DT O
fourth JJ O
phase NN O
, , O
the DT O
adult NN O
engaged VBN O
in IN O
a DT O
spontaneous JJ O
interaction NN O
. . O

During IN O
the DT O
third JJ O
phase NN O
( ( O
the DT O
second JJ O
still-face JJ O
condition NN O
) ) O
, , O
the DT O
children NNS O
in IN O
the DT O
imitation NN B-INTV
group NN O
spent VBD B-OC
less JJR I-OC
time NN I-OC
in IN O
gross JJ O
motor NN O
activity NN O
and CC O
more JJR B-OC
time NN I-OC
touching VBG I-OC
the DT I-OC
adult NN I-OC
, , O
as IN O
if IN O
attempting VBG O
to TO O
initiate VB O
an DT O
interaction NN O
. . O

The DT O
contingency NN B-INTV
condition NN O
appeared VBD O
to TO O
be VB O
a DT O
more RBR B-OC
effective JJ I-OC
way NN O
to TO O
facilitate VB O
a DT O
distal JJ B-OC
social JJ I-OC
behavior NN I-OC
( ( I-OC
attention NN I-OC
) ) I-OC
, , O
whereas IN O
the DT O
imitative JJ B-INTV
condition NN O
was VBD O
a DT O
more RBR B-OC
effective JJ I-OC
way NN O
to TO O
facilitate VB O
a DT O
proximal JJ B-OC
social JJ I-OC
behavior NN I-OC
( ( I-OC
touching VBG I-OC
) ) I-OC
. . O

-DOCSTART- -X- O O

Efficacy NN B-OC
of IN O
porcine NN B-INTV
secretin NN I-INTV
in IN O
children NNS B-POPU
with IN I-POPU
autism NN I-POPU
and CC I-POPU
pervasive JJ I-POPU
developmental JJ I-POPU
disorder NN I-POPU
. . O

Secretin NNP B-INTV
, , O
a DT O
gastrointestinal JJ O
( ( O
GI NNP O
) ) O
hormone NN O
, , O
was VBD O
reported VBN O
in IN O
a DT O
preliminary JJ O
study NN O
to TO O
improve VB O
language NN B-OC
and CC I-OC
behavior NN I-OC
in IN O
children NNS B-POPU
with IN I-POPU
autism/pervasive JJ I-POPU
developmental JJ I-POPU
disorder NN I-POPU
( ( I-POPU
PDD NNP I-POPU
) ) I-POPU
and CC I-POPU
chronic JJ I-POPU
diarrhea NN I-POPU
. . O

To TO O
determine VB O
the DT O
efficacy NN O
of IN O
secretin NN B-INTV
, , O
we PRP O
completed VBD O
a DT O
double-blind JJ O
, , O
placebo-controlled JJ B-INTV
, , O
crossover NN O
( ( O
3 CD O
weeks NNS O
) ) O
study NN O
in IN O
children NNS B-POPU
with IN I-POPU
autism/PDD NN I-POPU
and CC I-POPU
various JJ I-POPU
GI NNP I-POPU
conditions NNS I-POPU
using VBG O
a DT O
single JJ O
dose NN O
of IN O
intravenous JJ B-INTV
porcine NN I-INTV
secretin NN I-INTV
. . O

Children NNP B-POPU
with IN I-POPU
chronic NN I-POPU
, , I-POPU
active JJ I-POPU
diarrhea NN I-POPU
showed VBD O
a DT O
reduction NN O
in IN O
aberrant JJ B-OC
behaviors NNS I-OC
when WRB O
treated VBN O
with IN O
the DT O
secretin NN B-INTV
but CC O
not RB O
when WRB O
treated VBN O
with IN O
the DT O
placebo NN B-INTV
. . O

Children NNP B-POPU
with IN I-POPU
no DT I-POPU
GI NNP I-POPU
problems NNS I-POPU
are VBP O
unaffected VBN O
by IN O
either DT O
secretin NN B-INTV
or CC I-INTV
placebo NN I-INTV
. . O

The DT O
improvement NN O
seen VBN O
with IN O
secretin NN B-INTV
in IN O
children NNS B-POPU
with IN I-POPU
autism/PDD NN I-POPU
and CC I-POPU
chronic JJ I-POPU
diarrhea NN I-POPU
suggests VBZ O
that IN O
there EX O
may MD O
be VB O
a DT O
subtype NN O
of IN O
children NNS O
with IN O
autism/PDD NN O
who WP O
respond VBZ O
to TO O
secretin VB B-INTV
. . O

-DOCSTART- -X- O O

Double-blind JJ O
placebo-controlled JJ O
trial NN O
of IN O
secretin NN B-INTV
: : I-INTV
effects NNS O
on IN O
aberrant JJ B-OC
behavior NN I-OC
in IN I-OC
children NNS B-POPU
with IN I-POPU
autism NN I-POPU
. . O

Secretin NNP B-INTV
has VBZ O
been VBN O
proposed VBN O
as IN O
a DT O
treatment NN O
alternative NN O
for IN O
autistic JJ B-POPU
spectrum NN I-POPU
disorders NNS I-POPU
, , O
but CC O
empirical JJ O
support NN O
is VBZ O
lacking VBG O
. . O

A DT O
double-blind JJ O
placebo-controlled JJ O
study NN O
examined VBD O
the DT O
effect NN O
of IN O
a DT O
single JJ O
dose NN O
of IN O
synthetic JJ B-INTV
human JJ I-INTV
secretin NN I-INTV
on IN O
aberrant JJ B-OC
behavior NN I-OC
. . O

Parent NN B-POPU
and CC I-POPU
teacher NN I-POPU
data NNS I-POPU
from IN I-POPU
the DT I-POPU
Aberrant NNP I-POPU
Behavior NNP I-POPU
Checklist NNP I-POPU
for IN O
eight CD B-POPU
male JJ I-POPU
children NNS I-POPU
were VBD O
analyzed VBN O
for IN O
reliable JJ O
change NN O
in IN O
a DT O
clinical JJ O
replication NN O
series NN O
. . O

By IN O
parent NN O
and CC O
teacher NN O
report NN O
, , O
the DT O
majority NN O
of IN O
change NN O
occurred VBD O
either CC O
on IN O
the DT O
placebo NN B-INTV
trial NN O
or CC O
reflected VBN O
deterioration NN O
subsequent NN O
to TO O
secretin VB B-INTV
infusion NN O
. . O

Repeated-measures JJ O
multivariate JJ O
analysis NN O
of IN O
variance NN O
results NNS O
were VBD O
similar JJ O
. . O

Results NNS O
are VBP O
consistent JJ O
with IN O
other JJ O
studies NNS O
, , O
suggesting VBG O
that IN O
secretin NN B-INTV
may MD O
not RB O
be VB O
an DT O
effective JJ O
treatment NN O
option NN O
. . O

-DOCSTART- -X- O O

Multiple JJ O
doses NNS O
of IN O
secretin NN B-INTV
in IN O
the DT O
treatment NN O
of IN O
autism NN B-POPU
: : I-POPU
a DT O
controlled VBN O
study NN O
. . O

UNLABELLED NNP O
Dramatic JJ O
effects NNS O
on IN O
autistic JJ B-OC
behaviour NN I-OC
after IN O
repeated VBN O
injections NNS O
of IN O
the DT O
gastrointestinal JJ O
hormone NN O
secretin NN B-INTV
have VBP O
been VBN O
referred VBN O
in IN O
a DT O
number NN O
of IN O
case NN O
reports NNS O
. . O

In IN O
the DT O
absence NN O
of IN O
curative JJ O
and CC O
effective JJ O
treatments NNS O
for IN O
this DT O
disabling JJ O
condition NN O
, , O
this DT O
information NN O
has VBZ O
created VBN O
new JJ O
hope NN O
among IN O
parents NNS O
. . O

Although IN O
controlled JJ O
studies NNS O
on IN O
the DT O
effect NN O
of IN O
mainly RB O
one CD O
single JJ O
dose NN O
have VBP O
not RB O
documented VBN O
any DT O
effect NN O
, , O
many JJ O
children NNS B-POPU
still RB O
continue VBP O
to TO O
receive VB O
secretin NN B-INTV
. . O

Six NNP B-POPU
children NNS I-POPU
enrolled VBD I-POPU
in IN O
a DT O
double-blind JJ O
, , O
placebo-controlled JJ O
crossover NN O
study NN O
in IN O
which WDT O
each DT O
child NN O
was VBD O
its PRP$ O
own JJ O
control NN O
. . O

Human NNP B-INTV
synthetic JJ I-INTV
secretin NN I-INTV
, , I-INTV
mean VBP I-INTV
dose JJ I-INTV
3.4 CD I-INTV
clinical JJ I-INTV
units NNS I-INTV
, , I-INTV
and CC I-INTV
placebo NN I-INTV
were VBD I-INTV
administered VBN I-INTV
intravenously RB I-INTV
in IN I-INTV
randomized JJ I-INTV
order NN I-INTV
every DT I-INTV
4th CD I-INTV
wk NN I-INTV
, , I-INTV
on IN I-INTV
three CD I-INTV
occasions NNS I-INTV
each DT I-INTV
. . O

The DT O
measurement JJ O
instruments NNS O
were VBD O
the DT O
visual JJ B-OC
analogue NN I-OC
scale NN I-OC
( ( I-OC
VAS NNP I-OC
) ) I-OC
and CC I-OC
the DT I-OC
aberrant JJ I-OC
behaviour NN I-OC
checklist NN I-OC
( ( I-OC
ABC NNP I-OC
) ) I-OC
. . O

Statistically NNP O
significant JJ O
differences NNS O
were VBD O
found VBN O
for IN O
placebo NN O
in IN O
3 CD O
out IN O
of IN O
6 CD O
children NNS B-POPU
and CC O
for IN O
secretin NN B-INTV
in IN O
one CD O
child NN O
, , O
using VBG O
parental JJ B-OC
ratings NNS I-OC
only RB I-OC
( ( I-OC
VAS NNP I-OC
scores VBZ I-OC
) ) I-OC
. . O

Differences NNS O
were VBD O
small JJ O
and CC O
lacked JJ O
clinical JJ O
significance NN O
, , O
which WDT O
was VBD O
in IN O
accordance NN O
with IN O
the DT O
overall JJ O
impression NN O
of IN O
the DT O
parents NNS O
and CC O
teachers NNS O
and CC O
visual JJ O
inspection NN O
of IN O
graphs NN O
. . O

CONCLUSION NN O
In IN O
this DT O
placebo-controlled JJ O
study NN O
, , O
multiple JJ O
doses NNS O
of IN O
secretin NN O
did VBD O
not RB O
produce VB O
any DT O
symptomatic JJ O
improvement NN O
. . O

-DOCSTART- -X- O O

Risperidone NN B-INTV
in IN O
children NNS B-POPU
with IN I-POPU
autism NN I-POPU
and CC I-POPU
serious JJ I-POPU
behavioral JJ I-POPU
problems NNS I-POPU
. . O

BACKGROUND NNP O
Atypical NNP O
antipsychotic JJ O
agents NNS O
, , O
which WDT O
block VBP O
postsynaptic JJ O
dopamine NN O
and CC O
serotonin NN O
receptors NNS O
, , O
have VBP O
advantages NNS O
over IN O
traditional JJ O
antipsychotic JJ O
medications NNS O
in IN O
the DT O
treatment NN O
of IN O
adults NNS O
with IN O
schizophrenia NN O
and CC O
may MD O
be VB O
beneficial JJ O
in IN O
children NNS O
with IN O
autistic JJ O
disorder NN O
who WP O
have VBP O
serious JJ O
behavioral JJ O
disturbances NNS O
. . O

However RB O
, , O
data NNS O
on IN O
the DT O
safety NN O
and CC O
efficacy NN O
of IN O
atypical JJ B-INTV
antipsychotic JJ I-INTV
agents NNS O
in IN O
children NNS O
are VBP O
limited VBN O
. . O

METHODS NNP O
We PRP O
conducted VBD O
a DT O
multisite NN O
, , O
randomized VBN O
, , O
double-blind JJ O
trial NN O
of IN O
risperidone NN B-INTV
as IN O
compared VBN O
with IN O
placebo NN B-INTV
for IN O
the DT O
treatment NN B-POPU
of IN I-POPU
autistic JJ I-POPU
disorder NN I-POPU
accompanied VBN I-POPU
by IN I-POPU
severe JJ I-POPU
tantrums NNS I-POPU
, , I-POPU
aggression NN I-POPU
, , I-POPU
or CC I-POPU
self-injurious JJ I-POPU
behavior NN I-POPU
in IN I-POPU
children NNS I-POPU
5 CD I-POPU
to TO I-POPU
17 CD I-POPU
years NNS I-POPU
old JJ I-POPU
. . O

The DT O
primary JJ O
outcome NN O
measures NNS O
were VBD O
the DT O
score NN O
on IN O
the DT O
Irritability NNP O
subscale NN O
of IN O
the DT O
Aberrant NNP O
Behavior NNP O
Checklist NNP O
and CC O
the DT O
rating NN O
on IN O
the DT O
Clinical NNP O
Global NNP O
Impressions NNP O
- : O
Improvement NN O
( ( O
CGI-I NNP O
) ) O
scale NN O
at IN O
eight CD O
weeks NNS O
. . O

RESULTS VB O
A DT B-POPU
total NN I-POPU
of IN I-POPU
101 CD I-POPU
children NNS I-POPU
( ( I-POPU
82 CD I-POPU
boys NNS I-POPU
and CC I-POPU
19 CD I-POPU
girls NNS I-POPU
; : I-POPU
mean VB I-POPU
[ IN I-POPU
+/-SD JJ I-POPU
] NNP I-POPU
age NN I-POPU
, , I-POPU
8.8+/-2.7 CD I-POPU
years NNS I-POPU
) ) I-POPU
were VBD I-POPU
randomly RB I-POPU
assigned VBN I-POPU
to TO I-POPU
receive VB I-POPU
risperidone NN I-POPU
( ( I-POPU
49 CD I-POPU
children NNS I-POPU
) ) I-POPU
or CC I-POPU
placebo NN I-POPU
( ( I-POPU
52 CD I-POPU
) ) I-POPU
. . O

Treatment NN O
with IN O
risperidone NN B-INTV
for IN O
eight CD O
weeks NNS O
( ( O
dose JJ O
range NN O
, , O
0.5 CD O
to TO O
3.5 CD O
mg NNS O
per IN O
day NN O
) ) O
resulted VBD O
in IN O
a DT O
56.9 CD O
percent NN O
reduction NN O
in IN O
the DT O
Irritability NNP B-OC
score NN I-OC
, , O
as IN O
compared VBN O
with IN O
a DT O
14.1 CD O
percent NN O
decrease NN O
in IN O
the DT O
placebo NN B-INTV
group NN O
( ( O
P NNP O
< NNP O
0.001 CD O
) ) O
. . O

The DT O
rate NN O
of IN O
a DT O
positive JJ O
response NN O
, , O
defined VBD O
as IN O
at IN O
least JJS O
a DT O
25 CD O
percent NN O
decrease NN O
in IN O
the DT O
Irritability NNP B-OC
score NN I-OC
and CC O
a DT O
rating NN O
of IN O
much JJ O
improved VBN O
or CC O
very RB O
much JJ O
improved VBN O
on IN O
the DT O
CGI-I NNP B-OC
scale NN I-OC
, , O
was VBD O
69 CD O
percent NN O
in IN O
the DT O
risperidone NN B-INTV
group NN O
( ( O
34 CD O
of IN O
49 CD O
children NNS O
had VBD O
a DT O
positive JJ O
response NN O
) ) O
and CC O
12 CD O
percent NN O
in IN O
the DT O
placebo NN B-INTV
group NN O
( ( O
6 CD O
of IN O
52 CD O
, , O
P NNP O
< NNP O
0.001 CD O
) ) O
. . O

Risperidone NNP B-INTV
therapy NN O
was VBD O
associated VBN O
with IN O
an DT O
average JJ B-OC
weight JJ I-OC
gain NN I-OC
of IN O
2.7+/-2.9 JJ O
kg NN O
, , O
as IN O
compared VBN O
with IN O
0.8+/-2.2 JJ O
kg NN O
with IN O
placebo NN B-INTV
( ( O
P NNP O
< NNP O
0.001 CD O
) ) O
. . O

Increased VBN O
appetite RB B-OC
, , I-OC
fatigue NN I-OC
, , I-OC
drowsiness NN I-OC
, , I-OC
dizziness NN I-OC
, , I-OC
and CC I-OC
drooling VBG I-OC
were VBD O
more JJR O
common JJ O
in IN O
the DT O
risperidone NN B-INTV
group NN O
than IN O
in IN O
the DT O
placebo NN O
group NN O
( ( O
P NNP O
< VBZ O
0.05 CD O
for IN O
each DT O
comparison NN O
) ) O
. . O

In IN O
two CD O
thirds NNS O
of IN O
the DT O
children NNS O
with IN O
a DT O
positive JJ O
response NN O
to TO O
risperidone VB O
at IN O
eight CD O
weeks NNS O
( ( O
23 CD O
of IN O
34 CD O
) ) O
, , O
the DT O
benefit NN O
was VBD O
maintained VBN O
at IN O
six CD O
months NNS O
. . O

CONCLUSIONS NNP O
Risperidone NNP B-INTV
was VBD O
effective JJ O
and CC O
well RB O
tolerated VBN O
for IN O
the DT O
treatment NN O
of IN O
tantrums NNS O
, , O
aggression NN O
, , O
or CC O
self-injurious JJ O
behavior NN O
in IN O
children NNS B-POPU
with IN I-POPU
autistic JJ I-POPU
disorder NN I-POPU
. . O

The DT O
short JJ O
period NN O
of IN O
this DT O
trial NN O
limits VBZ O
inferences NNS O
about IN O
adverse JJ O
effects NNS O
such JJ O
as IN O
tardive JJ O
dyskinesia NN O
. . O

-DOCSTART- -X- O O

A DT O
randomised VBN O
, , O
controlled VBD O
study NN O
of IN O
dietary JJ B-INTV
intervention NN I-INTV
in IN O
autistic JJ B-POPU
syndromes NNS I-POPU
. . O

Impaired NNP O
social JJ O
interaction NN O
, , O
communication NN O
and CC O
imaginative JJ O
skills NNS O
characterize VBP O
autistic JJ O
syndromes NNS O
. . O

In IN O
these DT O
syndromes NNS O
urinary JJ O
peptide NN O
abnormalities NNS O
, , O
derived VBN O
from IN O
gluten NN O
, , O
gliadin NN O
, , O
and CC O
casein NN O
, , O
are VBP O
reported VBN O
. . O

They PRP O
reflect VBP O
processes NNS O
with IN O
opioid JJ O
effect NN O
. . O

The DT O
aim NN O
of IN O
this DT O
single JJ O
blind NN O
study NN O
was VBD O
to TO O
evaluate VB O
effect NN O
of IN O
gluten NN B-INTV
and CC I-INTV
casein-free JJ I-INTV
diet NN I-INTV
for IN O
children NNS B-POPU
with IN I-POPU
autistic JJ I-POPU
syndromes NNS I-POPU
and CC I-POPU
urinary JJ I-POPU
peptide NN I-POPU
abnormalities NNS I-POPU
. . O

A DT O
randomly RB O
selected VBN O
diet JJ B-POPU
and CC I-POPU
control NN I-POPU
group NN I-POPU
with IN I-POPU
10 CD I-POPU
children NNS I-POPU
in IN I-POPU
each DT I-POPU
group NN I-POPU
participated VBD I-POPU
. . O

Observations NNS B-OC
and CC I-OC
tests NNS I-OC
were VBD O
done VBN O
before RB O
and CC O
after IN O
a DT O
period NN O
of IN O
1 CD O
year NN O
. . O

The DT O
development NN B-OC
for IN O
the DT O
group NN O
of IN O
children NNS O
on IN O
diet NN O
was VBD O
significantly RB O
better JJR O
than IN O
for IN O
the DT O
controls NNS B-INTV
. . O

-DOCSTART- -X- O O

Multimodal NNP O
evaluation NN O
of IN O
risperidone NN B-INTV
for IN O
destructive JJ O
behavior NN O
: : O
functional JJ B-OC
analysis NN I-OC
, , I-OC
direct JJ I-OC
observations NNS I-OC
, , I-OC
rating NN I-OC
scales NNS I-OC
, , I-OC
and CC I-OC
psychiatric JJ I-OC
impressions NNS I-OC
. . O

Risperidone NNP B-INTV
, , O
an DT O
atypical JJ O
neuroleptic NN O
, , O
has VBZ O
become VBN O
a DT O
popular JJ O
option NN O
for IN O
treating VBG O
destructive JJ O
behaviors NNS O
of IN O
persons NNS B-POPU
with IN I-POPU
developmental JJ I-POPU
disabilities NNS I-POPU
. . O

A DT O
few JJ O
studies NNS O
have VBP O
been VBN O
conducted VBN O
that IN O
evaluate VBP O
the DT O
effects NNS O
of IN O
risperidone NN B-INTV
on IN O
destructive JJ O
behavior NN O
; : O
however RB O
, , O
none NN O
of IN O
these DT O
studies NNS O
have VBP O
combined VBN O
objective JJ O
measures NNS O
with IN O
rating NN O
scales NNS O
to TO O
evaluate VB O
the DT O
effects NNS O
of IN O
risperidone NN B-INTV
on IN O
destructive JJ O
behavior NN O
across IN O
home NN O
and CC O
clinical JJ O
settings NNS O
. . O

This DT O
study NN O
evaluated VBD O
the DT O
wide JJ O
range NN O
of IN O
effects NNS O
of IN O
risperidone NN B-INTV
on IN O
destructive JJ O
behavior NN O
of IN O
2 CD B-POPU
persons NNS I-POPU
with IN I-POPU
developmental JJ I-POPU
disabilities NNS I-POPU
using VBG O
weekly JJ O
functional JJ B-OC
analysis NN I-OC
sessions NNS I-OC
, , I-OC
daily JJ I-OC
observations NNS I-OC
, , I-OC
hourly RB I-OC
home NN I-OC
data NNS I-OC
, , I-OC
weekly JJ I-OC
rating NN I-OC
scales NNS I-OC
, , I-OC
and CC I-OC
monthly JJ I-OC
psychiatric JJ I-OC
impressions NNS I-OC
. . O

Results NNS O
indicate VBP O
that IN O
risperidone NN O
does VBZ O
decrease VB O
destructive JJ B-OC
behavior NN I-OC
and CC O
that IN O
, , O
for IN O
the DT O
most JJS O
part NN O
, , O
all DT O
of IN O
the DT O
various JJ O
measures NNS O
yielded VBD O
similar JJ O
results NNS O
. . O

-DOCSTART- -X- O O

A DT O
randomized JJ O
, , O
double-blind JJ O
, , O
placebo-controlled JJ B-INTV
trial NN O
of IN O
porcine NN B-INTV
versus NN O
synthetic JJ B-INTV
secretin NN I-INTV
for IN O
reducing VBG O
symptoms NNS B-OC
of IN I-OC
autism NN B-POPU
. . O

OBJECTIVE UH O
To TO O
compare VB O
the DT O
effects NNS O
of IN O
a DT O
single JJ O
dose NN O
of IN O
biologic NN B-INTV
and CC O
synthetic JJ B-INTV
porcine NN I-INTV
secretin NN I-INTV
to TO O
placebo VB B-INTV
on IN O
a DT O
variety NN O
of IN O
autism NN B-POPU
symptoms NNS O
. . O

METHOD NNP O
Eighty-five JJ B-POPU
children NNS I-POPU
with IN I-POPU
autism NN I-POPU
without IN I-POPU
other JJ I-POPU
medical JJ I-POPU
conditions NNS I-POPU
and CC I-POPU
not RB I-POPU
taking VBG I-POPU
other JJ I-POPU
psychotropic NN I-POPU
medications NNS I-POPU
participated VBD I-POPU
( ( I-POPU
ages NNS I-POPU
between IN I-POPU
3 CD I-POPU
and CC I-POPU
12 CD I-POPU
years NNS I-POPU
, , I-POPU
mean JJ I-POPU
IQ NNP I-POPU
= NNP I-POPU
55 CD I-POPU
) ) I-POPU
. . O

Children NNP O
were VBD O
grouped VBN O
into IN O
trios NNS O
matched VBN O
by IN O
age NN O
and CC O
communication NN O
level NN O
and CC O
then RB O
randomly RB O
assigned VBN O
to TO O
one CD O
of IN O
three CD O
treatment NN O
groups NNS O
: : O
biologic NN B-INTV
secretin NN I-INTV
( ( O
2 CD O
CU/kg NNP O
) ) O
, , O
synthetic JJ B-INTV
secretin NN I-INTV
( ( O
0.4 CD O
microg/kg NN O
) ) O
, , O
and CC O
placebo NN B-INTV
. . O

Measures NNS O
collected VBD O
1 CD O
week NN O
before RB O
and CC O
4 CD O
weeks NNS O
after IN O
infusion NN O
included VBD O
autism NN B-OC
symptoms NNS I-OC
, , I-OC
language NN I-OC
skills NNS I-OC
, , I-OC
and CC I-OC
problem NN I-OC
behaviors NNS I-OC
, , I-OC
gathered VBN I-OC
from IN I-OC
parents NNS I-OC
, , I-OC
teachers NNS I-OC
, , I-OC
and CC I-OC
investigators NNS I-OC
, , O
who WP O
were VBD O
all DT O
blind NNS O
to TO O
treatment NN O
. . O

Two-factor NN O
, , O
repeated-measures JJ O
analyses NNS O
of IN O
variance NN O
( ( O
3 CD O
treatment NN O
levels NNS O
by IN O
2 CD O
repeated JJ O
measures NNS O
, , O
pre- NN O
and CC O
postinfusion NN O
) ) O
were VBD O
used VBN O
to TO O
examine VB O
efficacy NN O
. . O

RESULTS NNP O
Direct JJ O
observation NN O
measures NNS O
did VBD O
not RB O
show VB O
change NN O
over IN O
time NN O
related VBN O
to TO O
secretin VB B-INTV
. . O

Parent NN O
reports NNS O
showed VBD O
an DT O
overall JJ O
reduction NN O
of IN O
symptom JJ B-OC
severity NN I-OC
for IN O
all DT O
treatment NN O
groups NNS O
, , O
including VBG O
the DT O
placebo NN B-INTV
group NN O
. . O

One CD O
teacher-report NN O
measure NN O
showed VBD O
decreases NNS O
in IN O
autism NN O
symptoms NNS O
in IN O
the DT O
placebo NN B-INTV
and CC O
synthetic JJ B-INTV
secretin NN I-INTV
groups NNS O
. . O

CONCLUSIONS NNP O
No NNP O
evidence NN O
that IN O
either DT O
biologic NN B-INTV
or CC O
synthetic JJ B-INTV
secretin NN I-INTV
provided VBD O
amelioration NN O
of IN O
symptoms NNS O
beyond IN O
placebo NN B-INTV
was VBD O
observed VBN O
. . O

This DT O
held VBD O
true JJ O
when WRB O
children NNS B-POPU
with IN I-POPU
and CC I-POPU
without IN I-POPU
gastrointestinal JJ I-POPU
problems NNS I-POPU
were VBD O
examined VBN O
separately RB O
. . O

-DOCSTART- -X- O O

Secretin NNP B-INTV
and CC O
sleep NN O
in IN O
children NNS B-POPU
with IN I-POPU
autism NN I-POPU
. . O

The DT O
objectives NNS O
of IN O
this DT O
pilot NN O
study NN O
were VBD O
1 CD O
) ) O
to TO O
examine VB O
possible JJ O
effects NNS O
of IN O
secretin JJ B-INTV
infusions NNS O
on IN O
sleep-wake JJ O
state NN O
organization NN O
in IN O
children NNS B-POPU
with IN I-POPU
autism NN I-POPU
, , I-POPU
and CC I-POPU
2 CD I-POPU
) ) I-POPU
to TO I-POPU
assess VB I-POPU
the DT I-POPU
feasibility NN I-POPU
of IN I-POPU
home NN I-POPU
recordings NNS I-POPU
using VBG I-POPU
time-lapse JJ I-POPU
videosomnography NN I-POPU
in IN I-POPU
children NNS I-POPU
with IN I-POPU
autism NN I-POPU
. . O

Participants NNS B-POPU
were VBD I-POPU
a DT I-POPU
subset NN I-POPU
of IN I-POPU
subjects NNS I-POPU
from IN I-POPU
two CD I-POPU
double JJ I-POPU
blind NN I-POPU
, , I-POPU
placebo-control NN I-POPU
, , I-POPU
multi-center JJ I-POPU
clinical JJ I-POPU
trials NNS I-POPU
. . O

One CD O
trial NN O
, , O
the DT O
UC NNP O
Irvine NNP O
study NN O
, , O
assessed VBD O
the DT O
effects NNS O
of IN O
porcine NN B-INTV
secretin NN I-INTV
vs. FW I-INTV
saline NN I-INTV
infusions NNS I-INTV
on IN O
children NNS O
's POS O
behavior NN B-OC
, , I-OC
language NN I-OC
and CC O
IQ NNP B-OC
. . O

The DT O
UC NNP O
Davis NNP O
trial NN O
assessed VBD O
the DT O
effects NNS O
of IN O
synthetic JJ B-INTV
human JJ I-INTV
secretin NN I-INTV
vs. FW I-INTV
saline NN I-INTV
infusions NNS I-INTV
on IN O
behavior NN B-OC
, , I-OC
language NN I-OC
and CC O
gastrointestinal JJ B-OC
function NN I-OC
. . O

The DT O
sleep NN O
study NN O
enrolled VBD B-POPU
some DT I-POPU
of IN I-POPU
the DT I-POPU
children NNS I-POPU
from IN I-POPU
each DT I-POPU
of IN I-POPU
the DT I-POPU
two CD I-POPU
trials NNS I-POPU
to TO O
observe VB O
possible JJ O
secretin JJ O
effects NNS O
on IN O
sleep NN O
. . O

To TO O
examine VB O
sleep NN O
, , O
the DT O
UC NNP O
Irvine NNP O
trial NN O
used VBD O
the DT O
Children NNP B-OC
's POS I-OC
Sleep NNP I-OC
Habits NNP I-OC
Questionnaire NNP I-OC
and CC I-OC
daily JJ I-OC
sleep NN I-OC
diaries NNS I-OC
, , O
whereas IN O
the DT O
UC NNP O
Davis NNP O
study NN O
used VBD O
home-recorded JJ B-OC
time-lapse JJ I-OC
videosomnography NN I-OC
. . O

Because IN O
of IN O
the DT O
small JJ O
sample NN O
size NN O
, , O
the DT O
results NNS O
from IN O
both DT O
trials NNS O
are VBP O
preliminary JJ O
. . O

They PRP O
suggest VBP O
that IN O
secretin NN B-INTV
, , I-INTV
porcine NN I-INTV
or CC I-INTV
synthetic JJ I-INTV
, , O
does VBZ O
not RB O
improve VB O
sleep-wake NN B-OC
state NN I-OC
organization NN I-OC
dramatically RB O
. . O

-DOCSTART- -X- O O

Risperidone NNP B-INTV
improves VBZ O
behavior RB B-OC
in IN O
children NNS B-POPU
with IN I-POPU
autism NN I-POPU
. . O

-DOCSTART- -X- O O

Oxytocin NNP B-INTV
infusion NN I-INTV
reduces NNS O
repetitive JJ B-OC
behaviors NNS I-OC
in IN O
adults NNS B-POPU
with IN I-POPU
autistic JJ I-POPU
and CC I-POPU
Asperger NNP I-POPU
's POS I-POPU
disorders NNS I-POPU
. . O

Autism NNP O
is VBZ O
a DT O
neurodevelopmental JJ O
disorder NN O
characterized VBN O
by IN O
dysfunction NN O
in IN O
three CD O
core NN O
behavioral JJ O
domains NNS O
: : O
repetitive JJ B-OC
behaviors NNS I-OC
, , O
social JJ O
deficits NNS O
, , O
and CC O
language NN O
abnormalities NNS O
. . O

There EX O
is VBZ O
evidence NN O
that IN O
abnormalities NNS O
exist VBP O
in IN O
peptide NN O
systems NNS O
, , O
particularly RB O
the DT O
oxytocin NN O
system NN O
, , O
in IN O
autism NN B-POPU
spectrum NN I-POPU
patients NNS I-POPU
. . O

Furthermore NNP O
, , O
oxytocin NN O
and CC O
the DT O
closely RB O
related JJ O
peptide NN O
vasopressin NN O
are VBP O
known VBN O
to TO O
play VB O
a DT O
role NN O
in IN O
social JJ O
and CC O
repetitive JJ O
behaviors NNS O
. . O

This DT O
study NN O
examined VBD O
the DT O
impact NN O
of IN O
oxytocin NN B-INTV
on IN O
repetitive JJ B-OC
behaviors NNS I-OC
in IN O
15 CD B-POPU
adults NNS I-POPU
with IN I-POPU
autism NN I-POPU
or CC I-POPU
Asperger NNP I-POPU
's POS I-POPU
disorder NN I-POPU
via IN O
randomized VBN O
double-blind NN O
oxytocin NN B-INTV
and CC I-INTV
placebo NN I-INTV
challenges NNS O
. . O

The DT O
primary JJ O
outcome NN O
measure NN O
was VBD O
an DT O
instrument NN O
rating NN O
six CD B-OC
repetitive JJ I-OC
behaviors NNS I-OC
: : I-OC
need NN I-OC
to TO I-OC
know VB I-OC
, , I-OC
repeating VBG I-OC
, , I-OC
ordering VBG I-OC
, , I-OC
need NN I-OC
to TO I-OC
tell/ask VB I-OC
, , I-OC
self-injury NN I-OC
, , I-OC
and CC I-OC
touching VBG I-OC
. . O

Patients NNS O
with IN O
autism NN O
spectrum NN O
disorders NNS O
showed VBD O
a DT O
significant JJ O
reduction NN O
in IN O
repetitive JJ B-OC
behaviors NNS I-OC
following VBG O
oxytocin JJ O
infusion NN O
in IN O
comparison NN O
to TO O
placebo VB O
infusion NN O
. . O

Repetitive JJ B-OC
behavior NN I-OC
in IN O
autism NN O
spectrum NN O
disorders NNS O
may MD O
be VB O
related VBN O
to TO O
abnormalities NNS O
in IN O
the DT O
oxytocin NN O
system NN O
, , O
and CC O
may MD O
be VB O
partially RB O
ameliorated VBN O
by IN O
synthetic JJ O
oxytocin NN O
infusion NN O
. . O

-DOCSTART- -X- O O

A DT O
pilot NN O
randomised VBN O
control NN O
trial NN O
of IN O
a DT O
parent NN B-INTV
training NN I-INTV
intervention NN I-INTV
for IN O
pre-school JJ B-POPU
children NNS I-POPU
with IN I-POPU
autism NN I-POPU
. . O

Preliminary JJ O
findings NNS O
and CC O
methodological JJ O
challenges NNS O
. . O

Few JJ O
attempts NNS O
have VBP O
been VBN O
made VBN O
to TO O
conduct VB O
randomised VBN O
control NN O
trials NNS O
( ( O
RCTs NNP O
) ) O
of IN O
interventions NNS O
for IN O
pre-school JJ B-POPU
children NNS I-POPU
with IN I-POPU
autism NN I-POPU
. . O

We PRP O
report VBP O
findings NNS O
of IN O
a DT O
pilot NN O
RCT NNP O
for IN O
a DT O
parent NN B-INTV
training NN I-INTV
intervention NN I-INTV
with IN O
a DT O
focus NN O
on IN O
the DT O
development NN O
of IN O
joint JJ O
attention NN O
skills NNS O
and CC O
joint JJ O
action NN O
routines NNS O
. . O

Twenty-four CD B-POPU
children NNS I-POPU
meeting VBG I-POPU
ICD-10 NNP I-POPU
criteria NNS I-POPU
for IN I-POPU
childhood NN I-POPU
autism NN I-POPU
( ( I-POPU
mean JJ I-POPU
age NN I-POPU
= VBD I-POPU
23 CD I-POPU
months NNS I-POPU
) ) I-POPU
were VBD O
identified VBN O
using VBG O
the DT O
CHAT NNP B-INTV
screen NN I-INTV
and CC I-INTV
randomised VBD I-INTV
to TO I-INTV
the DT I-INTV
parent NN I-INTV
training VBG I-INTV
group NN I-INTV
or CC I-INTV
to TO I-INTV
local JJ I-INTV
services NNS I-INTV
only RB I-INTV
. . O

A DT O
follow-up NN O
was VBD O
conducted VBN O
12 CD O
months NNS O
later RB O
( ( O
mean JJ O
age NN O
= VBD O
35 CD O
months NNS O
) ) O
. . O

There EX O
was VBD O
some DT O
evidence NN O
that IN O
the DT O
parent NN B-POPU
training NN I-POPU
group NN I-POPU
made VBD O
more JJR O
progress NN O
in IN O
language NN B-OC
development NN I-OC
than IN O
the DT O
local JJ O
services NNS O
group NN O
. . O

However RB O
, , O
the DT O
present JJ O
pilot NN O
study NN O
was VBD O
compromised VBN O
by IN O
several JJ O
factors NNS O
: : O
a DT O
reliance NN O
on IN O
parental JJ O
report NN O
to TO O
measure VB O
language NN O
, , O
non-matching NN O
of IN O
the DT O
groups NNS O
on IN O
initial JJ O
IQ NNP O
, , O
and CC O
a DT O
lack NN O
of IN O
systematic JJ O
checking NN O
regarding VBG O
the DT O
implementation NN O
of IN O
the DT O
parent NN O
training NN O
intervention NN O
. . O

Furthermore RB O
, , O
three CD B-POPU
parents NNS I-POPU
in IN I-POPU
the DT I-POPU
local JJ I-POPU
services NNS I-POPU
group NN I-POPU
commenced VBD O
intensive JJ O
, , O
home-based JJ B-INTV
behavioural JJ I-INTV
intervention NN I-INTV
during IN O
the DT O
course NN O
of IN O
the DT O
study NN O
. . O

The DT O
difficulties NNS O
encountered VBN O
in IN O
the DT O
conduct NN O
of IN O
RCTs NNP O
for IN O
pre-school JJ B-POPU
children NNS I-POPU
with IN I-POPU
autism NN I-POPU
are VBP O
discussed VBN O
. . O

Methodological JJ O
challenges NNS O
and CC O
strategies NNS O
for IN O
future JJ O
well-designed JJ O
RCTs NNP O
for IN O
autism NN O
interventions NNS O
are VBP O
highlighted VBN O
. . O

-DOCSTART- -X- O O

Lack NN O
of IN O
benefit NN O
of IN O
intravenous JJ B-INTV
synthetic JJ I-INTV
human NN I-INTV
secretin NN I-INTV
in IN O
the DT O
treatment NN O
of IN O
autism NN B-POPU
. . O

The DT O
objective NN O
of IN O
this DT O
study NN O
was VBD O
to TO O
determine VB O
if IN O
an DT O
intravenous JJ B-INTV
infusion NN I-INTV
of IN I-INTV
synthetic JJ I-INTV
human JJ I-INTV
secretin NN I-INTV
improves VBZ O
language NN B-OC
and CC O
behavioral JJ B-OC
symptoms NNS I-OC
in IN O
children NNS B-POPU
with IN I-POPU
autism NN I-POPU
. . O

Forty-two JJ B-POPU
children NNS I-POPU
with IN I-POPU
the DT I-POPU
diagnosis NN I-POPU
of IN I-POPU
autism NN I-POPU
were VBD O
randomized VBN O
to TO O
one CD O
of IN O
two CD O
groups NNS O
in IN O
this DT O
double-blind JJ O
cross-over JJ O
trial NN O
. . O

One CD O
group NN O
received VBD O
2 CD B-INTV
IU/kg NNP I-INTV
of IN I-INTV
intravenous JJ I-INTV
synthetic JJ I-INTV
human NN I-INTV
secretin NN I-INTV
at IN O
the DT O
first JJ O
visit NN O
, , O
followed VBN O
by IN O
an DT O
equal JJ O
volume NN O
of IN O
intravenous JJ B-INTV
saline NN I-INTV
placebo NN I-INTV
at IN O
week NN O
6 CD O
. . O

The DT O
other JJ O
group NN O
received VBD O
treatments NNS O
in IN O
the DT O
reverse NN O
order NN O
. . O

All DT O
children NNS O
were VBD O
evaluated VBN O
at IN O
weeks NNS O
1 CD O
, , O
3 CD O
, , O
6 CD O
, , O
9 CD O
, , O
and CC O
12 CD O
with IN O
standardized JJ O
assessments NNS B-OC
of IN I-OC
language NN I-OC
, , I-OC
behavior NN I-OC
, , I-OC
and CC I-OC
autism NN I-OC
symptomatology NN I-OC
. . O

There EX O
were VBD O
no DT O
significant JJ O
differences NNS O
in IN O
the DT O
mean JJ B-OC
scores NNS I-OC
on IN I-OC
any DT I-OC
measure NN I-OC
of IN I-OC
language NN I-OC
, , I-OC
behavior NN I-OC
, , I-OC
or CC I-OC
autism NN I-OC
symptom JJ I-OC
severity NN I-OC
after IN O
treatment NN O
with IN O
secretin NN O
compared VBN O
to TO O
treatment NN O
with IN O
placebo NN O
. . O

The DT O
results NNS O
of IN O
this DT O
study NN O
do VBP O
not RB O
support VB O
secretin NN O
as IN O
a DT O
treatment NN O
for IN O
autism NN O
. . O

-DOCSTART- -X- O O

Double-blind NNP O
, , O
placebo-controlled JJ B-INTV
study NN O
of IN O
L-carnosine NNP B-INTV
supplementation NN I-INTV
in IN O
children NNS B-POPU
with IN I-POPU
autistic JJ I-POPU
spectrum NN I-POPU
disorders NNS I-POPU
. . O

L-Carnosine NNP B-INTV
, , I-INTV
a DT I-INTV
dipeptide NN I-INTV
, , O
can MD O
enhance VB O
frontal JJ O
lobe NN O
function NN O
or CC O
be VB O
neuroprotective JJ O
. . O

It PRP O
can MD O
also RB O
correlate VB O
with IN O
gamma-aminobutyric JJ O
acid NN O
( ( O
GABA NNP O
) ) O
-homocarnosine NN O
interaction NN O
, , O
with IN O
possible JJ O
anticonvulsive JJ O
effects NNS O
. . O

We PRP O
investigated VBD O
31 CD B-POPU
children NNS I-POPU
with IN I-POPU
autistic JJ I-POPU
spectrum NN I-POPU
disorders NNS I-POPU
in IN I-POPU
an DT I-POPU
8-week JJ I-POPU
, , I-POPU
double-blinded JJ I-POPU
study NN I-POPU
to TO O
determine VB O
if IN O
800 CD O
mg JJ O
L-carnosine JJ B-INTV
daily NN O
would MD O
result VB O
in IN O
observable JJ O
changes NNS O
versus VBP O
placebo NN B-INTV
. . O

Outcome CC O
measures NNS O
were VBD O
the DT O
Childhood NNP B-OC
Autism NNP I-OC
Rating NNP I-OC
Scale NNP I-OC
, , I-OC
the DT I-OC
Gilliam NNP I-OC
Autism NNP I-OC
Rating NNP I-OC
Scale NNP I-OC
, , I-OC
the DT I-OC
Expressive NNP I-OC
and CC I-OC
Receptive NNP I-OC
One-Word NNP I-OC
Picture NNP I-OC
Vocabulary NNP I-OC
tests NNS I-OC
, , I-OC
and CC I-OC
Clinical NNP I-OC
Global NNP I-OC
Impressions NNP I-OC
of IN I-OC
Change NNP I-OC
. . O

Children NNP O
on IN O
placebo NN B-INTV
did VBD O
not RB O
show VB O
statistically RB O
significant JJ O
changes NNS O
. . O

After IN O
8 CD O
weeks NNS O
on IN O
L-carnosine NNP B-INTV
, , O
children NNS O
showed VBD O
statistically RB O
significant JJ O
improvements NNS O
on IN O
the DT O
Gilliam NNP B-OC
Autism NNP I-OC
Rating NNP I-OC
Scale NNP I-OC
( ( I-OC
total JJ I-OC
score NN I-OC
and CC I-OC
the DT I-OC
Behavior NNP I-OC
, , I-OC
Socialization NNP I-OC
, , I-OC
and CC I-OC
Communication NNP I-OC
subscales NNS I-OC
) ) I-OC
and CC I-OC
the DT I-OC
Receptive JJ I-OC
One-Word NNP I-OC
Picture NNP I-OC
Vocabulary NNP I-OC
test NN I-OC
( ( O
all DT O
P NNP O
< NNP O
.05 NNP O
) ) O
. . O

Improved VBN O
trends NNS O
were VBD O
noted VBN O
on IN O
other JJ O
outcome JJ O
measures NNS O
. . O

Although IN O
the DT O
mechanism NN O
of IN O
action NN O
of IN O
L-carnosine NNP B-INTV
is VBZ O
not RB O
well RB O
understood RB O
, , O
it PRP O
may MD O
enhance VB O
neurologic JJ O
function NN O
, , O
perhaps RB O
in IN O
the DT O
enterorhinal JJ O
or CC O
temporal JJ O
cortex NN O
. . O

-DOCSTART- -X- O O

The DT O
development NN O
and CC O
evaluation NN O
of IN O
a DT O
computer-based JJ B-INTV
program NN I-INTV
to TO O
test VB O
and CC O
to TO O
teach VB O
the DT O
recognition NN O
of IN O
facial JJ B-OC
affect NN I-OC
. . O

Autism NNP O
is VBZ O
a DT O
chronic JJ O
pervasive JJ O
neurodevelopmental JJ O
disorder NN O
characterized VBN O
by IN O
the DT O
early JJ O
onset NN O
of IN O
social JJ O
and CC O
communicative JJ O
impairments NNS O
as RB O
well RB O
as IN O
restricted VBN O
, , O
ritualized VBN O
, , O
stereotypic JJ O
behavior NN O
. . O

The DT O
endophenotype NN O
of IN O
autism NN O
includes VBZ O
neuropsychological JJ O
deficits NNS O
, , O
for IN O
instance NN O
a DT O
lack NN O
of IN O
" NNP O
Theory NNP O
of IN O
Mind NNP O
" NNP O
and CC O
problems NNS O
recognizing VBG O
facial JJ O
affect NN O
. . O

In IN O
this DT O
study NN O
, , O
we PRP O
report VBP O
the DT O
development NN O
and CC O
evaluation NN O
of IN O
a DT O
computer-based JJ B-INTV
program NN I-INTV
to TO O
teach VB O
and CC O
test VB O
the DT O
ability NN O
to TO O
identify VB O
basic JJ B-OC
facially RB I-OC
expressed VBN I-OC
emotions NNS I-OC
. . O

10 CD B-POPU
adolescent NN I-POPU
or CC I-POPU
adult NN I-POPU
subjects NNS I-POPU
with IN I-POPU
high-functioning JJ I-POPU
autism NN I-POPU
or CC I-POPU
Asperger-syndrome NNP I-POPU
were VBD I-POPU
included VBN I-POPU
in IN I-POPU
the DT I-POPU
investigation NN I-POPU
. . O

A DT O
priori FW O
the DT O
facial JJ O
affect NN O
recognition NN O
test NN O
had VBD O
shown VBN O
good JJ O
psychometric NN O
properties NNS O
in IN O
a DT O
normative JJ O
sample NN O
( ( O
internal JJ O
consistency NN O
: : O
rtt=.91-.95 NN O
; : O
retest JJS O
reliability NN O
: : O
rtt=.89-.92 NN O
) ) O
. . O

In IN O
a DT O
prepost NN O
design NN O
, , O
one CD O
half NN O
of IN O
the DT O
sample NN O
was VBD O
randomly RB O
assigned VBN O
to TO O
receive VB O
computer NN B-INTV
treatment NN I-INTV
while IN O
the DT O
other JJ O
half NN O
of IN O
the DT O
sample NN O
served VBD O
as IN O
control NN O
group NN O
. . O

The DT O
training NN O
was VBD O
conducted VBN O
for IN O
five CD O
weeks NNS O
, , O
consisting VBG O
of IN O
two CD O
hours NNS O
training VBG O
a DT O
week NN O
. . O

The DT O
trained JJ O
individuals NNS O
improved VBN O
significantly RB O
on IN O
the DT O
affect JJ B-OC
recognition NN I-OC
task NN I-OC
, , O
but CC O
not RB O
on IN O
any DT O
other JJ O
measure NN O
. . O

Results VB O
support NN O
the DT O
usefulness NN O
of IN O
the DT O
program NN O
to TO O
teach VB B-OC
the DT I-OC
detection NN I-OC
of IN I-OC
facial JJ I-OC
affect NN I-OC
. . O

However RB O
, , O
the DT O
improvement NN O
found VBD O
is VBZ O
limited VBN O
to TO O
a DT O
circumscribed JJ O
area NN O
of IN O
social-communicative JJ O
function NN O
and CC O
generalization NN O
is VBZ O
not RB O
ensured VBN O
. . O

-DOCSTART- -X- O O

Enhanced NNP O
pitch NN O
sensitivity NN O
in IN O
individuals NNS B-POPU
with IN I-POPU
autism NN I-POPU
: : I-POPU
a DT O
signal JJ O
detection NN O
analysis NN O
. . O

Past NNP O
research NN O
has VBZ O
shown VBN O
a DT O
superiority NN O
of IN O
participants NNS B-POPU
with IN I-POPU
high-functioning JJ I-POPU
autism NN I-POPU
over IN O
comparison NN O
groups NNS O
in IN O
memorizing VBG O
picture-pitch JJ O
associations NNS O
and CC O
in IN O
detecting VBG O
pitch NN O
changes NNS O
in IN O
melodies NNS O
. . O

A DT O
subset NN O
of IN O
individuals NNS B-POPU
with IN I-POPU
autism NN I-POPU
, , I-POPU
known VBN I-POPU
as IN I-POPU
" JJ I-POPU
musical JJ I-POPU
savants NNS I-POPU
, , I-POPU
" NN I-POPU
is VBZ O
also RB O
known VBN O
to TO O
possess VB O
absolute JJ O
pitch NN O
. . O

This DT O
superiority NN O
might MD O
be VB O
due JJ O
to TO O
an DT O
abnormally RB O
high JJ O
sensitivity NN O
to TO O
fine-grained JJ O
pitch NN O
differences NNS O
in IN O
sounds NNS O
. . O

To TO O
test VB O
this DT O
hypothesis NN O
, , O
psychoacoustic JJ B-INTV
tasks NNS I-INTV
were VBD O
devised VBN O
so RB O
as IN O
to TO O
use VB O
a DT O
signal JJ O
detection NN O
methodology NN O
. . O

Participants NNS B-POPU
were VBD I-POPU
all DT I-POPU
musically RB I-POPU
untrained JJ I-POPU
and CC I-POPU
were VBD I-POPU
divided VBN I-POPU
into IN I-POPU
a DT I-POPU
group NN I-POPU
of IN I-POPU
12 CD I-POPU
high-functioning JJ I-POPU
individuals NNS I-POPU
with IN I-POPU
autism NN I-POPU
and CC I-POPU
a DT I-POPU
group NN I-POPU
of IN I-POPU
12 CD I-POPU
normally RB I-POPU
developing VBG I-POPU
individuals NNS I-POPU
. . O

Their PRP$ O
task NN O
was VBD O
to TO O
judge VB O
the DT O
pitch NN B-INTV
of IN I-INTV
pure NN I-INTV
tones NNS I-INTV
in IN O
a DT O
" JJ O
same-different JJ O
" NN O
discrimination NN O
task NN O
and CC O
in IN O
a DT O
" JJ O
high-low JJ O
" NN O
categorization NN O
task NN O
. . O

In IN O
both DT O
tasks NNS O
, , O
the DT O
obtained VBN O
psychometric JJ O
functions NNS O
revealed VBD O
higher JJR B-OC
pitch NN I-OC
sensitivity NN I-OC
for IN O
subjects NNS O
with IN O
autism NN O
, , O
with IN O
a DT O
more RBR O
pronounced JJ O
advantage NN O
over IN O
control NN O
participants NNS O
in IN O
the DT O
categorization NN B-OC
task NN I-OC
. . O

These DT O
findings NNS O
confirm VBP O
that IN O
pitch NN B-OC
processing NN I-OC
is VBZ O
enhanced VBN O
in IN O
" JJ O
high-functioning JJ O
" NN O
autism NN O
. . O

Superior JJ O
performance NN O
in IN O
pitch NN B-OC
discrimination NN I-OC
and CC I-OC
categorization NN I-OC
extends VBZ O
previous JJ O
findings NNS O
of IN O
enhanced JJ O
visual JJ B-OC
performance NN I-OC
to TO O
the DT O
auditory NN O
domain NN O
. . O

Thus NNP O
, , O
and CC O
as IN O
predicted VBN O
by IN O
the DT O
enhanced JJ O
perceptual JJ O
functioning NN O
model NN O
for IN O
peaks NNS O
of IN O
ability NN O
in IN O
autism NN O
( ( O
Mottron NNP O
& CC O
Burack NNP O
, , O
2001 CD O
) ) O
, , O
autistic JJ B-POPU
individuals NNS I-POPU
outperform VBP O
typically RB O
developing VBG O
population NN O
in IN O
a DT O
variety NN O
of IN O
low-level JJ O
perceptual JJ O
tasks NNS O
. . O

-DOCSTART- -X- O O

Children NNP B-POPU
with IN I-POPU
autistic JJ I-POPU
spectrum NN I-POPU
disorders NNS I-POPU
. . O

I PRP O
: : O
comparison NN O
of IN O
placebo NN B-INTV
and CC O
single JJ O
dose NN O
of IN O
human JJ B-INTV
synthetic JJ I-INTV
secretin NN I-INTV
. . O

AIMS NNP O
To TO O
examine VB O
the DT O
effect NN O
of IN O
a DT O
single JJ O
dose NN O
of IN O
human JJ B-INTV
synthetic JJ I-INTV
secretin NN I-INTV
( ( I-INTV
HSS NNP I-INTV
) ) I-INTV
on IN O
behaviour NN O
and CC O
communication NN O
in IN O
children NNS B-POPU
with IN I-POPU
autism NN I-POPU
spectrum NN I-POPU
disorder NN I-POPU
( ( I-POPU
ASD NNP I-POPU
) ) I-POPU
using VBG O
an DT O
objective JJ O
measure NN O
of IN O
communication NN O
and CC O
social JJ O
reciprocity NN O
and CC O
standardised VBD O
rating NN O
scales NNS O
. . O

METHODS NNP O
Randomised VBD O
, , O
crossover NN O
, , O
double JJ O
blind NN O
, , O
and CC O
placebo NN B-INTV
controlled VBD O
trial NN O
of IN O
a DT O
single JJ O
intravenous JJ O
dose NN O
of IN O
human JJ B-INTV
synthetic JJ I-INTV
secretin NN I-INTV
( ( I-INTV
HSS NNP I-INTV
) ) I-INTV
2 CD O
CU/kg NNP O
. . O

The DT O
62 CD B-POPU
subjects NNS I-POPU
( ( I-POPU
3-8 CD I-POPU
years NNS I-POPU
) ) I-POPU
were VBD O
assigned VBN O
to TO O
group NN O
1 CD O
( ( B-INTV
saline JJ I-INTV
placebo/HSS NN I-INTV
) ) I-INTV
or CC O
group NN O
2 CD O
( ( B-INTV
HSS/saline NNP I-INTV
placebo NN I-INTV
) ) I-INTV
. . O

Diagnosis NN O
was VBD O
confirmed VBN O
by IN O
ADI-R NNP O
( ( O
Autism NNP O
Diagnostic NNP O
Interview-Revised JJ O
) ) O
algorithm NN O
. . O

Severity NN O
of IN O
symptoms NNS O
was VBD O
rated VBN O
using VBG O
the DT O
CARS NNP O
( ( O
Childhood NNP O
Autism NNP O
Rating NNP O
Scale NNP O
) ) O
. . O

Outcome NNP O
measures NNS O
included VBD O
Communication NNP B-OC
and CC I-OC
Symbolic NNP I-OC
Behavior NNP I-OC
Scale NNP I-OC
( ( I-OC
CSBS NNP I-OC
) ) I-OC
, , I-OC
Ritvo NNP I-OC
Real-life NNP I-OC
Rating NNP I-OC
Scale NNP I-OC
, , I-OC
weekly JJ I-OC
Global NNP I-OC
Rating NNP I-OC
Scale NNP I-OC
( ( I-OC
GBRS NNP I-OC
) ) I-OC
by IN O
parents NNS O
and CC O
teachers NNS O
, , O
and CC O
daily JJ O
log NN O
of IN O
gastrointestinal JJ O
symptoms NNS O
. . O

The DT O
communication NN O
subscale NN O
of IN O
the DT O
CSBS NNP O
, , O
specifying VBG O
communication NN O
function NN O
, , O
reciprocity NN O
, , O
and CC O
social-affective JJ O
signalling NN O
was VBD O
videotaped VBN O
and CC O
scored VBN O
by IN O
a DT O
blinded JJ O
, , O
trained JJ O
observer RB O
. . O

RESULTS NNP O
Sixty NNP B-POPU
one CD I-POPU
children NNS I-POPU
completed VBD I-POPU
the DT I-POPU
study NN I-POPU
. . O

After IN O
randomisation NN O
, , O
there EX O
were VBD O
no DT O
significant JJ O
differences NNS O
in IN O
gender NN O
, , O
race NN O
, , O
age NN O
, , O
and CC O
parent NN O
and CC O
teacher NN O
GBRS NNP B-OC
and CC O
Ritvo NNP O
Scale NNP O
between IN O
the DT O
two CD O
groups NNS O
. . O

Compared VBN O
with IN O
placebo NN B-INTV
, , I-INTV
secretin FW I-INTV
treatment NN I-INTV
was VBD O
not RB O
associated VBN O
with IN O
significant JJ O
improvement NN O
of IN O
CSBS NNP B-OC
standard JJ I-OC
scores NNS I-OC
from IN O
baseline NN O
to TO O
2 CD O
or CC O
4 CD O
weeks NNS O
post-infusion NN O
. . O

Five CD O
children NNS O
showed VBD O
clinical JJ O
improvement NN O
in IN O
standard JJ O
scores NNS O
: : O
two CD O
after IN O
HSS NNP B-INTV
and CC O
three CD O
after IN O
placebo NN B-INTV
. . O

There EX O
were VBD O
no DT O
significant JJ O
changes NNS O
in IN O
gastrointestinal NN B-OC
symptoms NNS I-OC
after IN O
HSS NNP B-INTV
or CC O
saline JJ B-INTV
placebo NN I-INTV
. . O

CONCLUSIONS VB O
A DT O
single JJ O
dose NN O
of IN O
intravenous JJ O
human JJ B-INTV
secretin NN I-INTV
is VBZ O
not RB O
effective JJ O
in IN O
changing VBG O
behaviour NN O
and CC O
communication NN O
in IN O
children NNS O
with IN O
ASD NNP O
when WRB O
compared VBN O
to TO O
placebo VB B-INTV
. . O

-DOCSTART- -X- O O

Children NNP B-POPU
with IN I-POPU
autistic JJ I-POPU
spectrum NN I-POPU
disorders NNS I-POPU
. . O

II NN O
: : O
parents NNS B-POPU
are VBP O
unable JJ O
to TO O
distinguish VB O
secretin NN O
from IN O
placebo NN O
under IN O
double-blind JJ O
conditions NNS O
. . O

BACKGROUND NNP O
Standardised VBD B-OC
measures NNS I-OC
of IN I-OC
behaviour NNS I-OC
have VBP O
failed VBN O
to TO O
detect VB O
short JJ B-OC
term NN I-OC
improvement NN I-OC
in IN O
children NNS B-POPU
with IN I-POPU
autism NN I-POPU
following VBG O
treatment NN O
with IN O
secretin NN B-INTV
. . O

However RB O
, , O
it PRP O
is VBZ O
possible JJ O
that IN O
standardised JJ O
measures NNS O
are VBP O
insensitive JJ O
to TO O
dimensions NNS O
of IN O
child NN O
behaviour NN O
that WDT O
are VBP O
nonetheless RB O
detectable JJ O
by IN O
parents NNS O
. . O

AIM NNP O
To TO O
determine VB O
the DT O
ability NN B-OC
of IN I-OC
parents NNS B-POPU
of IN I-POPU
children NNS I-POPU
with IN I-POPU
autism NN I-POPU
to TO O
guess VB O
, , O
under IN O
double JJ O
blind NN O
conditions NNS O
, , O
whether IN O
their PRP$ O
child NN O
had VBD O
received VBN O
secretin NN B-INTV
or CC O
placebo NN B-INTV
. . O

METHODS NNP O
2x2 CD O
crossover NN O
randomised VBD O
blinded VBN O
study NN O
, , O
comparing VBG O
the DT O
effect NN O
of IN O
synthetic JJ B-INTV
human JJ I-INTV
secretin NN I-INTV
2 CD O
U/kg NNP O
to TO O
placebo VB B-INTV
( ( I-INTV
saline NN I-INTV
) ) I-INTV
. . O

Sixty CD B-POPU
two CD I-POPU
children NNS I-POPU
with IN I-POPU
autism NN I-POPU
( ( I-POPU
aged VBN I-POPU
43-103 CD I-POPU
months NNS I-POPU
) ) I-POPU
were VBD O
randomly RB O
allocated VBN O
to TO O
two CD O
groups NNS O
: : O
group NN O
1 CD O
received VBD O
placebo NN B-INTV
, , I-INTV
followed VBD I-INTV
six CD I-INTV
weeks NNS I-INTV
later RB I-INTV
by IN I-INTV
secretin NN I-INTV
, , O
and CC O
group NN O
2 CD O
received VBD O
secretin NN B-INTV
followed VBN I-INTV
by IN I-INTV
placebo NN I-INTV
. . O

At IN O
the DT O
conclusion NN O
of IN O
the DT O
study NN O
, , O
parents NNS B-POPU
were VBD O
asked VBN O
to TO O
guess VB O
their PRP$ O
child NN O
's POS O
group NN O
assignment NN O
. . O

RESULTS NNP O
Twenty NNP B-POPU
seven CD I-POPU
families NNS I-POPU
guessed VBD O
their PRP$ O
child NN O
's POS O
group NN O
assignment NN O
correctly RB O
and CC O
27 CD B-POPU
guessed VBN I-POPU
incorrectly RB I-POPU
. . O

In IN O
48 CD O
instances NNS O
, , O
parents NNS O
based VBN O
their PRP$ O
guess NN O
on IN O
perceived JJ O
improvement NN B-OC
; : I-OC
in IN O
six CD O
cases NNS O
, , O
parents NNS O
based VBN O
their PRP$ O
guess NN O
on IN O
perceived JJ O
deterioration NN B-OC
. . O

Six NNP B-POPU
families NNS I-POPU
saw VBD O
no DT O
difference NN O
after IN O
either DT O
infusion NN O
, , O
and CC O
offered VBD O
no DT O
guess NN O
. . O

One CD O
family NN O
dropped VBD O
out RP O
after IN O
the DT O
first JJ O
infusion NN O
, , O
and CC O
one CD O
family NN O
was VBD O
lost VBN O
to TO O
follow VB O
up RP O
after IN O
the DT O
second JJ O
infusion NN O
. . O

CONCLUSION NNP O
In IN O
a DT O
controlled JJ O
setting NN O
, , O
parents NNS B-POPU
of IN I-POPU
young JJ I-POPU
children NNS I-POPU
with IN I-POPU
autism NN I-POPU
are VBP O
unable JJ O
to TO O
distinguish VB O
the DT O
short JJ B-OC
term NN I-OC
behavioural JJ I-OC
effects NNS I-OC
of IN O
secretin NN B-INTV
from IN O
placebo NN B-INTV
. . O

-DOCSTART- -X- O O

Observational NNP B-INTV
learning NN I-INTV
and CC O
the DT O
formation NN O
of IN O
classes NNS O
of IN O
reading VBG O
skills NNS O
by IN O
individuals NNS B-POPU
with IN I-POPU
autism NN I-POPU
and CC I-POPU
other JJ I-POPU
developmental JJ I-POPU
disabilities NNS I-POPU
. . O

We PRP O
investigated VBD O
whether IN O
individuals NNS B-POPU
with IN I-POPU
developmental JJ I-POPU
disabilities NNS I-POPU
will MD O
demonstrate VB O
stimulus NN B-OC
classes NNS I-OC
after IN O
observing VBG B-INTV
another DT I-INTV
individual JJ I-INTV
demonstrate NN I-INTV
the DT O
prerequisite JJ O
conditional JJ O
discriminations NNS O
. . O

In IN O
Experiment JJ O
1 CD O
, , O
participants NNS O
learned VBD B-INTV
conditional JJ I-INTV
discriminations NNS I-INTV
among IN I-INTV
dictated JJ I-INTV
words NNS I-INTV
, , I-INTV
pictures NNS I-INTV
, , I-INTV
and CC I-INTV
printed VBD I-INTV
words NNS I-INTV
. . O

They PRP B-INTV
also RB I-INTV
observed VBD I-INTV
a DT I-INTV
model NN I-INTV
without IN I-INTV
disabilities NNS I-INTV
demonstrate VBP I-INTV
conditional JJ I-INTV
discriminations NNS I-INTV
among IN I-INTV
a DT I-INTV
different JJ I-INTV
set NN I-INTV
of IN I-INTV
dictated JJ I-INTV
words NNS I-INTV
, , I-INTV
pictures NNS I-INTV
, , I-INTV
and CC I-INTV
printed VBD I-INTV
words NNS I-INTV
. . O

The DT B-INTV
classes NNS I-INTV
assigned VBD I-INTV
to TO I-INTV
each DT I-INTV
participant NN I-INTV
belonged VBD I-INTV
to TO I-INTV
a DT I-INTV
larger JJR I-INTV
superordinate JJ I-INTV
category NN I-INTV
, , I-INTV
as IN I-INTV
did VBD I-INTV
the DT I-INTV
classes NNS I-INTV
assigned VBD I-INTV
to TO I-INTV
each DT I-INTV
model NN I-INTV
. . O

The DT O
superordinate JJ B-INTV
categories NNS I-INTV
were VBD O
different JJ O
for IN O
participants NNS O
and CC O
models NNS O
. . O

All DT O
participants NNS O
subsequently RB O
demonstrated VBD O
full JJ O
stimulus NN O
classes NNS O
with IN O
the DT O
stimuli NNS O
involved VBN O
in IN O
direct JJ O
training NN O
: : O
They PRP O
named VBD O
pictures NNS O
, , O
read VBP O
printed VBN O
words NNS O
, , O
and CC O
matched VBD O
pictures NNS O
and CC O
words NNS O
to TO O
one CD O
another DT O
. . O

However RB O
, , O
based VBN O
on IN O
observing VBG O
a DT O
model NN O
, , O
none NN O
of IN O
the DT O
participants NNS O
demonstrated VBD O
full JJ O
stimulus NN B-OC
classes NNS I-OC
. . O

In IN O
Experiment JJ O
2 CD O
, , O
participants NNS O
learned VBD O
conditional JJ B-INTV
discriminations NNS I-INTV
among IN I-INTV
the DT I-INTV
stimuli NNS I-INTV
in IN O
three CD O
sets NNS O
, , O
and CC O
observed VBD B-INTV
a DT I-INTV
model NN I-INTV
's POS I-INTV
training NN I-INTV
with IN O
the DT O
stimuli NNS O
in IN O
three CD O
different JJ O
sets NNS O
. . O

The DT O
classes NNS O
assigned VBD O
to TO O
each DT O
participant NN O
belonged VBD O
to TO O
the DT O
same JJ O
larger JJR O
superordinate JJ O
category NN O
as IN O
did VBD O
those DT O
assigned VBN O
to TO O
their PRP$ O
respective JJ O
model NN O
. . O

All DT O
participants NNS O
subsequently RB O
demonstrated VBD O
full JJ B-OC
stimulus NN I-OC
classes NNS I-OC
with IN O
the DT O
stimuli NNS O
involved VBN O
in IN O
direct JJ O
training NN O
. . O

They PRP O
also RB O
demonstrated VBD O
full JJ B-OC
classes NNS I-OC
with IN O
at IN O
least JJS O
one CD O
of IN O
their PRP$ O
model NN O
's POS O
sets NNS O
of IN O
training NN O
stimuli NNS O
. . O

When WRB O
full JJ O
stimulus NN O
classes NNS O
did VBD O
not RB O
occur VB O
from IN O
observing VBG O
a DT O
model NN O
, , O
participants NNS O
named VBD O
the DT O
model NN O
's POS O
pictures NNS O
, , O
read VBD O
the DT O
model NN O
's POS O
printed JJ O
words NNS O
, , O
or CC O
matched VBD O
the DT O
model NN O
's POS O
pictures NNS O
and CC O
words NNS O
. . O

Stimulus CC B-INTV
class NN I-INTV
technology NN I-INTV
, , O
coupled VBN O
with IN O
the DT O
opportunity NN O
to TO O
observe VB B-INTV
another DT I-INTV
individual JJ I-INTV
perform NN I-INTV
a DT O
skill NN O
, , O
may MD O
be VB O
an DT O
economical JJ O
and CC O
efficient JJ O
means NNS O
of IN O
teaching VBG O
persons NNS B-POPU
with IN I-POPU
developmental JJ I-POPU
disabilities NNS I-POPU
. . O

-DOCSTART- -X- O O

The DT O
use NN O
of IN O
adrenocorticotrophic JJ B-INTV
hormone NN I-INTV
( ( I-INTV
4-9 JJ I-INTV
) ) I-INTV
analog NN I-INTV
ORG NNP I-INTV
2766 CD I-INTV
in IN O
autistic JJ B-POPU
children NNS I-POPU
: : I-POPU
effects NNS O
on IN O
the DT O
organization NN O
of IN O
behavior NN O
. . O

In IN O
a DT O
double-blind JJ O
placebo-controlled JJ O
crossover NN O
trial NN O
, , O
14 CD B-POPU
autistic JJ I-POPU
children NNS I-POPU
were VBD O
treated VBN O
with IN O
the DT O
neuropeptide NN B-INTV
ORG NNP I-INTV
2766 CD I-INTV
, , O
a DT O
synthetic JJ O
analog NN O
of IN O
adrenocorticotrophic JJ O
hormone NN O
( ( O
ACTH NNP O
) ) O
( ( O
4-9 JJ O
) ) O
. . O

ORG JJ B-INTV
2766 CD I-INTV
treatment NN I-INTV
( ( O
20 CD O
mg NNS O
per IN O
day NN O
during IN O
4 CD O
weeks NNS O
) ) O
was VBD O
associated VBN O
with IN O
an DT O
increased JJ O
amount NN O
and CC O
an DT O
improved JJ O
quality NN O
of IN O
the DT O
social JJ O
interaction NN O
of IN O
the DT O
autistic JJ B-POPU
children NNS I-POPU
with IN O
a DT O
familiar JJ O
experimenter NN O
. . O

These DT O
changes NNS O
in IN O
interaction NN O
were VBD O
clinically RB O
relevant JJ O
. . O

Following VBG O
treatment NN O
with IN O
ORG NNP B-INTV
2766 CD I-INTV
gaze NN B-OC
and CC I-OC
smile JJ I-OC
behaviors NNS I-OC
of IN O
child NN O
and CC O
experimenter NN O
showed VBD O
stronger JJR B-OC
temporal JJ I-OC
contingencies NNS I-OC
. . O

Further NNP O
, , O
after IN O
ORG NNP B-INTV
2766 CD I-INTV
, , O
stereotypies NNS O
were VBD O
temporally RB O
disconnected VBN O
from IN O
verbal JJ B-OC
initiatives NNS I-OC
. . O

The DT O
data NN O
supported VBD O
the DT O
notion NN O
of IN O
a DT O
stimulating JJ O
effect NN O
of IN O
ORG NNP B-INTV
2766 CD I-INTV
on IN O
social JJ O
interaction NN O
. . O

The DT O
implications NNS O
of IN O
these DT O
findings NNS O
for IN O
the DT O
endogenous JJ O
opioid JJ O
theory NN O
of IN O
autism NN O
are VBP O
discussed VBN O
. . O

-DOCSTART- -X- O O

The DT O
adrenocorticotrophic JJ B-INTV
hormone NN I-INTV
( ( I-INTV
4-9 JJ I-INTV
) ) I-INTV
analog NN I-INTV
ORG IN I-INTV
2766 CD I-INTV
benefits NNS O
autistic JJ B-POPU
children NNS I-POPU
: : I-POPU
report NN O
on IN O
a DT O
second JJ O
controlled JJ O
clinical JJ O
trial NN O
. . O

In IN O
a DT O
second JJ O
controlled VBN O
crossover NN O
trial NN O
, , O
20 CD B-POPU
autistic JJ I-POPU
children NNS I-POPU
received VBD I-POPU
40 CD I-POPU
mg/day NN I-POPU
of IN I-POPU
the DT I-POPU
neuropeptide NN I-POPU
ORG NNP I-POPU
2766 CD I-POPU
, , I-POPU
a DT I-POPU
synthetic JJ I-POPU
analog NN I-POPU
of IN I-POPU
ACTH NNP I-POPU
( ( I-POPU
4-9 JJ I-POPU
) ) I-POPU
, , I-POPU
for IN I-POPU
8 CD I-POPU
weeks NNS I-POPU
. . O

Parents NNS B-OC
' POS I-OC
checklist NN I-OC
ratings NNS I-OC
( ( I-OC
ABC NNP I-OC
) ) I-OC
as RB O
well RB O
as IN O
clinicians NNS B-OC
' POS I-OC
ratings NNS I-OC
( ( I-OC
CGI NNP I-OC
) ) I-OC
pointed VBD O
to TO O
significant JJ O
improvements NNS O
after IN O
the DT O
course NN O
of IN O
treatment NN O
; : O
improvements NNS O
were VBD O
clearest VBN O
on IN O
the DT O
ABC NNP B-OC
social JJ I-OC
withdrawal NN I-OC
subscale NN I-OC
. . O

The DT O
analysis NN O
of IN O
individual JJ O
target NN O
symptoms NNS O
and CC O
the DT O
parents NNS O
' POS O
treatment NN O
preferences NNS O
substantiated VBD O
the DT O
beneficial JJ O
effects NNS O
of IN O
ORG NNP B-INTV
2766 CD I-INTV
. . O

In IN O
an DT O
ethologically RB O
analyzed JJ O
playroom NN O
session NN O
, , O
ORG NNP O
2766 CD O
treatment NN O
was VBD O
associated VBN O
with IN O
an DT O
improvement NN O
in IN O
the DT O
children NNS B-OC
's POS I-OC
play NN I-OC
behavior NN I-OC
and CC O
a DT O
significant JJ O
increase NN O
in IN O
the DT O
social JJ B-OC
interaction NN I-OC
between IN I-OC
child NN I-OC
and CC I-OC
experimenter NN I-OC
. . O

Gaze NNP B-OC
coordination NN I-OC
between IN O
child NN O
and CC O
experimenter NN O
also RB O
was VBD O
improved VBN O
. . O

-DOCSTART- -X- O O

Amisulpride NNP B-INTV
versus NN O
bromocriptine NN B-INTV
in IN O
infantile JJ B-POPU
autism NN I-POPU
: : I-POPU
a DT O
controlled VBN O
crossover NN O
comparative NN O
study NN O
of IN O
two CD O
drugs NNS O
with IN O
opposite JJ O
effects NNS O
on IN O
dopaminergic JJ O
function NN O
. . O

An DT O
alteration NN O
of IN O
dopaminergic NN B-OC
( ( I-OC
DA NNP I-OC
) ) I-OC
function NN I-OC
much RB O
more RBR O
complex JJ O
than IN O
simple JJ O
hyperactivity NN O
has VBZ O
been VBN O
evoked VBN O
in IN O
infantile JJ B-POPU
autism NN I-POPU
. . O

We PRP O
therefore RB O
compared VBN O
the DT O
clinical JJ B-OC
efficacy NN I-OC
of IN O
a DT O
DA NNP B-INTV
antagonist NN I-INTV
( ( I-INTV
amisulpride IN I-INTV
) ) I-INTV
and CC O
a DT O
DA NNP B-INTV
agonist NN I-INTV
( ( I-INTV
bromocriptine NN I-INTV
) ) I-INTV
in IN O
a DT O
randomized JJ O
, , O
double-blind JJ O
, , O
crossover JJ O
trial NN O
in IN O
9 CD B-POPU
children NNS I-POPU
with IN I-POPU
autism NN I-POPU
, , I-POPU
likely RB I-POPU
severely RB I-POPU
mentally RB I-POPU
retarded JJ I-POPU
. . O

Amisulpride NNP B-INTV
acts VBZ O
preferentially RB O
on IN O
specific JJ O
autistic JJ O
symptoms NNS O
whereas VBP O
bromocriptine JJ B-INTV
acts NNS O
more RBR O
on IN O
motor NN B-OC
hyperactivity NN I-OC
and CC I-OC
attention NN I-OC
symptoms NNS I-OC
. . O

These DT O
findings NNS O
raise VBP O
the DT O
specificity NN O
of IN O
these DT O
two CD O
drugs NNS O
which WDT O
appear VBP O
to TO O
act VB O
preferentially RB O
on IN O
some DT O
target NN O
symptoms NNS O
and CC O
are VBP O
consistent JJ O
with IN O
some DT O
clinical JJ O
and CC O
pharmacological JJ O
observations NNS O
showing VBG O
a DT O
sedative JJ B-OC
effect NN I-OC
with IN O
low JJ O
doses NNS O
of IN O
DA NNP B-INTV
agonists NNS I-INTV
and CC O
a DT O
stimulant JJ B-OC
effect NN I-OC
with IN O
low JJ O
doses NNS O
of IN O
DA NNP B-INTV
antagonists NNS I-INTV
such JJ O
as IN O
the DT O
benzamides NNS B-INTV
. . O

-DOCSTART- -X- O O

[ JJ O
Platelet NNP O
serotonin NN O
in IN O
infantile JJ B-POPU
autism NN I-POPU
. . O

Cross-over JJ O
effects NNS O
of IN O
a DT O
dopamine JJ B-INTV
agonist NN I-INTV
and CC I-INTV
an DT I-INTV
antagonist JJ I-INTV
] NN I-INTV
. . O

In IN O
infantile JJ B-POPU
autism NN I-POPU
, , O
the DT O
serotoninergic NN O
( ( O
5-HT JJ O
) ) O
hypothesis NN O
is VBZ O
corroborated VBN O
by IN O
biological JJ O
dosages NNS O
and CC O
therapeutic JJ O
effects NNS O
of IN O
fenfluramine NN B-INTV
which WDT O
decrease NN O
blood NN O
serotonin NN O
. . O

However RB O
other JJ O
drugs NNS O
, , O
such JJ O
as IN O
dopaminergic JJ B-INTV
agonists NNS I-INTV
or CC O
antagonists NNS B-INTV
, , O
have VBP O
therapeutic JJ O
effects NNS O
. . O

Therefore RB O
, , O
we PRP O
tested VBD O
the DT O
hypothesis NN O
that WDT O
two CD O
dopaminergic NN B-INTV
( ( I-INTV
DA NNP I-INTV
) ) I-INTV
drugs NNS I-INTV
have VBP O
a DT O
similar JJ O
5-HT JJ O
effect NN O
underlying VBG O
the DT O
therapeutic JJ O
efficiency NN O
. . O

We PRP O
evaluated VBD O
in IN O
a DT O
randomized JJ O
, , O
double-blind JJ O
and CC O
cross-over JJ O
study NN O
, , O
the DT O
effects NNS O
of IN O
a DT O
DA NNP B-INTV
agonist NN I-INTV
( ( I-INTV
bromocriptine NN I-INTV
) ) I-INTV
and CC I-INTV
a DT I-INTV
DA NNP I-INTV
antagonist NN I-INTV
( ( I-INTV
amisulpride RB I-INTV
) ) I-INTV
on IN O
platelet NN O
5-HT JJ O
in IN O
infantile JJ B-POPU
autism NN I-POPU
. . O

The DT O
prolactinemia NN O
, , O
reflecting VBG O
the DT O
DA NNP O
action NN O
, , O
has VBZ O
been VBN O
also RB O
measured VBN O
. . O

Nine NNP B-POPU
children NNS I-POPU
, , I-POPU
aged VBN I-POPU
from IN I-POPU
4 CD I-POPU
to TO I-POPU
13 CD I-POPU
years NNS I-POPU
, , I-POPU
according VBG I-POPU
to TO I-POPU
the DT I-POPU
DSM NNP I-POPU
III NNP I-POPU
for IN I-POPU
infantile JJ I-POPU
autism NN I-POPU
, , O
received VBD O
either DT O
drug NN O
in IN O
a DT O
random JJ O
order NN O
during IN O
four CD O
weeks NNS O
with IN O
an DT O
in-between JJ O
placebo NN B-INTV
period NN O
of IN O
six CD O
weeks NNS O
. . O

The DT O
dosages NNS O
of IN O
platelet NN B-INTV
5-HT JJ I-INTV
and CC I-INTV
serum JJ I-INTV
prolactin NN I-INTV
were VBD O
carried VBN O
out RP O
at IN O
the DT O
beginning NN O
and CC O
at IN O
the DT O
end NN O
of IN O
every DT O
phase NN O
of IN O
treatment NN O
( ( O
active JJ O
or CC O
placebo NN B-INTV
) ) I-INTV
with IN O
radioenzymology NN O
and CC O
radioimmunoassay VB O
methods NNS O
respectively RB O
. . O

The DT O
principal JJ O
results NNS O
on IN O
serum JJ B-OC
prolactin NN I-OC
show NN O
neither DT O
order NN B-OC
x NNP I-OC
treatment NN I-OC
interaction NN I-OC
, , O
nor CC O
order NN O
effect NN O
but CC O
a DT O
significant JJ O
treatment NN B-OC
effect NN I-OC
( ( O
p JJ O
< NNP O
0.01 CD O
) ) O
: : O
amisulpride NN B-INTV
increases VBZ B-OC
serum JJ I-OC
prolactin NN I-OC
whereas NNS O
bromocriptine VBP B-INTV
decreases VBZ B-OC
according VBG O
to TO O
the DT O
usual JJ O
data NN O
. . O

About IN O
platelet NN B-OC
5-HT JJ I-OC
, , O
there EX O
is VBZ O
neither DT O
order NN O
x NNP O
treatment NN O
interaction NN O
, , O
nor CC O
treatment NN O
effect NN O
but CC O
a DT O
significant JJ O
order NN B-OC
effect NN I-OC
( ( O
p JJ O
< NNP O
0.01 CD O
) ) O
. . O

Both DT O
drugs NNS O
increase VBP B-OC
platelet NN I-OC
5-HT JJ I-OC
in IN O
the DT O
first JJ O
phase NN O
of IN O
treatment NN O
. . O

This DT O
order NN O
effect NN O
could MD O
be VB O
explained VBN O
by IN O
a DT O
remanent JJ O
effect NN O
of IN O
amisulpride NN O
after IN O
6 CD O
wash-out JJ O
weeks NNS O
. . O

( ( O
ABSTRACT NNP O
TRUNCATED NNP O
AT NNP O
250 CD O
WORDS NNP O
) ) O
-DOCSTART- -X- O O

Parent-defined JJ O
target NN O
symptoms NNS O
respond NN O
to TO O
risperidone VB B-INTV
in IN O
RUPP NNP B-POPU
autism NN I-POPU
study NN I-POPU
: : I-POPU
customer NN O
approach NN O
to TO O
clinical JJ O
trials NNS O
. . O

OBJECTIVE VB O
A DT O
consumer-oriented JJ O
efficacy NN O
assessment NN O
in IN O
clinical JJ O
trials NNS O
should MD O
measure VB O
changes NNS O
in IN O
chief NN O
complaint NN O
and CC O
consumer NN O
request NN O
( ( O
symptoms NNS O
of IN O
most JJS O
concern NN O
to TO O
patient/caregiver NN O
) ) O
, , O
which WDT O
may MD O
be VB O
diluted VBN O
in IN O
change NN O
scores NNS O
of IN O
multisymptom NN O
scales NNS O
. . O

METHOD NNP O
In IN O
the DT O
Research NNP B-POPU
Units NNP I-POPU
on IN I-POPU
Pediatric NNP I-POPU
Psychopharmacology NNP I-POPU
( ( I-POPU
RUPP NNP I-POPU
) ) I-POPU
Autism NNP I-POPU
Network NNP I-POPU
8-week JJ O
double-blind JJ O
trial NN O
of IN O
risperidone NN B-INTV
versus NN I-INTV
placebo NN I-INTV
, , O
the DT O
chief JJ O
concerns NNS O
of IN O
parents NNS B-POPU
were VBD O
collected VBN O
at IN O
0 CD O
, , O
4 CD O
, , O
and CC O
8 CD O
weeks NNS O
( ( O
endpoint NN O
) ) O
, , O
in IN O
addition NN O
to TO O
standardized JJ O
primary JJ O
measures NNS O
. . O

Blinded NNP O
clinical JJ O
judges NNS O
rated VBN O
change NN O
from IN O
baseline NN O
to TO O
4 CD O
and CC O
8 CD O
weeks NNS O
on IN O
a DT O
9-point JJ O
scale NN O
( ( O
1 CD O
= NNP O
normalized VBD O
, , O
5 CD O
= NN O
unchanged JJ O
, , O
9 CD O
= NNP O
disastrous JJ O
) ) O
; : O
94 CD B-POPU
participants NNS I-POPU
had VBD I-POPU
usable JJ I-POPU
data NNS I-POPU
. . O

RESULTS VB O
The DT O
most RBS O
common JJ O
symptoms NNS O
identified VBN O
by IN O
parents NNS O
were VBD O
tantrums NNS B-OC
, , I-OC
aggression NN I-OC
, , I-OC
and CC I-OC
hyperactivity NN I-OC
. . O

Interrater NNP B-OC
reliability NN I-OC
was VBD O
excellent JJ O
. . O

Mean JJ B-OC
ratings NNS I-OC
at IN I-OC
endpoint NN I-OC
were VBD O
2.8 CD O
+/- JJ O
1.2 CD O
on IN O
risperidone NN B-INTV
and CC O
4.5 CD O
+/- JJ O
1.3 CD O
on IN O
placebo NN B-INTV
( ( O
p JJ O
< NNP O
.001 NNP O
) ) O
. . O

Ratings NNS O
were VBD O
collinear JJ O
with IN O
Clinical JJ B-OC
Global NNP I-OC
Impression-Improvement NN I-OC
and CC O
Aberrant NNP B-OC
Behavior NNP I-OC
Checklist NNP I-OC
Irritability NNP I-OC
subscale NN O
( ( O
primary JJ O
dimensional JJ O
measure NN O
) ) O
. . O

Effect JJ B-OC
size NN I-OC
d NN I-OC
was VBD O
1.4 CD O
, , O
compared VBN O
to TO O
1.2 CD O
on IN O
the DT O
Aberrant NNP B-OC
Behavior NNP I-OC
Checklist NNP I-OC
Irritability NNP O
subscale NN O
. . O

Effect NNP B-OC
sizes VBZ I-OC
varied VBN O
twofold JJ O
by IN O
symptom JJ O
category NN O
, , O
largest JJS O
for IN O
self-injury NN O
( ( O
2.11 CD O
) ) O
and CC O
tantrums NNS O
( ( O
1.95 CD O
) ) O
. . O

CONCLUSIONS NNP O
Risperidone NNP B-INTV
was VBD O
superior JJ O
to TO O
placebo VB B-INTV
in IN O
reducing VBG O
symptoms NNS B-OC
of IN O
most JJS O
concern NN O
to TO O
parents NNS B-POPU
of IN I-POPU
autistic JJ I-POPU
children NNS I-POPU
with IN I-POPU
irritable JJ I-POPU
behavior NN I-POPU
. . O

Rating VBG O
individualized JJ O
participant-chosen JJ O
target NN O
symptoms NNS O
seems VBZ O
a DT O
reliable JJ O
, , O
sensitive JJ O
, , O
efficient JJ O
, , O
and CC O
consumer-friendly JJ O
way NN O
to TO O
assess VB O
treatment NN O
effect NN O
and CC O
might MD O
have VB O
clinical JJ O
application NN O
. . O

-DOCSTART- -X- O O

Clonidine NNP B-INTV
treatment NN O
of IN O
hyperactive JJ B-POPU
and CC I-POPU
impulsive JJ I-POPU
children NNS I-POPU
with IN I-POPU
autistic JJ I-POPU
disorder NN I-POPU
. . O

Many JJ O
autistic JJ B-POPU
children NNS I-POPU
have VBP O
associated VBN O
problems NNS O
of IN O
inattention NN B-OC
, , I-OC
impulsivity NN I-OC
, , I-OC
and CC I-OC
hyperactivity NN I-OC
that WDT O
limit VBZ O
the DT O
effectiveness NN O
of IN O
educational JJ O
and CC O
behavioral JJ O
interventions NNS O
. . O

Few NNP O
controlled VBD O
psychopharmacologic JJ O
trials NNS O
have VBP O
been VBN O
conducted VBN O
in IN O
autistic JJ B-POPU
children NNS I-POPU
to TO O
determine VB O
which WDT O
agents NNS O
may MD O
be VB O
effective JJ B-OC
for IN O
these DT O
associated VBN O
features NNS O
. . O

Eight NNP B-POPU
male NN I-POPU
children NNS I-POPU
( ( I-POPU
8.1 CD I-POPU
+/- JJ I-POPU
2.8 CD I-POPU
years NNS I-POPU
) ) I-POPU
with IN I-POPU
autistic JJ I-POPU
disorder NN I-POPU
, , I-POPU
diagnosed VBN I-POPU
by IN I-POPU
DSM-III-R NNP I-POPU
criteria NNS I-POPU
, , O
completed VBD O
a DT O
placebo-controlled JJ B-INTV
, , O
double-blind JJ O
crossover NN O
trial NN O
of IN O
clonidine NN B-INTV
. . O

Subjects NNS B-POPU
were VBD I-POPU
included VBN I-POPU
in IN I-POPU
the DT I-POPU
study NN I-POPU
if IN I-POPU
they PRP I-POPU
had VBD I-POPU
inattention NN I-POPU
, , I-POPU
impulsivity NN I-POPU
, , I-POPU
and CC I-POPU
hyperactivity NN I-POPU
that WDT I-POPU
was VBD I-POPU
excessive JJ I-POPU
for IN I-POPU
their PRP$ I-POPU
developmental JJ I-POPU
level NN I-POPU
. . O

Subjects NNS B-POPU
had VBD I-POPU
not RB I-POPU
tolerated VBN I-POPU
or CC I-POPU
responded VBN I-POPU
to TO I-POPU
other JJ I-POPU
psychopharmacologic JJ I-POPU
treatments NNS I-POPU
( ( I-POPU
neuroleptics NNS I-POPU
, , I-POPU
methylphenidate NN I-POPU
, , I-POPU
or CC I-POPU
desipramine NN I-POPU
) ) I-POPU
. . O

Teacher PRP$ B-OC
ratings NNS I-OC
on IN I-OC
the DT I-OC
Aberrant NNP I-OC
Behavior NNP I-OC
Checklist NNP I-OC
irritability NN I-OC
, , I-OC
stereotypy NN I-OC
, , I-OC
hyperactivity NN I-OC
, , I-OC
and CC I-OC
inappropriate JJ I-OC
speech NN I-OC
factors NNS I-OC
were VBD O
lower JJR O
during IN O
treatment NN O
with IN O
clonidine NN B-INTV
than IN O
during IN O
treatment NN O
with IN O
placebo NN B-INTV
. . O

Attention NNP O
deficit NN O
disorder NN O
with IN O
hyperactivity NN O
: : O
Comprehensive NNP B-OC
Teacher NNP I-OC
's POS I-OC
Rating NNP I-OC
Scale NNP I-OC
ratings NNS I-OC
were VBD O
not RB O
significantly RB O
improved VBN O
during IN O
the DT O
study NN O
, , O
except IN O
for IN O
oppositional JJ O
behavior NN O
. . O

Parent NN B-OC
Conners NNPS I-OC
Abbreviated NNP I-OC
Parent-Teacher NNP I-OC
Questionnaire NNP I-OC
ratings NNS I-OC
significantly RB O
improved VBN O
during IN O
clonidine JJ B-INTV
treatment NN O
. . O

Clonidine NNP O
led VBD O
to TO O
increased VBN O
ratings NNS O
of IN O
the DT O
side NN B-OC
effects NNS I-OC
of IN I-OC
drowsiness NN I-OC
and CC I-OC
decreased JJ I-OC
activity NN I-OC
. . O

Clinician JJ O
ratings NNS O
( ( B-OC
Children NNP I-OC
's POS I-OC
Psychiatric NNP I-OC
Rating NNP I-OC
Scale NNP I-OC
Autism NNP I-OC
, , I-OC
Hyperactivity NNP I-OC
, , I-OC
Anger NNP I-OC
and CC I-OC
Speech NNP I-OC
Deviance NNP I-OC
factors NNS I-OC
; : I-OC
Children NNP I-OC
's POS I-OC
Global NNP I-OC
Assessment NNP I-OC
Scale NNP I-OC
; : I-OC
Clinical NNP I-OC
Global NNP I-OC
Impressions NNP I-OC
efficacy NN I-OC
) ) I-OC
of IN O
videotaped JJ O
sessions NNS O
were VBD O
not RB O
significantly RB O
different JJ O
between IN O
clonidine NN B-INTV
and CC O
placebo NN B-INTV
. . O

Clonidine NNP B-INTV
was VBD O
modestly RB O
effective JJ O
in IN O
the DT O
short-term JJ O
treatment NN O
of IN O
irritability NN B-OC
and CC I-OC
hyperactivity NN I-OC
in IN O
some DT O
children NNS B-POPU
with IN I-POPU
autistic JJ I-POPU
disorder NN I-POPU
. . O

-DOCSTART- -X- O O

Clinical JJ O
effects NNS O
of IN O
naltrexone NN B-INTV
on IN O
autistic JJ B-POPU
behavior NN I-POPU
. . O

Eight NNP B-POPU
young JJ I-POPU
adults NNS I-POPU
who WP I-POPU
were VBD I-POPU
diagnosed VBN I-POPU
with IN I-POPU
autism NN I-POPU
were VBD O
given VBN O
the DT O
opiate JJ B-INTV
antagonist NN I-INTV
naltrexone NN I-INTV
to TO O
control VB O
self-injurious JJ O
behavior NN O
and CC O
maladaptive JJ O
idiosyncratic JJ O
mannerisms NNS O
. . O

The DT O
drug NN O
and CC O
placebo NN B-INTV
were VBD O
administered VBN O
in IN O
a DT O
double-blind JJ O
crossover NN O
design NN O
over IN O
17 CD O
weeks NNS O
. . O

Although IN O
one CD O
subject NN O
appeared VBD O
to TO O
have VB O
partial JJ B-OC
decreases NNS I-OC
in IN I-OC
maladaptive JJ I-OC
behaviors NNS I-OC
associated VBN O
with IN O
naltrexone NN B-INTV
use NN O
, , O
the DT O
drugs NNS O
, , O
as IN O
administered VBN O
in IN O
this DT O
study NN O
, , O
did VBD O
not RB O
reduce VB B-OC
the DT I-OC
self-injurious JJ I-OC
and CC I-OC
other JJ I-OC
maladaptive JJ I-OC
behaviors NNS I-OC
of IN O
the DT O
subjects NNS O
. . O

-DOCSTART- -X- O O

Reflexive JJ B-OC
orienting VBG I-OC
in IN O
response NN O
to TO O
eye NN O
gaze NN O
and CC O
an DT O
arrow NN B-INTV
in IN O
children NNS B-POPU
with IN I-POPU
and CC I-POPU
without IN I-POPU
autism NN I-POPU
. . O

BACKGROUND NNP O
This DT O
study NN O
investigated VBD O
whether IN O
another DT O
person NN O
's POS O
social JJ O
attention NN B-OC
, , O
specifically RB O
the DT O
direction NN O
of IN O
their PRP$ O
eye NN O
gaze NN O
, , O
and CC O
a DT O
non-social JJ O
directional JJ O
cue NN O
, , O
an DT O
arrow NN O
, , O
triggered VBD O
reflexive JJ B-OC
orienting NN I-OC
in IN O
children NNS B-POPU
with IN I-POPU
and CC I-POPU
without IN I-POPU
autism NN I-POPU
in IN O
an DT O
experimental JJ O
situation NN O
. . O

METHODS NNP O
Children NNP B-POPU
with IN I-POPU
autism NN I-POPU
and CC I-POPU
typically RB I-POPU
developed JJ I-POPU
children NNS I-POPU
participated VBN I-POPU
in IN O
one CD O
of IN O
two CD O
experiments NNS O
. . O

Both DT O
experiments NNS O
involved VBD O
the DT O
localization NN B-INTV
of IN I-INTV
a DT I-INTV
target NN I-INTV
that WDT I-INTV
appeared VBD I-INTV
to TO I-INTV
the DT I-INTV
left NN I-INTV
or CC I-INTV
right NN I-INTV
of IN I-INTV
the DT I-INTV
fixation NN I-INTV
point NN I-INTV
. . O

Before IN O
the DT O
target NN O
appeared VBD O
, , O
the DT B-INTV
participant NN I-INTV
's POS I-INTV
attention NN I-INTV
was VBD I-INTV
cued VBN I-INTV
to TO I-INTV
the DT I-INTV
left NN I-INTV
or CC I-INTV
right NN I-INTV
by IN I-INTV
either DT I-INTV
an DT I-INTV
arrow NN I-INTV
or CC I-INTV
the DT I-INTV
direction NN I-INTV
of IN I-INTV
eye NN I-INTV
gaze NN I-INTV
on IN I-INTV
a DT I-INTV
computerized JJ I-INTV
face NN I-INTV
. . O

RESULTS NNP O
Children NNP B-POPU
with IN I-POPU
autism NN I-POPU
were VBD O
slower JJR B-OC
to TO I-OC
respond VB I-OC
, , O
which WDT O
suggests VBZ O
a DT O
slight JJ O
difference NN O
in IN O
the DT O
general JJ O
cognitive JJ B-OC
ability NN I-OC
of IN O
the DT O
groups NNS O
. . O

In IN O
Experiment JJ O
1 CD O
, , O
although IN O
the DT O
participants NNS O
were VBD O
instructed VBN O
to TO O
disregard VB O
the DT O
cue NN O
and CC O
the DT O
target NN O
was VBD O
correctly RB O
cued VBN O
in IN O
only RB O
50 CD O
% NN O
of IN O
the DT O
trials NNS O
, , O
both DT O
groups NNS O
of IN O
children NNS O
responded VBD B-OC
significantly RB O
faster RBR O
to TO O
cued VB O
targets NNS O
than IN O
to TO O
uncued JJ O
targets NNS O
, , O
regardless RB O
of IN O
the DT O
cue NN O
. . O

In IN O
Experiment JJ O
2 CD O
, , O
children NNS O
were VBD O
instructed VBN O
to TO O
attend VB O
to TO O
the DT O
direction NN O
opposite IN O
that DT O
of IN O
the DT O
cues NNS O
and CC O
the DT O
target NN O
was VBD O
correctly RB O
cued VBN O
in IN O
only RB O
20 CD O
% NN O
of IN O
the DT O
trials NNS O
. . O

Typically RB O
developed JJ O
children NNS O
located VBN B-OC
targets NNS I-OC
cued VBN I-OC
by IN I-OC
eye NN I-OC
gaze NNS I-OC
more RBR O
quickly RB O
, , O
while IN O
the DT O
arrow NN O
cue NN O
did VBD O
not RB O
trigger VB O
such JJ O
reflexive JJ B-OC
orienting NN I-OC
in IN O
these DT O
children NNS O
. . O

However RB O
, , O
both DT O
social JJ O
and CC O
non-social JJ O
cues NNS O
shifted VBD O
attention NN B-OC
to TO O
the DT O
cued VBN O
location NN O
in IN O
children NNS O
with IN O
autism NN O
. . O

CONCLUSION NNP O
These DT O
results NNS O
indicate VBP O
that IN O
eye NN O
gaze NN O
attracted VBD O
attention NN B-OC
more RBR O
effectively RB O
than IN O
the DT O
arrow NN O
in IN O
typically RB B-POPU
developed JJ I-POPU
children NNS I-POPU
, , O
while IN O
children NNS B-POPU
with IN I-POPU
autism NN I-POPU
shifted VBN O
their PRP$ O
attention NN O
equally RB O
in IN O
response NN O
to TO O
eye NN O
gaze NN O
and CC O
arrow JJ O
direction NN O
, , O
failing VBG O
to TO O
show VB O
preferential JJ O
sensitivity NN B-OC
to TO O
the DT O
social JJ O
cue NN O
. . O

Difficulty NN O
in IN O
shifting VBG O
controlled JJ O
attention NN B-OC
to TO O
the DT O
instructed JJ O
side NN O
was VBD O
also RB O
found VBN O
in IN O
children NNS B-POPU
with IN I-POPU
autism NN I-POPU
. . O

-DOCSTART- -X- O O

Cyproheptadine NN B-INTV
in IN O
the DT O
treatment NN O
of IN O
autistic JJ B-POPU
disorder NN I-POPU
: : I-POPU
a DT O
double-blind JJ O
placebo-controlled JJ B-INTV
trial NN O
. . O

OBJECTIVE CC O
Autism NNP O
is VBZ O
a DT O
childhood-onset JJ O
disorder NN O
of IN O
unknown JJ O
, , O
possibly RB O
of IN O
multiple JJ O
aetiologies NNS O
. . O

The DT O
core NN O
symptoms NNS O
of IN O
autism NN O
are VBP O
abnormalities NNS O
in IN O
social JJ O
interaction NN O
, , O
communication NN O
and CC O
behaviour NN O
. . O

The DT O
involvement NN O
of IN O
neurotransmitters NNS O
such JJ O
as IN O
5-HT JJ O
has VBZ O
been VBN O
suggested VBN O
in IN O
neuropsychiatric JJ O
disorders NNS O
and CC O
particularly RB O
in IN O
autistic JJ O
disorder NN O
. . O

Increased VBN O
platelet NN O
5-HT JJ O
levels NNS O
were VBD O
found VBN O
in IN O
40 CD O
% NN O
of IN O
the DT O
autistic JJ O
population NN O
, , O
suggesting VBG O
that IN O
hyperserotonaemia NN O
may MD O
be VB O
a DT O
pathologic JJ O
factor NN O
in IN O
infantile JJ B-POPU
autism NN I-POPU
. . O

Therefore RB O
, , O
it PRP O
is VBZ O
of IN O
interest NN O
to TO O
assess VB O
the DT O
efficacy NN O
of IN O
cyproheptadine NN B-INTV
, , I-INTV
a DT I-INTV
5-HT2 JJ I-INTV
antagonist NN I-INTV
in IN O
the DT O
treatment NN O
of IN O
autistic JJ O
disorder NN O
. . O

In IN O
this DT O
8-week JJ O
double-blind NN O
, , O
placebo-controlled JJ B-INTV
trial NN O
, , O
we PRP O
assessed VBD O
the DT O
effects NNS O
of IN O
cyproheptadine NN B-INTV
plus CC I-INTV
haloperidol NN I-INTV
in IN O
the DT O
treatment NN O
of IN O
autistic JJ O
disorder NN O
. . O

METHODS NNP O
Children NNP B-POPU
between IN I-POPU
the DT I-POPU
ages NNS I-POPU
3 CD I-POPU
and CC I-POPU
11 CD I-POPU
years NNS I-POPU
( ( I-POPU
inclusive JJ I-POPU
) ) I-POPU
with IN I-POPU
a DT I-POPU
DSM NNP I-POPU
IV NNP I-POPU
clinical JJ I-POPU
diagnosis NN I-POPU
of IN I-POPU
autism NN I-POPU
and CC I-POPU
who WP I-POPU
were VBD I-POPU
outpatients NNS I-POPU
from IN I-POPU
a DT I-POPU
specialty NN I-POPU
clinic NN I-POPU
for IN I-POPU
children NNS I-POPU
at IN I-POPU
Roozbeh NNP I-POPU
Psychiatric NNP I-POPU
Teaching NNP I-POPU
Hospital NNP I-POPU
were VBD I-POPU
recruited VBN I-POPU
. . O

The DT O
children NNS B-POPU
presented VBN I-POPU
with IN I-POPU
a DT I-POPU
chief JJ I-POPU
complaint NN I-POPU
of IN I-POPU
severely RB I-POPU
disruptive JJ I-POPU
symptoms NNS I-POPU
related VBN I-POPU
to TO I-POPU
autistic JJ I-POPU
disorder NN I-POPU
. . O

Patients NNS O
were VBD O
randomly RB O
allocated VBN O
to TO O
cyproheptadine VB B-INTV
+ NNP I-INTV
haloperidol NN I-INTV
( ( O
Group NNP O
A NNP O
) ) O
or CC O
haloperidol JJ B-INTV
+ JJ I-INTV
placebo NN I-INTV
( ( O
Group NNP O
B NNP O
) ) O
for IN O
an DT O
8-week JJ O
, , O
double-blind JJ O
, , O
placebo-controlled JJ O
study NN O
. . O

The DT O
dose NN O
of IN O
haloperidol NN B-INTV
and CC I-INTV
cyproheptadine NN I-INTV
was VBD O
titrated VBN O
up RB O
to TO O
0.05 CD O
and CC O
0.2 CD O
mg/kg/day NN O
respectively RB O
. . O

Patients NNS O
were VBD O
assessed VBN O
by IN O
a DT O
third-year JJ O
resident NN O
of IN O
psychiatry NN O
at IN O
baseline NN O
and CC O
after IN O
2 CD O
, , O
4 CD O
, , O
6 CD O
and CC O
8 CD O
weeks NNS O
of IN O
starting VBG O
medication NN O
. . O

The DT O
primary JJ O
measure NN O
of IN O
the DT O
outcome NN O
was VBD O
the DT O
Aberrant NNP B-OC
Behaviour NNP I-OC
Checklist-Community NNP I-OC
( ( I-OC
ABC-C NNP I-OC
) ) I-OC
and CC O
the DT O
secondary JJ O
measure NN O
of IN O
the DT O
outcome NN O
was VBD O
the DT O
Childhood NNP B-OC
Autism NNP I-OC
Rating NNP I-OC
Scale NNP I-OC
( ( I-OC
relating VBG I-OC
to TO I-OC
people NNS I-OC
and CC I-OC
verbal JJ I-OC
communication NN I-OC
) ) I-OC
. . O

Side JJ O
effects NNS O
and CC O
extrapyramidal NN O
symptoms NNS O
were VBD O
systematically RB O
recorded VBN O
throughout IN O
the DT O
study NN O
and CC O
were VBD O
assessed VBN O
using VBG O
a DT O
checklist NN O
and CC O
the DT O
Extrapyramidal NNP O
Symptoms NNP O
Rating NNP O
Scale NNP O
, , O
administered VBN O
by IN O
a DT O
resident NN O
of IN O
psychiatry NN O
during IN O
weeks NNS O
1 CD O
, , O
2 CD O
, , O
4 CD O
, , O
6 CD O
and CC O
8 CD O
. . O

RESULTS VB O
The DT O
ABC-C NNP B-OC
and CC I-OC
the DT I-OC
Childhood NNP I-OC
Autism NNP I-OC
Rating NNP I-OC
Scale NNP I-OC
scores VBZ I-OC
improved VBN O
with IN O
cyproheptadine NN B-INTV
. . O

The DT O
behaviour NN B-OC
of IN O
the DT O
two CD O
treatments NNS O
was VBD O
not RB O
homogeneous JJ O
across IN O
time NN O
( ( O
groups-by-time JJ O
interaction NN O
, , O
Greenhouse-Geisser NNP O
correction NN O
; : O
F NNP O
= VBZ O
7.30 CD O
, , O
d.f NN O
. . O

= CC O
1.68 CD O
, , O
P NNP O
= NNP O
0.002 CD O
; : O
F NNP O
= VBZ O
8.21 CD O
, , O
d.f NN O
. . O

= CC O
1.19 CD O
, , O
P NNP O
= VBZ O
0.004 CD O
respectively RB O
) ) O
. . O

The DT O
difference NN O
between IN O
the DT O
two CD O
treatments NNS O
was VBD O
significant JJ O
as IN O
indicated VBN O
by IN O
the DT O
effect NN O
of IN O
group NN O
, , O
and CC O
the DT O
between-subjects NNS O
factor NN O
( ( O
F NNP O
= NNP O
4.17 CD O
, , O
d.f NN O
. . O

= CC O
1 CD O
, , O
P NNP O
= NNP O
0.048 CD O
; : O
F NNP O
= VBZ O
4.29 CD O
, , O
d.f NN O
. . O

= CC O
1 CD O
, , O
P NNP O
= VBZ O
0.045 CD O
respectively RB O
) ) O
. . O

No DT O
significant JJ O
difference NN O
was VBD O
observed VBN O
between IN O
the DT O
two CD O
groups NNS O
in IN O
terms NNS O
of IN O
extrapyramidal NN B-OC
symptoms NNS I-OC
( ( O
P NNP O
= NNP O
0.23 CD O
) ) O
. . O

The DT O
difference NN O
between IN O
the DT O
two CD O
groups NNS O
in IN O
the DT O
frequency NN B-OC
of IN I-OC
side NN I-OC
effects NNS I-OC
was VBD O
not RB O
significant JJ O
. . O

CONCLUSION VB O
The DT O
results NNS O
suggest VBP O
that IN O
the DT O
combination NN O
of IN O
cyproheptadine NN B-INTV
with IN I-INTV
a DT I-INTV
conventional JJ I-INTV
antipsychotic JJ I-INTV
may MD O
be VB O
superior JJ O
to TO O
conventional JJ B-INTV
antipsychotic JJ I-INTV
alone NN I-INTV
for IN O
children NNS B-POPU
with IN I-POPU
autistic JJ I-POPU
disorder NN I-POPU
. . O

However RB O
the DT O
results NNS O
need VBP O
confirmation NN O
by IN O
a DT O
larger JJR O
randomized VBN O
controlled VBN O
trial NN O
. . O

-DOCSTART- -X- O O

Increased VBN O
repetitive JJ O
behaviours NNS O
and CC O
prolactin JJ O
responsivity NN O
to TO O
oral JJ O
m-chlorophenylpiperazine NN B-INTV
in IN O
adults NNS B-POPU
with IN I-POPU
autism NN I-POPU
spectrum NN I-POPU
disorders NNS I-POPU
. . O

Autism NNP O
is VBZ O
a DT O
neurodevelopmental JJ O
disorder NN O
characterized VBN O
by IN O
dysfunction NN O
in IN O
three CD O
primary JJ O
behavioural JJ O
domains NNS O
: : O
repetitive JJ O
behaviours NNS O
, , O
social JJ O
deficits NNS O
, , O
and CC O
language NN O
abnormalities NNS O
. . O

There EX O
is VBZ O
evidence NN O
that IN O
abnormalities NNS O
exist VBP O
in IN O
the DT O
serotonin NN O
( ( O
5-HT JJ O
) ) O
system NN O
in IN O
autism NN O
spectrum NN O
patients NNS O
. . O

Furthermore RB O
, , O
5-HT JJ O
is VBZ O
known VBN O
to TO O
play VB O
a DT O
role NN O
in IN O
repetitive JJ O
and CC O
social JJ O
behaviours NN O
. . O

This DT O
study NN O
examined VBD O
the DT O
effect NN O
of IN O
m-chlorophenylpiperazine NN B-INTV
( ( I-INTV
m-CPP JJ I-INTV
) ) I-INTV
on IN O
repetitive JJ O
behaviours NNS O
and CC O
prolactin JJ O
response NN O
in IN O
11 CD B-POPU
adults NNS I-POPU
with IN I-POPU
autism NN I-POPU
or CC I-POPU
Aspergers NNS I-POPU
disorder VBP I-POPU
and CC I-POPU
8 CD I-POPU
age- JJ I-POPU
and CC I-POPU
gender-matched JJ I-POPU
healthy JJ I-POPU
controls NNS I-POPU
via IN I-POPU
randomized VBN I-POPU
double-blind NN I-POPU
, , I-POPU
m-CPP JJ I-POPU
and CC I-POPU
placebo JJ I-POPU
challenges NNS I-POPU
. . O

The DT O
primary JJ O
outcome NN O
measure NN O
was VBD O
an DT O
instrument NN B-OC
rating NN I-OC
six CD I-OC
repetitive JJ I-OC
behaviours NNS I-OC
: : I-OC
need NN I-OC
to TO I-OC
know VB I-OC
, , I-OC
repeating VBG I-OC
, , I-OC
ordering VBG I-OC
, , I-OC
need NN I-OC
to TO I-OC
tell/ask VB I-OC
, , I-OC
self-injury NN I-OC
, , I-OC
and CC I-OC
touching VBG I-OC
. . O

Patients NNS B-POPU
with IN I-POPU
autism NN I-POPU
spectrum NN I-POPU
disorders NNS I-POPU
showed VBD O
a DT O
significant JJ O
increase NN O
in IN O
repetitive JJ B-OC
behaviours NNS I-OC
at IN O
end-point NN O
following VBG O
oral JJ B-INTV
m-CPP NNS I-INTV
in IN O
comparison NN O
to TO O
placebo VB B-INTV
. . O

Additionally NNP O
subjects VBZ B-POPU
with IN I-POPU
autism NN I-POPU
spectrum NN I-POPU
disorders NNS I-POPU
showed VBD O
a DT O
significantly RB O
increased VBN O
prolactin NN B-OC
response NN I-OC
to TO I-OC
m-CPP NN B-INTV
compared VBN O
to TO O
normal JJ O
controls NNS O
, , O
with IN O
neither DT O
group NN O
responding VBG O
to TO O
placebo VB O
. . O

This DT O
study NN O
provides VBZ O
further JJ O
evidence NN O
for IN O
altered JJ O
5-HT JJ O
sensitivity NN O
in IN O
individuals NNS O
with IN O
autism NN O
spectrum NN O
disorders NNS O
, , O
as RB O
well RB O
as IN O
a DT O
possible JJ O
relationship NN O
between IN O
repetitive JJ O
behaviours NNS O
in IN O
autism NN O
spectrum NN O
disorders NNS O
and CC O
abnormalities NNS O
in IN O
the DT O
5-HT JJ O
system NN O
. . O

-DOCSTART- -X- O O

Weight NNP B-OC
and CC I-OC
leptin JJ I-OC
changes NNS I-OC
among IN O
risperidone-treated JJ B-POPU
youths NNS I-POPU
with IN I-POPU
autism NN I-POPU
: : I-POPU
6-month JJ O
prospective JJ O
data NNS O
. . O

OBJECTIVE IN O
The DT O
authors NNS O
examined VBD O
the DT O
developmental JJ O
impact NN O
and CC O
temporal JJ O
characteristics NNS O
of IN O
risperidone-associated JJ B-INTV
weight NN B-OC
change NN I-OC
. . O

METHOD NNP O
Weight NNP B-OC
change NN I-OC
was VBD O
measured VBN O
for IN O
63 CD B-POPU
children NNS I-POPU
and CC I-POPU
adolescents NNS I-POPU
with IN I-POPU
autism NN I-POPU
treated VBN I-POPU
with IN I-POPU
risperidone NN I-POPU
for IN I-POPU
6 CD I-POPU
months NNS I-POPU
. . O

Change NNP B-OC
in IN I-OC
serum NN I-OC
leptin NN I-OC
levels NNS I-OC
after IN O
2 CD O
months NNS O
was VBD O
examined VBN O
as IN O
a DT O
predictor NN O
of IN O
final JJ B-OC
weight NN I-OC
gain NN I-OC
in IN O
mixed JJ O
regression NN O
models NNS O
that WDT O
controlled VBD O
for IN O
site NN O
, , O
gender NN O
, , O
age NN O
, , O
and CC O
risperidone NN B-INTV
dose NN O
. . O

RESULTS NNP O
Age- JJ O
and CC O
gender-standardized JJ O
weight NN B-OC
increased VBD I-OC
after IN O
6 CD O
months NNS O
of IN O
treatment NN O
( ( O
gross JJ O
: : O
mean=5.6 NN O
kg NN O
[ NNP O
SD=3.9 NNP O
] NNP O
; : O
standardized VBN O
: : O
mean=0.6 NN O
z NN O
[ NNP O
SD=0.5 NNP O
] NNP O
) ) O
and CC O
was VBD O
positively RB O
correlated VBN O
with IN O
weight NN B-OC
gained VBN I-OC
after IN O
1 CD O
month NN O
. . O

Change NN B-OC
in IN I-OC
leptin NN I-OC
levels NNS I-OC
after IN O
2 CD O
months NNS O
of IN O
treatment NN O
( ( O
mean=-0.3 JJ O
ng/ml NN O
, , O
SD=6.2 NNP O
) ) O
( ( O
N=48 NNP O
) ) O
did VBD O
not RB O
predict JJ O
final JJ B-OC
weight NN I-OC
gain NN I-OC
. . O

CONCLUSIONS NNP O
Chronic NNP O
risperidone NN B-INTV
exposure NN O
in IN O
children NNS O
with IN O
autism NN O
causes NNS O
weight VBD B-OC
gain NN I-OC
in IN O
excess NN O
of IN O
developmentally RB O
expected VBN O
norms NNS O
that WDT O
follows VBZ O
a DT O
curvilinear JJ O
trajectory NN O
and CC O
decelerates VBZ O
over IN O
time NN O
. . O

Serum NNP B-OC
leptin JJ I-OC
change NN I-OC
does VBZ O
not RB O
reliably VB O
predict JJ O
risperidone-associated JJ O
weight NN B-OC
gain NN I-OC
. . O

-DOCSTART- -X- O O

Parent NNP B-POPU
management NN I-POPU
training NN I-POPU
and CC I-POPU
Asperger NNP I-POPU
syndrome NN I-POPU
: : I-POPU
a DT O
randomized NN O
controlled VBN O
trial NN O
to TO O
evaluate VB O
a DT O
parent NN B-POPU
based VBN I-POPU
intervention NN B-INTV
. . O

This DT O
controlled JJ O
trial NN O
of IN O
a DT O
parent NN B-INTV
management NN I-INTV
intervention NN I-INTV
aimed VBN O
to TO O
increase VB O
parental JJ O
competence NN O
in IN O
management NN O
of IN O
problem NN O
behaviours NNS O
associated VBN O
with IN O
Asperger NNP B-POPU
syndrome NN I-POPU
. . O

The DT O
intervention NN O
compared VBN O
two CD O
formats NNS O
, , O
a DT O
1 CD B-INTV
day NN I-INTV
workshop NN I-INTV
and CC I-INTV
six CD I-INTV
individual JJ I-INTV
sessions NNS I-INTV
. . O

Measures NNS O
were VBD O
taken VBN O
on IN O
three CD O
occasions NNS O
: : O
pre-intervention NN O
, , O
at IN O
4 CD O
weeks NNS O
, , O
and CC O
at IN O
3 CD O
month NN O
follow-up NN O
. . O

Variables NNS O
of IN O
interest NN O
were VBD O
number NN B-OC
and CC I-OC
intensity NN I-OC
of IN I-OC
problem NN I-OC
behaviours NN I-OC
, , I-OC
and CC I-OC
parent JJ I-OC
evaluation NN I-OC
of IN I-OC
social JJ I-OC
interaction NN I-OC
skills NNS I-OC
. . O

Results NNS O
showed VBD O
parents NNS O
reporting VBG O
fewer JJR O
and CC O
lower JJR O
intensity NN B-OC
of IN I-OC
problem NN I-OC
behaviours NNS I-OC
and CC O
increased VBD B-OC
social JJ I-OC
interactions NNS I-OC
at IN O
4 CD O
weeks NNS O
and CC O
3 CD O
months NNS O
. . O

Results NNS O
held VBD O
across IN O
formats NNS O
and CC O
suggest VBP O
that IN O
parent NN O
management NN O
training NN O
can MD O
provide VB O
an DT O
effective JJ B-OC
intervention NN I-OC
for IN I-OC
parents NNS B-POPU
of IN I-POPU
a DT I-POPU
child NN I-POPU
with IN I-POPU
Asperger NNP I-POPU
syndrome NN I-POPU
. . O

Group NNP O
differences VBZ O
on IN O
outcome NN O
measures NNS O
and CC O
in IN O
the DT O
use NN O
of IN O
strategies NNS O
are VBP O
discussed VBN O
along IN O
with IN O
limitations NNS O
of IN O
the DT O
study NN O
. . O

-DOCSTART- -X- O O

Differential JJ O
response NN O
of IN O
seven CD B-POPU
subjects NNS I-POPU
with IN I-POPU
autistic JJ I-POPU
disorder NN I-POPU
to TO O
clomipramine VB B-INTV
and CC O
desipramine VB B-INTV
. . O

OBJECTIVE NNP O
Clomipramine NNP O
, , O
a DT O
serotonin JJ O
reuptake NN O
blocker NN O
that WDT O
has VBZ O
unique JJ O
antiobsessional JJ O
properties NNS O
, , O
was VBD O
hypothesized VBN O
to TO O
have VB O
a DT O
different JJ O
effect NN O
from IN O
that DT O
of IN O
desipramine NN O
, , O
a DT O
tricyclic JJ O
antidepressant NN O
with IN O
selective JJ O
adrenergic JJ O
effects NNS O
, , O
for IN O
the DT O
stereotyped NN O
, , O
repetitive JJ O
behaviors NNS O
in IN O
autism NN O
. . O

METHOD NNP O
Seven NNP B-POPU
subjects NNS I-POPU
, , I-POPU
ages VBZ I-POPU
6-18 CD I-POPU
years NNS I-POPU
, , I-POPU
with IN I-POPU
autistic JJ I-POPU
disorder NN I-POPU
completed VBD O
a DT O
10-week JJ O
double-blind NN O
, , O
crossover JJ O
trial NN O
of IN O
clomipramine NN B-INTV
and CC I-INTV
desipramine NN I-INTV
following VBG O
a DT O
2-week JJ O
single-blind NN O
, , O
placebo JJ B-INTV
phase NN O
. . O

RESULTS NNP O
Clomipramine NNP O
was VBD O
superior JJ O
to TO O
desipramine VB O
and CC O
placebo VB O
, , O
as IN O
indicated VBN O
by IN O
standardized JJ O
ratings NNS B-OC
of IN I-OC
autism NN I-OC
and CC I-OC
anger NN I-OC
as RB O
well RB O
as IN O
ratings NNS B-OC
of IN I-OC
repetitive JJ I-OC
and CC I-OC
compulsive JJ I-OC
behaviors NNS I-OC
. . O

Clomipramine NNP O
and CC O
desipramine NN O
were VBD O
equally RB O
superior JJ O
to TO O
placebo VB O
for IN O
ratings NNS B-OC
of IN I-OC
hyperactivity NN I-OC
. . O

Parents NNS O
of IN O
all DT O
seven CD B-POPU
subjects NNS I-POPU
elected VBN O
to TO O
have VB O
their PRP$ O
children NNS O
continue VBP O
to TO O
take VB O
clomipramine NN O
after IN O
the DT O
study NN O
. . O

CONCLUSIONS NNP O
Clomipramine NNP O
and CC O
desipramine NN O
are VBP O
differentially RB O
effective JJ O
in IN O
treating VBG O
the DT O
obsessive-compulsive JJ B-OC
and CC I-OC
core NN I-OC
symptoms NNS I-OC
in IN O
autistic JJ O
disorder NN O
. . O

Biological JJ O
links NNS O
between IN O
compulsions NNS O
and CC O
stereotyped VBD O
, , O
repetitive JJ O
behaviors NNS O
in IN O
autistic JJ O
disorder NN O
should MD O
be VB O
explored VBN O
. . O

-DOCSTART- -X- O O

A DT O
double-blind JJ O
, , O
placebo-controlled JJ B-INTV
study NN O
of IN O
the DT O
efficacy NN O
of IN O
transdermal JJ B-INTV
clonidine NN I-INTV
in IN O
autism NN B-POPU
. . O

BACKGROUND NNP O
Autistic JJ B-POPU
individuals NNS I-POPU
often RB I-POPU
exhibit VBP I-POPU
hyperarousal JJ I-POPU
behaviors NNS I-POPU
( ( I-POPU
e.g. NN I-POPU
, , O
stereotyped VBD B-POPU
body NN I-POPU
movements NNS I-POPU
, , I-POPU
self-stimulation NN I-POPU
, , I-POPU
hypervigilance NN I-POPU
, , I-POPU
and CC I-POPU
hyperactivity NN I-POPU
) ) I-POPU
. . O

Clonidine NNP B-INTV
, , O
an DT O
alpha JJ O
2-adrenergic JJ O
receptor NN O
agonist NN O
, , O
has VBZ O
been VBN O
shown VBN O
to TO O
be VB O
effective JJ O
in IN O
reducing VBG O
impulsivity NN O
, , O
inattention NN O
, , O
and CC O
hyperactivity NN O
associated VBN O
with IN O
attention NN O
deficit NN O
disorder NN O
with IN O
hyperactivity NN O
. . O

This DT O
study NN O
investigated VBD O
the DT O
efficacy NN B-OC
and CC I-OC
safety NN I-OC
of IN O
transdermal JJ O
clonidine NN B-INTV
in IN O
reducing VBG O
hyperarousal JJ B-POPU
behaviors NNS I-POPU
associated VBN I-POPU
with IN I-POPU
autism NN I-POPU
. . O

METHOD VB O
A DT O
double-blind JJ O
, , O
placebo-crossover JJ B-INTV
study NN O
with IN O
transdermal JJ O
clonidine NN B-INTV
was VBD O
performed VBN O
in IN O
nine CD B-POPU
autistic JJ I-POPU
males NNS I-POPU
( ( I-POPU
aged VBN I-POPU
5 CD I-POPU
to TO I-POPU
33 CD I-POPU
years NNS I-POPU
) ) I-POPU
. . O

Subjects VBZ O
received VBN O
either DT O
clonidine NN B-INTV
( ( O
approximately RB O
0.005 CD O
mg/kg/day NN O
) ) O
or CC O
placebo VBN B-INTV
by IN O
a DT O
weekly JJ O
transdermal NN O
patch NN O
. . O

Each DT O
trial NN O
lasted VBD O
4 CD O
weeks NNS O
with IN O
a DT O
2-week JJ O
washout NN O
period NN O
between IN O
treatment NN O
phases NNS O
. . O

Subjects NNS O
were VBD O
evaluated VBN O
every DT O
2 CD O
weeks NNS O
by IN O
clinician JJ O
raters NNS O
and CC O
weekly JJ O
by IN O
parents NNS O
. . O

RESULTS VB O
The DT O
clonidine NN B-INTV
treatment NN O
showed VBD O
a DT O
significant JJ O
difference NN O
from IN O
placebo NN B-INTV
treatment NN O
on IN O
three CD O
subscales NNS O
of IN O
the DT O
Ritvo-Freeman NNP B-OC
Real NNP I-OC
Life NNP I-OC
Rating NNP I-OC
Scale NNP I-OC
( ( I-OC
i.e. FW I-OC
, , O
social JJ B-OC
relationship NN I-OC
to TO I-OC
people NNS I-OC
, , I-OC
affectual JJ I-OC
responses NNS I-OC
, , I-OC
and CC I-OC
sensory JJ I-OC
responses NNS I-OC
) ) I-OC
. . O

The DT O
Clinical JJ B-OC
Global NNP I-OC
Impressions NNP I-OC
scale NN I-OC
indicated VBD O
that IN O
clonidine NN B-INTV
produced VBD O
a DT O
significant JJ O
improvement NN O
on IN O
severity NN B-OC
of IN I-OC
illness NN I-OC
, , I-OC
global JJ I-OC
improvement NN I-OC
, , I-OC
and CC I-OC
efficacy NN I-OC
index NN I-OC
for IN O
therapeutic JJ O
effect NN O
of IN O
the DT O
drug NN O
. . O

A DT O
patient JJ B-OC
global JJ I-OC
rating NN I-OC
scale NN I-OC
showed VBD O
clonidine JJ B-INTV
treatment NN O
resulted VBD O
in IN O
significant JJ O
improvement NN O
in IN O
comparison NN O
with IN O
placebo NN B-INTV
. . O

Adverse JJ B-OC
effects NNS I-OC
included VBN I-OC
sedation NN I-OC
and CC I-OC
fatigue NN I-OC
during IN O
the DT O
first JJ O
2 CD O
weeks NNS O
of IN O
clonidine NN B-INTV
treatment NN O
. . O

CONCLUSION NNP O
Results NNP O
from IN O
this DT O
preliminary JJ O
study NN O
show NN O
that IN O
clonidine NN B-INTV
was VBD O
effective JJ O
in IN O
reducing VBG O
several JJ B-OC
hyperarousal NN I-OC
behaviors NNS I-OC
and CC O
improved VBN O
social JJ B-OC
relationships NNS I-OC
in IN O
some DT B-POPU
autistic JJ I-POPU
subjects NNS I-POPU
. . O

Further JJ O
studies NNS O
are VBP O
needed VBN O
in IN O
a DT O
larger JJR B-POPU
autistic JJ I-POPU
population NN I-POPU
to TO O
determine VB O
the DT O
dose-response JJ O
relationship NN O
of IN O
clonidine NN B-INTV
. . O

-DOCSTART- -X- O O

A DT O
new JJ O
social JJ B-INTV
communication NN I-INTV
intervention NN I-INTV
for IN O
children NNS B-POPU
with IN I-POPU
autism NN I-POPU
: : I-POPU
pilot NN O
randomised VBD O
controlled VBN O
treatment NN O
study NN O
suggesting VBG O
effectiveness NN O
. . O

BACKGROUND NNP O
Psychosocial NNP O
treatments NNS O
are VBP O
the DT O
mainstay NN O
of IN O
management NN O
of IN O
autism NN O
in IN O
the DT O
UK NNP O
but CC O
there EX O
is VBZ O
a DT O
notable JJ O
lack NN O
of IN O
a DT O
systematic JJ O
evidence NN O
base NN O
for IN O
their PRP$ O
effectiveness NN O
. . O

Randomised VBN O
controlled JJ O
trial NN O
( ( O
RCT NNP O
) ) O
studies NNS O
in IN O
this DT O
area NN O
have VBP O
been VBN O
rare JJ O
but CC O
are VBP O
essential JJ O
because IN O
of IN O
the DT O
developmental JJ O
heterogeneity NN O
of IN O
the DT O
disorder NN O
. . O

We PRP O
aimed VBD O
to TO O
test VB O
a DT O
new JJ B-INTV
theoretically RB I-INTV
based VBN I-INTV
social JJ I-INTV
communication NN I-INTV
intervention NN I-INTV
targeting VBG I-INTV
parental JJ I-INTV
communication NN I-INTV
in IN O
a DT O
randomised JJ O
design NN O
against IN O
routine JJ B-INTV
care NN I-INTV
alone RB I-INTV
. . O

METHODS NNP O
The DT O
intervention NN B-INTV
was VBD I-INTV
given VBN I-INTV
in IN I-INTV
addition NN I-INTV
to TO I-INTV
existing VBG I-INTV
care NN I-INTV
and CC O
involved VBN O
regular JJ B-INTV
monthly JJ I-INTV
therapist NN I-INTV
contact NN I-INTV
for IN O
6 CD O
months NNS O
with IN O
a DT O
further JJ O
6 CD O
months NNS O
of IN O
2-monthly JJ O
consolidation NN O
sessions NNS O
. . O

It PRP O
aimed VBD O
to TO O
educate VB O
parents NNS O
and CC O
train VB O
them PRP O
in IN O
adapted VBN O
communication NN O
tailored VBN O
to TO O
their PRP$ O
child NN O
's POS O
individual JJ O
competencies NNS O
. . O

Twenty-eight JJ B-POPU
children NNS I-POPU
with IN I-POPU
autism NN I-POPU
were VBD O
randomised VBN O
between IN O
this DT O
treatment NN B-INTV
and CC I-INTV
routine JJ I-INTV
care NN I-INTV
alone RB I-INTV
, , O
stratified VBD B-POPU
for IN I-POPU
age NN I-POPU
and CC I-POPU
baseline NN I-POPU
severity NN I-POPU
. . O

Outcome NNP O
was VBD O
measured VBN O
at IN O
12 CD O
months NNS O
from IN O
commencement NN O
of IN O
intervention NN O
, , O
using VBG O
standardised JJ O
instruments NNS O
. . O

RESULTS NNP O
All NNP O
cases NNS O
studied VBD O
met VBN O
full JJ O
Autism NNP O
Diagnostic NNP O
Interview NNP O
( ( O
ADI NNP O
) ) O
criteria NN O
for IN O
classical JJ O
autism NN O
. . O

Treatment NN O
and CC O
controls NNS O
had VBD O
similar JJ O
routine JJ O
care NN O
during IN O
the DT O
study NN O
period NN O
and CC O
there EX O
were VBD O
no DT O
study NN O
dropouts VBZ O
after IN O
treatment NN O
had VBD O
started VBN O
. . O

The DT O
active JJ O
treatment NN O
group NN O
showed VBD O
significant JJ O
improvement NN O
compared VBN O
with IN O
controls NNS O
on IN O
the DT O
primary JJ O
outcome JJ O
measure NN B-OC
-- : I-OC
Autism NNP I-OC
Diagnostic NNP I-OC
Observation NNP I-OC
Schedule NNP I-OC
( ( I-OC
ADOS NNP I-OC
) ) I-OC
total NN I-OC
score NN I-OC
, , I-OC
particularly RB I-OC
in IN I-OC
reciprocal JJ I-OC
social JJ I-OC
interaction NN I-OC
-- : I-OC
and CC I-OC
on IN O
secondary JJ O
measures NNS O
of IN O
expressive JJ B-OC
language NN I-OC
, , I-OC
communicative JJ I-OC
initiation NN I-OC
and CC I-OC
parent-child JJ I-OC
interaction NN I-OC
. . O

Suggestive JJ O
but CC O
non-significant JJ O
results NNS O
were VBD O
found VBN O
in IN O
Vineland NNP B-OC
Adaptive NNP I-OC
Behaviour NNP I-OC
Scales NNP I-OC
( ( I-OC
Communication NNP I-OC
Sub-domain NNP I-OC
) ) I-OC
and CC I-OC
ADOS NNP I-OC
stereotyped VBD I-OC
and CC I-OC
restricted VBD I-OC
behaviour NN I-OC
domain NN I-OC
. . O

CONCLUSIONS VB O
A DT O
Randomised JJ O
Treatment NNP O
Trial NNP O
design NN O
of IN O
this DT O
kind NN O
in IN O
classical JJ O
autism NN O
is VBZ O
feasible JJ O
and CC O
acceptable JJ O
to TO O
patients NNS O
. . O

This DT O
pilot NN O
study NN O
suggests VBZ O
significant JJ O
additional JJ O
treatment NN O
benefits NNS O
following VBG O
a DT O
targeted JJ O
( ( O
but CC O
relatively RB O
non-intensive JJ O
) ) O
dyadic VBZ O
social JJ O
communication NN O
treatment NN O
, , O
when WRB O
compared VBN O
with IN O
routine JJ O
care NN O
. . O

The DT O
study NN O
needs VBZ O
replication NN O
on IN O
larger JJR O
and CC O
independent JJ O
samples NNS O
. . O

It PRP O
should MD O
encourage VB O
further JJ O
RCT NNP O
designs NNS O
in IN O
this DT O
area NN O
. . O

-DOCSTART- -X- O O

Risperidone NN B-INTV
in IN O
the DT O
treatment NN O
of IN O
disruptive JJ O
behavioral NN O
symptoms NNS O
in IN O
children NNS B-POPU
with IN I-POPU
autistic JJ I-POPU
and CC I-POPU
other JJ I-POPU
pervasive JJ I-POPU
developmental NN I-POPU
disorders NNS I-POPU
. . O

OBJECTIVE NNP O
To TO O
investigate VB O
the DT O
efficacy NN O
and CC O
safety NN O
of IN O
risperidone NN B-INTV
for IN O
the DT O
treatment NN O
of IN O
disruptive JJ O
behavioral NN O
symptoms NNS O
in IN O
children NNS B-POPU
with IN I-POPU
autism NN I-POPU
and CC I-POPU
other JJ I-POPU
pervasive JJ I-POPU
developmental NN I-POPU
disorders NNS I-POPU
( ( I-POPU
PDD NNP I-POPU
) ) I-POPU
. . O

METHODS NNP O
In IN O
this DT O
8-week JJ O
, , O
randomized VBN O
, , O
double-blind JJ O
, , O
placebo-controlled JJ O
trial NN O
, , O
risperidone/placebo JJ B-INTV
solution NN I-INTV
( ( O
0.01-0.06 JJ O
mg/kg/day NN O
) ) O
was VBD O
administered VBN O
to TO O
79 CD B-POPU
children NNS I-POPU
who WP I-POPU
were VBD I-POPU
aged VBN I-POPU
5 CD I-POPU
to TO I-POPU
12 CD I-POPU
years NNS I-POPU
and CC I-POPU
had VBD I-POPU
PDD NNP I-POPU
. . O

Behavioral NNP O
symptoms NNS O
were VBD O
assessed VBN O
using VBG O
the DT O
Aberrant NNP B-OC
Behavior NNP I-OC
Checklist NNP I-OC
( ( I-OC
ABC NNP I-OC
) ) I-OC
, , O
Nisonger NNP O
Child NNP O
Behavior NNP O
Rating NNP O
Form NNP O
, , O
and CC O
Clinical JJ O
Global NNP O
Impression-Change NNP O
. . O

Safety NNP O
assessments NNS O
included VBD O
vital JJ O
signs NNS O
, , O
electrocardiogram NN O
, , O
extrapyramidal NN O
symptoms NNS O
, , O
adverse JJ O
events NNS O
, , O
and CC O
laboratory NN O
tests NNS O
. . O

RESULTS NNP O
Subjects NNPS O
who WP O
were VBD O
taking VBG O
risperidone NN B-INTV
( ( O
mean JJ O
dosage NN O
: : O
0.04 CD O
mg/kg/day NN O
; : O
1.17 CD O
mg/day NN O
) ) O
experienced VBD O
a DT O
significantly RB O
greater JJR O
mean JJ B-OC
decrease NN I-OC
on IN I-OC
the DT I-OC
irritability NN I-OC
subscale NN I-OC
of IN I-OC
the DT I-OC
ABC NNP I-OC
( ( O
primary JJ O
endpoint NN O
) ) O
compared VBN O
with IN O
those DT O
who WP O
were VBD O
taking VBG O
placebo NN O
. . O

By IN O
study NN O
endpoint NN O
, , O
risperidone-treated JJ B-INTV
subjects NNS O
exhibited VBD O
a DT O
64 CD O
% NN O
improvement NN O
over IN O
baseline NN O
in IN O
the DT O
irritability NN B-OC
score NN I-OC
almost RB O
double JJ O
that IN O
of IN O
placebo-treated JJ B-INTV
subjects NNS O
( ( O
31 CD O
% NN O
) ) O
. . O

Risperidone-treated JJ B-INTV
subjects NNS O
also RB O
exhibited VBD O
significantly RB O
greater JJR O
decreases NNS O
on IN O
the DT O
other JJ O
4 CD B-OC
subscales NNS I-OC
of IN I-OC
the DT I-OC
ABC NNP I-OC
; : I-OC
on IN O
the DT O
conduct NN B-OC
problem NN I-OC
, , I-OC
insecure/anxious JJ I-OC
, , I-OC
hyperactive JJ I-OC
, , I-OC
and CC I-OC
overly RB I-OC
sensitive JJ I-OC
subscales NNS I-OC
of IN I-OC
the DT I-OC
Nisonger NNP I-OC
Child NNP I-OC
Behavior NNP I-OC
Rating NNP I-OC
Form NNP I-OC
( ( I-OC
parent JJ I-OC
version NN I-OC
) ) I-OC
; : I-OC
and CC I-OC
on IN I-OC
the DT I-OC
Visual NNP I-OC
Analog NNP I-OC
Scale NNP I-OC
of IN O
the DT O
most RBS O
troublesome JJ O
symptom NN O
. . O

More JJR O
risperidone-treated JJ B-INTV
subjects NNS O
( ( O
87 CD O
% NN O
) ) O
showed VBD O
global JJ O
improvement NN O
in IN O
their PRP$ O
condition NN O
compared VBN O
with IN O
the DT O
placebo NN B-INTV
group NN O
( ( O
40 CD O
% NN O
) ) O
. . O

Somnolence NN B-OC
, , O
the DT O
most RBS O
frequently RB O
reported VBD O
adverse JJ O
event NN O
, , O
was VBD O
noted VBN O
in IN O
72.5 CD O
% NN O
versus IN O
7.7 CD O
% NN O
of IN O
subjects NNS O
( ( B-INTV
risperidone NN I-INTV
vs NN I-INTV
placebo NN I-INTV
) ) I-INTV
and CC O
seemed VBD O
manageable JJ O
with IN O
dose/dose-schedule JJ O
modification NN O
. . O

Risperidone-treated JJ B-INTV
subjects NNS O
experienced VBD O
statistically RB O
significantly RB O
greater JJR O
increases NNS O
in IN O
weight NN B-OC
( ( O
2.7 CD O
vs RB O
1.0 CD O
kg NN O
) ) O
, , O
pulse JJ B-OC
rate NN I-OC
, , I-OC
and CC I-OC
systolic JJ I-OC
blood NN I-OC
pressure NN I-OC
. . O

Extrapyramidal NNP O
symptoms JJ O
scores NNS O
were VBD O
comparable JJ O
between IN O
groups NNS O
. . O

CONCLUSIONS NNP O
Risperidone NNP B-INTV
was VBD O
well RB O
tolerated VBN O
and CC O
efficacious JJ O
in IN O
treating VBG O
behavioral JJ O
symptoms NNS O
associated VBN O
with IN O
PDD NNP B-POPU
in IN I-POPU
children NNS I-POPU
. . O

-DOCSTART- -X- O O

A DT O
placebo NN O
controlled VBN O
crossover RB O
trial NN O
of IN O
liquid JJ B-INTV
fluoxetine NN I-INTV
on IN O
repetitive JJ B-OC
behaviors NNS I-OC
in IN B-POPU
childhood NN I-POPU
and CC I-POPU
adolescent JJ I-POPU
autism NN I-POPU
. . O

Repetitive JJ B-OC
behaviors NNS I-OC
are VBP O
a DT O
core NN O
symptom NN O
domain NN O
in IN O
autism NN O
that WDT O
has VBZ O
been VBN O
linked VBN O
to TO O
alterations NNS O
in IN O
the DT O
serotonin NN O
system NN O
. . O

While IN O
the DT O
selective JJ O
serotonin-receptive JJ B-INTV
inhibitor NN I-INTV
fluvoxamine NN I-INTV
has VBZ O
been VBN O
shown VBN O
to TO O
be VB O
effective JJ O
in IN O
adults NNS O
with IN O
autism NN O
, , O
as IN O
yet RB O
no DT O
published VBN O
placebo NN B-INTV
controlled VBN O
trials NNS O
with IN O
these DT O
agents NNS O
document NN O
safety NN B-OC
and CC O
efficacy NN B-OC
in IN O
children NNS B-POPU
with IN I-POPU
autism NN I-POPU
. . O

This DT O
study NN O
examines VBZ O
the DT O
selective JJ O
serotonin NN B-INTV
reuptake NN I-INTV
inhibitor NN I-INTV
liquid JJ I-INTV
fluoxetine NN I-INTV
in IN O
the DT O
treatment NN O
of IN O
repetitive JJ B-POPU
behaviors NNS I-POPU
in IN I-POPU
childhood NN I-POPU
and CC I-POPU
adolescent JJ I-POPU
autism NN I-POPU
spectrum NN I-POPU
disorders NNS I-POPU
( ( I-POPU
ASDs NNP I-POPU
) ) I-POPU
. . O

In IN O
total JJ O
, , O
45 CD B-POPU
child NN I-POPU
or CC I-POPU
adolescent JJ I-POPU
patients NNS I-POPU
with IN I-POPU
ASD NNP I-POPU
were VBD I-POPU
randomized VBN I-POPU
into IN I-POPU
two CD I-POPU
acute JJ I-POPU
8-week JJ I-POPU
phases NNS I-POPU
in IN I-POPU
a DT I-POPU
double-blind JJ I-POPU
placebo-controlled JJ I-POPU
crossover NN I-POPU
study NN I-POPU
of IN I-POPU
liquid JJ I-POPU
fluoxetine NN I-POPU
. . O

Study NNP O
design NN O
included VBD O
two CD O
randomized VBN O
8-week JJ O
fluoxetine NN B-INTV
and CC O
placebo NN B-INTV
phases NNS O
separated VBN O
by IN O
a DT O
4-week JJ O
washout NN O
phase NN O
. . O

Outcome NNP O
measures NNS O
included VBD O
measures NNS B-OC
of IN I-OC
repetitive JJ I-OC
behaviors NNS I-OC
and CC I-OC
global JJ I-OC
improvement NN I-OC
. . O

Low-dose JJ O
liquid JJ B-INTV
fluoxetine NN I-INTV
( ( O
mean JJ O
final JJ O
dose NN O
: : O
9.9+/-4.35 JJ O
mg/day NN O
) ) O
was VBD O
superior JJ O
to TO O
placebo VB B-INTV
in IN O
the DT O
treatment NN O
of IN O
repetitive JJ B-POPU
behaviors NNS I-POPU
by IN O
CY-BOCS NNP B-OC
compulsion NN I-OC
scale NN I-OC
. . O

The DT O
effect NN B-OC
size NN I-OC
was VBD O
in IN O
the DT O
moderate NN O
to TO O
large JJ O
range NN O
, , O
and CC O
the DT O
doses NNS O
used VBN O
were VBD O
low JJ O
. . O

Liquid NNP B-INTV
fluoxetine NN I-INTV
was VBD O
only RB O
slightly RB O
, , O
and CC O
not RB O
significantly RB O
, , O
superior JJ O
to TO O
placebo VB O
on IN O
CGI NNP B-OC
autism NN I-OC
score NN I-OC
partially RB O
due JJ O
to TO O
a DT O
phase NN B-OC
order NN I-OC
effect NN I-OC
. . O

However RB O
, , O
fluoxetine NN B-INTV
was VBD O
marginally RB O
superior JJ O
to TO O
placebo VB B-INTV
on IN O
a DT O
composite JJ B-OC
measure NN I-OC
of IN I-OC
global JJ I-OC
effectiveness NN I-OC
. . O

Liquid NNP O
fluoxetine NN O
did VBD O
not RB O
significantly RB O
differ VBP O
from IN O
placebo NN B-INTV
on IN O
treatment NN B-OC
emergent JJ I-OC
side NN I-OC
effects NNS I-OC
. . O

Liquid NNP B-INTV
fluoxetine NN I-INTV
in IN O
low JJ O
doses NNS O
is VBZ O
more RBR O
effective JJ O
than IN O
placebo NN B-INTV
in IN O
the DT O
treatment NN O
of IN O
repetitive JJ B-OC
behaviors NNS I-OC
in IN O
childhood NN O
autism NN O
. . O

Limitations NNS O
include VBP O
small JJ O
sample JJ O
size NN O
and CC O
the DT O
crossover NN O
design NN O
of IN O
the DT O
study NN O
. . O

Further NNP O
replication NN O
and CC O
long-term JJ O
maintenance NN O
trials NNS O
are VBP O
needed VBN O
. . O

-DOCSTART- -X- O O

Pilot NNP O
study NN O
of IN O
a DT O
moderate JJ B-INTV
dose JJ I-INTV
multivitamin/mineral JJ I-INTV
supplement NN I-INTV
for IN O
children NNS B-POPU
with IN I-POPU
autistic JJ I-POPU
spectrum NN I-POPU
disorder NN I-POPU
. . O

OBJECTIVE NNP O
Determine NNP O
the DT O
effect NN O
of IN O
a DT O
moderate JJ O
dose JJ O
multivitamin/mineral JJ B-INTV
supplement NN I-INTV
on IN O
children NNS B-POPU
with IN I-POPU
autistic JJ I-POPU
spectrum NN I-POPU
disorder NN I-POPU
. . O

DESIGN NNP O
Randomized NNP O
, , O
double-blind NN O
, , O
placebo-controlled JJ B-INTV
3-month JJ O
study NN O
. . O

SUBJECTS NNP O
Twenty NNP B-POPU
( ( I-POPU
20 CD I-POPU
) ) I-POPU
children NNS I-POPU
with IN I-POPU
autistic JJ I-POPU
spectrum NN I-POPU
disorder NN I-POPU
, , I-POPU
ages VBZ I-POPU
3-8 CD I-POPU
years NNS I-POPU
. . O

RESULTS VB O
A DT O
Global JJ O
Impressions NNP O
parental NN O
questionnaire NN O
found VBD O
that IN O
the DT O
supplement NN O
group NN O
reported VBD O
statistically RB B-OC
significant JJ I-OC
improvements NNS I-OC
in IN O
sleep NN B-OC
and CC I-OC
gastrointestinal JJ I-OC
problems NNS I-OC
compared VBN O
to TO O
the DT O
placebo NN B-INTV
group NN O
. . O

An DT O
evaluation NN O
of IN O
vitamin NN B-OC
B NNP I-OC
( ( I-OC
6 CD I-OC
) ) I-OC
levels NNS I-OC
prior RB O
to TO O
the DT O
study NN O
found VBD O
that IN O
the DT O
autistic JJ B-POPU
children NNS I-POPU
had VBD O
substantially RB B-OC
elevated VBN I-OC
levels NNS I-OC
of IN I-OC
B6 NNP I-OC
compared VBN O
to TO O
a DT O
control NN O
group NN O
of IN O
typical JJ O
children NNS O
( ( O
75 CD O
% NN O
higher JJR O
, , O
p JJ O
< NNP O
0.0000001 CD O
) ) O
. . O

Vitamin NNP B-OC
C NNP I-OC
levels NNS I-OC
were VBD O
measured VBN O
at IN O
the DT O
end NN O
of IN O
the DT O
study NN O
, , O
and CC O
the DT O
placebo NN O
group NN O
had VBD O
levels NNS O
that WDT O
were VBD O
significantly RB B-OC
below JJ I-OC
average NN I-OC
for IN O
typical JJ O
children NNS O
, , O
whereas IN O
the DT O
supplement NN O
group NN O
had VBD O
near-average JJ O
levels NNS O
. . O

DISCUSSION VB O
The DT O
finding NN O
of IN O
high JJ B-OC
vitamin NN I-OC
B NNP I-OC
( ( I-OC
6 CD I-OC
) ) I-OC
levels NNS I-OC
is VBZ O
consistent JJ O
with IN O
recent JJ O
reports NNS O
of IN O
low JJ O
levels NNS B-OC
of IN I-OC
pyridoxal-5-phosphate NN I-OC
and CC O
low JJ O
activity NN B-OC
of IN I-OC
pyridoxal NN I-OC
kinase NN I-OC
( ( O
i.e. FW O
, , O
pyridoxal NN O
is VBZ O
only RB O
poorly RB O
converted VBN O
to TO O
pyridoxal-5-phosphate NN O
, , O
the DT O
enzymatically RB O
active JJ O
form NN O
) ) O
. . O

This DT O
may MD O
explain VB O
the DT O
functional JJ O
need NN O
for IN O
high-dose JJ O
vitamin NN B-INTV
B NNP I-INTV
( ( I-INTV
6 CD I-INTV
) ) I-INTV
supplementation NN I-INTV
in IN O
many JJ O
children NNS O
and CC O
adults NNS O
with IN O
autism NN O
. . O

-DOCSTART- -X- O O

The DT O
overt JJ B-INTV
aggression NN I-INTV
scale NN I-INTV
for IN I-INTV
rating NN I-INTV
aggression NN I-INTV
in IN O
outpatient JJ B-POPU
youth NN I-POPU
with IN I-POPU
autistic JJ I-POPU
disorder NN I-POPU
: : I-POPU
preliminary JJ O
findings NNS O
. . O

Aggression NNP O
is VBZ O
a DT O
common JJ O
and CC O
costly JJ O
problem NN O
in IN O
youth NN B-POPU
with IN I-POPU
developmental JJ I-POPU
disabilities NNS I-POPU
. . O

Rating VBG O
scales NNS O
that WDT O
accurately RB O
capture NN O
and CC O
measure NN O
subtypes NNS O
of IN O
aggression NN O
phenomenology NN O
, , O
frequency NN O
and CC O
severity NN O
are VBP O
urgently RB O
needed VBN O
, , O
in IN O
both DT O
clinical JJ O
practice NN O
and CC O
research NN O
. . O

The DT O
authors NNS O
studied VBD O
the DT O
Overt NNP B-INTV
Aggression NNP I-INTV
Scale NNP I-INTV
( ( I-INTV
OAS NNP I-INTV
) ) I-INTV
in IN O
a DT O
preliminary JJ O
sample NN O
of IN O
eight CD B-POPU
outpatients NNS I-POPU
who WP I-POPU
participated VBD I-POPU
in IN I-POPU
an DT I-POPU
ongoing JJ I-POPU
placebo-controlled JJ I-POPU
study NN I-POPU
of IN I-POPU
valproate NN I-POPU
for IN I-POPU
aggression NN I-POPU
in IN I-POPU
autism NN I-POPU
. . O

Subjects NNS O
' POS O
OAS NNP B-INTV
aggression NN I-INTV
scores NNS I-INTV
showed VBD O
significant JJ O
correlation NN O
with IN O
the DT O
already RB O
validated VBN O
retrospectively RB O
rated VBN O
Aberrant NNP B-OC
Behavior NNP I-OC
Checklist NNP I-OC
Community NNP I-OC
Scale NNP I-OC
irritability NN I-OC
subscale NN I-OC
. . O

Further NNP O
study NN O
of IN O
the DT O
OAS NNP B-INTV
in IN O
outpatients NNS O
with IN O
aggression NN O
and CC O
developmental JJ O
disabilities NNS O
is VBZ O
warranted VBN O
. . O

-DOCSTART- -X- O O

Outcome NN O
at IN O
7 CD O
years NNS O
of IN O
children NNS B-POPU
diagnosed VBN I-POPU
with IN I-POPU
autism NN I-POPU
at IN I-POPU
age NN I-POPU
2 CD I-POPU
: : I-POPU
predictive JJ O
validity NN O
of IN O
assessments NNS O
conducted VBN O
at IN O
2 CD B-POPU
and CC I-POPU
3 CD I-POPU
years NNS I-POPU
of IN I-POPU
age NN I-POPU
and CC O
pattern NN O
of IN O
symptom JJ O
change NN O
over IN O
time NN O
. . O

OBJECTIVE UH O
To TO O
examine VB O
the DT O
predictive JJ O
validity NN O
of IN O
symptom JJ B-OC
severity NN I-OC
, , I-OC
cognitive JJ I-OC
and CC I-OC
language NN I-OC
measures NNS I-OC
taken VBN O
at IN O
ages NNS O
2 CD O
and CC O
3 CD O
years NNS O
to TO O
outcome VB O
at IN O
age NN O
7 CD O
in IN O
a DT O
sample NN B-POPU
of IN I-POPU
children NNS I-POPU
diagnosed VBN I-POPU
with IN I-POPU
autism NN I-POPU
at IN I-POPU
age NN I-POPU
2 CD I-POPU
. . O

METHOD NNP O
Twenty-six JJ B-POPU
children NNS I-POPU
diagnosed VBN I-POPU
with IN I-POPU
autism NN I-POPU
at IN I-POPU
age NN I-POPU
2 CD I-POPU
were VBD O
re-assessed VBN O
at IN O
ages NNS O
3 CD O
and CC O
7 CD O
years NNS O
. . O

At IN O
each DT O
age NN O
symptom JJ B-INTV
severity NN I-INTV
, , I-INTV
cognitive JJ I-INTV
and CC I-INTV
language NN I-INTV
assessments NNS I-INTV
were VBD O
completed VBN O
. . O

RESULTS VB O
The DT O
pattern NN O
of IN O
autistic JJ O
symptom NN O
severity NN O
varied VBN O
over IN O
time NN O
by IN O
domain NN O
. . O

Across IN O
time NN O
, , O
children NNS O
moved VBD O
across IN O
diagnostic JJ O
boundaries NNS O
both DT O
in IN O
terms NNS O
of IN O
clinical JJ O
diagnosis NN O
and CC O
in IN O
terms NNS O
of IN O
instrument NN O
diagnosis NN O
on IN O
the DT O
Autism NNP B-OC
Diagnostic NNP I-OC
Interview-Revised JJ I-OC
( ( I-OC
ADI-R NNP I-OC
) ) I-OC
. . O

On IN O
all DT O
measures NNS O
group NN O
variability NN O
in IN O
scores NNS O
increased VBN O
with IN O
age NN O
. . O

Although IN O
non-verbal JJ O
IQ NNP O
( ( O
NVIQ NNP O
) ) O
for IN O
the DT O
group NN O
as IN O
a DT O
whole NN O
was VBD O
stable JJ O
across IN O
the DT O
3 CD O
assessments NNS O
, , O
this DT O
masked VBD O
considerable JJ O
individual JJ O
instability NN O
. . O

Standard JJ O
assessments NNS O
at IN O
age NN O
2 CD O
did VBD O
not RB O
predict VB O
outcome NN O
at IN O
age NN O
7 CD O
even RB O
within IN O
the DT O
same JJ O
domain NN O
of IN O
functioning VBG O
. . O

In IN O
contrast NN O
, , O
standard JJ O
assessments NNS O
at IN O
age NN O
3 CD O
did VBD O
predict JJ O
outcome NN O
. . O

However RB O
, , O
a DT O
measure NN O
of IN O
rate NN B-OC
of IN I-OC
non-verbal JJ I-OC
communicative JJ I-OC
acts NNS I-OC
taken VBN O
from IN O
an DT O
interactive JJ O
play-based JJ O
assessment NN O
at IN O
age NN O
2 CD O
was VBD O
significantly RB O
associated VBN O
with IN O
language NN B-OC
, , I-OC
communication NN I-OC
and CC I-OC
social JJ I-OC
outcomes NNS I-OC
at IN O
age NN O
7 CD O
. . O

CONCLUSIONS VB O
The DT O
trajectory NN O
of IN O
autism NN O
symptoms NNS O
over IN O
time NN O
differed VBN O
in IN O
different JJ O
domains NNS O
, , O
suggesting VBG O
that IN O
they PRP O
may MD O
be VB O
, , O
at IN O
least JJS O
in IN O
part NN O
, , O
separable JJ O
. . O

Variability NN O
in IN O
language NN B-OC
, , I-OC
NVIQ NNP I-OC
and CC I-OC
symptom JJ I-OC
severity NN I-OC
increased VBD O
over IN O
time NN O
. . O

Caution NN O
is VBZ O
required VBN O
when WRB O
interpreting VBG O
the DT O
findings NNS O
from IN O
assessments NNS O
of IN O
children NNS B-POPU
with IN I-POPU
autism NN I-POPU
at IN I-POPU
age NN I-POPU
2 CD I-POPU
years NNS I-POPU
. . O

At IN O
this DT O
age NN O
measures VBZ O
of IN O
rate NN O
of IN O
non-verbal JJ O
communication NN O
might MD O
be VB O
more RBR O
informative JJ O
than IN O
scores NNS O
on IN O
standard JJ O
psychometric NN O
tests NNS O
. . O

Predictive JJ O
validity NN O
of IN O
assessments NNS O
at IN O
age NN O
3 CD O
years NNS O
was VBD O
greater JJR O
. . O

-DOCSTART- -X- O O

Risperidone NNP B-INTV
treatment NN O
of IN O
autistic JJ O
disorder NN O
: : O
longer-term JJ O
benefits NNS O
and CC O
blinded VBD O
discontinuation NN O
after IN O
6 CD O
months NNS O
. . O

OBJECTIVE NNP O
Risperidone NNP B-INTV
is VBZ O
effective JJ O
for IN O
short-term JJ O
treatment NN O
of IN O
aggression NN O
, , O
temper JJ O
outbursts NNS O
, , O
and CC O
self-injurious JJ O
behavior NN O
in IN O
children NNS B-POPU
with IN I-POPU
autism NN I-POPU
. . O

Because IN O
these DT O
behaviors NNS O
may MD O
be VB O
chronic JJ O
, , O
there EX O
is VBZ O
a DT O
need NN O
to TO O
establish VB O
the DT O
efficacy NN O
and CC O
safety NN O
of IN O
longer-term JJ O
treatment NN O
with IN O
this DT O
agent NN O
. . O

METHOD NNP O
The DT O
authors NNS O
conducted VBD O
a DT O
multisite NN O
, , O
two-part JJ O
study NN O
of IN O
risperidone NN B-POPU
in IN I-POPU
children NNS I-POPU
ages NNS I-POPU
5 CD I-POPU
to TO I-POPU
17 CD I-POPU
years NNS I-POPU
with IN I-POPU
autism NN I-POPU
accompanied VBN I-POPU
by IN I-POPU
severe JJ I-POPU
tantrums NNS I-POPU
, , I-POPU
aggression NN I-POPU
, , I-POPU
and/or JJ I-POPU
self-injurious JJ I-POPU
behavior NN I-POPU
who WP I-POPU
showed VBD I-POPU
a DT I-POPU
positive JJ I-POPU
response NN I-POPU
in IN I-POPU
an DT I-POPU
earlier JJR I-POPU
8-week JJ I-POPU
trial NN I-POPU
. . O

Part NN O
I PRP O
consisted VBD O
of IN O
4-month JJ O
open-label JJ O
treatment NN O
with IN O
risperidone NN B-INTV
, , O
starting VBG O
at IN O
the DT O
established VBN O
optimal JJ O
dose NN O
; : O
part NN O
II NNP O
was VBD O
an DT O
8-week JJ O
randomized NN O
, , O
double-blind JJ O
, , O
placebo-substitution JJ B-INTV
study NN O
of IN O
risperidone NN B-INTV
withdrawal NN O
. . O

Primary JJ O
outcome JJ O
measures NNS O
were VBD O
the DT O
Aberrant NNP B-OC
Behavior NNP I-OC
Checklist NNP I-OC
irritability NN I-OC
subscale NN I-OC
and CC I-OC
the DT I-OC
Clinical NNP I-OC
Global NNP I-OC
Impression NNP I-OC
improvement NN I-OC
scale NN I-OC
. . O

RESULTS NNP O
Part NNP B-POPU
I PRP I-POPU
included VBD I-POPU
63 CD I-POPU
children NNS I-POPU
. . O

The DT O
mean JJ O
risperidone NN B-INTV
dose NN O
was VBD O
1.96 CD O
mg/day NN O
at IN O
entry NN O
and CC O
remained VBD O
stable JJ O
over IN O
16 CD O
weeks NNS O
of IN O
open JJ O
treatment NN O
. . O

The DT O
change NN O
on IN O
the DT O
Aberrant NNP B-OC
Behavior NNP I-OC
Checklist NNP I-OC
irritability NN I-OC
subscale NN I-OC
was VBD O
small JJ O
and CC O
clinically JJ O
insignificant NN O
. . O

Reasons NNS O
for IN O
discontinuation NN O
of IN O
part NN O
I PRP O
included VBD O
loss NN B-OC
of IN I-OC
efficacy NN I-OC
( ( O
N=5 NNP O
) ) O
and CC O
adverse JJ B-OC
effects NNS I-OC
( ( O
N=1 NNP O
) ) O
. . O

The DT O
subjects NNS O
gained VBD O
an DT O
average NN O
of IN O
5.1 CD O
kg NNS O
. . O

Part NNP B-POPU
II NNP I-POPU
included VBD I-POPU
32 CD I-POPU
patients NNS I-POPU
. . O

The DT O
relapse NN B-OC
rates NNS I-OC
were VBD O
62.5 CD O
% NN O
for IN O
gradual JJ O
placebo NN O
substitution NN O
and CC O
12.5 CD O
% NN O
for IN O
continued JJ O
risperidone NN B-INTV
; : I-INTV
this DT O
difference NN O
was VBD O
statistically RB O
significant JJ O
. . O

CONCLUSIONS NNP O
Risperidone NNP B-INTV
showed VBD O
persistent JJ O
efficacy NN B-OC
and CC O
good JJ O
tolerability NN B-OC
for IN O
intermediate-length JJ O
treatment NN O
of IN O
children NNS B-POPU
with IN I-POPU
autism NN I-POPU
characterized VBN I-POPU
by IN I-POPU
tantrums NNS I-POPU
, , I-POPU
aggression NN I-POPU
, , I-POPU
and/or JJ I-POPU
self-injurious JJ I-POPU
behavior NN I-POPU
. . O

Discontinuation NN O
after IN O
6 CD O
months NNS O
was VBD O
associated VBN O
with IN O
a DT O
rapid JJ O
return NN O
of IN O
disruptive JJ O
and CC O
aggressive JJ O
behavior NN O
in IN O
most JJS O
subjects NNS O
. . O

-DOCSTART- -X- O O

Autism-Spectrum JJ B-INTV
Quotient-Japanese JJ I-INTV
version NN O
and CC O
its PRP$ O
short JJ O
forms NNS O
for IN O
screening VBG B-POPU
normally RB I-POPU
intelligent JJ I-POPU
persons NNS I-POPU
with IN I-POPU
pervasive JJ I-POPU
developmental NN I-POPU
disorders NNS I-POPU
. . O

A DT O
Japanese JJ B-INTV
version NN I-INTV
of IN I-INTV
the DT I-INTV
Autism NNP I-INTV
Spectrum NNP I-INTV
Quotient NNP I-INTV
( ( I-INTV
AQ NNP I-INTV
) ) I-INTV
, , I-INTV
AQ-J NNP I-INTV
was VBD O
administered VBN O
to TO O
25 CD B-POPU
normally RB I-POPU
intelligent JJ I-POPU
high-functioning JJ I-POPU
pervasive JJ I-POPU
developmental NN I-POPU
disorder NN I-POPU
( ( I-POPU
HPDD NNP I-POPU
) ) I-POPU
patients NNS I-POPU
( ( I-POPU
mean JJ I-POPU
age NN I-POPU
, , I-POPU
24.2 CD I-POPU
years NNS I-POPU
; : I-POPU
24 CD I-POPU
male NN I-POPU
, , I-POPU
one CD I-POPU
female NN I-POPU
) ) I-POPU
and CC I-POPU
215 CD I-POPU
controls NNS I-POPU
( ( I-POPU
mean JJ I-POPU
age NN I-POPU
, , I-POPU
30.4 CD I-POPU
years NNS I-POPU
; : I-POPU
86 CD I-POPU
male NN I-POPU
, , I-POPU
129 CD I-POPU
female NN I-POPU
) ) I-POPU
randomly RB I-POPU
selected VBN I-POPU
from IN I-POPU
the DT I-POPU
general JJ I-POPU
population NN I-POPU
. . O

The DT O
AQ-J NNP B-INTV
had VBD O
satisfactory JJ B-OC
internal JJ I-OC
consistency NN I-OC
reliability NN I-OC
( ( O
Cronbach NNP O
's POS O
alpha NN O
> VBD O
0.70 CD O
in IN O
the DT O
two CD O
groups NNS O
) ) O
, , O
test-retest JJ B-OC
reliability NN I-OC
, , I-OC
and CC I-OC
discriminant JJ I-OC
validity NN I-OC
[ NNP O
i.e NN O
. . O

the DT O
AQ-J NNP O
score NN O
was VBD O
significantly RB O
higher JJR O
in IN O
the DT O
HPDD NNP O
( ( O
mean NN O
, , O
29.6 CD O
) ) O
than IN O
controls NNS O
( ( O
mean VB O
, , O
22.2 CD O
) ) O
] NN O
. . O

At IN O
a DT O
cut-off NN O
of IN O
26 CD O
, , O
the DT O
AQ-J NNP B-INTV
had VBD O
satisfactory JJ B-OC
sensitivity NN I-OC
, , I-OC
specificity NN I-OC
, , I-OC
and CC I-OC
negative JJ I-OC
predictive JJ I-OC
value NN I-OC
, , O
but CC O
it PRP O
had VBD O
low JJ B-OC
positive JJ I-OC
predictive NN I-OC
value NN I-OC
( ( O
0.24 CD O
) ) O
possibly RB O
due JJ O
to TO O
the DT O
facts NNS O
that IN O
the DT O
25 CD O
mild JJ O
HPDD NNP O
patients NNS O
scored VBD O
lower JJR O
and CC O
the DT O
controls NNS O
scored VBD O
higher JJR O
on IN O
the DT O
AQ-J NNP B-INTV
than IN O
British NNP O
counterparts NNS O
on IN O
the DT O
AQ NNP O
. . O

The DT O
AQ-J-21 NNP B-INTV
( ( B-OC
consisting VBG I-OC
of IN I-OC
21 CD I-OC
items NNS I-OC
significantly RB I-OC
associated VBN I-OC
with IN I-OC
HPDD NNP I-OC
diagnosis NN I-OC
) ) I-OC
and CC O
the DT O
AQ-J-10 NNP B-INTV
( ( B-OC
consisting VBG I-OC
of IN I-OC
10 CD I-OC
of IN I-OC
the DT I-OC
21 CD I-OC
items NNS I-OC
with IN I-OC
an DT I-OC
effect NN I-OC
size NN I-OC
> NNP I-OC
0.17 CD I-OC
) ) I-OC
had VBD O
higher JJR B-OC
, , O
although IN O
not RB B-OC
satisfactory JJ I-OC
, , I-OC
positive JJ I-OC
predictive JJ I-OC
values NNS I-OC
of IN O
0.35 CD O
and CC O
0.46 CD O
at IN O
cut-offs NNS O
of IN O
12 CD O
and CC O
7 CD O
, , O
respectively RB O
, , O
than IN O
the DT O
AQ-J NNP B-INTV
. . O

The DT O
AQ-J JJ B-INTV
and CC O
two CD O
short JJ O
forms NNS O
are VBP O
useful JJ O
not RB O
to TO O
predict VB O
but CC O
to TO O
rule VB O
out RP O
mild NN B-OC
HPDD NNP I-OC
, , O
the DT O
most RBS O
difficult JJ O
part NN O
of IN O
HPDD NNP O
to TO O
be VB O
distinguished VBN O
from IN O
non-PDD JJ O
conditions NNS O
, , O
in IN O
persons NNS O
scoring VBG O
under IN O
the DT O
cut-offs NNS O
and CC O
to TO O
consider VB O
professionals NNS O
' POS O
examination NN O
of IN O
HPDD NNP O
in IN O
persons NNS O
scoring VBG O
over IN O
them PRP O
, , O
because IN O
their PRP$ O
negative JJ O
predictive JJ O
values NNS O
were VBD O
satisfactory JJ O
. . O

-DOCSTART- -X- O O

Clinical JJ O
efficacy NN O
of IN O
fluvoxamine NN B-INTV
and CC O
functional JJ O
polymorphism NN O
in IN O
a DT O
serotonin NN O
transporter NN O
gene NN O
on IN O
childhood NN B-POPU
autism NN I-POPU
. . O

We PRP O
studied VBD O
the DT O
correlation NN O
between IN O
response NN O
to TO O
fluvoxamine VB B-INTV
and CC O
serotonin VB O
transporter NN O
gene NN O
promoter NN O
region NN O
polymorphism NN O
( ( O
5-HTTLPR JJ O
) ) O
. . O

Eighteen JJ B-POPU
children NNS I-POPU
with IN I-POPU
autistic JJ I-POPU
disorder NN I-POPU
completed VBD O
a DT O
12-week JJ O
double-blind NN O
, , O
placebo-controlled JJ B-INTV
, , O
randomized VBN O
crossover NN O
study NN O
of IN O
fluvoxamine NN B-INTV
. . O

Behavioral JJ B-OC
assessments NNS I-OC
were VBD O
obtained VBN O
before IN O
and CC O
at IN O
12 CD O
weeks NNS O
of IN O
treatment NN O
. . O

5-HTTLPR JJ O
( ( O
long JJ O
( ( O
l NN O
) ) O
or CC O
short JJ O
( ( O
s PRP O
) ) O
) ) O
, , O
was VBD O
analyzed VBN O
by IN O
the DT O
PCR NNP B-INTV
method NN I-INTV
. . O

Ten CD O
out IN O
of IN O
18 CD O
patients NNS O
responded VBD O
to TO O
fluvoxamine VB B-INTV
treatment NN O
; : O
allele CC B-OC
type JJ I-OC
analysis NN I-OC
revealed VBD O
that IN O
clinical JJ O
global JJ O
effectiveness NN O
was VBD O
noted VBN O
significantly RB O
more RBR O
in IN O
the DT O
l NN O
allele NN O
than IN O
in IN O
the DT O
s NN O
allele NN O
. . O

However RB O
, , O
with IN O
respect NN O
to TO O
language NN B-OC
use NN I-OC
, , O
a DT O
significant JJ O
effectiveness NN O
was VBD O
noted VBN O
in IN O
the DT O
s NN O
allele NN O
. . O

5-HTTLPR JJ O
may MD O
influence VB O
the DT O
individual NN O
responses VBZ O
to TO O
fluvoxamine VB B-INTV
administration NN O
. . O

-DOCSTART- -X- O O

Tetrahydrobiopterin NN B-INTV
in IN O
the DT O
treatment NN O
of IN O
children NNS B-POPU
with IN I-POPU
autistic JJ I-POPU
disorder NN I-POPU
: : I-POPU
a DT O
double-blind JJ O
placebo-controlled JJ B-INTV
crossover NN O
study NN O
. . O

Twelve NNP B-POPU
children NNS I-POPU
, , I-POPU
all DT I-POPU
boys NNS I-POPU
, , I-POPU
aged VBD I-POPU
4 CD I-POPU
to TO I-POPU
7 CD I-POPU
years NNS I-POPU
, , I-POPU
with IN I-POPU
a DT I-POPU
diagnosis NN I-POPU
of IN I-POPU
autistic JJ I-POPU
disorder NN I-POPU
and CC I-POPU
low JJ I-POPU
concentrations NNS I-POPU
of IN I-POPU
spinal JJ I-POPU
6R-l-erythro-5,6,7,8-tetrahydrobiopterin JJ I-POPU
( ( I-POPU
tetrahydrobiopterin NN I-POPU
) ) I-POPU
were VBD O
selected VBN O
to TO O
participate VB O
in IN O
a DT O
double-blind NN O
, , O
randomized VBN O
, , O
placebo-controlled JJ B-INTV
, , O
crossover NN O
study NN O
. . O

The DT O
children NNS O
received VBD O
a DT O
daily JJ O
dose NN O
of IN O
3 CD O
mg NNS O
tetrahydrobiopterin JJ B-INTV
per IN O
kilogram NN O
during IN O
6 CD O
months NNS O
alternating VBG O
with IN O
placebo NN B-INTV
. . O

Treatment-induced JJ B-OC
effects NNS I-OC
were VBD O
assessed VBN O
with IN O
the DT O
Childhood NNP B-OC
Autism NNP I-OC
Rating NNP I-OC
Scale NNP I-OC
every DT O
third JJ O
month NN O
. . O

The DT O
results NNS O
showed VBD O
small JJ O
nonsignificant JJ O
changes NNS O
in IN O
the DT O
total JJ B-OC
scores NNS I-OC
of IN I-OC
Childhood NNP I-OC
Autism NNP I-OC
Rating NNP I-OC
Scale NNP I-OC
after IN O
3- JJ O
and CC O
6-month JJ O
treatment NN O
. . O

Post NNP O
hoc NN O
analysis NN O
looking VBG O
at IN O
the DT O
3 CD O
core NN O
symptoms NNS O
of IN O
autism NN O
, , O
that WDT O
is VBZ O
, , O
social JJ B-OC
interaction NN I-OC
, , I-OC
communication NN I-OC
, , I-OC
and CC I-OC
stereotyped VBD I-OC
behaviors NNS I-OC
, , O
revealed VBD O
a DT O
significant JJ O
improvement NN O
of IN O
the DT O
social JJ B-OC
interaction NN I-OC
score NN I-OC
after IN O
6 CD O
months NNS O
of IN O
active JJ O
treatment NN O
. . O

In IN O
addition NN O
, , O
a DT O
high JJ O
positive JJ O
correlation NN O
was VBD O
found VBN O
between IN O
response NN B-OC
of IN I-OC
the DT I-OC
social JJ I-OC
interaction NN I-OC
score NN I-OC
and CC I-OC
IQ NNP I-OC
. . O

The DT O
results NNS O
indicate VBP O
a DT O
possible JJ O
effect NN O
of IN O
tetrahydrobiopterin NN B-INTV
treatment NN O
. . O

-DOCSTART- -X- O O

Comparison NNP O
of IN O
the DT O
effectiveness NN B-OC
of IN O
oral JJ O
diazepam NN B-INTV
and CC I-INTV
midazolam NN I-INTV
for IN O
the DT O
sedation NN B-POPU
of IN I-POPU
autistic JJ I-POPU
patients NNS I-POPU
during IN I-POPU
dental JJ I-POPU
treatment NN I-POPU
. . O

PURPOSE VB O
This DT O
study NN O
was VBD O
undertaken VBN O
to TO O
compare VB O
the DT O
effectiveness NN B-OC
of IN O
oral JJ O
diazepam NN B-INTV
and CC I-INTV
midazolam NN I-INTV
in IN O
sedating VBG B-POPU
autistic JJ I-POPU
patients NNS I-POPU
during IN I-POPU
dental JJ I-POPU
treatment NN I-POPU
. . O

METHODS NNP O
The DT O
treatment NN O
regimen NNS O
consisted VBD O
of IN O
nitrous JJ B-INTV
oxide/oxygen NN I-INTV
inhalation NN I-INTV
in IN O
conjunction NN O
with IN O
oral JJ B-INTV
administration NN I-INTV
of IN I-INTV
either DT I-INTV
diazepam NN I-INTV
0.3 CD I-INTV
mg/kg NN I-INTV
or CC I-INTV
midazolam VB I-INTV
0.5 CD I-INTV
mg/kg NN I-INTV
in IN O
a DT O
cross-over JJ O
design NN O
study NN O
of IN O
13 CD B-POPU
subjects NNS I-POPU
aged VBD I-POPU
5.8 CD I-POPU
to TO I-POPU
14.7 CD I-POPU
years NNS I-POPU
. . O

A DT O
drug NN O
was VBD O
classified VBN O
as IN O
being VBG O
effective JJ B-OC
when WRB O
over RB O
70 CD O
% NN O
of IN O
the DT O
patients NNS O
taking VBG O
the DT O
drug NN O
were VBD O
judged VBN O
as IN O
" JJ O
success NN O
" NN O
in IN O
all DT O
3 CD O
behavioral JJ O
criteria NNS O
: : O
( ( O
1 CD O
) ) O
sleeping NN O
; : O
( ( O
2 CD O
) ) O
body NN O
movement NN O
; : O
and CC O
( ( O
3 CD O
) ) O
crying NN O
behaviors NNS O
. . O

The DT O
study NN O
was VBD O
observed VBN O
by IN O
an DT O
independent JJ O
clinician NN O
with IN O
an DT O
intraexaminer NN O
reliability NN O
of IN O
88 CD O
% NN O
. . O

RESULTS NNP O
For IN O
sleeping VBG B-OC
behavior NN I-OC
, , O
midazolam NN O
was VBD O
found VBN O
to TO O
be VB O
significantly RB B-OC
more RBR I-OC
effective JJ I-OC
than IN O
diazepam RB O
as IN O
the DT O
duration NN O
of IN O
stimulation NN O
increased VBN O
( ( O
P NNP O
< NNP O
.05 NNP O
) ) O
. . O

For IN O
the DT O
movement NN B-OC
and CC I-OC
crying NN I-OC
behaviors NNS I-OC
, , O
midazolam NN O
also RB O
proved VBD O
to TO O
be VB O
significantly RB B-OC
more RBR I-OC
effective JJ I-OC
from IN O
the DT O
start NN O
of IN O
treatment NN O
through IN O
the DT O
35- JJ O
and CC O
40-min JJ O
markers NNS O
, , O
respectively RB O
( ( O
P NNP O
< NNP O
.05 NNP O
) ) O
. . O

For IN O
the DT O
remainder NN B-OC
of IN I-OC
treatment NN I-OC
, , O
however RB O
, , O
there EX O
was VBD O
no DT B-OC
statistically RB I-OC
significant JJ I-OC
difference NN I-OC
in IN O
these DT O
behaviors NNS O
between IN O
the DT O
trials NNS O
( ( O
P NNP O
> NNP O
.05 NNP O
) ) O
. . O

Diazepam NNP O
and CC O
midazolam NNS O
were VBD O
rated VBN O
as IN O
77 CD O
% NN O
and CC O
100 CD O
% NN O
successful JJ B-OC
, , O
according VBG O
to TO O
the DT O
overall JJ O
behavior NN B-OC
evaluation NN I-OC
criteria NNS O
( ( O
P=.02 NNP O
) ) O
. . O

CONCLUSIONS NNP O
Both NNP O
diazepam NN O
and CC O
midazolam NN O
were VBD O
shown VBN O
to TO O
be VB O
effective JJ B-OC
sedative JJ O
agents NNS O
, , O
successfully RB O
and CC O
safely RB O
used VBN O
to TO O
sedate VB O
autistic JJ B-POPU
patients NNS I-POPU
for IN O
dental JJ O
treatment NN O
. . O

Midazolam NNP O
was VBD O
significantly RB O
more RBR O
effective JJ O
than IN O
diazepam NN O
in IN O
those DT O
portions NNS O
of IN O
the DT O
procedure NN O
with IN O
increased JJ O
stimulation NN O
. . O

-DOCSTART- -X- O O

Intensive JJ B-INTV
behavioral JJ I-INTV
treatment NN I-INTV
for IN O
children NNS B-POPU
with IN I-POPU
autism NN I-POPU
: : I-POPU
four-year JJ O
outcome NN O
and CC O
predictors NNS O
. . O

Twenty-four JJ B-POPU
children NNS I-POPU
with IN I-POPU
autism NN I-POPU
were VBD O
randomly RB O
assigned VBN B-POPU
to TO I-POPU
a DT I-POPU
clinic-directed JJ I-POPU
group NN I-POPU
, , O
replicating VBG O
the DT O
parameters NNS O
of IN O
the DT O
early JJ B-INTV
intensive JJ I-INTV
behavioral JJ I-INTV
treatment NN I-INTV
developed VBD I-INTV
at IN I-INTV
UCLA NNP I-INTV
, , I-INTV
or CC B-POPU
to TO I-POPU
a DT I-POPU
parent-directed JJ I-POPU
group NN I-POPU
that WDT B-INTV
received VBD I-INTV
intensive JJ I-INTV
hours NNS I-INTV
but CC I-INTV
less JJR I-INTV
supervision NN I-INTV
by IN I-INTV
equally RB I-INTV
well-trained JJ I-INTV
supervisors NNS I-INTV
. . O

Outcome NNP O
after IN O
4 CD O
years NNS O
of IN O
treatment NN O
, , O
including VBG O
cognitive JJ B-OC
, , I-OC
language NN I-OC
, , I-OC
adaptive JJ I-OC
, , I-OC
social JJ I-OC
, , I-OC
and CC I-OC
academic JJ I-OC
measures NNS I-OC
, , O
was VBD O
similar JJ O
for IN O
both DT O
groups NNS O
. . O

After IN O
combining VBG O
groups NNS O
, , O
we PRP O
found VBD O
that IN O
48 CD O
% NN O
of IN O
all DT O
children NNS O
showed VBD O
rapid JJ B-OC
learning NN I-OC
, , O
achieved VBN O
average JJ B-OC
posttreatment JJ I-OC
scores NNS I-OC
, , O
and CC O
at IN O
age NN O
7 CD O
, , O
were VBD O
succeeding VBG O
in IN O
regular JJ O
education NN O
classrooms NNS O
. . O

Treatment NNP O
outcome NN O
was VBD O
best RB O
predicted VBN O
by IN O
pretreatment JJ B-OC
imitation NN I-OC
, , I-OC
language NN I-OC
, , I-OC
and CC I-OC
social JJ I-OC
responsiveness NN I-OC
. . O

These DT O
results NNS O
are VBP O
consistent JJ O
with IN O
those DT O
reported VBN O
by IN O
Lovaas NNP O
and CC O
colleagues NNS O
( ( O
Lovaas NNP O
, , O
1987 CD O
; : O
McEachin NNP O
, , O
Smith NNP O
, , O
& CC O
Lovaas NNP O
, , O
1993 CD O
) ) O
. . O

-DOCSTART- -X- O O

Long-term JJ O
effects NNS O
of IN O
risperidone NN B-INTV
in IN O
children NNS B-POPU
with IN I-POPU
autism NN I-POPU
spectrum NN I-POPU
disorders NNS I-POPU
: : I-POPU
a DT O
placebo NN B-INTV
discontinuation NN O
study NN O
. . O

OBJECTIVE IN O
The DT O
short-term JJ O
benefit NN O
of IN O
risperidone NN B-INTV
in IN O
ameliorating VBG O
severe JJ B-OC
disruptive JJ I-OC
behavior NN I-OC
in IN O
pediatric JJ B-POPU
patients NNS I-POPU
with IN I-POPU
autism NN I-POPU
spectrum NN I-POPU
disorders NNS I-POPU
is VBZ O
well RB O
established VBN O
; : O
however RB O
, , O
only RB O
one CD O
placebo-controlled JJ B-INTV
, , O
long-term JJ O
study NN O
of IN O
efficacy NN O
is VBZ O
available JJ O
. . O

METHOD NNP O
Thirty-six JJ B-POPU
children NNS I-POPU
with IN I-POPU
an DT I-POPU
autism NN I-POPU
spectrum NN I-POPU
disorder NN I-POPU
( ( I-POPU
5-17 JJ I-POPU
years NNS I-POPU
old JJ I-POPU
) ) I-POPU
accompanied VBN I-POPU
by IN I-POPU
severe JJ I-POPU
tantrums NNS I-POPU
, , I-POPU
aggression NN I-POPU
, , I-POPU
or CC I-POPU
self-injurious JJ I-POPU
behavior NN I-POPU
, , O
started VBD O
8-week JJ O
open-label JJ O
treatment NN O
with IN O
risperidone NN B-INTV
. . O

Responders NNP O
( ( O
n JJ O
= NNP O
26 CD O
) ) O
continued VBD O
treatment NN O
for IN O
another DT O
16 CD O
weeks NNS O
, , O
followed VBN O
by IN O
a DT O
double-blind JJ O
discontinuation NN O
( ( O
n JJ O
= VBZ O
24 CD O
; : O
two CD O
patients NNS O
discontinued VBN O
treatment NN O
because IN O
of IN O
weight JJ O
gain NN O
) ) O
consisting NN O
of IN O
either CC O
3 CD O
weeks NNS O
of IN O
taper NN O
and CC O
5 CD O
weeks NNS O
of IN O
placebo NN B-INTV
only RB O
or CC O
continuing VBG O
use NN O
of IN O
risperidone NN B-INTV
. . O

Relapse NNP O
was VBD O
defined VBN O
as IN O
a DT O
significant JJ O
deterioration NN O
of IN O
symptoms NNS O
based VBN O
on IN O
clinical JJ O
judgment NN O
and CC O
a DT O
parent NN O
questionnaire NN O
. . O

RESULTS NNP O
Risperidone NNP B-INTV
was VBD O
superior JJ O
to TO O
placebo VB B-INTV
in IN O
preventing VBG O
relapse NN B-OC
: : I-OC
this DT O
occurred VBD O
in IN O
3 CD O
of IN O
12 CD O
patients NNS O
continuing VBG O
on IN O
risperidone NN O
versus NN O
8 CD O
of IN O
12 CD O
who WP O
switched VBD O
to TO O
placebo VB O
( ( O
p JJ O
= NNP O
.049 NNP O
) ) O
. . O

Weight NNP B-OC
gain NN I-OC
, , I-OC
increased VBD I-OC
appetite RB I-OC
, , I-OC
anxiety NN I-OC
, , I-OC
and CC I-OC
fatigue NN I-OC
were VBD O
the DT O
most RBS O
frequently RB O
reported VBN O
side NN O
effects NNS O
. . O

CONCLUSIONS VB O
This DT O
study NN O
indicates VBZ O
the DT O
effectiveness NN O
of IN O
risperidone NN O
during IN O
a DT O
period NN O
of IN O
several JJ O
months NNS O
, , O
reducing VBG O
disruptive JJ B-OC
behavior NN I-OC
in IN O
about IN O
half NN O
of IN O
the DT O
children NNS B-POPU
with IN I-POPU
autism NN I-POPU
spectrum NN I-POPU
disorders NNS I-POPU
. . O

The DT O
results NNS O
provide VBP O
a DT O
rationale NN O
for IN O
the DT O
continuing VBG O
use NN O
of IN O
risperidone NN B-INTV
beyond IN O
6 CD O
months NNS O
, , O
although IN O
considerable JJ O
weight JJ B-OC
gain NN I-OC
can MD O
limit VB O
the DT O
use NN O
of IN O
this DT O
agent NN O
. . O

-DOCSTART- -X- O O

Randomized VBN O
, , O
controlled VBN O
, , O
crossover JJ O
trial NN O
of IN O
methylphenidate NN B-INTV
in IN O
pervasive JJ O
developmental NN O
disorders NNS O
with IN O
hyperactivity NN O
. . O

CONTEXT NNP O
Hyperactivity NNP O
and CC O
inattention NN O
are VBP O
common JJ O
symptoms NNS O
in IN O
children NNS O
with IN O
autistic JJ O
disorder NN O
and CC O
related JJ O
pervasive JJ O
developmental NN O
disorders NNS O
, , O
but CC O
studies NNS O
of IN O
stimulants NNS O
in IN O
these DT O
conditions NNS O
have VBP O
been VBN O
inconclusive JJ O
. . O

OBJECTIVES NN O
To TO O
determine VB O
the DT O
efficacy NN O
and CC O
safety NN O
of IN O
methylphenidate JJ B-INTV
hydrochloride NN B-POPU
in IN I-POPU
children NNS I-POPU
with IN O
pervasive JJ O
developmental NN O
disorders NNS O
and CC O
hyperactivity NN O
. . O

DESIGN NNP O
Double-blind NNP O
, , O
placebo-controlled JJ O
, , O
crossover JJ O
trial NN O
followed VBN O
by IN O
open-label JJ O
continuation NN O
. . O

SETTING NNP O
Five CD O
academic JJ O
outpatient NN O
clinics NNS O
. . O

PARTICIPANTS VB O
Seventy-two JJ B-POPU
drug-free JJ I-POPU
children NNS I-POPU
, , I-POPU
aged VBD I-POPU
5 CD I-POPU
to TO I-POPU
14 CD I-POPU
years NNS I-POPU
, , I-POPU
with IN I-POPU
pervasive JJ I-POPU
developmental NN I-POPU
disorders NNS I-POPU
accompanied VBN I-POPU
by IN I-POPU
moderate JJ I-POPU
to TO I-POPU
severe JJ I-POPU
hyperactivity NN I-POPU
. . O

INTERVENTIONS NNP O
Prior NNP O
to TO O
randomization NN O
, , O
subjects NNS B-POPU
entered VBD O
a DT O
1-week JJ O
test-dose JJ O
phase NN O
in IN O
which WDT O
each DT O
subject NN O
received VBD O
placebo NN B-INTV
for IN O
1 CD O
day NN O
followed VBN O
by IN O
increasing VBG O
doses NNS B-INTV
of IN I-INTV
methylphenidate NN I-INTV
( ( O
low JJ O
, , O
medium NN O
, , O
and CC O
high JJ O
doses NNS O
) ) O
that WDT O
were VBD O
each DT O
given VBN O
for IN O
2 CD O
days NNS O
. . O

The DT O
low JJ O
, , O
medium NN O
, , O
and CC O
high JJ O
doses NNS O
of IN O
methylphenidate NN B-INTV
hydrochloride NN I-INTV
were VBD O
based VBN O
on IN O
weight NN O
, , O
and CC O
they PRP O
ranged VBD O
from IN O
7.5 CD O
mg/d NNS O
to TO O
50.0 CD O
mg/d NNS O
in IN O
divided JJ O
doses NNS O
. . O

Subjects NNS B-POPU
who WP I-POPU
tolerated VBD I-POPU
the DT I-POPU
test NN I-POPU
dose NN I-POPU
( ( O
n JJ O
= NNP O
66 CD O
) ) O
were VBD O
assigned VBN O
to TO O
receive VB O
placebo NN B-INTV
for IN O
1 CD O
week NN O
and CC O
then RB O
3 CD O
methylphenidate NN B-INTV
doses NNS O
in IN O
random JJ O
order NN O
during IN O
a DT O
double-blind NN O
, , O
crossover NN O
phase NN O
. . O

Children NNP B-POPU
responding VBG I-POPU
to TO I-POPU
methylphenidate VB I-POPU
then RB O
entered VBD O
8 CD O
weeks NNS O
of IN O
open-label JJ O
treatment NN O
at IN O
the DT O
individually RB O
determined VBN O
best JJS O
dose NN O
. . O

MAIN NNP O
OUTCOME NNP O
MEASURES NNP O
The DT O
primary JJ O
outcome NN O
measure NN O
was VBD O
the DT O
teacher-rated JJ B-OC
hyperactivity NN I-OC
subscale NN I-OC
of IN I-OC
the DT I-OC
Aberrant NNP I-OC
Behavior NNP I-OC
Checklist NNP I-OC
. . O

Response NNP O
was VBD O
defined VBN O
as IN O
" JJ B-OC
much JJ I-OC
improved VBN I-OC
" NN I-OC
or CC O
" VB B-OC
very RB I-OC
much RB I-OC
improved VBN I-OC
" NN I-OC
on IN O
the DT O
Clinical NNP B-OC
Global NNP I-OC
Impressions NNP I-OC
Improvement NNP I-OC
item NN I-OC
coupled VBD O
with IN O
considerable JJ O
reductions NNS O
in IN O
the DT O
parent-rated JJ B-OC
and/or JJ I-OC
teacher-rated JJ I-OC
Aberrant NNP I-OC
Behavior NNP I-OC
Checklist NNP I-OC
hyperactivity NN I-OC
subscale NN I-OC
score NN I-OC
. . O

RESULTS NNP O
Methylphenidate NNP B-INTV
was VBD O
superior JJ O
to TO O
placebo VB B-INTV
on IN O
the DT O
primary JJ O
outcome NN O
measure NN O
, , O
with IN O
effect NN B-OC
sizes NNS I-OC
ranging VBG O
from IN O
0.20 CD O
to TO O
0.54 CD O
depending VBG O
on IN O
dose NN O
and CC O
rater NN O
. . O

Thirty-five JJ B-POPU
( ( I-POPU
49 CD I-POPU
% NN I-POPU
) ) I-POPU
of IN I-POPU
72 CD I-POPU
enrolled JJ I-POPU
subjects NNS I-POPU
were VBD O
classified VBN O
as IN O
methylphenidate NN B-INTV
responders NNS O
. . O

Adverse JJ B-OC
effects NNS I-OC
led VBN O
to TO O
the DT O
discontinuation NN O
of IN O
study NN O
medication NN O
in IN O
13 CD B-POPU
( ( I-POPU
18 CD I-POPU
% NN I-POPU
) ) I-POPU
of IN I-POPU
72 CD I-POPU
subjects NNS I-POPU
. . O

CONCLUSIONS NNP O
Methylphenidate NNP B-INTV
was VBD O
often RB O
efficacious JJ O
in IN O
treating VBG O
hyperactivity NN O
associated VBN O
with IN O
pervasive JJ O
developmental NN O
disorders NNS O
, , O
but CC O
the DT O
magnitude NN O
of IN O
response NN O
was VBD O
less JJR O
than IN O
that DT O
seen VBN O
in IN O
typically RB O
developing VBG O
children NNS O
with IN O
attention-deficit/hyperactivity NN O
disorder NN O
. . O

Adverse JJ O
effects NNS O
were VBD O
more RBR O
frequent JJ O
. . O

-DOCSTART- -X- O O

A DT O
training NN O
study NN O
of IN O
theory NN O
of IN O
mind NN O
and CC O
executive NN O
function NN O
in IN O
children NNS B-POPU
with IN I-POPU
autistic JJ I-POPU
spectrum NN I-POPU
disorders NNS I-POPU
. . O

This DT O
study NN O
investigated VBD O
the DT O
relationship NN O
between IN O
theory NN O
of IN O
mind NN O
and CC O
executive NN O
functioning NN O
in IN O
children NNS B-POPU
with IN I-POPU
autistic JJ I-POPU
spectrum NN I-POPU
disorders NNS I-POPU
through IN O
a DT O
training NN O
study NN O
. . O

Ten CD B-POPU
children NNS I-POPU
were VBD I-POPU
trained VBN I-POPU
on IN I-POPU
theory NN I-POPU
of IN I-POPU
mind NN I-POPU
, , I-POPU
whilst WP I-POPU
ten EX I-POPU
were VBD I-POPU
trained VBN I-POPU
in IN I-POPU
executive JJ I-POPU
function NN I-POPU
. . O

Seven JJ B-POPU
children NNS I-POPU
were VBD I-POPU
assigned VBN I-POPU
to TO I-POPU
a DT I-POPU
control NN I-POPU
group NN I-POPU
, , I-POPU
receiving VBG I-POPU
no DT I-POPU
intervention NN I-POPU
. . O

Training VBG O
programmes NNS O
were VBD O
administered VBN O
individually RB O
, , O
lasting VBG O
for IN O
25 CD O
minutes NNS O
per IN O
day NN O
for IN O
5-10 JJ O
days NNS O
. . O

Children NNP O
were VBD O
tested VBN O
before IN O
training NN O
, , O
after IN O
training NN O
and CC O
at IN O
a DT O
two-month JJ O
follow-up NN O
. . O

Significant JJ O
improvements NNS O
were VBD O
seen VBN O
in IN O
performance NN B-OC
on IN I-OC
theory NN I-OC
of IN I-OC
mind NN I-OC
tasks NNS I-OC
in IN O
both DT O
trained JJ O
groups NNS O
, , O
whilst IN O
the DT O
control NN O
group NN O
showed VBD O
no DT B-OC
improvement NN I-OC
. . O

No DT O
improvement NN O
on IN O
the DT O
executive NN B-OC
function NN I-OC
tasks NNS I-OC
was VBD O
seen VBN O
in IN O
any DT O
of IN O
the DT O
groups NNS O
. . O

The DT O
implications NNS O
of IN O
these DT O
findings NNS O
are VBP O
discussed VBN O
. . O

-DOCSTART- -X- O O

Divalproex NNP B-INTV
sodium NN I-INTV
vs. FW I-INTV
placebo NN I-INTV
in IN O
the DT O
treatment NN O
of IN O
repetitive JJ B-OC
behaviours NNS I-OC
in IN O
autism NN B-POPU
spectrum NN I-POPU
disorder NN I-POPU
. . O

Autism NNP O
is VBZ O
a DT O
neurodevelopmental JJ O
disorder NN O
characterized VBN O
by IN O
impairment NN O
in IN O
three CD O
core NN O
symptom NN O
domains NNS O
: : O
socialization NN O
, , O
communication NN O
, , O
and CC O
repetitive/stereotyped VBD O
behaviours NNS O
. . O

Other JJ O
associated JJ O
symptom NN O
domains NNS O
are VBP O
also RB O
affected JJ O
including VBG O
impulsivity/aggression NN O
, , O
self-injury NN O
, , O
anxiety NN O
, , O
and CC O
mood NN O
lability NN O
. . O

Divalproex NNP B-INTV
has VBZ O
been VBN O
shown VBN O
to TO O
have VB O
efficacy NN O
in IN O
treating VBG O
epilepsy NN O
, , O
bipolar JJ O
disorder NN O
, , O
mood NN O
lability NN O
, , O
and CC O
impulsive JJ O
aggression NN O
. . O

The DT O
present JJ O
study NN O
evaluated VBD O
the DT O
use NN O
of IN O
divalproex NN B-INTV
in IN O
the DT O
treatment NN O
of IN O
repetitive JJ B-OC
, , I-OC
compulsive-like JJ B-POPU
symptoms NNS I-POPU
of IN I-POPU
autism NN I-POPU
spectrum NN I-POPU
disorder NN I-POPU
( ( I-POPU
ASD NNP I-POPU
) ) I-POPU
. . O

Thirteen JJ B-POPU
individuals NNS I-POPU
with IN I-POPU
ASD NNP I-POPU
participated VBD O
in IN O
an DT O
8-wk JJ O
, , O
double-blind JJ O
, , O
placebo-controlled JJ B-INTV
trial NN O
of IN O
divalproex NN B-INTV
sodium NN I-INTV
vs. FW I-INTV
placebo NN I-INTV
. . O

There EX O
was VBD O
a DT O
significant JJ O
group NN O
difference NN O
on IN O
improvement NN O
in IN O
repetitive JJ B-OC
behaviours NNS I-OC
as IN O
measured VBN O
by IN O
the DT O
Children NNP B-OC
's POS I-OC
Yale-Brown JJ I-OC
Obsessive NNP I-OC
Compulsive NNP I-OC
Scale NNP I-OC
( ( I-OC
C-YBOCS NNP I-OC
) ) I-OC
( ( O
p=0.037 NN O
) ) O
and CC O
a DT O
large JJ O
effect NN O
size NN O
( ( O
d=1.616 NN O
) ) O
. . O

This DT O
study NN O
provides VBZ O
preliminary JJ O
support NN O
for IN O
the DT O
use NN O
of IN O
divalproex NN B-INTV
in IN O
treating VBG O
repetitive JJ B-OC
behaviours NNS I-OC
in IN O
ASD NNP B-POPU
. . O

Further NNP O
research NN O
is VBZ O
needed VBN O
to TO O
evaluate VB O
the DT O
specificity NN O
and CC O
mechanism NN O
of IN O
action NN O
of IN O
these DT O
findings NNS O
. . O

-DOCSTART- -X- O O

Acute NNP B-OC
and CC I-OC
long-term JJ I-OC
safety NN I-OC
and CC I-OC
tolerability NN I-OC
of IN O
risperidone NN B-INTV
in IN O
children NNS B-POPU
with IN I-POPU
autism NN I-POPU
. . O

Treatment-emergent JJ O
adverse JJ B-OC
events NNS I-OC
( ( O
AEs NNP O
) ) O
were VBD O
monitored VBN O
during IN O
an DT O
8-week JJ O
, , O
double-blind JJ O
, , O
placebo-controlled JJ B-INTV
trial NN O
of IN O
risperidone NN B-INTV
( ( O
0.5-3.5 JJ O
mg/day NN O
) ) O
in IN O
101 CD B-POPU
children NNS I-POPU
and CC I-POPU
adolescents NNS I-POPU
with IN I-POPU
a DT I-POPU
lifetime JJ I-POPU
diagnosis NN I-POPU
of IN I-POPU
autistic JJ I-POPU
disorder NN I-POPU
. . O

In IN O
addition NN O
, , O
37 CD O
placebo NN B-INTV
nonresponders NNS O
received VBD O
open-label JJ O
risperidone NN B-INTV
for IN O
another DT O
8 CD O
weeks NNS O
. . O

Of IN O
all PDT O
the DT O
risperidone NN B-INTV
responders NNS O
( ( O
n=65 NN O
) ) O
, , O
63 CD O
entered VBD O
an DT O
open JJ O
extension NN O
of IN O
another DT O
16 CD O
weeks NNS O
( ( O
6 CD O
months NNS O
total JJ O
risperidone NN B-INTV
exposure NN O
) ) O
, , O
and CC O
32 CD O
of IN O
them PRP O
were VBD O
rerandomized VBN O
to TO O
either DT O
continued VBN O
risperidone NN B-INTV
therapy NN O
( ( O
n=16 JJ O
) ) O
or CC O
gradual JJ O
replacement NN O
with IN O
placebo NN B-INTV
( ( O
n=16 JJ O
) ) O
over IN O
8 CD O
weeks NNS O
. . O

We PRP O
collected VBD O
the DT O
following JJ O
measures NNS O
of IN O
safety NN B-OC
and CC I-OC
tolerability NN I-OC
: : I-OC
( ( O
1 CD O
) ) O
laboratory NN B-OC
blood NN I-OC
assessments NNS I-OC
( ( I-OC
CBC NNP I-OC
with IN I-OC
differential JJ I-OC
, , I-OC
electrolytes NNS I-OC
, , I-OC
and CC I-OC
liver JJ I-OC
function NN I-OC
tests NNS I-OC
) ) I-OC
and CC I-OC
urinalyses NNS I-OC
, , O
( ( O
2 CD O
) ) O
vital NN B-OC
signs NNS I-OC
, , O
( ( O
3 CD O
) ) O
Side NNP B-OC
Effects NNP I-OC
Review NNP I-OC
of IN I-OC
AEs NNP I-OC
thought VBD O
to TO O
be VB O
associated VBN O
with IN O
risperidone NN O
, , O
( ( O
4 CD O
) ) O
sleep NN B-OC
records NNS I-OC
, , O
( ( O
5 CD O
) ) O
Simpson NNP B-OC
Angus NNP I-OC
Neurological NNP I-OC
Rating NNP I-OC
Scale NNP I-OC
( ( I-OC
SARS NNP I-OC
) ) I-OC
, , O
( ( O
6 CD O
) ) O
Abnormal NNP B-OC
Involuntary NNP I-OC
Movement NNP I-OC
Scale NNP I-OC
( ( I-OC
AIMS NNP I-OC
) ) I-OC
, , O
and CC O
( ( O
7 CD O
) ) O
height NN B-OC
and CC I-OC
weight NN I-OC
. . O

No DT O
clinically RB O
significant JJ O
changes NNS O
were VBD O
found VBN O
on IN O
the DT O
lab NN O
tests NNS O
. . O

During IN O
the DT O
8-week JJ O
acute JJ O
trial NN O
, , O
the DT O
most RBS O
common JJ O
AEs NNP O
on IN O
the DT O
Side NNP O
Effects NNP O
Review NNP O
, , O
scored VBD O
as IN O
moderate JJ O
or CC O
higher JJR O
, , O
were VBD O
as IN O
follows VBZ O
( ( B-INTV
placebo NN I-INTV
and CC O
risperidone NN O
, , O
respectively RB O
) ) O
: : O
Somnolence NN B-OC
( ( O
12 CD O
% NN O
and CC O
37 CD O
% NN O
) ) O
, , O
enuresis NN B-OC
( ( O
29 CD O
% NN O
and CC O
33 CD O
% NN O
) ) O
, , O
excessive JJ B-OC
appetite NN I-OC
( ( O
10 CD O
% NN O
and CC O
33 CD O
% NN O
) ) O
, , O
rhinitis NN B-OC
( ( O
8 CD O
% NN O
and CC O
16 CD O
% NN O
) ) O
, , O
difficulty NN B-OC
waking NN I-OC
( ( O
8 CD O
% NN O
and CC O
12 CD O
% NN O
) ) O
, , O
and CC O
constipation NN B-OC
( ( O
12 CD O
% NN O
and CC O
10 CD O
% NN O
) ) O
. . O

" $ B-OC
Difficulty NNP I-OC
falling VBG I-OC
asleep RB I-OC
" NN I-OC
and CC I-OC
anxiety NN I-OC
actually RB O
favored VBD O
the DT O
risperidone NN O
condition NN O
at IN O
statistically RB O
significant JJ O
levels NNS O
. . O

The DT O
same JJ O
AEs NNP B-OC
tended VBD O
to TO O
recur VB O
through IN O
6 CD O
months NNS O
of IN O
treatment NN O
, , O
although IN O
often RB O
at IN O
reduced VBN O
levels NNS O
. . O

Using VBG O
Centers NNPS O
for IN O
Disease NNP O
Control NNP O
( ( O
CDC NNP O
) ) O
standardized VBD O
scores NNS O
, , O
both DT O
weight NN B-OC
and CC I-OC
body NN I-OC
mass NN I-OC
index NN I-OC
( ( I-OC
BMI NNP I-OC
) ) I-OC
increased VBD O
with IN O
risperidone NN B-INTV
during IN O
the DT O
acute JJ O
trial NN O
( ( O
0.5 CD O
and CC O
0.6 CD O
SDs NNP O
, , O
respectively RB O
, , O
for IN O
risperidone NN B-INTV
; : I-INTV
0.0 CD O
and CC O
0.1 CD O
SDs NNP O
, , O
respectively RB O
, , O
for IN O
placebo NN B-INTV
) ) I-INTV
and CC O
into IN O
open-label JJ O
extension NN O
( ( O
0.19 CD O
and CC O
0.16 CD O
SDs NNP O
, , O
respectively RB O
) ) O
, , O
although IN O
the DT O
amount NN O
of IN O
gain NN O
decelerated VBN O
with IN O
time NN O
. . O

Extrapyramidal NNP B-OC
symptoms NNS I-OC
, , O
as IN O
assessed VBN O
by IN O
the DT O
SARS NNP O
, , O
were VBD O
no DT O
more RBR O
common JJ O
for IN O
drug NN O
than IN O
placebo NN B-INTV
, , O
although IN O
drooling NN O
was VBD O
reported VBN O
more RBR O
often RB O
in IN O
the DT O
risperidone NN B-INTV
group NN O
. . O

There EX O
were VBD O
no DT O
differences NNS O
between IN O
groups NNS O
on IN O
the DT O
AIMS NNP O
. . O

Two CD O
subjects NNS O
had VBD O
seizures NNS B-OC
( ( O
one CD O
taking VBG O
placebo NN B-INTV
) ) I-INTV
, , O
but CC O
these DT O
were VBD O
considered VBN O
unrelated JJ O
to TO O
active JJ O
drug NN O
. . O

Most JJS O
AEs NNPS O
were VBD O
mild JJ O
to TO O
moderate VB O
and CC O
failed VBD O
to TO O
interfere VB O
with IN O
therapeutic JJ O
changes NNS O
; : O
there EX O
were VBD O
no DT O
unanticipated JJ O
AEs NNP O
. . O

The DT O
side NN O
effects NNS O
of IN O
most JJS O
concern NN O
were VBD O
somnolence NN B-OC
and CC I-OC
weight JJ I-OC
gain NN I-OC
. . O

-DOCSTART- -X- O O

The DT O
gluten-free JJ B-INTV
, , I-INTV
casein-free JJ I-INTV
diet NN I-INTV
in IN O
autism NN B-POPU
: : I-POPU
results NNS O
of IN O
a DT O
preliminary JJ O
double NN O
blind VB O
clinical JJ O
trial NN O
. . O

This DT O
study NN O
tested VBD O
the DT O
efficacy NN O
of IN O
a DT O
gluten-free JJ B-INTV
and CC I-INTV
casein-free JJ I-INTV
( ( I-INTV
GFCF NNP I-INTV
) ) I-INTV
diet NN I-INTV
in IN O
treating VBG O
autism NN B-POPU
using VBG O
a DT O
randomized VBN O
, , O
double JJ O
blind NN O
repeated VBD O
measures NNS O
crossover RB O
design NN O
. . O

The DT O
sample NN O
included VBD O
15 CD B-POPU
children NNS I-POPU
aged VBN I-POPU
2-16 CD I-POPU
years NNS I-POPU
with IN I-POPU
autism NN I-POPU
spectrum NN I-POPU
disorder NN I-POPU
. . O

Data NNP O
on IN O
autistic JJ B-OC
symptoms NNS I-OC
and CC I-OC
urinary JJ I-OC
peptide NN I-OC
levels NNS I-OC
were VBD O
collected VBN O
in IN O
the DT O
subjects NNS O
' POS O
homes NNS O
over IN O
the DT O
12 CD O
weeks NNS O
that IN O
they PRP O
were VBD O
on IN O
the DT O
diet JJ O
. . O

Group NNP O
data VBD O
indicated VBD O
no DT O
statistically RB O
significant JJ O
findings NNS O
even RB O
though IN O
several JJ O
parents NNS O
reported VBD O
improvement NN B-OC
in IN O
their PRP$ O
children NNS O
. . O

Although IN O
preliminary JJ O
, , O
this DT O
study NN O
demonstrates VBZ O
how WRB O
a DT O
controlled JJ O
clinical JJ O
trial NN O
of IN O
the DT O
GFCF NNP B-INTV
diet NN I-INTV
can MD O
be VB O
conducted VBN O
, , O
and CC O
suggests VBZ O
directions NNS O
for IN O
future JJ O
research NN O
. . O

-DOCSTART- -X- O O

A DT O
crossover NN O
study NN O
of IN O
risperidone NN B-INTV
in IN O
children NNS B-POPU
, , I-POPU
adolescents NNS I-POPU
and CC I-POPU
adults NNS I-POPU
with IN I-POPU
mental JJ I-POPU
retardation NN I-POPU
. . O

Risperidone NN B-INTV
has VBZ O
shown VBN O
safety NN B-OC
and CC I-OC
efficacy NN I-OC
for IN O
aggressive JJ O
and CC O
destructive JJ B-POPU
behaviors NNS O
in IN O
short-term JJ O
studies NNS O
. . O

This DT O
longer-duration NN O
study NN O
includes VBZ O
a DT O
broad JJ O
sample NN O
. . O

Forty NNP B-POPU
subjects NNS I-POPU
, , I-POPU
aged VBN I-POPU
8-56 CD I-POPU
years NNS I-POPU
( ( I-POPU
mean=22 NN I-POPU
) ) I-POPU
, , I-POPU
all DT I-POPU
with IN I-POPU
mental JJ I-POPU
retardation NN I-POPU
and CC I-POPU
36 CD I-POPU
with IN I-POPU
autism NN I-POPU
spectrum NN I-POPU
disorders NNS I-POPU
participated VBD I-POPU
in IN O
this DT O
22-week JJ O
crossover NN O
study NN O
, , O
with IN O
24 CD O
weeks NNS O
of IN O
open JJ O
maintenance NN O
thereafter RB O
. . O

Of IN O
40 CD O
subjects NNS O
, , O
23 CD O
( ( O
57.5 CD O
% NN O
) ) O
responded VBD O
fully RB O
( ( O
50 CD O
% NN O
decrease NN B-OC
in IN I-OC
Aberrant NNP I-OC
Behavior NNP I-OC
Checklist-Community NNP I-OC
Irritability NNP I-OC
subscale NNP I-OC
score NN I-OC
) ) I-OC
, , O
while IN O
35 CD O
subjects NNS O
( ( O
87.5 CD O
% NN O
) ) O
showed VBD O
a DT O
25 CD O
% NN O
decrease NN B-OC
. . O

Gender NNP O
, , O
mood NN O
disorder NN O
, , O
and CC O
antiseizure NN O
medications NNS O
did VBD O
not RB O
alter VB O
response NN O
. . O

Increased VBN B-OC
appetite NN I-OC
and CC I-OC
weight JJ I-OC
gain NN I-OC
were VBD O
common JJ O
. . O

Low JJ O
dose JJ O
risperidone NN O
was VBD O
effective JJ B-OC
for IN I-OC
aggressive JJ I-OC
behavior NN I-OC
in IN O
persons NNS O
with IN O
MR. NNP O
More NNP O
long-term JJ O
studies NNS O
are VBP O
needed VBN O
, , O
incorporating VBG O
weight NN O
control NN O
interventions NNS O
. . O

-DOCSTART- -X- O O

Risperidone NN B-INTV
and CC O
adaptive JJ B-OC
behavior NN I-OC
in IN O
children NNS B-POPU
with IN I-POPU
autism NN I-POPU
. . O

OBJECTIVE UH O
To TO O
evaluate VB O
the DT O
impact NN O
of IN O
risperidone NN B-INTV
on IN O
adaptive JJ B-OC
behavior NN I-OC
in IN O
children NNS B-POPU
with IN I-POPU
autistic JJ I-POPU
disorder NN I-POPU
who WP I-POPU
have VBP I-POPU
serious JJ I-POPU
behavior NN I-POPU
problems NNS I-POPU
and CC O
to TO O
examine VB O
different JJ O
methods NNS O
of IN O
scoring VBG O
the DT O
Vineland NNP O
Adaptive NNP O
Behavior NNP O
Scales NNP O
to TO O
measure VB O
change NN O
. . O

METHOD NNP O
Forty-eight JJ B-POPU
children NNS I-POPU
( ( I-POPU
5 CD I-POPU
years NNS I-POPU
to TO I-POPU
16 CD I-POPU
years NNS I-POPU
, , I-POPU
5 CD I-POPU
months NNS I-POPU
) ) I-POPU
who WP I-POPU
showed VBD I-POPU
behavioral JJ I-POPU
improvement NN I-POPU
during IN I-POPU
acute JJ I-POPU
treatment NN I-POPU
with IN I-POPU
risperidone NN I-POPU
were VBD B-INTV
followed VBN I-INTV
for IN I-INTV
6 CD I-INTV
months NNS I-INTV
and CC O
assessed VBN O
with IN O
the DT O
Vineland NNP O
Scales NNP O
. . O

RESULTS NNP O
Raw NNP B-OC
scores VBZ I-OC
, , I-OC
age-equivalents NNS I-OC
, , I-OC
and CC I-OC
special JJ I-OC
norm NN I-OC
percentile NN I-OC
scores VBZ I-OC
all DT O
showed VBD O
significant JJ O
increases NNS O
in IN O
adaptive JJ B-OC
behavior NN I-OC
in IN I-OC
the DT I-OC
areas NNS I-OC
of IN I-OC
communication NN I-OC
, , I-OC
daily JJ I-OC
living NN I-OC
skills NNS I-OC
, , I-OC
and CC I-OC
socialization NN I-OC
( ( O
p JJ O
< NNP O
.01 NNP O
) ) O
. . O

During IN O
a DT O
period NN O
of IN O
6 CD O
to TO O
8 CD O
months NNS O
, , O
children NNS O
gained VBD O
an DT O
average NN O
of IN O
7.8 CD O
age-equivalent JJ O
months NNS O
in IN O
the DT O
area NN B-OC
of IN I-OC
socialization NN I-OC
, , O
a DT O
> JJ O
6 CD O
% NN O
improvement NN O
beyond IN O
what WP O
would MD O
be VB O
expected VBN O
based VBN O
on IN O
baseline JJ O
growth NN O
rates NNS O
. . O

CONCLUSIONS NNP O
Although IN O
limited VBN O
by IN O
the DT O
absence NN O
of IN O
a DT O
control NN O
group NN O
, , O
these DT O
results NNS O
suggest VBP O
that IN O
risperidone NN O
may MD O
improve VB O
adaptive JJ B-OC
skills NNS I-OC
in IN O
children NNS B-POPU
with IN I-POPU
autistic JJ I-POPU
disorder NN I-POPU
accompanied VBN O
by IN O
serious JJ O
behavioral JJ O
problems NNS O
. . O

Vineland NNP O
age-equivalent JJ O
scores NNS O
appear VBP O
to TO O
be VB O
most RBS O
useful JJ O
in IN O
assessing VBG O
change NN O
with IN O
treatment NN O
over IN O
time NN O
. . O

-DOCSTART- -X- O O

The DT O
effect NN O
of IN O
a DT O
parent-implemented JJ B-INTV
imitation NN I-INTV
intervention NN I-INTV
on IN O
spontaneous JJ B-OC
imitation NN I-OC
skills NNS I-OC
in IN O
young JJ B-POPU
children NNS I-POPU
with IN I-POPU
autism NN I-POPU
. . O

Children NNP B-POPU
with IN I-POPU
autism NN I-POPU
exhibit NN O
significant JJ O
deficits NNS O
in IN O
their PRP$ O
ability NN O
to TO O
spontaneously RB B-OC
imitate VB I-OC
the DT O
play NN B-OC
actions NNS I-OC
and CC I-OC
descriptive JJ I-OC
gestures NNS I-OC
of IN O
others NNS O
. . O

Reciprocal JJ B-INTV
imitation NN I-INTV
training NN I-INTV
( ( I-INTV
RIT NNP I-INTV
) ) I-INTV
is VBZ I-INTV
a DT I-INTV
naturalistic JJ I-INTV
imitation NN I-INTV
intervention NN I-INTV
designed VBN O
to TO O
teach VB O
spontaneous JJ B-OC
imitation NN I-OC
skills NNS I-OC
during IN O
play NN O
. . O

This DT O
study NN O
assessed VBD O
the DT O
effectiveness NN B-OC
of IN O
parent-implemented JJ O
RIT NNP B-INTV
using VBG O
a DT O
multiple-baseline JJ O
design NN O
across IN O
three CD B-POPU
young JJ I-POPU
children NNS I-POPU
with IN I-POPU
autism NN I-POPU
and CC I-POPU
their PRP$ I-POPU
mothers NNS I-POPU
. . O

After IN O
an DT O
initial JJ O
baseline NN O
, , O
mothers NNS O
were VBD O
taught VBN O
to TO O
implement VB O
RIT NNP B-INTV
techniques NNS O
with IN O
their PRP$ O
child NN O
twice RB O
a DT O
week NN O
for IN O
10 CD O
weeks NNS O
in IN O
a DT O
clinic JJ O
setting NN O
. . O

Two CD O
mothers NNS O
were VBD O
taught VBN O
to TO O
use VB O
RIT NNP B-INTV
to TO O
teach VB O
object JJ O
imitation NN O
. . O

The DT O
third JJ O
mother NN O
was VBD O
taught VBN O
to TO O
use VB O
RIT NNP B-INTV
to TO O
target VB O
both DT O
object JJ O
and CC O
gesture JJ O
imitation NN O
in IN O
a DT O
multiple-baseline JJ O
design NN O
across IN O
behaviors NNS O
. . O

Generalization NNP O
was VBD O
assessed VBN O
in IN O
the DT O
families NNS O
' POS O
homes NNS O
at IN O
the DT O
end NN O
of IN O
treatment NN O
and CC O
a DT O
1-month JJ O
follow-up NN O
. . O

Parents NNS O
learned VBD B-OC
to TO O
use VB O
the DT O
intervention NN O
strategies NNS O
and CC O
their PRP$ O
children NNS O
exhibited VBN O
increases NNS O
in IN O
spontaneous JJ B-OC
imitation NN I-OC
. . O

These DT O
findings NNS O
replicate VBP O
the DT O
results NNS O
from IN O
previous JJ O
studies NNS O
, , O
indicating VBG O
that IN O
RIT NNP O
is VBZ O
effective JJ O
for IN O
teaching VBG O
imitation NN B-OC
skills NNS I-OC
to TO O
young JJ B-POPU
children NNS I-POPU
with IN I-POPU
autism NN I-POPU
in IN O
a DT O
naturalistic JJ O
setting NN O
and CC O
extend VB O
the DT O
findings NNS O
to TO O
parents NNS B-POPU
. . O

-DOCSTART- -X- O O

Effects NNS O
on IN O
parental JJ B-OC
mental JJ I-OC
health NN I-OC
of IN O
an DT O
education NN B-INTV
and CC I-INTV
skills NNS I-INTV
training VBG I-INTV
program NN I-INTV
for IN O
parents NNS B-POPU
of IN I-POPU
young JJ I-POPU
children NNS I-POPU
with IN I-POPU
autism NN I-POPU
: : I-POPU
a DT O
randomized NN O
controlled VBN O
trial NN O
. . O

OBJECTIVE NN O
To TO O
determine VB O
the DT O
impact NN O
of IN O
a DT O
parent NN B-INTV
education NN I-INTV
and CC I-INTV
behavior JJ I-INTV
management NN I-INTV
intervention NN I-INTV
( ( I-INTV
PEBM NNP I-INTV
) ) I-INTV
on IN O
the DT O
mental JJ O
health NN O
and CC O
adjustment NN O
of IN O
parents NNS B-POPU
with IN I-POPU
preschool JJ I-POPU
children NNS I-POPU
with IN I-POPU
autism NN I-POPU
. . O

METHOD NNP O
A NNP O
randomized JJ O
, , O
group-comparison JJ O
design NN O
involving VBG O
a DT O
parent NN B-INTV
education NN I-INTV
and CC I-INTV
counseling VBG I-INTV
intervention NN I-INTV
to TO O
control VB O
for IN O
nonspecific JJ O
therapist NN O
effects NNS O
and CC O
a DT O
control NN O
sample NN O
was VBD O
used VBN O
. . O

Two CD B-POPU
metropolitan JJ I-POPU
and CC I-POPU
two CD I-POPU
rural JJ I-POPU
regions NNS I-POPU
were VBD O
randomly RB O
allocated VBN O
to TO O
intervention NN O
groups NNS O
( ( O
n JJ O
= NNP O
70 CD O
) ) O
or CC O
control NN O
( ( O
n JJ O
= NNP O
35 CD O
) ) O
. . O

The DT B-POPU
parents NNS I-POPU
of IN I-POPU
consecutive JJ I-POPU
children NNS I-POPU
with IN I-POPU
autism NN I-POPU
( ( I-POPU
2 CD I-POPU
( ( I-POPU
1/2 CD I-POPU
) ) I-POPU
-5 CD I-POPU
years NNS I-POPU
old JJ I-POPU
) ) I-POPU
from IN I-POPU
the DT I-POPU
autism NN I-POPU
assessment NN I-POPU
services NNS I-POPU
for IN I-POPU
the DT I-POPU
intervention NN I-POPU
regions NNS I-POPU
were VBD O
then RB O
randomly RB O
allocated VBN O
to TO O
either VB O
a DT O
20-week JJ B-INTV
manual-based JJ I-INTV
parent NN I-INTV
education NN I-INTV
and CC I-INTV
behavior JJ I-INTV
management NN I-INTV
intervention NN I-INTV
( ( I-INTV
n JJ I-INTV
= NNP I-INTV
35 CD I-INTV
) ) I-INTV
or CC I-INTV
a DT I-INTV
manual-based JJ I-INTV
parent NN I-INTV
education NN I-INTV
and CC I-INTV
counseling VBG I-INTV
intervention NN I-INTV
( ( O
n JJ O
= NNP O
35 CD O
) ) O
. . O

The DT O
main JJ O
outcome JJ O
measure NN O
of IN O
parental JJ B-OC
mental JJ I-OC
health NN I-OC
was VBD O
the DT O
General NNP B-OC
Health NNP I-OC
Questionnaire NNP I-OC
used VBD O
pre- NN O
and CC O
postintervention NN O
and CC O
at IN O
6-month JJ O
follow-up NN O
. . O

RESULTS NNP O
Both NNP O
treatments NNS O
resulted VBD O
in IN O
significant JJ B-OC
and CC I-OC
progressive JJ I-OC
improvement NN I-OC
in IN I-OC
overall JJ I-OC
mental JJ I-OC
health NN I-OC
at IN O
follow-up NN O
( ( O
F NNP O
= NNP O
2 CD O
, , O
97 CD O
, , O
p FW O
=.007 NN O
) ) O
and CC O
mental JJ B-OC
health NN I-OC
significantly RB I-OC
improved VBN I-OC
over RP I-OC
time NN I-OC
in IN O
the DT O
54 CD O
% NN O
of IN O
principal JJ O
caregivers NNS O
who WP O
had VBD O
the DT O
highest JJS O
levels NNS O
of IN O
mental JJ O
health NN O
problems NNS O
. . O

The DT O
parent NN B-INTV
education NN I-INTV
and CC I-INTV
behavior JJ I-INTV
management NN I-INTV
intervention NN O
was VBD O
effective JJ O
in IN O
alleviating VBG B-OC
a DT I-OC
greater JJR I-OC
percentage NN I-OC
of IN I-OC
anxiety NN I-OC
, , I-OC
insomnia NN I-OC
, , I-OC
and CC I-OC
somatic JJ I-OC
symptoms NNS I-OC
and CC I-OC
family NN I-OC
dysfunction NN I-OC
than IN O
parent NN O
education NN O
and CC O
counseling VBG O
at IN O
6-month JJ O
follow-up NN O
. . O

CONCLUSIONS VB O
A DT O
20-week JJ O
parent NN B-INTV
education NN I-INTV
and CC I-INTV
skills NNS I-INTV
training VBG I-INTV
program NN I-INTV
for IN O
parents NNS B-POPU
of IN I-POPU
young JJ I-POPU
children NNS I-POPU
newly RB I-POPU
diagnosed VBN I-POPU
with IN I-POPU
autism NN I-POPU
provides VBZ O
significant JJ O
improvements NNS O
in IN O
parental JJ B-OC
mental JJ I-OC
health NN I-OC
and CC I-OC
adjustment NN I-OC
, , O
justifying VBG O
its PRP$ O
addition NN O
to TO O
early JJ O
intervention NN O
programs NNS O
at IN O
least JJS O
for IN O
parents NNS B-POPU
with IN I-POPU
mental JJ I-POPU
health NN I-POPU
problems NNS I-POPU
. . O

-DOCSTART- -X- O O

Joint JJ O
attention NN O
and CC O
symbolic JJ O
play NN O
in IN O
young JJ B-POPU
children NNS I-POPU
with IN I-POPU
autism NN I-POPU
: : I-POPU
a DT O
randomized VBN O
controlled VBN O
intervention NN O
study NN O
. . O

BACKGROUND NNP O
Delays NNPS O
and CC O
deficits NNS O
in IN O
joint JJ O
attention NN O
and CC O
symbolic JJ O
play NN O
constitute NN O
two CD O
important JJ O
developmental NN O
problems NNS O
in IN O
young JJ B-POPU
children NNS I-POPU
with IN I-POPU
autism NN I-POPU
. . O

These DT O
areas NNS O
of IN O
deficit NN O
have VBP O
been VBN O
well RB O
studied VBN O
in IN O
autism NN O
but CC O
have VBP O
rarely RB O
been VBN O
the DT O
focus NN O
of IN O
treatment NN O
efforts NNS O
( ( O
see VB O
Kasari NNP O
, , O
Freeman NNP O
, , O
& CC O
Paparella NNP O
, , O
2001 CD O
) ) O
. . O

In IN O
this DT O
study NN O
, , O
we PRP O
examine VBP O
the DT O
efficacy NN O
of IN O
targeted JJ O
interventions NNS O
of IN O
joint JJ B-INTV
attention NN I-INTV
and CC I-INTV
symbolic JJ I-INTV
play NN I-INTV
. . O

METHODS NNP O
Participants NNPS B-POPU
were VBD I-POPU
58 CD I-POPU
children NNS I-POPU
with IN I-POPU
autism NN I-POPU
aged VBN I-POPU
3 CD I-POPU
and CC I-POPU
4 CD I-POPU
years NNS I-POPU
( ( I-POPU
46 CD I-POPU
boys NNS I-POPU
) ) I-POPU
. . O

Children NNP O
were VBD O
randomized VBN O
to TO O
a DT O
joint JJ B-INTV
attention NN I-INTV
intervention NN I-INTV
, , I-INTV
a DT I-INTV
symbolic JJ I-INTV
play NN I-INTV
intervention NN I-INTV
, , I-INTV
or CC I-INTV
control NN I-INTV
group NN I-INTV
. . O

Interventions NNS O
were VBD O
conducted VBN O
30 CD O
minutes NNS O
daily RB O
for IN O
5-6 JJ O
weeks NNS O
. . O

Both DT O
structured JJ O
assessments NNS O
of IN O
joint JJ O
attention NN O
and CC O
play NN O
skills NNS O
and CC O
mother-child JJ O
interactions NNS O
were VBD O
collected VBN O
pre NN O
and CC O
post NN O
intervention NN O
by IN O
independent JJ O
assessors NNS O
. . O

RESULTS NNP O
Results NNP O
indicate VBP O
that IN O
both DT O
intervention NN O
groups NNS O
improved VBN O
significantly RB O
over IN O
the DT O
control NN O
group NN O
on IN O
certain JJ O
behaviors NNS O
. . O

Children NNP O
in IN O
the DT O
joint JJ O
attention NN O
intervention NN O
initiated VBN O
significantly RB O
more RBR O
showing JJ B-OC
and CC O
responsiveness NN B-OC
to TO I-OC
joint JJ I-OC
attention NN I-OC
on IN O
the DT O
structured VBN B-OC
joint JJ I-OC
attention NN I-OC
assessment NN I-OC
and CC O
more JJR O
child-initiated JJ B-OC
joint NN I-OC
attention NN I-OC
in IN O
the DT O
mother-child JJ B-OC
interaction NN I-OC
. . O

The DT O
children NNS O
in IN O
the DT O
play NN O
group NN O
showed VBD O
more JJR O
diverse JJ O
types NNS B-OC
of IN I-OC
symbolic JJ I-OC
play NN I-OC
in IN O
interaction NN O
with IN O
their PRP$ O
mothers NNS O
and CC O
higher JJR O
play NN B-OC
levels NNS I-OC
on IN O
both DT O
the DT O
play NN B-OC
assessment NN I-OC
and CC O
in IN O
interaction NN B-OC
with IN I-OC
their PRP$ I-OC
mothers NNS I-OC
. . O

CONCLUSIONS VB O
This DT O
randomized VBN O
controlled JJ O
trial NN O
provides VBZ O
promising JJ O
data NNS O
on IN O
the DT O
specificity NN B-OC
and CC I-OC
generalizability NN I-OC
of IN I-OC
joint JJ I-OC
attention NN I-OC
and CC I-OC
play NN I-OC
interventions NNS I-OC
for IN O
young JJ B-POPU
children NNS I-POPU
with IN I-POPU
autism NN I-POPU
. . O

Future JJ O
studies NNS O
need VBP O
to TO O
examine VB O
the DT O
long-term JJ O
effects NNS O
of IN O
these DT O
early JJ O
interventions NNS O
on IN O
children NNS O
's POS O
development NN O
. . O

-DOCSTART- -X- O O

Effects NNS O
of IN O
short- JJ O
and CC O
long-term JJ O
risperidone NN B-INTV
treatment NN B-POPU
on IN I-POPU
prolactin NN I-POPU
levels NNS I-POPU
in IN I-POPU
children NNS I-POPU
with IN I-POPU
autism NN I-POPU
. . O

BACKGROUND IN O
The DT O
effects NNS O
of IN O
short- JJ O
and CC O
long-term JJ O
risperidone NN B-INTV
treatment NN O
on IN O
serum NN O
prolactin NN O
were VBD O
assessed VBN O
in IN O
children NNS B-POPU
and CC I-POPU
adolescents NNS I-POPU
with IN I-POPU
autism NN I-POPU
. . O

METHODS NNP O
Patients NNPS B-POPU
with IN I-POPU
autism NN I-POPU
( ( I-POPU
N NNP I-POPU
= NNP I-POPU
101 CD I-POPU
, , I-POPU
5-17 CD I-POPU
years NNS I-POPU
of IN I-POPU
age NN I-POPU
) ) I-POPU
were VBD O
randomized VBN O
to TO O
an DT O
8-week JJ O
trial NN O
of IN O
risperidone NN B-INTV
or CC I-INTV
placebo NN I-INTV
and CC O
63 CD B-POPU
then RB I-POPU
took VBD I-POPU
part NN I-POPU
in IN I-POPU
a DT I-POPU
4-month JJ I-POPU
open-label JJ I-POPU
follow-up JJ I-POPU
phase NN I-POPU
. . O

Serum NNP O
samples NNS O
were VBD O
obtained VBN O
at IN O
Baseline NNP O
and CC O
Week-8 NNP O
( ( O
N NNP O
= NNP O
78 CD O
) ) O
, , O
and CC O
at IN O
6-month JJ O
( ( O
N NNP O
= NNP O
43 CD O
) ) O
and CC O
22-month JJ O
( ( O
N NNP O
= NNP O
30 CD O
) ) O
follow-up NN O
. . O

Serum NNP O
prolactin NN O
was VBD O
determined VBN O
by IN O
immunoradiometric JJ O
assay NN O
; : O
dopamine JJ B-OC
type-2 JJ I-OC
receptor NN I-OC
( ( I-OC
DRD2 NNP I-OC
) ) I-OC
polymorphisms NNS I-OC
were VBD I-OC
genotyped VBN I-OC
. . O

RESULTS NNP O
Baseline NNP B-OC
prolactin NN I-OC
levels NNS I-OC
were VBD O
similar JJ O
in IN O
the DT O
risperidone NN B-INTV
( ( O
N NNP O
= NNP O
42 CD O
) ) O
and CC O
placebo NN B-INTV
( ( O
N NNP O
= NNP O
36 CD O
) ) O
groups NNS O
( ( O
9.3 CD O
+/- JJ O
7.5 CD O
and CC O
9.3 CD O
+/- JJ O
7.6 CD O
ng/ml NN O
, , O
respectively RB O
) ) O
. . O

After IN O
8 CD O
weeks NNS O
of IN O
risperidone NN B-INTV
, , O
prolactin NN B-OC
increased VBD O
to TO O
39.0 CD O
+/- JJ O
19.2 CD O
ng/ml NN O
, , O
compared VBN O
with IN O
10.1 CD O
+/- JJ O
8.8 CD O
ng/ml NN O
for IN O
placebo NN O
( ( O
p JJ O
< NNP O
.0001 NNP O
) ) O
. . O

Prolactin NN B-OC
levels NNS I-OC
were VBD O
also RB O
significantly RB O
increased VBN O
at IN O
6 CD O
months NNS O
( ( O
32.4 CD O
+/- JJ O
17.8 CD O
ng/ml NN O
; : O
N NNP O
= VBZ O
43 CD O
, , O
p NN O
< NNP O
.0001 NNP O
) ) O
and CC O
at IN O
22 CD O
months NNS O
( ( O
N NNP O
= NNP O
30 CD O
, , O
25.3 CD O
+/- JJ O
15.6 CD O
ng/ml NN O
, , O
p NN O
< NNP O
.0001 NNP O
) ) O
. . O

Prolactin NN B-OC
levels NNS I-OC
were VBD O
not RB O
associated VBN O
with IN O
adverse JJ O
effects NNS O
and CC O
DRD2 NNP O
alleles NNS O
( ( O
Taq1A NNP O
, , O
-141C NNP O
Ins/Del NNP O
, , O
C957T NNP O
) ) O
did VBD O
not RB O
significantly RB O
influence VB O
baseline NN O
levels NNS O
or CC O
risperidone-induced JJ O
increases NNS O
in IN O
prolactin NN O
. . O

CONCLUSIONS NNP O
Risperidone NNP B-INTV
treatment NN O
was VBD O
associated VBN O
with IN O
two- JJ O
to TO O
four-fold JJ O
mean NN O
increases NNS O
in IN O
serum NN O
prolactin NN O
in IN O
children NNS B-POPU
with IN I-POPU
autism NN I-POPU
. . O

Although IN O
risperidone-induced JJ O
increases NNS O
tended VBD O
to TO O
diminish VB O
with IN O
time NN O
, , O
further JJ O
research NN O
on IN O
the DT O
consequences NNS O
of IN O
long-term JJ O
prolactin NN O
elevations NNS O
in IN O
children NNS B-POPU
and CC I-POPU
adolescents NNS I-POPU
is VBZ O
needed VBN O
. . O

-DOCSTART- -X- O O

Randomized NNP O
comparison NN O
of IN O
two CD B-INTV
communication NN I-INTV
interventions NNS I-INTV
for IN O
preschoolers NNS B-POPU
with IN I-POPU
autism NN I-POPU
spectrum NN I-POPU
disorders NNS I-POPU
. . O

This DT O
randomized JJ O
group NN O
experiment NN O
compared VBN O
the DT O
efficacy NN O
of IN O
2 CD B-INTV
communication NN I-INTV
interventions NNS I-INTV
( ( I-INTV
Responsive JJ I-INTV
Education NN I-INTV
and CC I-INTV
Prelinguistic NNP I-INTV
Milieu NNP I-INTV
Teaching NNP I-INTV
[ NNP I-INTV
RPMT NNP I-INTV
] NNP I-INTV
and CC I-INTV
the DT I-INTV
Picture NNP I-INTV
Exchange NNP I-INTV
Communication NNP I-INTV
System NNP I-INTV
[ NNP I-INTV
PECS NNP I-INTV
] NNP I-INTV
) ) I-INTV
in IN O
36 CD B-POPU
preschoolers NNS I-POPU
with IN I-POPU
autism NN I-POPU
spectrum NN I-POPU
disorders NNS I-POPU
. . O

Each DT O
treatment NN O
was VBD O
delivered VBN O
3 CD O
times NNS O
per IN O
week NN O
, , O
in IN O
20-min JJ O
sessions NNS O
, , O
for IN O
6 CD O
months NNS O
. . O

The DT O
results NNS O
revealed VBD O
that IN O
the DT O
RPMT NNP B-INTV
facilitated VBD O
the DT O
frequency NN B-OC
of IN I-OC
generalized JJ I-OC
turn NN I-OC
taking VBG I-OC
and CC I-OC
generalized VBN I-OC
initiating NN I-OC
joint JJ I-OC
attention NN I-OC
more RBR O
than IN O
did VBD O
the DT O
PECS NNP O
. . O

The DT O
latter JJ O
effect NN O
occurred VBD O
only RB O
for IN O
children NNS O
who WP O
began VBD O
treatment NN O
with IN O
at IN O
least JJS O
some DT O
initiating VBG B-OC
joint JJ I-OC
attention NN I-OC
. . O

In IN O
contrast NN O
, , O
the DT O
PECS NNP B-INTV
facilitated VBD O
generalized JJ B-OC
requests NNS I-OC
more RBR O
than IN O
the DT O
RPMT NNP O
in IN O
children NNS O
with IN O
very RB O
little JJ O
initiating VBG B-OC
joint JJ I-OC
attention NN I-OC
prior RB O
to TO O
treatment NN O
. . O

These DT O
effect NN B-OC
sizes NNS I-OC
were VBD O
large JJ B-OC
. . O

-DOCSTART- -X- O O

Analysis NN O
of IN O
face NN B-INTV
gaze NN I-INTV
in IN O
autism NN B-POPU
using VBG O
" JJ O
Bubbles NNP O
" NNP O
. . O

One CD O
of IN O
the DT O
components NNS O
of IN O
abnormal JJ O
social JJ O
functioning NN O
in IN O
autism NN B-POPU
is VBZ O
an DT O
impaired JJ O
ability NN O
to TO O
direct VB O
eye NN O
gaze NN O
onto IN O
other JJ O
people NNS O
's POS O
faces VBZ O
in IN O
social JJ O
situations NNS O
. . O

Here RB O
, , O
we PRP O
investigated VBD O
the DT O
relationship NN O
between IN O
gaze NN B-OC
onto IN I-OC
the DT I-OC
eye NN I-OC
and CC I-OC
mouth JJ I-OC
regions NNS I-OC
of IN I-OC
faces VBZ I-OC
, , O
and CC O
the DT O
visual JJ O
information NN O
that WDT O
was VBD O
present JJ O
within IN O
those DT O
regions NNS O
. . O

We PRP O
used VBD O
the DT O
" JJ B-INTV
Bubbles NNP I-INTV
" NNP I-INTV
method NN I-INTV
to TO O
vary VB O
the DT O
facial JJ O
information NN O
available JJ O
on IN O
any DT O
given VBN O
trial NN O
by IN O
revealing VBG O
only RB O
small JJ O
parts NNS O
of IN O
the DT O
face NN O
, , O
and CC O
measured VBD O
the DT O
eye NN B-OC
movements NNS I-OC
made VBN O
as IN O
participants NNS O
viewed IN O
these DT O
stimuli NNS O
. . O

Compared VBN B-POPU
to TO I-POPU
ten VB I-POPU
IQ- NNP I-POPU
and CC I-POPU
age-matched JJ I-POPU
healthy JJ I-POPU
controls NNS I-POPU
, , I-POPU
eight CD I-POPU
participants NNS I-POPU
with IN I-POPU
autism NN I-POPU
showed VBD O
less JJR O
fixation JJ B-OC
specificity NN I-OC
to TO O
the DT O
eyes NNS O
and CC O
mouth NN O
, , O
a DT O
greater JJR O
tendency NN O
to TO O
saccade VB O
away RB O
from IN O
the DT O
eyes NNS O
when WRB O
information NN O
was VBD O
present JJ O
in IN O
those DT O
regions NNS O
, , O
and CC O
abnormal JJ O
directionality NN O
of IN O
saccades NNS O
. . O

The DT O
findings NNS O
provide VBP O
novel JJ O
detail NN O
to TO O
the DT O
abnormal JJ O
way NN O
in IN O
which WDT O
people NNS O
with IN O
autism NN O
look NN O
at IN O
faces VBZ O
, , O
an DT O
impairment NN O
that WDT O
likely JJ O
influences VBZ O
all DT O
subsequent JJ O
face NN O
processing NN O
. . O

-DOCSTART- -X- O O

Teaching VBG O
young JJ B-POPU
nonverbal JJ I-POPU
children NNS I-POPU
with IN I-POPU
autism NN I-POPU
useful JJ O
speech NN O
: : O
a DT O
pilot NN O
study NN O
of IN O
the DT O
Denver NNP B-INTV
Model NNP I-INTV
and CC I-INTV
PROMPT NNP I-INTV
interventions NNS I-INTV
. . O

This DT O
single JJ O
subject NN O
design NN O
study NN O
examined VBD O
two CD O
models NNS O
of IN O
intervention NN O
: : O
Denver NNP B-INTV
Model NNP I-INTV
( ( I-INTV
which WDT I-INTV
merges VBZ I-INTV
behavioral JJ I-INTV
, , I-INTV
developmental JJ I-INTV
, , I-INTV
and CC I-INTV
relationship-oriented JJ I-INTV
intervention NN I-INTV
) ) I-INTV
, , I-INTV
and CC I-INTV
PROMPT NNP I-INTV
( ( I-INTV
a DT I-INTV
neuro-developmental JJ I-INTV
approach NN I-INTV
for IN I-INTV
speech JJ I-INTV
production NN I-INTV
disorders NNS I-INTV
) ) I-INTV
. . O

Ten CD B-POPU
young JJ I-POPU
, , I-POPU
nonverbal JJ I-POPU
children NNS I-POPU
with IN I-POPU
autism NN I-POPU
were VBD O
matched VBN O
in IN O
pairs NNS O
and CC O
randomized VBN O
to TO O
treatment NN O
. . O

They PRP O
received VBD O
12 CD O
1-h JJ O
weekly JJ O
sessions NNS O
of IN O
therapy NN O
and CC O
daily JJ O
1-h JJ O
home NN O
intervention NN O
delivered VBN O
by IN O
parents NNS O
. . O

Fidelity NNP O
criteria NNS O
were VBD O
maintained VBN O
throughout IN O
. . O

Eight NNP O
of IN O
the DT O
ten JJ O
children NNS O
used VBN O
five CD O
or CC O
more JJR O
novel JJ O
, , O
functional JJ B-OC
words NNS O
spontaneously RB O
and CC O
spoke VBD O
multiple JJ B-OC
times NNS I-OC
per IN I-OC
hour NN I-OC
by IN O
the DT O
conclusion NN O
of IN O
treatment NN O
. . O

There EX O
were VBD O
no DT O
differences NNS O
in IN O
acquired VBN B-OC
language NN I-OC
skills NNS I-OC
by IN O
intervention NN O
group NN O
. . O

Initial JJ O
characteristics NNS O
of IN O
the DT O
best JJS O
responders NNS O
were VBD O
mild JJ B-POPU
to TO I-POPU
moderate VB I-POPU
symptoms NNS I-POPU
of IN I-POPU
autism NN I-POPU
, , I-POPU
better JJR I-POPU
motor NN I-POPU
imitation NN I-POPU
skills NNS I-POPU
, , B-OC
and CC I-OC
emerging VBG B-POPU
joint JJ I-POPU
attention NN I-POPU
skills NNS I-POPU
. . O

-DOCSTART- -X- O O

Divalproex NNP B-INTV
versus NN I-INTV
placebo NN I-INTV
for IN O
the DT O
prevention NN O
of IN O
irritability NN B-OC
associated VBN O
with IN O
fluoxetine JJ B-INTV
treatment NN O
in IN O
autism NN B-POPU
spectrum NN I-POPU
disorder NN I-POPU
. . O

-DOCSTART- -X- O O

Oxytocin NNP B-INTV
increases VBZ O
retention NN B-OC
of IN I-OC
social JJ I-OC
cognition NN I-OC
in IN O
autism NN O
. . O

BACKGROUND NNP O
Oxytocin NNP B-INTV
dysfunction NN O
might MD O
contribute VB O
to TO O
the DT O
development NN O
of IN O
social JJ O
deficits NNS O
in IN O
autism NN O
, , O
a DT O
core NN O
symptom NN O
domain NN O
and CC O
potential JJ O
target NN O
for IN O
intervention NN O
. . O

This DT O
study NN O
explored VBD O
the DT O
effect NN O
of IN O
intravenous JJ O
oxytocin JJ B-INTV
administration NN O
on IN O
the DT O
retention NN O
of IN O
social JJ O
information NN O
in IN O
autism NN O
. . O

METHODS NNP O
Oxytocin NNP B-INTV
and CC I-INTV
placebo NN I-INTV
challenges NNS O
were VBD O
administered VBN O
to TO O
15 CD B-POPU
adult NN I-POPU
subjects NNS I-POPU
diagnosed VBN I-POPU
with IN I-POPU
autism NN I-POPU
or CC I-POPU
Asperger NNP I-POPU
's POS I-POPU
disorder NN I-POPU
, , I-POPU
and CC I-POPU
comprehension NN I-POPU
of IN I-POPU
affective JJ I-POPU
speech NN I-POPU
( ( I-POPU
happy JJ I-POPU
, , I-POPU
indifferent JJ I-POPU
, , I-POPU
angry JJ I-POPU
, , I-POPU
and CC I-POPU
sad NN I-POPU
) ) I-POPU
in IN O
neutral JJ O
content NN O
sentences NNS O
was VBD O
tested VBN O
. . O

RESULTS NNP O
All NNP O
subjects VBZ O
showed VBD O
improvements NNS O
in IN O
affective JJ B-OC
speech NN I-OC
comprehension NN I-OC
from IN O
pre- JJ O
to TO O
post-infusion NN O
; : O
however RB O
, , O
whereas NNS O
those DT O
who WP O
received VBD O
placebo NN B-INTV
first RB O
tended VBD O
to TO O
revert VB O
to TO O
baseline VB O
after IN O
a DT O
delay NN O
, , O
those DT O
who WP O
received VBD O
oxytocin PRP O
first RB O
retained VBD O
the DT O
ability NN O
to TO O
accurately RB O
assign VB B-OC
emotional JJ I-OC
significance NN I-OC
to TO I-OC
speech VB I-OC
intonation NN I-OC
on IN O
the DT O
speech NN O
comprehension NN O
task NN O
. . O

CONCLUSIONS NNP O
These DT O
results NNS O
are VBP O
consistent JJ O
with IN O
studies NNS O
linking VBG O
oxytocin NN B-INTV
to TO O
social JJ B-OC
recognition NN I-OC
in IN O
rodents NNS O
as RB O
well RB O
as IN O
studies NNS O
linking VBG O
oxytocin NN O
to TO O
prosocial JJ B-OC
behavior NN I-OC
in IN O
humans NNS O
and CC O
suggest VBP O
that IN O
oxytocin NN O
might MD O
facilitate VB O
social JJ O
information NN O
processing NN O
in IN O
those DT O
with IN O
autism NN O
. . O

These DT O
findings NNS O
also RB O
provide VBP O
preliminary JJ O
support NN O
for IN O
the DT O
use NN O
of IN O
oxytocin NN B-INTV
in IN O
the DT O
treatment NN O
of IN O
autism NN O
. . O

-DOCSTART- -X- O O

A DT O
randomized JJ O
comparison NN O
of IN O
the DT O
effect NN O
of IN O
two CD O
prelinguistic JJ B-INTV
communication NN I-INTV
interventions NNS I-INTV
on IN O
the DT O
acquisition NN O
of IN O
spoken JJ O
communication NN O
in IN O
preschoolers NNS B-POPU
with IN I-POPU
ASD NNP I-POPU
. . O

PURPOSE NNP O
This DT O
randomized VBN O
group NN O
experiment NN O
compared VBN O
the DT O
efficacy NN O
of IN O
2 CD O
communication NN B-INTV
interventions NNS I-INTV
( ( I-INTV
Responsive JJ I-INTV
Education NN I-INTV
and CC I-INTV
Prelinguistic NNP I-INTV
Milieu NNP I-INTV
Teaching NNP I-INTV
[ NNP I-INTV
RPMT NNP I-INTV
] NNP I-INTV
and CC I-INTV
the DT I-INTV
Picture NNP I-INTV
Exchange NNP I-INTV
Communication NNP I-INTV
System NNP I-INTV
[ NNP I-INTV
PECS NNP I-INTV
] NNP I-INTV
) ) I-INTV
on IN O
spoken JJ O
communication NN O
in IN O
36 CD B-POPU
preschoolers NNS I-POPU
with IN I-POPU
autism NN I-POPU
spectrum NN I-POPU
disorders NNS I-POPU
( ( I-POPU
ASD NNP I-POPU
) ) I-POPU
. . O

METHOD NNP O
Each DT O
treatment NN O
was VBD O
delivered VBN O
to TO O
children NNS O
for IN O
a DT O
maximum JJ O
total NN O
of IN O
24 CD O
hr NN O
over IN O
a DT O
6-month JJ O
period NN O
. . O

Spoken NNP O
communication NN O
was VBD O
assessed VBN O
in IN O
a DT O
rigorous JJ O
test NN O
of IN O
generalization NN O
at IN O
pretreatment NN O
, , O
posttreatment NN O
, , O
and CC O
6-month JJ O
follow-up JJ O
periods NNS O
. . O

RESULTS NNP O
PECS NNP B-OC
was VBD I-OC
more RBR I-OC
successful JJ I-OC
than IN I-OC
RPMT NNP I-OC
in IN I-OC
increasing VBG I-OC
the DT I-OC
number NN I-OC
of IN I-OC
nonimitative JJ I-OC
spoken JJ I-OC
communication NN I-OC
acts NNS I-OC
and CC I-OC
the DT I-OC
number NN I-OC
of IN I-OC
different JJ I-OC
nonimitative JJ I-OC
words NNS I-OC
used VBN I-OC
at IN I-OC
the DT I-OC
posttreatment JJ I-OC
period NN I-OC
. . O

Considering VBG O
growth NN O
over IN O
all DT O
3 CD O
measurement NN O
periods NNS O
, , O
an DT O
exploratory NN O
analysis NN O
showed VBD O
that IN O
growth NN B-OC
rate NN I-OC
of IN I-OC
the DT I-OC
number NN I-OC
of IN I-OC
different JJ I-OC
nonimitative JJ I-OC
words NNS I-OC
was VBD I-OC
faster RBR I-OC
in IN I-OC
the DT I-OC
PECS NNP I-OC
group NN O
than IN O
in IN O
the DT O
RPMT NNP O
group NN O
for IN O
children NNS O
who WP O
began VBD O
treatment NN O
with IN O
relatively RB O
high JJ O
object JJ O
exploration NN O
. . O

In IN O
contrast NN O
, , O
analogous JJ B-OC
slopes NNS I-OC
were VBD O
steeper VBN O
in IN O
the DT O
RPMT NNP O
group NN O
than IN O
in IN O
the DT O
PECS NNP O
group NN O
for IN O
children NNS O
who WP O
began VBD O
treatment NN O
with IN O
relatively RB O
low JJ O
object JJ O
exploration NN O
. . O

-DOCSTART- -X- O O

Randomized VBN O
controlled JJ O
trial NN O
of IN O
melatonin NN B-INTV
for IN O
children NNS B-POPU
with IN I-POPU
autistic JJ I-POPU
spectrum NN I-POPU
disorders NNS I-POPU
and CC I-POPU
sleep JJ I-POPU
problems NNS I-POPU
. . O

BACKGROUND NNP O
Melatonin NNP O
is VBZ O
often RB O
used VBN O
for IN O
autistic JJ B-POPU
children NNS I-POPU
with IN I-POPU
sleep NN I-POPU
disorders NNS I-POPU
, , O
despite IN O
a DT O
lack NN O
of IN O
published VBN O
evidence NN O
in IN O
this DT O
population NN O
. . O

METHODS NNP O
A NNP O
randomized JJ O
, , O
placebo-controlled JJ B-INTV
double-blind NN O
crossover NN O
trial NN O
of IN O
melatonin NN B-INTV
was VBD O
undertaken VBN O
in IN O
11 CD B-POPU
children NNS I-POPU
with IN I-POPU
autistic JJ I-POPU
spectrum NN I-POPU
disorder NN I-POPU
( ( I-POPU
ASD NNP I-POPU
) ) I-POPU
. . O

RESULTS NNP O
Seven NNP B-POPU
children NNS I-POPU
completed VBD I-POPU
the DT I-POPU
trial NN I-POPU
. . O

Sleep JJ B-OC
latency NN I-OC
was VBD O
2.6 CD O
h NN O
[ JJ O
95 CD O
% NN O
confidence NN O
intervals NNS O
( ( O
CI NNP O
) ) O
2.28-2.93 CD O
] JJ O
baseline NN O
, , O
1.91 CD O
h NN O
( ( O
95 CD O
% NN O
CI NNP O
1.78-2.03 CD O
) ) O
with IN O
placebo NN O
and CC O
1.06 CD O
h NN O
( ( O
95 CD O
% NN O
CI NNP O
0.98-1.13 NN O
) ) O
with IN O
melatonin NN O
. . O

Wakings NNS B-OC
per IN I-OC
night NN I-OC
were VBD O
0.35 CD O
( ( O
95 CD O
% NN O
CI NNP O
0.18-0.53 NN O
) ) O
baseline NN O
, , O
0.26 CD O
( ( O
95 CD O
% NN O
CI NNP O
0.20-0.34 NN O
) ) O
with IN O
placebo NN B-INTV
and CC O
0.08 CD O
( ( O
95 CD O
% NN O
CI NNP O
0.04-0.12 NN O
) ) O
with IN O
melatonin NN O
. . O

Total JJ B-OC
sleep JJ I-OC
duration NN I-OC
was VBD O
8.05 CD O
h NN O
( ( O
95 CD O
% NN O
CI NNP O
7.65-8.44 CD O
) ) O
baseline NN O
, , O
8.75 CD O
h NN O
( ( O
95 CD O
% NN O
CI NNP O
8.56-8.98 CD O
) ) O
with IN O
placebo NN O
and CC O
9.84 CD O
h NN O
( ( O
95 CD O
% NN O
CI NNP O
9.68-9.99 CD O
) ) O
with IN O
melatonin NN O
. . O

CONCLUSIONS NNP O
Although IN O
the DT O
study NN O
was VBD O
small JJ O
owing NN O
to TO O
recruitment VB O
difficulties NNS O
, , O
it PRP O
still RB O
provides VBZ O
evidence NN O
of IN O
effectiveness NN B-OC
of IN O
melatonin NN O
in IN O
children NNS B-POPU
with IN I-POPU
sleep JJ I-POPU
difficulties NNS I-POPU
and CC I-POPU
ASD NNP I-POPU
, , O
which WDT O
we PRP O
predict VBP O
a DT O
larger JJR O
study NN O
would MD O
confirm VB O
. . O

-DOCSTART- -X- O O

Omega-3 JJ B-INTV
fatty JJ I-INTV
acids NNS I-INTV
supplementation NN I-INTV
in IN O
children NNS B-POPU
with IN I-POPU
autism NN I-POPU
: : I-POPU
a DT O
double-blind JJ O
randomized NN O
, , O
placebo-controlled JJ B-INTV
pilot NN O
study NN O
. . O

BACKGROUND NNP O
There EX O
is VBZ O
increasing VBG O
evidence NN O
that IN O
fatty JJ O
acid JJ O
deficiencies NNS O
or CC O
imbalances NNS O
may MD O
contribute VB O
to TO O
childhood VB B-POPU
neurodevelopmental JJ I-POPU
disorders NNS I-POPU
. . O

METHODS NNP O
We PRP O
conducted VBD O
a DT O
randomized VBN O
, , O
double-blind JJ O
, , O
placebo-controlled JJ B-INTV
6-week JJ O
pilot NN O
trial NN O
investigating VBG O
the DT O
effects NNS O
of IN O
1.5 CD B-INTV
g/d NN I-INTV
of IN I-INTV
omega-3 JJ I-INTV
fatty JJ I-INTV
acids NNS I-INTV
( ( I-INTV
.84 JJ I-INTV
g/d NN I-INTV
eicosapentaenoic NN I-INTV
acid NN I-INTV
, , I-INTV
.7 NNP I-INTV
g/d NN I-INTV
docosahexaenoic NN I-INTV
acid NN I-INTV
) ) I-INTV
supplementation NN I-INTV
in IN O
13 CD B-POPU
children NNS I-POPU
( ( I-POPU
aged VBN I-POPU
5 CD I-POPU
to TO I-POPU
17 CD I-POPU
years NNS I-POPU
) ) I-POPU
with IN I-POPU
autistic JJ I-POPU
disorders NNS I-POPU
accompanied VBN I-POPU
by IN I-POPU
severe JJ I-POPU
tantrums NNS I-POPU
, , I-POPU
aggression NN I-POPU
, , I-POPU
or CC I-POPU
self-injurious JJ I-POPU
behavior NN I-POPU
. . O

The DT O
outcome NN O
measure NN O
was VBD O
the DT O
Aberrant NNP B-OC
Behavior NNP I-OC
Checklist NNP I-OC
( ( I-OC
ABC NNP I-OC
) ) I-OC
at IN O
6 CD O
weeks NNS O
. . O

RESULTS NNP O
We PRP O
observed VBD O
an DT O
advantage NN O
of IN O
omega-3 JJ B-INTV
fatty JJ I-INTV
acids NNS I-INTV
compared VBN O
with IN O
placebo NN B-INTV
for IN O
hyperactivity NN B-OC
and CC I-OC
stereotypy NN I-OC
, , O
each DT O
with IN O
a DT O
large JJ O
effect NN O
size NN O
. . O

Repeated-measures NNS O
ANOVA NNP O
indicated VBD O
a DT O
trend NN O
toward IN O
superiority NN O
of IN O
omega-3 JJ B-INTV
fatty JJ I-INTV
acids NNS I-INTV
over IN O
placebo NN O
for IN O
hyperactivity NN B-OC
. . O

No DT O
clinically RB O
relevant JJ O
adverse JJ B-OC
effects NNS I-OC
were VBD O
elicited VBN O
in IN O
either DT O
group NN O
. . O

CONCLUSIONS VBZ O
The DT O
results NNS O
of IN O
this DT O
study NN O
provide VBP O
preliminary JJ O
evidence NN O
that IN O
omega-3 JJ B-INTV
fatty JJ I-INTV
acids NNS I-INTV
may MD O
be VB O
an DT O
effective JJ O
treatment NN O
for IN O
children NNS B-POPU
with IN I-POPU
autism NN I-POPU
. . O

-DOCSTART- -X- O O

Children NNP O
's POS O
Yale-Brown JJ O
Obsessive NNP O
Compulsive NNP O
Scale NNP O
modified VBD O
for IN O
pervasive JJ O
developmental NN O
disorders NNS O
. . O

OBJECTIVE NNP O
To TO O
examine VB O
the DT O
psychometric JJ O
properties NNS O
of IN O
the DT O
Children NNP B-POPU
's POS I-POPU
Yale-Brown JJ I-POPU
Obsessive NNP I-POPU
Compulsive NNP I-POPU
Scales NNP I-POPU
( ( B-INTV
CYBOCS NNP I-INTV
) ) I-INTV
modified VBD I-INTV
for IN I-INTV
pervasive JJ I-INTV
developmental NN I-INTV
disorders NNS I-INTV
( ( I-INTV
PDDs NNP I-INTV
) ) I-INTV
. . O

METHOD NNP O
Raters NNPS O
from IN O
five CD O
Research NNP O
Units NNS O
on IN O
Pediatric NNP O
Psychopharmacology NNP O
( ( O
RUPP NNP O
) ) O
Autism NNP O
Network NNP O
were VBD O
trained VBN O
to TO O
reliability NN O
. . O

The DT O
modified JJ O
scale NN O
( ( B-INTV
CYBOCS-PDD NNP I-INTV
) ) I-INTV
, , O
which WDT O
contains VBZ O
only RB O
the DT O
five CD B-INTV
Compulsion NNP I-INTV
severity NN I-INTV
items NNS I-INTV
( ( O
range VB O
0-20 NN O
) ) O
, , O
was VBD O
administered VBN B-POPU
to TO I-POPU
172 CD I-POPU
medication-free JJ I-POPU
children NNS I-POPU
( ( I-POPU
mean JJ I-POPU
8.2 CD I-POPU
+/- JJ I-POPU
2.6 CD I-POPU
years NNS I-POPU
) ) I-POPU
with IN I-POPU
PDD NNP I-POPU
( ( I-POPU
autistic JJ I-POPU
disorder NN I-POPU
, , I-POPU
n JJ I-POPU
= VBP I-POPU
152 CD I-POPU
; : I-POPU
Asperger NNP I-POPU
's POS I-POPU
disorder NN I-POPU
, , I-POPU
n JJ I-POPU
= VBP I-POPU
6 CD I-POPU
; : I-POPU
PDD NNP I-POPU
not RB I-POPU
otherwise RB I-POPU
specified VBN I-POPU
, , I-POPU
n JJ I-POPU
= NNP I-POPU
14 CD I-POPU
) ) I-POPU
participating NN I-POPU
in IN I-POPU
RUPP NNP I-POPU
clinical JJ I-POPU
trials NNS I-POPU
. . O

Reliability NNP B-OC
was VBD O
assessed VBN O
by IN O
intraclass NN O
correlation NN O
coefficient NN O
( ( O
ICC NNP O
) ) O
and CC O
internal JJ O
consistency NN O
by IN O
Cronbach NNP O
's POS O
alpha JJ O
coefficient NN O
. . O

Correlations NNS O
with IN O
ratings NNS O
of IN O
repetitive JJ O
behavior NN O
and CC O
disruptive JJ O
behavior NN O
were VBD O
examined VBN O
for IN O
validity NN O
. . O

RESULTS NNP O
Eleven NNP O
raters NNS O
showed VBD O
excellent JJ O
reliability NN B-OC
( ( O
ICC NNP O
= NNP O
0.97 CD O
) ) O
. . O

The DT O
mean JJ B-OC
CYBOCS NNP I-OC
score NN I-OC
was VBD O
14.4 CD O
( ( O
+/- JJ O
3.86 CD O
) ) O
with IN O
excellent JJ O
internal JJ B-OC
consistency NN I-OC
( ( O
alpha JJ O
= NNP O
.85 NNP O
) ) O
. . O

Correlations NNS O
with IN O
other JJ O
measures NNS O
of IN O
repetitive JJ O
behavior NN O
ranged VBD O
from IN O
r NN O
= $ O
0.11 CD O
to TO O
r VB O
= JJ O
0.28 CD O
and CC O
were VBD O
similar JJ O
to TO O
correlations NNS O
with IN O
measures NNS B-OC
of IN I-OC
irritability NN I-OC
( ( O
r JJ O
= NNP O
0.24 CD O
) ) O
and CC O
hyperactivity NN B-OC
( ( O
r JJ O
= NNP O
0.25 CD O
) ) O
. . O

Children NNP B-POPU
with IN I-POPU
higher JJR I-POPU
scores NNS I-POPU
on IN O
the DT O
CYBOCS-PDD NNP O
had VBD O
higher JJR O
levels NNS O
of IN O
maladaptive JJ B-OC
behaviors NNS I-OC
and CC I-OC
lower JJR I-OC
adaptive JJ I-OC
functioning NN I-OC
. . O

CONCLUSIONS VB O
The DT O
five-item JJ O
CYBOCS-PDD NNP O
is VBZ O
reliable JJ O
, , O
distinct JJ O
from IN O
other JJ O
measures NNS O
of IN O
repetitive JJ O
behavior NN O
, , O
and CC O
sensitive JJ O
to TO O
change VB O
. . O

-DOCSTART- -X- O O

Risperidone NN B-INTV
in IN O
children NNS B-POPU
with IN I-POPU
autism NN I-POPU
: : I-POPU
randomized VBN O
, , O
placebo-controlled JJ O
, , O
double-blind JJ O
study NN O
. . O

Some DT O
open-label JJ O
studies NNS O
suggest VBP O
that IN O
risperidone NN B-INTV
can MD O
be VB O
useful JJ O
in IN O
the DT O
treatment NN O
of IN O
certain JJ O
target NN O
symptoms NNS O
in IN O
children NNS B-POPU
with IN I-POPU
autism NN I-POPU
. . O

We PRP O
aimed VBD O
to TO O
study VB O
whether IN O
the DT O
use NN O
of IN O
risperidone NN B-INTV
in IN O
comparison NN O
with IN O
placebo NN B-INTV
improved VBN O
functioning NN O
in IN O
children NNS B-POPU
with IN I-POPU
autism NN I-POPU
with IN O
regard NN O
to TO O
behavior VB O
( ( O
aggressiveness NN O
, , O
hyperactivity NN O
, , O
irritability NN O
) ) O
, , O
social JJ O
and CC O
emotional JJ O
responsiveness NN O
, , O
and CC O
communication NN O
skills NNS O
. . O

We PRP O
conducted VBD O
a DT O
randomized VBN O
, , O
double-blind JJ O
, , O
placebo-controlled JJ B-INTV
trial NN O
with IN O
40 CD B-POPU
consecutive JJ I-POPU
children NNS I-POPU
with IN I-POPU
autism NN I-POPU
, , I-POPU
whose WP$ I-POPU
ages NNS I-POPU
ranged VBD I-POPU
from IN I-POPU
2 CD I-POPU
to TO I-POPU
9 CD I-POPU
years NNS I-POPU
, , I-POPU
who WP I-POPU
were VBD I-POPU
receiving VBG I-POPU
either CC I-POPU
risperidone NN I-POPU
or CC I-POPU
placebo VB I-POPU
given VBN I-POPU
orally RB I-POPU
at IN I-POPU
a DT I-POPU
dose NN I-POPU
of IN I-POPU
1 CD I-POPU
mg/day NN I-POPU
for IN I-POPU
6 CD I-POPU
months NNS I-POPU
. . O

Autism NN O
symptoms NNS O
were VBD O
monitored VBN O
periodically RB O
. . O

The DT O
outcome NN O
variables NNS O
were VBD O
total JJ O
scores NNS O
on IN O
the DT O
Childhood NNP O
Autism NNP O
Rating NNP O
Scale NNP O
( ( O
CARS NNP O
) ) O
and CC O
the DT O
Children NNP O
's POS O
Global NNP O
Assessment NNP O
Scale NNP O
( ( O
CGAS NNP O
) ) O
after IN O
6 CD O
months NNS O
. . O

Of IN O
the DT O
40 CD B-POPU
children NNS I-POPU
enrolled VBD I-POPU
, , O
39 CD O
completed VBD O
the DT O
trial NN O
over IN O
a DT O
period NN O
of IN O
18 CD O
months NNS O
; : O
19 CD O
received VBD O
risperidone NN B-INTV
, , O
and CC O
20 CD O
received VBD O
placebo NN B-INTV
. . O

In IN O
the DT O
risperidone NN B-INTV
group NN O
, , O
12 CD O
of IN O
19 CD O
children NNS O
showed VBD O
improvement NN O
in IN O
the DT O
total JJ B-OC
Childhood NNP I-OC
Autism NNP I-OC
Rating NNP I-OC
Scale NNP I-OC
score NN I-OC
and CC O
17 CD O
of IN O
19 CD O
children NNS O
in IN O
the DT O
Children NNP B-OC
's POS I-OC
Global NNP I-OC
Assessment NNP I-OC
Scale NNP I-OC
score NN I-OC
compared VBN O
with IN O
0 CD O
of IN O
20 CD O
children NNS O
for IN O
the DT O
Childhood NNP B-OC
Autism NNP I-OC
Rating NNP I-OC
Scale NNP I-OC
score NN I-OC
and CC O
2 CD O
of IN O
20 CD O
children NNS O
for IN O
the DT O
Children NNP B-OC
's POS I-OC
Global NNP I-OC
Assessment NNP I-OC
Scale NNP I-OC
score NN I-OC
in IN O
the DT O
placebo NN B-INTV
group NN O
( ( O
P NNP O
< NNP O
.001 NNP O
and CC O
P NNP O
= NNP O
.035 NNP O
, , O
respectively RB O
) ) O
. . O

Risperidone NNP B-INTV
also RB O
improved VBD O
social JJ B-OC
responsiveness NN I-OC
and CC I-OC
nonverbal JJ I-OC
communication NN I-OC
and CC O
reduced VBD O
the DT O
symptoms NNS B-OC
of IN I-OC
hyperactivity NN I-OC
and CC I-OC
aggression NN I-OC
. . O

Risperidone NN B-INTV
was VBD O
associated VBN O
with IN O
increased VBN O
appetite NN B-OC
and CC I-OC
a DT I-OC
mild JJ I-OC
weight NN I-OC
gain NN I-OC
, , I-OC
mild JJ I-OC
sedation NN I-OC
in IN I-OC
20 CD I-OC
% NN I-OC
, , I-OC
and CC I-OC
transient NN I-OC
dyskinesias NN I-OC
in IN O
three CD O
children NNS O
. . O

Risperidone NN B-INTV
improved VBD O
global JJ B-OC
functioning NN I-OC
and CC I-OC
social JJ I-OC
responsiveness NN I-OC
while IN O
reducing VBG B-OC
hyperactivity NN I-OC
and CC I-OC
aggression NN I-OC
in IN O
children NNS B-POPU
with IN I-POPU
autism NN I-POPU
and CC O
was VBD O
well RB O
tolerated VBN O
. . O

-DOCSTART- -X- O O

Atomoxetine NNP B-INTV
for IN O
hyperactivity NN B-POPU
in IN I-POPU
autism NN I-POPU
spectrum NN I-POPU
disorders NNS I-POPU
: : I-POPU
placebo-controlled JJ O
crossover NN O
pilot NN O
trial NN O
. . O

OBJECTIVE UH O
To TO O
explore VB O
placebo-controlled JJ O
efficacy NN O
and CC O
safety NN O
of IN O
atomoxetine NN B-INTV
( ( I-INTV
ATX NNP I-INTV
) ) I-INTV
for IN O
attention-deficit/hyperactivity NN B-POPU
disorder NN I-POPU
( ( I-POPU
ADHD NNP I-POPU
) ) I-POPU
symptoms NNS I-POPU
in IN I-POPU
children NNS I-POPU
with IN I-POPU
autism NN I-POPU
spectrum NN I-POPU
disorders NNS I-POPU
( ( I-POPU
ASD NNP I-POPU
) ) I-POPU
. . O

METHOD NNP O
Children NNP B-POPU
ages VBZ I-POPU
5 CD I-POPU
to TO I-POPU
15 CD I-POPU
with IN I-POPU
ASD NNP I-POPU
and CC I-POPU
prominent JJ I-POPU
ADHD NNP I-POPU
symptoms NNS I-POPU
were VBD O
randomly RB O
assigned VBN O
to TO O
order NN O
in IN O
a DT O
crossover NN O
of IN O
clinically RB B-INTV
titrated VBN I-INTV
ATX NNP I-INTV
and CC I-INTV
placebo NN I-INTV
, , I-INTV
6 CD I-INTV
weeks NNS I-INTV
each DT I-INTV
, , I-INTV
separated VBN I-INTV
by IN I-INTV
1-week JJ I-INTV
washout NN I-INTV
. . O

Slopes NNP O
for IN O
each DT O
condition NN O
were VBD O
compared VBN O
by IN O
paired JJ O
t JJ O
test NN O
. . O

RESULTS NNP O
In IN B-POPU
2004-2005 JJ I-POPU
, , I-POPU
12 CD I-POPU
boys NNS I-POPU
and CC I-POPU
4 CD I-POPU
girls NNS I-POPU
( ( I-POPU
7 CD I-POPU
with IN I-POPU
autistic JJ I-POPU
disorder NN I-POPU
, , I-POPU
1 CD I-POPU
Asperger NNP I-POPU
's POS I-POPU
, , I-POPU
8 CD I-POPU
pervasive JJ I-POPU
developmental NN I-POPU
disorder NN I-POPU
not RB I-POPU
otherwise RB I-POPU
specified VBN I-POPU
) ) I-POPU
all DT O
completed VBN O
at IN O
least JJS O
3 CD O
weeks NNS O
of IN O
each DT O
condition NN O
. . O

On IN O
the DT O
primary JJ O
outcome NN O
, , O
the DT O
Hyperactivity NNP B-OC
subscale NN I-OC
of IN I-OC
the DT I-OC
Aberrant NNP I-OC
Behavior NNP I-OC
Checklist NNP I-OC
, , I-OC
ATX NNP I-OC
was VBD O
superior JJ O
to TO O
placebo VB O
( ( O
p JJ O
=.043 NN O
, , O
effect NN O
size NN O
d NN O
= NNP O
0.90 CD O
) ) O
. . O

It PRP O
was VBD O
also RB O
superior JJ O
on IN O
a DT O
0 CD O
to TO O
3 CD O
rating NN O
of IN O
nine CD O
DSM-IV NNP B-OC
ADHD NNP I-OC
hyperactive/impulsive NN I-OC
symptoms NNS I-OC
( ( O
p JJ O
=.005 NN O
, , O
d NN O
= NNP O
1.27 CD O
) ) O
, , O
but CC O
missed VBD O
significance NN O
on IN O
nine CD O
inattentive JJ O
symptoms NNS O
( ( O
p JJ O
=.053 NN O
, , O
d= VB O
0.89 CD O
) ) O
. . O

Nine JJ O
subjects NNS O
responded VBD O
to TO O
ATX NNP O
, , O
four CD O
to TO O
placebo VB B-INTV
( ( O
25 CD O
% NN O
improvement NN O
on IN O
the DT O
Hyperactivity NNP B-OC
subscale NN I-OC
plus CC I-OC
Clinical JJ I-OC
Global NNP I-OC
Impressions-Improvement NN I-OC
of IN O
1-2 JJ O
. . O

One CD O
was VBD O
rehospitalized VBN B-OC
for IN O
recurrent JJ O
violence NN O
on IN O
ATX NNP O
. . O

Adverse JJ B-OC
events NNS I-OC
were VBD O
otherwise RB O
tolerable JJ O
, , O
with IN O
no DT O
tendency NN O
to TO O
stereotypy VB O
. . O

CONCLUSIONS NNP O
ATX NNP O
appears VBZ O
safe JJ O
and CC O
effective JJ O
for IN O
treating VBG O
hyperactivity NN B-POPU
in IN I-POPU
some DT I-POPU
children NNS I-POPU
with IN I-POPU
autism NN I-POPU
spectrum NN I-POPU
disorders NNS I-POPU
. . O

The DT O
effect NN O
appears VBZ O
as RB O
large JJ O
as IN O
in IN O
a DT O
multisite JJ O
methylphenidate NN B-INTV
trial NN O
in IN O
the DT O
same JJ O
population NN O
, , O
with IN O
fewer JJR O
intolerable JJ O
side NN O
effects NNS O
. . O

Further NNP O
study NN O
in IN O
autism NN O
spectrum NN O
disorders NNS O
is VBZ O
indicated VBN O
. . O

-DOCSTART- -X- O O

Risperidone NNP B-INTV
improves VBZ O
behavioral JJ B-OC
symptoms NNS I-OC
in IN O
children NNS B-POPU
with IN I-POPU
autism NN I-POPU
in IN O
a DT O
randomized JJ O
, , O
double-blind JJ O
, , O
placebo-controlled JJ B-INTV
trial NN O
. . O

Subgroup NNP O
analysis NN O
of IN O
children NNS B-POPU
( ( I-POPU
5-12 CD I-POPU
years NNS I-POPU
) ) I-POPU
with IN I-POPU
autism NN I-POPU
enrolled VBN O
in IN O
an DT O
8-week JJ O
, , O
double-blind JJ O
, , O
placebo-controlled JJ B-INTV
trial NN O
of IN O
risperidone NN B-INTV
for IN O
pervasive JJ O
developmental NN O
disorders NNS O
. . O

The DT O
primary JJ O
efficacy NN O
measure NN O
was VBD O
the DT O
Aberrant NNP B-OC
Behavior NNP I-OC
Checklist-Irritability NNP I-OC
( ( I-OC
ABC-I NNP I-OC
) ) I-OC
subscale NN I-OC
. . O

Data NNS O
were VBD O
available JJ O
for IN O
55 CD B-POPU
children NNS I-POPU
given VBN O
risperidone NN B-INTV
( ( O
n=27 JJ O
) ) O
or CC O
placebo NN B-INTV
( ( O
n=28 JJ O
) ) O
; : O
mean JJ O
baseline NN O
ABC-I NNP O
( ( O
+/- JJ O
SD NNP O
) ) O
was VBD O
20.6 CD O
( ( O
8.1 CD O
) ) O
and CC O
21.6 CD O
( ( O
10.2 CD O
) ) O
. . O

Risperidone NNP B-INTV
[ JJ O
mean NN O
dose NN O
( ( O
+/- JJ O
SD NNP O
) ) O
: : O
1.37 CD O
mg/day NN O
( ( O
0.7 CD O
) ) O
] NN O
resulted VBD O
in IN O
significantly RB O
greater JJR O
reduction NN O
from IN O
baseline NN O
to TO O
endpoint VB O
in IN O
ABC-I NNP B-OC
versus NN O
placebo NN B-INTV
[ JJ O
mean JJ O
change NN O
( ( O
+/- JJ O
SD NNP O
) ) O
: : O
-13.4 NN O
( ( O
1.5 CD O
) ) O
vs. FW O
-7.2 NNP O
( ( O
1.4 CD O
) ) O
, , O
P NNP O
< NNP O
0.05 CD O
; : O
ES=-0.7 JJ O
] NN O
. . O

The DT O
most RBS O
common JJ O
adverse JJ O
effect NN O
with IN O
risperidone NN B-INTV
was VBD O
somnolence NN B-OC
( ( O
74 CD O
% NN O
vs. FW O
7 CD O
% NN O
with IN O
placebo NN B-INTV
) ) I-INTV
. . O

Risperidone CD B-INTV
treatment NN O
was VBD O
well RB O
tolerated VBN B-OC
and CC O
significantly RB O
improved VBN O
behavioral JJ B-OC
problems NNS I-OC
associated VBN O
with IN O
autism NN O
. . O

-DOCSTART- -X- O O

DTkid NN O
: : O
interactive JJ O
simulation NN O
software NN O
for IN O
training VBG O
tutors NNS B-POPU
of IN I-POPU
children NNS I-POPU
with IN I-POPU
autism NN I-POPU
. . O

Discrete-trial JJ B-INTV
training NN I-INTV
( ( O
DTT NNP O
) ) O
relies VBZ O
critically RB O
on IN O
implementation NN O
by IN O
trained JJ B-POPU
tutors NNS I-POPU
. . O

We PRP O
report VBP O
three CD O
experiments NNS O
carried VBD O
out RP O
in IN O
the DT O
development NN O
of IN O
" NNP O
DTkid NNP O
" NNP O
-- : O
interactive JJ O
computer NN O
simulation NN O
software NN O
that WDT O
presents VBZ O
" JJ O
SIMon NNP O
" NNP O
, , O
a DT O
realistic JJ O
virtual JJ O
child NN O
with IN O
whom WP O
novice JJ O
tutors NNS O
can MD O
learn VB O
and CC O
practise VB O
DTT NNP O
techniques NNS O
. . O

Experiments NNS O
1 CD O
and CC O
2 CD O
exposed JJ O
groups NNS O
of IN O
participants NNS O
either DT O
to TO O
DTkid NNP B-INTV
training NN I-INTV
or CC I-INTV
to TO I-INTV
a DT I-INTV
control NN I-INTV
task NN I-INTV
. . O

Participants NNS O
in IN O
the DT O
former JJ O
groups NNS O
demonstrated VBD O
significantly RB O
greater JJR O
procedural JJ B-OC
and CC I-OC
declarative JJ I-OC
knowledge NN I-OC
of IN I-OC
DTT NNP I-OC
. . O

Experiment NNP O
3 CD O
confirmed VBD O
this DT O
finding NN O
, , O
further JJ O
demonstrating NN O
that IN O
observation NN O
of IN O
DTkid NNP B-INTV
training NN I-INTV
trials NNS I-INTV
alone RB O
was VBD O
sufficient JJ O
to TO O
enhance VB O
participants NNS O
' POS O
declarative NN B-OC
and CC I-OC
procedural JJ I-OC
knowledge NN I-OC
of IN O
DTT NNP O
. . O

Results NNP O
indicate VBP O
that IN O
DTkid NNP O
offers VBZ O
the DT O
potential NN O
for IN O
an DT O
effective JJ O
means NNS O
of IN O
teaching VBG O
DTT NNP O
skills NNS O
to TO O
novice JJ B-POPU
tutors NNS I-POPU
of IN I-POPU
children NNS I-POPU
with IN I-POPU
autism NN I-POPU
. . O

-DOCSTART- -X- O O

Classroom NNP B-INTV
intervention NN I-INTV
for IN O
illness-related JJ O
problem NN O
behavior NN O
in IN O
children NNS B-POPU
with IN I-POPU
developmental JJ I-POPU
disabilities NNS I-POPU
. . O

There EX O
is VBZ O
growing VBG O
evidence NN O
of IN O
an DT O
association NN O
between IN O
physical JJ O
illness NN O
and CC O
problem NN O
behavior NN O
in IN O
children NNS B-POPU
with IN I-POPU
developmental JJ I-POPU
disabilities NNS I-POPU
. . O

Such JJ O
behavior NN O
can MD O
compromise VB O
school NN O
performance NN O
. . O

Therefore RB O
, , O
the DT O
purpose NN O
of IN O
the DT O
present JJ O
study NN O
was VBD O
to TO O
evaluate VB O
, , O
using VBG O
a DT O
group NN O
design NN O
, , O
the DT O
effectiveness NN O
of IN O
medical JJ B-INTV
intervention NN I-INTV
alone RB I-INTV
( ( O
N NNP O
= NNP O
11 CD O
) ) O
versus NN O
behavioral JJ B-INTV
plus CC I-INTV
medical JJ I-INTV
intervention NN I-INTV
( ( O
N NNP O
= NNP O
10 CD O
) ) O
for IN O
illness-related JJ O
problem NN O
behavior NN O
in IN O
a DT O
school NN O
setting VBG O
. . O

Following VBG O
intervention NN O
, , O
the DT O
behavioral JJ O
plus CC O
medical JJ O
intervention NN O
group NN O
showed VBD O
lower JJR O
levels NNS O
of IN O
problem NN B-OC
behavior NN I-OC
and CC O
completed VBD B-OC
more JJR I-OC
academic JJ I-OC
tasks NNS I-OC
than IN O
did VBD O
the DT O
medical JJ O
intervention NN O
alone RB O
group NN O
. . O

The DT O
results NNS O
are VBP O
discussed VBN O
with IN O
respect NN O
to TO O
the DT O
concept NN B-OC
of IN I-OC
illness NN I-OC
and CC I-OC
pain NN I-OC
as IN O
a DT O
setting NN O
event NN O
for IN O
problem NN O
behavior NN O
. . O

The DT O
need NN O
for IN O
research NN O
to TO O
develop VB O
algorithms NN O
that WDT O
allow VBP O
one CD O
to TO O
select VB O
the DT O
best JJS O
combination NN O
of IN O
medical JJ B-INTV
and CC I-INTV
behavioral JJ I-INTV
interventions NNS I-INTV
for IN O
specific JJ O
illnesses NNS O
and CC O
contexts NN O
is VBZ O
noted VBN O
. . O

-DOCSTART- -X- O O

The DT O
Social NNP B-INTV
Communication NNP I-INTV
Assessment NNP I-INTV
for IN I-INTV
Toddlers NNP I-INTV
with IN I-INTV
Autism NNP I-INTV
( ( I-INTV
SCATA NNP I-INTV
) ) I-INTV
: : I-INTV
an DT O
instrument NN O
to TO O
measure VB O
the DT O
frequency NN B-OC
, , O
form NN O
and CC O
function NN B-OC
of IN I-OC
communication NN I-OC
in IN O
toddlers NNS B-POPU
with IN I-POPU
autism NN I-POPU
spectrum NN I-POPU
disorder NN I-POPU
. . O

The DT O
Social NNP B-INTV
Communication NNP I-INTV
Assessment NNP I-INTV
for IN I-INTV
Toddlers NNP I-INTV
with IN I-INTV
Autism NNP I-INTV
( ( I-INTV
SCATA NNP I-INTV
) ) I-INTV
was VBD O
designed VBN O
to TO O
measure VB O
non-verbal JJ B-OC
communication NN I-OC
, , I-OC
including VBG I-OC
early JJ I-OC
and CC I-OC
atypical JJ I-OC
communication NN I-OC
, , O
in IN O
young JJ B-POPU
children NNS I-POPU
with IN I-POPU
autism NN I-POPU
spectrum NN I-POPU
disorder NN I-POPU
. . O

Each DT O
communicative JJ O
act NN O
is VBZ O
scored VBN O
according VBG O
to TO O
its PRP$ O
form NN O
, , O
function NN O
, , O
role NN O
and CC O
complexity NN O
. . O

The DT O
SCATA NNP B-INTV
was VBD O
used VBN O
to TO O
measure VB O
communicative JJ O
ability NN O
longitudinally RB O
in IN O
two CD O
samples NNS O
of IN O
toddlers NNS B-POPU
with IN I-POPU
autism NN I-POPU
spectrum NN I-POPU
disorder NN I-POPU
. . O

Overall JJ B-OC
frequency NN I-OC
of IN I-OC
non-verbal JJ I-OC
communicative JJ I-OC
acts NNS I-OC
did VBD O
not RB O
change NN O
between IN O
the DT O
two CD O
assessments NNS O
. . O

However RB O
, , O
the DT O
form NN B-OC
and CC I-OC
complexity NN I-OC
, , I-OC
the DT I-OC
function NN I-OC
and CC I-OC
the DT I-OC
role NN I-OC
the DT O
child NN O
took VBD O
in IN O
the DT O
interaction NN O
did VBD O
change VB O
with IN O
time NN O
. . O

Both DT O
frequency NN B-OC
and CC I-OC
function NN I-OC
of IN I-OC
communicative JJ I-OC
acts NNS I-OC
in IN O
toddlerhood NN O
were VBD O
positively RB O
associated VBN O
with IN O
later JJ B-OC
language NN I-OC
ability NN I-OC
: : I-OC
social JJ I-OC
acts NNS I-OC
, , I-OC
comments NNS I-OC
and CC I-OC
initiations NNS I-OC
showed VBD O
greater JJR O
predictive JJ O
association NN O
than IN O
requests NNS O
and CC O
responses NNS O
. . O

-DOCSTART- -X- O O

Effect NN O
of IN O
CX516 NNP B-INTV
, , O
an DT O
AMPA-modulating JJ B-INTV
compound NN I-INTV
, , O
on IN O
cognition NN B-POPU
and CC I-POPU
behavior NN I-POPU
in IN I-POPU
fragile JJ I-POPU
X JJ I-POPU
syndrome NN I-POPU
: : I-POPU
a DT O
controlled JJ O
trial NN O
. . O

A DT O
Phase NNP O
II NNP O
, , O
4-week JJ O
randomized VBN O
, , O
double-blind JJ O
, , O
placebo-controlled JJ B-INTV
clinical JJ O
trial NN O
was VBD O
conducted VBN O
to TO O
evaluate VB O
the DT O
safety NN B-OC
and CC I-OC
efficacy NN I-OC
of IN O
the DT O
Ampakine NNP B-INTV
compound NN O
CX516 NNP B-INTV
as IN O
a DT O
potential JJ O
treatment NN O
for IN O
the DT O
underlying JJ B-POPU
disorder NN I-POPU
in IN I-POPU
fragile JJ I-POPU
X NNP I-POPU
syndrome NN I-POPU
( ( I-POPU
FXS NNP I-POPU
) ) I-POPU
. . O

After IN O
baseline NN O
screening NN O
, , O
subjects VBZ B-POPU
with IN I-POPU
FXS NNP I-POPU
( ( I-POPU
n JJ I-POPU
= NNP I-POPU
49 CD I-POPU
) ) I-POPU
underwent NN O
a DT O
1-week JJ B-INTV
placebo NN I-INTV
lead-in NN I-INTV
and CC I-INTV
then RB I-INTV
were VBD I-INTV
randomized VBN I-INTV
to TO I-INTV
study VB I-INTV
drug NN I-INTV
or CC I-INTV
placebo NN I-INTV
for IN I-INTV
a DT I-INTV
4-week JJ I-INTV
period NN I-INTV
. . O

Cognitive JJ B-OC
and CC I-OC
behavioral JJ I-OC
outcome NN O
measures NNS O
were VBD O
administered VBN O
prior RB O
to TO O
treatment NN O
, , O
at IN O
the DT O
end NN O
of IN O
treatment NN O
, , O
and CC O
2 CD O
weeks NNS O
posttreatment NN O
. . O

There EX O
were VBD O
minimal JJ B-OC
side NN I-OC
effects NNS I-OC
, , O
no DT O
significant JJ B-OC
changes NNS I-OC
in IN I-OC
safety NN I-OC
parameters NNS I-OC
, , O
and CC O
no DT B-OC
serious JJ I-OC
adverse JJ I-OC
events NNS I-OC
. . O

There EX O
was VBD O
a DT O
12.5 CD B-OC
% NN I-OC
frequency NN I-OC
of IN O
allergic JJ B-OC
rash NN I-OC
in IN O
the DT O
CX516 NNP B-INTV
group NN O
and CC O
1 CD O
subject NN O
developed VBD O
a DT O
substantial JJ B-OC
rash NN I-OC
. . O

There EX O
was VBD O
also RB O
no DT O
significant JJ B-OC
improvement NN I-OC
in IN O
memory NN B-OC
, , O
the DT O
primary JJ O
outcome NN O
measure NN O
, , O
or CC O
in IN O
secondary JJ O
measures NNS O
of IN O
language NN B-OC
, , I-OC
attention/executive JJ I-OC
function NN I-OC
, , I-OC
behavior NN I-OC
, , I-OC
and CC I-OC
overall JJ I-OC
functioning NN I-OC
in IN O
CX516-treated JJ B-INTV
subjects NNS O
compared VBN O
to TO O
placebo VB B-INTV
. . O

This DT O
study NN O
did VBD O
demonstrate VB O
that IN O
many JJ O
outcome JJ O
measures NNS B-OC
were VBD O
reproducible JJ O
in IN O
this DT O
test-retest JJ O
setting NN O
for IN O
the DT O
FXS NNP O
population NN O
, , O
yet CC O
some DT O
were VBD O
too RB O
difficult JJ O
or CC O
variable JJ O
. . O

Adult NNP B-POPU
subjects VBZ I-POPU
with IN I-POPU
FXS NNP I-POPU
were VBD O
able JJ O
to TO O
complete VB O
an DT O
intensive JJ O
clinical JJ O
trial NN O
, , O
and CC O
some DT O
valid JJ O
outcome NN O
measures NNS O
were VBD O
identified VBN O
for IN O
future JJ O
FXS NNP O
trial NN O
design NN O
. . O

Problems VBZ O
with IN O
potency NN O
of IN O
CX516 NNP B-INTV
in IN O
other JJ O
studies NNS O
have VBP O
suggested VBN O
dosing NN O
may MD O
have VB O
been VBN O
inadequate JJ O
for IN O
therapeutic JJ O
effect NN O
and CC O
thus RB O
it PRP O
remains VBZ O
unclear JJ O
whether IN O
modulation NN O
of IN O
AMPA-mediated JJ O
neurotransmission NN O
is VBZ O
a DT O
viable JJ B-OC
therapeutic JJ I-OC
strategy NN I-OC
for IN O
the DT O
treatment NN O
of IN O
FXS NNP O
. . O

-DOCSTART- -X- O O

A DT O
double-blind JJ O
placebo-controlled JJ B-INTV
pilot NN O
study NN O
of IN O
olanzapine NN B-INTV
in IN O
childhood/adolescent JJ B-POPU
pervasive JJ I-POPU
developmental NN I-POPU
disorder NN I-POPU
. . O

Atypical JJ O
antipsychotics NNS O
have VBP O
been VBN O
shown VBN O
to TO O
improve VB O
disruptive NN B-OC
and CC I-OC
repetitive JJ I-OC
behaviors NNS I-OC
in IN O
pervasive JJ O
developmental NN O
disorders NNS O
( ( O
PDDs NNP O
) ) O
, , O
but CC O
they PRP O
require VBP O
assessment NN O
of IN O
potential JJ O
side NN B-OC
effects NNS I-OC
. . O

This DT O
is VBZ O
the DT O
first JJ O
placebo-controlled JJ B-INTV
trial NN O
of IN O
olanzapine NN B-INTV
in IN O
the DT O
treatment NN O
of IN O
children NNS O
and CC O
adolescents NNS O
with IN O
PDD NNP O
. . O

Eleven NNP B-POPU
patients NNS I-POPU
with IN I-POPU
a DT I-POPU
diagnosis NN I-POPU
of IN I-POPU
either DT I-POPU
autism NN I-POPU
, , I-POPU
Asperger NNP I-POPU
's POS I-POPU
syndrome NN I-POPU
, , I-POPU
or CC I-POPU
PDD NNP I-POPU
not RB I-POPU
otherwise RB I-POPU
specified VBN I-POPU
( ( I-POPU
PDD-NOS NNP I-POPU
) ) I-POPU
and CC I-POPU
aged VBN I-POPU
6-14 CD I-POPU
years NNS I-POPU
were VBD O
randomized VBN O
into IN O
an DT O
8-week JJ O
double-blind NN O
, , O
placebo-controlled JJ B-INTV
, , O
parallel JJ O
treatment NN O
study NN O
with IN O
olanzapine NN B-INTV
. . O

There EX O
was VBD O
a DT O
significant JJ O
linear JJ O
trend NN O
x NNP O
group NN O
interaction NN O
on IN O
the DT O
Clinical JJ B-OC
Global NNP I-OC
Impressions- NNP I-OC
Improvement NNP I-OC
( ( I-OC
CGI-I NNP I-OC
) ) I-OC
and CC O
50 CD O
% NN O
on IN O
olanzapine JJ O
versus NN O
20 CD O
% NN O
on IN O
placebo NN O
were VBD O
responders NNS O
. . O

Olanzapine NNP O
was VBD O
associated VBN O
with IN O
significant JJ B-OC
weight JJ I-OC
gain NN I-OC
( ( O
7.5 CD O
+/- JJ O
4.8 CD O
lbs NN O
vs. FW O
1.5 CD O
+/- JJ O
1.5 CD O
lbs NN O
on IN O
placebo NN O
) ) O
. . O

Olanzapine NN O
may MD O
be VB O
a DT O
promising JJ O
treatment NN O
for IN O
improving VBG O
global JJ B-OC
functioning NN I-OC
of IN I-OC
PDDs NNP I-OC
, , O
but CC O
the DT O
risk NN O
of IN O
significant JJ O
weight JJ B-OC
gain NN I-OC
remains VBZ O
a DT O
concern NN O
. . O

Additional JJ O
studies NNS O
are VBP O
needed VBN O
to TO O
determine VB O
the DT O
efficacy NN O
and CC O
safety NN O
of IN O
olanzapine NN O
in IN O
the DT O
treatment NN O
of IN O
children NNS O
with IN O
PDD NNP O
. . O

-DOCSTART- -X- O O

A DT O
randomized VBN O
controlled JJ O
trial NN O
of IN O
a DT O
cognitive JJ B-INTV
behavioural JJ I-INTV
intervention NN I-INTV
for IN O
anger JJ O
management NN O
in IN O
children NNS B-POPU
diagnosed VBN I-POPU
with IN I-POPU
Asperger NNP I-POPU
syndrome NN I-POPU
. . O

The DT O
purpose NN O
of IN O
the DT O
study NN O
described VBD O
was VBD O
to TO O
evaluate VB O
the DT O
effectiveness NN O
of IN O
a DT O
cognitive JJ O
behavioural JJ O
intervention NN O
for IN O
anger JJ O
management NN O
with IN O
children NNS B-POPU
diagnosed VBN I-POPU
with IN I-POPU
Asperger NNP I-POPU
syndrome NN I-POPU
. . O

Forty-five JJ B-POPU
children NNS I-POPU
and CC I-POPU
their PRP$ I-POPU
parents NNS I-POPU
were VBD O
randomly RB O
assigned VBN O
to TO O
either DT O
intervention NN B-INTV
or CC O
wait-list JJ B-INTV
control NN I-INTV
conditions NNS I-INTV
. . O

Children NNP O
in IN O
the DT O
intervention NN O
participated VBD O
in IN O
six CD B-INTV
2-h JJ I-INTV
weekly JJ I-INTV
sessions NNS I-INTV
while IN O
parents NNS O
participated VBN O
in IN O
a DT O
larger JJR O
parent NN O
group NN O
. . O

Parent NN O
reports NNS O
indicated VBD O
a DT O
significant JJ O
decrease NN O
in IN O
episodes NNS B-OC
of IN I-OC
anger NN I-OC
following VBG O
intervention NN O
and CC O
a DT O
significant JJ O
increase NN O
in IN O
their PRP$ O
own JJ O
confidence NN B-OC
in IN O
managing VBG B-OC
anger NN I-OC
in IN I-OC
their PRP$ I-OC
child NN I-OC
. . O

Qualitative JJ O
information NN O
gathered VBN O
from IN O
parents NNS O
and CC O
teachers NNS O
indicated VBD O
some DT O
generalization NN O
of IN O
strategies NNS O
learned VBN O
in IN O
the DT O
clinic JJ O
setting NN O
to TO O
both DT O
home NN O
and CC O
school NN O
settings NNS O
. . O

Limitations NNS O
of IN O
the DT O
study NN O
and CC O
suggestions NNS O
for IN O
future JJ O
research NN O
are VBP O
also RB O
discussed VBN O
. . O

-DOCSTART- -X- O O

Parent NN O
satisfaction NN O
in IN O
a DT O
multi-site JJ O
acute JJ O
trial NN O
of IN O
risperidone NN B-INTV
in IN O
children NNS O
with IN O
autism NN O
: : O
a DT O
social JJ O
validity NN O
study NN O
. . O

RATIONALE NNP O
Subjects NNPS O
who WP O
view VBP O
experimental JJ O
procedures NNS O
as IN O
worthwhile NN O
are VBP O
more RBR O
likely JJ O
to TO O
participate VB O
in IN O
clinical JJ O
trials NNS O
and CC O
comply NN O
with IN O
study NN O
procedures NNS O
. . O

Designing VBG O
studies NNS O
that WDT O
consider VBP O
the DT O
consumer NN O
's POS O
perspective NN O
will MD O
help VB O
to TO O
forge VB O
a DT O
better JJR O
alliance NN O
between IN O
participants NNS O
and CC O
researchers NNS O
. . O

OBJECTIVE NNP O
Participant NNP O
satisfaction NN O
is VBZ O
seldom RB O
assessed VBN O
in IN O
pharmacological JJ O
research NN O
. . O

In IN O
this DT O
paper NN O
, , O
we PRP O
report VBP O
on IN O
parent NN O
satisfaction NN O
in IN O
a DT O
randomized JJ O
clinical JJ O
trial NN O
in IN O
children NNS B-POPU
with IN I-POPU
autistic JJ I-POPU
disorder NN I-POPU
and CC I-POPU
severely RB I-POPU
disruptive JJ I-POPU
behavior NN I-POPU
. . O

METHOD NNP O
Parents NNP B-POPU
of IN I-POPU
101 CD I-POPU
children NNS I-POPU
with IN I-POPU
autism NN I-POPU
who WP I-POPU
had VBD I-POPU
participated VBN I-POPU
in IN I-POPU
a DT I-POPU
multi-site JJ I-POPU
8-week JJ I-POPU
double-blind JJ I-POPU
clinical JJ I-POPU
trial NN I-POPU
of IN I-POPU
risperidone NN I-POPU
were VBD I-POPU
given VBN I-POPU
a DT I-POPU
questionnaire NN I-POPU
at IN I-POPU
the DT I-POPU
end NN I-POPU
to TO I-POPU
elicit VB I-POPU
their PRP$ I-POPU
perceptions NNS I-POPU
of IN I-POPU
the DT I-POPU
appropriateness NN I-POPU
and CC I-POPU
acceptability NN I-POPU
of IN I-POPU
clinical JJ I-POPU
trial NN I-POPU
procedures NNS I-POPU
. . O

RESULTS VB O
Ninety-six NNP B-POPU
( ( I-POPU
95.0 CD I-POPU
% NN I-POPU
) ) I-POPU
parents NNS I-POPU
returned VBD I-POPU
the DT I-POPU
questionnaire NN I-POPU
. . O

Of IN O
these DT O
, , O
80.0 CD O
to TO O
96.8 CD O
% NN O
, , O
depending VBG O
on IN O
the DT O
question NN O
, , O
expressed VBN O
satisfaction NN O
with IN O
their PRP$ O
child NN O
's POS O
research NN O
participation NN O
regardless NN O
of IN O
treatment NN O
outcome NN O
or CC O
assignment NN O
to TO O
active JJ O
drug NN O
or CC O
placebo NN B-INTV
. . O

In IN O
all DT O
, , O
90.5 CD O
% NN O
of IN O
parents NNS O
indicated VBN O
that IN O
they PRP O
would MD O
" VB O
definitely RB O
" JJ O
recommend VBP O
the DT O
clinical JJ O
trial NN O
to TO O
other JJ O
families NNS O
with IN O
similar JJ O
children NNS O
. . O

A DT O
total NN O
of IN O
92.7 CD O
% NN O
indicated VBD O
that IN O
they PRP O
would MD O
rejoin VB O
the DT O
clinical JJ O
trial NN O
if IN O
they PRP O
had VBD O
to TO O
do VB O
it PRP O
all DT O
over RB O
again RB O
. . O

Ethnic JJ O
minority NN O
subjects NNS O
were VBD O
more RBR O
satisfied JJ O
than IN O
white JJ O
participants NNS O
with IN O
the DT O
use NN O
of IN O
" JJ O
learning VBG O
tests NNS O
" NNP O
. . O

CONCLUSIONS NNP O
Parents NNPS O
of IN O
children NNS O
participating VBG O
in IN O
this DT O
trial NN O
were VBD O
highly RB B-OC
satisfied JJ I-OC
and CC I-OC
supportive JJ I-OC
of IN I-OC
the DT I-OC
clinical JJ I-OC
trial NN I-OC
procedures NNS I-OC
. . O

Random NNP O
assignment NN O
to TO O
drug NN O
or CC O
placebo NN B-INTV
and CC O
the DT O
clinical JJ O
response NN O
of IN O
their PRP$ O
children NNS O
did VBD O
not RB O
appear VB O
to TO O
influence VB O
their PRP$ O
views NNS O
. . O

Further JJ O
satisfaction NN O
studies NNS O
of IN O
this DT O
sort NN O
are VBP O
encouraged VBN O
. . O

-DOCSTART- -X- O O

Treating VBG O
anxiety NN B-POPU
disorders NNS I-POPU
in IN I-POPU
children NNS I-POPU
with IN I-POPU
high JJ I-POPU
functioning VBG I-POPU
autism NN I-POPU
spectrum NN I-POPU
disorders NNS I-POPU
: : I-POPU
a DT O
controlled JJ O
trial NN O
. . O

A DT O
family-based JJ O
, , O
cognitive JJ O
behavioural JJ O
treatment NN O
for IN O
anxiety NN O
in IN O
47 CD B-POPU
children NNS I-POPU
with IN I-POPU
comorbid NN I-POPU
anxiety NN I-POPU
disorders NNS I-POPU
and CC I-POPU
High NNP I-POPU
Functioning NNP I-POPU
Autism NNP I-POPU
Spectrum NNP I-POPU
Disorder NNP I-POPU
( ( I-POPU
HFA NNP I-POPU
) ) I-POPU
was VBD O
evaluated VBN O
. . O

Treatment NNP B-INTV
involved VBD I-INTV
12 CD I-INTV
weekly JJ I-INTV
group NN I-INTV
sessions NNS I-INTV
and CC I-INTV
was VBD I-INTV
compared VBN I-INTV
with IN I-INTV
a DT I-INTV
waiting VBG I-INTV
list NN I-INTV
condition NN I-INTV
. . O

Changes NNS B-INTV
between IN I-INTV
pre- NN I-INTV
and CC I-INTV
post-treatment NN I-INTV
were VBD I-INTV
examined VBN I-INTV
using VBG I-INTV
clinical JJ I-INTV
interviews NNS I-INTV
as RB I-INTV
well RB I-INTV
as IN I-INTV
child- NN I-INTV
, , I-INTV
parent- JJ I-INTV
and CC I-INTV
teacher-report JJ I-INTV
measures NNS I-INTV
. . O

Following VBG O
treatment NN O
, , O
71.4 CD O
% NN O
of IN O
the DT O
treated JJ O
participants NNS O
no RB O
longer RB O
fulfilled VBN O
diagnostic JJ O
criteria NNS O
for IN O
an DT O
anxiety NN O
disorder NN O
. . O

Comparisons NNS O
between IN O
the DT O
two CD O
conditions NNS O
indicated VBD O
significant JJ O
reductions NNS O
in IN O
anxiety NN B-OC
symptoms NNS I-OC
as IN I-OC
measured VBN I-OC
by IN I-OC
self-report NN I-OC
, , I-OC
parent NN I-OC
report NN I-OC
and CC I-OC
teacher JJ I-OC
report NN I-OC
. . O

Discussion NNP O
focuses VBZ O
on IN O
the DT O
implications NNS O
for IN O
the DT O
use NN O
of IN O
cognitive JJ O
behaviour NN O
therapy NN O
with IN O
HFA NNP B-POPU
children NNS I-POPU
, , O
for IN O
theory NN O
of IN O
mind NN O
research NN O
and CC O
for IN O
further JJ O
research NN O
on IN O
the DT O
treatment NN O
components NNS O
. . O

-DOCSTART- -X- O O

Dietary JJ O
status NN O
and CC O
impact NN O
of IN O
risperidone NN B-INTV
on IN O
nutritional JJ B-OC
balance NN I-OC
in IN O
children NNS B-POPU
with IN I-POPU
autism NN I-POPU
: : I-POPU
a DT O
pilot NN O
study NN O
. . O

BACKGROUND NNP O
Risperidone NNP B-INTV
may MD O
be VB O
effective JJ O
in IN O
improving VBG O
tantrums NNS B-OC
, , I-OC
aggression NN I-OC
, , I-OC
or CC I-OC
self-injurious JJ I-OC
behaviour NN I-OC
in IN O
children NNS B-POPU
with IN I-POPU
autism NN I-POPU
, , O
but CC O
often RB O
leads VBZ O
to TO O
weight VB B-OC
gain NN I-OC
. . O

METHOD NNP O
Using VBG O
a DT O
quantitative JJ O
Food NNP B-OC
Frequency NNP I-OC
Questionnaire NNP I-OC
( ( I-OC
FFQ NNP I-OC
) ) I-OC
, , O
we PRP O
prospectively RB O
examined VBD O
the DT O
nutritional JJ O
intake NN O
of IN O
20 CD B-POPU
children NNS I-POPU
with IN I-POPU
autism NN I-POPU
participating VBG I-POPU
in IN I-POPU
a DT I-POPU
randomised JJ I-POPU
placebo-controlled JJ I-POPU
trial NN I-POPU
of IN I-POPU
risperidone NN I-POPU
for IN I-POPU
disruptive JJ I-POPU
behaviours NNS I-POPU
. . O

RESULTS NNP O
At IN O
baseline NN O
, , O
the DT O
mean NN B-OC
intakes NNS I-OC
for IN I-OC
macronutrients NNS I-OC
, , I-OC
vitamins NNS I-OC
and CC I-OC
minerals NNS I-OC
exceeded VBD O
Dietary NNP O
Reference NNP O
Intakes NNP O
( ( O
DRIs NNP O
) ) O
. . O

However RB O
there EX O
was VBD O
substantial JJ O
inter-participant JJ O
variability NN O
, , O
with IN O
individual JJ B-OC
deficiencies NNS I-OC
( ( O
< VB O
80 CD O
% NN O
of IN O
DRI NNP O
) ) O
in IN O
the DT O
intake NN B-OC
of IN I-OC
calcium NN I-OC
( ( O
9 CD O
of IN O
20 CD O
participants NNS O
) ) O
, , O
pantothenic JJ B-OC
acid NN I-OC
( ( O
6 CD O
of IN O
20 CD O
) ) O
, , O
vitamin FW B-OC
D NNP I-OC
( ( O
5 CD O
of IN O
20 CD O
) ) O
and CC O
vitamin $ O
K NNP O
( ( O
8 CD O
of IN O
20 CD O
) ) O
. . O

For IN O
the DT O
participants NNS O
for IN O
whom WP O
FFQs NNP O
were VBD O
available JJ O
, , O
there EX O
was VBD O
an DT O
increase NN B-OC
in IN I-OC
weight NN I-OC
and CC O
an DT O
increase NN B-OC
in IN I-OC
vitamin JJ I-OC
K NNP I-OC
intake NN I-OC
after IN O
2 CD O
months NNS O
of IN O
risperidone NN B-INTV
treatment NN O
( ( O
n JJ O
= NNP O
9 CD O
) ) O
compared VBN O
to TO O
placebo VB B-INTV
( ( O
n JJ O
= NNP O
8 CD O
) ) O
. . O

An DT O
additional JJ O
4 CD O
months NNS O
of IN O
risperidone NN B-INTV
treatment NN O
( ( O
n JJ O
= NNP O
8 CD O
) ) O
did VBD O
not RB O
result VB O
in IN O
significant JJ O
changes NNS O
in IN O
reported JJ O
nutritional JJ B-OC
balance NN I-OC
. . O

CONCLUSION NNP O
These DT O
pilot NN O
data NNS O
suggest VBP O
that IN O
treatment NN O
with IN O
risperidone NN B-INTV
did VBD O
not RB O
significantly RB B-OC
affect VBP I-OC
the DT O
nutritional JJ B-OC
balance NN I-OC
of IN O
this DT O
small JJ O
group NN O
of IN O
children NNS O
. . O

-DOCSTART- -X- O O

Relationship NN O
of IN O
dietary JJ B-INTV
intake NN I-INTV
to TO O
gastrointestinal VB B-OC
symptoms NNS I-OC
in IN O
children NNS B-POPU
with IN I-POPU
autistic JJ I-POPU
spectrum NN I-POPU
disorders NNS I-POPU
. . O

BACKGROUND NNP O
Gastrointestinal NNP O
( ( O
GI NNP O
) ) O
symptoms NNS O
and CC O
abnormalities NNS O
in IN O
stool NN O
consistency NN O
are VBP O
frequently RB O
reported VBN O
by IN O
parents NNS B-POPU
of IN I-POPU
children NNS I-POPU
with IN I-POPU
autism NN I-POPU
spectrum NN I-POPU
disorders NNS I-POPU
( ( I-POPU
ASD NNP I-POPU
) ) I-POPU
. . O

The DT O
purpose NN O
of IN O
this DT O
study NN O
was VBD O
to TO O
1 CD O
) ) O
describe NN O
dietary JJ O
intake NN O
of IN O
a DT O
cohort NN O
of IN O
children NNS O
with IN O
ASD NNP O
compared VBN O
with IN O
normative JJ O
data NNS O
and CC O
2 CD O
) ) O
determine NN O
whether IN O
GI NNP O
symptoms NNS O
and CC O
stool JJ O
consistency NN O
are VBP O
related VBN O
to TO O
dietary JJ O
intake NN O
. . O

METHODS NNP O
Data NNP B-POPU
from IN I-POPU
diet JJ I-POPU
diaries NNS I-POPU
of IN I-POPU
children NNS I-POPU
( ( I-POPU
3-8 CD I-POPU
years NNS I-POPU
) ) I-POPU
with IN I-POPU
ASD NNP I-POPU
( ( I-POPU
n JJ I-POPU
= NNP I-POPU
62 CD I-POPU
) ) I-POPU
were VBD I-POPU
analyzed VBN I-POPU
by IN O
a DT O
registered JJ O
pediatric JJ O
dietician NN O
to TO O
compare VB O
to TO O
RDA NNP O
standards NNS O
for IN O
total JJ O
calories NNS O
, , O
protein NN O
, , O
carbohydrate NN O
, , O
and CC O
fat NN O
. . O

Dietary NNP O
intake NN O
was VBD O
correlated VBN O
with IN O
descriptors NNS O
of IN O
stool NN O
consistency NN O
using VBG O
cumulative JJ O
logistic JJ O
regression NN O
methods NNS O
. . O

RESULTS NNP O
Intake NNP O
of IN O
calories NNS O
, , O
carbohydrates NNS O
, , O
and CC O
fat NN O
were VBD O
in IN O
the DT O
average JJ O
range NN O
; : O
protein CC O
intake VB O
was VBD O
increased VBN O
( ( O
211 CD O
% NN O
of IN O
RDA NNP O
) ) O
. . O

Reported VBN O
frequency NN B-OC
of IN I-OC
GI NNP I-OC
abnormalities NNS I-OC
, , I-OC
including VBG I-OC
abnormal JJ I-OC
stool NN I-OC
consistency NN I-OC
( ( I-OC
e.g. JJ I-OC
, , O
bulky NN B-OC
or CC I-OC
loose JJ I-OC
) ) I-OC
, , O
was VBD O
increased VBN O
( ( O
54 CD O
% NN O
) ) O
. . O

No DT O
statistically RB O
significant JJ O
relationships NNS O
between IN O
stool NN O
consistency NN O
and CC O
dietary JJ O
intake NN O
were VBD O
observed VBN O
. . O

CONCLUSIONS NNP O
In IN O
this DT O
sample NN O
, , O
there EX O
was VBD O
a DT O
high JJ O
rate NN O
of IN O
reported VBN O
gastrointestinal JJ B-OC
symptoms NNS I-OC
, , O
despite IN O
lack NN O
of IN O
medical JJ O
causes NNS O
. . O

Intake NNP O
was VBD O
adequate JJ O
for IN O
calories NNS O
and CC O
carbohydrates NNS O
and CC O
increased VBD O
for IN O
protein NN O
. . O

The DT O
children NNS B-POPU
did VBD O
not RB O
exhibit VB O
excessive JJ O
carbohydrate NN O
intake NN O
. . O

There EX O
was VBD O
no DT O
association NN O
of IN O
nutrient JJ O
intake NN O
to TO O
changes NNS O
in IN O
stool NN O
consistency NN O
. . O

-DOCSTART- -X- O O

Positive JJ O
effects NNS O
of IN O
methylphenidate NN B-INTV
on IN O
inattention NN B-POPU
and CC I-POPU
hyperactivity NN I-POPU
in IN I-POPU
pervasive JJ I-POPU
developmental JJ I-POPU
disorders NNS I-POPU
: : I-POPU
an DT O
analysis NN O
of IN O
secondary JJ O
measures NNS O
. . O

BACKGROUND NNP O
Methylphenidate NNP B-INTV
has VBZ O
been VBN O
shown VBN O
elsewhere RB O
to TO O
improve VB O
hyperactivity NN B-OC
in IN O
about IN O
half NN O
of IN O
treated JJ O
children NNS B-POPU
who WP I-POPU
have VBP I-POPU
pervasive JJ I-POPU
developmental NN I-POPU
disorders NNS I-POPU
( ( I-POPU
PDD NNP I-POPU
) ) I-POPU
and CC I-POPU
significant JJ I-POPU
hyperactive-inattentive JJ I-POPU
symptoms NNS I-POPU
. . O

We PRP O
present JJ O
secondary JJ O
analyses NNS O
to TO O
better JJR O
define VB O
the DT O
scope NN O
of IN O
effects NNS O
of IN O
methylphenidate NN B-INTV
on IN O
symptoms NNS O
that WDT O
define VBP O
attention-deficit/hyperactivity NN O
disorder NN O
( ( O
ADHD NNP O
) ) O
and CC O
oppositional JJ O
defiant NN O
disorder NN O
( ( O
ODD NNP O
) ) O
, , O
as RB O
well RB O
as IN O
the DT O
core NN O
autistic JJ O
symptom NN O
domain NN O
of IN O
repetitive JJ O
behavior NN O
. . O

METHODS NNP O
Sixty-six JJ B-POPU
children NNS I-POPU
( ( I-POPU
mean JJ I-POPU
age NN I-POPU
7.5 CD I-POPU
y NN I-POPU
) ) I-POPU
with IN I-POPU
autistic JJ I-POPU
disorder NN I-POPU
, , I-POPU
Asperger NNP I-POPU
's POS I-POPU
disorder NN I-POPU
, , I-POPU
and CC I-POPU
PDD NNP I-POPU
not RB I-POPU
otherwise RB I-POPU
specified VBN I-POPU
, , O
were VBD O
randomized VBN O
to TO O
varying VBG O
sequences NNS O
of IN O
placebo NN B-INTV
and CC I-INTV
three CD I-INTV
different JJ I-INTV
doses NNS I-INTV
of IN I-INTV
methylphenidate NN I-INTV
during IN O
a DT O
4-week JJ O
blinded NN O
, , O
crossover NN O
study NN O
. . O

Methylphenidate NNP O
doses NNS O
used VBD O
approximated JJ O
.125 NNP O
, , O
.25 NNP O
, , O
and CC O
.5 NNP O
mg/kg VBP O
per IN O
dose NN O
, , O
twice RB O
daily RB O
, , O
with IN O
an DT O
additional JJ O
half-dose NN O
in IN O
the DT O
late JJ O
afternoon NN O
. . O

Outcome NNP O
measures NNS O
included VBD O
the DT O
Swanson NNP B-OC
, , I-OC
Nolan NNP I-OC
, , I-OC
and CC I-OC
Pelham NNP I-OC
Questionnaire NNP I-OC
revised VBD I-OC
for IN I-OC
DSM-IV NNP I-OC
( ( I-OC
ADHD NNP I-OC
and CC I-OC
ODD NNP I-OC
scales NNS I-OC
) ) I-OC
and CC I-OC
the DT I-OC
Children NNP I-OC
's POS I-OC
Yale-Brown JJ I-OC
Obsessive NNP I-OC
Compulsive NNP I-OC
Scales NNP I-OC
for IN I-OC
PDD NNP I-OC
. . O

RESULTS NNP O
Methylphenidate NNP B-INTV
was VBD O
associated VBN O
with IN O
significant JJ O
improvement NN O
that WDT O
was VBD O
most RBS O
evident JJ O
at IN O
the DT O
.25- JJ O
and CC O
.5-mg/kg JJ O
doses NNS O
. . O

Hyperactivity NNP B-OC
and CC I-OC
impulsivity NN I-OC
improved VBD O
more JJR O
than IN O
inattention NN B-OC
. . O

There EX O
were VBD O
not RB O
significant JJ O
effects NNS O
on IN O
ODD NNP B-OC
or CC I-OC
stereotyped VBN I-OC
and CC I-OC
repetitive JJ I-OC
behavior NN I-OC
. . O

CONCLUSIONS NNP O
Convergent NNP O
evidence NN O
from IN O
different JJ O
assessments NNS O
and CC O
raters NNS O
confirms VBP O
methylphenidate NN B-INTV
's POS I-INTV
efficacy NN B-OC
in IN O
relieving VBG O
ADHD NNP B-OC
symptoms NNS I-OC
in IN O
some DT O
children NNS B-POPU
with IN I-POPU
PDD NNP I-POPU
. . O

Optimal NNP O
dose JJ O
analyses NNS O
suggested VBD O
significant JJ O
interindividual JJ O
variability NN O
in IN O
dose JJ O
response NN O
. . O

-DOCSTART- -X- O O

Information NNP B-INTV
source NN I-INTV
affects VBZ O
peers NNS O
' POS O
initial JJ O
attitudes NNS O
toward IN O
autism NN B-POPU
. . O

Authors NNS O
examined VBD O
the DT O
effects NNS O
of IN O
information NN O
source NN O
on IN O
peers NNS O
' POS O
cognitive NN B-OC
and CC I-OC
behavioral JJ I-OC
attitudes NNS I-OC
toward IN O
an DT O
unfamiliar JJ B-POPU
child NN I-POPU
with IN I-POPU
autism NN I-POPU
. . O

Children NNP B-POPU
( ( I-POPU
N=296 NNP I-POPU
; : I-POPU
M NNP I-POPU
age=10.21 IN I-POPU
years NNS I-POPU
) ) I-POPU
received VBD O
information NN O
about IN O
an DT O
unfamiliar JJ B-POPU
child NN I-POPU
with IN I-POPU
autism NN I-POPU
from IN O
one CD O
of IN O
the DT O
following JJ O
sources NNS O
: : O
( ( O
a DT O
) ) O
videotape NN B-INTV
, , O
( ( O
b NN O
) ) O
teacher NN B-POPU
, , O
( ( O
c NN O
) ) O
hypothetical JJ B-POPU
mother NN I-POPU
, , O
( ( O
d NN O
) ) O
hypothetical JJ B-POPU
father NN I-POPU
, , O
or CC O
( ( O
e NN O
) ) O
hypothetical JJ B-POPU
" NNP I-POPU
doctor NN I-POPU
. . O

" JJ B-POPU
Interactive JJ O
effects NNS O
between IN O
source NN O
, , O
and CC O
sex NN O
and CC O
grade NN O
were VBD O
found VBN O
for IN O
cognitive JJ O
and CC O
behavioral JJ O
attitudes NNS O
. . O

Fifth-graders NNS B-POPU
reported VBD O
more RBR O
favorable JJ O
cognitive JJ B-OC
and CC I-OC
behavioral JJ I-OC
attitudes NNS I-OC
when WRB O
information NN O
was VBD O
provided VBN O
by IN O
extra-familial JJ O
sources NNS O
( ( O
i.e. NN O
, , O
" NNP O
doctor NN O
" NN O
) ) O
versus NN O
parent NN O
sources NNS O
. . O

Mother NNP O
yielded VBD O
more RBR B-OC
persuasive JJ I-OC
effects NNS I-OC
on IN I-OC
behavioral JJ I-OC
attitudes NNS I-OC
for IN O
third-graders NNS O
versus JJ O
fifth-graders NNS O
. . O

Attitudes NNS O
toward IN O
autism NN O
differ VBP O
depending VBG O
on IN O
who WP O
provides VBZ O
information NN O
about IN O
the DT O
disability NN O
. . O

Persuasion NNP O
theory NN O
appears VBZ O
useful JJ O
to TO O
guide VB O
evaluation NN O
of IN O
educational JJ O
interventions NNS O
to TO O
improve VB O
attitudes NNS B-OC
towards IN I-OC
autism NN I-OC
. . O

Implications NNS O
of IN O
the DT O
findings NNS O
, , O
study NN O
limitations NNS O
, , O
and CC O
recommendations NNS O
for IN O
future JJ O
research NN O
are VBP O
discussed VBN O
. . O

-DOCSTART- -X- O O

Comparison NNP O
of IN O
indicators NNS O
for IN O
a DT O
primary JJ O
care NN O
medical JJ O
home NN O
between IN O
children NNS B-POPU
with IN I-POPU
autism NN I-POPU
or CC I-POPU
asthma NN I-POPU
and CC I-POPU
other JJ I-POPU
special JJ I-POPU
health NN I-POPU
care NN I-POPU
needs NNS I-POPU
: : I-POPU
National NNP O
Survey NNP O
of IN O
Children NNP O
's POS O
Health NNP O
. . O

OBJECTIVE NNP O
To TO O
assess VB O
the DT O
extent NN O
to TO O
which WDT O
parents NNS B-POPU
of IN I-POPU
children NNS I-POPU
with IN I-POPU
autism NN I-POPU
compared VBN I-POPU
with IN I-POPU
parents NNS I-POPU
of IN I-POPU
children NNS I-POPU
with IN I-POPU
asthma NN I-POPU
or CC I-POPU
other JJ I-POPU
special JJ I-POPU
health NN I-POPU
care NN I-POPU
needs VBZ I-POPU
report NN O
receiving VBG O
primary JJ O
care NN O
for IN O
their PRP$ O
child NN O
consistent NN O
with IN O
the DT O
American JJ O
Academy NNP O
of IN O
Pediatrics NNP O
medical JJ O
home NN O
model NN O
. . O

DESIGN NNP O
Population-based JJ O
cross-sectional JJ O
study NN O
. . O

SETTING NNP O
National NNP B-INTV
Survey NNP I-INTV
for IN I-INTV
Children NNP I-INTV
's POS I-INTV
Health NNP I-INTV
2003-2004 CD I-INTV
telephone NN I-INTV
interview NN I-INTV
. . O

PARTICIPANTS NNP O
Parents NNPS B-POPU
of IN I-POPU
495 CD I-POPU
children NNS I-POPU
with IN I-POPU
autism NN I-POPU
, , I-POPU
parents NNS I-POPU
of IN I-POPU
6716 CD I-POPU
children NNS I-POPU
with IN I-POPU
asthma NN I-POPU
, , I-POPU
and CC I-POPU
parents NNS I-POPU
of IN I-POPU
11,403 CD I-POPU
children NNS I-POPU
with IN I-POPU
other JJ I-POPU
special JJ I-POPU
health NN I-POPU
care NN I-POPU
needs VBZ I-POPU
without IN I-POPU
asthma NN I-POPU
. . O

Main NNP O
Exposures NNPS O
Autism NNP O
and CC O
other JJ O
special JJ O
health NN O
care NN O
needs VBZ O
including VBG O
asthma NN O
. . O

MAIN NNP O
OUTCOME NNP O
MEASURES NNP O
Medical NNP O
home NN O
score NN O
and CC O
components NNS O
of IN O
care NN O
, , O
as IN O
follows VBZ O
: : O
personal JJ O
provider NN O
and CC O
preventive NN O
; : O
family-centered JJ O
, , O
compassionate NN O
, , O
and CC O
culturally RB O
appropriate JJ O
; : O
accessible JJ O
; : O
comprehensive JJ O
; : O
and CC O
coordinated VBD O
. . O

RESULTS VB O
The DT O
odds NNS B-OC
of IN I-OC
parents NNS I-OC
reporting VBG I-OC
care NN I-OC
consistent JJ I-OC
with IN I-OC
that DT I-OC
in IN I-OC
a DT I-OC
medical JJ I-OC
home NN I-OC
were VBD O
less RBR B-OC
likely JJ I-OC
for IN I-OC
children NNS I-OC
with IN I-OC
autism NN I-OC
( ( O
odds NNS O
ratio NN O
, , O
0.45 CD O
; : O
95 CD O
% NN O
confidence NN O
interval NN O
, , O
0.30-0.66 JJ O
) ) O
and CC O
more RBR O
likely JJ O
for IN O
children NNS O
with IN O
asthma NN O
( ( O
odds NNS O
ratio NN O
, , O
1.17 CD O
; : O
95 CD O
% NN O
confidence NN O
interval NN O
, , O
1.06-1.30 JJ O
) ) O
compared VBN O
with IN O
children NNS O
with IN O
other JJ O
special JJ O
health NN O
care NN O
needs NNS O
( ( O
1 CD O
[ NN O
reference NN O
] NN O
) ) O
. . O

These DT O
differences NNS O
persisted VBD O
even RB O
after IN O
controlling VBG O
for IN O
condition NN O
severity NN O
, , O
personal JJ O
characteristics NNS O
, , O
and CC O
insurance NN O
status NN O
. . O

Specific JJ O
components NNS O
of IN O
a DT O
medical JJ O
home NN O
less RBR O
prevalent JJ O
among IN O
children NNS O
with IN O
autism NN O
than IN O
among IN O
children NNS O
with IN O
other JJ O
special JJ O
health NN O
care NN O
needs VBZ O
included VBN O
family-centered JJ O
, , O
comprehensive JJ O
, , O
and CC O
coordinated VBD O
care NN O
. . O

CONCLUSION NNP O
Although IN O
we PRP O
could MD O
not RB O
evaluate VB O
the DT O
reasons NNS O
why WRB O
, , O
a DT O
large JJ O
percentage NN O
of IN O
children NNS O
with IN O
autism NN O
do VBP O
not RB O
receive VB O
primary JJ B-OC
care NN I-OC
consistent JJ I-OC
with IN I-OC
that DT I-OC
in IN I-OC
a DT I-OC
medical JJ I-OC
home NN I-OC
. . O

-DOCSTART- -X- O O

Temporal JJ B-INTV
judgements NNS I-INTV
of IN O
internal JJ O
and CC O
external JJ O
events NNS O
in IN O
persons NNS B-POPU
with IN I-POPU
and CC I-POPU
without IN I-POPU
autism NN I-POPU
. . O

When WRB O
participants NNS O
make VBP O
judgments NNS B-INTV
about IN O
the DT O
onset NN O
of IN O
self-initiated JJ O
movements NNS O
they PRP O
typically RB O
report VBP O
the DT O
movement NN O
occurred VBD O
earlier JJR O
than IN O
it PRP O
had VBD O
[ NNP O
Obhi NNP O
, , O
S. NNP O
S. NNP O
, , O
& CC O
Haggard NNP O
, , O
P. NNP O
( ( O
2004 CD O
) ) O
. . O

Free NNP O
will MD O
and CC O
free JJ O
wo MD O
n't RB O
. . O

American JJ O
Scientific NNP O
, , O
92 CD O
, , O
358-365. JJ O
] NN O
. . O

One CD O
interpretation NN O
is VBZ O
that IN O
feed-forward JJ O
processes NNS O
lead VBP O
to TO O
awareness NN O
of IN O
the DT O
movement NN O
prior RB O
to TO O
execution NN O
. . O

Because IN O
individuals NNS B-POPU
with IN I-POPU
autism NN I-POPU
experience NN O
reduced VBD O
preparatory JJ O
activity NN O
prior RB O
to TO O
a DT O
voluntary JJ O
movement NN O
, , O
the DT O
present JJ O
study NN O
sought VBD O
to TO O
determine VB O
whether IN O
these DT O
anticipatory JJ O
biases NNS O
are VBP O
exhibited VBN O
by IN O
persons NNS B-POPU
with IN I-POPU
autism NN I-POPU
. . O

Participants NNS B-INTV
watched VBD I-INTV
a DT I-INTV
dot JJ I-INTV
move NN I-INTV
in IN I-INTV
a DT I-INTV
circle NN I-INTV
and CC I-INTV
pressed VBD I-INTV
the DT I-INTV
spacebar NN I-INTV
any DT I-INTV
time NN I-INTV
after IN I-INTV
one CD I-INTV
revolution NN I-INTV
. . O

A DT O
tone NN O
either CC O
followed VBD O
the DT O
participants NNS O
' POS O
voluntary JJ O
movement NN O
or CC O
was VBD O
computer NN O
generated VBN O
. . O

Participants NNS O
in IN O
both DT O
groups NNS O
made VBD O
anticipatory JJ O
judgements NNS B-INTV
regarding VBG O
movement NN B-OC
initiation NN I-OC
( ( O
approximately RB O
100 CD O
ms NN O
) ) O
. . O

When WRB O
the DT O
movement NN O
and CC O
tone NN O
occurred VBD O
together RB O
this DT O
anticipatory NN O
bias NN O
was VBD O
also RB O
present JJ O
, , O
regardless RB O
of IN O
which WDT O
event NN O
participants NNS O
focused VBD O
on IN O
. . O

Individuals NNS B-POPU
with IN I-POPU
autism NN I-POPU
appear VBP O
to TO O
have VB O
access NN O
to TO O
a DT O
similar JJ O
representation NN O
of IN O
voluntary JJ B-OC
movements NNS I-OC
, , O
however RB O
this DT O
representation NN O
may MD O
be VB O
more RBR O
variable JJ O
. . O

-DOCSTART- -X- O O

The DT O
effectiveness NN O
of IN O
Picture NNP B-INTV
Exchange NNP I-INTV
Communication NNP I-INTV
System NNP I-INTV
( ( I-INTV
PECS NNP I-INTV
) ) I-INTV
training NN I-INTV
for IN O
teachers NNS B-POPU
of IN I-POPU
children NNS I-POPU
with IN I-POPU
autism NN I-POPU
: : I-POPU
a DT O
pragmatic JJ O
, , O
group NN O
randomised VBD O
controlled VBN O
trial NN O
. . O

OBJECTIVE UH O
To TO O
assess VB O
the DT O
effectiveness NN O
of IN O
expert JJ O
training NN O
and CC O
consultancy NN O
for IN O
teachers NNS B-POPU
of IN I-POPU
children NNS I-POPU
with IN I-POPU
autism NN I-POPU
spectrum NN I-POPU
disorder NN I-POPU
in IN O
the DT O
use NN O
of IN O
the DT O
Picture NNP B-INTV
Exchange NNP I-INTV
Communication NNP I-INTV
System NNP I-INTV
( ( I-INTV
PECS NNP I-INTV
) ) I-INTV
. . O

METHOD NNP O
DESIGN NNP O
Group NNP O
randomised VBD O
, , O
controlled VBN O
trial NN O
( ( O
3 CD O
groups NNS O
: : O
immediate JJ O
treatment NN O
, , O
delayed VBN O
treatment NN O
, , O
no DT O
treatment NN O
) ) O
. . O

PARTICIPANTS $ O
84 CD B-POPU
elementary JJ I-POPU
school NN I-POPU
children NNS I-POPU
, , I-POPU
mean JJ I-POPU
age NN I-POPU
6.8 CD I-POPU
years NNS I-POPU
. . O

TREATMENT VB O
A DT B-INTV
2-day JJ I-INTV
PECS NNP I-INTV
workshop NN I-INTV
for IN I-INTV
teachers NNS B-POPU
plus CC B-INTV
6 CD I-INTV
half-day JJ I-INTV
, , I-INTV
school-based JJ I-INTV
training NN I-INTV
sessions NNS I-INTV
with IN I-INTV
expert JJ I-INTV
consultants NNS I-INTV
over IN I-INTV
5 CD I-INTV
months NNS I-INTV
. . O

OUTCOME NNP O
MEASURES NNP O
Rates NNPS O
of IN O
: : O
communicative JJ B-OC
initiations NNS I-OC
, , I-OC
use NN I-OC
of IN I-OC
PECS NNP B-INTV
, , B-OC
and CC I-OC
speech NN I-OC
in IN I-OC
the DT I-OC
classroom NN I-OC
; : I-OC
Autism NNP I-OC
Diagnostic NNP I-OC
Observation NNP I-OC
Schedule-Generic NNP I-OC
( ( I-OC
ADOS-G NNP I-OC
) ) I-OC
domain NN I-OC
scores NNS I-OC
for IN I-OC
Communication NNP I-OC
and CC I-OC
Reciprocal NNP I-OC
Social NNP I-OC
Interaction NNP I-OC
; : I-OC
scores NNS I-OC
on IN I-OC
formal JJ I-OC
language NN I-OC
tests NNS I-OC
. . O

RESULTS NNP O
Controlling VBG O
for IN O
baseline NN O
age NN O
, , O
developmental JJ B-OC
quotient NN I-OC
( ( I-OC
DQ NNP I-OC
) ) I-OC
and CC I-OC
language NN I-OC
; : I-OC
rates NNS I-OC
of IN I-OC
initiations NNS I-OC
and CC I-OC
PECS NNP I-OC
usage NN I-OC
increased VBD O
significantly RB O
immediately RB O
post-treatment JJ O
( ( O
Odds NNP O
Ratio NNP O
( ( O
OR NNP O
) ) O
of IN O
being VBG O
in IN O
a DT O
higher JJR O
ordinal JJ O
rate NN O
category NN O
2.72 CD O
, , O
95 CD O
% NN O
confidence NN O
interval JJ O
1.22-6.09 JJ O
, , O
p JJ O
< NNP O
.05 NNP O
and CC O
OR NNP O
3.90 CD O
( ( O
95 CD O
% NN O
CI NNP O
1.75-8.68 CD O
) ) O
, , O
p JJ O
< NNP O
.001 NNP O
, , O
respectively RB O
) ) O
. . O

There EX O
were VBD O
no DT O
increases NNS O
in IN O
frequency NN B-OC
of IN I-OC
speech NN I-OC
, , I-OC
or CC I-OC
improvements NNS I-OC
in IN I-OC
ADOS-G NNP I-OC
ratings NNS I-OC
or CC I-OC
language NN I-OC
test NN I-OC
scores NNS I-OC
. . O

CONCLUSIONS VB O
The DT O
results NNS O
indicate VBP O
modest JJ O
effectiveness NN O
of IN O
PECS NNP B-INTV
teacher NN I-INTV
training/consultancy NN I-INTV
. . O

Rates NNS O
of IN O
pupils NNS O
' POS O
initiations NNS O
and CC O
use NN O
of IN O
symbols NNS O
in IN O
the DT O
classroom NN O
increased VBD O
, , O
although IN O
there EX O
was VBD O
no DT O
evidence NN O
of IN O
improvement NN O
in IN O
other JJ O
areas NNS O
of IN O
communication NN O
. . O

TREATMENT NNP O
effects NNS O
were VBD O
not RB O
maintained VBN O
once RB O
active JJ O
intervention NN O
ceased VBD O
. . O

-DOCSTART- -X- O O

Improvement NN O
in IN O
sensory JJ O
impairment NN O
and CC O
social JJ O
interaction NN O
in IN O
young JJ B-POPU
children NNS I-POPU
with IN I-POPU
autism NN I-POPU
following VBG O
treatment NN O
with IN O
an DT O
original JJ B-INTV
Qigong NNP I-INTV
massage NN I-INTV
methodology NN I-INTV
. . O

In IN O
clinical JJ O
research NN O
, , O
sensory JJ O
impairment NN O
is VBZ O
considered VBN O
one CD O
of IN O
the DT O
core NN O
deficits NNS O
in IN O
autism NN O
and CC O
is VBZ O
associated VBN O
with IN O
impaired JJ O
socialization NN O
, , O
behavioral JJ O
disturbances NNS O
and CC O
bowel NN O
and CC O
sleep JJ O
problems NNS O
. . O

The DT O
effectiveness NN O
of IN O
the DT O
Cignolini NNP B-INTV
methodology NN I-INTV
, , I-INTV
an DT I-INTV
original JJ I-INTV
Qigong NNP I-INTV
massage NN I-INTV
methodology NN I-INTV
, , O
in IN O
treating VBG O
sensory JJ B-POPU
impairment NN I-POPU
in IN I-POPU
young JJ I-POPU
children NNS I-POPU
with IN O
autism NN O
was VBD O
evaluated VBN O
in IN O
a DT O
small JJ O
, , O
controlled VBN O
study NN O
. . O

Thirteen NNP B-POPU
children NNS I-POPU
with IN I-POPU
autism NN I-POPU
between IN I-POPU
the DT I-POPU
ages NNS I-POPU
of IN I-POPU
three CD I-POPU
and CC I-POPU
six CD I-POPU
received VBD O
daily JJ O
treatment NN O
according VBG O
to TO O
the DT O
methodology NN O
for IN O
5 CD O
months NNS O
. . O

Compared VBN O
with IN O
untreated JJ O
children NNS O
, , O
treated VBD O
children NNS O
experienced VBD O
significant JJ O
improvement NN O
of IN O
their PRP$ O
sensory JJ B-OC
impairment NN I-OC
( ( O
p JJ O
< NNP O
0.01 CD O
) ) O
, , O
and CC O
demonstrated VBD O
increased VBN O
social JJ B-OC
skills NNS I-OC
( ( O
p JJ O
< NNP O
0.04 CD O
) ) O
and CC O
basic JJ B-OC
living NN I-OC
skills NNS I-OC
( ( O
p JJ O
< NNP O
0.02 CD O
) ) O
on IN O
standardized JJ O
measures NNS O
. . O

In IN O
addition NN O
, , O
all DT O
of IN O
the DT O
children NNS B-POPU
with IN I-POPU
bowel NN I-POPU
and CC I-POPU
sleep JJ I-POPU
abnormalities NNS I-POPU
demonstrated VBD O
improvement NN O
after IN O
treatment NN O
. . O

-DOCSTART- -X- O O

A DT O
randomized VBN O
, , O
controlled VBD O
trial NN O
of IN O
a DT O
home-based JJ B-INTV
intervention NN I-INTV
program NN I-INTV
for IN O
children NNS B-POPU
with IN I-POPU
autism NN I-POPU
and CC I-POPU
developmental JJ I-POPU
delay NN I-POPU
. . O

OBJECTIVE CC O
This DT O
study NN O
aimed VBN O
to TO O
( ( O
1 CD O
) ) O
investigate NN O
whether IN O
provision NN O
of IN O
a DT O
home-based JJ B-INTV
program NN I-INTV
in IN I-INTV
addition NN I-INTV
to TO I-INTV
a DT I-INTV
center-based JJ I-INTV
program NN I-INTV
improves VBZ O
development NN O
in IN O
young JJ B-POPU
children NNS I-POPU
with IN I-POPU
disabilities NNS I-POPU
and CC I-POPU
coping VBG I-POPU
abilities NNS I-POPU
of IN I-POPU
their PRP$ I-POPU
families NNS I-POPU
and CC I-POPU
( ( I-POPU
2 CD I-POPU
) ) I-POPU
describe VB I-POPU
the DT I-POPU
characteristics NNS I-POPU
of IN I-POPU
children NNS I-POPU
and CC I-POPU
families NNS I-POPU
who WP I-POPU
benefit VBP I-POPU
most RBS I-POPU
from IN I-POPU
the DT I-POPU
intervention NN I-POPU
. . O

METHODS NNP O
Fifty-nine JJ B-POPU
children NNS I-POPU
, , I-POPU
aged VBN I-POPU
3-5 CD I-POPU
years NNS I-POPU
, , I-POPU
with IN I-POPU
no DT I-POPU
cerebral JJ I-POPU
palsy NN I-POPU
, , O
participated VBN O
in IN O
the DT O
study NN O
. . O

Half NNP O
of IN O
the DT O
group NN O
was VBD O
randomized VBN O
to TO O
receive VB O
an DT O
additional JJ B-INTV
program NN I-INTV
in IN I-INTV
their PRP$ I-INTV
homes NNS I-INTV
. . O

A DT B-POPU
special JJ I-POPU
education NN I-POPU
teacher NN I-POPU
provided VBD I-POPU
40 CD I-POPU
visits NNS I-POPU
over IN I-POPU
12 CD I-POPU
months NNS I-POPU
working VBG I-POPU
with IN I-POPU
the DT I-POPU
families NNS I-POPU
to TO O
help VB O
generalize VB O
skills NNS O
to TO O
the DT O
home NN O
environment NN O
and CC O
assist NN O
with IN O
their PRP$ O
concerns NNS O
. . O

All DT O
children NNS O
were VBD O
assessed VBN O
before IN O
and CC O
after IN O
the DT O
intervention NN O
, , O
and CC O
families NNS O
completed VBN O
questionnaires NNS O
assessing VBG O
family NN B-OC
stress NN I-OC
, , I-OC
support NN I-OC
, , I-OC
and CC I-OC
empowerment NN I-OC
on IN O
both DT O
occasions NNS O
. . O

Differences NNS O
in IN O
change NN O
over IN O
time NN O
and CC O
between IN O
the DT O
intervention NN O
and CC O
control NN O
group NN O
were VBD O
analyzed VBN O
by IN O
repeated JJ O
measures NNS O
and CC O
the DT O
association NN O
between IN O
characteristics NNS O
of IN O
children NNS O
and CC O
families NNS O
with IN O
improved JJ O
outcome NN O
by IN O
multivariate JJ O
analysis NN O
of IN O
variance NN O
. . O

RESULTS NNP O
Change NNP B-OC
in IN I-OC
cognitive JJ I-OC
development NN I-OC
and CC I-OC
behavior NN I-OC
( ( O
in IN O
the DT O
centers NNS O
) ) O
over IN O
time NN O
favored VBN O
the DT O
children NNS O
who WP O
received VBD O
the DT O
extra JJ O
intervention NN O
( ( O
p JJ O
= NNP O
.007 NNP O
and CC O
p VB O
= NNP O
.007 NNP O
, , O
respectively RB O
) ) O
. . O

The DT O
groups NNS O
did VBD O
not RB O
differ VB B-OC
on IN O
any DT O
of IN O
the DT O
family NN B-OC
measures NNS I-OC
of IN I-OC
change NN I-OC
. . O

Multivariate NNP O
analysis NN O
of IN O
variance NN O
revealed VBD O
more RBR O
improvement NN O
for IN O
children NNS O
in IN O
the DT O
intervention NN O
group NN O
from IN O
higher JJR O
than IN O
lower JJR O
stressed JJ O
families NNS O
. . O

CONCLUSIONS NNP O
Results NNP O
suggest VBP O
the DT O
need NN O
for IN O
daily JJ O
reinforcement NN O
of IN O
skills NNS O
learned VBN O
at IN O
the DT O
center-based JJ O
program NN O
and CC O
the DT O
importance NN O
of IN O
involving VBG O
families NNS O
, , O
especially RB O
those DT O
with IN O
few JJ O
resources NNS O
and CC O
relatively RB O
high JJ O
stress NN O
. . O

-DOCSTART- -X- O O

[ JJ O
Effect NNP O
of IN O
acupuncture NN B-INTV
on IN O
rehabilitation NN O
training NN O
of IN O
child NN B-POPU
's POS I-POPU
autism NN I-POPU
] NN I-POPU
. . O

OBJECTIVE UH O
To TO O
observe VB O
the DT O
effect NN O
of IN O
acupuncture NN B-INTV
on IN O
rehabilitation NN O
training NN O
for IN O
children NNS B-POPU
's POS I-POPU
autism NN I-POPU
. . O

METHODS NNP O
Forty NNP B-POPU
autistic JJ I-POPU
children NNS I-POPU
receiving VBG I-POPU
rehabilitation NN I-POPU
training NN I-POPU
were VBD O
divided VBN O
into IN O
a DT O
control NN O
group NN O
and CC O
a DT O
treatment NN O
group NN O
, , O
20 CD O
cases NNS O
in IN O
each DT O
group NN O
. . O

The DT O
control NN O
group NN O
received VBD O
rehabilitation NN B-INTV
training NN I-INTV
including VBG I-INTV
ABA NNP I-INTV
training NN I-INTV
, , I-INTV
the DT I-INTV
Conductive NNP I-INTV
Education NNP I-INTV
Approach NNP I-INTV
and CC I-INTV
the DT I-INTV
training NN I-INTV
of IN I-INTV
sensory JJ I-INTV
integration NN I-INTV
, , O
about RB O
90 CD O
sessions NNS O
for IN O
each DT O
training NN O
; : O
the DT O
treatment NN O
group NN O
received VBD O
acupuncture JJ B-INTV
treatment NN I-INTV
for IN O
60-90 JJ O
sessions NNS O
after IN B-INTV
the DT I-INTV
rehabilitation NN I-INTV
training NN I-INTV
. . O

Their PRP$ O
results NNS O
were VBD O
detected VBN O
by IN O
the DT O
revised VBN B-OC
Chinese JJ I-OC
version NN I-OC
of IN I-OC
Psycho-Educational NNP I-OC
Profile NNP I-OC
for IN I-OC
autistic JJ I-OC
and CC I-OC
developmentally RB I-OC
disabled JJ I-OC
children NNS I-OC
( ( I-OC
C-PEP NNP I-OC
) ) I-OC
. . O

RESULTS VB O
The DT O
markedly RB O
effective JJ B-OC
rate NN I-OC
was VBD O
55.0 CD O
% NN O
in IN O
the DT O
treatment NN O
group NN O
and CC O
15.0 CD O
% NN O
in IN O
the DT O
control NN O
group NN O
with IN O
a DT O
very RB O
significant JJ O
difference NN O
between IN O
the DT O
two CD O
groups NNS O
( ( O
P NNP O
< NNP O
0.01 CD O
) ) O
; : O
the DT O
differences NNS O
before IN O
and CC O
after IN O
training NN O
in IN O
some DT O
projects NNS O
such JJ O
as IN O
the DT O
total JJ B-OC
score NN I-OC
of IN I-OC
development NN I-OC
, , I-OC
imitation NN I-OC
, , I-OC
oral JJ I-OC
cognition NN I-OC
in IN O
the DT O
treatment NN O
group NN O
were VBD O
very RB O
significantly RB O
different JJ O
from IN O
those DT O
in IN O
the DT O
control NN O
group NN O
( ( O
P NNP O
< NNP O
0.01 CD O
) ) O
. . O

CONCLUSION NNP O
Acupuncture NNP B-INTV
combined VBN O
with IN O
scientific JJ B-INTV
and CC I-INTV
effective JJ I-INTV
rehabilitation NN I-INTV
training NN I-INTV
has VBZ O
a DT O
better RBR O
therapeutic JJ B-OC
effect NN I-OC
than IN O
that DT O
of IN O
the DT O
simple JJ B-INTV
rehabilitation NN I-INTV
training NN I-INTV
for IN O
child NN B-POPU
's POS I-POPU
autism NN I-POPU
. . O

-DOCSTART- -X- O O

[ JJ O
Effects NNS O
of IN O
electroacupuncture NN B-INTV
combined VBN I-INTV
with IN I-INTV
behavior JJ I-INTV
therapy NN I-INTV
on IN O
intelligence NN O
and CC O
behavior NN O
of IN O
children NNS B-POPU
of IN I-POPU
autism NN I-POPU
] NNP I-POPU
. . O

OBJECTIVE NNP O
To TO O
find VB O
out RP O
an DT O
effective JJ O
therapy NN O
for IN O
autism NN O
. . O

METHODS NNP O
Sixty NNP B-POPU
children NNS I-POPU
of IN I-POPU
autism NN I-POPU
were VBD O
randomly RB O
divided VBN O
into IN O
an DT O
electroacupuncture NN B-INTV
( ( I-INTV
EA NNP I-INTV
) ) I-INTV
plus CC I-INTV
behavior JJ I-INTV
therapy NN I-INTV
group NN I-INTV
and CC I-INTV
a DT I-INTV
behavior JJ I-INTV
therapy NN I-INTV
group NN I-INTV
, , O
30 CD O
cases NNS O
in IN O
each DT O
group NN O
. . O

The DT O
patients NNS O
in IN O
the DT O
two CD O
groups NNS O
were VBD O
treated VBN O
with IN O
routine JJ B-INTV
behavior NN I-INTV
, , O
with IN O
EA NNP B-INTV
at IN O
Baihui NNP O
( ( O
GV NNP O
20 CD O
) ) O
, , O
Sishencong NNP O
( ( O
EX-HN NNP O
1 CD O
) ) O
, , O
Shenting NNP O
( ( O
GV NNP O
24 CD O
) ) O
, , O
Benshen NNP O
( ( O
GB NNP O
13 CD O
) ) O
, , O
Yintang NNP O
( ( O
EX-HN NNP O
3 CD O
) ) O
, , O
Naohu NNP O
( ( O
GV NNP O
17 CD O
) ) O
, , O
Naokong NNP O
( ( O
GB NNP O
19 CD O
) ) O
, , O
Neiguan NNP O
( ( O
PC NNP O
6 CD O
) ) O
and CC O
scalp JJ B-INTV
acupuncture NN I-INTV
at IN O
Speech NNP O
Areas NNP O
I PRP O
, , O
II NNP O
, , O
III NNP O
added VBD O
for IN O
the DT O
EA NNP B-INTV
plus CC I-INTV
behavior JJ I-INTV
therapy NN I-INTV
group NN O
. . O

Their PRP$ O
therapeutic JJ O
effects NNS O
were VBD O
observed VBN O
, , O
and CC O
the DT O
picture NN B-OC
and CC I-OC
vocabulary JJ I-OC
scale NN I-OC
( ( I-OC
PPVT NNP I-OC
) ) I-OC
and CC O
behavior JJ B-OC
ability NN I-OC
were VBD O
detected VBN O
. . O

RESULTS VB O
The DT O
total JJ B-OC
effective JJ I-OC
rate NN I-OC
was VBD O
86.7 CD O
% NN O
in IN O
the DT O
EA NNP B-INTV
plus CC I-INTV
behavior JJ I-INTV
therapy NN I-INTV
group NN O
which WDT O
was VBD O
better JJR O
than IN O
56.7 CD O
% NN O
of IN O
the DT O
behavior JJ O
therapy NN O
group NN O
, , O
and CC O
had VBD O
significant JJ O
enhancement NN O
in IN O
sensation NN B-OC
, , I-OC
association NN I-OC
, , I-OC
body NN I-OC
, , I-OC
and CC I-OC
ability NN I-OC
of IN I-OC
self-care NN I-OC
( ( O
P NNP O
< NNP O
0.05 CD O
) ) O
and CC O
was VBD O
better JJR O
than IN O
the DT O
behavior JJ O
therapy NN O
group NN O
in IN O
sensation NN B-OC
, , I-OC
body NN I-OC
and CC I-OC
self-care JJ I-OC
factors NNS I-OC
, , O
with IN O
no DT O
significantly RB O
improvement NN O
in IN O
the DT O
scores NNS O
of IN O
PPVT NNP B-OC
in IN O
the DT O
two CD O
groups NNS O
( ( O
P NNP O
> NNP O
0.05 CD O
) ) O
. . O

CONCLUSION NNP O
EA NNP B-INTV
combined VBD I-INTV
with IN I-INTV
behavior JJ I-INTV
therapy NN I-INTV
can MD O
significantly RB O
improve VB O
clinical JJ O
symptoms NNS O
of IN O
autism NN O
, , O
but CC O
does VBZ O
not RB O
improve VB O
intelligence NN O
. . O

-DOCSTART- -X- O O

A DT O
double-blind JJ O
placebo NN B-INTV
controlled VBD O
trial NN O
of IN O
piracetam NN B-INTV
added VBN O
to TO O
risperidone VB B-INTV
in IN O
patients NNS B-POPU
with IN I-POPU
autistic JJ I-POPU
disorder NN I-POPU
. . O

It PRP O
has VBZ O
been VBN O
reported VBN O
that IN O
autism NN O
is VBZ O
a DT O
hypoglutamatergic JJ O
disorder NN O
. . O

Therefore RB O
, , O
it PRP O
was VBD O
of IN O
interest NN O
to TO O
assess VB O
the DT O
efficacy NN B-OC
of IN O
piracetam NN B-INTV
, , O
a DT O
positive JJ O
modulator NN O
of IN O
AMPA-sensitive JJ O
glutamate NN O
receptors NNS O
in IN O
autistic JJ O
disorder NN O
. . O

About IN B-POPU
40 CD I-POPU
children NNS I-POPU
between IN I-POPU
the DT I-POPU
ages NNS I-POPU
three CD I-POPU
and CC I-POPU
11 CD I-POPU
years NNS I-POPU
( ( I-POPU
inclusive JJ I-POPU
) ) I-POPU
with IN I-POPU
a DT I-POPU
DSM NNP I-POPU
IV NNP I-POPU
clinical JJ I-POPU
diagnosis NN I-POPU
of IN I-POPU
autism NN I-POPU
and CC I-POPU
who WP I-POPU
were VBD I-POPU
outpatients NNS I-POPU
from IN I-POPU
a DT I-POPU
specialty NN I-POPU
clinic NN I-POPU
for IN I-POPU
children NNS I-POPU
were VBD I-POPU
recruited VBN I-POPU
. . O

The DT O
children NNS B-POPU
presented VBN I-POPU
with IN I-POPU
a DT I-POPU
chief JJ I-POPU
complaint NN I-POPU
of IN I-POPU
severely RB I-POPU
disruptive JJ I-POPU
symptoms NNS I-POPU
related VBN I-POPU
to TO I-POPU
autistic JJ I-POPU
disorder NN I-POPU
. . O

Patients NNS O
were VBD O
randomly RB O
allocated VBN O
to TO O
piracetam VB B-INTV
+ NNP I-INTV
risperidone NN I-INTV
( ( I-INTV
Group NNP I-INTV
A NNP I-INTV
) ) I-INTV
or CC I-INTV
placebo JJ I-INTV
+ NN I-INTV
risperidone NN I-INTV
( ( O
Group NNP O
B NNP O
) ) O
for IN O
a DT O
10-week JJ O
, , O
double-blind JJ O
, , O
placebo-controlled JJ O
study NN O
. . O

The DT O
dose NN O
of IN O
risperidone NN B-INTV
was VBD O
titrated VBN O
up RB O
to TO O
2 CD O
mg/day NN O
for IN O
children NNS O
between IN O
10 CD O
and CC O
40 CD O
kg NN O
and CC O
3 CD O
mg/day NN O
for IN O
children NNS O
weighting VBG O
above IN O
40 CD O
kg NN O
. . O

The DT O
dose NN O
of IN O
piracetam NN B-INTV
was VBD O
titrated VBN O
up RB O
to TO O
800 CD O
mg/day NN O
. . O

Patients NNS O
were VBD O
assessed VBN O
at IN O
baseline NN O
and CC O
after IN O
2 CD O
, , O
4 CD O
, , O
6 CD O
, , O
8 CD O
and CC O
10 CD O
weeks NNS O
of IN O
starting VBG O
medication NN O
. . O

The DT O
measure NN O
of IN O
the DT O
outcome NN O
was VBD O
the DT O
Aberrant NNP B-OC
Behavior NNP I-OC
Checklist-Community NNP I-OC
( ( I-OC
ABC-C NNP I-OC
) ) I-OC
Rating VBG I-OC
Scale NNP I-OC
( ( I-OC
total JJ I-OC
score NN I-OC
) ) I-OC
. . O

The DT O
ABC-C JJ B-OC
Rating NNP I-OC
Scale NNP I-OC
scores VBZ I-OC
improved VBN O
with IN O
piracetam NN O
. . O

The DT O
difference NN O
between IN O
the DT O
two CD O
protocols NNS O
was VBD O
significant JJ O
as IN O
indicated VBN O
by IN O
the DT O
effect NN O
of IN O
group NN O
, , O
the DT O
between IN O
subjects NNS O
factor NN O
( ( O
F NNP O
= NNP O
5.85 CD O
, , O
d.f NN O
. . O

= CC O
1 CD O
, , O
P NNP O
= NNP O
0.02 CD O
) ) O
. . O

The DT O
changes NNS O
at IN O
the DT O
endpoint NN O
compared VBN O
with IN O
baseline NN O
were VBD O
: : O
-11.90 JJ O
+/- JJ O
3.79 CD O
( ( O
mean JJ O
+/- NNP O
SD NNP O
) ) O
and CC O
-5.15 JJ O
+/- JJ O
3.04 CD O
for IN O
group NN O
A NNP O
and CC O
B NNP O
respectively RB O
. . O

A DT O
significant JJ O
difference NN O
was VBD O
observed VBN O
on IN O
the DT O
change NN O
in IN O
scores NNS B-OC
in IN I-OC
the DT I-OC
ABC-C NNP I-OC
Rating NNP I-OC
Scale NNP I-OC
in IN O
week NN O
10 CD O
compared VBN O
with IN O
baseline NN O
in IN O
the DT O
two CD O
groups NNS O
( ( O
t JJ O
= NN O
6.017 CD O
, , O
d.f NN O
. . O

= CC O
38 CD O
, , O
P NNP O
< NNP O
0.0001 CD O
) ) O
. . O

The DT O
results NNS O
suggest VBP O
that IN O
a DT O
combination NN O
of IN O
atypical JJ O
antipsychotic JJ O
medications NNS O
and CC O
a DT O
glutamate JJ O
agent NN O
such JJ O
as IN O
piracetam NNS O
, , O
might MD O
have VB O
increase VBN O
synergistic JJ O
effects NNS O
in IN O
the DT O
treatment NN O
of IN O
autism NN O
. . O

-DOCSTART- -X- O O

Children NNP B-POPU
with IN I-POPU
autism NN I-POPU
's POS I-POPU
response NN B-OC
to TO I-OC
novel VB B-INTV
stimuli NNS I-INTV
while IN O
participating VBG O
in IN O
interventions NNS O
targeting VBG O
joint JJ B-INTV
attention NN I-INTV
or CC O
symbolic JJ B-INTV
play NN I-INTV
skills NNS O
. . O

Thirty-five JJ B-POPU
children NNS I-POPU
diagnosed VBN I-POPU
with IN I-POPU
autism NN I-POPU
were VBD O
randomly RB O
assigned VBN O
to TO O
either VB O
a DT O
joint JJ B-INTV
attention NN I-INTV
or CC I-INTV
a DT I-INTV
symbolic JJ I-INTV
play NN I-INTV
intervention NN I-INTV
. . O

During IN O
the DT O
5-8 JJ O
week NN O
treatment NN O
, , O
three CD O
novel NN O
probes NNS O
were VBD O
administered VBN O
to TO O
determine VB O
mastery NN B-OC
of IN I-OC
joint JJ I-OC
attention NN I-OC
skills NNS I-OC
. . O

The DT O
probes NNS O
consisted VBD O
of IN O
auditory NN O
and CC O
visual JJ O
stimuli NN O
, , O
such JJ O
as IN O
a DT O
loud JJ O
spider NN O
crawling NN O
or CC O
a DT O
musical JJ O
ball NN O
bouncing NN O
. . O

The DT O
current JJ O
study NN O
examined VBD O
affect JJ B-OC
, , I-OC
gaze JJ I-OC
, , I-OC
joint JJ I-OC
attention NN I-OC
behaviors NNS I-OC
, , O
and CC O
verbalizations NNS B-OC
at IN O
three CD O
different JJ O
time NN O
points NNS O
of IN O
intervention NN O
. . O

Results NNS O
revealed VBD O
that IN O
children NNS O
randomized VBN O
to TO O
the DT O
joint JJ B-INTV
attention NN I-INTV
group NN O
were VBD O
more RBR O
likely JJ O
to TO O
acknowledge VB B-OC
the DT I-OC
probe NN I-OC
and CC I-OC
engage NN I-OC
in IN I-OC
shared VBN I-OC
interactions NNS I-OC
between IN O
intervener NN O
and CC O
probe NN O
upon IN O
termination NN O
of IN O
intervention NN O
. . O

Additionally RB O
, , O
the DT O
joint JJ O
attention NN O
group NN O
improved VBD O
in IN O
the DT O
proportion NN B-OC
of IN I-OC
time NN I-OC
spent VBN I-OC
sharing VBG I-OC
coordinated VBN I-OC
joint JJ I-OC
looks NNS I-OC
between IN O
intervener NN O
and CC O
probe NN O
. . O

These DT O
results NNS O
suggest VBP O
that IN O
generalization NN O
of IN O
joint JJ O
attention NN O
skills NNS O
to TO O
a DT O
novel JJ O
probe NN O
did VBD O
occur VB O
for IN O
the DT O
group NN O
targeting VBG O
joint JJ O
attention NN O
and CC O
provides VBZ O
further JJ O
evidence NN O
of IN O
the DT O
effectiveness NN O
of IN O
the DT O
joint JJ O
attention NN O
intervention NN O
. . O

-DOCSTART- -X- O O

Long-term JJ O
psychosocial NN O
and CC O
health NN O
economy NN O
consequences NNS O
of IN O
ADHD NNP B-POPU
, , I-POPU
autism NN I-POPU
, , I-POPU
and CC I-POPU
reading-writing JJ I-POPU
disorder NN I-POPU
: : I-POPU
a DT O
prospective JJ O
service NN O
evaluation NN O
project NN O
. . O

OBJECTIVE CC O
The DT O
study NN O
aims VBZ O
to TO O
evaluate VB O
psychosocial JJ O
, , O
societal JJ O
, , O
and CC O
family NN O
cost NN O
consequences NNS O
of IN O
a DT O
psychoeducational JJ O
intervention NN O
program NN O
. . O

METHODS NNP O
Sixty NNP B-POPU
boys VBZ I-POPU
with IN I-POPU
ADHD NNP I-POPU
, , I-POPU
Asperger NNP I-POPU
syndrome/high-functioning JJ I-POPU
autism NN I-POPU
( ( I-POPU
AS/HFA NNP I-POPU
) ) I-POPU
, , I-POPU
and CC I-POPU
reading NN I-POPU
and CC I-POPU
writing VBG I-POPU
disorder NN I-POPU
( ( I-POPU
RD/WD NNP I-POPU
) ) I-POPU
were VBD O
allocated VBN O
to TO O
participate VB O
in IN O
a DT O
service NN O
evaluation NN O
project NN O
. . O

Every DT O
other JJ O
boy NN O
in IN O
each DT O
diagnostic JJ O
group NN O
was VBD O
randomly RB O
allocated VBN O
to TO O
receive VB O
either RB O
( ( B-INTV
a DT I-INTV
) ) I-INTV
a DT I-INTV
special JJ I-INTV
education NN I-INTV
program NN I-INTV
( ( I-INTV
clinical JJ I-INTV
index NN I-INTV
group NN I-INTV
) ) I-INTV
or CC I-INTV
( ( I-INTV
b NN I-INTV
) ) I-INTV
follow-up NN I-INTV
without IN I-INTV
the DT I-INTV
special JJ I-INTV
education NN I-INTV
program NN I-INTV
( ( I-INTV
clinical JJ I-INTV
comparison NN I-INTV
group NN I-INTV
) ) I-INTV
. . O

Nine CD O
years NNS O
after IN O
initial JJ O
assessments NNS O
the DT O
stability NN O
of IN O
the DT O
psychosocial NN O
and CC O
economic JJ O
resource NN O
consequences NNS O
over IN O
time NN O
was VBD O
studied VBN O
. . O

RESULTS NNP O
ADHD NNP O
, , O
AS/HFA NNP O
, , O
and CC O
RD/WD NNP O
all DT O
had VBD O
severe JJ O
impact NN O
on IN O
family NN B-OC
life NN I-OC
quality NN I-OC
. . O

The DT O
societal JJ O
costs NNS O
were VBD O
high JJ O
, , O
but CC O
no DT O
significant JJ O
differences NNS O
in IN O
resource NN B-OC
use NN I-OC
or CC I-OC
in IN I-OC
total JJ I-OC
costs NNS I-OC
were VBD O
found VBN O
between IN O
the DT O
clinical JJ O
index NN O
and CC O
the DT O
comparison NN O
groups NNS O
. . O

CONCLUSIONS VB O
The DT O
results NNS O
underscore VBP O
the DT O
very RB O
long-term JJ O
need NN O
for IN O
support NN O
including VBG O
individually RB O
tailored VBN O
reevaluations NNS O
and CC O
carefully RB O
monitored VBN O
intervention NN O
programs NNS O
adapted VBD O
to TO O
family NN O
needs NNS O
and CC O
severity NN O
of IN O
child NN O
disorder NN O
. . O

-DOCSTART- -X- O O

Comparison NNP O
of IN O
long-term JJ B-OC
efficacy NN I-OC
and CC I-OC
safety NN I-OC
of IN O
risperidone NN B-INTV
and CC I-INTV
haloperidol NN I-INTV
in IN O
children NNS B-POPU
and CC I-POPU
adolescents NNS I-POPU
with IN I-POPU
autistic JJ I-POPU
disorder NN I-POPU
. . O

An DT O
open JJ O
label NN O
maintenance NN O
study NN O
. . O

BACKGROUND NNP O
The DT O
aim NN O
of IN O
the DT O
study NN O
was VBD O
to TO O
investigate VB O
safety NN B-OC
, , I-OC
efficacy NN I-OC
and CC I-OC
tolerability NN I-OC
of IN O
risperidone NN B-INTV
in IN O
comparison NN O
with IN O
haloperidol NN B-INTV
in IN O
the DT O
long-term JJ O
treatment NN O
of IN O
autistic JJ B-POPU
disorder NN I-POPU
. . O

METHODS NNP O
This DT O
was VBD O
an DT O
open-label JJ O
continuation NN O
study NN O
of IN O
the DT O
randomized VBN O
, , O
double-blind NN O
, , O
controlled VBD O
trial NN O
of IN O
risperidone NN B-INTV
and CC I-INTV
haloperidol NN I-INTV
study NN O
for IN O
12 CD O
week NN O
in IN B-POPU
autistic JJ I-POPU
children NNS I-POPU
and CC I-POPU
adolescents NNS I-POPU
. . O

A DT B-POPU
total NN I-POPU
of IN I-POPU
28 CD I-POPU
subjects NNS I-POPU
between IN I-POPU
8 CD I-POPU
and CC I-POPU
18 CD I-POPU
ages NNS I-POPU
with IN I-POPU
autistic JJ I-POPU
disorder NN I-POPU
were VBD O
enrolled VBN O
to TO O
the DT O
open JJ O
label NN O
phase NN O
of IN O
the DT O
study NN O
. . O

Behavioral NNP B-OC
rating NN I-OC
scales NNS I-OC
( ( I-OC
Clinical JJ I-OC
Global NNP I-OC
Impression NNP I-OC
Scale NNP I-OC
[ NNP I-OC
CGI-I NNP I-OC
] NNP I-OC
, , I-OC
Ritvo-Freeman NNP I-OC
Real NNP I-OC
Life NNP I-OC
Rating NNP I-OC
Scale NNP I-OC
[ NNP I-OC
RF-RLRS NNP I-OC
] NNP I-OC
) ) I-OC
, , I-OC
Aberrant NNP I-OC
Behavior NNP I-OC
Checklist NNP I-OC
[ NNP I-OC
ABC NNP I-OC
] NNP I-OC
, , I-OC
Turgay NNP I-OC
DSM-IV NNP I-OC
Pervasive NNP I-OC
Developmental NNP I-OC
Disorder NNP I-OC
Rating NNP I-OC
Scale NNP I-OC
[ NNP I-OC
TPDDRS NNP I-OC
] NNP I-OC
) ) I-OC
and CC I-OC
safety NN I-OC
assessment NN I-OC
scales NNS I-OC
( ( I-OC
Extrapyramidal NNP I-OC
Symptoms NNP I-OC
Rating NNP I-OC
Scale NNP I-OC
[ NNP I-OC
ESRS NNP I-OC
] NNP I-OC
, , I-OC
UKU-Side JJ I-OC
Effect NNP I-OC
Rating NNP I-OC
Scale NNP I-OC
) ) I-OC
were VBD O
performed VBN O
at IN O
12 CD O
, , O
16 CD O
, , O
20 CD O
and CC O
24 CD O
weeks NNS O
, , O
following VBG O
the DT O
12 CD O
week NN O
double-blind JJ O
phase NN O
. . O

Risperidone NN B-INTV
and CC I-INTV
haloperidol NN I-INTV
treatments NNS O
were VBD O
applied VBN O
with IN O
a DT O
once RB O
daily JJ O
dosage NN O
regimen NNS O
as IN O
0.01-0.08 JJ O
mg/kg/day NN O
. . O

RESULTS NNP O
Risperidone NNP O
led VBD O
to TO O
a DT O
significant JJ O
greater JJR O
reduction NN B-OC
on IN O
CGI NNP B-OC
scale NN I-OC
. . O

There EX O
was VBD O
significant JJ O
improvement NN O
on IN O
RF-RLRS NNP B-OC
sensory JJ I-OC
motor NN I-OC
and CC I-OC
language NN I-OC
subscale NN I-OC
and CC I-OC
ABC NNP I-OC
scores NNS I-OC
in IN O
risperidone NN O
group NN O
. . O

Weight NNP B-OC
gain NN I-OC
was VBD O
observed VBN O
more RBR O
frequently RB O
in IN O
the DT O
haloperidol NN O
group NN O
at IN O
week NN O
24 CD O
. . O

CONCLUSIONS VB O
These DT O
results NNS O
demonstrate VBP O
that IN O
risperidone NN O
is VBZ O
more RBR O
efficacious JJ O
and CC O
well RB O
tolerated VBN O
than IN O
haloperidol NN O
in IN O
the DT O
long-term JJ O
maintenance NN O
treatment NN O
of IN O
autistic JJ O
disorder NN O
. . O

-DOCSTART- -X- O O

A DT O
randomized JJ O
, , O
placebo-controlled JJ B-INTV
trial NN O
of IN O
controlled JJ O
release NN O
melatonin NN B-INTV
treatment NN I-INTV
of IN O
delayed JJ B-POPU
sleep JJ I-POPU
phase NN I-POPU
syndrome NN I-POPU
and CC O
impaired JJ B-POPU
sleep JJ I-POPU
maintenance NN I-POPU
in IN O
children NNS B-POPU
with IN I-POPU
neurodevelopmental JJ I-POPU
disabilities NNS I-POPU
. . O

The DT O
purpose NN O
of IN O
this DT O
study NN O
was VBD O
to TO O
determine VB O
the DT O
efficacy NN B-OC
of IN O
controlled-release NN O
( ( O
CR NNP O
) ) O
melatonin NN B-INTV
in IN O
the DT O
treatment NN O
of IN O
delayed JJ B-POPU
sleep JJ I-POPU
phase NN I-POPU
syndrome NN I-POPU
and CC O
impaired JJ B-POPU
sleep JJ I-POPU
maintenance NN I-POPU
of IN O
children NNS B-POPU
with IN I-POPU
neurodevelopmental JJ I-POPU
disabilities NNS I-POPU
including VBG I-POPU
autistic JJ I-POPU
spectrum NN I-POPU
disorders NNS I-POPU
. . O

A DT O
randomized JJ O
double-blind NN O
, , O
placebo-controlled JJ B-INTV
crossover NN O
trial NN O
of IN O
CR NNP B-INTV
melatonin NN I-INTV
( ( O
5 CD O
mg NN O
) ) O
followed VBN O
by IN O
a DT O
3-month JJ O
open-label NN O
study NN O
was VBD O
conducted VBN O
during IN O
which WDT O
the DT O
dose NN O
was VBD O
gradually RB O
increased VBN O
until IN O
the DT O
therapy NN O
showed VBD O
optimal JJ O
beneficial JJ O
effects NNS O
. . O

Sleep JJ B-OC
characteristics NNS I-OC
were VBD O
measured VBN O
by IN O
caregiver NN O
who WP O
completed VBD O
somnologs NNS O
and CC O
wrist JJ O
actigraphs NN O
. . O

Clinician JJ B-OC
rating NN I-OC
of IN O
severity NN O
of IN O
the DT O
sleep JJ O
disorder NN O
and CC O
improvement NN O
from IN O
baseline NN O
, , O
along IN O
with IN O
caregiver JJ B-OC
ratings NNS I-OC
of IN O
global JJ O
functioning NN O
and CC O
family NN O
stress NN O
were VBD O
also RB O
obtained VBN O
. . O

Fifty-one CD B-POPU
children NNS I-POPU
( ( I-POPU
age NN I-POPU
range NN I-POPU
2-18 CD I-POPU
years NNS I-POPU
) ) I-POPU
who WP I-POPU
did VBD I-POPU
not RB I-POPU
respond VB I-POPU
to TO I-POPU
sleep VB I-POPU
hygiene NN I-POPU
intervention NN I-POPU
were VBD O
enrolled VBN O
. . O

Fifty JJ O
patients NNS O
completed VBD O
the DT O
crossover NN O
trial NN O
and CC O
47 CD O
completed VBD O
the DT O
open-label JJ O
phase NN O
. . O

Recordings NNS O
of IN O
total JJ B-OC
night-time JJ I-OC
sleep NN I-OC
and CC O
sleep JJ B-OC
latency NN I-OC
showed VBD O
significant JJ O
improvement NN O
of IN O
approximately RB O
30 CD O
min NNS O
. . O

Similarly RB O
, , O
significant JJ B-OC
improvement NN I-OC
was VBD O
observed VBN O
in IN O
clinician JJ B-OC
and CC I-OC
parent JJ I-OC
ratings NNS I-OC
. . O

There EX O
was VBD O
additional JJ O
improvement NN B-OC
in IN O
the DT O
open-label JJ B-OC
somnolog NN I-OC
measures NNS I-OC
of IN O
sleep JJ B-OC
efficiency NN I-OC
and CC O
the DT B-OC
longest JJS I-OC
sleep JJ I-OC
episode NN I-OC
in IN O
the DT O
open-label JJ O
phase NN O
. . O

Overall UH O
, , O
the DT O
therapy NN O
improved VBD B-OC
the DT I-OC
sleep NN I-OC
of IN O
47 CD O
children NNS O
and CC O
was VBD O
effective JJ B-OC
in IN I-OC
reducing VBG I-OC
family NN I-OC
stress NN I-OC
. . O

Children NNP B-POPU
with IN I-POPU
neurodevelopmental JJ I-POPU
disabilities NNS I-POPU
, , O
who WP O
had VBD B-POPU
treatment NN I-POPU
resistant JJ I-POPU
chronic JJ I-POPU
delayed VBN I-POPU
sleep JJ I-POPU
phase NN I-POPU
syndrome NN I-POPU
and CC I-POPU
impaired JJ I-POPU
sleep JJ I-POPU
maintenance NN I-POPU
, , O
showed VBD O
improvement NN O
in IN O
melatonin NN B-INTV
therapy NN I-INTV
. . O

-DOCSTART- -X- O O

Risperidone NNP B-INTV
versus NN I-INTV
haloperidol NN I-INTV
in IN B-POPU
children NNS I-POPU
and CC I-POPU
adolescents NNS I-POPU
with IN I-POPU
AD NNP I-POPU
: : O
a DT O
randomized NN O
, , O
controlled VBN O
, , O
double-blind JJ O
trial NN O
. . O

OBJECTIVE CC O
The DT O
aim NN O
of IN O
the DT O
study NN O
was VBD O
to TO O
compare VB O
safety NN B-OC
, , I-OC
efficacy NN I-OC
and CC I-OC
tolerability NN I-OC
of IN O
risperidone NN B-INTV
with IN I-INTV
haloperidol NN I-INTV
in IN O
the DT O
treatment NN O
of IN O
Autistic JJ B-POPU
Disorder NNP I-POPU
( ( I-POPU
AD NNP I-POPU
) ) I-POPU
. . O

METHOD NNP O
This DT O
study NN O
was VBD O
designed VBN O
as IN O
a DT O
double-blind NN O
, , O
prospective JJ O
, , O
for IN O
a DT O
12-week JJ O
period NN O
. . O

A DT B-POPU
total NN I-POPU
of IN I-POPU
30 CD I-POPU
subjects NNS I-POPU
, , I-POPU
between IN I-POPU
the DT I-POPU
ages NNS I-POPU
of IN I-POPU
8 CD I-POPU
and CC I-POPU
18 CD I-POPU
with IN I-POPU
AD NNP I-POPU
based VBN I-POPU
on IN I-POPU
DSM NNP I-POPU
IV NNP I-POPU
criteria NNS I-POPU
, , I-POPU
were VBD I-POPU
included VBN I-POPU
in IN I-POPU
the DT I-POPU
study NN I-POPU
. . O

Behavioral NNP B-OC
Rating VBG I-OC
Scales NNS I-OC
were VBD O
performed VBN O
by IN O
the DT O
investigators NNS O
and CC O
the DT O
parents NNS O
. . O

Safety NNP B-OC
assessment NN I-OC
included VBD O
vital JJ B-OC
signs NNS I-OC
, , I-OC
electrocardiogram NN B-INTV
, , I-INTV
electroencephalogram NN I-INTV
, , B-OC
adverse JJ I-OC
events NNS I-OC
, , I-OC
laboratory NN I-OC
tests NNS I-OC
, , I-OC
extrapyramidal NN I-OC
symptoms NNS I-OC
and CC I-OC
the DT I-OC
side NN I-OC
effects NNS I-OC
. . O

Both DT O
treatments NNS O
were VBD O
applied VBN O
in IN O
a DT O
once RB O
daily JJ O
dosage NN O
regimen NNS O
of IN O
0.01-0.08 JJ O
mg/kg/day NN O
. . O

RESULTS VB O
The DT O
reduction NN O
from IN O
baseline NN O
in IN O
Ritvo-Freeman NNP B-OC
Real NNP I-OC
Life NNP I-OC
Rating NNP I-OC
Scale NNP I-OC
( ( I-OC
RF-RLRS NNP I-OC
) ) I-OC
, , I-OC
sensory JJ I-OC
motor NN I-OC
( ( I-OC
subscale JJ I-OC
I PRP I-OC
) ) I-OC
and CC I-OC
language NN I-OC
( ( I-OC
subscale JJ I-OC
V NNP I-OC
) ) I-OC
scores NNS I-OC
were VBD O
significant JJ O
in IN O
risperidone NN O
group NN O
( ( O
P NNP O
< NNP O
0.05 CD O
) ) O
. . O

Compared VBN O
to TO O
haloperidol VB O
, , O
risperidone NN O
led VBD O
to TO O
a DT O
significantly RB O
greater JJR O
reduction NN O
in IN O
the DT O
Aberrant NNP B-OC
Behavior NNP I-OC
Checklist NNP I-OC
( ( I-OC
ABC NNP I-OC
) ) I-OC
and CC I-OC
Turgay NNP I-OC
DSM-IV NNP I-OC
Pervasive NNP I-OC
Developmental NNP I-OC
Disorder NNP I-OC
( ( I-OC
PDD NNP I-OC
) ) I-OC
scale NN I-OC
scores NNS I-OC
( ( O
P NNP O
< NNP O
0.05 CD O
and CC O
P NNP O
< NNP O
0.01 CD O
) ) O
. . O

There EX O
was VBD O
a DT O
greater JJR O
increase NN O
of IN O
prolactin NN B-OC
in IN O
the DT O
risperidone NN O
group NN O
, , O
while IN O
alanine JJ B-OC
amino NN I-OC
transferase NN I-OC
( ( I-OC
ALT NNP I-OC
) ) I-OC
had VBD O
further RBR O
increased VBN O
in IN O
the DT O
haloperidol NN O
group NN O
. . O

Sensory NNP B-OC
motor NN I-OC
behaviors NNS I-OC
( ( I-OC
subscale JJ I-OC
I PRP I-OC
) ) I-OC
and CC O
language NN B-OC
at IN O
the DT O
end NN O
of IN O
the DT O
12th CD O
week NN O
, , O
RF-RLRS NNP B-OC
sensory NN I-OC
motor NN I-OC
and CC I-OC
language NN I-OC
subscale JJ I-OC
scores NNS I-OC
decreased VBN O
in IN O
the DT O
risperidone NN O
group NN O
further RBR O
than IN O
the DT O
other JJ O
group NN O
( ( O
P NNP O
< NNP O
0.05 CD O
) ) O
. . O

CONCLUSIONS NNP O
Risperidone NNP O
was VBD O
found VBN O
to TO O
be VB O
more RBR O
effective JJ O
than IN O
haloperidol NN O
in IN O
the DT O
treatment NN O
of IN O
behavioral JJ B-OC
symptoms NNS I-OC
, , I-OC
impulsivity NN I-OC
, , I-OC
language NN I-OC
skills NNS I-OC
, , O
and CC O
impaired JJ B-OC
social JJ I-OC
relations NNS I-OC
in IN O
children NNS B-POPU
with IN I-POPU
AD NNP I-POPU
. . O

These DT O
results NNS O
demonstrated VBD O
that IN O
both DT O
drugs NNS O
were VBD O
safe JJ O
and CC O
well RB O
tolerated VBN O
in IN O
the DT O
treatment NN O
of IN O
AD NNP O
. . O

-DOCSTART- -X- O O

Qigong JJ B-INTV
massage NN I-INTV
treatment NN I-INTV
for IN O
sensory JJ B-POPU
and CC I-POPU
self-regulation JJ I-POPU
problems NNS I-POPU
in IN I-POPU
young JJ I-POPU
children NNS I-POPU
with IN I-POPU
autism NN I-POPU
: : I-POPU
a DT O
randomized NN O
controlled VBN O
trial NN O
. . O

Autism NN O
is VBZ O
commonly RB O
associated VBN O
with IN O
sensory JJ B-OC
and CC I-OC
self-regulatory JJ I-OC
disturbances NNS I-OC
. . O

This DT O
article NN O
presents VBZ O
a DT O
randomized VBN O
controlled VBN O
study NN O
evaluating VBG O
the DT O
effect NN O
of IN O
a DT O
5-month JJ O
intervention NN O
directed VBD O
toward IN O
improving VBG O
sensory JJ B-OC
impairment NN I-OC
, , I-OC
digestion NN I-OC
, , I-OC
and CC I-OC
sleep NN I-OC
in IN O
46 CD B-POPU
children NNS I-POPU
with IN I-POPU
autism NN I-POPU
< NNP I-POPU
age NN I-POPU
6 CD I-POPU
. . O

The DT O
intervention NN O
, , O
Qigong NNP B-INTV
Sensory NNP I-INTV
Training NNP I-INTV
( ( I-INTV
QST NNP I-INTV
) ) I-INTV
, , O
is VBZ O
a DT O
qigong JJ B-INTV
massage NN I-INTV
intervention NN I-INTV
based VBN O
in IN O
Chinese JJ O
medicine NN O
. . O

It PRP O
is VBZ O
two-pronged JJ O
: : O
Trainers NNS O
work VBP O
with IN O
children NNS O
directly RB O
20 CD O
times NNS O
over IN O
5 CD O
months NNS O
, , O
and CC O
parents NNS O
give VBP O
the DT O
massage NN O
daily RB O
to TO O
their PRP$ O
children NNS O
. . O

Improvement NN O
was VBD O
evaluated VBN O
in IN O
two CD O
settings NNS O
-- : O
preschool NN O
and CC O
home NN O
-- : O
by IN O
teachers NNS O
( ( O
blind IN O
to TO O
group NN O
) ) O
and CC O
parents NNS O
. . O

Teacher CC O
evaluations NNS O
showed VBD O
that IN O
treated JJ O
children NNS O
had VBD O
significant JJ O
classroom NN O
improvement NN O
of IN O
social JJ B-OC
and CC I-OC
language NN I-OC
skills NNS I-OC
and CC O
reduction NN B-OC
in IN I-OC
autistic JJ I-OC
behavior NN I-OC
compared VBN O
with IN O
wait-list JJ O
control NN O
participants NNS O
. . O

These DT O
findings NNS O
were VBD O
confirmed VBN O
by IN O
parent NN O
data NNS O
, , O
indicating VBG O
that IN O
the DT O
gains NNS B-OC
had VBD O
generalized VBN O
across IN O
contexts NN O
. . O

A DT O
model NN O
and CC O
supporting VBG O
data NNS O
for IN O
understanding NN O
and CC O
treating VBG O
sensory JJ B-OC
and CC I-OC
self-regulation JJ I-OC
problems NNS I-OC
in IN O
autism NN O
is VBZ O
presented VBN O
. . O

-DOCSTART- -X- O O

Double-blind JJ O
placebo-controlled JJ O
trial NN O
of IN O
pentoxifylline NN B-INTV
added VBN I-INTV
to TO I-INTV
risperidone VB I-INTV
: : I-INTV
effects NNS O
on IN O
aberrant JJ B-OC
behavior NN I-OC
in IN I-OC
children NNS B-POPU
with IN I-POPU
autism NN I-POPU
. . O

BACKGROUND IN O
There EX O
are VBP O
several JJ O
lines NNS O
of IN O
evidence NN O
to TO O
indicate VB O
that IN O
the DT O
immune NN O
system NN O
plays VBZ O
an DT O
important JJ O
role NN O
in IN O
the DT O
pathophysiology NN O
of IN O
autism NN O
. . O

The DT O
objective NN O
of IN O
this DT O
study NN O
was VBD O
to TO O
access NN O
the DT O
effects NNS O
of IN O
pentoxifylline NN B-INTV
plus CC I-INTV
risperidone NN I-INTV
in IN O
the DT O
treatment NN B-OC
of IN I-OC
autistic JJ I-OC
disorder NN I-OC
. . O

METHODS NNP O
Forty NNP B-POPU
children NNS I-POPU
between IN I-POPU
the DT I-POPU
ages NNS I-POPU
4 CD I-POPU
and CC I-POPU
12 CD I-POPU
years NNS I-POPU
with IN I-POPU
a DT I-POPU
DSM NNP I-POPU
IV-TR NNP I-POPU
clinical JJ I-POPU
diagnosis NN I-POPU
of IN I-POPU
autism NN I-POPU
were VBD I-POPU
recruited VBN I-POPU
. . O

The DT B-POPU
children NNS I-POPU
presented VBN I-POPU
with IN I-POPU
a DT I-POPU
chief JJ I-POPU
complaint NN I-POPU
of IN I-POPU
severely RB I-POPU
disruptive JJ I-POPU
symptoms NNS I-POPU
related VBN I-POPU
to TO I-POPU
autistic JJ I-POPU
disorder NN I-POPU
. . O

Patients NNS O
were VBD O
randomly RB O
allocated VBN O
to TO O
pentoxifylline+risperidone VB B-INTV
or CC I-INTV
placebo+risperidone VB I-INTV
for IN O
a DT O
10-week JJ O
, , O
double-blind JJ O
, , O
placebo-controlled JJ O
study NN O
. . O

The DT O
dose NN O
of IN O
risperidone NN B-INTV
was VBD O
titrated VBN O
up RB O
to TO O
3 CD O
mg/day NN O
, , O
pentoxifylline NN B-INTV
was VBD O
titrated VBN O
to TO O
600 CD O
mg/day NN O
. . O

Patients NNS O
were VBD O
assessed VBN O
at IN O
baseline NN O
and CC O
after IN O
2 CD O
, , O
4 CD O
, , O
6 CD O
, , O
8 CD O
and CC O
10 CD O
weeks NNS O
of IN O
starting VBG O
medication NN O
. . O

The DT O
measure NN O
of IN O
the DT O
outcome NN O
was VBD O
the DT O
Aberrant NNP B-OC
Behavior NNP I-OC
Checklist-Community NNP I-OC
( ( I-OC
ABC-C NNP I-OC
) ) I-OC
. . O

RESULTS VB O
The DT O
difference NN O
between IN O
the DT O
two CD O
protocols NNS O
was VBD O
significant JJ O
as IN O
the DT O
group NN O
that WDT O
received VBD O
pentoxifylline NN B-INTV
had VBD O
greater JJR O
reduction NN O
in IN O
ABC-C NNP B-OC
subscale NN I-OC
scores NNS I-OC
for IN I-OC
Irritability NNP I-OC
, , I-OC
Lethargy/Social NNP I-OC
Withdrawal NNP I-OC
, , I-OC
Stereotypic NNP I-OC
Behavior NNP I-OC
, , I-OC
Hyperactivity/Noncompliance NNP I-OC
and CC I-OC
Inappropriate NNP I-OC
Speech NNP I-OC
. . O

CONCLUSION NNP O
The DT O
results NNS O
suggest VBP O
that IN O
combination NN B-INTV
of IN I-INTV
atypical JJ I-INTV
antipsychotic JJ I-INTV
medications NNS I-INTV
and CC I-INTV
pentoxifylline NN I-INTV
might MD O
have VB O
synergistic JJ O
effects NNS O
in IN O
treatment NN O
of IN O
behavioral JJ B-OC
problems NNS I-OC
of IN I-OC
children NNS B-POPU
with IN I-POPU
autism NN I-POPU
. . O

-DOCSTART- -X- O O

A DT O
placebo-controlled JJ B-INTV
, , O
fixed-dose JJ O
study NN O
of IN O
aripiprazole NN B-INTV
in IN O
children NNS B-POPU
and CC I-POPU
adolescents NNS I-POPU
with IN I-POPU
irritability NN I-POPU
associated VBN I-POPU
with IN I-POPU
autistic JJ I-POPU
disorder NN I-POPU
. . O

OBJECTIVE UH O
To TO O
evaluate VB O
the DT O
short-term JJ O
efficacy NN B-OC
and CC O
safety NN B-OC
of IN O
aripiprazole NN B-INTV
in IN O
the DT O
treatment NN O
of IN O
irritability NN O
in IN O
children NNS B-POPU
and CC I-POPU
adolescents NNS I-POPU
with IN I-POPU
autistic JJ I-POPU
disorder NN I-POPU
. . O

METHOD NNP O
Two CD B-POPU
hundred VBD I-POPU
eighteen JJ I-POPU
children NNS I-POPU
and CC I-POPU
adolescents NNS I-POPU
( ( I-POPU
aged VBN I-POPU
6-17 CD I-POPU
years NNS I-POPU
) ) I-POPU
with IN I-POPU
a DT I-POPU
diagnosis NN I-POPU
of IN I-POPU
autistic JJ I-POPU
disorder NN I-POPU
, , I-POPU
and CC I-POPU
with IN I-POPU
behaviors NNS I-POPU
such JJ I-POPU
as IN I-POPU
tantrums NNS I-POPU
, , I-POPU
aggression NN I-POPU
, , I-POPU
self-injurious JJ I-POPU
behavior NN I-POPU
, , I-POPU
or CC I-POPU
a DT I-POPU
combination NN I-POPU
of IN I-POPU
these DT I-POPU
symptoms NNS I-POPU
, , O
were VBD O
randomized VBN O
1:1:1:1 CD O
to TO O
aripiprazole VB B-INTV
( ( I-INTV
5 CD I-INTV
, , I-INTV
10 CD I-INTV
, , I-INTV
or CC I-INTV
15 CD I-INTV
mg/day NN I-INTV
) ) I-INTV
or CC I-INTV
placebo NN I-INTV
in IN O
this DT O
8-week JJ O
double-blind NN O
, , O
randomized VBN O
, , O
placebo-controlled JJ O
, , O
parallel-group JJ O
study NN O
. . O

Efficacy NNP B-OC
was VBD O
evaluated VBN O
using VBG O
the DT O
caregiver-rated JJ O
Aberrant NNP B-OC
Behavior NNP I-OC
Checklist NNP I-OC
Irritability NNP I-OC
subscale NN I-OC
( ( I-OC
primary JJ I-OC
efficacy NN I-OC
measure NN I-OC
) ) I-OC
and CC I-OC
the DT I-OC
clinician-rated JJ I-OC
Clinical JJ I-OC
Global NNP I-OC
Impressions-Improvement NNP I-OC
score NN I-OC
. . O

Safety NNP B-OC
and CC I-OC
tolerability NN I-OC
were VBD O
also RB O
assessed VBN O
. . O

RESULTS NNP O
At IN O
week NN O
8 CD O
, , O
all DT O
aripiprazole JJ B-INTV
doses NNS O
produced VBN O
significantly RB O
greater JJR O
improvement NN B-OC
than IN O
placebo NN O
in IN O
mean JJ O
Aberrant NNP B-OC
Behavior NNP I-OC
Checklist NNP I-OC
Irritability NNP I-OC
subscale NN I-OC
scores NNS I-OC
( ( O
5 CD O
mg/day NN O
, , O
-12.4 NNP O
; : O
10 CD O
mg/day NN O
, , O
-13.2 NNP O
; : O
15 CD O
mg/day NN O
, , O
-14.4 NNP O
; : O
versus NN O
placebo NN O
, , O
-8.4 NNP O
; : O
all DT O
p VBP O
< NNP O
.05 NNP O
) ) O
. . O

All DT O
aripiprazole JJ B-INTV
doses NNS O
demonstrated VBN O
significantly RB O
greater JJR O
improvements NNS B-OC
in IN I-OC
mean JJ I-OC
Clinical JJ I-OC
Global NNP I-OC
Impressions-Improvement NNP I-OC
score NN I-OC
than IN O
placebo NN B-INTV
at IN O
week NN O
8 CD O
. . O

Discontinuation NN O
rates NNS O
due JJ O
to TO O
adverse JJ B-OC
events NNS I-OC
were VBD O
as IN O
follows VBZ O
: : O
placebo VB O
7.7 CD O
% NN O
, , O
aripiprazole JJ O
5 CD O
mg/day JJ O
9.4 CD O
% NN O
, , O
10 CD O
mg/day JJ O
13.6 CD O
% NN O
, , O
and CC O
15 CD O
mg/day JJ O
7.4 CD O
% NN O
. . O

The DT O
most RBS O
common JJ O
adverse JJ B-OC
event NN I-OC
leading VBG O
to TO O
discontinuation NN O
was VBD O
sedation NN B-OC
. . O

There EX O
were VBD O
two CD O
serious JJ B-OC
adverse JJ I-OC
events NNS I-OC
: : I-OC
presyncope NN I-OC
( ( O
5 CD O
mg/day NN O
) ) O
and CC O
aggression NN B-OC
( ( O
10 CD O
mg/day NN O
) ) O
. . O

At IN O
week NN O
8 CD O
, , O
mean JJ O
weight NN B-OC
change NN I-OC
( ( O
last JJ O
observation NN O
carried VBD O
forward RB O
) ) O
was VBD O
as IN O
follows VBZ O
: : O
placebo NN O
+0.3 NNP O
kg NN O
, , O
aripiprazole JJ B-INTV
5 CD O
mg/day JJ O
+1.3 NNP O
kg NN O
, , O
10 CD O
mg/day NN O
+1.3 NNP O
kg NN O
, , O
and CC O
15 CD O
mg/day NN O
+1.5 NNP O
kg NN O
; : O
all DT O
p VBP O
< JJ O
.05 NNP O
versus NN O
placebo NN B-INTV
. . O

CONCLUSIONS NNP O
Aripiprazole NNP B-INTV
was VBD O
efficacious JJ B-OC
and CC O
generally RB O
safe JJ B-OC
and CC O
well RB B-OC
tolerated VBN I-OC
in IN O
the DT O
treatment NN O
of IN O
children NNS B-POPU
and CC I-POPU
adolescents NNS I-POPU
with IN I-POPU
irritability NN I-POPU
associated VBN I-POPU
with IN I-POPU
autistic JJ I-POPU
disorder NN I-POPU
. . O

-DOCSTART- -X- O O

Eye NNP O
movements NNS O
affirm NN O
: : O
automatic JJ B-OC
overt NN I-OC
gaze NN I-OC
and CC I-OC
arrow NN I-OC
cueing NN I-OC
for IN O
typical JJ B-POPU
adults NNS I-POPU
and CC I-POPU
adults NNS I-POPU
with IN I-POPU
autism NN I-POPU
spectrum NN I-POPU
disorder NN I-POPU
. . O

People NNS B-POPU
with IN I-POPU
autism NN I-POPU
spectrum NN I-POPU
disorder NN I-POPU
( ( I-POPU
ASD NNP I-POPU
) ) I-POPU
show NN O
reduced VBN O
interest NN B-OC
towards NNS O
social JJ B-OC
aspects NNS I-OC
of IN I-OC
the DT I-OC
environment NN I-OC
and CC O
a DT O
lesser JJR O
tendency NN B-OC
to TO O
follow VB B-OC
other JJ I-OC
people NNS I-OC
's POS I-OC
gaze NN I-OC
in IN O
the DT O
real JJ O
world NN O
. . O

However RB O
, , O
most JJS O
studies NNS O
have VBP O
shown VBN O
that IN O
people NNS B-POPU
with IN I-POPU
ASD NNP I-POPU
do VBP O
respond VB O
to TO O
eye-gaze JJ O
cues NNS O
in IN O
experimental JJ O
paradigms NN O
, , O
though IN O
it PRP O
is VBZ O
possible JJ O
that IN O
this DT O
behaviour NN O
is VBZ O
based VBN O
on IN O
an DT O
atypical JJ O
strategy NN O
. . O

We PRP O
tested VBD O
this DT O
possibility NN O
in IN O
adults NNS B-POPU
with IN I-POPU
ASD NNP I-POPU
using VBG O
a DT O
cueing NN B-INTV
task NN I-INTV
combined VBN I-INTV
with IN I-INTV
eye-movement JJ I-INTV
recording NN I-INTV
. . O

Both DT O
eye NN O
gaze NN O
and CC O
arrow VB O
pointing VBG O
distractors NNS O
resulted VBD O
in IN O
overt JJ B-OC
cueing NN I-OC
effects NNS I-OC
, , O
both DT O
in IN O
terms NNS O
of IN O
increased VBN B-OC
saccadic JJ I-OC
reaction NN I-OC
times NNS I-OC
, , O
and CC O
in IN O
proportions NNS B-OC
of IN I-OC
saccades NNS I-OC
executed VBN I-OC
to TO I-OC
the DT I-OC
cued VBN I-OC
direction NN I-OC
instead RB I-OC
of IN I-OC
to TO I-OC
the DT I-OC
target NN I-OC
, , O
for IN O
both DT O
participant JJ O
groups NNS O
. . O

Our PRP$ O
results NNS O
confirm VBP O
previous JJ O
reports NNS O
that IN O
eye NN O
gaze NN O
cues NNS O
as RB O
well RB O
as IN O
arrow NN O
cues NNS O
result VBP O
in IN O
automatic JJ B-OC
orienting NN I-OC
of IN I-OC
overt JJ I-OC
attention NN I-OC
. . O

Moreover RB O
, , O
since IN O
there EX O
were VBD O
no DT O
group NN O
differences VBZ O
between IN O
arrow NN O
and CC O
eye NN O
gaze NN O
cues NNS O
, , O
we PRP O
conclude VBP O
that IN O
overt JJ B-OC
attentional JJ I-OC
orienting NN I-OC
in IN O
ASD NNP O
, , O
at IN O
least JJS O
in IN O
response NN O
to TO O
centrally RB O
presented VBN O
schematic JJ O
directional JJ O
distractors NNS O
, , O
is VBZ O
typical JJ O
. . O

-DOCSTART- -X- O O

Safety NN B-OC
and CC I-OC
efficacy NN I-OC
of IN O
oral JJ O
DMSA NNP B-INTV
therapy NN I-INTV
for IN O
children NNS B-POPU
with IN I-POPU
autism NN I-POPU
spectrum NN I-POPU
disorders NNS I-POPU
: : I-POPU
Part VB O
A DT O
-- : O
medical JJ O
results NNS O
. . O

BACKGROUND NNP O
This DT O
study NN O
investigated VBD O
the DT O
effect NN O
of IN O
oral JJ B-INTV
dimercapto NN I-INTV
succinic JJ I-INTV
acid NN I-INTV
( ( I-INTV
DMSA NNP I-INTV
) ) I-INTV
therapy NN I-INTV
for IN O
children NNS B-POPU
with IN I-POPU
autism NN I-POPU
spectrum NN I-POPU
disorders NNS I-POPU
ages VBZ I-POPU
3-8 CD I-POPU
years NNS I-POPU
. . O

METHODS NNP O
Phase NNP B-POPU
1 CD I-POPU
involved VBD I-POPU
65 CD I-POPU
children NNS I-POPU
who WP I-POPU
received VBD I-POPU
one CD I-POPU
round NN I-POPU
of IN I-POPU
DMSA NNP I-POPU
( ( I-POPU
3 CD I-POPU
days NNS I-POPU
) ) I-POPU
. . O

Participants NNS B-POPU
who WP I-POPU
had VBD I-POPU
high JJ I-POPU
urinary JJ I-POPU
excretion NN I-POPU
of IN I-POPU
toxic JJ I-POPU
metals NNS I-POPU
were VBD O
selected VBN O
to TO O
continue VB O
on IN O
to TO O
phase VB O
2 CD O
. . O

In IN O
phase NN B-POPU
2 CD I-POPU
, , I-POPU
49 CD I-POPU
participants NNS I-POPU
were VBD O
randomly RB O
assigned VBN O
in IN O
a DT O
double-blind JJ O
design NN O
to TO O
receive VB O
an DT O
additional JJ O
6 CD O
rounds NNS O
of IN O
either DT O
DMSA NNP B-INTV
or CC I-INTV
placebo NN I-INTV
. . O

RESULTS NNP O
DMSA NNP O
greatly RB O
increased VBD O
the DT O
excretion NN B-OC
of IN I-OC
lead NN I-OC
, , O
substantially RB O
increased VBN O
excretion NN B-OC
of IN I-OC
tin NN I-OC
and CC I-OC
bismuth NN I-OC
, , O
and CC O
somewhat RB O
increased VBD O
the DT O
excretion NN B-OC
of IN I-OC
thallium NN I-OC
, , I-OC
mercury NN I-OC
, , I-OC
antimony NN I-OC
, , I-OC
and CC I-OC
tungsten RB I-OC
. . O

There EX O
was VBD O
some DT O
increase NN O
in IN O
urinary JJ B-OC
excretion NN I-OC
of IN I-OC
essential JJ I-OC
minerals NNS I-OC
, , O
especially RB O
potassium JJ O
and CC O
chromium NN O
. . O

The DT O
Phase NNP O
1 CD O
single JJ O
round NN O
of IN O
DMSA NNP B-INTV
led VBD O
to TO O
a DT O
dramatic JJ O
normalization NN B-OC
of IN I-OC
RBC NNP I-OC
glutathione NN I-OC
in IN O
almost RB O
all DT O
cases NNS O
, , O
and CC O
greatly RB O
improved VBN O
abnormal JJ B-OC
platelet NN I-OC
counts NNS I-OC
, , O
suggesting VBG O
a DT O
significant JJ O
decrease NN O
in IN O
inflammation NN B-OC
. . O

CONCLUSION NNP O
Overall NNP O
, , O
DMSA NNP B-INTV
therapy NN O
seems VBZ O
to TO O
be VB O
reasonably RB O
safe JJ B-OC
, , I-OC
effective JJ I-OC
in IN O
removing VBG O
several JJ O
toxic JJ B-OC
metals NNS I-OC
( ( O
especially RB O
lead VBP O
) ) O
, , O
dramatically RB O
effective JJ O
in IN O
normalizing VBG B-OC
RBC NNP I-OC
glutathione NN I-OC
, , O
and CC O
effective JJ O
in IN O
normalizing VBG B-OC
platelet NN I-OC
counts NNS I-OC
. . O

Only RB O
1 CD O
round NN O
( ( O
3 CD O
days NNS O
) ) O
was VBD O
sufficient JJ O
to TO O
improve VB O
glutathione NN B-OC
and CC I-OC
platelets NNS I-OC
. . O

Additional JJ O
rounds NNS O
increased VBD O
excretion NN B-OC
of IN I-OC
toxic JJ I-OC
metals NNS I-OC
. . O

-DOCSTART- -X- O O

Safety NN B-OC
and CC I-OC
efficacy NN I-OC
of IN O
oral JJ O
DMSA NNP B-INTV
therapy NN I-INTV
for IN O
children NNS B-POPU
with IN I-POPU
autism NN I-POPU
spectrum NN I-POPU
disorders NNS I-POPU
: : I-POPU
part NN O
B NNP O
- : O
behavioral JJ O
results NNS O
. . O

BACKGROUND NNP O
This DT O
study NN O
investigated VBD O
the DT O
effects NNS O
of IN O
oral JJ B-INTV
dimercapto NN I-INTV
succinic JJ I-INTV
acid NN I-INTV
( ( I-INTV
DMSA NNP I-INTV
) ) I-INTV
therapy NN I-INTV
on IN O
the DT O
behavioural JJ O
symptoms NNS O
of IN O
children NNS B-POPU
with IN I-POPU
autism NN I-POPU
spectrum NN I-POPU
disorders NNS I-POPU
( ( I-POPU
ASD NNP I-POPU
) ) I-POPU
ages VBZ I-POPU
3-8 JJ I-POPU
years NNS I-POPU
. . O

METHODS NNP O
Phase NNP B-POPU
1 CD I-POPU
involved VBD I-POPU
65 CD I-POPU
children NNS I-POPU
with IN I-POPU
ASD NNP I-POPU
who WP I-POPU
received VBD I-POPU
one CD I-POPU
round NN I-POPU
of IN I-POPU
DMSA NNP I-POPU
( ( I-POPU
3 CD I-POPU
days NNS I-POPU
) ) I-POPU
. . O

Participants NNS B-POPU
who WP I-POPU
had VBD I-POPU
high JJ I-POPU
urinary JJ I-POPU
excretion NN I-POPU
of IN I-POPU
toxic JJ I-POPU
metals NNS I-POPU
were VBD I-POPU
selected VBN I-POPU
to TO I-POPU
continue VB I-POPU
on IN I-POPU
to TO I-POPU
phase VB I-POPU
2 CD I-POPU
. . O

In IN O
phase NN B-POPU
2 CD I-POPU
, , I-POPU
49 CD I-POPU
participants NNS I-POPU
were VBD I-POPU
randomly RB I-POPU
assigned VBN I-POPU
in IN I-POPU
a DT I-POPU
double-blind JJ I-POPU
design NN I-POPU
to TO I-POPU
receive VB I-POPU
an DT I-POPU
additional JJ I-POPU
6 CD I-POPU
rounds NNS I-POPU
of IN I-POPU
either DT I-POPU
DMSA NNP I-POPU
or CC I-POPU
placebo NN I-POPU
. . O

RESULTS VB O
The DT O
groups NNS O
receiving VBG O
one CD O
round NN O
and CC O
seven CD O
rounds NNS O
of IN O
DMSA NNP B-INTV
had VBD O
significant JJ O
improvements NNS O
on IN O
all PDT O
the DT O
assessment JJ O
measures NNS O
. . O

For IN O
the DT O
seven CD O
round NN O
group NN O
, , O
the DT O
degree NN O
of IN O
improvement NN B-OC
on IN O
the DT O
assessment NN B-OC
measures NNS I-OC
could MD O
be VB O
partially RB O
explained VBN O
by IN O
a DT O
regression NN O
analysis NN O
based VBN O
on IN O
excretion NN B-OC
of IN I-OC
toxic JJ I-OC
metals NNS I-OC
and CC I-OC
changes NNS I-OC
in IN I-OC
glutathione NN I-OC
( ( O
adjusted VBN O
R2 NNP O
of IN O
0.28-0.75 NNP O
, , O
p NN O
< VBD O
0.02 CD O
in IN O
all DT O
cases NNS O
) ) O
. . O

One CD O
round NN O
of IN O
DMSA NNP O
had VBD O
nearly RB O
the DT O
same JJ O
benefit NN O
as IN O
seven CD O
rounds NNS O
. . O

The DT O
assessment JJ O
measures NNS O
correlated VBN O
reasonably RB O
with IN O
one CD O
another DT O
at IN O
the DT O
beginning NN O
of IN O
the DT O
study NN O
( ( O
r JJ O
= NNP O
0.60-0.87 NN O
) ) O
and CC O
even RB O
better JJR O
at IN O
the DT O
end NN O
of IN O
the DT O
study NN O
( ( O
r JJ O
= NNP O
0.63-0.94 NN O
) ) O
. . O

CONCLUSION NNP O
Overall NNP O
, , O
both DT O
one CD O
and CC O
seven CD O
rounds NNS O
of IN O
DMSA NNP B-INTV
therapy NN O
seems VBZ O
to TO O
be VB O
reasonably RB O
safe JJ B-OC
in IN O
children NNS B-POPU
with IN I-POPU
ASD NNP I-POPU
who WP I-POPU
have VBP I-POPU
high JJ I-POPU
urinary JJ I-POPU
excretion NN I-POPU
of IN I-POPU
toxic JJ I-POPU
metals NNS I-POPU
, , O
and CC O
possibly RB O
helpful JJ O
in IN O
reducing VBG O
some DT O
of IN O
the DT O
symptoms NNS O
of IN O
autism NN O
in IN O
those DT O
children NNS O
. . O

-DOCSTART- -X- O O

Medication NN O
and CC O
parent NN O
training NN O
in IN O
children NNS B-POPU
with IN I-POPU
pervasive JJ I-POPU
developmental NN I-POPU
disorders NNS I-POPU
and CC I-POPU
serious JJ I-POPU
behavior NN I-POPU
problems NNS I-POPU
: : I-POPU
results NNS O
from IN O
a DT O
randomized JJ O
clinical JJ O
trial NN O
. . O

OBJECTIVE NNP O
Many JJ O
children NNS B-POPU
with IN I-POPU
pervasive JJ I-POPU
developmental NN I-POPU
disorders NNS I-POPU
( ( I-POPU
PDDs NNP I-POPU
) ) I-POPU
have VBP I-POPU
serious JJ I-POPU
, , I-POPU
functionally RB I-POPU
impairing VBG I-POPU
behavioral JJ I-POPU
problems NNS I-POPU
. . O

We PRP O
tested VBD O
whether IN O
combined VBN B-INTV
treatment NN I-INTV
( ( I-INTV
COMB NNP I-INTV
) ) I-INTV
with IN I-INTV
risperidone NN I-INTV
and CC I-INTV
parent NN I-INTV
training NN I-INTV
( ( I-INTV
PT NNP I-INTV
) ) I-INTV
in IN O
behavior JJ O
management NN O
is VBZ O
superior JJ O
to TO O
medication VB O
alone RB O
( ( O
MED NNP O
) ) O
in IN O
improving VBG O
severe JJ B-OC
behavioral JJ I-OC
problems NNS I-OC
in IN O
children NNS B-POPU
with IN I-POPU
PDDs NNP I-POPU
. . O

METHOD NNP O
This DT O
24-week JJ O
, , O
three-site JJ O
, , O
randomized VBN O
, , O
parallel-groups JJ O
clinical JJ O
trial NN O
enrolled VBD O
124 CD B-POPU
children NNS I-POPU
, , I-POPU
aged VBD I-POPU
4 CD I-POPU
through IN I-POPU
13 CD I-POPU
years NNS I-POPU
, , I-POPU
with IN I-POPU
PDDs NNP I-POPU
, , I-POPU
accompanied VBN I-POPU
by IN I-POPU
frequent JJ I-POPU
tantrums NNS I-POPU
, , I-POPU
self-injury NN I-POPU
, , I-POPU
and CC I-POPU
aggression NN I-POPU
. . O

The DT O
children NNS O
were VBD O
randomized VBN O
3:2 CD O
to TO O
COMB NNP O
( ( O
n JJ O
= NNP O
75 CD O
) ) O
or CC O
MED NNP O
( ( O
n JJ O
= NNP O
49 CD O
) ) O
. . O

The DT O
participants NNS O
received VBD O
risperidone JJ B-INTV
monotherapy NN I-INTV
from IN O
0.5 CD O
to TO O
3.5 CD O
mg/day NN O
( ( O
with IN O
switch NN O
to TO O
aripiprazole VB B-INTV
if IN O
risperidone NN B-INTV
was VBD O
ineffective JJ O
) ) O
. . O

Parents NNS O
in IN O
the DT O
COMB NNP O
group NN O
( ( O
n JJ O
= VBZ O
75 CD O
; : O
60.5 CD O
% NN O
) ) O
received VBD O
a DT O
mean NN O
of IN O
10.9 CD O
PT NNP O
sessions NNS O
. . O

The DT O
primary JJ O
measure NN O
of IN O
compliance NN O
was VBD O
the DT O
Home NNP B-OC
Situations NNP I-OC
Questionnaire NNP I-OC
( ( I-OC
HSQ NNP I-OC
) ) I-OC
score NN I-OC
. . O

RESULTS NNP O
Primary JJ O
: : O
intent-to-treat JJ O
random NN O
effects NNS O
regression NN O
showed VBD O
that IN O
COMB NNP B-INTV
was VBD O
superior JJ O
to TO O
MED NNP O
on IN O
HSQ NNP B-OC
( ( O
p JJ O
= NNP O
.006 NNP O
) ) O
[ VBP O
effect NN O
size NN O
at IN O
week NN O
24 CD O
( ( O
d NN O
) ) O
= VBZ O
0.34 CD O
] NN O
. . O

The DT O
HSQ NNP B-OC
score NN I-OC
declined VBD O
from IN O
4.31 CD O
( ( O
 $ O
1.67 CD O
) ) O
to TO O
1.23 CD O
( ( O
 $ O
1.36 CD O
) ) O
for IN O
COMB NNP O
compared VBN O
with IN O
4.16 CD O
( ( O
 $ O
1.47 CD O
) ) O
to TO O
1.68 CD O
( ( O
 $ O
1.36 CD O
) ) O
for IN O
MED NNP O
. . O

Secondary JJ O
: : O
groups NNS O
did VBD O
not RB O
differ VB B-OC
on IN I-OC
Clinical JJ I-OC
Global NNP I-OC
Impressions-Improvement NN I-OC
scores NNS I-OC
at IN O
endpoint NN O
; : O
compared VBN O
with IN O
MED NNP O
, , O
COMB NNP O
showed VBD O
significant JJ O
reductions NNS B-OC
on IN I-OC
Aberrant NNP I-OC
Behavior NNP I-OC
Checklist NNP I-OC
Irritability NNP I-OC
( ( O
d JJ O
= VBZ O
0.48 CD O
; : O
p NN O
= NNP O
.01 NNP B-OC
) ) I-OC
, , I-OC
Stereotypic NNP I-OC
Behavior NNP I-OC
( ( O
d JJ O
= VBZ O
0.23 CD O
; : O
p NN O
= NNP O
.04 NNP O
) ) O
, , O
and CC B-OC
Hyperactivity/Noncompliance NNP I-OC
subscales NNS I-OC
( ( O
d VB O
= RB O
0.55 CD O
; : O
p NN O
= NNP O
.04 NNP O
) ) O
. . O

Final NNP B-INTV
risperidone NN I-INTV
mean NN B-OC
dose NN I-OC
for IN O
MED NNP O
was VBD O
2.26 CD O
mg/day NN O
( ( O
0.071 CD O
mg/kg NN O
) ) O
, , O
compared VBN O
with IN O
1.98 CD O
mg/day NN O
for IN O
COMB NNP O
( ( O
0.066 CD O
mg/kg NN O
) ) O
( ( O
p JJ O
= NNP O
.04 NNP O
) ) O
. . O

CONCLUSIONS NNP B-INTV
Medication NNP I-INTV
plus CC I-INTV
PT NNP O
resulted VBD O
in IN O
greater JJR B-OC
reduction NN I-OC
of IN I-OC
serious JJ I-OC
maladaptive JJ I-OC
behavior NN I-OC
than IN O
MED NNP B-POPU
in IN I-POPU
children NNS I-POPU
with IN I-POPU
PDDs NNP I-POPU
, , O
with IN O
a DT O
lower JJR O
risperidone NN O
dose NN O
. . O

-DOCSTART- -X- O O

Intranasal NNP O
oxytocin PRP B-INTV
improves VBZ O
emotion NN B-OC
recognition NN I-OC
for IN O
youth NN B-POPU
with IN I-POPU
autism NN I-POPU
spectrum NN I-POPU
disorders NNS I-POPU
. . O

BACKGROUND VB O
A NNP O
diagnostic JJ O
hallmark NN O
of IN O
autism NN O
spectrum NN O
disorders NNS O
is VBZ O
a DT O
qualitative JJ O
impairment NN O
in IN O
social JJ O
communication NN O
and CC O
interaction NN O
. . O

Deficits NNS O
in IN O
the DT O
ability NN O
to TO O
recognize VB O
the DT O
emotions NNS O
of IN O
others NNS O
are VBP O
believed VBN O
to TO O
contribute VB O
to TO O
this DT O
. . O

There EX O
is VBZ O
currently RB O
no DT O
effective JJ O
treatment NN O
for IN O
these DT O
problems NNS O
. . O

METHODS NNP O
In IN O
a DT O
double-blind NN O
, , O
randomized VBN O
, , O
placebo-controlled JJ O
, , O
crossover JJ O
design NN O
, , O
we PRP O
administered VBD O
oxytocin RP B-INTV
nasal JJ I-INTV
spray NN I-INTV
( ( O
18 CD O
or CC O
24 CD O
IU NNPS O
) ) O
or CC O
a DT O
placebo NN B-INTV
to TO O
16 CD B-POPU
male NN I-POPU
youth NN I-POPU
aged VBD I-POPU
12 CD I-POPU
to TO I-POPU
19 CD I-POPU
who WP I-POPU
were VBD I-POPU
diagnosed VBN I-POPU
with IN I-POPU
Autistic NNP I-POPU
or CC I-POPU
Asperger NNP I-POPU
's POS I-POPU
Disorder NNP I-POPU
. . O

Participants NNS B-POPU
then RB O
completed VBD O
the DT O
Reading VBG B-OC
the DT I-OC
Mind NNP I-OC
in IN I-OC
the DT I-OC
Eyes NNP I-OC
Task NNP I-OC
, , O
a DT O
widely RB O
used VBN O
and CC O
reliable JJ O
test NN O
of IN O
emotion NN B-OC
recognition NN I-OC
. . O

RESULTS NNP O
In IN O
comparison NN O
with IN O
placebo NN B-INTV
, , I-INTV
oxytocin JJ I-INTV
administration NN O
improved VBD O
performance NN B-OC
on IN I-OC
the DT I-OC
Reading VBG I-OC
the DT I-OC
Mind NNP I-OC
in IN I-OC
the DT I-OC
Eyes NNP I-OC
Task NNP I-OC
. . O

This DT O
effect NN O
was VBD O
also RB O
shown VBN O
when WRB O
analysis NN O
was VBD O
restricted VBN O
to TO O
the DT O
younger JJR B-POPU
participants NNS I-POPU
aged VBD I-POPU
12 CD I-POPU
to TO I-POPU
15 CD I-POPU
who WP O
received VBD O
the DT O
lower JJR O
dose NN O
. . O

CONCLUSIONS VB O
This DT O
study NN O
provides VBZ O
the DT O
first JJ O
evidence NN O
that IN O
oxytocin JJ O
nasal NN O
spray NN O
improves VBZ O
emotion NN B-OC
recognition NN I-OC
in IN O
young JJ B-POPU
people NNS I-POPU
diagnosed VBN I-POPU
with IN I-POPU
autism NN I-POPU
spectrum NN I-POPU
disorders NNS I-POPU
. . O

Findings NNS O
suggest VBP O
the DT O
potential NN O
of IN O
earlier JJR O
intervention NN O
and CC O
further JJ O
evaluation NN O
of IN O
oxytocin JJ B-INTV
nasal JJ O
spray NN O
as IN O
a DT O
treatment NN O
to TO O
improve VB O
social JJ O
communication NN O
and CC O
interaction NN O
in IN O
young JJ B-POPU
people NNS I-POPU
with IN I-POPU
autism NN I-POPU
spectrum NN I-POPU
disorders NNS I-POPU
. . O

-DOCSTART- -X- O O

Brief JJ O
Report NNP O
: : O
Randomized JJ O
test NN O
of IN O
the DT O
efficacy NN O
of IN O
picture NN B-INTV
exchange NN I-INTV
communication NN I-INTV
system NN I-INTV
on IN O
highly RB O
generalized JJ B-OC
picture NN I-OC
exchanges NNS I-OC
in IN O
children NNS B-POPU
with IN I-POPU
ASD NNP I-POPU
. . O

A NNP O
randomized VBD O
control NN O
trial NN O
comparing VBG O
two CD O
social-communication JJ B-INTV
interventions NNS I-INTV
in IN O
young JJ B-POPU
children NNS I-POPU
with IN I-POPU
autism NN I-POPU
examined VBN O
far-transfer NN B-OC
of IN I-OC
the DT I-OC
use NN I-OC
of IN I-OC
picture NN B-INTV
exchange NN I-INTV
to TO B-OC
communicate VB I-OC
. . O

Thirty-six JJ B-POPU
children NNS I-POPU
were VBD O
randomly RB O
assigned VBN O
to TO O
one CD O
of IN O
two CD O
treatment NN O
conditions NNS O
, , O
one CD B-INTV
of IN I-INTV
which WDT I-INTV
was VBD I-INTV
the DT I-INTV
Picture NNP I-INTV
Exchange NNP I-INTV
Communication NNP I-INTV
System NNP I-INTV
( ( I-INTV
PECS NNP I-INTV
) ) I-INTV
. . O

All DT O
children NNS O
had VBD O
access NN O
to TO O
picture VB B-INTV
symbols NNS I-INTV
during IN I-INTV
assessments NNS I-INTV
. . O

Post-treatment JJ O
measurement NN O
of IN O
the DT O
number NN B-OC
of IN I-OC
picture NN I-OC
exchanges NNS I-OC
in IN I-OC
a DT I-OC
far-transfer NN I-OC
, , O
assessment JJ O
context NN O
favored VBD O
the DT O
PECS NNP B-INTV
intervention NN O
. . O

These DT O
findings NNS O
were VBD O
interpreted VBN O
as IN O
support NN O
for IN O
the DT O
hypothesis NN O
that IN O
the DT O
PECS NNP B-INTV
curriculum NN O
can MD O
successfully RB O
teach VB O
a DT O
generalized JJ O
means NN O
of IN O
showing VBG O
coordinated JJ B-OC
attention NN I-OC
to TO I-OC
object VB I-OC
and CC I-OC
person NN I-OC
without IN I-OC
requiring VBG I-OC
eye NN I-OC
contact NN I-OC
to TO O
children NNS B-POPU
with IN I-POPU
ASD NNP I-POPU
. . O

-DOCSTART- -X- O O

Low-frequency NNP B-INTV
repetitive JJ I-INTV
transcranial JJ I-INTV
magnetic JJ I-INTV
stimulation NN I-INTV
( ( I-INTV
rTMS NN I-INTV
) ) I-INTV
affects VBZ O
event-related JJ O
potential JJ O
measures NNS O
of IN O
novelty NN O
processing NN O
in IN O
autism NN B-POPU
. . O

In IN O
our PRP$ O
previous JJ O
study NN O
on IN O
individuals NNS B-POPU
with IN I-POPU
autism NN I-POPU
spectrum NN I-POPU
disorder NN I-POPU
( ( I-POPU
ASD NNP I-POPU
) ) I-POPU
( ( O
Sokhadze NNP O
et RB O
al. RB O
, , O
Appl NNP O
Psychophysiol NNP O
Biofeedback NNP O
34:37-51 JJ O
, , O
2009a CD O
) ) O
we PRP O
reported VBD O
abnormalities NNS O
in IN O
the DT O
attention-orienting JJ O
frontal JJ O
event-related JJ O
potentials NNS O
( ( O
ERP NNP O
) ) O
and CC O
the DT O
sustained-attention JJ O
centro-parietal JJ O
ERPs NNP O
in IN O
a DT O
visual JJ O
oddball NN O
experiment NN O
. . O

These DT O
results NNS O
suggest VBP O
that IN O
individuals NNS B-POPU
with IN I-POPU
autism NN I-POPU
over-process JJ O
information NN O
needed VBN O
for IN O
the DT O
successful JJ O
differentiation NN O
of IN O
target NN O
and CC O
novel JJ O
stimuli NNS O
. . O

In IN O
the DT O
present JJ O
study NN O
we PRP O
examine VBP O
the DT O
effects NNS O
of IN O
low-frequency NN B-INTV
, , I-INTV
repetitive JJ I-INTV
Transcranial NNP I-INTV
Magnetic NNP I-INTV
Stimulation NNP I-INTV
( ( I-INTV
rTMS NN I-INTV
) ) I-INTV
on IN O
novelty NN O
processing NN O
as RB O
well RB O
as IN O
behavior NN O
and CC O
social JJ O
functioning NN O
in IN O
13 CD B-POPU
individuals NNS I-POPU
with IN I-POPU
ASD NNP I-POPU
. . O

Our PRP$ O
hypothesis NN O
was VBD O
that IN O
low-frequency NN B-INTV
rTMS NN I-INTV
application NN O
to TO O
dorsolateral JJ O
prefrontal JJ O
cortex NN O
( ( O
DLFPC NNP O
) ) O
would MD O
result VB O
in IN O
an DT O
alteration NN O
of IN O
the DT O
cortical JJ O
excitatory/inhibitory NN O
balance NN O
through IN O
the DT O
activation NN O
of IN O
inhibitory JJ O
GABAergic NNP O
double JJ O
bouquet NN O
interneurons NNS O
. . O

We PRP O
expected VBD O
to TO O
find VB O
post-TMS JJ O
differences NNS O
in IN O
amplitude NN O
and CC O
latency NN O
of IN O
early JJ O
and CC O
late JJ O
ERP NNP O
components NNS O
. . O

The DT O
results NNS O
of IN O
our PRP$ O
current JJ O
study NN O
validate VBP O
the DT O
use NN O
of IN O
low-frequency NN O
rTMS NN O
as IN O
a DT O
modulatory NN O
tool NN O
that WDT O
altered VBD O
the DT O
disrupted VBN O
ratio NN O
of IN O
cortical JJ O
excitation NN O
to TO O
inhibition NN O
in IN O
autism NN O
. . O

After IN O
rTMS VBG O
the DT O
parieto-occipital JJ B-OC
P50 NNP I-OC
amplitude NN I-OC
decreased VBD I-OC
to TO I-OC
novel JJ I-OC
distracters NNS I-OC
but CC I-OC
not RB I-OC
to TO I-OC
targets NNS I-OC
; : I-OC
also RB O
the DT O
amplitude NN B-OC
and CC I-OC
latency NN I-OC
to TO I-OC
targets NNS I-OC
increased VBN I-OC
for IN I-OC
the DT I-OC
frontal JJ I-OC
P50 NNP I-OC
while IN I-OC
decreasing VBG I-OC
to TO I-OC
non-target JJ I-OC
stimuli NNS I-OC
. . O

Low-frequency NNP O
rTMS NN O
minimized VBD B-OC
early JJ I-OC
cortical JJ I-OC
responses NNS I-OC
to TO I-OC
irrelevant VB I-OC
stimuli JJ I-OC
and CC O
increased JJ B-OC
responses NNS I-OC
to TO I-OC
relevant VB I-OC
stimuli NN I-OC
. . O

Improved VBN O
selectivity NN O
in IN O
early JJ O
cortical JJ O
responses NNS O
lead VBP O
to TO O
better JJR B-OC
stimulus JJ I-OC
differentiation NN I-OC
at IN I-OC
later-stage JJ I-OC
responses NNS I-OC
as IN O
was VBD O
made VBN O
evident JJ O
by IN O
our PRP$ O
P3b NNP O
and CC O
P3a NNP O
component NN O
findings NNS O
. . O

These DT O
results NNS O
indicate VBP O
a DT O
significant JJ B-OC
change NN I-OC
in IN I-OC
early JJ I-OC
, , I-OC
middle-latency JJ I-OC
and CC I-OC
late JJ I-OC
ERP NNP I-OC
components NNS I-OC
at IN I-OC
the DT I-OC
frontal JJ I-OC
, , I-OC
centro-parietal JJ I-OC
, , I-OC
and CC I-OC
parieto-occipital JJ I-OC
regions NNS I-OC
of IN I-OC
interest NN I-OC
in IN I-OC
response NN I-OC
to TO I-OC
target VB I-OC
and CC I-OC
distracter VB I-OC
stimuli NNS I-OC
as IN O
a DT O
result NN O
of IN O
rTMS NN O
treatment NN O
. . O

Overall JJ O
, , O
our PRP$ O
preliminary JJ O
results NNS O
show VBP O
that IN O
rTMS NN O
may MD O
prove VB O
to TO O
be VB O
an DT O
important JJ O
research NN O
tool NN O
or CC O
treatment NN O
modality NN O
in IN O
addressing VBG O
the DT O
stimulus JJ O
hypersensitivity NN O
characteristic NN O
of IN O
autism NN O
spectrum NN O
disorders NNS O
. . O

-DOCSTART- -X- O O

Randomized VBN O
, , O
controlled VBD O
trial NN O
of IN O
an DT O
intervention NN B-INTV
for IN O
toddlers NNS B-POPU
with IN I-POPU
autism NN I-POPU
: : I-POPU
the DT O
Early JJ O
Start NNP O
Denver NNP O
Model NNP O
. . O

OBJECTIVE NNP O
To TO O
conduct VB O
a DT O
randomized NN O
, , O
controlled VBD O
trial NN O
to TO O
evaluate VB O
the DT O
efficacy NN B-OC
of IN O
the DT O
Early JJ B-INTV
Start NNP I-INTV
Denver NNP I-INTV
Model NNP I-INTV
( ( I-INTV
ESDM NNP I-INTV
) ) I-INTV
, , O
a DT O
comprehensive JJ O
developmental JJ O
behavioral JJ O
intervention NN O
, , O
for IN O
improving VBG O
outcomes NNS O
of IN O
toddlers NNS B-POPU
diagnosed VBN I-POPU
with IN I-POPU
autism NN I-POPU
spectrum NN I-POPU
disorder NN I-POPU
( ( I-POPU
ASD NNP I-POPU
) ) I-POPU
. . O

METHODS NNP O
Forty-eight JJ B-POPU
children NNS I-POPU
diagnosed VBN I-POPU
with IN I-POPU
ASD NNP I-POPU
between IN I-POPU
18 CD I-POPU
and CC I-POPU
30 CD I-POPU
months NNS I-POPU
of IN I-POPU
age NN I-POPU
were VBD O
randomly RB O
assigned VBN O
to TO O
1 CD O
of IN O
2 CD O
groups NNS O
: : O
( ( O
1 CD O
) ) O
ESDM NNP B-INTV
intervention NN I-INTV
, , O
which WDT O
is VBZ O
based VBN O
on IN O
developmental JJ O
and CC O
applied JJ O
behavioral JJ O
analytic JJ O
principles NNS O
and CC O
delivered VBN O
by IN O
trained JJ O
therapists NNS O
and CC O
parents NNS O
for IN O
2 CD O
years NNS O
; : O
or CC O
( ( O
2 CD O
) ) O
referral NN B-INTV
to TO I-INTV
community NN I-INTV
providers NNS I-INTV
for IN I-INTV
intervention NN I-INTV
commonly RB I-INTV
available JJ I-INTV
in IN I-INTV
the DT I-INTV
community NN I-INTV
. . O

RESULTS NNP O
Compared VBD O
with IN O
children NNS O
who WP O
received VBD O
community-intervention NN O
, , O
children NNS O
who WP O
received VBD O
ESDM NNP O
showed VBD O
significant JJ O
improvements NNS O
in IN O
IQ NNP B-OC
, , I-OC
adaptive JJ I-OC
behavior NN I-OC
, , I-OC
and CC I-OC
autism NN I-OC
diagnosis NN I-OC
. . O

Two CD O
years NNS O
after IN O
entering VBG O
intervention NN O
, , O
the DT O
ESDM NNP O
group NN O
on IN O
average NN O
improved VBD O
17.6 CD O
standard NN O
score NN O
points NNS O
( ( O
1 CD O
SD NNP O
: : O
15 CD O
points NNS O
) ) O
compared VBN O
with IN O
7.0 CD O
points NNS O
in IN O
the DT O
comparison NN O
group NN O
relative VBP O
to TO O
baseline VB O
scores NNS O
. . O

The DT O
ESDM NNP O
group NN O
maintained VBD O
its PRP$ O
rate NN B-OC
of IN I-OC
growth NN I-OC
in IN I-OC
adaptive JJ I-OC
behavior NN I-OC
compared VBN O
with IN O
a DT O
normative JJ O
sample NN O
of IN O
typically RB O
developing VBG O
children NNS O
. . O

In IN O
contrast NN O
, , O
over IN O
the DT O
2-year JJ O
span NN O
, , O
the DT O
comparison NN O
group NN O
showed VBD O
greater JJR O
delays NNS O
in IN O
adaptive JJ B-OC
behavior NN I-OC
. . O

Children NNP O
who WP O
received VBD O
ESDM NNP B-INTV
also RB O
were VBD O
more RBR O
likely JJ O
to TO O
experience VB O
a DT O
change NN B-OC
in IN I-OC
diagnosis NN I-OC
from IN O
autism NN O
to TO O
pervasive VB O
developmental JJ O
disorder NN O
, , O
not RB O
otherwise RB O
specified VBN O
, , O
than IN O
the DT O
comparison NN O
group NN O
. . O

CONCLUSIONS NNP O
This DT O
is VBZ O
the DT O
first JJ O
randomized VBN O
, , O
controlled VBN O
trial NN O
to TO O
demonstrate VB O
the DT O
efficacy NN O
of IN O
a DT O
comprehensive JJ O
developmental JJ O
behavioral JJ O
intervention NN O
for IN O
toddlers NNS B-POPU
with IN I-POPU
ASD NNP I-POPU
for IN O
improving VBG O
cognitive JJ B-OC
and CC I-OC
adaptive JJ I-OC
behavior NN I-OC
and CC O
reducing VBG O
severity NN B-OC
of IN I-OC
ASD NNP I-OC
diagnosis NN I-OC
. . O

Results NNS O
of IN O
this DT O
study NN O
underscore VBD O
the DT O
importance NN O
of IN O
early JJ O
detection NN O
of IN O
and CC O
intervention NN O
in IN O
autism NN O
. . O

-DOCSTART- -X- O O

Aripiprazole NNP B-INTV
in IN O
the DT O
treatment NN O
of IN O
irritability NN B-OC
in IN O
children NNS B-POPU
and CC I-POPU
adolescents NNS I-POPU
with IN I-POPU
autistic JJ I-POPU
disorder NN I-POPU
. . O

OBJECTIVE CC O
The DT O
objective NN O
of IN O
this DT O
study NN O
was VBD O
to TO O
evaluate VB O
short-term JJ B-OC
efficacy NN I-OC
and CC I-OC
safety NN I-OC
of IN O
aripiprazole NN B-INTV
in IN O
the DT O
treatment NN O
of IN O
irritability NN B-OC
in IN O
children NNS B-POPU
and CC I-POPU
adolescents NNS I-POPU
with IN I-POPU
autistic JJ I-POPU
disorder NN I-POPU
who WP I-POPU
were VBD I-POPU
manifesting VBG I-POPU
behaviors NNS I-POPU
such JJ I-POPU
as IN I-POPU
tantrums NNS I-POPU
, , I-POPU
aggression NN I-POPU
, , I-POPU
self-injurious JJ I-POPU
behavior NN I-POPU
, , I-POPU
or CC I-POPU
a DT I-POPU
combination NN I-POPU
of IN I-POPU
these DT I-POPU
. . O

METHODS NN O
This DT O
8-week JJ O
, , O
double-blind JJ O
, , O
randomized VBN O
, , O
placebo-controlled JJ O
, , O
parallel-group JJ O
study NN O
was VBD O
conducted VBN O
of IN O
children NNS B-POPU
and CC I-POPU
adolescents NNS I-POPU
( ( I-POPU
aged VBN I-POPU
6-17 CD I-POPU
years NNS I-POPU
) ) I-POPU
with IN I-POPU
autistic JJ I-POPU
disorder NN I-POPU
. . O

Patients NNS B-INTV
were VBD I-INTV
randomly RB I-INTV
assigned VBN I-INTV
( ( I-INTV
1:1 CD I-INTV
) ) I-INTV
to TO I-INTV
flexibly RB I-INTV
dosed JJ I-INTV
aripiprazole NN I-INTV
( ( I-INTV
target NN I-INTV
dosage NN I-INTV
: : I-INTV
5 CD I-INTV
, , I-INTV
10 CD I-INTV
, , I-INTV
or CC I-INTV
15 CD I-INTV
mg/day NN I-INTV
) ) I-INTV
or CC I-INTV
placebo NN I-INTV
. . O

Efficacy NNP O
outcome JJ O
measures NNS O
included VBD O
the DT O
Aberrant NNP B-OC
Behavior NNP I-OC
Checklist NNP I-OC
irritability NN I-OC
subscale NN I-OC
and CC I-OC
the DT I-OC
Clinical JJ I-OC
Global NNP I-OC
Impression-Improvement NN I-OC
score NN I-OC
( ( I-OC
CGI-I NNP I-OC
) ) I-OC
. . O

Safety NN B-OC
and CC I-OC
tolerability NN I-OC
were VBD O
also RB O
assessed VBN O
. . O

RESULTS JJ O
Ninety-eight JJ B-POPU
patients NNS I-POPU
were VBD O
randomly RB O
assigned VBN O
to TO O
receive VB O
placebo NN B-INTV
( ( O
n JJ O
= NNP O
51 CD O
) ) O
or CC O
aripiprazole JJ O
( ( O
n JJ O
= NNP O
47 CD O
) ) O
. . O

Mean JJ O
improvement NN O
in IN O
Aberrant NNP B-OC
Behavior NNP I-OC
Checklist NNP I-OC
irritability NN I-OC
subscale NN I-OC
score NN I-OC
was VBD O
significantly RB O
greater JJR O
with IN O
aripiprazole NN B-INTV
than IN O
with IN O
placebo NN B-INTV
from IN O
week NN O
1 CD O
through IN O
week NN O
8 CD O
. . O

Aripiprazole NNP O
demonstrated VBD O
significantly RB O
greater JJR O
global JJ O
improvements NNS O
than IN O
placebo NN O
, , O
as IN O
assessed VBN O
by IN O
the DT O
mean JJ O
CGI-I NNP B-OC
score NN I-OC
from IN O
week NN O
1 CD O
through IN O
week NN O
8 CD O
; : O
however RB O
, , O
clinically RB O
significant JJ O
residual JJ B-OC
symptoms NNS I-OC
may MD O
still RB O
persist VB O
for IN O
some DT O
patients NNS O
. . O

Discontinuation NNP B-OC
rates NNS I-OC
as IN O
a DT O
result NN O
of IN O
adverse JJ O
events NNS O
( ( O
AEs NNP O
) ) O
were VBD O
10.6 CD O
% NN O
for IN O
aripiprazole NN B-INTV
and CC O
5.9 CD O
% NN O
for IN O
placebo NN B-INTV
. . O

Extrapyramidal NNP B-OC
symptom-related JJ I-OC
AE NNP I-OC
rates NNS I-OC
were VBD O
14.9 CD O
% NN O
for IN O
aripiprazole NN B-INTV
and CC O
8.0 CD O
% NN O
for IN O
placebo NN B-INTV
. . O

No DT O
serious JJ O
AEs NNP O
were VBD O
reported VBN O
. . O

Mean NNP O
weight VBD B-OC
gain NN I-OC
was VBD O
2.0 CD O
kg NN O
on IN O
aripiprazole NN O
and CC O
0.8 CD O
kg NN O
on IN O
placebo NN O
at IN O
week NN O
8 CD O
. . O

CONCLUSIONS NNP O
Aripiprazole NNP B-INTV
was VBD O
efficacious JJ O
in IN O
children NNS B-POPU
and CC I-POPU
adolescents NNS I-POPU
with IN I-POPU
irritability NN I-POPU
associated VBN I-POPU
with IN I-POPU
autistic JJ I-POPU
disorder NN I-POPU
and CC O
was VBD O
generally RB O
safe JJ O
and CC O
well RB O
tolerated VBN O
. . O

-DOCSTART- -X- O O

The DT O
efficacy NN O
of IN O
melatonin NN B-INTV
for IN O
sleep JJ O
problems NNS O
in IN O
children NNS O
with IN O
autism NN O
, , O
fragile JJ O
X NNP O
syndrome NN O
, , O
or CC O
autism NN O
and CC O
fragile JJ O
X NNP O
syndrome NN O
. . O

STUDY NNP O
OBJECTIVE NNP O
To TO O
determine VB O
the DT O
efficacy NN O
of IN O
melatonin NN B-POPU
on IN I-POPU
sleep NN I-POPU
problems NNS I-POPU
in IN I-POPU
children NNS I-POPU
with IN O
autistic JJ O
spectrum NN O
disorder NN O
( ( O
ASD NNP O
) ) O
and CC O
fragile JJ O
X NNP O
syndrome NN O
( ( O
FXS NNP O
) ) O
. . O

METHODS VB O
A DT O
4-week JJ O
, , O
randomized VBN O
, , O
double JJ O
blind NN O
, , O
placebo-controlled JJ O
, , O
crossover JJ O
design NN O
was VBD O
conducted VBN O
following VBG O
a DT O
1-week JJ O
baseline NN O
period NN O
. . O

Either CC O
melatonin NN B-INTV
, , O
3 CD O
mg NN O
, , O
or CC O
placebo NN B-INTV
was VBD O
given VBN O
to TO O
participants NNS B-POPU
for IN I-POPU
2 CD I-POPU
weeks NNS I-POPU
and CC O
then RB O
alternated VBD O
for IN O
another DT O
2 CD O
weeks NNS O
. . O

Sleep JJ B-OC
variables NNS I-OC
, , O
including VBG O
sleep JJ B-OC
duration NN I-OC
, , I-OC
sleep-onset JJ I-OC
time NN I-OC
, , I-OC
sleep-onset JJ I-OC
latency NN I-OC
time NN I-OC
, , I-OC
and CC I-OC
the DT I-OC
number NN I-OC
of IN I-OC
night NN I-OC
awakenings NNS I-OC
, , O
were VBD O
recorded VBN O
using VBG O
an DT O
Actiwatch NN O
and CC O
from IN O
sleep JJ O
diaries NNS O
completed VBN O
by IN O
parents NNS O
. . O

All DT B-POPU
participants NNS I-POPU
had VBD O
been VBN O
thoroughly RB O
assessed VBN O
for IN O
ASD NNP O
and CC O
also RB O
had VBD O
DNA NNP O
testing VBG O
for IN O
the DT O
diagnosis NN O
of IN O
FXS NNP O
. . O

RESULTS NNP O
Data NNP O
were VBD O
successfully RB O
obtained VBN O
from IN O
the DT O
12 CD B-POPU
of IN I-POPU
18 CD I-POPU
subjects NNS I-POPU
who WP I-POPU
completed VBD I-POPU
the DT I-POPU
study NN I-POPU
( ( I-POPU
11 CD I-POPU
males NNS I-POPU
, , I-POPU
age NN I-POPU
range NN I-POPU
2 CD I-POPU
to TO I-POPU
15.25 CD I-POPU
years NNS I-POPU
, , I-POPU
mean JJ I-POPU
5.47 CD I-POPU
, , I-POPU
SD NNP I-POPU
3.6 CD I-POPU
) ) I-POPU
. . O

Five CD B-POPU
participants NNS I-POPU
met VBD O
diagnostic JJ O
criteria NNS O
for IN O
ASD NNP O
, , O
3 CD O
for IN O
FXS NNP O
alone RB O
, , O
3 CD O
for IN O
FXS NNP O
and CC O
ASD NNP O
, , O
and CC O
1 CD O
for IN O
fragile JJ O
X NNP O
premutation NN O
. . O

Eight CD B-POPU
out IN I-POPU
of IN I-POPU
12 CD I-POPU
had VBD I-POPU
melatonin VBN I-POPU
first RB I-POPU
. . O

The DT O
conclusions NNS O
from IN O
a DT O
nonparametric JJ O
repeated-measures NNS O
technique NN O
indicate VBP O
that IN O
mean JJ B-OC
night NN I-OC
sleep NN I-OC
duration NN I-OC
was VBD O
longer RBR O
on IN O
melatonin NN B-INTV
than IN O
placebo NN B-INTV
by IN O
21 CD O
minutes NNS O
( ( O
p JJ O
= NNP O
.02 NNP O
) ) O
, , O
mean JJ B-OC
sleep-onset JJ I-OC
latency NN I-OC
was VBD O
shorter JJR O
by IN O
28 CD O
minutes NNS O
( ( O
p JJ O
= NNP O
.0001 NNP O
) ) O
, , O
and CC O
mean VB B-OC
sleep-onset JJ I-OC
time NN I-OC
was VBD O
earlier RB O
by IN O
42 CD O
minutes NNS O
( ( O
p JJ O
= NNP O
.02 NNP O
) ) O
. . O

CONCLUSION VB O
The DT O
results NNS O
of IN O
this DT O
study NN O
support VBD O
the DT O
efficacy NN O
and CC O
tolerability NN O
of IN O
melatonin NN B-INTV
treatment NN O
for IN O
sleep JJ O
problems NNS O
in IN O
children NNS O
with IN O
ASD NNP O
and CC O
FXS NNP O
. . O

-DOCSTART- -X- O O

Effects NNS O
of IN O
Thai NNP O
traditional JJ O
massage NN O
on IN O
autistic JJ B-POPU
children NNS I-POPU
's POS I-POPU
behavior NN I-POPU
. . O

OBJECTIVES CC O
The DT O
objective NN O
of IN O
this DT O
study NN O
was VBD O
to TO O
access NN O
whether IN O
there EX O
were VBD O
any DT O
therapeutic JJ O
effects NNS O
of IN O
Thai NNP B-INTV
Traditional NNP I-INTV
Massage NNP I-INTV
( ( I-INTV
TTM NNP I-INTV
) ) I-INTV
on IN O
major JJ O
behavioral JJ B-POPU
and CC I-POPU
emotional JJ I-POPU
disturbances NNS I-POPU
in IN I-POPU
Thai NNP I-POPU
autistic JJ I-POPU
children NNS I-POPU
. . O

DESIGN NN O
This DT O
was VBD O
a DT O
randomized VBN O
controlled VBN O
trial NN O
study NN O
. . O

SETTINGS/LOCATION NNP O
The DT B-POPU
study NN I-POPU
was VBD I-POPU
conducted VBN I-POPU
at IN I-POPU
the DT I-POPU
Rehabilitation NNP I-POPU
Centre NNP I-POPU
of IN I-POPU
the DT I-POPU
Thai NNP I-POPU
Red NNP I-POPU
Cross NNP I-POPU
Society NNP I-POPU
. . O

SUBJECTS NNP O
A NNP B-POPU
total NN I-POPU
of IN I-POPU
60 CD I-POPU
autistic JJ I-POPU
children NNS I-POPU
between IN I-POPU
the DT I-POPU
ages NNS I-POPU
of IN I-POPU
3 CD I-POPU
and CC I-POPU
10 CD I-POPU
completed VBD I-POPU
this DT I-POPU
study NN I-POPU
. . O

INTERVENTIONS NNP O
Standard NNP B-INTV
sensory JJ I-INTV
integration NN I-INTV
therapy NN I-INTV
( ( I-INTV
SI NNP I-INTV
) ) I-INTV
was VBD O
compared VBN O
to TO O
the DT O
SI NNP O
with IN O
TTM NNP B-INTV
treatments NNS O
. . O

OUTCOME NNP O
MEASURES NNP O
Parents NNP O
and CC O
teachers NNS O
assessed VBD O
major JJ B-OC
behavior NN I-OC
disturbances NNS I-OC
using VBG O
the DT O
Conners NNPS B-OC
' POS I-OC
Rating VBG I-OC
Scales NNS I-OC
at IN O
0 CD O
and CC O
8 CD O
weeks NNS O
. . O

Sleep JJ B-OC
Diary NNP I-OC
( ( I-OC
SD NNP I-OC
) ) I-OC
, , O
recorded VBN O
by IN O
the DT O
parents NNS O
, , O
assessed VBD O
the DT O
patient NN O
's POS O
sleeping NN O
patterns NNS O
every DT O
week NN O
. . O

RESULTS NNP O
Sixty NNP B-POPU
( ( I-POPU
60 CD I-POPU
) ) I-POPU
autistic JJ I-POPU
children NNS I-POPU
, , I-POPU
mean JJ I-POPU
age NN I-POPU
4.67 CD I-POPU
+/- JJ I-POPU
1.82 CD I-POPU
, , I-POPU
were VBD I-POPU
recruited VBN I-POPU
. . O

No DT O
statistical JJ O
differences NNS O
were VBD O
seen VBN O
in IN O
the DT O
demographic JJ O
and CC O
baseline JJ O
data NN O
among IN O
both DT O
groups NNS O
. . O

From IN O
both CC O
the DT O
Conners NNPS B-OC
' POS I-OC
Teacher NNP I-OC
Questionnaire NNP I-OC
and CC I-OC
SD NNP I-OC
, , O
statistical JJ O
improvement NN O
was VBD O
detected VBN O
for IN O
conduct NN B-OC
problem NN I-OC
, , I-OC
hyperactivity NN I-OC
, , I-OC
inattention-passivity NN I-OC
, , I-OC
hyperactivity NN I-OC
index NN I-OC
, , I-OC
and CC I-OC
sleeping VBG I-OC
behavior NN I-OC
. . O

However RB O
, , O
results NNS O
from IN O
the DT O
Conners NNP B-OC
' POS I-OC
Parent NNP I-OC
Questionnaire NNP I-OC
revealed VBD O
an DT O
improvement NN O
only RB O
for IN O
anxiety NN B-OC
( ( O
p JJ O
= NNP O
0.04 CD O
) ) O
in IN O
the DT O
massage NN O
group NN O
, , O
whereas IN O
when WRB O
both DT O
groups NNS O
were VBD O
compared VBN O
, , O
a DT O
significant JJ O
improvement NN O
in IN O
conduct NN B-OC
problem NN I-OC
( ( O
p JJ O
= NNP O
0.03 CD O
) ) O
and CC O
anxiety NN B-OC
( ( O
p JJ O
= NNP O
0.01 CD O
) ) O
was VBD O
found VBN O
. . O

Results NNS O
indicated VBD O
that IN O
TTM NNP O
may MD O
have VB O
a DT O
positive JJ O
effect NN O
in IN O
improving VBG O
stereotypical JJ B-OC
behaviors NNS I-OC
in IN O
autistic JJ O
children NNS O
. . O

CONCLUSIONS NNP O
Over IN O
a DT O
period NN O
of IN O
8 CD O
weeks NNS O
, , O
our PRP$ O
findings NNS O
suggested VBD O
that IN O
TTM NNP O
could MD O
be VB O
used VBN O
as IN O
a DT O
complementary JJ O
therapy NN O
for IN O
autistic JJ O
children NNS O
in IN O
Thailand NNP B-POPU
. . O

-DOCSTART- -X- O O

Divalproex NNP B-INTV
sodium NN I-INTV
vs NN I-INTV
placebo NN I-INTV
for IN O
the DT O
treatment NN O
of IN O
irritability NN B-OC
in IN O
children NNS B-POPU
and CC I-POPU
adolescents NNS I-POPU
with IN I-POPU
autism NN I-POPU
spectrum NN I-POPU
disorders NNS I-POPU
. . O

Autism NNP O
spectrum NN O
disorders NNS O
( ( O
ASDs NNP O
) ) O
are VBP O
neurodevelopmental JJ O
disorders NNS O
characterized VBN O
by IN O
social JJ O
and CC O
language NN O
deficits NNS O
and CC O
by IN O
repetitive JJ O
behaviors NNS O
and CC O
interests NNS O
. . O

Irritability/aggression NN O
is VBZ O
a DT O
significant JJ O
comorbid NN O
symptom NN O
in IN O
this DT O
population NN O
, , O
which WDT O
greatly RB O
impacts VBZ O
burden NN O
of IN O
care NN O
. . O

This DT O
study NN O
examined VBD O
the DT O
effect NN O
of IN O
divalproex NN B-INTV
sodium NN I-INTV
for IN O
irritability/aggression NN O
in IN O
children NNS B-POPU
and CC I-POPU
adolescents NNS I-POPU
with IN I-POPU
ASD NNP I-POPU
. . O

This DT O
was VBD O
a DT O
12-week JJ O
randomized NN O
, , O
double-blind JJ O
, , O
placebo-controlled JJ B-INTV
trial NN O
. . O

All DT O
efficacy NN O
measures NNS O
were VBD O
obtained VBN O
by IN O
an DT O
independent JJ O
evaluator NN O
blinded VBD O
to TO O
randomization VB O
condition NN O
and CC O
side NN O
effects NNS O
. . O

A DT O
total NN B-POPU
of IN I-POPU
55 CD I-POPU
subjects NNS I-POPU
gavetheir JJ I-POPU
consent NN I-POPU
and CC I-POPU
27 CD I-POPU
were VBD I-POPU
randomized VBN I-POPU
in IN I-POPU
a DT I-POPU
1 CD I-POPU
: : I-POPU
1 CD I-POPU
manner NN I-POPU
( ( I-POPU
mean JJ I-POPU
age NN I-POPU
9.46+/-2.46 CD I-POPU
, , I-POPU
mean FW I-POPU
nonverbal JJ I-POPU
IQ NNP I-POPU
63.3+/-23.9 NN I-POPU
) ) I-POPU
. . O

Two CD O
subjects NNS O
from IN O
the DT O
active JJ O
group NN O
and CC O
one CD O
subject NN O
from IN O
the DT O
placebo NN B-INTV
group NN O
discontinued VBD O
the DT O
study NN O
because IN O
of IN O
either CC O
a DT O
lack NN O
of IN O
efficacy NN B-OC
or CC O
side NN B-OC
effects NNS I-OC
( ( O
increased JJ O
irritability NN O
) ) O
. . O

Primary JJ O
outcome JJ O
measures NNS O
were VBD O
Aberrant NNP B-OC
Behavior NNP I-OC
Checklist-Irritability NNP I-OC
subscale NN I-OC
and CC I-OC
Clinical JJ I-OC
Global NNP I-OC
Impression-Improvement NNP I-OC
, , O
which WDT O
focused VBD O
on IN O
irritability NN O
. . O

Overall NNP O
, , O
62.5 CD O
% NN O
of IN O
divalproex JJ B-INTV
subjects NNS O
vs VBP O
9 CD O
% NN O
of IN O
placebo JJ B-INTV
subjects NNS O
were VBD O
responders NNS B-OC
( ( O
CGI-irritability NN O
OR NNP O
: : O
16.7 CD O
, , O
Fisher NNP O
's POS O
exact JJ O
p=0.008 NN O
) ) O
. . O

A DT O
statistically RB O
significant JJ O
improvement NN O
was VBD O
also RB O
noted VBN O
on IN O
the DT O
ABC-Irritability NNP B-OC
subscale NN I-OC
( ( O
p=0.048 NN O
) ) O
. . O

There EX O
was VBD O
a DT O
trend NN O
for IN O
responders NNS O
to TO O
have VB O
higher JJR O
valproate NN B-OC
blood NN I-OC
levels NNS I-OC
compared VBN O
with IN O
nonresponders NNS O
. . O

This DT O
study NN O
suggests VBZ O
the DT O
efficacy NN B-OC
of IN O
divalproex NN B-INTV
for IN O
the DT O
treatment NN O
of IN O
irritability NN B-OC
in IN O
children NNS O
and CC O
adolescents NNS O
with IN O
ASD NNP O
. . O

Larger NNP O
sample JJ O
follow-up JJ O
studies NNS O
are VBP O
warranted VBN O
. . O

-DOCSTART- -X- O O

Randomized VBN O
controlled JJ O
trial NN O
for IN O
early JJ B-INTV
intervention NN I-INTV
for IN O
autism NN O
: : O
a DT O
pilot NN O
study NN O
of IN O
the DT O
Autism NNP B-INTV
1-2-3 JJ I-INTV
Project NNP I-INTV
. . O

We PRP O
piloted VBD O
a DT O
2-week JJ O
" JJ B-INTV
Autism-1-2-3 NNP I-INTV
" NNP I-INTV
early JJ I-INTV
intervention NN I-INTV
for IN B-POPU
children NNS I-POPU
with IN I-POPU
autism NN I-POPU
and CC I-POPU
their PRP$ I-POPU
parents NNS I-POPU
immediately RB O
after IN O
diagnosis NN O
that WDT O
targeted VBD O
at IN O
( ( B-INTV
1 CD I-INTV
) ) I-INTV
eye NN I-INTV
contact NN I-INTV
, , I-INTV
( ( I-INTV
2 CD I-INTV
) ) I-INTV
gesture NN I-INTV
and CC I-INTV
( ( I-INTV
3 CD I-INTV
) ) I-INTV
vocalization/words NNS I-INTV
. . O

Seventeen JJ B-POPU
children NNS I-POPU
were VBD I-POPU
randomized VBN I-POPU
into IN I-POPU
the DT I-POPU
Intervention NNP I-POPU
( ( I-POPU
n JJ I-POPU
= NNP I-POPU
9 CD I-POPU
) ) I-POPU
and CC I-POPU
Control NNP I-POPU
( ( I-POPU
n JJ I-POPU
= NNP I-POPU
8 CD I-POPU
) ) I-POPU
groups NNS I-POPU
. . O

Outcome NNP O
measures NNS O
included VBD O
the DT O
Autism NNP B-OC
Diagnostic NNP I-OC
Observation NNP I-OC
Schedule NNP I-OC
, , I-OC
Ritvo-Freeman NNP I-OC
Real NNP I-OC
Life NNP I-OC
Rating NNP I-OC
Scale NNP I-OC
, , I-OC
Symbolic NNP I-OC
Play NNP I-OC
Test NNP I-OC
, , I-OC
and CC I-OC
Parenting NNP I-OC
Stress NNP I-OC
Index NNP I-OC
. . O

Children NNP B-POPU
with IN I-POPU
autism NN I-POPU
improved VBN O
in IN O
language/communication NN B-OC
, , I-OC
reciprocal JJ I-OC
social JJ I-OC
interaction NN I-OC
, , I-OC
and CC I-OC
symbolic JJ I-OC
play NN I-OC
. . O

Parents NNS O
perceived VBD O
significant JJ O
improvement NN O
in IN O
their PRP$ O
children NNS B-OC
's POS I-OC
language NN I-OC
, , I-OC
social JJ I-OC
interaction NN I-OC
, , I-OC
and CC I-OC
their PRP$ I-OC
own JJ I-OC
stress NN I-OC
level NN I-OC
. . O

This DT O
intervention NN O
can MD O
serve VB O
as IN O
short-term JJ O
training NN B-INTV
on IN I-INTV
communication NN I-INTV
and CC I-INTV
social JJ I-INTV
interaction NN I-INTV
for IN O
children NNS O
with IN O
autism NN O
, , O
and CC O
reduce VB O
the DT O
stress NN O
of IN O
their PRP$ O
parents NNS O
during IN O
the DT O
long JJ O
waiting NN O
time NN O
for IN O
public JJ O
health NN O
services NNS O
. . O

-DOCSTART- -X- O O

A DT O
randomized VBN O
controlled VBN O
study NN O
of IN O
parent-assisted JJ B-INTV
Children NNP I-INTV
's POS I-INTV
Friendship NNP I-INTV
Training NNP I-INTV
with IN O
children NNS B-POPU
having VBG I-POPU
autism NN I-POPU
spectrum NN I-POPU
disorders NNS I-POPU
. . O

This DT O
study NN O
evaluated VBD O
Children NNP B-INTV
's POS I-INTV
Friendship NNP I-INTV
Training NNP I-INTV
( ( I-INTV
CFT NNP I-INTV
) ) I-INTV
, , I-INTV
a DT I-INTV
manualized JJ I-INTV
parent-assisted JJ I-INTV
intervention NN I-INTV
to TO O
improve VB O
social JJ O
skills NNS O
among IN O
second JJ B-POPU
to TO I-POPU
fifth VB I-POPU
grade JJ I-POPU
children NNS I-POPU
with IN I-POPU
autism NN I-POPU
spectrum NN I-POPU
disorders NNS I-POPU
. . O

Comparison NNP O
was VBD O
made VBN O
with IN O
a DT O
delayed JJ B-INTV
treatment NN I-INTV
control NN I-INTV
group NN I-INTV
( ( I-INTV
DTC NNP I-INTV
) ) I-INTV
. . O

Targeted VBN O
skills NNS O
included VBD O
conversational JJ B-OC
skills NNS I-OC
, , I-OC
peer VBP I-OC
entry NN I-OC
skills NNS I-OC
, , I-OC
developing VBG I-OC
friendship JJ I-OC
networks NNS I-OC
, , I-OC
good JJ I-OC
sportsmanship NN I-OC
, , I-OC
good JJ I-OC
host NN I-OC
behavior NN I-OC
during IN I-OC
play NN I-OC
dates NNS I-OC
, , I-OC
and CC I-OC
handling VBG I-OC
teasing NN I-OC
. . O

At IN O
post-testing NN O
, , O
the DT O
CFT NNP B-POPU
group NN I-POPU
was VBD O
superior JJ O
to TO O
the DT O
DTC NNP B-POPU
group NN I-POPU
on IN O
parent NN O
measures NNS O
of IN O
social JJ B-OC
skill NN I-OC
and CC I-OC
play NN I-OC
date NN I-OC
behavior NN I-OC
, , O
and CC O
child JJ O
measures NNS O
of IN O
popularity NN B-OC
and CC I-OC
loneliness NN I-OC
, , O
At IN O
3-month JJ O
follow-up NN O
, , O
parent NN O
measures NNS O
showed VBD O
significant JJ O
improvement NN O
from IN O
baseline NN O
. . O

Post-hoc JJ O
analysis NN O
indicated VBD O
more JJR O
than IN O
87 CD O
% NN O
of IN O
children NNS O
receiving VBG O
CFT NNP B-INTV
showed VBD O
reliable JJ O
change NN O
on IN O
at IN O
least JJS O
one CD O
measure NN O
at IN O
post-test NN O
and CC O
66.7 CD O
% NN O
after IN O
3 CD O
months NNS O
follow-up RB O
. . O

-DOCSTART- -X- O O

[ JJ B-INTV
Gluten-free NNP I-INTV
diet NN I-INTV
in IN O
infantile JJ B-POPU
autism NN I-POPU
. . O

A NNP O
therapeutic JJ O
trial NN O
] NN O
. . O

It PRP O
has VBZ O
been VBN O
postulated VBN O
that IN O
there EX O
may MD O
be VB O
a DT O
connection NN O
between IN O
wheat-gluten/milk-casein NN O
and CC O
mental JJ O
disorders NNS O
such JJ O
as IN O
schizophrenia NN O
, , O
hyperactivity NN O
and CC O
autism NN O
. . O

In IN O
this DT O
study NN O
seven CD B-POPU
patients NNS I-POPU
with IN I-POPU
infantile JJ I-POPU
autism NN I-POPU
, , I-POPU
three CD I-POPU
before IN I-POPU
puberty NN I-POPU
and CC I-POPU
four CD I-POPU
after IN I-POPU
puberty NN I-POPU
, , O
were VBD O
given VBN O
a DT O
gluten-free JJ B-INTV
diet NN I-INTV
. . O

Three CD O
children NNS O
were VBD O
provoked VBN O
with IN O
gluten/placebo NN B-INTV
in IN O
a DT O
double-blind NN O
study NN O
. . O

Four CD O
young JJ O
patients NNS O
participated VBN O
in IN O
an DT O
open JJ O
study NN O
and CC O
were VBD O
given VBN O
a DT O
gluten-free JJ B-INTV
diet NN I-INTV
in IN I-INTV
six CD I-INTV
months NNS I-INTV
. . O

Behaviour NNP B-OC
was VBD O
registered VBN O
before RB O
, , O
during IN O
and CC O
after IN O
the DT O
period NN O
with IN O
a DT O
gluten-free JJ B-INTV
diet NN I-INTV
. . O

Visual NNP B-OC
Analogue NNP I-OC
Scale NNP I-OC
and CC I-OC
Real NNP I-OC
Life NNP I-OC
Rating NNP I-OC
Scale NNP I-OC
were VBD O
used VBN O
to TO O
register VB O
changes NNS O
in IN O
behaviour NN O
. . O

No DT O
connection NN O
was VBD O
observed VBN O
between IN O
gluten NNS B-OC
and CC I-OC
behaviour VB I-OC
typical JJ O
for IN O
these DT O
patients NNS O
. . O

On IN O
the DT O
contrary JJ O
, , O
the DT O
gluten-free JJ B-INTV
diet NN I-INTV
seemed VBD O
to TO O
be VB O
another DT O
negative JJ O
factor NN O
leading VBG O
to TO O
further JJ O
social JJ B-OC
isolation NN I-OC
in IN O
this DT O
group NN O
of IN O
highly RB B-POPU
socially RB I-POPU
handicapped JJ I-POPU
patients NNS I-POPU
and CC O
families NNS O
. . O

-DOCSTART- -X- O O

Randomized VBN O
controlled VBD O
caregiver RB B-POPU
mediated VBN B-INTV
joint JJ I-INTV
engagement NN I-INTV
intervention NN I-INTV
for IN O
toddlers NNS B-POPU
with IN I-POPU
autism NN I-POPU
. . O

This DT O
study NN O
aimed VBD O
to TO O
determine VB O
if IN O
a DT O
joint JJ B-INTV
attention NN I-INTV
intervention NN I-INTV
would MD O
result VB O
in IN O
greater JJR O
joint JJ O
engagement NN O
between IN O
caregivers NNS B-POPU
and CC I-POPU
toddlers NNS I-POPU
with IN I-POPU
autism NN I-POPU
. . O

The DT O
intervention NN B-INTV
consisted VBD O
of IN O
24 CD B-POPU
caregiver-mediated JJ I-POPU
sessions NNS I-POPU
with IN O
follow-up JJ O
1 CD O
year NN O
later RB O
. . O

Compared VBN O
to TO O
caregivers NNS O
and CC O
toddlers NNS O
randomized VBN O
to TO O
the DT O
waitlist NN B-INTV
control NN I-INTV
group NN I-INTV
the DT O
immediate JJ O
treatment NN O
( ( O
IT NNP O
) ) O
group NN O
made VBD O
significant JJ O
improvements NNS O
in IN O
targeted JJ O
areas NNS O
of IN O
joint JJ B-OC
engagement NN I-OC
. . O

The DT O
IT NNP O
group NN O
demonstrated VBD O
significant JJ O
improvements NNS O
with IN O
medium NN O
to TO O
large JJ O
effect NN O
sizes NNS O
in IN O
their PRP$ O
responsiveness NN B-OC
to TO I-OC
joint VB I-OC
attention NN I-OC
and CC I-OC
their PRP$ I-OC
diversity NN I-OC
of IN I-OC
functional JJ I-OC
play NN I-OC
acts NNS I-OC
after IN O
the DT O
intervention NN O
with IN O
maintenance NN O
of IN O
these DT O
skills NNS O
1 CD O
year NN O
post-intervention NN O
. . O

These DT O
are VBP O
among IN O
the DT O
first JJ O
randomized VBN O
controlled VBN O
data NNS O
to TO O
suggest VB O
that IN O
short-term JJ B-INTV
parent-mediated JJ I-INTV
interventions NNS I-INTV
can MD O
have VB O
important JJ O
effects NNS O
on IN O
core NN O
impairments NNS O
in IN O
toddlers NNS B-POPU
with IN I-POPU
autism NN I-POPU
. . O

Clinical JJ O
Trials NNS O
# # O
: : O
NCT00065910 NN O
. . O

-DOCSTART- -X- O O

Pilot NNP O
randomized VBD O
controlled VBN O
trial NN O
of IN O
Reciprocal NNP B-INTV
Imitation NNP I-INTV
Training NNP I-INTV
for IN O
teaching VBG O
elicited VBN O
and CC O
spontaneous JJ B-OC
imitation NN I-OC
to TO O
children NNS B-POPU
with IN I-POPU
autism NN I-POPU
. . O

Children NNP B-POPU
with IN I-POPU
autism NN I-POPU
exhibit NN O
significant JJ O
deficits NNS O
in IN O
imitation NN B-OC
skills NNS I-OC
. . O

Reciprocal JJ B-INTV
Imitation NNP I-INTV
Training NNP I-INTV
( ( I-INTV
RIT NNP I-INTV
) ) I-INTV
, , O
a DT O
naturalistic JJ O
imitation NN O
intervention NN O
, , O
was VBD O
developed VBN O
to TO O
teach VB O
young JJ B-POPU
children NNS I-POPU
with IN I-POPU
autism NN I-POPU
to TO O
imitate VB O
during IN O
play NN O
. . O

This DT O
study NN O
used VBD O
a DT O
randomized JJ O
controlled VBN O
trial NN O
to TO O
evaluate VB O
the DT O
efficacy NN B-OC
of IN O
RIT NNP O
on IN O
elicited VBN O
and CC O
spontaneous JJ O
imitation NN B-OC
skills NNS I-OC
in IN O
21 CD B-POPU
young JJ I-POPU
children NNS I-POPU
with IN I-POPU
autism NN I-POPU
. . O

Results NNP O
found VBD O
that IN O
children NNS O
in IN O
the DT O
treatment NN O
group NN O
made VBD O
significantly RB B-OC
more RBR I-OC
gains NNS I-OC
in IN O
elicited JJ B-OC
and CC I-OC
spontaneous JJ I-OC
imitation NN I-OC
, , O
replicating VBG O
previous JJ O
single-subject JJ O
design NN O
studies NNS O
. . O

Number NNP B-OC
of IN I-OC
spontaneous JJ I-OC
play NN I-OC
acts NNS I-OC
at IN O
pre-treatment NN O
was VBD O
related VBN O
to TO O
improvements NNS O
in IN O
imitation NN B-OC
during IN O
the DT O
intervention NN O
, , O
suggesting VBG O
that IN O
children NNS O
with IN O
a DT O
greater JJR O
play NN O
repertoire NN O
make VBP O
greater JJR O
gains NNS O
during IN O
RIT NNP O
. . O

-DOCSTART- -X- O O

Promoting VBG B-INTV
social JJ I-INTV
skill NN I-INTV
development NN I-INTV
in IN O
children NNS B-POPU
with IN I-POPU
pervasive JJ I-POPU
developmental JJ I-POPU
disorders NNS I-POPU
: : I-POPU
a DT O
feasibility NN O
and CC O
efficacy NN O
study NN O
. . O

A DT O
randomized JJ O
controlled JJ O
design NN O
was VBD O
employed VBN O
to TO O
evaluate VB O
a DT O
social JJ B-INTV
skills NNS I-INTV
intervention NN I-INTV
for IN O
children NNS B-POPU
with IN I-POPU
pervasive JJ I-POPU
developmental NN I-POPU
disorders NNS I-POPU
. . O

Aims NNP O
included VBD O
evaluating VBG O
the DT O
acceptability NN O
of IN O
the DT O
program NN O
and CC O
gathering VBG O
preliminary JJ O
evidence NN O
on IN O
efficacy NN O
. . O

Forty-four JJ B-POPU
children NNS I-POPU
, , I-POPU
ages VBZ I-POPU
8-11 CD I-POPU
years NNS I-POPU
, , I-POPU
were VBD I-POPU
randomly RB I-POPU
assigned VBN I-POPU
to TO I-POPU
treatment NN I-POPU
or CC I-POPU
wait JJ I-POPU
list NN I-POPU
. . O

Treatment NNP O
consisted VBD O
of IN O
a DT O
16-week JJ O
group NN B-INTV
intervention NN I-INTV
designed VBN I-INTV
to TO I-INTV
teach VB I-INTV
appropriate JJ I-INTV
social JJ I-INTV
behavior NN I-INTV
. . O

Between NNP O
group NN O
comparisons NNS O
showed VBD O
that IN O
children NNS O
in IN O
treatment NN O
were VBD O
rated VBN O
as IN O
improved VBN O
on IN O
the DT O
primary JJ B-OC
outcome NN I-OC
measure NN I-OC
, , I-OC
( ( I-OC
unblinded JJ I-OC
parent NN I-OC
report NN I-OC
) ) I-OC
, , O
but CC O
not RB O
on IN O
the DT O
secondary JJ O
outcome NN O
measure NN O
, , O
a DT O
parent NN B-OC
questionnaire NN I-OC
. . O

Parents NNS B-POPU
reported VBD O
a DT O
high JJ O
level NN B-OC
of IN I-OC
satisfaction NN I-OC
with IN O
the DT O
intervention NN O
. . O

The DT O
study NN O
supports VBZ O
the DT O
feasibility NN O
of IN O
this DT O
intervention NN O
to TO O
families NNS B-POPU
and CC O
highlights NNS O
challenges NNS O
for IN O
future JJ O
research NN O
in IN O
social JJ B-INTV
skills NNS I-INTV
intervention NN I-INTV
. . O

-DOCSTART- -X- O O

Digestive JJ B-INTV
enzyme NN I-INTV
supplementation NN I-INTV
for IN O
autism NN B-POPU
spectrum NN I-POPU
disorders NNS I-POPU
: : I-POPU
a DT O
double-blind JJ O
randomized NN O
controlled VBD O
trial NN O
. . O

To TO O
examine VB O
the DT O
effects NNS O
of IN O
a DT O
digestive JJ B-INTV
enzyme NN I-INTV
supplement NN I-INTV
in IN O
improving VBG O
expressive JJ B-OC
language NN I-OC
, , I-OC
behaviour NN I-OC
and CC I-OC
other JJ I-OC
symptoms NNS I-OC
in IN O
children NNS B-POPU
with IN I-POPU
Autism NNP I-POPU
Spectrum NNP I-POPU
Disorder NNP I-POPU
. . O

Randomized VBN O
, , O
double-blind JJ O
placebo-controlled JJ B-INTV
trial NN O
using VBG O
crossover NN O
design NN O
over IN O
6 CD O
months NNS O
for IN O
43 CD B-POPU
children NNS I-POPU
, , I-POPU
aged VBN I-POPU
3-8 CD I-POPU
years NNS I-POPU
. . O

Outcome NNP O
measurement NN O
tools NNS O
included VBD O
monthly JJ O
Global NNP B-OC
Behaviour NNP I-OC
Rating NNP I-OC
Scales NNP I-OC
, , I-OC
Additional NNP I-OC
Rating NNP I-OC
Scales NNP I-OC
of IN I-OC
other JJ I-OC
symptoms NNS I-OC
by IN I-OC
parents NNS I-OC
and CC I-OC
therapists NNS I-OC
, , O
and CC O
monthly JJ B-OC
completion NN I-OC
of IN I-OC
the DT I-OC
Rescorla NNP I-OC
Language NNP I-OC
Development NNP I-OC
Survey NNP I-OC
. . O

Compared VBN O
with IN O
placebo NN B-INTV
, , O
treatment NN O
with IN O
enzyme NN B-INTV
was VBD O
not RB O
associated VBN O
with IN O
clinically RB O
significant JJ B-OC
improvement NN I-OC
in IN I-OC
behaviour NN I-OC
, , I-OC
food NN I-OC
variety NN I-OC
, , I-OC
gastrointestinal JJ I-OC
symptoms NNS I-OC
, , I-OC
sleep JJ I-OC
quality NN I-OC
, , I-OC
engagement NN I-OC
with IN I-OC
therapist NN I-OC
, , I-OC
or CC I-OC
the DT I-OC
Language NNP I-OC
Development NNP I-OC
Survey NNP I-OC
Vocabulary NNP I-OC
or CC I-OC
Sentence NNP I-OC
Complexity NNP I-OC
Scores NNP I-OC
. . O

A NNP O
small JJ O
statistically RB O
significant JJ B-OC
improvement NN I-OC
on IN O
enzyme NN O
therapy NN O
was VBD O
seen VBN O
for IN O
the DT O
food NN O
variety NN O
scores NNS O
. . O

No DT O
clinically RB O
significant JJ O
effect NN O
improvement NN O
of IN O
autism NN B-OC
symptoms NNS I-OC
with IN O
enzyme NN O
use NN O
was VBD O
shown VBN O
with IN O
this DT O
trial NN O
, , O
however RB O
, , O
possible JJ O
effects NNS O
on IN O
improvement NN B-OC
in IN I-OC
food NN I-OC
variety NN I-OC
warrants NNS O
further RBR O
detailed JJ O
investigation NN O
. . O

-DOCSTART- -X- O O

RCT NNP O
of IN O
a DT O
manualized JJ O
social JJ B-INTV
treatment NN I-INTV
for IN O
high-functioning JJ B-POPU
autism NN I-POPU
spectrum NN I-POPU
disorders NNS I-POPU
. . O

This DT O
RCT NNP O
examined VBD O
the DT O
efficacy NN O
of IN O
a DT O
manualized VBN B-INTV
social JJ I-INTV
intervention NN I-INTV
for IN O
children NNS B-POPU
with IN I-POPU
HFASDs NNP I-POPU
. . O

Participants NNS O
were VBD O
randomly RB O
assigned VBN O
to TO O
treatment NN B-INTV
or CC O
wait-list JJ B-INTV
conditions NNS I-INTV
. . O

Treatment NNP B-INTV
included VBD O
instruction NN B-INTV
and CC I-INTV
therapeutic JJ I-INTV
activities NNS I-INTV
targeting VBG I-INTV
social JJ I-INTV
skills NNS I-INTV
, , I-INTV
face-emotion NN I-INTV
recognition NN I-INTV
, , I-INTV
interest NN I-INTV
expansion NN I-INTV
, , I-INTV
and CC I-INTV
interpretation NN I-INTV
of IN I-INTV
non-literal JJ I-INTV
language NN I-INTV
. . O

A DT O
response-cost JJ O
program NN O
was VBD O
applied VBN O
to TO O
reduce VB O
problem NN O
behaviors NNS O
and CC O
foster JJ O
skills NNS O
acquisition NN O
. . O

Significant NNP O
treatment NN O
effects NNS O
were VBD O
found VBN O
for IN O
five CD B-OC
of IN I-OC
seven CD I-OC
primary JJ I-OC
outcome JJ I-OC
measures NNS I-OC
( ( I-OC
parent NN I-OC
ratings NNS I-OC
and CC I-OC
direct JJ I-OC
child NN I-OC
measures NNS I-OC
) ) I-OC
. . O

Secondary JJ O
measures NNS O
based VBN O
on IN O
staff NN B-OC
ratings NNS I-OC
( ( O
treatment NN O
group NN O
only RB O
) ) O
corroborated VBD O
gains NNS O
reported VBN O
by IN O
parents NNS O
. . O

High JJ O
levels NNS O
of IN O
parent NN B-OC
, , I-OC
child NN I-OC
and CC I-OC
staff NN I-OC
satisfaction NN I-OC
were VBD O
reported VBN O
, , O
along IN O
with IN O
high JJ O
levels NNS O
of IN O
treatment NN B-OC
fidelity NN I-OC
. . O

Standardized JJ O
effect NN O
size NN O
estimates NNS O
were VBD O
primarily RB O
in IN O
the DT O
medium NN O
and CC O
large JJ O
ranges NNS O
and CC O
favored VBD O
the DT O
treatment NN O
group NN O
. . O

-DOCSTART- -X- O O

The DT O
ScanBrit NNP O
randomised VBD O
, , O
controlled VBD O
, , O
single-blind JJ O
study NN O
of IN O
a DT O
gluten- JJ B-INTV
and CC I-INTV
casein-free JJ I-INTV
dietary JJ I-INTV
intervention NN I-INTV
for IN O
children NNS B-POPU
with IN I-POPU
autism NN I-POPU
spectrum NN I-POPU
disorders NNS I-POPU
. . O

There EX O
is VBZ O
increasing VBG O
interest NN O
in IN O
the DT O
use NN O
of IN O
gluten- JJ B-INTV
and CC I-INTV
casein-free JJ I-INTV
diets NNS I-INTV
for IN O
children NNS B-POPU
with IN I-POPU
autism NN I-POPU
spectrum NN I-POPU
disorders NNS I-POPU
( ( I-POPU
ASDs NNP I-POPU
) ) I-POPU
. . O

We PRP O
report VBP O
results NNS O
from IN O
a DT O
two-stage NN O
, , O
24-month JJ O
, , O
randomised VBN O
, , O
controlled VBN O
trial NN O
incorporating VBG O
an DT O
adaptive JJ O
'catch-up NN O
' POS O
design NN O
and CC O
interim JJ O
analysis NN O
. . O

Stage NN O
1 CD O
of IN O
the DT O
trial NN O
saw VBD O
72 CD B-POPU
Danish JJ I-POPU
children NNS I-POPU
( ( I-POPU
aged VBN I-POPU
4 CD I-POPU
years NNS I-POPU
to TO I-POPU
10 CD I-POPU
years NNS I-POPU
11 CD I-POPU
months NNS I-POPU
) ) I-POPU
assigned VBD I-POPU
to TO I-POPU
diet VB I-POPU
( ( I-POPU
A DT I-POPU
) ) I-POPU
or CC I-POPU
non-diet JJ I-POPU
( ( I-POPU
B NNP I-POPU
) ) I-POPU
groups NNS I-POPU
by IN I-POPU
stratified JJ I-POPU
randomisation NN I-POPU
. . O

Autism NNP B-OC
Diagnostic NNP I-OC
Observation NNP I-OC
Schedule NNP I-OC
( ( I-OC
ADOS NNP I-OC
) ) I-OC
and CC I-OC
the DT I-OC
Gilliam NNP I-OC
Autism NNP I-OC
Rating NNP I-OC
Scale NNP I-OC
( ( I-OC
GARS NNP I-OC
) ) I-OC
were VBD I-OC
used VBN I-OC
to TO I-OC
assess VB I-OC
core NN I-OC
autism NN I-OC
behaviours NNS I-OC
, , I-OC
Vineland NNP I-OC
Adaptive NNP I-OC
Behaviour NNP I-OC
Scales NNP I-OC
( ( I-OC
VABS NNP I-OC
) ) I-OC
to TO I-OC
ascertain VB I-OC
developmental JJ I-OC
level NN I-OC
, , O
and CC O
Attention-Deficit NNP B-OC
Hyperactivity NNP I-OC
Disorder NNP I-OC
- : I-OC
IV NNP I-OC
scale NN I-OC
( ( I-OC
ADHD-IV NNP I-OC
) ) I-OC
to TO I-OC
determine VB I-OC
inattention NN I-OC
and CC I-OC
hyperactivity NN I-OC
. . O

Participants NNS O
were VBD O
tested VBN O
at IN O
baseline NN O
, , O
8 CD O
, , O
and CC O
12 CD O
months NNS O
. . O

Based VBN O
on IN O
per IN O
protocol NN O
repeated VBN O
measures NNS O
analysis NN O
, , O
data NNS O
for IN O
26 CD B-POPU
diet JJ I-POPU
children NNS I-POPU
and CC I-POPU
29 CD I-POPU
controls NNS I-POPU
were VBD O
available JJ O
at IN O
12 CD O
months NNS O
. . O

At IN O
this DT O
point NN O
, , O
there EX O
was VBD O
a DT O
significant JJ O
improvement NN O
to TO O
mean VB O
diet JJ O
group NN O
scores NNS O
( ( O
time*treatment JJ O
interaction NN O
) ) O
on IN O
sub-domains NNS O
of IN O
ADOS NNP B-OC
, , I-OC
GARS NNP I-OC
and CC I-OC
ADHD-IV NNP I-OC
measures NNS I-OC
. . O

Surpassing VBG O
of IN O
predefined JJ O
statistical JJ O
thresholds NNS O
as IN O
evidence NN O
of IN O
improvement NN O
in IN O
group NN O
A NNP O
at IN O
12 CD O
months NNS O
sanctioned VBD O
the DT O
re-assignment NN O
of IN O
group NN O
B NNP O
participants NNS O
to TO O
active JJ O
dietary JJ O
treatment NN O
. . O

Stage NN O
2 CD O
data NNS O
for IN O
18 CD O
group NN O
A NNP O
and CC O
17 CD O
group NN O
B NNP O
participants NNS O
were VBD O
available JJ O
at IN O
24 CD O
months NNS O
. . O

Multiple NNP O
scenario NN O
analysis NN O
based VBN O
on IN O
inter- JJ O
and CC O
intra-group JJ O
comparisons NNS O
showed VBD O
some DT O
evidence NN O
of IN O
sustained JJ O
clinical JJ O
group NN O
improvements NNS O
although IN O
possibly RB O
indicative JJ O
of IN O
a DT O
plateau NN O
effect NN O
for IN O
intervention NN O
. . O

Our PRP$ O
results NNS O
suggest VBP O
that IN O
dietary JJ B-INTV
intervention NN I-INTV
may MD O
positively RB O
affect VB O
developmental JJ O
outcome NN O
for IN O
some DT O
children NNS B-POPU
diagnosed VBN I-POPU
with IN I-POPU
ASD NNP I-POPU
. . O

In IN O
the DT O
absence NN O
of IN O
a DT O
placebo NN B-INTV
condition NN O
to TO O
the DT O
current JJ O
investigation NN O
, , O
we PRP O
are VBP O
, , O
however RB O
, , O
unable JJ O
to TO O
disqualify VB O
potential JJ O
effects NNS O
derived VBN O
from IN O
intervention NN O
outside IN O
of IN O
dietary JJ O
changes NNS O
. . O

Further JJ O
studies NNS O
are VBP O
required VBN O
to TO O
ascertain VB O
potential JJ O
best- NN O
and CC O
non-responders NNS O
to TO O
intervention NN O
. . O

The DT O
study NN O
was VBD O
registered VBN O
with IN O
ClincialTrials.gov NNP O
, , O
number NN O
NCT00614198 NNP O
. . O

-DOCSTART- -X- O O

Randomized VBN O
controlled JJ O
trial NN O
of IN O
the DT O
focus NN O
parent NN O
training NN O
for IN O
toddlers NNS B-POPU
with IN I-POPU
autism NN I-POPU
: : I-POPU
1-year JJ O
outcome NN O
. . O

This DT O
randomized VBD O
controlled JJ O
trial NN O
compared VBN O
results NNS O
obtained VBD O
after IN O
12 CD O
months NNS O
of IN B-INTV
nonintensive JJ I-INTV
parent NN I-INTV
training VBG I-INTV
plus CC I-INTV
care-as-usual JJ I-INTV
and CC I-INTV
care-as-usual JJ I-INTV
alone NN I-INTV
. . O

The DT B-INTV
training NN I-INTV
focused VBD I-INTV
on IN I-INTV
stimulating VBG I-INTV
joint JJ I-INTV
attention NN I-INTV
and CC I-INTV
language NN I-INTV
skills NNS I-INTV
and CC I-INTV
was VBD I-INTV
based VBN I-INTV
on IN I-INTV
the DT I-INTV
intervention NN I-INTV
described VBN I-INTV
by IN I-INTV
Drew NNP I-INTV
et CC I-INTV
al NN I-INTV
. . O

( ( O
Eur NNP O
Child NNP O
Adolesc NNP O
Psychiatr NNP O
11:266-272 CD O
, , O
2002 CD O
) ) O
. . O

Seventy-five JJ B-POPU
toddlers NNS I-POPU
with IN I-POPU
autism NN I-POPU
spectrum NN I-POPU
disorder NN I-POPU
( ( I-POPU
65 CD I-POPU
autism NN I-POPU
, , I-POPU
10 CD I-POPU
PDD-NOS NN I-POPU
, , I-POPU
mean JJ I-POPU
age NN I-POPU
= VBD I-POPU
34.4 CD I-POPU
months NNS I-POPU
, , I-POPU
SD NNP I-POPU
= NNP I-POPU
6.2 CD I-POPU
) ) I-POPU
were VBD O
enrolled VBN O
. . O

Analyses NNS O
were VBD O
conducted VBN O
on IN O
a DT O
final JJ O
sample NN B-POPU
of IN I-POPU
67 CD I-POPU
children NNS I-POPU
( ( O
lost VBN O
to TO O
follow-up JJ O
= NNP O
8 CD O
) ) O
. . O

No DT O
significant JJ O
intervention NN B-OC
effects NNS O
were VBD O
found VBN O
for IN O
any DT B-OC
of IN I-OC
the DT I-OC
primary JJ I-OC
( ( I-OC
language NN I-OC
) ) I-OC
, , I-OC
secondary JJ I-OC
( ( I-OC
global JJ I-OC
clinical JJ I-OC
improvement NN I-OC
) ) I-OC
, , I-OC
or CC I-OC
mediating NN I-OC
( ( I-OC
child JJ I-OC
engagement NN I-OC
, , I-OC
early JJ I-OC
precursors NNS I-OC
of IN I-OC
social JJ I-OC
communication NN I-OC
, , I-OC
or CC I-OC
parental JJ I-OC
skills NNS I-OC
) ) I-OC
outcome VBP I-OC
variables NNS I-OC
, , O
suggesting VBG O
that IN O
the DT O
'Focus NNP O
parent NN O
training VBG O
' '' O
was VBD O
not RB O
of IN O
additional JJ O
value NN O
to TO O
the DT O
more JJR O
general JJ O
care-as-usual JJ O
. . O

-DOCSTART- -X- O O

Response NN B-OC
to TO I-OC
familiar JJ B-INTV
faces VBZ I-INTV
, , I-INTV
newly RB I-INTV
familiar JJ I-INTV
faces VBZ I-INTV
, , O
and CC O
novel JJ B-INTV
faces VBZ I-INTV
as IN O
assessed VBN O
by IN O
ERPs NNP O
is VBZ O
intact JJ O
in IN O
adults NNS B-POPU
with IN I-POPU
autism NN I-POPU
spectrum NN I-POPU
disorders NNS I-POPU
. . O

Individuals NNS B-POPU
with IN I-POPU
autism NN I-POPU
spectrum NN I-POPU
disorders NNS I-POPU
( ( I-POPU
ASD NNP I-POPU
) ) I-POPU
have VBP O
pervasive JJ O
impairments NNS O
in IN O
social JJ O
functioning NN O
, , O
which WDT O
may MD O
include VB O
problems NNS O
with IN O
processing NN O
and CC O
remembering NN O
faces VBZ O
. . O

In IN O
this DT O
study NN O
, , O
we PRP O
examined VBD O
whether IN O
posterior JJ O
ERP NNP O
components NNS O
associated VBN O
with IN O
identity NN O
processing NN O
( ( O
P2 NNP O
, , O
N250 NNP O
and CC O
face-N400 NN O
) ) O
and CC O
components NNS O
associated VBN O
with IN O
early-stage JJ O
face NN O
processing NN O
( ( O
P1 NNP O
and CC O
N170 NNP O
) ) O
are VBP O
atypical JJ O
in IN O
ASD NNP O
. . O

We PRP O
collected VBD O
ERP NNP B-INTV
responses NNS I-INTV
to TO B-OC
a DT I-OC
familiar JJ B-INTV
repeated VBN I-INTV
face NN I-INTV
( ( I-INTV
Familiar NNP I-INTV
) ) I-INTV
, , O
an DT O
unfamiliar JJ B-INTV
repeated JJ I-INTV
face NN I-INTV
( ( I-INTV
Other JJ I-INTV
) ) I-INTV
and CC B-OC
novel JJ B-INTV
faces VBZ I-INTV
( ( I-INTV
Novels NNP I-INTV
) ) I-INTV
in IN O
29 CD B-POPU
high-functioning JJ I-POPU
adults NNS I-POPU
with IN I-POPU
ASD NNP I-POPU
and CC I-POPU
matched VBD I-POPU
controls NNS I-POPU
. . O

For IN O
both DT O
groups NNS O
, , O
the DT O
P2 NNP O
and CC O
N250 NNP O
were VBD O
sensitive JJ O
to TO O
repetition NN O
( ( O
Other JJ O
vs. FW O
Novels NNP O
) ) O
and CC O
personal JJ O
familiarity NN O
( ( O
Familiar NNP O
vs. IN O
Other JJ O
) ) O
, , O
and CC O
the DT O
face-N400 NN O
was VBD O
sensitive JJ O
to TO O
repetition NN O
. . O

Adults NNS B-POPU
with IN I-POPU
ASD NNP I-POPU
did VBD O
not RB O
show VB O
significantly RB O
atypical JJ O
processing NN B-OC
of IN I-OC
facial JJ I-OC
familiarity NN I-OC
and CC I-OC
repetition NN I-OC
in IN O
an DT O
ERP NNP O
paradigm NN O
, , O
despite IN O
showing VBG O
significantly RB O
poorer JJR O
performance NN O
than IN O
controls NNS O
on IN O
a DT O
behavioral JJ O
test NN O
of IN O
face NN B-OC
memory NN I-OC
. . O

This DT O
study NN O
found VBD O
no DT O
evidence NN O
that IN O
early-stage JJ O
facial JJ O
identity NN O
processing NN O
is VBZ O
a DT O
primary JJ O
contributor NN O
to TO O
the DT O
face NN O
recognition NN O
deficit NN O
in IN O
high-functioning JJ O
ASD NNP O
. . O

-DOCSTART- -X- O O

Efficacy NN O
of IN O
TeachTown NNP O
: : O
Basics NNS B-INTV
computer-assisted JJ I-INTV
intervention NN I-INTV
for IN O
the DT O
Intensive NNP O
Comprehensive NNP O
Autism NNP O
Program NNP O
in IN O
Los NNP O
Angeles NNP O
Unified NNP O
School NNP O
District NNP O
. . O

Computer NNP B-INTV
Assisted NNP I-INTV
Instruction NNP I-INTV
( ( I-INTV
CAI NNP I-INTV
) ) I-INTV
has VBZ O
shown VBN O
increased VBN O
popularity NN O
recently RB O
and CC O
there EX O
are VBP O
many JJ O
studies NNS O
showing VBG O
promise NN O
for IN O
this DT O
approach NN O
for IN O
children NNS B-POPU
with IN I-POPU
Autism NNP I-POPU
Spectrum NNP I-POPU
Disorders NNP I-POPU
( ( I-POPU
ASD NNP I-POPU
) ) I-POPU
. . O

However RB O
, , O
there EX O
are VBP O
no DT O
between-subject JJ O
studies NNS O
to TO O
date NN O
assessing VBG O
the DT O
efficacy NN O
of IN O
CAI NNP B-INTV
with IN O
this DT O
population NN O
. . O

In IN O
this DT O
study NN O
, , O
47 CD B-POPU
preschool NN I-POPU
and CC I-POPU
K-1 JJ I-POPU
students NNS I-POPU
in IN I-POPU
ASD NNP I-POPU
classrooms NNS I-POPU
participated VBD I-POPU
from IN I-POPU
Los NNP I-POPU
Angeles NNP I-POPU
Unified NNP I-POPU
School NNP I-POPU
District NNP I-POPU
. . O

TeachTown NN B-INTV
: : I-INTV
Basics NNS I-INTV
, , I-INTV
a DT I-INTV
CAI NNP I-INTV
program NN I-INTV
which WDT I-INTV
also RB I-INTV
includes VBZ I-INTV
supplementary JJ I-INTV
off-computer NN I-INTV
activities NNS I-INTV
, , O
was VBD O
implemented VBN O
over IN O
3 CD O
months NNS O
for IN O
approximately RB O
20 CD O
minutes NNS O
per IN O
day NN O
on IN O
the DT O
computer NN B-INTV
and CC O
20 CD B-INTV
minutes NNS I-INTV
per IN I-INTV
day NN I-INTV
in IN I-INTV
supplementary JJ I-INTV
TeachTown NN I-INTV
: : I-INTV
Basics JJ I-INTV
activities NNS I-INTV
. . O

Compared VBN O
to TO O
the DT O
students NNS O
in IN O
the DT O
control NN O
group NN O
, , O
the DT O
TeachTown NNP O
: : O
Basics NNS O
students NNS O
showed VBD O
more RBR O
improvement NN O
overall JJ B-OC
on IN I-OC
language NN I-OC
and CC I-OC
cognitive JJ I-OC
outcome NN I-OC
measures NNS I-OC
. . O

In IN O
addition NN O
, , O
students NNS O
who WP O
used VBD O
TeachTown NNP O
: : O
Basics NNS O
demonstrated VBD O
significant JJ O
progress NN B-OC
overall NN I-OC
in IN I-OC
the DT I-OC
software NN I-OC
and CC O
those DT O
students NNS O
who WP O
used VBD O
the DT O
program NN O
for IN O
more JJR O
time NN O
demonstrated VBD B-OC
larger JJR I-OC
gains NNS I-OC
within IN I-OC
the DT I-OC
software NN I-OC
and CC I-OC
in IN I-OC
outcome JJ I-OC
measures NNS I-OC
. . O

Although IN O
not RB O
conclusive JJ O
, , O
these DT O
findings NNS O
offer VBP O
possibilities NNS O
for IN O
the DT O
use NN O
of IN O
CAI NNP B-INTV
for IN O
remediating VBG O
many JJ O
deficits NNS O
for IN O
children NNS B-POPU
with IN I-POPU
ASD NNP I-POPU
and CC I-POPU
other JJ I-POPU
special JJ I-POPU
needs NNS I-POPU
. . O

In IN O
addition NN O
, , O
CAI NNP B-INTV
may MD O
offer VB O
solutions NNS O
to TO O
schools NNS O
and CC O
parents NNS O
with IN O
insufficient JJ O
funds NNS O
for IN O
more RBR O
expensive JJ O
treatments NNS O
. . O

-DOCSTART- -X- O O

Parent-mediated JJ B-INTV
communication-focused JJ I-INTV
treatment NN I-INTV
in IN O
children NNS B-POPU
with IN I-POPU
autism NN I-POPU
( ( O
PACT NNP O
) ) O
: : O
a DT O
randomised JJ O
controlled VBN O
trial NN O
. . O

BACKGROUND NNP O
Results NNP O
of IN O
small JJ O
trials NNS O
suggest VBP O
that IN O
early JJ O
interventions NNS O
for IN O
social JJ O
communication NN O
are VBP O
effective JJ O
for IN O
the DT O
treatment NN O
of IN O
autism NN B-POPU
in IN I-POPU
children NNS I-POPU
. . O

We PRP O
therefore RB O
investigated VBD O
the DT O
efficacy NN B-OC
of IN O
such JJ O
an DT O
intervention NN O
in IN O
a DT O
larger JJR O
trial NN O
. . O

METHODS NNP O
Children NNP B-POPU
with IN I-POPU
core NN I-POPU
autism NN I-POPU
( ( I-POPU
aged VBN I-POPU
2 CD I-POPU
years NNS I-POPU
to TO I-POPU
4 CD I-POPU
years NNS I-POPU
and CC I-POPU
11 CD I-POPU
months NNS I-POPU
) ) I-POPU
were VBD I-POPU
randomly RB I-POPU
assigned VBN I-POPU
in IN I-POPU
a DT I-POPU
one-to-one JJ I-POPU
ratio NN I-POPU
to TO I-POPU
a DT I-POPU
parent-mediated JJ I-POPU
communication-focused JJ I-POPU
( ( B-INTV
Preschool NNP I-INTV
Autism NNP I-INTV
Communication NNP I-INTV
Trial NNP I-INTV
[ NNP I-INTV
PACT NNP I-INTV
] NNP I-INTV
) ) I-INTV
intervention NN I-INTV
or CC O
treatment NN B-INTV
as IN I-INTV
usual JJ I-INTV
at IN O
three CD O
specialist NN O
centres NNS O
in IN O
the DT O
UK NNP O
. . O

Those DT O
assigned VBN O
to TO O
PACT NNP O
were VBD O
also RB O
given VBN O
treatment NN O
as IN O
usual JJ O
. . O

Randomisation NN O
was VBD B-POPU
by IN I-POPU
use NN I-POPU
of IN I-POPU
minimisation NN I-POPU
of IN I-POPU
probability NN I-POPU
in IN I-POPU
the DT I-POPU
marginal JJ I-POPU
distribution NN I-POPU
of IN I-POPU
treatment NN I-POPU
centre NN I-POPU
, , I-POPU
age NN I-POPU
( ( I-POPU
< JJ I-POPU
/=42 NNP I-POPU
months NNS I-POPU
or CC I-POPU
> $ I-POPU
42 CD I-POPU
months NNS I-POPU
) ) I-POPU
, , I-POPU
and CC I-POPU
autism NN I-POPU
severity NN I-POPU
( ( I-POPU
Autism NNP I-POPU
Diagnostic NNP I-POPU
Observation NNP I-POPU
Schedule-Generic NNP I-POPU
[ NNP I-POPU
ADOS-G NNP I-POPU
] NNP I-POPU
algorithm VBZ I-POPU
score RB I-POPU
12-17 JJ I-POPU
or CC I-POPU
18-24 JJ I-POPU
) ) I-POPU
. . O

Primary JJ O
outcome NN O
was VBD O
severity NN B-OC
of IN I-OC
autism NN I-OC
symptoms NNS I-OC
( ( I-OC
a DT I-OC
total NN I-OC
score NN I-OC
of IN I-OC
social JJ I-OC
communication NN I-OC
algorithm NNS I-OC
items NNS I-OC
from IN I-OC
ADOS-G NNP I-OC
, , I-OC
higher JJR I-OC
score NN I-OC
indicating VBG I-OC
greater JJR I-OC
severity NN I-OC
) ) I-OC
at IN I-OC
13 CD I-OC
months NNS I-OC
. . O

Complementary NNP O
secondary JJ O
outcomes NNS O
were VBD O
measures NNS B-OC
of IN I-OC
parent-child JJ B-POPU
interaction NN B-OC
, , I-OC
child JJ I-OC
language NN I-OC
, , I-OC
and CC I-OC
adaptive JJ I-OC
functioning NN I-OC
in IN I-OC
school NN I-OC
. . O

Analysis NN O
was VBD O
by IN O
intention NN O
to TO O
treat VB O
. . O

This DT O
study NN O
is VBZ O
registered VBN O
as IN O
an DT O
International NNP O
Standard NNP O
Randomised VBD O
Controlled NNP O
Trial NNP O
, , O
number NN O
ISRCTN58133827 NNP O
. . O

RESULTS NNP O
152 CD B-POPU
children NNS I-POPU
were VBD I-POPU
recruited VBN I-POPU
. . O

77 CD B-POPU
were VBD I-POPU
assigned VBN I-POPU
to TO I-POPU
PACT NNP I-POPU
( ( I-POPU
London NNP I-POPU
[ NNP I-POPU
n=26 MD I-POPU
] VB I-POPU
, , I-POPU
Manchester NNP I-POPU
[ NNP I-POPU
n=26 MD I-POPU
] VB I-POPU
, , I-POPU
and CC I-POPU
Newcastle NNP I-POPU
[ NNP I-POPU
n=25 FW I-POPU
] NNP I-POPU
) ) I-POPU
; : I-POPU
and CC I-POPU
75 CD I-POPU
to TO I-POPU
treatment NN I-POPU
as IN I-POPU
usual JJ I-POPU
( ( I-POPU
London NNP I-POPU
[ NNP I-POPU
n=26 MD I-POPU
] VB I-POPU
, , I-POPU
Manchester NNP I-POPU
[ NNP I-POPU
n=26 MD I-POPU
] VB I-POPU
, , I-POPU
and CC I-POPU
Newcastle NNP I-POPU
[ NNP I-POPU
n=23 FW I-POPU
] NNP I-POPU
) ) I-POPU
. . O

At IN O
the DT O
13-month JJ O
endpoint NN O
, , O
the DT O
severity NN B-OC
of IN I-OC
symptoms NNS I-OC
was VBD O
reduced VBN O
by IN O
3.9 CD O
points NNS O
( ( O
SD NNP O
4.7 CD O
) ) O
on IN O
the DT O
ADOS-G NNP O
algorithm NN O
in IN O
the DT O
group NN O
assigned VBD O
to TO O
PACT NNP O
, , O
and CC O
2.9 CD O
( ( O
3.9 CD O
) ) O
in IN O
the DT O
group NN O
assigned VBD O
to TO O
treatment NN O
as IN O
usual JJ O
, , O
representing VBG O
a DT O
between-group JJ O
effect NN O
size NN O
of IN O
-0.24 NNP O
( ( O
95 CD O
% NN O
CI NNP O
-0.59 NNP O
to TO O
0.11 CD O
) ) O
, , O
after IN O
adjustment NN O
for IN O
centre NN O
, , O
sex NN O
, , O
socioeconomic JJ O
status NN O
, , O
age NN O
, , O
and CC O
verbal JJ O
and CC O
non-verbal JJ O
abilities NNS O
. . O

Treatment NNP O
effect NN O
was VBD O
positive JJ O
for IN O
parental JJ B-OC
synchronous JJ I-OC
response NN I-OC
to TO O
child VB O
( ( O
1.22 CD O
, , O
0.85 CD O
to TO O
1.59 CD O
) ) O
, , O
child JJ O
initiations NNS O
with IN O
parent NN O
( ( O
0.41 CD O
, , O
0.08 CD O
to TO O
0.74 CD O
) ) O
, , O
and CC O
for IN O
parent-child JJ O
shared VBN O
attention NN O
( ( O
0.33 CD O
, , O
-0.02 NN O
to TO O
0.68 CD O
) ) O
. . O

Effects NNS O
on IN O
directly RB B-OC
assessed VBN I-OC
language NN I-OC
and CC I-OC
adaptive JJ I-OC
functioning NN I-OC
in IN O
school NN O
were VBD O
small JJ O
. . O

INTERPRETATION NN O
On IN O
the DT O
basis NN O
of IN O
our PRP$ O
findings NNS O
, , O
we PRP O
can MD O
not RB O
recommend VB O
the DT O
addition NN O
of IN O
the DT O
PACT NNP B-INTV
intervention NN I-INTV
to TO O
treatment NN O
as IN O
usual JJ O
for IN O
the DT O
reduction NN O
of IN O
autism NN O
symptoms NNS O
; : O
however RB O
, , O
a DT O
clear JJ O
benefit NN O
was VBD O
noted VBN O
for IN O
parent-child JJ B-OC
dyadic JJ I-OC
social JJ I-OC
communication NN I-OC
. . O

FUNDING NN O
UK NNP O
Medical NNP O
Research NNP O
Council NNP O
, , O
and CC O
UK NNP O
Department NNP O
for IN O
Children NNP O
, , O
Schools NNP O
and CC O
Families NNP O
. . O

-DOCSTART- -X- O O

Effects NNS O
of IN O
a DT O
leisure NN B-INTV
programme NN I-INTV
on IN O
quality NN B-OC
of IN I-OC
life NN I-OC
and CC I-OC
stress NN I-OC
of IN O
individuals NNS B-POPU
with IN I-POPU
ASD NNP I-POPU
. . O

BACKGROUND NNP O
Even RB O
though IN O
there EX O
is VBZ O
research NN O
demonstrating VBG O
a DT O
positive JJ O
relationship NN O
between IN O
leisure NN O
participation NN O
and CC O
the DT O
two CD O
constructs NNS O
of IN O
quality NN B-OC
of IN I-OC
life NN I-OC
and CC I-OC
stress NN I-OC
reduction NN O
, , O
current JJ O
conceptualisation NN O
of IN O
leisure NN O
as IN O
a DT O
contributor NN O
to TO O
quality NN O
of IN O
life NN O
is VBZ O
limited VBN O
. . O

In IN O
addition NN O
, , O
in IN O
spite NN O
of IN O
improvements NNS O
in IN O
accurate JJ O
diagnosis NN O
of IN O
autism NN B-POPU
spectrum NN I-POPU
disorder NN I-POPU
( ( I-POPU
ASD NNP I-POPU
) ) I-POPU
at IN O
increasingly RB O
earlier JJR O
ages NNS O
and CC O
proliferation NN O
of IN O
interventions NNS O
, , O
research NN O
associated VBN O
with IN O
leisure NN O
and CC O
quality NN O
of IN O
life NN O
for IN O
people NNS B-POPU
with IN I-POPU
ASD NNP I-POPU
is VBZ O
lacking VBG O
. . O

METHODS NNP O
Therefore NNP O
, , O
a DT O
study NN O
using VBG O
a DT O
repeated JJ O
measures NNS O
design NN O
was VBD O
used VBN O
to TO O
measure VB O
effects NNS O
of IN O
a DT O
1-year JJ B-INTV
group NN I-INTV
leisure NN I-INTV
programme NN I-INTV
intended VBN O
to TO O
facilitate VB O
interaction NN B-INTV
with IN I-INTV
media NNS I-INTV
, , I-INTV
engagement NN I-INTV
in IN I-INTV
exercise NN I-INTV
, , I-INTV
playing VBG I-INTV
games NNS I-INTV
and CC I-INTV
doing VBG I-INTV
crafts NNS I-INTV
, , I-INTV
attending VBG I-INTV
events NNS I-INTV
, , I-INTV
and CC I-INTV
participating VBG I-INTV
in IN I-INTV
other JJ I-INTV
recreation NN I-INTV
activities NNS I-INTV
on IN O
quality NN O
of IN O
life NN O
and CC O
stress NN O
of IN O
37 CD B-POPU
participants NNS I-POPU
( ( I-POPU
22 CD I-POPU
male NN I-POPU
, , I-POPU
15 CD I-POPU
female NN I-POPU
) ) I-POPU
, , I-POPU
ages VBZ I-POPU
17-39 JJ I-POPU
( ( I-POPU
M NNP I-POPU
= NNP I-POPU
31.49 CD I-POPU
) ) I-POPU
years NNS I-POPU
at IN I-POPU
the DT I-POPU
beginning NN I-POPU
of IN I-POPU
the DT I-POPU
programme NN I-POPU
) ) I-POPU
diagnosed VBD I-POPU
with IN I-POPU
an DT I-POPU
ASD NNP I-POPU
and CC I-POPU
a DT I-POPU
group NN I-POPU
of IN I-POPU
34 CD I-POPU
adults NNS I-POPU
with IN I-POPU
ASD NNP I-POPU
as IN I-POPU
control NN I-POPU
group NN I-POPU
( ( I-POPU
waiting VBG I-POPU
list NN I-POPU
) ) I-POPU
( ( I-POPU
19 CD I-POPU
male NN I-POPU
, , I-POPU
15 CD I-POPU
female NN I-POPU
) ) I-POPU
, , I-POPU
ages VBZ I-POPU
24-38 JJ I-POPU
( ( I-POPU
M NNP I-POPU
= VBZ I-POPU
30 CD I-POPU
at IN I-POPU
programme JJ I-POPU
initiation NN I-POPU
) ) I-POPU
years NNS I-POPU
. . O

RESULTS NNP O
There EX O
was VBD O
a DT O
significant JJ O
decrease NN O
in IN O
overall JJ O
scores NNS O
of IN O
stress NN B-OC
levels NNS I-OC
for IN O
participants NNS O
over IN O
the DT O
course NN O
of IN O
the DT O
study NN O
and CC O
there EX O
was VBD O
a DT O
significant JJ O
increase NN O
in IN O
the DT O
four CD O
factors NNS O
of IN O
quality NN B-OC
of IN I-OC
life NN I-OC
that WDT O
were VBD O
measured VBN O
( ( B-OC
satisfaction NN I-OC
, , I-OC
independence NN I-OC
, , I-OC
competence NN I-OC
and CC I-OC
social JJ I-OC
interaction NN I-OC
) ) I-OC
as RB O
well RB O
as IN O
the DT O
total JJ B-OC
score NN I-OC
for IN I-OC
quality NN I-OC
of IN I-OC
life NN I-OC
from IN O
baseline NN O
to TO O
the DT O
end NN O
of IN O
the DT O
intervention NN O
12 CD O
months NNS O
later RB O
. . O

In IN O
contrast NN O
, , O
the DT O
control NN O
group NN O
demonstrated VBD O
no DT O
significant JJ O
improvements NNS O
related VBN O
to TO O
stress VB B-OC
or CC I-OC
quality NN I-OC
of IN I-OC
life NN I-OC
. . O

Implications NNS O
of IN O
these DT O
findings NNS O
to TO O
leisure VB O
services NNS O
and CC O
the DT O
quality NN B-OC
of IN I-OC
life NN I-OC
of IN O
individuals NNS B-POPU
with IN I-POPU
ASD NNP I-POPU
are VBP O
discussed VBN O
. . O

CONCLUSION NNP O
Findings NNP O
support NN O
the DT O
contention NN O
that WDT O
participation NN O
in IN O
recreation NN O
activities NNS O
positively RB O
influenced VBD O
the DT O
stress NN B-OC
and CC I-OC
quality NN I-OC
of IN I-OC
life NN I-OC
of IN O
adults NNS B-POPU
with IN I-POPU
ASD NNP I-POPU
. . O

-DOCSTART- -X- O O

Effects NNS O
of IN O
cognitive JJ B-INTV
behavioral JJ I-INTV
therapy NN I-INTV
on IN O
daily JJ B-OC
living NN I-OC
skills NNS I-OC
in IN B-POPU
children NNS I-POPU
with IN I-POPU
high-functioning JJ I-POPU
autism NN I-POPU
and CC I-POPU
concurrent JJ I-POPU
anxiety NN I-POPU
disorders NNS I-POPU
. . O

CBT NNP B-INTV
is VBZ O
a DT O
promising JJ O
treatment NN O
for IN O
children NNS B-POPU
with IN I-POPU
autism NN I-POPU
spectrum NN I-POPU
disorders NNS I-POPU
( ( I-POPU
ASD NNP I-POPU
) ) I-POPU
and CC O
focuses VBZ O
, , O
in IN O
part NN O
, , O
on IN O
children NNS O
's POS O
independence NN B-OC
and CC I-OC
self-help JJ I-OC
skills NNS I-OC
. . O

In IN O
a DT O
trial NN O
of IN O
CBT NNP B-INTV
for IN O
anxiety NN O
in IN O
ASD NNP O
( ( O
Wood NNP O
et RB O
al RB O
. . O

in IN O
J NNP O
Child NNP O
Psychol NNP O
Psychiatry NNP O
50:224-234 CD O
, , O
2009 CD O
) ) O
, , O
children NNS O
's POS O
daily JJ O
living NN O
skills NNS O
and CC O
related JJ O
parental JJ B-OC
intrusiveness NN I-OC
were VBD O
assessed VBN O
. . O

Forty NNP B-POPU
children NNS I-POPU
with IN I-POPU
ASD NNP I-POPU
( ( I-POPU
7-11 CD I-POPU
years NNS I-POPU
) ) I-POPU
and CC I-POPU
their PRP$ I-POPU
primary JJ I-POPU
caregiver NN I-POPU
were VBD O
randomly RB B-INTV
assigned VBN I-INTV
to TO I-INTV
an DT I-INTV
immediate JJ I-INTV
treatment NN I-INTV
( ( I-INTV
IT NNP I-INTV
; : I-INTV
n JJ I-INTV
= NNP I-INTV
17 CD I-INTV
) ) I-INTV
or CC I-INTV
3-month JJ I-INTV
waitlist NN I-INTV
( ( I-INTV
WL NNP I-INTV
; : I-INTV
n CC I-INTV
= VB I-INTV
23 CD I-INTV
) ) I-INTV
condition NN I-INTV
. . O

In IN O
comparison NN O
to TO O
WL NNP O
, , O
IT NNP O
parents VBZ O
reported VBN O
increases NNS O
in IN O
children NNS O
's POS O
total NN B-OC
and CC I-OC
personal JJ I-OC
daily JJ I-OC
living NN I-OC
skills NNS I-OC
, , O
and CC O
reduced JJ O
involvement NN B-OC
in IN I-OC
their PRP$ I-OC
children NNS I-OC
's POS I-OC
private JJ I-OC
daily JJ I-OC
routines NNS I-OC
. . O

Reductions NNS O
correlated VBD O
with IN O
reduced JJ O
anxiety NN O
severity NN B-OC
. . O

These DT O
results NNS O
provide VBP O
preliminary JJ O
evidence NN O
that IN O
CBT NNP O
may MD O
yield VB O
increased JJ O
independence NN B-OC
and CC I-OC
daily JJ I-OC
living NN I-OC
skills NNS I-OC
among IN O
children NNS B-POPU
with IN I-POPU
ASD NNP I-POPU
. . O

-DOCSTART- -X- O O

Magnocellular JJ B-INTV
visual JJ I-INTV
evoked VBN O
potential JJ O
delay NN O
with IN O
high JJ B-POPU
autism NN I-POPU
spectrum JJ I-POPU
quotient NN I-POPU
yields NNS O
a DT O
neural JJ O
mechanism NN O
for IN O
altered JJ B-OC
perception NN I-OC
. . O

Everyone NN O
has VBZ O
autistic JJ O
characteristics NNS O
to TO O
a DT O
greater JJR O
or CC O
lesser JJR O
degree NN O
, , O
encapsulated VBN O
in IN O
the DT O
Autism NNP B-OC
Spectrum NNP I-OC
Quotient NNP I-OC
, , O
a DT O
scale NN O
that WDT O
measures VBZ O
the DT O
degree NN O
to TO O
which WDT O
an DT O
adult NN B-POPU
of IN I-POPU
normal JJ I-POPU
intelligence NN I-POPU
displays NNS O
traits NNS O
associated VBN O
with IN O
autism NN O
spectrum NN O
disorders NNS O
. . O

Recent JJ O
psychophysical JJ O
analyses NNS O
of IN O
autism NN O
spectrum NN O
disorders NNS O
point VBP O
to TO O
superior VB O
local JJ O
processing NN O
, , O
and CC O
impaired VBD O
or CC O
ignored VBN O
global JJ O
and CC O
contextual JJ O
processing NN O
. . O

The DT O
aim NN O
of IN O
this DT O
study NN O
was VBD O
to TO O
test VB O
whether IN O
low- JJ B-POPU
and CC I-POPU
high-scoring JJ I-POPU
individuals NNS I-POPU
on IN I-POPU
the DT I-POPU
Autism NNP I-POPU
Spectrum NNP I-POPU
Quotient NNP I-POPU
differ NN O
on IN O
a DT O
measure NN O
of IN O
local JJ B-INTV
and CC I-INTV
global JJ I-INTV
processing NN I-INTV
, , I-INTV
motion NN I-INTV
processing NN I-INTV
and CC I-INTV
visual JJ I-INTV
pathway NN I-INTV
integrity NN I-INTV
. . O

Fifteen NNP B-POPU
low-scoring JJ I-POPU
individuals NNS I-POPU
and CC I-POPU
14 CD I-POPU
high-scoring JJ I-POPU
individuals NNS I-POPU
derived VBN I-POPU
from IN I-POPU
a DT I-POPU
normal JJ I-POPU
population NN I-POPU
participated VBD I-POPU
in IN I-POPU
the DT I-POPU
study NN I-POPU
. . O

The DT O
results NNS O
indicate VBP O
that IN O
the DT O
initial JJ O
cortical JJ B-OC
response NN I-OC
to TO O
the DT O
magnocellular JJ O
afferents NNS O
is VBZ O
weaker JJR O
at IN O
low JJ O
contrast NN O
in IN O
the DT O
high JJ O
autistic JJ O
tendency NN O
group NN O
and CC O
that IN O
a DT O
second-order JJ O
response NN O
, , O
reflecting VBG O
magnocellular JJ O
activity NN O
, , O
demonstrated VBD O
a DT B-OC
delay NN I-OC
for IN O
high JJ O
versus NN O
low JJ O
scorers NNS O
when WRB O
the DT O
parvocellular JJ O
pathway NN O
was VBD O
also RB O
active JJ O
in IN O
response NN O
to TO O
a DT O
high JJ O
contrast NN O
stimulus NN O
. . O

High-scoring JJ O
individuals NNS O
also RB O
demonstrated VBD O
difficulty NN O
in IN O
identifying VBG B-OC
the DT I-OC
global JJ I-OC
components NNS I-OC
of IN O
locally RB O
salient JJ O
hierarchical JJ O
Navon NNP O
figures NNS O
. . O

Furthermore RB O
, , O
cross-validated JJ O
discriminant NN O
analysis NN O
, , O
using VBG O
four CD O
physiologically RB O
and CC O
three CD O
psychophysically RB O
derived JJ O
parameters NNS O
, , O
correctly RB O
classified VBD O
83 CD O
% NN O
of IN O
individuals NNS O
who WP O
scored VBD O
either CC O
high JJ O
or CC O
low JJ O
on IN O
the DT O
Autism NNP O
Spectrum NNP O
Quotient NNP O
. . O

These DT O
findings NNS O
in IN O
the DT O
group NN O
scoring VBG O
high JJ O
on IN O
the DT O
Autism NNP B-POPU
Spectrum NNP I-POPU
Quotient NNP I-POPU
indicate VBP O
that IN O
a DT O
delay NN O
in IN O
primary JJ O
visual/prestriate JJ O
cortical JJ O
processing NN O
of IN O
magnocellular JJ O
input NN O
diminishes VBZ O
the DT O
advantage NN O
of IN O
its PRP$ O
early JJ O
arrival NN O
to TO O
primary JJ O
visual JJ O
cortex NN O
. . O

This DT O
appears VBZ O
to TO O
be VB O
associated VBN O
with IN O
impaired JJ B-OC
global JJ I-OC
visual JJ I-OC
perception NN I-OC
, , O
predicting VBG O
with IN O
high JJ O
accuracy NN O
behavioural JJ B-OC
tendencies NNS I-OC
associated VBN O
with IN O
autism NN O
spectrum NN O
disorders NNS O
. . O

It PRP O
has VBZ O
been VBN O
proposed VBN O
that IN O
perceptual JJ O
impairment NN O
in IN O
autism NN O
may MD O
be VB O
attributed VBN O
to TO O
a DT O
dysfunction NN O
of IN O
horizontal JJ O
connections NNS O
within IN O
early JJ O
visual JJ O
areas NNS O
, , O
presumably RB O
parvocellular JJ O
in IN O
nature NN O
. . O

However RB O
, , O
the DT O
timing NN O
of IN O
such JJ O
form NN O
processing NN O
aberrations NNS O
is VBZ O
much RB O
later RBR O
than IN O
the DT O
timing NN O
of IN O
abnormal JJ O
magnocellular JJ O
visual JJ O
processing NN O
measured VBN O
directly RB O
here RB O
. . O

Thus VB O
it PRP O
is VBZ O
proposed VBN O
that IN O
a DT O
magnocellular JJ O
processing NN O
delay NN O
decreases VBZ O
the DT O
ability NN O
of IN O
autistic JJ B-POPU
individuals NNS I-POPU
to TO O
benefit VB O
perceptually RB O
from IN O
feedback NN O
normally RB O
associated VBN O
with IN O
the DT O
magnocellular JJ O
advantage NN O
. . O

-DOCSTART- -X- O O

Melatonin NNP B-INTV
versus NN I-INTV
placebo NN I-INTV
in IN O
children NNS B-POPU
with IN I-POPU
autism NN I-POPU
spectrum NN I-POPU
conditions NNS I-POPU
and CC I-POPU
severe JJ I-POPU
sleep NN I-POPU
problems NNS I-POPU
not RB I-POPU
amenable JJ I-POPU
to TO I-POPU
behaviour VB I-POPU
management NN I-POPU
strategies NNS I-POPU
: : I-POPU
a DT O
randomised JJ O
controlled VBN O
crossover NN O
trial NN O
. . O

Twenty-two JJ B-POPU
children NNS I-POPU
with IN I-POPU
autism NN I-POPU
spectrum NN I-POPU
disorders NNS I-POPU
who WP I-POPU
had VBD I-POPU
not RB I-POPU
responded VBN I-POPU
to TO I-POPU
supported VB I-POPU
behaviour JJ I-POPU
management NN I-POPU
strategies NNS I-POPU
for IN I-POPU
severe JJ I-POPU
dysomnias NN I-POPU
entered VBD O
a DT O
double JJ O
blind NN O
, , O
randomised VBN O
, , O
controlled VBD O
crossover RB O
trial NN O
involving VBG O
3 CD O
months NNS O
of IN O
placebo NN B-INTV
versus IN O
3 CD O
months NNS O
of IN O
melatonin NN B-INTV
to TO O
a DT O
maximum JJ O
dose NN O
of IN O
10 CD O
mg. NNS O
17 CD B-POPU
children NNS I-POPU
completed VBD I-POPU
the DT I-POPU
study NN I-POPU
. . O

There EX O
were VBD O
no DT B-OC
significant JJ I-OC
differences NNS I-OC
between IN O
sleep JJ B-OC
variables NNS I-OC
at IN O
baseline NN O
. . O

Melatonin NNP B-INTV
significantly RB O
improved VBD B-OC
sleep JJ I-OC
latency NN I-OC
( ( O
by IN O
an DT O
average NN O
of IN O
47 CD O
min NN O
) ) O
and CC O
total JJ B-OC
sleep NN I-OC
( ( O
by IN O
an DT O
average NN O
of IN O
52 CD O
min NN O
) ) O
compared VBN O
to TO O
placebo VB B-INTV
, , O
but CC O
not RB O
number NN O
of IN O
night NN O
wakenings NNS O
. . O

The DT O
side NN B-OC
effect NN I-OC
profile NN I-OC
was VBD O
low JJ B-OC
and CC I-OC
not RB I-OC
significantly RB I-OC
different JJ I-OC
between IN O
the DT O
two CD O
arms NNS O
. . O

-DOCSTART- -X- O O

Types NNS O
of IN O
parent NN B-POPU
verbal JJ B-INTV
responsiveness NN I-INTV
that WDT O
predict VBP O
language NN O
in IN O
young JJ B-POPU
children NNS I-POPU
with IN I-POPU
autism NN I-POPU
spectrum NN I-POPU
disorder NN I-POPU
. . O

PURPOSE VB O
This DT O
study NN O
examined VBD O
short-term JJ O
predictive JJ O
associations NNS O
between IN O
5 CD O
different JJ O
types NNS O
of IN O
parent NN B-POPU
verbal JJ B-INTV
responsiveness NN I-INTV
and CC O
later RB O
spoken JJ O
vocabulary NN O
for IN O
32 CD B-POPU
young JJ I-POPU
children NNS I-POPU
with IN I-POPU
a DT I-POPU
confirmed JJ I-POPU
diagnosis NN I-POPU
of IN I-POPU
autism NN I-POPU
spectrum NN I-POPU
disorder NN I-POPU
( ( I-POPU
ASD NNP I-POPU
) ) I-POPU
. . O

METHOD NNP O
Parent NNP B-INTV
verbal JJ I-INTV
utterances NNS I-INTV
were VBD O
coded VBN O
from IN O
videotapes NNS B-INTV
of IN I-INTV
naturalistic JJ I-INTV
parent-child JJ I-INTV
play NN I-INTV
sessions NNS I-INTV
using VBG O
interval JJ B-INTV
and CC O
event-based JJ B-INTV
coding NN I-INTV
. . O

A DT O
vocabulary JJ B-OC
difference NN I-OC
score NN I-OC
, , O
calculated VBD O
using VBG O
the DT O
MacArthur NNP O
Communicative NNP O
Development NNP O
Inventories NNP O
( ( O
L. NNP O
Fenson NNP O
et FW O
al. NN O
, , O
1993 CD O
) ) O
, , O
was VBD O
used VBN O
as IN O
the DT O
outcome NN O
measure NN O
of IN O
spoken JJ O
vocabulary JJ O
6 CD O
months NNS O
later RB O
. . O

RESULTS VB O
Parent JJ O
follow-in JJ O
comments NNS O
and CC O
follow-in JJ O
directives NNS O
predicted VBD O
spoken JJ O
vocabulary JJ O
after IN O
controlling VBG O
for IN O
child JJ O
engagement NN O
. . O

Parent NNP B-OC
expansions NNS I-OC
of IN I-OC
child NN I-OC
verbal JJ I-OC
utterances NNS I-OC
predicted VBD O
spoken JJ B-OC
vocabulary JJ I-OC
after IN O
controlling VBG O
for IN O
child NN O
talkativeness NN O
. . O

When WRB O
entered VBN O
together RB O
into IN O
a DT O
regression NN O
analysis NN O
, , O
metrics NNS O
that IN O
represented VBD O
( ( O
a DT O
) ) O
the DT B-OC
number NN I-OC
of IN I-OC
parent NN B-INTV
utterances NNS I-INTV
following VBG B-OC
into IN I-OC
the DT I-OC
child NN I-OC
's POS I-OC
focus NN I-OC
of IN I-OC
attention NN I-OC
and CC O
( ( O
b NN O
) ) O
the DT B-OC
number NN I-OC
of IN I-OC
parent NN B-INTV
utterances NNS I-INTV
responding VBG B-OC
to TO I-OC
child VB I-OC
verbal JJ I-OC
communication NN I-OC
acts NNS O
both DT O
accounted VBD O
for IN O
unique JJ O
variance NN O
in IN O
predicting VBG O
change NN O
in IN O
spoken JJ B-OC
vocabulary NN I-OC
from IN O
Time NNP O
1 CD O
to TO O
Time NNP O
2 CD O
. . O

CONCLUSION NNP O
Parent NNP B-INTV
verbal JJ I-INTV
utterances NNS I-INTV
that WDT O
follow VBP O
into IN O
the DT O
child NN O
's POS O
current JJ O
focus NN O
of IN O
attention NN O
or CC O
respond NN O
to TO O
child VB O
verbal JJ O
communication NN O
acts NNS O
may MD O
facilitate VB O
the DT O
process NN O
of IN O
early JJ O
vocabulary JJ O
acquisition NN O
by IN O
mitigating VBG O
the DT O
need NN O
for IN O
children NNS B-POPU
with IN I-POPU
ASD NNP I-POPU
to TO O
use VB O
attention-following JJ O
as IN O
a DT O
word-learning JJ O
strategy NN O
. . O

-DOCSTART- -X- O O

Effect NN O
of IN O
" NNP B-INTV
developmental JJ I-INTV
speech NN I-INTV
and CC I-INTV
language NN I-INTV
training NN I-INTV
through IN I-INTV
music NN I-INTV
" NN I-INTV
on IN O
speech NN B-OC
production NN I-OC
in IN O
children NNS B-POPU
with IN I-POPU
autism NN I-POPU
spectrum NN I-POPU
disorders NNS I-POPU
. . O

The DT O
study NN O
compared VBN O
the DT O
effect NN O
of IN O
music NN B-INTV
training NN I-INTV
, , I-INTV
speech NN I-INTV
training NN I-INTV
and CC O
no-training NN B-INTV
on IN O
the DT O
verbal JJ O
production NN O
of IN O
children NNS B-POPU
with IN I-POPU
Autism NNP I-POPU
Spectrum NNP I-POPU
Disorders NNP I-POPU
( ( I-POPU
ASD NNP I-POPU
) ) I-POPU
. . O

Participants NNS B-POPU
were VBD I-POPU
50 CD I-POPU
children NNS I-POPU
with IN I-POPU
ASD NNP I-POPU
, , I-POPU
age NN I-POPU
range NN I-POPU
3 CD I-POPU
to TO I-POPU
5 CD I-POPU
years NNS I-POPU
, , I-POPU
who WP I-POPU
had VBD I-POPU
previously RB I-POPU
been VBN I-POPU
evaluated VBN I-POPU
on IN I-POPU
standard JJ I-POPU
tests NNS I-POPU
of IN I-POPU
language NN I-POPU
and CC I-POPU
level NN I-POPU
of IN I-POPU
functioning VBG I-POPU
. . O

They PRP O
were VBD O
randomly RB O
assigned VBN O
to TO O
one CD O
of IN O
three CD O
3-day JJ O
conditions NNS O
. . O

Participants NNS O
in IN O
music NN B-INTV
training NN I-INTV
( ( O
n JJ O
= NNP O
18 CD O
) ) O
watched VBD O
a DT O
music NN B-INTV
video NN I-INTV
containing VBG I-INTV
6 CD I-INTV
songs NNS I-INTV
and CC I-INTV
pictures NNS I-INTV
of IN I-INTV
the DT I-INTV
36 CD I-INTV
target NN I-INTV
words NNS I-INTV
; : I-INTV
those DT O
in IN O
speech JJ B-INTV
training NN I-INTV
( ( O
n JJ O
= NNP O
18 CD O
) ) O
watched VBD O
a DT O
speech NN B-INTV
video NN I-INTV
containing VBG I-INTV
6 CD I-INTV
stories NNS I-INTV
and CC I-INTV
pictures NNS I-INTV
, , O
and CC O
those DT O
in IN O
the DT O
control NN B-INTV
condition NN I-INTV
( ( O
n JJ O
= NNP O
14 CD O
) ) O
received VBD O
no DT B-INTV
treatment NN I-INTV
. . O

Participants NNS O
' POS O
verbal JJ O
production NN O
including VBG O
semantics NNS O
, , O
phonology NN O
, , O
pragmatics NNS O
, , O
and CC O
prosody NN O
was VBD O
measured VBN O
by IN O
an DT O
experimenter NN O
designed VBN O
verbal JJ O
production NN O
evaluation NN O
scale NN O
. . O

Results NNS O
showed VBD O
that IN O
participants NNS O
in IN O
both DT O
music NN B-INTV
and CC O
speech NN B-INTV
training NN I-INTV
significantly RB O
increased VBD O
their PRP$ O
pre NN B-OC
to TO I-OC
posttest VB I-OC
verbal JJ I-OC
production NN I-OC
. . O

Results NNP O
also RB O
indicated VBD O
that IN O
both DT O
high JJ O
and CC O
low JJ O
functioning NN O
participants NNS O
improved VBD O
their PRP$ O
speech NN B-OC
production NN I-OC
after IN O
receiving VBG O
either CC O
music NN O
or CC O
speech NN O
training NN O
; : O
however RB O
, , O
low JJ O
functioning NN O
participants NNS O
showed VBD O
a DT O
greater JJR B-OC
improvement NN I-OC
after IN O
the DT O
music NN B-INTV
training NN I-INTV
than IN O
the DT O
speech NN O
training NN O
. . O

Children NNP B-POPU
with IN I-POPU
ASD NNP I-POPU
perceive JJ O
important JJ O
linguistic JJ O
information NN O
embedded VBN O
in IN O
music NN O
stimuli NNS O
organized VBN O
by IN O
principles NNS O
of IN O
pattern JJ O
perception NN O
, , O
and CC O
produce VBP O
the DT O
functional JJ O
speech NN O
. . O

-DOCSTART- -X- O O

Double-blind NNP O
, , O
placebo-controlled JJ O
trial NN O
of IN O
risperidone NN B-INTV
plus CC I-INTV
topiramate NN I-INTV
in IN O
children NNS B-POPU
with IN I-POPU
autistic JJ I-POPU
disorder NN I-POPU
. . O

BACKGROUND NNP O
Autism NNP O
is VBZ O
a DT O
complex JJ O
neurodevelopmental JJ O
disorder NN O
that WDT O
forms VBZ O
part NN O
of IN O
a DT O
spectrum NN O
of IN O
related JJ O
disorders NNS O
referred VBD O
to TO O
as IN O
Autism NNP O
Spectrum NNP O
Disorders NNP O
. . O

The DT O
present JJ O
study NN O
assessed VBD O
the DT O
effects NNS O
of IN O
topiramate NN B-INTV
plus CC I-INTV
risperidone NN I-INTV
in IN O
the DT O
treatment NN O
of IN O
autistic JJ B-POPU
disorder NN I-POPU
. . O

METHOD NNP O
Forty NNP B-POPU
children NNS I-POPU
between IN I-POPU
the DT I-POPU
ages NNS I-POPU
of IN I-POPU
4 CD I-POPU
and CC I-POPU
12 CD I-POPU
years NNS I-POPU
with IN I-POPU
a DT I-POPU
DSM NNP I-POPU
IV NNP I-POPU
clinical JJ I-POPU
diagnosis NN I-POPU
of IN I-POPU
autism NN I-POPU
who WP I-POPU
were VBD I-POPU
outpatients NNS I-POPU
from IN I-POPU
a DT I-POPU
specialty NN I-POPU
clinic NN I-POPU
for IN I-POPU
children NNS I-POPU
were VBD I-POPU
recruited VBN I-POPU
. . O

The DT O
children NNS B-POPU
presented VBN O
with IN O
a DT O
chief JJ O
complaint NN O
of IN O
severely RB B-POPU
disruptive JJ I-POPU
symptoms NNS I-POPU
related VBN I-POPU
to TO I-POPU
autistic JJ I-POPU
disorder NN I-POPU
. . O

Patients NNS O
were VBD O
randomly RB O
allocated VBN O
to TO O
topiramate+risperidone VB B-INTV
( ( I-INTV
Group NNP I-INTV
A NNP I-INTV
) ) I-INTV
or CC I-INTV
placebo+risperidone NN I-INTV
( ( I-INTV
Group NNP I-INTV
B NNP I-INTV
) ) I-INTV
for IN O
an DT O
8-week JJ O
, , O
double-blind JJ O
, , O
placebo-controlled JJ O
study NN O
. . O

The DT O
dose NN O
of IN O
risperidone NN B-INTV
was VBD O
titrated VBN O
up RB O
to TO O
2 CD O
mg/day NN O
for IN O
children NNS O
between IN O
10 CD O
and CC O
40 CD O
kg NN O
and CC O
3 CD O
mg/day NN O
for IN O
children NNS O
weighting VBG O
above IN O
40 CD O
kg NN O
. . O

The DT O
dose NN O
of IN O
topiramate NN B-INTV
was VBD O
titrated VBN O
up RB O
to TO O
200 CD O
mg/day NN O
depending VBG O
on IN O
weight NN O
( ( O
100 CD O
mg/day NN O
for IN O
< $ O
30 CD O
kg NN O
and CC O
200 CD O
mg/day NN O
for IN O
> $ O
30 CD O
kg NN O
) ) O
. . O

Patients NNS O
were VBD O
assessed VBN O
at IN O
baseline NN O
and CC O
after IN O
2 CD O
, , O
4 CD O
, , O
6 CD O
and CC O
8 CD O
weeks NNS O
after IN O
starting VBG O
medication NN O
. . O

Measure NN O
of IN O
outcome NN O
was VBD O
the DT O
Aberrant NNP B-OC
Behavior NNP I-OC
Checklist-Community NNP I-OC
( ( I-OC
ABC-C NNP I-OC
) ) I-OC
Rating VBG I-OC
Scale NNP I-OC
. . O

RESULTS NNP O
Difference NNP O
between IN O
the DT O
two CD O
protocols NNS O
was VBD O
significant JJ O
as IN O
the DT O
group NN O
that WDT O
received VBD O
topiramate NN B-INTV
had VBD O
a DT O
greater JJR O
reduction NN B-OC
in IN I-OC
ABC-C NNP I-OC
subscale NN I-OC
scores NNS I-OC
for IN I-OC
irritability NN I-OC
, , I-OC
stereotypic JJ I-OC
behavior NN I-OC
and CC I-OC
hyperactivity/noncompliance NN I-OC
. . O

CONCLUSION VB O
The DT O
results NNS O
suggest VBP O
that IN O
the DT O
combination NN O
of IN O
topiramate NN B-INTV
with IN O
risperidone NN O
may MD O
be VB O
superior JJ O
to TO O
risperidone VB O
monotherapy NN O
for IN O
children NNS B-POPU
with IN I-POPU
autistic JJ I-POPU
disorder NN I-POPU
. . O

However RB O
the DT O
results NNS O
need VBP O
to TO O
be VB O
further RB O
confirmed VBN O
by IN O
a DT O
larger JJR O
randomized VBN O
controlled VBN O
trial NN O
. . O

-DOCSTART- -X- O O

Anxiety NN O
disorders NNS O
in IN O
typically RB O
developing VBG O
youth NN O
: : O
autism NN O
spectrum NN O
symptoms NNS O
as IN O
a DT O
predictor NN O
of IN O
cognitive-behavioral JJ B-INTV
treatment NN I-INTV
. . O

Symptoms NNS O
of IN O
autism NN O
spectrum NN O
disorder NN O
( ( O
ASD NNP O
) ) O
were VBD O
assessed VBN O
( ( O
Social NNP O
Responsiveness NNP O
Scale-Parent NNP O
( ( O
SRS-P NNP O
) ) O
; : O
coded VBN O
in-session NN O
behavior NN O
) ) O
in IN O
typically-developing NN B-POPU
, , I-POPU
anxiety-disordered JJ I-POPU
children NNS I-POPU
( ( I-POPU
N NNP I-POPU
= NNP I-POPU
50 CD I-POPU
) ) I-POPU
treated VBN O
with IN B-INTV
cognitive-behavioral JJ I-INTV
therapy NN I-INTV
( ( I-INTV
CBT NNP I-INTV
) ) I-INTV
. . O

Study $ O
1 CD B-POPU
: : I-POPU
children NNS I-POPU
with IN I-POPU
moderate JJ I-POPU
autistic JJ I-POPU
symptomology NN I-POPU
( ( O
per IN O
SRS-P NNP O
) ) O
were VBD O
significantly RB O
more RBR O
likely JJ O
to TO O
improve VB O
from IN B-INTV
family NN I-INTV
CBT NNP I-INTV
( ( I-INTV
FCBT NNP I-INTV
) ) I-INTV
than IN I-INTV
individual JJ I-INTV
CBT NNP I-INTV
( ( I-INTV
ICBT NNP I-INTV
; : I-INTV
OR NNP O
= VBZ O
8.67 CD O
) ) O
. . O

Coded VBN O
behavior NN O
did VBD O
not RB O
predict JJ O
outcome NN O
. . O

Study CC B-INTV
2 CD I-INTV
: : I-INTV
CBT JJ O
components NNS O
were VBD O
compared VBN O
by IN O
treatment NN O
and CC O
ASD NNP O
symptom NN O
status NN B-OC
. . O

At-home JJ B-OC
exposure NN I-OC
completion NN I-OC
was VBD O
greater JJR B-INTV
in IN I-INTV
FCBT NNP I-INTV
and CC O
there EX O
was VBD O
an DT O
interaction NN O
in IN O
child JJ O
involvement NN O
for IN O
treatment NN O
and CC O
ASD NNP O
status NN O
. . O

Though IN O
both DT O
treatments NNS O
reduced VBD B-OC
anxiety NN B-INTV
, , I-INTV
FCBT NNP I-INTV
outperformed VBD I-INTV
ICBT NNP I-INTV
for IN O
children NNS O
with IN O
moderate JJ O
ASD NNP O
symptoms NNS O
, , O
a DT O
benefit NN O
potentially RB O
linked VBN O
to TO O
more RBR O
at-home JJ O
exposures NNS O
and CC O
greater JJR O
child NN O
involvement NN B-INTV
in IN I-INTV
FCBT NNP I-INTV
. . O

-DOCSTART- -X- O O

Promoting VBG O
imitation NN O
in IN O
young JJ B-POPU
children NNS I-POPU
with IN I-POPU
autism NN I-POPU
: : I-POPU
a DT O
comparison NN O
of IN O
reciprocal JJ B-INTV
imitation NN I-INTV
training NN I-INTV
and CC O
video NN B-INTV
modeling NN I-INTV
. . O

The DT O
inability NN O
to TO O
imitate VB O
is VBZ O
a DT O
salient JJ O
diagnostic JJ O
marker NN O
for IN O
autism NN B-POPU
. . O

It PRP O
has VBZ O
been VBN O
suggested VBN O
that IN O
for IN O
children NNS B-POPU
with IN I-POPU
autism NN I-POPU
, , O
imitation NN O
may MD O
be VB O
a DT O
prerequisite NN O
skill NN O
that WDT O
can MD O
assist VB O
in IN O
the DT O
development NN O
of IN O
various JJ O
skills NNS O
. . O

Using VBG O
a DT O
multiple JJ O
baseline NN O
design NN O
across IN O
subjects NNS O
, , O
the DT O
purpose NN O
of IN O
this DT O
research NN O
was VBD O
to TO O
determine VB O
if IN O
two CD O
interventions NNS O
, , O
reciprocal JJ B-INTV
imitation NN I-INTV
training NN I-INTV
and CC I-INTV
video NN I-INTV
modeling NN I-INTV
were VBD O
effective JJ O
in IN O
promoting VBG B-OC
imitation NN I-OC
acquisition NN I-OC
in IN O
young JJ O
children NNS O
with IN O
autism NN O
. . O

Six NNP B-POPU
boys NNS I-POPU
were VBD I-POPU
matched VBN I-POPU
across IN I-POPU
various JJ I-POPU
features NNS I-POPU
( ( I-POPU
i.e. FW I-POPU
, , O
age NN B-POPU
, , I-POPU
language NN I-POPU
, , I-POPU
autism NN I-POPU
severity NN I-POPU
) ) I-POPU
and CC O
randomly RB O
placed VBN O
in IN O
a DT O
treatment NN O
condition NN O
. . O

Results NNS O
indicated VBD O
that IN O
all DT O
six CD O
participants NNS O
increased VBD O
their PRP$ O
imitation NN B-OC
skills NNS I-OC
to TO O
varying VBG O
degrees NNS O
in IN O
both DT O
conditions NNS O
, , O
and CC O
imitation NN O
maintained VBD O
and CC O
generalized VBD O
at IN O
higher JJR O
than IN O
baseline NN O
levels NNS O
post NN O
treatment NN O
. . O

-DOCSTART- -X- O O

Randomized VBN O
controlled JJ O
trial NN O
of IN O
electro-acupuncture NN B-INTV
for IN O
autism NN B-POPU
spectrum NN I-POPU
disorder NN I-POPU
. . O

OBJECTIVE UH O
To TO O
study VB O
the DT O
efficacy NN O
, , O
safety NN O
, , O
and CC O
compliance NN O
of IN O
short-term JJ O
electro-acupuncture NN B-INTV
for IN O
children NNS B-POPU
with IN I-POPU
autism NN I-POPU
spectrum NN I-POPU
disorder NN I-POPU
( ( I-POPU
ASD NNP I-POPU
) ) I-POPU
. . O

DESIGN NNP O
Randomized NNP O
, , O
double-blind NN O
, , O
sham-controlled JJ O
, , O
clinical JJ O
trial NN O
. . O

SUBJECTS NNP O
AND NNP O
METHODS NNP O
Children NNP B-POPU
with IN I-POPU
ASD NNP I-POPU
were VBD O
randomly RB O
assigned VBN O
to TO O
an DT O
electro-acupuncture NN B-POPU
( ( I-POPU
EA NNP I-POPU
) ) I-POPU
group NN I-POPU
( ( I-POPU
n=30 JJ I-POPU
) ) I-POPU
or CC I-POPU
a DT I-POPU
sham JJ I-POPU
electro-acupuncture NN I-POPU
( ( I-POPU
SEA NNP I-POPU
) ) I-POPU
group NN I-POPU
( ( I-POPU
n=25 RB I-POPU
) ) I-POPU
matched VBN I-POPU
by IN I-POPU
age NN I-POPU
and CC I-POPU
severity NN I-POPU
of IN I-POPU
autism NN I-POPU
. . O

The DT O
EA NNP O
group NN O
received VBD O
electro-acupuncture NN O
for IN O
selected VBN O
acupoints NNS O
while IN O
the DT O
SEA NNP O
group NN O
received VBD O
sham JJ O
electro-acupuncture NN O
to TO O
sham VB O
acupoints NNS O
. . O

A DT O
total NN O
of IN O
12 CD O
EA NNP O
and CC O
SEA NNP O
sessions NNS O
over IN O
four CD O
weeks NNS O
were VBD O
given VBN O
. . O

Primary JJ B-OC
outcome NN I-OC
measures NNS I-OC
included VBD I-OC
Functional NNP I-OC
Independence NNP I-OC
Measure NN I-OC
for IN I-OC
Children NNP I-OC
( ( I-OC
WeeFIM NNP I-OC
) ) I-OC
, , I-OC
Pediatric NNP I-OC
Evaluation NNP I-OC
of IN I-OC
Disability NNP I-OC
Inventory NNP I-OC
( ( I-OC
PEDI NNP I-OC
) ) I-OC
, , I-OC
Leiter NNP I-OC
International NNP I-OC
Performance NNP I-OC
Scale-Revised JJ I-OC
( ( I-OC
Leiter-R NNP I-OC
) ) I-OC
, , O
and CC O
Clinical JJ B-OC
Global NNP I-OC
Impression-Improvement NNP I-OC
( ( I-OC
CGI-I NNP I-OC
) ) I-OC
scale NN I-OC
. . O

Secondary JJ O
outcome NN O
measures NNS O
consisted VBN O
of IN O
Aberrant NNP B-OC
Behavior NNP I-OC
Checklist NNP I-OC
( ( I-OC
ABC NNP I-OC
) ) I-OC
, , I-OC
Ritvo-Freeman JJ I-OC
Real NNP I-OC
Life NNP I-OC
Scale NNP I-OC
( ( I-OC
RFRLS NNP I-OC
) ) I-OC
, , I-OC
Reynell NNP I-OC
Developmental NNP I-OC
Language NNP I-OC
Scale NNP I-OC
( ( I-OC
RDLS NNP I-OC
) ) I-OC
, , I-OC
and CC I-OC
a DT I-OC
standardized JJ I-OC
parental JJ I-OC
report NN I-OC
. . O

Data NNP O
were VBD O
analyzed VBN O
by IN O
the DT O
Mann-Whitney NNP O
test NN O
. . O

RESULTS CC O
There EX O
were VBD O
significant JJ O
improvements NNS B-OC
in IN I-OC
the DT I-OC
language NN I-OC
comprehension NN I-OC
domain NN I-OC
of IN I-OC
WeeFIM NNP I-OC
( ( I-OC
p=0.02 NN I-OC
) ) I-OC
, , I-OC
self-care JJ I-OC
caregiver NN I-OC
assistant NN I-OC
domain NN I-OC
of IN I-OC
PEDI NNP I-OC
( ( I-OC
p=0.028 NN I-OC
) ) I-OC
, , I-OC
and CC I-OC
CGI-I NNP I-OC
( ( O
p=0.003 NN O
) ) O
in IN O
the DT O
EA NNP O
group NN O
compared VBN O
to TO O
the DT O
SEA NNP O
group NN O
. . O

As IN O
for IN O
the DT O
parental JJ O
report NN O
, , O
the DT O
EA NNP O
group NN O
also RB O
showed VBD O
significantly RB O
better RBR B-OC
social JJ I-OC
initiation NN I-OC
( ( I-OC
p=0.01 NN I-OC
) ) I-OC
, , I-OC
receptive JJ I-OC
language NN I-OC
( ( I-OC
p=0.006 NN I-OC
) ) I-OC
, , I-OC
motor NN I-OC
skills NNS I-OC
( ( I-OC
p=0.034 NN I-OC
) ) I-OC
, , I-OC
coordination NN I-OC
( ( I-OC
p=0.07 NN I-OC
) ) I-OC
, , I-OC
and CC I-OC
attention NN I-OC
span NN I-OC
( ( O
p=0.003 NN O
) ) O
. . O

More JJR O
than IN O
70 CD O
percent NN O
of IN O
children NNS B-POPU
with IN I-POPU
ASD NNP I-POPU
adapted VBD B-OC
to TO I-OC
acupuncture VB I-OC
easily RB I-OC
, , O
while IN O
eight CD O
percent NN O
had VBD O
poor JJ B-OC
acupuncture NN I-OC
compliance NN I-OC
. . O

Mild NNP B-OC
side JJ I-OC
effects NNS I-OC
of IN I-OC
minor JJ I-OC
superficial JJ I-OC
bleeding NN I-OC
or CC I-OC
irritability NN I-OC
during IN I-OC
acupuncture NN I-OC
were VBD O
observed VBN O
. . O

CONCLUSION VB O
A DT O
short JJ O
, , O
four-week JJ O
( ( O
12 CD O
sessions NNS O
) ) O
course NN O
of IN O
electro-acupuncture NN O
is VBZ O
useful JJ O
to TO O
improve VB O
specific JJ O
functions NNS O
in IN O
children NNS B-POPU
with IN I-POPU
ASD NNP I-POPU
, , O
especially RB O
for IN O
language NN O
comprehension NN O
and CC O
self-care JJ O
ability NN O
. . O

-DOCSTART- -X- O O

Line-item JJ O
analysis NN O
of IN O
the DT O
Aberrant NNP O
Behavior NNP O
Checklist NNP O
: : O
results NNS O
from IN O
two CD B-POPU
studies NNS I-POPU
of IN I-POPU
aripiprazole NN I-POPU
in IN I-POPU
the DT I-POPU
treatment NN I-POPU
of IN I-POPU
irritability NN I-POPU
associated VBN I-POPU
with IN I-POPU
autistic JJ I-POPU
disorder NN I-POPU
. . O

OBJECTIVES CC O
The DT O
aim NN O
of IN O
this DT O
study NN O
was VBD O
to TO O
evaluate VB O
the DT O
efficacy NN O
of IN O
aripiprazole NN B-INTV
in IN O
the DT O
treatment NN O
of IN O
discrete JJ O
symptoms NNS O
of IN O
irritability NN O
associated VBN O
with IN O
autistic JJ O
disorder NN O
, , O
as RB O
well RB O
as IN O
other JJ O
symptoms NNS O
captured VBN O
on IN O
the DT O
Aberrant NNP O
Behavior NNP O
Checklist NNP O
( ( O
ABC NNP O
) ) O
. . O

METHODS NNP O
This DT O
was VBD O
a DT O
post NN O
hoc NN O
analysis NN O
of IN O
data NNS O
from IN O
two CD B-POPU
8-week JJ I-POPU
, , I-POPU
randomized VBN I-POPU
, , I-POPU
double-blind JJ I-POPU
, , I-POPU
multicenter JJ I-POPU
trials NNS I-POPU
to TO O
evaluate VB O
the DT O
efficacy NN O
of IN O
aripiprazole NN B-INTV
dosed VBN I-INTV
flexibly RB I-INTV
( ( O
2-15 JJ O
mg/day NN O
, , O
n=47 NN O
) ) O
or CC O
fixed VBN O
( ( O
5 CD O
, , O
10 CD O
, , O
or CC O
15 CD O
mg/day NN O
, , O
n JJ O
= NNP O
166 CD O
) ) O
versus NN O
placebo NN B-INTV
( ( O
flexibly RB O
dosed VBN O
, , O
n JJ O
= VBP O
51 CD O
; : O
fixed VBN O
dose NN O
, , O
n JJ O
= NNP O
52 CD O
) ) O
. . O

The DT O
effects NNS O
of IN O
treatment NN O
on IN O
the DT O
58 CD O
ABC NNP O
items NNS O
were VBD O
evaluated VBN O
. . O

RESULTS NNP O
Statistically NNP O
significantly RB O
greater JJR O
improvement NN O
was VBD O
seen VBN O
with IN O
aripiprazole JJ B-INTV
versus NN I-INTV
placebo NN I-INTV
( ( O
p JJ O
< NNP O
0.05 CD O
) ) O
for IN O
all DT O
arms NNS O
in IN O
both DT O
trials NNS O
on IN O
the DT O
ABC-Irritability NNP B-OC
total JJ I-OC
subscale NN I-OC
score NN I-OC
and CC I-OC
on IN I-OC
the DT I-OC
following JJ I-OC
individual JJ I-OC
ABC-Irritability NNP I-OC
items NNS I-OC
: : I-OC
Mood NNP I-OC
changes NNS I-OC
quickly RB I-OC
, , I-OC
cries/screams NNS I-OC
inappropriately RB I-OC
, , I-OC
and CC I-OC
stamps JJ I-OC
feet/bangs NNS I-OC
objects NNS I-OC
. . O

Several JJ O
additional JJ O
items NNS O
measuring VBG O
tantrum-like JJ B-OC
behaviors NNS I-OC
improved VBN O
in IN O
the DT O
flexibly RB O
dosed VBN O
trial NN O
and CC O
at IN O
least JJS O
one CD O
arm NN O
of IN O
the DT O
fixed-dose JJ O
trial NN O
( ( O
p JJ O
< NNP O
0.05 CD O
) ) O
. . O

Measures NNS B-OC
of IN I-OC
self-injurious JJ I-OC
behavior NN I-OC
, , O
which WDT O
had VBD O
low JJ O
baseline NN O
values NNS O
, , O
demonstrated VBD O
numerical JJ O
, , O
but CC O
not RB O
statistically RB O
significant JJ O
, , O
improvement NN O
in IN O
both DT O
trials NNS O
. . O

Statistically RB O
significantly RB O
greater JJR O
improvement NN O
in IN O
ABC NNP B-OC
Stereotypic NNP I-OC
Behavior NNP I-OC
and CC I-OC
Hyperactivity NNP I-OC
total JJ I-OC
subscale NN I-OC
scores NNS I-OC
was VBD O
also RB O
consistent JJ O
across IN O
all DT O
arms NNS O
in IN O
both DT O
trials NNS O
. . O

In IN O
particular JJ O
, , O
there EX O
was VBD O
a DT O
cluster NN O
of IN O
items NNS O
related VBN O
to TO O
hyperkinesis VB B-OC
that WDT O
were VBD O
consistently RB O
sensitive JJ O
to TO O
treatment NN O
. . O

CONCLUSIONS NNP O
Aripiprazole NNP B-INTV
is VBZ O
efficacious JJ O
in IN O
the DT O
treatment NN O
of IN O
irritability NN O
in IN O
children NNS B-POPU
and CC I-POPU
adolescents NNS I-POPU
with IN I-POPU
autistic JJ I-POPU
disorder NN I-POPU
, , O
particularly RB O
with IN O
respect NN O
to TO O
symptoms NNS O
associated VBN O
with IN O
tantrum JJ O
behavior NN O
. . O

-DOCSTART- -X- O O

Theory NN O
of IN O
Mind NNP B-INTV
training NN I-INTV
in IN O
children NNS B-POPU
with IN I-POPU
autism NN I-POPU
: : I-POPU
a DT O
randomized NN O
controlled VBN O
trial NN O
. . O

Many JJ O
children NNS B-POPU
with IN I-POPU
Autism NNP I-POPU
Spectrum NNP I-POPU
Disorders NNP I-POPU
( ( I-POPU
ASD NNP I-POPU
) ) I-POPU
participate NN O
in IN O
social JJ O
skills NNS O
or CC O
Theory NN B-INTV
of IN I-INTV
Mind NNP I-INTV
( ( I-INTV
ToM NNP I-INTV
) ) I-INTV
treatments NNS I-INTV
. . O

However RB O
, , O
few JJ O
studies NNS O
have VBP O
shown VBN O
evidence NN O
for IN O
their PRP$ O
effectiveness NN O
. . O

The DT O
current JJ O
study NN O
used VBD O
a DT O
randomized JJ O
controlled JJ O
design NN O
to TO O
test VB O
the DT O
effectiveness NN B-OC
of IN O
a DT O
16-week JJ O
ToM NNP B-INTV
treatment NN I-INTV
in IN O
8-13 JJ B-POPU
year NN I-POPU
old JJ I-POPU
children NNS I-POPU
with IN I-POPU
ASD NNP I-POPU
and CC I-POPU
normal JJ I-POPU
IQs NNP I-POPU
( ( I-POPU
n JJ I-POPU
= NNP I-POPU
40 CD I-POPU
) ) I-POPU
. . O

The DT O
results NNS O
showed VBD O
that IN O
, , O
compared VBN O
to TO O
controls NNS O
, , O
the DT O
treated JJ O
children NNS O
with IN O
ASD NNP B-OC
improved VBN I-OC
in IN O
their PRP$ B-OC
conceptual JJ I-OC
ToM NNP I-OC
skills NNS I-OC
, , O
but CC O
their PRP$ B-OC
elementary JJ I-OC
understanding NN I-OC
, , I-OC
self PRP I-OC
reported VBD I-OC
empathic JJ I-OC
skills NNS I-OC
or CC I-OC
parent NN I-OC
reported VBN I-OC
social JJ I-OC
behaviour NN I-OC
did VBD O
not RB O
improve VB O
. . O

Despite IN O
the DT O
effects NNS O
on IN O
conceptual JJ O
understanding NN O
, , O
the DT O
current JJ O
study NN O
does VBZ O
not RB O
indicate VB O
strong JJ O
evidence NN O
for IN O
the DT O
effectiveness NN O
of IN O
a DT O
ToM NNP O
treatment NN O
on IN O
the DT O
daily JJ O
life NN B-OC
mindreading VBG I-OC
skills NNS O
. . O

-DOCSTART- -X- O O

Intervention NN B-INTV
targeting VBG O
development NN O
of IN O
socially RB O
synchronous JJ O
engagement NN O
in IN O
toddlers NNS B-POPU
with IN I-POPU
autism NN I-POPU
spectrum NN I-POPU
disorder NN I-POPU
: : I-POPU
a DT O
randomized NN O
controlled VBN O
trial NN O
. . O

BACKGROUND NNP O
Social NNP O
and CC O
communication NN O
impairments NNS O
are VBP O
core JJ O
deficits NNS O
and CC O
prognostic JJ O
indicators NNS O
of IN O
autism NN O
. . O

We PRP O
evaluated VBD O
the DT O
impact NN O
of IN O
supplementing VBG O
a DT O
comprehensive JJ B-INTV
intervention NN I-INTV
with IN O
a DT O
curriculum NN O
targeting VBG O
socially RB O
synchronous JJ O
behavior NN O
on IN O
social JJ O
outcomes NNS O
of IN O
toddlers NNS B-POPU
with IN I-POPU
autism NN I-POPU
spectrum NN I-POPU
disorders NNS I-POPU
( ( I-POPU
ASD NNP I-POPU
) ) I-POPU
. . O

METHODS NNP O
Fifty NNP B-POPU
toddlers NNS I-POPU
with IN I-POPU
ASD NNP I-POPU
, , I-POPU
ages VBZ I-POPU
21 CD I-POPU
to TO I-POPU
33 CD I-POPU
months NNS I-POPU
, , O
were VBD O
randomized VBN O
to TO O
one CD O
of IN O
two CD O
six-month JJ O
interventions NNS O
: : O
Interpersonal NNP B-INTV
Synchrony NNP I-INTV
or CC O
Non-Interpersonal JJ B-INTV
Synchrony NNP I-INTV
. . O

The DT O
interventions NNS O
provided VBD O
identical JJ O
intensity NN O
( ( O
10 CD O
hours NNS O
per IN O
week NN O
in IN O
classroom NN O
) ) O
, , O
student-to-teacher JJ O
ratio NN O
, , O
schedule NN O
, , O
home-based JJ O
parent NN O
training NN O
( ( O
1.5 CD O
hours NNS O
per IN O
month NN O
) ) O
, , O
parent JJ O
education NN O
( ( O
38 CD O
hours NNS O
) ) O
, , O
and CC O
instructional JJ O
strategies NNS O
, , O
except IN O
the DT O
Interpersonal NNP O
Synchrony NNP O
condition NN O
provided VBD O
a DT O
supplementary JJ O
curriculum NN O
targeting VBG O
socially RB O
engaged VBN O
imitation NN O
, , O
joint JJ O
attention NN O
, , O
and CC O
affect JJ O
sharing NN O
; : O
measures NNS O
of IN O
these DT O
were VBD O
primary JJ O
outcomes NNS O
. . O

Assessments NNS O
were VBD O
conducted VBN O
pre-intervention NN O
, , O
immediately RB O
post-intervention NN O
, , O
and CC O
, , O
to TO O
assess VB O
maintenance NN O
, , O
at IN O
six-month JJ O
follow-up NN O
. . O

Random NNP O
effects NNS O
models NNS O
were VBD O
used VBN O
to TO O
examine VB O
differences NNS O
between IN O
groups NNS O
over IN O
time NN O
. . O

Secondary JJ O
analyses NNS O
examined VBD O
gains NNS B-OC
in IN I-OC
expressive JJ I-OC
language NN I-OC
and CC I-OC
nonverbal JJ I-OC
cognition NN I-OC
, , O
and CC O
time NN B-OC
effects NNS I-OC
during IN O
the DT O
intervention NN O
and CC O
follow-up JJ O
periods NNS O
. . O

RESULTS VB O
A DT O
significant JJ O
treatment NN O
effect NN O
was VBD O
found VBN O
for IN O
socially RB O
engaged VBN O
imitation NN O
( ( O
p JJ O
= NNP O
.02 NNP O
) ) O
, , O
with IN O
more JJR O
than IN O
doubling VBG O
( ( O
17 CD O
% NN O
to TO O
42 CD O
% NN O
) ) O
of IN O
imitated JJ O
acts NNS O
paired VBN O
with IN O
eye NN O
contact NN O
in IN O
the DT O
Interpersonal NNP O
Synchrony NNP O
group NN O
after IN O
the DT O
intervention NN O
. . O

This DT O
skill NN O
was VBD O
generalized VBN O
to TO O
unfamiliar VB O
contexts NN O
and CC O
maintained VBD O
through IN O
follow-up NN O
. . O

Similar JJ O
gains NNS O
were VBD O
observed VBN O
for IN O
initiation NN O
of IN O
joint JJ B-OC
attention NN I-OC
and CC O
shared VBD O
positive JJ O
affect NN O
, , O
but CC O
between-group JJ O
differences NNS O
did VBD O
not RB O
reach VB O
statistical JJ O
significance NN O
. . O

A DT O
significant JJ O
time NN O
effect NN O
was VBD O
found VBN O
for IN O
all DT O
outcomes NNS O
( ( O
p JJ O
< NNP O
.001 NNP O
) ) O
; : O
greatest JJS O
change NN O
occurred VBD O
during IN O
the DT O
intervention NN O
period NN O
, , O
particularly RB O
in IN O
the DT O
Interpersonal NNP O
Synchrony NNP O
group NN O
. . O

CONCLUSIONS NNP O
This DT O
is VBZ O
the DT O
first JJ O
ASD NNP O
randomized VBN O
trial NN O
involving VBG O
toddlers NNS B-POPU
to TO O
identify VB O
an DT O
active JJ O
ingredient NN O
for IN O
enhancing VBG O
socially RB O
engaged VBN O
imitation NN O
. . O

Adding VBG O
social JJ O
engagement JJ O
targets NNS O
to TO O
intervention VB O
improves NNS O
short-term JJ O
outcome NN O
at IN O
no DT O
additional JJ O
cost NN O
to TO O
the DT O
intervention NN O
. . O

The DT O
social JJ O
, , O
language NN O
, , O
and CC O
cognitive JJ O
gains NNS O
in IN O
our PRP$ O
participants NNS O
provide VBP O
evidence NN O
for IN O
plasticity NN O
of IN O
these DT O
developmental JJ O
systems NNS O
in IN O
toddlers NNS B-POPU
with IN I-POPU
ASD NNP I-POPU
. . O

http NN O
: : O
//www.clinicaltrials.gov/ct2/show/NCT00106210 NN O
? . O
term NN O
= NNP O
landa NN O
& CC O
rank NN O
= NN O
3 CD O
. . O

-DOCSTART- -X- O O

Avatar NNP O
assistant NN O
: : O
improving VBG O
social JJ B-OC
skills NNS I-OC
in IN O
students NNS B-POPU
with IN I-POPU
an DT I-POPU
ASD NNP I-POPU
through IN O
a DT O
computer-based JJ B-INTV
intervention NN I-INTV
. . O

This DT O
study NN O
assessed VBD O
the DT O
efficacy NN B-OC
of IN O
FaceSay NNP B-INTV
, , I-INTV
a DT I-INTV
computer-based JJ I-INTV
social JJ I-INTV
skills NNS I-INTV
training VBG I-INTV
program NN I-INTV
for IN O
children NNS B-POPU
with IN I-POPU
Autism NNP I-POPU
Spectrum NNP I-POPU
Disorders NNP I-POPU
( ( I-POPU
ASD NNP I-POPU
) ) I-POPU
. . O

This DT O
randomized VBD O
controlled VBN O
study NN B-POPU
( ( I-POPU
N NNP I-POPU
= NNP I-POPU
49 CD I-POPU
) ) I-POPU
indicates VBZ O
that IN O
providing VBG B-POPU
children NNS I-POPU
with IN I-POPU
low-functioning JJ I-POPU
autism NN I-POPU
( ( I-POPU
LFA NNP I-POPU
) ) I-POPU
and CC I-POPU
high JJ I-POPU
functioning NN I-POPU
autism NN I-POPU
( ( I-POPU
HFA NNP I-POPU
) ) I-POPU
opportunities VBZ O
to TO O
practice NN O
attending VBG O
to TO O
eye NN O
gaze NN O
, , O
discriminating VBG O
facial JJ O
expressions NNS O
and CC O
recognizing VBG O
faces VBZ O
and CC O
emotions NNS O
in IN O
FaceSay NNP O
's POS O
structured JJ O
environment NN O
with IN O
interactive JJ O
, , O
realistic JJ O
avatar NN O
assistants NNS O
improved VBD O
their PRP$ B-OC
social JJ I-OC
skills NNS I-OC
abilities NNS I-OC
. . O

The DT O
children NNS O
with IN O
LFA NNP O
demonstrated VBD O
improvements NNS O
in IN O
two CD O
areas NNS O
of IN O
the DT O
intervention NN B-OC
: : I-OC
emotion NN I-OC
recognition NN I-OC
and CC I-OC
social JJ I-OC
interactions NNS I-OC
. . O

The DT O
children NNS O
with IN O
HFA NNP O
demonstrated VBD O
improvements NNS O
in IN O
all DT O
three CD O
areas NNS B-OC
: : I-OC
facial JJ I-OC
recognition NN I-OC
, , I-OC
emotion NN I-OC
recognition NN I-OC
, , I-OC
and CC I-OC
social JJ I-OC
interactions NNS I-OC
. . O

These DT O
findings NNS O
, , O
particularly RB O
the DT O
measured JJ O
improvements NNS O
to TO B-OC
social JJ I-OC
interactions NNS I-OC
in IN O
a DT O
natural JJ O
environment NN O
, , O
are VBP O
encouraging VBG O
. . O

-DOCSTART- -X- O O

Effectiveness NN O
of IN O
sensory JJ B-INTV
integration NN I-INTV
interventions NNS I-INTV
in IN O
children NNS B-POPU
with IN I-POPU
autism NN I-POPU
spectrum NN I-POPU
disorders NNS I-POPU
: : I-POPU
a DT O
pilot NN O
study NN O
. . O

The DT O
purpose NN O
of IN O
this DT O
pilot NN O
study NN O
was VBD O
to TO O
establish VB O
a DT O
model NN O
for IN O
randomized VBN O
controlled JJ O
trial NN O
research NN O
, , O
identify VB O
appropriate JJ O
outcome NN O
measures NNS O
, , O
and CC O
address VB O
the DT O
effectiveness NN O
of IN O
sensory JJ B-INTV
integration NN I-INTV
( ( I-INTV
SI NNP I-INTV
) ) I-INTV
interventions NNS O
in IN O
children NNS B-POPU
with IN I-POPU
autism NN I-POPU
spectrum NN I-POPU
disorders NNS I-POPU
( ( I-POPU
ASD NNP I-POPU
) ) I-POPU
. . O

Children NNP B-POPU
ages VBZ I-POPU
6-12 NN I-POPU
with IN I-POPU
ASD NNP I-POPU
were VBD O
randomly RB O
assigned VBN O
to TO O
a DT O
fine JJ B-INTV
motor NN I-INTV
or CC O
SI NNP B-INTV
treatment NN I-INTV
group NN O
. . O

Pretests NNS O
and CC O
posttests NNS O
measured VBD O
social JJ B-OC
responsiveness NN I-OC
, , I-OC
sensory JJ I-OC
processing NN I-OC
, , I-OC
functional JJ I-OC
motor NN I-OC
skills NNS I-OC
, , I-OC
and CC I-OC
social-emotional JJ I-OC
factors NNS I-OC
. . O

Results NNS O
identified VBD O
significant JJ O
positive JJ O
changes NNS O
in IN O
Goal NNP B-OC
Attainment NNP I-OC
Scaling NNP I-OC
scores NNS I-OC
for IN O
both DT O
groups NNS O
; : O
more RBR O
significant JJ O
changes NNS O
occurred VBD O
in IN O
the DT O
SI NNP O
group NN O
, , O
and CC O
a DT O
significant JJ O
decrease NN O
in IN O
autistic JJ B-OC
mannerisms NNS I-OC
occurred VBD O
in IN O
the DT O
SI NNP O
group NN O
. . O

No DT O
other JJ O
results NNS O
were VBD O
significant JJ O
. . O

The DT O
study NN O
discusses VBZ O
considerations NNS O
for IN O
designing VBG O
future JJ O
outcome NN O
studies NNS O
for IN O
children NNS B-POPU
with IN I-POPU
ASD NNP I-POPU
. . O

-DOCSTART- -X- O O

Safety NN O
and CC O
efficacy NN O
of IN O
donepezil NN B-INTV
in IN O
children NNS B-POPU
and CC I-POPU
adolescents NNS I-POPU
with IN I-POPU
autism NN I-POPU
: : I-POPU
neuropsychological JJ O
measures NNS O
. . O

OBJECTIVE NNP O
There EX O
has VBZ O
been VBN O
recent JJ O
interest NN O
in IN O
the DT O
use NN O
of IN O
cognitive JJ B-INTV
enhancing VBG I-INTV
drugs NNS I-INTV
, , O
such JJ O
as IN O
cholinesterase NN B-INTV
inhibitors NNS I-INTV
, , O
as IN O
a DT O
possible JJ O
treatment NN O
for IN O
executive NN B-OC
functioning NN I-OC
( ( O
EF NNP O
) ) O
deficits NNS O
in IN O
autism NN B-POPU
spectrum NN I-POPU
disorder NN I-POPU
( ( I-POPU
ASD NNP I-POPU
) ) I-POPU
. . O

The DT O
goal NN O
of IN O
this DT O
study NN O
was VBD O
to TO O
assess VB O
the DT O
tolerability NN B-OC
, , I-OC
safety NN I-OC
, , I-OC
and CC I-OC
efficacy NN I-OC
of IN O
donepezil NN O
on IN O
EF NNP O
in IN O
a DT O
sample NN B-POPU
of IN I-POPU
children NNS I-POPU
and CC I-POPU
adolescents NNS I-POPU
with IN I-POPU
ASD NNP I-POPU
. . O

METHOD NNP O
Thirty-four JJ B-POPU
children NNS I-POPU
and CC I-POPU
adolescents NNS I-POPU
with IN I-POPU
ASD NNP I-POPU
( ( I-POPU
age NN I-POPU
range NN I-POPU
8-17 CD I-POPU
years NNS I-POPU
; : I-POPU
IQ NNP I-POPU
> NNP I-POPU
75 CD I-POPU
) ) I-POPU
were VBD I-POPU
enrolled VBN I-POPU
in IN O
a DT O
10-week JJ O
, , O
double-blind JJ O
, , O
placebo-controlled JJ B-INTV
trial NN O
of IN O
donepezil NN B-INTV
( ( I-INTV
doses NNS I-INTV
of IN I-INTV
5 CD I-INTV
and CC I-INTV
10 CD I-INTV
mg NN I-INTV
) ) I-INTV
, , I-INTV
followed VBN I-INTV
by IN I-INTV
a DT I-INTV
10-week JJ I-INTV
open JJ I-INTV
label NN I-INTV
trial NN I-INTV
for IN I-INTV
placebo NN I-INTV
nonresponders NNS I-INTV
. . O

RESULTS VB O
The DT O
effect NN O
of IN B-INTV
donepezil NN I-INTV
treatment NN O
on IN O
EF NNP O
was VBD O
examined VBN O
. . O

Despite IN O
improvement NN O
on IN O
a DT O
number NN O
of IN B-OC
EF NNP I-OC
measures NNS I-OC
, , O
no DT O
statistically RB O
significant JJ O
between-group JJ O
differences NNS O
were VBD O
found VBN O
( ( O
with IN O
gains NNS O
observed VBN O
for IN O
both DT O
the DT O
placebo NN O
and CC O
donepezil NN O
groups NNS O
) ) O
. . O

CONCLUSIONS VB O
The DT O
results NNS O
suggest VBP O
that IN O
short-term JJ O
treatment NN O
with IN O
donepezil NN O
may MD O
have VB O
limited VBN O
impact NN O
on IN O
cognitive JJ O
functioning NN O
in IN O
ASD NNP O
. . O

Future NNP O
controlled VBD O
trials NNS O
may MD O
need VB O
to TO O
consider VB O
a DT O
longer RBR O
treatment NN O
period NN O
to TO O
detect VB O
significant JJ O
gains NNS O
on IN O
EF NNP O
measures NNS O
. . O

-DOCSTART- -X- O O

A DT O
randomized VBN O
controlled JJ O
trial NN O
of IN O
Hanen NNP B-INTV
's POS I-INTV
'More JJR I-INTV
Than NNP I-INTV
Words NNP I-INTV
' POS I-INTV
in IN O
toddlers NNS B-POPU
with IN I-POPU
early JJ I-POPU
autism NN I-POPU
symptoms NNS I-POPU
. . O

BACKGROUND NNP O
This DT O
randomized VBD O
controlled JJ O
trial NN O
compared VBN O
Hanen NNP B-INTV
's POS I-INTV
'More JJR I-INTV
than IN I-INTV
Words NNS I-INTV
' POS I-INTV
( ( I-INTV
HMTW NNP I-INTV
) ) I-INTV
, , I-INTV
a DT I-INTV
parent-implemented JJ I-INTV
intervention NN I-INTV
, , O
to TO O
a DT O
'business NN B-INTV
as IN I-INTV
usual JJ I-INTV
' POS I-INTV
control NN I-INTV
group NN O
. . O

METHODS NNP O
Sixty-two JJ B-POPU
children NNS I-POPU
( ( I-POPU
51 CD I-POPU
boys NNS I-POPU
and CC I-POPU
11 CD I-POPU
girls NNS I-POPU
; : I-POPU
M NNP I-POPU
age NN I-POPU
= VBD I-POPU
20 CD I-POPU
months NNS I-POPU
; : I-POPU
SD NNP I-POPU
= NNP I-POPU
2.6 CD I-POPU
) ) I-POPU
who WP I-POPU
met VBD I-POPU
criteria NNS I-POPU
for IN I-POPU
autism NN I-POPU
spectrum NN I-POPU
disorders NNS I-POPU
( ( I-POPU
ASD NNP I-POPU
) ) I-POPU
and CC I-POPU
their PRP$ I-POPU
parents NNS I-POPU
participated VBN I-POPU
in IN I-POPU
the DT I-POPU
study NN I-POPU
. . O

The DT O
HMTW NNP B-INTV
intervention NN I-INTV
was VBD O
provided VBN O
over IN O
3.5 CD O
months NNS O
. . O

There EX O
were VBD O
three CD O
measurement NN O
periods NNS O
: : O
prior RB B-INTV
to TO I-INTV
randomization NN I-INTV
( ( I-INTV
Time NNP I-INTV
1 CD I-INTV
) ) I-INTV
and CC I-INTV
at IN I-INTV
5 CD I-INTV
and CC I-INTV
9 CD I-INTV
months NNS I-INTV
post VBN I-INTV
enrollment NN I-INTV
( ( I-INTV
Times NNP I-INTV
2 CD I-INTV
and CC I-INTV
3 CD I-INTV
) ) I-INTV
. . O

Children NNP B-INTV
's POS I-INTV
communication NN I-INTV
and CC I-INTV
parental JJ I-INTV
responsivity NN I-INTV
were VBD I-INTV
measured VBN I-INTV
at IN I-INTV
each DT I-INTV
time NN I-INTV
point NN I-INTV
. . O

Children NNP B-INTV
's POS I-INTV
object JJ I-INTV
interest NN I-INTV
, , I-INTV
a DT I-INTV
putative JJ I-INTV
moderator NN I-INTV
, , I-INTV
was VBD I-INTV
measured VBN I-INTV
at IN I-INTV
Time NNP I-INTV
1 CD I-INTV
. . O

RESULTS VB O
There EX O
were VBD O
no DT O
main JJ O
effects NNS O
of IN O
the DT O
HMTW NNP B-INTV
intervention NN O
on IN O
either DT O
parental JJ B-OC
responsivity NN I-OC
or CC O
children NNS B-OC
's POS I-OC
communication NN I-OC
. . O

However RB O
, , O
the DT O
effects NNS O
on IN O
residualized JJ O
gains NNS O
in IN O
parental JJ B-OC
responsivity NN I-OC
from IN O
Time NNP O
1 CD O
to TO O
both DT O
Times NNP O
2 CD O
and CC O
3 CD O
yielded VBN O
noteworthy JJ O
effect NN O
sizes NNS O
( ( O
Glass NNP O
's POS O
 NNP O
= NNP O
.71 NNP O
, , O
.50 NNP O
respectively RB O
) ) O
. . O

In IN O
contrast NN O
, , O
there EX O
were VBD O
treatment NN O
effects NNS O
on IN B-OC
child JJ I-OC
communication NN I-OC
gains NNS O
to TO O
Time VB O
3 CD O
that WDT O
were VBD O
moderated VBN O
by IN O
children NNS O
's POS O
Time NNP O
1 CD O
object JJ O
interest NN O
. . O

Children NNP O
with IN O
lower JJR O
levels NNS O
of IN O
Time NNP O
1 CD B-OC
object JJ I-OC
interest NN I-OC
exhibited VBN O
facilitated JJ O
growth NN O
in IN B-OC
communication NN I-OC
; : I-OC
children NNS O
with IN O
higher JJR O
levels NNS O
of IN B-OC
object JJ I-OC
interest NN I-OC
exhibited VBD I-OC
growth NN I-OC
attenuation NN I-OC
. . O

CONCLUSIONS VB O
The DT B-INTV
HMTW NNP I-INTV
intervention NN O
showed VBD O
differential JJ O
effects NNS O
on IN B-OC
child NN I-OC
communication NN I-OC
depending VBG O
on IN O
a DT O
baseline NN O
child NN O
factor NN O
. . O

HMTW NNP B-INTV
facilitated VBD B-OC
communication NN I-OC
in IN O
children NNS O
with IN O
lower JJR O
levels NNS O
of IN O
Time NNP O
1 CD O
object JJ O
interest NN O
. . O

Parents NNS B-POPU
of IN I-POPU
children NNS I-POPU
who WP I-POPU
evidence NN I-POPU
higher JJR I-POPU
object JJ I-POPU
interest NN I-POPU
may MD O
require VB O
greater JJR O
support NN O
to TO O
implement VB O
the DT B-INTV
HMTW NNP I-INTV
strategies NNS O
, , O
or CC O
may MD O
require VB O
different JJ O
strategies NNS O
than IN O
those DT O
provided VBN O
by IN O
the DT B-INTV
HMTW NNP I-INTV
curriculum NN O
. . O

-DOCSTART- -X- O O

Improving VBG O
emotion NN B-OC
regulation NN I-OC
with IN O
CBT NNP B-INTV
in IN O
young JJ B-POPU
children NNS I-POPU
with IN I-POPU
high JJ I-POPU
functioning VBG I-POPU
autism NN I-POPU
spectrum NN I-POPU
disorders NNS I-POPU
: : I-POPU
a DT O
pilot NN O
study NN O
. . O

BACKGROUND NNP O
AND CC O
AIMS NNP O
This DT O
pilot NN O
study NN O
tested VBD O
the DT O
efficacy NN O
of IN O
a DT O
developmentally RB O
modified VBN O
CBT NNP B-INTV
for IN O
young JJ B-POPU
children NNS I-POPU
with IN I-POPU
Autism NNP I-POPU
Spectrum NNP I-POPU
Disorders NNP I-POPU
( ( I-POPU
ASD NNP I-POPU
) ) I-POPU
to TO O
teach VB O
emotion NN B-OC
regulation NN I-OC
strategies NNS O
for IN O
reducing VBG O
anger NN B-OC
and CC I-OC
anxiety NN I-OC
, , O
commonly RB O
noted VBD O
problems NNS O
in IN O
this DT O
population NN O
. . O

METHOD NNP O
Eleven NNP B-POPU
5-7 JJ I-POPU
year-old JJ I-POPU
children NNS I-POPU
participated VBN I-POPU
in IN O
a DT O
CBT-group NNP B-INTV
while IN O
parents NNS O
participated VBN B-INTV
in IN I-INTV
psychoeducation NN I-INTV
. . O

Children NNP B-INTV
were VBD I-INTV
randomly RB I-INTV
assigned VBN I-INTV
to TO I-INTV
an DT I-INTV
experimental JJ I-INTV
or CC I-INTV
delayed-treatment JJ I-INTV
control NN I-INTV
group NN I-INTV
. . O

RESULTS CC O
From IN O
pre- JJ O
to TO O
post-treatment JJ O
, , O
all DT O
children NNS O
had VBD O
less RBR O
parent NN B-POPU
reported VBD I-POPU
negativity/lability NN I-POPU
, , O
better JJR O
parent NN O
reported VBD O
emotion NN B-OC
regulation NN I-OC
, , I-OC
and CC I-OC
shorter JJR I-OC
outbursts NNS I-OC
, , O
and CC O
also RB O
generated VBD B-OC
more RBR I-OC
coping JJ I-OC
strategies NNS I-OC
in IN O
response NN O
to TO O
vignettes NNS O
. . O

Parents NNS O
also RB O
reported VBD O
increases NNS O
in IN O
their PRP$ O
own JJ O
confidence NN B-OC
and CC O
their PRP$ O
child NN O
's POS O
ability NN B-OC
to TO I-OC
deal VB I-OC
with IN I-OC
anger NN I-OC
and CC I-OC
anxiety NN I-OC
. . O

CONCLUSIONS VB O
This DT O
study NN O
suggests VBZ O
that IN O
young JJ B-POPU
children NNS I-POPU
with IN I-POPU
high JJ I-POPU
functioning VBG I-POPU
ASD NNP I-POPU
may MD O
benefit VB O
from IN O
CBT NNP B-INTV
to TO O
improve VB O
regulation NN B-OC
of IN I-OC
anger NN I-OC
and CC I-OC
anxiety NN I-OC
, , O
and CC O
parent NN O
training NN O
may MD O
improve VB O
parental JJ B-OC
self-efficacy NN I-OC
. . O

Future JJ O
studies NNS O
are VBP O
needed VBN O
to TO O
make VB O
conclusions NNS O
about IN O
its PRP$ O
efficacy NN O
. . O

-DOCSTART- -X- O O

The DT O
effects NNS O
of IN O
face NN B-INTV
expertise NN I-INTV
training NN I-INTV
on IN O
the DT B-OC
behavioral JJ I-OC
performance NN I-OC
and CC O
brain NN B-OC
activity NN I-OC
of IN O
adults NNS B-POPU
with IN I-POPU
high JJ I-POPU
functioning VBG I-POPU
autism NN I-POPU
spectrum NN I-POPU
disorders NNS I-POPU
. . O

The DT O
effect NN O
of IN O
expertise NN B-INTV
training NN I-INTV
with IN I-INTV
faces VBZ I-INTV
was VBD O
studied VBN O
in IN O
adults NNS B-POPU
with IN I-POPU
ASD NNP I-POPU
who WP I-POPU
showed VBD I-POPU
initial JJ I-POPU
impairment NN I-POPU
in IN I-POPU
face NN I-POPU
recognition NN I-POPU
. . O

Participants NNS O
were VBD O
randomly RB O
assigned VBN O
to TO O
a DT O
computerized JJ B-INTV
training NN I-INTV
program NN I-INTV
involving VBG I-INTV
either CC I-INTV
faces VBZ I-INTV
or CC I-INTV
houses NNS I-INTV
. . O

Pre- JJ O
and CC O
post-testing NN O
included VBD O
standardized JJ O
and CC O
experimental JJ O
measures NNS O
of IN O
behavior NN B-OC
and CC I-OC
event-related JJ I-OC
brain NN I-OC
potentials NNS I-OC
( ( I-OC
ERPs NNP I-OC
) ) I-OC
, , O
as RB O
well RB O
as IN O
interviews NNS B-OC
after IN O
training NN O
. . O

After IN O
training NN O
, , O
all DT O
participants NNS O
met VBD O
behavioral JJ B-OC
criteria NNS I-OC
for IN O
expertise NN O
with IN O
the DT O
specific JJ O
stimuli NN O
on IN O
which WDT O
they PRP O
received VBD O
training NN O
. . O

Scores NNS B-OC
on IN I-OC
standardized JJ I-OC
measures NNS I-OC
improved VBN O
after IN O
training VBG O
for IN O
both DT O
groups NNS O
, , O
but CC O
only RB O
the DT O
face NN O
training NN O
group NN O
showed VBD O
an DT O
increased JJ O
face NN B-OC
inversion NN I-OC
effect NN I-OC
behaviorally RB I-OC
and CC I-OC
electrophysiological JJ I-OC
changes NNS I-OC
to TO I-OC
faces VBZ I-OC
in IN O
the DT O
P100 NNP O
component NN O
. . O

These DT O
findings NNS O
suggest VBP O
that IN O
individuals NNS B-POPU
with IN I-POPU
ASD NNP I-POPU
can MD O
gain VB O
expertise NN O
in IN O
face NN B-OC
processing NN I-OC
through IN O
training NN B-INTV
. . O

-DOCSTART- -X- O O

Effect NN O
of IN O
propranolol NN B-INTV
on IN O
word NN O
fluency NN O
in IN O
autism NN B-POPU
. . O

OBJECTIVE NNP O
AND CC O
BACKGROUND NNP O
Autism NNP O
is VBZ O
characterized VBN O
by IN O
repetitive JJ O
behaviors NNS O
and CC O
impaired JJ O
socialization NN O
and CC O
communication NN O
. . O

Preliminary JJ O
evidence NN O
showed VBD O
possible JJ O
language NN O
benefits NNS O
in IN O
autism NN O
from IN O
the DT O
-adrenergic JJ B-INTV
antagonist NN I-INTV
propranolol NN I-INTV
. . O

Earlier JJR O
studies NNS O
in IN O
other JJ O
populations NNS O
suggested VBD B-INTV
propranolol NN I-INTV
might MD O
benefit VB O
performance NN O
on IN O
tasks NNS O
involving VBG O
a DT O
search NN O
of IN O
semantic JJ O
and CC O
associative JJ O
networks NNS O
under IN O
certain JJ O
conditions NNS O
. . O

Therefore RB O
, , O
we PRP O
wished VBD O
to TO O
determine VB O
whether IN O
this DT O
benefit NN O
of IN B-INTV
propranolol NN I-INTV
includes VBZ O
an DT O
effect NN O
on IN O
semantic JJ O
fluency NN O
in IN O
autism NN O
. . O

METHODS NNP B-POPU
A NNP I-POPU
sample NN I-POPU
of IN I-POPU
14 CD I-POPU
high-functioning JJ I-POPU
adolescent NN I-POPU
and CC I-POPU
adult NN I-POPU
participants NNS I-POPU
with IN I-POPU
autism NN I-POPU
and CC I-POPU
14 CD I-POPU
matched VBN I-POPU
controls NNS I-POPU
were VBD O
given VBN O
letter NN O
and CC O
category NN O
word NN O
fluency NN O
tasks NNS O
on IN O
2 CD O
separate JJ O
testing NN O
sessions NNS O
; : O
1 CD O
test NN O
was VBD O
given VBN O
60 CD O
minutes NNS O
after IN O
the DT O
administration NN O
of IN O
40 CD O
mg NNS B-INTV
propranolol JJ I-INTV
orally RB O
, , O
and CC O
1 CD O
test NN O
was VBD O
given VBN O
after IN B-INTV
placebo NN I-INTV
, , O
administered VBN O
in IN O
a DT O
double-blinded JJ O
, , O
counterbalanced JJ O
manner NN O
. . O

RESULTS JJ B-POPU
Participants NNS I-POPU
with IN I-POPU
autism NN I-POPU
were VBD O
significantly RB O
impaired VBN O
compared VBN O
with IN O
controls NNS O
on IN O
both DT B-OC
fluency NN I-OC
tasks NNS I-OC
. . O

Propranolol NNP B-INTV
significantly RB O
improved VBD B-OC
performance NN I-OC
on IN I-OC
category NN I-OC
fluency NN I-OC
, , O
but CC O
not RB B-OC
letter NN I-OC
fluency NN I-OC
among IN O
autism NN B-POPU
participants NNS I-POPU
. . O

No DT B-OC
drug NN I-OC
effect NN I-OC
was VBD O
observed VBN O
among IN O
controls NNS O
. . O

Expected VBN O
drug NN O
effects NNS O
on IN B-OC
heart NN I-OC
rate NN I-OC
and CC I-OC
blood NN I-OC
pressure NN I-OC
were VBD O
observed VBN O
in IN O
both CC O
the DT O
groups NNS O
. . O

CONCLUSIONS NNP O
Results NNP O
are VBP O
consistent JJ O
with IN O
a DT O
selective JJ O
beneficial JJ O
effect NN O
of IN B-INTV
propranolol NN I-INTV
on IN O
flexibility NN O
of IN O
access NN O
to TO O
semantic JJ O
and CC O
associative JJ O
networks NNS O
in IN O
autism NN O
, , O
with IN O
no DT O
observed JJ O
effect NN O
on IN O
phonological JJ O
networks NNS O
. . O

Further NNP O
study NN O
will MD O
be VB O
necessary JJ O
to TO O
understand VB O
potential JJ O
clinical JJ O
implications NNS O
of IN O
this DT O
finding NN O
. . O

-DOCSTART- -X- O O

Brief JJ O
report NN O
: : O
mediation NN O
of IN O
treatment NN O
effect NN O
in IN O
a DT O
communication NN O
intervention NN O
for IN O
pre-school JJ B-POPU
children NNS I-POPU
with IN I-POPU
autism NN I-POPU
. . O

Tests NNS O
of IN O
mediation NN O
in IN O
treatment NN O
trials NNS O
can MD O
illuminate VB O
processes NNS O
of IN O
change NN O
and CC O
suggest NN O
causal NN O
influences NNS O
in IN O
development NN O
. . O

We PRP O
conducted VBD O
a DT O
mediation NN O
analysis NN O
of IN O
a DT O
previously RB O
published VBN O
randomised VBN O
controlled JJ O
trial NN O
of IN O
parent-mediated JJ B-INTV
communication-focused JJ I-INTV
treatment NN I-INTV
for IN O
autism NN B-POPU
against IN I-POPU
ordinary JJ I-POPU
care NN I-POPU
, , I-POPU
with IN I-POPU
28 CD I-POPU
children NNS I-POPU
aged VBN I-POPU
2-5 CD I-POPU
years NNS I-POPU
( ( O
Aldred NNP O
et RB O
al RB O
. . O

in IN O
J NNP O
Child NNP O
Psychol NNP O
Psychiatr NNP O
45:1-11 CD O
, , O
2004 CD O
) ) O
. . O

The DT O
hypothesised JJ O
mediating NN O
process NN O
, , O
targeted VBN O
by IN O
the DT O
intervention NN O
, , O
was VBD O
an DT O
increase NN O
in IN B-OC
parental JJ I-OC
synchronous JJ I-OC
response NN I-OC
within IN I-OC
parent-child JJ I-OC
interaction NN I-OC
. . O

The DT O
results NNS O
showed VBD B-OC
partial JJ I-OC
mediation NN I-OC
, , O
with IN O
change NN O
in IN B-OC
synchrony NN I-OC
accounting NN I-OC
for IN O
34 CD O
% NN O
of IN O
the DT O
positive JJ O
intervention NN O
effect NN O
on IN O
autism NN O
symptomatology NN O
( ( O
Autism NNP O
Diagnostic NNP O
Observation NNP O
Schedule NNP O
communication NN O
and CC O
social JJ O
domain NN O
algorithm NN O
) ) O
; : O
the DT O
result NN O
was VBD O
confirmed VBN O
by IN O
bootstrap NN O
estimation NN O
. . O

Improved VBN B-OC
parental JJ I-OC
synchronous JJ I-OC
response NN I-OC
to TO O
child VB O
communication NN O
can MD O
alter VB O
short-term JJ O
autism NN O
symptom VBZ O
outcome RP O
with IN O
targeted JJ O
therapy NN O
. . O

-DOCSTART- -X- O O

The DT O
effects NNS O
of IN O
aerobic JJ B-INTV
exercise NN I-INTV
on IN O
academic JJ O
engagement NN O
in IN O
young JJ B-POPU
children NNS I-POPU
with IN I-POPU
autism NN I-POPU
spectrum NN I-POPU
disorder NN I-POPU
. . O

PURPOSE NNP O
To TO O
determine VB O
whether IN O
participation NN O
in IN O
aerobic JJ B-INTV
exercise NN I-INTV
before IN O
classroom NN O
activities NNS O
improves VBZ O
academic JJ O
engagement NN O
and CC O
reduces NNS O
stereotypic VBP O
behaviors NNS O
in IN O
young JJ B-POPU
children NNS I-POPU
with IN I-POPU
autism NN I-POPU
spectrum NN I-POPU
disorder NN I-POPU
. . O

METHODS NNP O
This DT O
study NN O
employed VBD O
a DT O
within-subjects NNS O
crossover NN O
design NN O
, , O
using VBG O
a DT O
treatment NN O
condition NN O
( ( B-INTV
aerobic JJ I-INTV
exercise NN I-INTV
) ) I-INTV
and CC O
a DT O
control NN B-INTV
condition NN I-INTV
, , O
across IN O
4 CD O
classrooms NNS O
. . O

The DT B-INTV
treatment NN I-INTV
condition NN I-INTV
included VBD I-INTV
15 CD I-INTV
minutes NNS I-INTV
of IN I-INTV
running/jogging VBG I-INTV
followed VBN I-INTV
by IN I-INTV
a DT I-INTV
classroom NN I-INTV
task NN I-INTV
. . O

The DT B-INTV
control NN I-INTV
condition NN I-INTV
included VBD I-INTV
a DT I-INTV
classroom NN I-INTV
task NN I-INTV
not RB I-INTV
preceded VBN I-INTV
by IN I-INTV
exercise NN I-INTV
. . O

The DT O
number NN B-INTV
of IN I-INTV
stereotypic JJ I-INTV
behaviors NNS I-INTV
, , I-INTV
percentage NN I-INTV
of IN I-INTV
on-task JJ I-INTV
behavior NN I-INTV
, , I-INTV
and CC I-INTV
correct/incorrect JJ I-INTV
responses NNS I-INTV
were VBD I-INTV
measured VBN I-INTV
. . O

The DT B-INTV
Wilcoxon NNP I-INTV
signed VBD I-INTV
rank JJ I-INTV
test NN I-INTV
was VBD I-INTV
used VBN I-INTV
to TO I-INTV
compare VB I-INTV
differences NNS I-INTV
between IN I-INTV
conditions NNS I-INTV
. . O

RESULTS NNP O
Statistically NNP O
significant JJ O
improvements NNS O
were VBD O
found VBN O
in IN O
correct JJ O
responding VBG O
following VBG O
exercise NN O
( ( O
P NNP O
< NNP O
.05 NNP O
) ) O
. . O

No DT O
significant JJ O
differences NNS O
were VBD O
found VBN O
for IN O
on-task JJ B-OC
behavior NN I-OC
or CC O
stereotypic NN B-OC
behaviors NNS I-OC
. . O

CONCLUSIONS NNP O
Consistent NNP O
with IN O
findings NNS O
in IN O
older JJR O
children NNS O
, , O
these DT O
results NNS O
indicate VBP O
that IN O
aerobic JJ B-INTV
exercise NN I-INTV
prior RB O
to TO O
classroom VB O
activities NNS O
may MD O
improve VB O
academic JJ O
responding NN O
in IN O
young JJ B-POPU
children NNS I-POPU
with IN I-POPU
autism NN I-POPU
spectrum NN I-POPU
disorder NN I-POPU
. . O

-DOCSTART- -X- O O

Comparison NNP O
of IN O
the DT O
evolutional JJ B-OC
process NN I-OC
of IN O
children NNS B-POPU
with IN I-POPU
autism NN I-POPU
spectrum NN I-POPU
disorders NNS I-POPU
in IN O
different JJ O
language NN B-INTV
therapeutic JJ I-INTV
interventions NNS I-INTV
. . O

PURPOSE NNP O
To TO O
analyze VB O
and CC O
compare VB O
the DT B-OC
extension NN I-OC
and CC I-OC
the DT I-OC
speed NN I-OC
of IN I-OC
the DT I-OC
evolutional JJ I-OC
process NN I-OC
of IN O
children NNS B-POPU
with IN I-POPU
Autism NNP I-POPU
Spectrum NNP I-POPU
Disorders NNP I-POPU
in IN O
direct JJ B-INTV
and CC I-INTV
indirect JJ I-INTV
interventions NNS I-INTV
as IN O
opposed VBN O
to TO O
only RB O
indirect VB O
intervention NN O
. . O

METHODS NNP O
The DT O
design NN O
of IN O
this DT O
study NN O
is VBZ O
a DT O
clinical JJ O
trial NN O
. . O

The DT O
sample NN O
was VBD O
composed VBN O
of IN O
11 CD B-POPU
children NNS I-POPU
diagnosed VBN I-POPU
with IN I-POPU
Autism NNP I-POPU
( ( I-POPU
n=6 NN I-POPU
) ) I-POPU
and CC I-POPU
Asperger NNP I-POPU
syndrome VBP I-POPU
( ( I-POPU
n=5 NN I-POPU
) ) I-POPU
by IN I-POPU
a DT I-POPU
multidisciplinary JJ I-POPU
team NN I-POPU
, , I-POPU
that WDT I-POPU
attended VBD I-POPU
specialized JJ I-POPU
speech-language JJ I-POPU
pathology NN I-POPU
therapy NN I-POPU
at IN I-POPU
the DT I-POPU
institution NN I-POPU
were VBD I-POPU
the DT I-POPU
study NN I-POPU
was VBD I-POPU
carried VBN I-POPU
out RP I-POPU
. . O

These DT O
children NNS O
were VBD O
randomly RB O
divided VBN O
into IN O
two CD O
groups NNS O
: : O
Therapy NNP B-INTV
Group NNP I-INTV
( ( I-INTV
TG NNP I-INTV
) ) I-INTV
- : I-INTV
composed VBN I-INTV
by IN I-INTV
six CD I-INTV
subjects NNS I-INTV
receiving VBG I-INTV
both DT I-INTV
direct JJ I-INTV
and CC I-INTV
indirect JJ I-INTV
intervention NN I-INTV
; : I-INTV
and CC I-INTV
Orientation NNP I-INTV
Group NNP I-INTV
( ( I-INTV
OG NNP I-INTV
) ) I-INTV
- : I-INTV
constituted VBN I-INTV
by IN I-INTV
five CD I-INTV
subjects NNS I-INTV
receiving VBG I-INTV
exclusively RB I-INTV
indirect JJ I-INTV
intervention NN I-INTV
. . O

It PRP O
was VBD O
used VBN O
the DT O
Autism NNP B-INTV
Behavior NNP I-INTV
Checklist NNP I-INTV
( ( I-INTV
ABC NNP I-INTV
) ) I-INTV
to TO I-INTV
interview NN I-INTV
the DT I-INTV
mothers NNS I-INTV
, , I-INTV
and CC I-INTV
the DT I-INTV
Sample NNP I-INTV
of IN I-INTV
Vocal NNP I-INTV
Behavior NNP I-INTV
( ( I-INTV
SVB NNP I-INTV
) ) I-INTV
, , I-INTV
in IN I-INTV
three CD I-INTV
occasions NNS I-INTV
: : I-INTV
at IN I-INTV
the DT I-INTV
beginning NN I-INTV
of IN I-INTV
the DT I-INTV
intervention NN I-INTV
process NN I-INTV
( ( I-INTV
time NN I-INTV
0 CD I-INTV
) ) I-INTV
, , I-INTV
six CD I-INTV
months NNS I-INTV
later RB I-INTV
( ( I-INTV
time NN I-INTV
1 CD I-INTV
) ) I-INTV
and CC I-INTV
12 CD I-INTV
months NNS I-INTV
later RB I-INTV
( ( I-INTV
time NN I-INTV
2 CD I-INTV
) ) I-INTV
. . O

RESULTS VB O
It PRP O
was VBD O
observed VBN O
greater JJR O
speed NN B-OC
and CC I-OC
extension NN I-OC
in IN I-OC
the DT I-OC
evolutional JJ I-OC
process NN I-OC
of IN O
the DT O
TG NNP O
Group NNP O
, , O
both DT O
in IN O
the DT O
analysis NN O
of IN O
the DT O
Autism NNP B-OC
Behavior NNP I-OC
Checklist NNP I-OC
( ( I-OC
total JJ I-OC
and CC I-OC
partial JJ I-OC
scores NNS I-OC
) ) I-OC
and CC O
the DT O
Sample NNP B-OC
of IN I-OC
Vocal NNP I-OC
Behavior NNP I-OC
, , O
especially RB O
in IN O
the DT O
item NN O
Full NNP O
Language NNP O
. . O

The DT O
performance NN O
of IN O
children NNS B-POPU
with IN I-POPU
Asperger NNP I-POPU
syndrome NN I-POPU
was VBD O
considered VBN O
more RBR O
positive JJ O
when WRB O
compared VBN O
to TO O
that DT O
of IN O
children NNS B-POPU
with IN I-POPU
autism NN I-POPU
. . O

There EX O
was VBD O
greater JJR O
evolution NN B-OC
in IN O
younger JJR O
children NNS O
and CC O
with IN O
normal JJ O
, , O
mild JJ O
, , O
and CC O
moderate JJ O
adaptive JJ B-OC
functioning NN I-OC
. . O

CONCLUSION VB O
The DT O
tendency NN O
towards NNS O
better RBR O
performance NN B-OC
of IN O
the DT O
children NNS O
attending VBG O
direct JJ B-INTV
and CC I-INTV
indirect JJ I-INTV
intervention NN I-INTV
showed VBD O
that IN O
this DT O
association NN O
is VBZ O
fundamental JJ O
in IN O
the DT O
therapeutic JJ O
process NN O
of IN O
children NNS B-POPU
with IN I-POPU
Autism NNP I-POPU
Spectrum NNP I-POPU
Disorders NNP I-POPU
. . O

-DOCSTART- -X- O O

Literacy NNP O
skills NNS O
in IN O
primary JJ B-POPU
school-aged JJ I-POPU
children NNS I-POPU
with IN I-POPU
pragmatic JJ I-POPU
language NN I-POPU
impairment NN I-POPU
: : I-POPU
a DT O
comparison NN O
with IN O
children NNS B-POPU
with IN I-POPU
specific JJ I-POPU
language NN I-POPU
impairment NN I-POPU
. . O

BACKGROUND NNP O
Children NNP B-POPU
with IN I-POPU
pragmatic JJ I-POPU
language NN I-POPU
impairment NN I-POPU
( ( I-POPU
CwPLI NNP I-POPU
) ) I-POPU
are VBP O
characterized VBN O
by IN O
difficulties NNS O
with IN O
the DT O
interpersonal JJ O
use NN O
of IN O
language NN O
in IN O
social JJ O
contexts NN O
and CC O
they PRP O
possess VBP O
a DT O
range NN O
of IN O
language NN O
difficulties NNS O
that WDT O
affect VBP O
their PRP$ O
educational JJ O
attainment NN O
. . O

Since IN O
literacy NN O
skills NNS O
are VBP O
central JJ O
to TO O
this DT O
attainment NN O
, , O
one CD O
way NN O
of IN O
identifying VBG O
appropriate JJ O
support NN O
needs NNS O
for IN O
CwPLI NNP B-POPU
would MD O
be VB O
to TO O
profile VB O
their PRP$ O
reading NN O
and CC O
writing VBG O
skills NNS O
as IN O
a DT O
group NN O
. . O

AIMS NNP O
To TO O
investigate VB O
the DT O
word NN B-OC
reading NN I-OC
, , I-OC
non-word JJ I-OC
reading NN I-OC
, , I-OC
reading VBG I-OC
comprehension NN I-OC
, , I-OC
and CC I-OC
written VBN I-OC
expression NN I-OC
skills NNS I-OC
of IN O
CwPLI NNP O
and CC O
a DT O
comparison NN O
group NN O
of IN O
children NNS B-POPU
with IN I-POPU
specific JJ I-POPU
language NN I-POPU
impairment NN I-POPU
( ( I-POPU
CwSLI NNP I-POPU
) ) I-POPU
. . O

CwSLI NNP O
were VBD O
recruited VBN O
in IN O
order NN O
to TO O
examine VB O
any DT O
overlaps NNS O
in IN O
literacy NN O
impairments NNS O
for IN O
the DT O
two CD O
groups NNS O
. . O

METHODS NNP O
& CC O
PROCEDURES NNP O
Primary NNP B-POPU
school-aged JJ I-POPU
CwPLI NNP I-POPU
( ( I-POPU
n= JJ I-POPU
59 CD I-POPU
) ) I-POPU
and CC I-POPU
CwSLI NNP I-POPU
( ( I-POPU
n= JJ I-POPU
12 CD I-POPU
) ) I-POPU
were VBD I-POPU
recruited VBN I-POPU
from IN I-POPU
speech NN I-POPU
and CC I-POPU
language NN I-POPU
therapists NNS I-POPU
. . O

Children NNP O
completed VBD O
standardized JJ B-INTV
assessments NNS I-INTV
of IN O
literacy NN O
skills NNS O
. . O

The DT O
level NN O
of IN O
impairment NN O
for IN O
each DT O
component NN O
literacy NN O
skill NN O
was VBD O
examined VBN O
for IN O
CwPLI NNP O
and CC O
CwSLI NNP O
. . O

OUTCOMES NNP O
& CC O
RESULTS NNP O
For IN O
the DT O
CwPLI NNP O
, , O
group NN O
mean JJ O
scores NNS O
on IN O
each DT O
of IN O
the DT O
literacy NN B-OC
skills NNS I-OC
were VBD O
at IN O
the DT O
lower JJR O
end NN O
of IN O
the DT O
normal JJ O
range NN O
compared VBN O
with IN O
population NN O
norms NNS O
. . O

The DT O
range NN O
of IN O
individual JJ B-OC
scores NNS I-OC
was VBD O
large JJ O
, , O
with IN O
some DT O
children NNS O
scoring VBG O
near IN O
floor NN O
level NN O
and CC O
others NNS O
scoring VBG O
up RB O
to TO O
2 CD O
SDs NNP O
( ( O
standard JJ O
deviations NNS O
) ) O
above IN O
the DT O
mean NN O
, , O
illustrating VBG O
the DT O
heterogeneity NN O
of IN O
literacy NN O
skills NNS O
within IN O
the DT O
group NN O
. . O

For IN O
the DT O
CwSLI NNP O
, , O
group NN O
mean JJ B-OC
scores NNS I-OC
on IN I-OC
each DT I-OC
of IN I-OC
the DT I-OC
literacy NN I-OC
skills NNS I-OC
were VBD O
between IN O
1 CD O
SD NNP O
and CC O
2 CD O
SDs NNP O
below IN O
the DT O
population NN O
mean NN O
. . O

CwSLI NNP O
were VBD O
significantly RB O
more JJR O
impaired JJ O
on IN O
all DT O
of IN O
the DT O
literacy NN B-OC
measures NNS I-OC
compared VBN O
with IN O
CwPLI NNP O
. . O

This DT O
difference NN O
remained VBD O
even RB O
when WRB O
receptive JJ O
language NN B-OC
ability NN I-OC
and CC O
non-verbal JJ B-OC
intelligence NN I-OC
were VBD O
controlled VBN O
for IN O
. . O

CONCLUSIONS NNP O
& CC O
IMPLICATIONS NNP O
The DT O
results NNS O
demonstrate VBP O
that IN O
there EX O
is VBZ O
a DT O
high JJ O
level NN B-OC
of IN I-OC
literacy NN I-OC
impairment NN I-OC
within IN O
CwPLI NNP B-POPU
and CC I-POPU
CwSLI NNP I-POPU
, , O
providing VBG O
evidence NN O
that IN O
individualized JJ O
literacy NN O
skill NN O
intervention NN O
is VBZ O
important JJ O
for IN O
the DT O
long-term JJ O
academic JJ O
outcome NN O
of IN O
these DT O
children NNS O
. . O

-DOCSTART- -X- O O

Do VB O
sheltered VBD B-INTV
workshops NNS I-INTV
enhance VB O
employment NN B-OC
outcomes NNS I-OC
for IN O
adults NNS B-POPU
with IN I-POPU
autism NN I-POPU
spectrum NN I-POPU
disorder NN I-POPU
? . O
This DT O
study NN O
investigated VBD O
whether IN O
sheltered VBN B-INTV
workshops NNS I-INTV
help VBP O
prepare VB O
individuals NNS B-POPU
with IN I-POPU
autism NN I-POPU
spectrum NN I-POPU
disorder NN I-POPU
( ( I-POPU
ASD NNP I-POPU
) ) I-POPU
for IN O
competitive JJ B-OC
employment NN I-OC
within IN O
the DT O
community NN O
. . O

Two CD O
groups NNS O
of IN O
individuals NNS O
were VBD O
compared VBN O
: : O
( ( B-POPU
a DT I-POPU
) ) I-POPU
215 CD I-POPU
supported VBN I-POPU
employees NNS I-POPU
who WP I-POPU
were VBD I-POPU
in IN I-POPU
sheltered JJ I-POPU
workshops NNS I-POPU
prior RB I-POPU
to TO I-POPU
entering VBG I-POPU
supported JJ I-POPU
employment NN I-POPU
and CC I-POPU
( ( I-POPU
b NN I-POPU
) ) I-POPU
215 CD I-POPU
supported VBN I-POPU
employees NNS I-POPU
who WP I-POPU
were VBD I-POPU
not RB I-POPU
in IN I-POPU
sheltered JJ I-POPU
workshops NNS I-POPU
. . O

Individuals NNS O
from IN O
both DT O
groups NNS O
were VBD O
matched VBN O
based VBN O
on IN O
their PRP$ O
primary JJ O
diagnosis NN O
, , O
secondary JJ O
diagnosis NN O
( ( O
if IN O
present NN O
) ) O
, , O
and CC O
gender NN O
. . O

Results NNS O
showed VBD O
that IN O
there EX O
were VBD O
no DT O
differences NNS O
in IN O
rates NNS B-OC
of IN I-OC
employment NN I-OC
between IN O
these DT O
two CD O
groups NNS O
. . O

However RB O
, , O
individuals NNS O
who WP O
participated VBD O
in IN O
sheltered JJ B-INTV
workshops NNS I-INTV
earned VBD B-OC
significantly RB I-OC
less JJR I-OC
( ( O
US NNP O
$ $ O
129.36 CD O
versus NN O
US NNP O
$ $ O
191.42 CD O
per IN O
week NN O
) ) O
, , O
and CC O
cost NN B-OC
significantly RB I-OC
more RBR I-OC
to TO O
serve VB O
( ( O
US NNP O
$ $ O
6,065.08 CD O
versus NN O
US NNP O
$ $ O
2,440.60 CD O
) ) O
, , O
than IN O
their PRP$ O
non-sheltered JJ B-INTV
workshop NN I-INTV
peers NNS O
. . O

Results NNS O
presented VBD O
here RB O
suggest VBP O
that IN O
individuals NNS B-POPU
with IN I-POPU
ASD NNP I-POPU
achieve VBP O
better RBR B-OC
vocational JJ I-OC
outcomes NNS I-OC
if IN O
they PRP O
do VBP O
not RB O
participate VB O
in IN O
sheltered JJ O
workshops NNS O
prior RB O
to TO O
enrolling VBG O
in IN O
supported JJ O
employment NN O
. . O

-DOCSTART- -X- O O

A DT O
prospective JJ O
double-blind NN O
, , O
randomized VBD O
clinical JJ O
trial NN O
of IN O
levocarnitine NN B-INTV
to TO O
treat VB O
autism NN B-POPU
spectrum NN I-POPU
disorders NNS I-POPU
. . O

BACKGROUND NNP O
L-carnitine NNP B-INTV
was VBD O
proposed VBN O
as IN O
a DT O
potential JJ O
treatment NN O
for IN O
patients NNS B-POPU
diagnosed VBN I-POPU
with IN I-POPU
an DT I-POPU
autism NN I-POPU
spectrum NN I-POPU
disorder NN I-POPU
to TO O
improve VB O
mitochondrial JJ O
dysfunction NN O
, , O
but CC O
no DT O
prior JJ O
randomized VBN O
controlled VBN O
trials NNS O
have VBP O
been VBN O
conducted VBN O
. . O

MATERIAL/METHODS NNP O
Thirty NNP B-POPU
subjects NNS I-POPU
diagnosed VBD I-POPU
with IN I-POPU
an DT I-POPU
ASD NNP I-POPU
were VBD O
randomly RB O
assigned VBN O
to TO O
receive VB O
a DT O
standardized JJ B-INTV
regimen NN I-INTV
( ( I-INTV
50 CD I-INTV
mg RB I-INTV
L-carnitine/kg NNP I-INTV
bodyweight/day NN I-INTV
) ) I-INTV
of IN I-INTV
liquid JJ I-INTV
L-carnitine NNP I-INTV
( ( I-INTV
n=19 NN I-INTV
) ) I-INTV
or CC I-INTV
placebo NN I-INTV
( ( I-INTV
n=11 JJ I-INTV
) ) I-INTV
for IN I-INTV
3-months JJ I-INTV
. . O

Measures NNS O
included VBD O
changes NNS O
in IN O
professionally RB O
completed VBN O
Childhood NNP B-OC
Autism NNP I-OC
Rating NNP I-OC
Scale NNP I-OC
( ( I-OC
CARS NNP I-OC
) ) I-OC
, , I-OC
hand NN I-OC
muscle NN I-OC
testing NN I-OC
, , I-OC
and CC I-OC
modified VBD I-OC
clinical JJ I-OC
global JJ I-OC
impression NN I-OC
( ( I-OC
CGI NNP I-OC
) ) I-OC
forms VBZ I-OC
; : I-OC
parent NN I-OC
completed VBD I-OC
Autism NNP I-OC
Treatment NNP I-OC
Evaluation NNP I-OC
Checklist NNP I-OC
( ( I-OC
ATEC NNP I-OC
) ) I-OC
, , I-OC
treatment NN I-OC
adherence NN I-OC
measurement NN I-OC
( ( I-OC
TAM NNP I-OC
) ) I-OC
, , I-OC
frequency NN I-OC
and CC I-OC
intensity NN I-OC
of IN I-OC
side JJ I-OC
effect NN I-OC
rating NN I-OC
( ( I-OC
FISER NNP I-OC
) ) I-OC
/global VBD I-OC
rating NN I-OC
of IN I-OC
side JJ I-OC
effect NN I-OC
burden NN I-OC
( ( I-OC
GRSEB NNP I-OC
) ) I-OC
/patient VBD I-OC
report NN I-OC
of IN I-OC
incidence NN I-OC
of IN I-OC
side NN I-OC
effects NNS I-OC
( ( I-OC
PRISE NNP I-OC
) ) I-OC
forms NNS I-OC
; : I-OC
and CC I-OC
lab VB I-OC
testing VBG I-OC
. . O

RESULTS NNP O
Significant JJ O
improvements NNS O
were VBD O
observed VBN O
in IN O
CARS NNP B-OC
( ( O
-2.03 NNP O
, , O
95 CD O
% NN O
CI=-3.7 NNP O
to TO O
-0.31 VB O
) ) O
, , O
CGI NNP B-OC
( ( O
-0.69 NNP O
, , O
95 CD O
% NN O
CI=-1.1 NNP O
to TO O
-0.06 VB O
) ) O
, , O
and CC O
ATEC NNP B-OC
scores NNS I-OC
. . O

Significant JJ O
correlations NNS O
between IN O
changes NNS O
in IN O
serum JJ O
free-carnitine JJ O
levels NNS O
and CC O
positive JJ O
clinical JJ O
changes NNS O
were VBD O
observed VBN O
for IN O
hand NN B-OC
muscle NN I-OC
strength NN I-OC
( ( O
R2=0.23 NNP O
, , O
P=0.046 NNP O
) ) O
, , O
cognitive JJ B-OC
scores NNS I-OC
( ( O
R2=0.27 NNP O
, , O
P=0.019 NNP O
) ) O
, , O
and CC O
CARS NNP B-OC
scores NNS I-OC
( ( O
R2=0.20 NNP O
, , O
P=0.047 NNP O
) ) O
. . O

Study NNP O
subjects NNS O
were VBD O
protocol-compliant JJ O
( ( O
average JJ O
adherence NN O
was VBD O
> JJ O
85 CD O
% NN O
) ) O
and CC O
generally RB O
well-tolerated VBD O
the DT O
L-carnitine JJ B-INTV
therapy NN I-INTV
given VBN O
. . O

CONCLUSIONS NNP O
L-carnitine JJ B-INTV
therapy NN I-INTV
( ( O
50 CD O
mg/kilogram-bodyweight/day NN O
) ) O
administered VBD O
for IN O
3-months JJ O
significantly RB O
improved VBN O
several JJ O
clinical JJ O
measurements NNS O
of IN O
ASD NNP O
severity NN O
, , O
but CC O
subsequent JJ O
studies NNS O
are VBP O
recommended VBN O
. . O

-DOCSTART- -X- O O

[ JJ O
Effects NNS O
of IN O
an DT O
intensive JJ B-INTV
therapy NN I-INTV
program NN I-INTV
for IN O
behaviorally RB B-POPU
disordered VBN I-POPU
mentally RB I-POPU
handicapped JJ I-POPU
patients NNS I-POPU
on IN I-POPU
staff NN I-POPU
personnel NNS I-POPU
in IN I-POPU
residential JJ I-POPU
care NN I-POPU
] NNP I-POPU
. . O

This DT O
study NN O
evaluates VBZ O
the DT O
effects NNS O
of IN O
an DT O
intensive JJ B-INTV
therapy NN I-INTV
program NN I-INTV
designed VBN O
for IN O
mentally RB B-POPU
handicapped JJ I-POPU
persons NNS I-POPU
with IN I-POPU
severely RB I-POPU
disturbed VBN I-POPU
or CC I-POPU
autistic JJ I-POPU
behavior NN I-POPU
on IN I-POPU
their PRP$ I-POPU
staff NN I-POPU
personal JJ I-POPU
which WDT I-POPU
had VBD I-POPU
an DT I-POPU
active JJ I-POPU
role NN I-POPU
in IN I-POPU
the DT I-POPU
program NN I-POPU
. . O

The DT O
staff NN O
members NNS O
rated VBD O
their PRP$ O
professional JJ O
competence NN O
, , O
quality NN O
of IN O
interaction NN O
with IN O
the DT O
client NN O
, , O
team JJ O
culture NN O
and CC O
work NN O
satisfaction NN O
before IN O
and CC O
after IN O
being VBG O
engaged VBN O
in IN O
the DT O
program NN O
, , O
with IN O
additional JJ O
ratings NNS O
of IN O
their PRP$ O
personal JJ O
aims NNS O
at IN O
the DT O
beginning NN O
of IN O
the DT O
program NN O
. . O

Three NNP O
sets NNS O
of IN O
data NNS O
were VBD O
obtained VBN O
with IN O
the DT O
program NN O
being VBG O
conducted VBN O
three CD O
times NNS O
in IN O
a DT O
row NN O
. . O

The DT O
testings NNS O
of IN O
the DT O
related VBN O
as RB O
well RB O
as IN O
the DT O
independent JJ O
samples NNS O
show VBP O
differentiated JJ O
program NN O
effects NNS O
. . O

The DT O
main JJ O
effect NN O
is VBZ O
an DT O
increase NN O
of IN O
the DT O
professional JJ B-OC
competence NN I-OC
and CC I-OC
quality NN I-OC
of IN I-OC
interaction NN I-OC
, , O
especially RB O
by IN O
the DT O
qualified JJ O
staff NN O
members NNS O
. . O

Trainees NNP O
put VBD O
emphasis NN O
on IN O
the DT O
development NN O
of IN O
their PRP$ O
personal JJ O
relationship NN O
with IN O
the DT O
client NN O
. . O

The DT O
results NNS O
are VBP O
discussed VBN O
in IN O
terms NNS O
of IN O
the DT O
impact NN O
of IN O
learning VBG O
processes NNS O
specific JJ O
to TO O
the DT O
roles NNS O
of IN O
the DT O
staff NN O
members NNS O
and CC O
motivational JJ O
factors NNS O
on IN O
learning NN O
and CC O
therapy NN O
outcome NN O
, , O
along IN O
with IN O
institutional JJ O
conditions NNS O
influencing VBG O
successful JJ O
learning NN O
. . O

Thus VB O
the DT O
program NN O
facilitates VBZ O
the DT O
professional JJ O
and CC O
interpersonal JJ O
learning NN O
process NN O
of IN O
staff NN O
members NNS O
in IN O
a DT O
specific JJ O
way NN O
with IN O
success NN O
as RB O
well RB O
as IN O
with IN O
limitations NNS O
. . O

-DOCSTART- -X- O O

A DT O
preliminary JJ O
trial NN O
of IN O
ascorbic JJ B-INTV
acid NN I-INTV
as IN O
supplemental JJ O
therapy NN O
for IN O
autism NN B-POPU
. . O

1 CD O
. . O

This DT O
study NN O
presents VBZ O
the DT O
results NNS O
of IN O
a DT O
30-week JJ O
double-blind NN O
, , O
placebo-controlled JJ B-INTV
trial NN O
exploring VBG O
the DT O
effectiveness NN O
of IN O
ascorbic JJ B-INTV
acid NN I-INTV
( ( O
8g/70kg/day CD O
) ) O
as IN O
a DT O
supplemental JJ O
pharmacological JJ O
treatment NN O
for IN O
autistic JJ B-POPU
children NNS I-POPU
in IN I-POPU
residential JJ I-POPU
treatment NN I-POPU
. . O

2 CD O
. . O

Residential JJ B-POPU
school NN I-POPU
children NNS I-POPU
( ( I-POPU
N NNP I-POPU
= NNP I-POPU
18 CD I-POPU
) ) I-POPU
were VBD O
randomly RB O
assigned VBN O
to TO O
either DT O
ascorbate-ascorbate-placebo JJ B-INTV
treatment NN I-INTV
order NN I-INTV
group NN I-INTV
or CC I-INTV
ascorbate-placebo-ascorbate JJ I-INTV
treatment NN I-INTV
order NN I-INTV
group NN O
. . O

Each DT O
treatment NN O
phase NN O
lasted VBD O
10 CD O
weeks NNS O
and CC O
behaviors NNS O
were VBD O
rated VBN O
weekly JJ O
using VBG O
the DT O
Ritvo-Freeman NNP O
scale NN O
. . O

3 CD O
. . O

Significant JJ O
group NN O
by IN O
phase NN O
interactions NNS O
were VBD O
found VBN O
for IN O
total JJ B-OC
scores NNS I-OC
and CC O
also RB O
sensory JJ B-OC
motor NN I-OC
scores NNS I-OC
indicating VBG O
a DT O
reduction NN O
in IN O
symptom JJ B-OC
severity NN I-OC
associated VBN O
with IN O
the DT O
ascorbic JJ B-INTV
acid NN I-INTV
treatment NN I-INTV
. . O

4 CD O
. . O

These DT O
results NNS O
were VBD O
consistent JJ O
with IN O
a DT O
hypothesized VBN O
dopaminergic NN O
mechanism NN O
of IN O
action NN O
of IN O
ascorbic JJ B-INTV
acid NN I-INTV
. . O

-DOCSTART- -X- O O

[ JJ O
Opiate NNP O
hypothesis NN O
in IN O
infantile JJ B-POPU
autism NN I-POPU
? . O
Therapeutic JJ O
trials NNS O
with IN O
naltrexone JJ B-INTV
] NN I-INTV
. . O

The DT O
opioid JJ O
hypothesis NN O
suggests VBZ O
that IN O
childhood NN O
autism NN O
may MD O
result VB O
from IN O
excessive JJ O
brain NN O
opioid JJ O
activity NN O
during IN O
neonatal JJ O
period NN O
which WDT O
may MD O
constitutionally RB O
inhibit VB O
social JJ O
motivation NN O
, , O
yielding VBG O
autistic JJ O
isolation NN O
and CC O
aloofness NN O
( ( O
Panksepp NNP O
, , O
1979 CD O
) ) O
. . O

This DT O
hypothesis NN O
has VBZ O
now RB O
received VBN O
strong JJ O
support NN O
and CC O
is VBZ O
currently RB O
based VBN O
on IN O
three CD O
types NNS O
of IN O
arguments NNS O
: : O
( ( O
1 CD O
) ) O
similarity NN O
between IN O
autistic JJ O
symptomatology NN O
and CC O
abnormal JJ O
behaviors NNS O
induced VBD O
in IN O
young JJ O
animals NNS O
by IN O
injections NNS O
of IN O
exogenous JJ O
opioids NNS O
, , O
such JJ O
as IN O
increasing VBG O
social JJ O
aloofness NN O
and CC O
decreasing VBG O
social JJ O
vocalization NN O
; : O
( ( O
2 CD O
) ) O
direct JJ O
biochemical JJ O
evidence NN O
of IN O
abnormalities NNS O
of IN O
peripheral JJ O
endogenous JJ O
opioids NNS O
being VBG O
reported VBN O
in IN O
autism NN O
and CC O
( ( O
3 CD O
) ) O
therapeutic JJ O
effects NNS O
of IN O
the DT O
long JJ O
lasting NN O
opioid JJ O
receptor NN O
blocking VBG O
agent NN O
naltrexone NN O
in IN O
autism NN O
. . O

In IN O
this DT O
article NN O
, , O
we PRP O
give VBP O
description NN O
of IN O
open JJ O
and CC O
double-blind JJ O
studies NNS O
of IN O
naltrexone NN B-INTV
in IN O
autism NN O
. . O

Naltrexone NN B-INTV
has VBZ O
been VBN O
tested VBN O
in IN O
several JJ O
open JJ O
studies NNS O
. . O

We PRP O
performed VBD O
an DT O
open JJ O
trial NN O
with IN O
naltrexone NN B-INTV
in IN O
2 CD B-POPU
autistic JJ I-POPU
girls NNS I-POPU
, , I-POPU
displaying VBG I-POPU
serious JJ I-POPU
self-injurious JJ I-POPU
behavior NN I-POPU
, , I-POPU
reduced VBD I-POPU
crying NN I-POPU
and CC I-POPU
a DT I-POPU
marked JJ I-POPU
preference NN I-POPU
for IN I-POPU
salty NN I-POPU
and CC I-POPU
spicy NN I-POPU
foods NNS I-POPU
, , I-POPU
symptoms NNS I-POPU
that WDT I-POPU
could MD I-POPU
be VB I-POPU
related VBN I-POPU
to TO I-POPU
a DT I-POPU
dysfunction NN I-POPU
of IN I-POPU
the DT I-POPU
opioid JJ I-POPU
system NN I-POPU
. . O

With IN O
dosages NNS O
of IN O
1 CD O
mg/kg/day NN O
, , O
we PRP O
observed VBD O
an DT O
immediate JJ O
reduction NN B-OC
of IN I-OC
hyperactivity NN I-OC
, , I-OC
self-injurious JJ I-OC
behavior NN I-OC
and CC I-OC
aggressiveness NN I-OC
, , I-OC
while IN I-OC
attention NN I-OC
improved VBN I-OC
. . O

In IN O
addition NN O
, , O
social JJ B-OC
behaviors NNS I-OC
, , I-OC
smiling VBG I-OC
, , I-OC
social JJ I-OC
seeking VBG I-OC
behaviors NNS I-OC
and CC I-OC
play VB I-OC
interactions NNS I-OC
increased VBN O
( ( O
Leboyer NNP O
, , O
Bouvard NNP O
et VBZ O
Dugas NNP O
, , O
1988 CD O
) ) O
. . O

Campbell NNP O
et CC O
al NN O
. . O

( ( O
1988 CD O
) ) O
has VBZ O
also RB O
reported VBN O
a DT O
tranquilizing NN B-OC
and CC I-OC
a DT I-OC
stimulating JJ I-OC
effect NN I-OC
in IN O
6 CD O
out IN O
of IN O
8 CD O
children NNS O
with IN O
autism NN O
. . O

We PRP O
did VBD O
confirm VB O
these DT O
preliminary JJ O
results NNS O
in IN O
a DT O
double-blind NN O
study NN O
performed VBD O
on IN O
4 CD B-POPU
children NNS I-POPU
with IN I-POPU
autism NN I-POPU
. . O

In IN O
a DT O
cross-over JJ O
double-blind NN O
study NN O
, , O
three CD O
dosages NNS O
of IN O
naltrexone NN O
( ( O
0.5 CD O
, , O
1 CD O
and CC O
2 CD O
mg/kg/day NN O
) ) O
and CC O
placebo NN O
were VBD O
compared VBN O
. . O

( ( O
ABSTRACT NNP O
TRUNCATED NNP O
AT NNP O
250 CD O
WORDS NNP O
) ) O
-DOCSTART- -X- O O

Naltrexone NN B-POPU
in IN I-POPU
autistic JJ I-POPU
children NNS I-POPU
: : I-POPU
behavioral NN O
symptoms NNS O
and CC O
attentional JJ O
learning NN O
. . O

OBJECTIVE UH O
To TO O
assess VB O
critically RB O
the DT O
short-term JJ O
efficacy NN B-OC
and CC I-OC
safety NN I-OC
of IN O
naltrexone NN B-POPU
in IN I-POPU
autistic JJ I-POPU
children NNS I-POPU
and CC O
its PRP$ O
effects NNS O
on IN O
discrimination NN O
learning NN O
in IN O
the DT O
laboratory NN O
. . O

METHOD NNP O
A NNP O
parallel JJ O
group NN O
design NN O
was VBD O
employed VBN O
. . O

After IN O
a DT O
2-week JJ O
placebo NN O
baseline NN O
period NN O
, , O
children NNS O
were VBD O
randomly RB O
assigned VBN O
either RB O
to TO O
naltrexone CD B-INTV
or CC I-INTV
to TO I-INTV
placebo VB I-INTV
for IN O
a DT O
period NN O
of IN O
3 CD O
weeks NNS O
followed VBN O
by IN O
a DT O
one-week JJ O
posttreatment NN O
placebo NN O
period NN O
. . O

Multiple JJ O
raters NNS O
and CC O
rating NN O
scales NNS O
were VBD O
employed VBN O
in IN O
a DT O
variety NN O
of IN O
conditions NNS O
. . O

Forty-one CD B-POPU
children NNS I-POPU
, , I-POPU
all DT I-POPU
inpatients NNS I-POPU
, , I-POPU
ages VBZ I-POPU
2.9 CD I-POPU
to TO I-POPU
7.8 CD I-POPU
years NNS I-POPU
, , I-POPU
completed VBD I-POPU
the DT I-POPU
study NN I-POPU
. . O

Naltrexone NNP B-INTV
reduced VBD O
hyperactivity NN B-OC
and CC O
had VBD O
no DT O
effect NN O
on IN O
discrimination NN B-OC
learning NN I-OC
in IN O
the DT O
laboratory NN O
. . O

There EX O
was VBD O
a DT O
suggestion NN O
that IN O
it PRP O
had VBD O
a DT O
beneficial JJ O
effect NN O
on IN O
decreasing VBG O
self-injurious JJ B-OC
behavior NN I-OC
. . O

Untoward JJ B-OC
effects NNS I-OC
were VBD O
mild JJ O
and CC O
transient NN O
. . O

CONCLUSION NNP O
In IN O
the DT O
present JJ O
study NN O
, , O
naltrexone RB O
significantly RB O
reduced VBN O
only RB O
hyperactivity NN B-POPU
, , O
and CC O
no DT O
serious JJ B-OC
untoward JJ I-OC
effects NNS I-OC
were VBD O
observed VBN O
. . O

The DT O
effectiveness NN O
of IN O
naltrexone NN B-INTV
in IN O
the DT O
treatment NN O
of IN O
autism NN O
and CC O
self-injurious JJ O
behavior NN O
requires VBZ O
additional JJ O
assessment NN O
in IN O
a DT O
sample NN O
of IN O
children NNS B-POPU
with IN I-POPU
moderate JJ I-POPU
to TO I-POPU
severe VB I-POPU
self-injurious JJ I-POPU
behavior NN I-POPU
. . O

-DOCSTART- -X- O O

A DT O
double-blind JJ O
comparison NN O
of IN O
clomipramine NN B-INTV
, , I-INTV
desipramine NN I-INTV
, , I-INTV
and CC I-INTV
placebo NN I-INTV
in IN O
the DT O
treatment NN O
of IN O
autistic JJ B-POPU
disorder NN I-POPU
. . O

OBJECTIVE UH O
To TO O
determine VB O
whether IN O
clomipramine NN B-INTV
hydrochloride NN I-INTV
, , O
a DT O
serotonin JJ O
reuptake NN O
blocker NN O
with IN O
unique JJ O
anti-obsessional JJ O
properties NNS O
, , O
is VBZ O
differentially RB O
effective JJ O
for IN O
obsessive-compulsive JJ O
and CC O
stereotyped VBD O
motor NN O
behaviors NNS O
in IN O
autistic JJ O
disorder NN O
compared VBN O
with IN O
placebo NN B-INTV
and CC O
with IN O
the DT O
noradrenergic JJ B-INTV
tricyclic JJ I-INTV
antidepressant NN I-INTV
agent NN I-INTV
, , I-INTV
desipramine JJ I-INTV
hydrochloride NN I-INTV
. . O

DESIGN NNP O
Following VBG O
a DT O
2-week JJ O
, , O
single-blind JJ O
placebo NN B-INTV
washout IN O
phase NN O
, , O
12 CD B-POPU
autistic JJ I-POPU
subjects NNS I-POPU
completed VBD O
a DT O
10-week JJ O
, , O
double-blind JJ O
, , O
crossover JJ O
comparison NN O
of IN O
clomipramine NN B-INTV
and CC I-INTV
placebo NN I-INTV
, , O
and CC O
12 CD B-POPU
different JJ I-POPU
subjects NNS I-POPU
completed VBD O
a DT O
similar JJ O
comparison NN O
of IN O
clomipramine NN B-INTV
and CC O
desipramine NN B-INTV
. . O

SETTING CC O
Outpatient JJ O
clinic NN O
. . O

PATIENTS VB O
A DT B-POPU
referral JJ I-POPU
sample NN I-POPU
of IN I-POPU
30 CD I-POPU
male NN I-POPU
and CC I-POPU
female JJ I-POPU
autistic JJ I-POPU
patients NNS I-POPU
were VBD I-POPU
enrolled VBN I-POPU
, , I-POPU
and CC I-POPU
24 CD I-POPU
completed VBD I-POPU
the DT I-POPU
study NN I-POPU
. . O

MEASURES NNP O
Key NNP O
outcome NN O
measures NNS O
were VBD O
the DT O
Autism NNP B-OC
Relevant NNP I-OC
Subscale NNP I-OC
of IN I-OC
the DT I-OC
Children NNP I-OC
's POS I-OC
Psychiatric NNP I-OC
Rating NNP I-OC
Scale NNP I-OC
, , I-OC
the DT I-OC
Modified NNP I-OC
Comprehensive NNP I-OC
Psychopathological NNP I-OC
Rating NNP I-OC
Scale-Obsessive-Compulsive JJ I-OC
Disorder NNP I-OC
Subscale NNP I-OC
, , I-OC
and CC I-OC
the DT I-OC
Clinical NNP I-OC
Global NNP I-OC
Impressions NNP I-OC
Scale NNP I-OC
. . O

RESULTS NNP O
Clomipramine NNP B-INTV
was VBD O
superior JJ O
to TO O
both DT O
placebo NN O
and CC O
desipramine NN O
on IN O
ratings NNS O
of IN O
autistic JJ B-OC
symptoms NNS I-OC
( ( I-OC
including VBG I-OC
stereotypies NNS I-OC
) ) I-OC
, , I-OC
anger NN I-OC
, , I-OC
and CC I-OC
compulsive JJ I-OC
, , I-OC
ritualized JJ I-OC
behaviors NNS I-OC
( ( O
P NNP O
< NNP O
.05 NNP O
) ) O
, , O
with IN O
no DT O
differences NNS O
between IN O
desipramine NN B-INTV
and CC O
placebo NN B-INTV
. . O

Clomipramine NNP B-INTV
was VBD O
equal JJ O
to TO O
desipramine VB B-INTV
and CC O
both DT O
tricyclic JJ O
agents NNS O
were VBD O
superior JJ O
to TO O
placebo VB O
for IN O
amelioration NN O
of IN O
hyperactivity NN B-OC
. . O

CONCLUSION NNP O
Biological NNP O
links NNS O
between IN O
compulsions NNS O
and CC O
stereotyped VBD O
, , O
repetitive JJ O
behaviors NNS O
in IN O
autistic JJ B-POPU
disorder NN I-POPU
should MD O
be VB O
explored VBN O
. . O

-DOCSTART- -X- O O

Low-dose JJ O
naltrexone NN B-INTV
effects NNS O
on IN O
plasma NN O
chemistries NNS O
and CC O
clinical JJ O
symptoms NNS O
in IN O
autism NN B-POPU
: : I-POPU
a DT O
double-blind NN O
, , O
placebo-controlled JJ O
study NN O
. . O

The DT O
effect NN O
of IN O
month-long JJ O
naltrexone NN B-INTV
( ( I-INTV
NTX NNP I-INTV
) ) I-INTV
treatment NN O
at IN O
a DT O
daily JJ B-INTV
oral JJ I-INTV
dose NN I-INTV
of IN I-INTV
0.5 CD I-INTV
mg/kg/day NN I-INTV
was VBD I-INTV
contrasted VBN I-INTV
with IN I-INTV
placebo NN I-INTV
( ( I-INTV
PLC NNP I-INTV
) ) I-INTV
in IN O
a DT O
double-blind NN O
study NN O
with IN O
conjoint NN O
clinical JJ O
and CC O
biochemical JJ O
evaluations NNS O
of IN O
therapeutic JJ O
effects NNS O
. . O

Modest NNP O
clinical JJ O
benefits NNS O
were VBD O
achieved VBN O
with IN O
both DT O
PLC NNP B-INTV
and CC O
NTX NNP B-INTV
, , O
with IN O
marginally RB O
better JJR O
overall JJ O
results NNS O
following VBG O
NTX NNP O
, , O
and CC O
degree NN O
of IN O
improvement NN O
appeared VBD O
to TO O
be VB O
related VBN O
to TO O
plasma VB O
chemical JJ O
profiles NNS O
. . O

Massively RB O
elevated JJ O
levels NNS O
of IN O
beta-endorphin NN B-OC
were VBD O
observed VBN O
in IN O
all DT O
children NNS B-POPU
with IN O
assays NNS O
using VBG O
C-terminal JJ O
antibody NN O
but CC O
not RB O
with IN O
an DT O
N-terminal JJ O
antibody NN O
assay NN O
. . O

In IN O
addition NN O
, , O
70 CD O
% NN O
of IN O
the DT O
children NNS B-POPU
exhibited VBD O
abnormally RB O
low JJ O
levels NNS O
of IN O
adrenocorticotropic NN B-OC
hormone NN I-OC
, , O
and CC O
smaller JJR O
subsets NNS O
exhibited VBD O
elevated JJ O
norepinephrine NN B-OC
( ( I-OC
60 CD I-OC
% NN I-OC
) ) I-OC
, , I-OC
arginine-vasopressin JJ I-OC
( ( I-OC
50 CD I-OC
% NN I-OC
) ) I-OC
, , I-OC
and CC I-OC
serotonin NN I-OC
( ( O
20 CD O
% NN O
) ) O
. . O

The DT O
best JJS O
clinical JJ O
responders NNS O
exhibited VBD O
the DT O
clearest JJS O
normalization NN O
of IN O
the DT O
elevated JJ O
plasma NN B-OC
chemistries NNS I-OC
, , O
especially RB O
in IN O
C-terminal-beta-endorphin NNP O
and CC O
serotonin NN O
. . O

There EX O
was VBD O
some DT O
evidence NN O
of IN O
therapeutic JJ O
carry-over JJ O
effects NNS O
in IN O
both DT O
clinical JJ O
and CC O
biochemical JJ O
measures NNS O
in IN O
those DT O
children NNS B-POPU
who WP O
received VBD O
NTX NNP B-INTV
before IN O
PLC NNP B-INTV
. . O

The DT O
results NNS O
suggest VBP O
that IN O
NTX NNP B-INTV
only RB O
benefits NNS O
a DT O
subgroup NN O
of IN O
autistic JJ B-POPU
children NNS I-POPU
, , O
who WP O
may MD O
be VB O
identified VBN O
by IN O
the DT O
presence NN O
of IN O
certain JJ O
plasma JJ O
abnormalities NNS O
. . O

These DT O
results NNS O
suggest VBP O
a DT O
possible JJ O
linkage NN O
between IN O
abnormal JJ O
plasma NN O
chemistries NNS O
, , O
especially RB O
those DT O
related VBN O
to TO O
the DT O
pro-opiomelanocortin JJ O
system NN O
, , O
and CC O
autistic JJ O
symptoms NNS O
. . O

-DOCSTART- -X- O O

Placebo-controlled JJ B-INTV
acute JJ O
dosage NN O
naltrexone NN B-INTV
study NN O
in IN O
young JJ B-POPU
autistic JJ I-POPU
children NNS I-POPU
. . O

In IN O
a DT O
double-blind JJ O
, , O
placebo-controlled JJ B-INTV
crossover NN O
trial NN O
23 CD B-POPU
autistic JJ I-POPU
children NNS I-POPU
were VBD O
treated VBN O
with IN O
a DT O
single JJ O
40-mg JJ O
dose NN O
of IN O
the DT O
opiate JJ O
antagonist NN O
naltrexone NN B-INTV
. . O

Drug JJ O
effects NNS B-OC
were VBD O
monitored VBN O
by IN O
detailed JJ O
playroom NN O
observations NNS O
, , O
actometers NNS O
, , O
and CC O
parents NNS O
' POS O
checklist NN O
ratings NNS O
( ( B-OC
Aberrant NNP I-OC
Behavior NNP I-OC
Checklist NNP I-OC
, , I-OC
social JJ I-OC
items NNS I-OC
and CC I-OC
target NN I-OC
behaviors NNS I-OC
) ) I-OC
. . O

Naltrexone CD B-INTV
treatment NN O
failed VBD O
to TO O
produce VB O
significant JJ B-OC
changes NNS I-OC
in IN O
social JJ B-OC
behavior NN I-OC
, , O
but CC O
it PRP O
did VBD O
reduce VB B-OC
irritability NN I-OC
and CC I-OC
target NN I-OC
scores NNS I-OC
on IN I-OC
behavior JJ I-OC
checklists NNS I-OC
. . O

The DT O
playroom NN O
data NNS O
indicated VBD O
that IN O
naltrexone NN B-INTV
significantly RB B-OC
affected VBD I-OC
indices NNS O
of IN O
activity NN B-OC
and CC I-OC
attention NN I-OC
. . O

-DOCSTART- -X- O O

The DT O
effects NNS O
of IN O
chronic JJ O
naltrexone NN B-INTV
treatment NN I-INTV
in IN O
young JJ B-POPU
autistic JJ I-POPU
children NNS I-POPU
: : I-POPU
a DT O
double-blind JJ O
placebo-controlled JJ O
crossover NN O
study NN O
. . O

In IN O
a DT O
double-blind JJ O
placebo-controlled JJ O
crossover NN O
trial NN O
23 CD B-POPU
autistic JJ I-POPU
children NNS I-POPU
, , I-POPU
aged VBN I-POPU
3-7 CD I-POPU
years NNS I-POPU
, , O
were VBD O
treated VBN O
with IN B-INTV
a DT I-INTV
mean JJ I-INTV
daily JJ I-INTV
dosage NN I-INTV
of IN I-INTV
1 CD I-INTV
mg/kg NNS I-INTV
naltrexone RB I-INTV
for IN I-INTV
4 CD I-INTV
weeks NNS I-INTV
. . O

Drug JJ O
effects NNS O
were VBD O
monitored VBN O
with IN B-INTV
behavior JJ I-INTV
checklists NNS I-INTV
rated VBN I-INTV
by IN I-INTV
parents NNS I-INTV
and CC I-INTV
teachers NNS I-INTV
, , I-INTV
and CC I-INTV
ethological JJ I-INTV
playroom NN I-INTV
observations NNS I-INTV
. . O

On IN O
average NN O
, , O
parents NNS O
' POS O
checklists NNS O
and CC O
playroom NN O
data NNS O
could MD O
not RB O
differentiate VB O
between IN O
naltrexone JJ O
treatment NN O
and CC O
placebo NN O
treatment NN O
; : O
however RB O
, , O
teachers NNS O
significantly RB O
favored VBD O
naltrexone JJ B-INTV
treatment NN O
. . O

They PRP O
reported VBD O
a DT O
decrease NN O
in IN O
hyperactivity NN B-OC
and CC I-OC
irritability NN I-OC
. . O

No DT O
effects NNS O
of IN O
naltrexone NN O
on IN O
social JJ O
and CC O
stereotypic JJ O
behavior NN O
could MD O
be VB O
demonstrated VBN O
. . O

-DOCSTART- -X- O O

The DT O
influence NN O
of IN O
nonhandicapped JJ B-INTV
peers NNS I-INTV
on IN O
the DT O
social JJ B-OC
interactions NNS I-OC
of IN O
children NNS B-POPU
with IN I-POPU
a DT I-POPU
pervasive JJ I-POPU
development NN I-POPU
disorder NN I-POPU
. . O

This DT O
study NN O
investigated VBD O
whether IN O
or CC O
not RB O
children NNS B-POPU
with IN I-POPU
autism NN I-POPU
or CC I-POPU
a DT I-POPU
related JJ I-POPU
pervasive JJ I-POPU
developmental NN I-POPU
disorder NN I-POPU
( ( I-POPU
PDD NNP I-POPU
) ) I-POPU
can MD O
benefit VB B-OC
from IN O
regular JJ B-INTV
opportunities NNS I-INTV
to TO I-INTV
interact VB I-INTV
with IN I-INTV
a DT I-INTV
normally RB I-INTV
developing VBG I-INTV
peer NN I-INTV
, , O
matched VBD O
as IN O
to TO O
sex NN O
and CC O
age NN O
. . O

An DT O
experimental JJ O
design NN O
with IN O
random JJ O
assignment NN O
of IN O
subjects NNS O
to TO O
treatment NN O
and CC O
control NN O
groups NNS O
was VBD O
used VBN O
to TO O
demonstrate VB O
the DT O
impact NN B-OC
of IN O
this DT O
peer-mediated JJ B-INTV
intervention NN I-INTV
. . O

In IN O
the DT O
treatment NN O
group NN O
, , O
we PRP O
found VBD O
significant JJ O
improvements NNS O
in IN O
the DT O
social JJ B-OC
behavior NN I-OC
of IN O
the DT O
children NNS O
with IN O
PDD NNP O
. . O

Several JJ O
gains NNS B-OC
were VBD O
also RB O
generalized VBN O
to TO O
interactions NNS B-OC
with IN I-OC
an DT I-OC
unfamiliar JJ I-OC
nonhandicapped JJ I-OC
peer NN I-OC
, , O
to TO O
interactions NNS B-OC
with IN I-OC
another DT I-OC
child NN I-OC
with IN I-OC
PDD NNP I-OC
, , I-OC
and CC I-OC
to TO I-OC
the DT I-OC
large JJ I-OC
school NN I-OC
setting VBG I-OC
. . O

In IN O
the DT O
untreated JJ O
control NN O
group NN O
, , O
no DT O
positive JJ B-OC
changes NNS I-OC
were VBD O
observed VBN O
. . O

Results VB O
suggest JJS O
that IN O
children NNS B-POPU
with IN I-POPU
PDD NNP I-POPU
can MD O
develop VB O
peer JJ B-OC
relations NNS I-OC
if IN O
appropriate JJ O
social JJ O
contexts NN O
are VBP O
made VBN O
available JJ O
for IN O
them PRP O
. . O

-DOCSTART- -X- O O

The DT O
long-term JJ O
effects NNS O
of IN O
auditory JJ B-INTV
training NN I-INTV
on IN O
children NNS B-POPU
with IN I-POPU
autism NN I-POPU
. . O

Eighty NNP B-POPU
children NNS I-POPU
, , I-POPU
3-17 JJ I-POPU
years NNS I-POPU
of IN I-POPU
age NN I-POPU
, , I-POPU
with IN I-POPU
autism NN I-POPU
or CC I-POPU
Asperger NNP I-POPU
syndrome NN I-POPU
and CC I-POPU
mild NN I-POPU
to TO I-POPU
severe VB I-POPU
distress NN I-POPU
in IN I-POPU
the DT I-POPU
presence NN I-POPU
of IN I-POPU
some DT I-POPU
sounds NNS I-POPU
, , O
were VBD O
randomly RB O
allocated VBN O
to TO O
two CD O
groups NNS O
. . O

The DT O
experimental JJ O
group NN O
received VBD O
auditory JJ B-INTV
training NN I-INTV
and CC I-INTV
the DT I-INTV
control NN I-INTV
group NN I-INTV
listened VBD I-INTV
to TO I-INTV
the DT I-INTV
same JJ I-INTV
unmodified JJ I-INTV
music NN I-INTV
under IN I-INTV
the DT I-INTV
same JJ I-INTV
conditions NNS I-INTV
. . O

Significant JJ O
improvements NNS O
in IN O
behavior NN B-OC
and CC I-OC
severity NN I-OC
of IN I-OC
autism NN I-OC
were VBD O
maintained VBN O
for IN O
12 CD O
months NNS O
by IN O
both DT O
groups NNS O
. . O

Informal NNP O
data NN O
suggested VBD O
that IN O
a DT O
range NN B-OC
of IN I-OC
abnormal JJ I-OC
responses NNS I-OC
to TO O
sound VB B-OC
and CC I-OC
other JJ I-OC
sensory JJ I-OC
abnormalities NNS I-OC
may MD O
also RB O
have VB O
improved VBN O
. . O

Verbal NNP B-OC
and CC I-OC
performance NN I-OC
IQ NNP I-OC
increased VBD O
significantly RB O
3 CD O
to TO O
12 CD O
months NNS O
after IN O
interventions NNS O
. . O

Findings NNS O
suggest VBP O
that IN O
some DT O
aspect NN O
of IN O
both DT O
auditory JJ B-INTV
training NN I-INTV
and CC I-INTV
listening VBG I-INTV
to TO O
selected VBN O
unmodified JJ O
music NN O
may MD O
have VB O
a DT O
beneficial JJ B-OC
effect NN I-OC
on IN O
children NNS B-POPU
with IN I-POPU
autism NN I-POPU
and CC I-POPU
sound JJ I-POPU
sensitivity NN I-POPU
, , O
and CC O
indicate VBP O
a DT O
need NN O
for IN O
further JJ O
research NN O
into IN O
the DT O
effects NNS O
that WDT O
led VBD O
to TO O
these DT O
changes NNS O
and CC O
the DT O
mechanisms NNS O
involved VBN O
in IN O
the DT O
sensory JJ O
abnormalities NNS O
commonly RB O
associated VBN O
with IN O
autism NN O
. . O

-DOCSTART- -X- O O

Effects NNS O
of IN O
ORG-2766 NNP B-INTV
on IN O
brain NN O
event-related JJ O
potentials NNS O
of IN O
autistic JJ B-POPU
children NNS I-POPU
. . O

A DT O
double-blind JJ O
, , O
placebo-controlled JJ O
study NN O
examined VBD O
the DT O
effects NNS O
of IN O
6 CD O
weeks NNS O
of IN O
treatment NN O
with IN O
the DT O
adrenocorticotropin4-9 JJ B-INTV
analogue NN I-INTV
ORG-2766 NNP I-INTV
( ( O
40 CD O
mg/day NN O
) ) O
on IN O
brain NN O
event-related JJ O
potentials NNS O
( ( O
ERPs NNP O
) ) O
of IN O
autistic JJ B-POPU
children NNS I-POPU
. . O

In IN O
visual JJ O
and CC O
auditory JJ O
oddball NN O
paradigms NN O
( ( O
with IN O
task NN O
and CC O
nontask JJ O
conditions NNS O
) ) O
, , O
standard JJ O
( ( O
80 CD O
% NN O
) ) O
, , O
target NN O
( ( O
10 CD O
% NN O
) ) O
, , O
and CC O
unexpected JJ O
novel NN O
stimuli NNS O
( ( O
10 CD O
% NN O
) ) O
were VBD O
presented VBN O
. . O

ORG-2766 NNP O
( ( O
a DT O
) ) O
increased VBD B-OC
the DT I-OC
occipital JJ I-OC
P3 NNP I-OC
component NN I-OC
of IN I-OC
the DT I-OC
ERP NNP I-OC
to TO I-OC
visual JJ I-OC
targets NNS I-OC
, , I-OC
( ( I-OC
b NN I-OC
) ) I-OC
decreased VBD I-OC
the DT I-OC
occipital JJ I-OC
P3 NNP I-OC
component NN I-OC
of IN I-OC
the DT I-OC
ERP NNP I-OC
to TO I-OC
auditory JJ I-OC
targets NNS I-OC
, , I-OC
( ( I-OC
c NN I-OC
) ) I-OC
did VBD I-OC
not RB I-OC
affect VB I-OC
visual JJ I-OC
and CC I-OC
auditory JJ I-OC
parietal JJ I-OC
target NN I-OC
P3 NNP I-OC
components NNS I-OC
, , I-OC
and CC I-OC
( ( I-OC
d NN I-OC
) ) I-OC
also RB I-OC
did VBD I-OC
not RB I-OC
affect VB I-OC
the DT I-OC
A/Pcz/300 NNP I-OC
to TO I-OC
auditory VB I-OC
novel JJ I-OC
stimuli NNS I-OC
. . O

In IN O
addition NN O
, , O
ORG-2766 NNP O
treatment NN O
increased VBD B-OC
the DT I-OC
N1 NNP I-OC
component NN I-OC
of IN I-OC
the DT I-OC
ERP NNP I-OC
to TO I-OC
task-irrelevant JJ I-OC
auditory NN I-OC
stimuli NNS I-OC
. . O

-DOCSTART- -X- O O

Using VBG O
a DT O
choice NN B-INTV
assessment NN I-INTV
to TO O
predict VB O
reinforcer NN O
effectiveness NN O
. . O

A DT B-INTV
choice NN I-INTV
assessment NN I-INTV
has VBZ O
been VBN O
found VBN O
to TO O
be VB O
a DT O
more RBR O
accurate JJ O
method NN O
of IN O
identifying VBG O
preferences NNS O
than IN O
is VBZ O
single-item JJ O
presentation NN O
. . O

However RB O
, , O
it PRP O
is VBZ O
not RB O
clear JJ O
whether IN O
the DT O
effectiveness NN O
of IN O
reinforcement NN O
varies NNS O
positively RB O
with IN O
the DT O
degree NN O
of IN O
preference NN O
( ( O
i.e. FW O
, , O
whether IN O
the DT O
relative JJ O
preference NN O
based VBN O
on IN O
the DT O
results NNS O
of IN O
a DT O
choice NN O
assessment NN O
predicts VBZ O
relative JJ O
reinforcer NN O
effectiveness NN O
) ) O
. . O

In IN O
the DT O
current JJ O
study NN O
, , O
we PRP O
attempted VBD O
to TO O
address VB O
this DT O
question NN O
by IN O
categorizing VBG O
stimuli NNS O
as RB O
high JJ O
, , O
middle JJ O
, , O
and CC O
low JJ O
preference NN O
based VBN O
on IN O
the DT O
results NNS O
of IN O
a DT O
choice NN B-INTV
assessment NN I-INTV
, , O
and CC O
then RB O
comparing VBG O
the DT O
reinforcing VBG O
effectiveness NN O
of IN O
these DT O
stimuli NNS O
using VBG O
a DT O
concurrent NN B-INTV
operants VBZ I-INTV
paradigm JJ I-INTV
. . O

High-preference NN O
stimuli NNS O
consistently RB O
functioned VBN O
as IN O
reinforcers NNS O
for IN O
all DT O
4 CD B-POPU
clients NNS I-POPU
. . O

Middle-preference NN O
stimuli NN O
functioned VBD O
as IN O
reinforcers NNS O
for IN O
2 CD B-POPU
clients NNS I-POPU
, , O
but CC O
only RB O
when WRB O
compared VBN O
with IN O
low-preference NN O
stimuli NNS O
. . O

Low-preference NNP O
stimuli NN O
did VBD O
not RB O
function NN O
as IN O
reinforcers NNS O
when WRB O
compared VBN O
to TO O
high- JJ O
and CC O
middle-preference JJ O
stimuli NNS O
. . O

These DT O
results NNS O
suggest VBP O
that IN O
a DT O
choice NN B-INTV
assessment NN I-INTV
can MD O
be VB O
used VBN O
to TO O
predict VB O
the DT O
relative JJ O
reinforcing VBG O
value NN O
of IN O
various JJ O
stimuli NNS B-OC
, , O
which WDT O
, , O
in IN O
turn NN O
, , O
may MD O
help VB O
to TO O
improve VB O
programs NNS O
for IN O
clients NNS B-POPU
with IN I-POPU
severe JJ I-POPU
to TO I-POPU
profound VB I-POPU
disabilities NNS I-POPU
. . O

-DOCSTART- -X- O O

Pedantic JJ B-INTV
speaking NN I-INTV
style NN O
differentiates VBZ O
Asperger NNP O
syndrome NN O
from IN O
high-functioning JJ O
autism NN O
. . O

Asperger NNP O
syndrome NN O
( ( O
AS IN O
) ) O
is VBZ O
a DT O
pervasive JJ O
developmental NN O
disorder NN O
recently RB O
introduced VBD O
as IN O
a DT O
new JJ O
diagnostic JJ O
category NN O
in IN O
the DT O
ICD-10 NNP O
and CC O
the DT O
DSM-IV NNP O
. . O

Along IN O
with IN O
motor NN O
clumsiness NN O
, , O
pedantic JJ B-INTV
speech NN I-INTV
has VBZ O
been VBN O
proposed VBN O
as IN O
a DT O
clinical JJ O
feature NN O
of IN O
AS NNP O
. . O

However RB O
, , O
few JJ O
attempts NNS O
have VBP O
been VBN O
made VBN O
to TO O
define VB O
and CC O
measure VB O
this DT O
symptom NN O
. . O

We PRP O
studied VBD O
17 CD B-POPU
patients NNS I-POPU
with IN I-POPU
AS NNP I-POPU
( ( I-POPU
ICD-10 NNP I-POPU
; : I-POPU
14 CD I-POPU
male NN I-POPU
, , I-POPU
3 CD I-POPU
female NN I-POPU
; : I-POPU
mean JJ I-POPU
age NN I-POPU
16.4 CD I-POPU
years NNS I-POPU
, , I-POPU
mean JJ I-POPU
full-scale JJ I-POPU
IQ NNP I-POPU
97 CD I-POPU
) ) I-POPU
and CC O
compared VBN B-POPU
them PRP I-POPU
with IN I-POPU
a DT I-POPU
control NN I-POPU
group NN I-POPU
of IN I-POPU
13 CD I-POPU
patients NNS I-POPU
with IN I-POPU
normal-intelligence JJ I-POPU
autism NN I-POPU
or CC I-POPU
high-functioning JJ I-POPU
autism NN I-POPU
( ( I-POPU
HFA NNP I-POPU
) ) I-POPU
( ( I-POPU
ICD-10/DSM-III-R NNP I-POPU
; : I-POPU
12 CD I-POPU
male NN I-POPU
, , I-POPU
1 CD I-POPU
female NN I-POPU
; : I-POPU
mean JJ I-POPU
age NN I-POPU
15.5 CD I-POPU
years NNS I-POPU
, , I-POPU
mean JJ I-POPU
full-scale JJ I-POPU
IQ NNP I-POPU
81.2 CD I-POPU
) ) I-POPU
. . O

An DT O
operational JJ O
definition NN O
of IN O
pedantic JJ O
speech NN O
was VBD O
formulated VBN O
and CC O
a DT O
rating NN O
scale NN O
devised VBD O
. . O

13 CD B-POPU
( ( I-POPU
76 CD I-POPU
% NN I-POPU
) ) I-POPU
of IN I-POPU
the DT I-POPU
AS NNP I-POPU
patients NNS I-POPU
were VBD O
rated VBN O
as IN O
pedantic JJ B-INTV
compared VBN O
to TO O
4 CD B-POPU
( ( I-POPU
31 CD I-POPU
% NN I-POPU
) ) I-POPU
of IN I-POPU
the DT I-POPU
HFA NNP I-POPU
group NN I-POPU
( ( O
chi JJ O
2 CD O
= JJ O
6.3 CD O
; : O
p NN O
= NNP O
.01 NNP O
) ) O
. . O

Results VB O
suggest JJS O
that IN O
pedantic JJ B-INTV
speech NN I-INTV
is VBZ O
common JJ O
in IN O
AS NNP O
and CC O
may MD O
help VB O
differentiate VB B-OC
AS IN I-OC
from IN I-OC
high-functioning JJ I-OC
autism NN I-OC
. . O

-DOCSTART- -X- O O

Opioid-immune JJ O
interactions NNS O
in IN O
autism NN B-POPU
: : I-POPU
behavioural JJ O
and CC O
immunological JJ O
assessment NN O
during IN O
a DT O
double-blind JJ O
treatment NN O
with IN O
naltrexone NN B-INTV
. . O

The DT O
emerging VBG O
concept NN O
of IN O
opioid JJ O
peptides NNS O
as IN O
a DT O
new JJ O
class NN O
of IN O
chemical JJ O
messengers NNS O
of IN O
the DT O
neuroimmune JJ O
axis NN O
and CC O
the DT O
presence NN O
of IN O
a DT O
number NN O
of IN O
immunological JJ O
abnormalities NNS O
in IN O
infantile JJ O
autism NN O
prompted VBD O
us PRP O
to TO O
correlate VB O
biological JJ O
( ( O
hormonal JJ O
and CC O
immunological JJ O
) ) O
determinations NNS O
and CC O
behavioural JJ O
performances NNS O
during IN O
treatment NN O
with IN O
the DT O
potent NN O
opiate JJ O
antagonist NN O
, , O
naltrexone NN B-INTV
( ( I-INTV
NAL NNP I-INTV
) ) I-INTV
. . O

Twelve NNP B-POPU
autistic JJ I-POPU
patients NNS I-POPU
ranging VBG I-POPU
from IN I-POPU
7 CD I-POPU
to TO I-POPU
15 CD I-POPU
years NNS I-POPU
, , I-POPU
diagnosed VBD I-POPU
according VBG I-POPU
to TO I-POPU
DSM-III-R NNP I-POPU
, , O
entered VBD O
a DT O
double-blind JJ B-INTV
crossover NN I-INTV
study NN I-INTV
with IN I-INTV
NAL NNP I-INTV
at IN I-INTV
the DT I-INTV
doses NNS I-INTV
of IN I-INTV
0.5 CD I-INTV
, , I-INTV
1.0 CD I-INTV
and CC I-INTV
1.5 CD I-INTV
mg/kg NN I-INTV
every DT I-INTV
48 CD I-INTV
hours NNS I-INTV
. . O

The DT B-INTV
behavioural JJ I-INTV
evaluation NN I-INTV
was VBD I-INTV
conducted VBN I-INTV
using VBG I-INTV
the DT I-INTV
specific JJ I-INTV
BSE NNP I-INTV
and CC I-INTV
CARS NNP I-INTV
rating NN I-INTV
scales NNS I-INTV
NAL NNP I-INTV
treatment NN I-INTV
produced VBD I-INTV
a DT I-INTV
significant JJ I-INTV
reduction NN I-INTV
of IN I-INTV
the DT I-INTV
autistic JJ I-INTV
symptomatology NN I-INTV
in IN I-INTV
seven CD I-INTV
( ( I-INTV
" JJ I-INTV
responders NNS I-INTV
" VBP I-INTV
) ) I-INTV
out IN I-INTV
of IN I-INTV
12 CD I-INTV
children NNS B-POPU
. . O

The DT O
behavioural JJ O
improvement NN O
was VBD O
accompanied VBN O
by IN O
alterations NNS O
in IN O
the DT O
distribution NN O
of IN O
the DT O
major JJ O
lymphocyte NN O
subsets NNS O
, , O
with IN O
a DT O
significant JJ O
increase NN O
of IN O
the DT O
T-helper-inducers NNP B-OC
( ( I-OC
CD4+CD8- NNP I-OC
) ) I-OC
and CC O
a DT O
significant JJ O
reduction NN O
of IN O
the DT O
T-cytotoxic-suppressor NNP B-OC
( ( I-OC
CD4-CD8+ NNP I-OC
) ) I-OC
resulting VBG O
in IN O
a DT O
normalization NN O
of IN O
the DT O
CD4/CD8 NNP B-OC
ratio NN I-OC
. . O

Changes NNS O
in IN O
natural JJ B-OC
killer NN I-OC
cells NNS I-OC
and CC I-OC
activity NN I-OC
were VBD O
inversely RB O
related VBN O
to TO O
plasma VB O
beta-endorphin JJ O
levels NNS O
. . O

It PRP O
is VBZ O
suggested VBN O
that IN O
the DT O
mechanisms NNS O
underlying VBG O
opioid-immune JJ O
interactions NNS O
are VBP O
altered VBN O
in IN O
this DT O
population NN B-POPU
of IN I-POPU
autistic JJ I-POPU
children NNS I-POPU
and CC O
that DT O
an DT O
immunological JJ O
screening NN O
may MD O
have VB O
prognostic JJ O
value NN O
for IN O
the DT O
pharmacological JJ B-INTV
therapy NN I-INTV
with IN I-INTV
opiate JJ I-INTV
antagonists NNS I-INTV
. . O

-DOCSTART- -X- O O

Treatment NN O
with IN O
buspirone NN B-INTV
in IN O
a DT O
patient NN B-POPU
with IN I-POPU
autism NN I-POPU
. . O

This DT O
study NN O
evaluates VBZ O
the DT O
safety NN O
and CC O
efficacy NN O
of IN O
buspirone NN B-INTV
hydrochloride NN I-INTV
for IN O
the DT O
treatment NN O
of IN O
a DT O
patient NN B-POPU
with IN I-POPU
autism NN I-POPU
and CC I-POPU
hyperactivity NN I-POPU
disorder NN I-POPU
and CC O
determines VBZ O
the DT O
effect NN O
of IN O
buspirone NN B-INTV
on IN O
the DT O
number NN O
of IN O
performance NN O
tasks NNS O
completed VBN O
by IN O
the DT O
patient NN O
at IN O
school NN O
. . O

A DT O
3-week JJ O
, , O
double-blind JJ O
, , O
placebo-controlled JJ B-INTV
crossover NN O
study NN O
was VBD O
performed VBN O
in IN B-POPU
a DT I-POPU
private JJ I-POPU
physician NN I-POPU
, , I-POPU
office-based JJ I-POPU
practice NN I-POPU
. . O

A DT B-POPU
child NN I-POPU
with IN I-POPU
autism NN I-POPU
, , I-POPU
which WDT I-POPU
was VBD I-POPU
diagnosed VBN I-POPU
by IN I-POPU
Diagnostic NNP I-POPU
and CC I-POPU
Statistical NNP I-POPU
Manual NNP I-POPU
of IN I-POPU
Mental NNP I-POPU
Disorders NNP I-POPU
, , I-POPU
Third NNP I-POPU
Edition NNP I-POPU
, , I-POPU
Revised VBN I-POPU
, , I-POPU
criteria NNS I-POPU
, , I-POPU
was VBD I-POPU
studied VBN I-POPU
. . O

The DT O
child NN O
received VBD O
placebo NN B-INTV
for IN I-INTV
3 CD I-INTV
weeks NNS I-INTV
and CC I-INTV
buspirone NN I-INTV
for IN O
3 CD O
weeks NNS O
; : O
there EX O
was VBD O
a DT O
1-week JJ O
interval NN O
between IN O
the DT O
2 CD O
treatments NNS O
. . O

The DT O
outcome NN O
was VBD O
measured VBN O
by IN O
using VBG O
Conners NNS B-OC
abbreviated VBD I-OC
parent NN I-OC
and CC I-OC
teacher NN I-OC
questionnaires NNS I-OC
and CC O
by IN O
determining VBG O
the DT O
number NN O
of IN O
daily JJ O
performance NN O
tasks NNS O
completed VBN O
by IN O
the DT O
child NN O
at IN O
school NN O
. . O

Statistical JJ O
analysis NN O
was VBD O
performed VBN O
by IN O
linear JJ O
models NNS O
and CC O
standard JJ O
F NNP O
tests NNS O
. . O

Buspirone NNP B-INTV
was VBD O
found VBN O
to TO O
be VB O
safe JJ B-OC
and CC I-OC
efficacious JJ I-OC
, , I-OC
without IN I-OC
side JJ I-OC
effects NNS I-OC
, , O
for IN O
decreasing VBG O
hyperactivity NN B-OC
and CC O
increasing VBG O
completed VBN B-OC
performance NN I-OC
tasks NNS I-OC
. . O

The DT O
beneficial JJ O
effects NNS O
of IN O
buspirone NN B-INTV
in IN O
helping VBG O
this DT O
patient NN O
with IN O
autism NN B-POPU
in IN O
his PRP$ O
natural JJ O
daily JJ O
settings NNS O
suggest VBP O
that IN O
buspirone NN O
may MD O
be VB O
an DT O
alternative JJ O
to TO O
neuroleptic JJ O
agents NNS O
in IN O
the DT O
medical JJ O
therapy NN O
of IN O
autism NN O
; : O
further JJ O
study NN O
in IN O
other JJ O
patients NNS O
is VBZ O
needed VBN O
. . O

-DOCSTART- -X- O O

Brief JJ O
report NN O
: : O
autistic JJ B-POPU
children NNS I-POPU
's POS I-POPU
attentiveness NN B-OC
and CC I-OC
responsivity NN I-OC
improve VBP O
after IN O
touch JJ B-INTV
therapy NN I-INTV
. . O

-DOCSTART- -X- O O

High-dose JJ B-INTV
pyridoxine NN I-INTV
and CC I-INTV
magnesium NN I-INTV
administration NN I-INTV
in IN O
children NNS B-POPU
with IN I-POPU
autistic JJ I-POPU
disorder NN I-POPU
: : I-POPU
an DT O
absence NN O
of IN O
salutary JJ O
effects NNS O
in IN O
a DT O
double-blind JJ O
, , O
placebo-controlled JJ O
study NN O
. . O

Several JJ O
reports NNS O
have VBP O
described VBN O
salutary JJ O
effects NNS O
such JJ O
as IN O
decreased JJ O
physical JJ O
aggression NN O
and CC O
improved VBN O
social JJ O
responsiveness NN O
being VBG O
associated VBN O
with IN O
the DT O
administration NN O
of IN O
high JJ O
doses NNS O
of IN O
pyridoxine NN B-INTV
and CC I-INTV
magnesium NN I-INTV
( ( I-INTV
HDPM NNP I-INTV
) ) I-INTV
in IN O
open-labeled JJ O
and CC O
controlled JJ O
studies NNS O
of IN O
patients NNS B-POPU
with IN I-POPU
autism NN I-POPU
. . O

Despite IN O
this DT O
fact NN O
, , O
this DT O
intervention NN O
remains VBZ O
controversial JJ O
. . O

A DT O
10-week JJ O
double-blind NN O
, , O
placebo-controlled JJ O
trial NN O
was VBD O
undertaken VBN O
to TO O
examine VB O
both DT O
the DT O
efficacy NN O
and CC O
safety NN O
of IN O
HDPM NNP B-INTV
in IN O
autism NN O
. . O

Twelve CD B-POPU
patients NNS I-POPU
were VBD I-POPU
enrolled VBN I-POPU
, , I-POPU
and CC I-POPU
10 CD I-POPU
patients NNS I-POPU
( ( I-POPU
mean JJ I-POPU
age NN I-POPU
6 CD I-POPU
years NNS I-POPU
3 CD I-POPU
months NNS I-POPU
) ) I-POPU
were VBD I-POPU
able JJ I-POPU
to TO I-POPU
complete VB I-POPU
the DT I-POPU
study NN I-POPU
. . O

HDPM NNP B-INTV
at IN O
an DT O
average JJ O
dose NN O
of IN O
638.9 CD O
mg NN O
of IN O
pyridoxine NN B-INTV
and CC O
216.3 CD O
mg NN O
of IN O
magnesium NN B-INTV
oxide NN I-INTV
was VBD O
ineffective JJ O
in IN O
ameliorating VBG B-OC
autistic JJ I-OC
behaviors NNS I-OC
as IN O
assessed VBN O
by IN O
the DT O
Children NNP B-OC
's POS I-OC
Psychiatric NNP I-OC
Rating NNP I-OC
Scale NNP I-OC
( ( I-OC
CPRS NNP I-OC
) ) I-OC
, , I-OC
the DT I-OC
Clinical NNP I-OC
Global NNP I-OC
Impression NNP I-OC
Scale NNP I-OC
, , I-OC
and CC I-OC
the DT I-OC
NIMH NNP I-OC
Global NNP I-OC
Obsessive NNP I-OC
Compulsive NNP I-OC
Scale NNP I-OC
. . O

Furthermore NNP O
, , O
no DT O
clinically RB O
significant JJ O
side NN O
effects NNS O
were VBD O
noted VBN O
during IN O
HDPM NNP B-INTV
administration NN O
. . O

A DT O
trend NN O
for IN O
a DT O
transient JJ O
change NN O
on IN O
the DT O
CPRS NNP O
was VBD O
found VBN O
that IN O
was VBD O
possibly RB O
due JJ O
to TO O
a DT O
placebo NN O
response NN O
. . O

This DT O
study NN O
raises VBZ O
doubts NNS O
about IN O
the DT O
clinical JJ O
effectiveness NN O
of IN O
HDPM NNP B-INTV
in IN O
autistic JJ O
disorder NN O
. . O

-DOCSTART- -X- O O

Naltrexone NN B-INTV
in IN O
young JJ B-POPU
autistic JJ I-POPU
children NNS I-POPU
: : I-POPU
replication NN O
study NN O
and CC O
learning NN O
measures NNS O
. . O

OBJECTIVE NNP O
This DT O
study NN O
expanded VBD O
upon RB O
previous JJ O
work NN O
on IN O
naltrexone JJ B-INTV
efficacy NN O
and CC O
safety NN O
in IN O
young JJ B-POPU
autistic JJ I-POPU
children NNS I-POPU
and CC O
assessed JJ O
performance NN O
on IN O
learning VBG O
measures NNS O
. . O

METHOD NNP O
Eleven NNP B-POPU
children NNS I-POPU
with IN I-POPU
autistic JJ I-POPU
disorder NN I-POPU
, , I-POPU
aged VBD I-POPU
3.0 CD I-POPU
to TO I-POPU
8.3 CD I-POPU
years NNS I-POPU
, , O
were VBD O
studied VBN O
in IN O
home NN O
, , O
school NN O
, , O
and CC O
outpatient JJ O
laboratory NN O
, , O
bringing VBG O
to TO O
24 CD O
the DT O
combined VBN O
study NN O
sample NN O
. . O

Naltrexone NNP B-INTV
, , O
1.0 CD O
mg/kg NN O
, , O
was VBD O
given VBN O
daily RB O
in IN O
a DT O
randomized JJ O
, , O
double-blind JJ O
, , O
crossover JJ O
design NN O
. . O

Dependent JJ O
measures NNS O
were VBD O
parent NN O
and CC O
teacher RB O
Clinical JJ B-OC
Global NNP I-OC
Impressions NNP I-OC
( ( I-OC
CGI NNP I-OC
) ) I-OC
and CC O
Naltrexone NNP B-OC
Side NNP I-OC
Effects NNP I-OC
Rating NNP I-OC
Scale NNP I-OC
( ( I-OC
SE NNP I-OC
) ) I-OC
, , I-OC
Conners NNPS I-OC
Parent NNP I-OC
Impulsivity/Hyperactivity NNP I-OC
Factor NNP I-OC
, , I-OC
Teacher NNP I-OC
Hyperactivity NNP I-OC
Factor NNP I-OC
, , O
laboratory NN O
CGI NNP O
, , O
and CC O
analysis NN O
of IN O
videotaped JJ O
behavior NN O
. . O

Learning VBG O
measures NNS O
were VBD O
the DT O
Early JJ B-OC
Intervention NNP I-OC
Developmental NNP I-OC
Profile-Language NNP I-OC
and CC O
paired-associate JJ B-OC
learning NN I-OC
. . O

RESULTS JJ O
Comparisons NNPS O
between IN O
naltrexone NN B-INTV
and CC O
baseline NN O
, , O
but CC O
not RB O
naltrexone RB B-INTV
and CC O
placebo NN B-INTV
, , O
on IN O
parent NN O
and CC O
teacher NN O
ratings NNS O
showed VBD O
statistical JJ O
significance NN O
. . O

Three CD O
of IN O
11 CD O
subjects NNS O
improved VBN O
in IN O
two CD O
or CC O
more JJR O
settings NNS O
. . O

Side JJ B-OC
effects NNS I-OC
were VBD O
mild JJ O
. . O

Administering VBG O
naltrexone NN B-INTV
was VBD O
a DT O
challenge NN O
. . O

The DT O
combined JJ O
study NN O
sample NN O
showed VBD O
improvement NN O
on IN O
all DT O
parent NN B-OC
measures NNS I-OC
and CC O
on IN O
Teacher NNP B-OC
CGI NNP I-OC
and CC O
SE-Restlessness NNP B-OC
compared VBN O
with IN O
baseline NN O
and CC O
placebo NN B-INTV
. . O

Eleven NNP O
of IN O
the DT O
24 CD B-POPU
children NNS I-POPU
improved VBN O
in IN O
two CD O
or CC O
more JJR O
settings NNS O
. . O

Scores NNS O
on IN O
learning VBG B-OC
measures NNS I-OC
did VBD O
not RB O
change VB O
across IN O
conditions NNS O
. . O

CONCLUSIONS NNP O
Naltrexone NNP B-INTV
was VBD O
associated VBN O
with IN O
modest JJ O
improvement NN O
of IN O
behavior NN B-OC
in IN O
11 CD O
of IN O
24 CD O
children NNS O
, , O
but CC O
learning VBG B-OC
did VBD O
not RB O
improve VB O
. . O

-DOCSTART- -X- O O

A DT O
double-blind JJ O
, , O
placebo-controlled JJ O
study NN O
of IN O
risperidone NN B-INTV
in IN O
adults NNS B-POPU
with IN I-POPU
autistic JJ I-POPU
disorder NN I-POPU
and CC I-POPU
other JJ I-POPU
pervasive JJ I-POPU
developmental NN I-POPU
disorders NNS I-POPU
. . O

BACKGROUND NNP O
Neurobiological NNP O
research NN O
has VBZ O
implicated VBN O
the DT O
dopamine NN O
and CC O
serotonin JJ O
systems NNS O
in IN O
the DT O
pathogenesis NN O
of IN O
autism NN B-POPU
. . O

Open-label JJ O
reports NNS O
suggest VBP O
that IN O
the DT O
serotonin2A-dopamine JJ B-INTV
D2 NNP I-INTV
antagonist NN I-INTV
risperidone NN I-INTV
may MD O
be VB O
safe JJ O
and CC O
effective JJ O
in IN O
reducing VBG O
the DT O
interfering NN O
symptoms NNS O
of IN O
patients NNS B-POPU
with IN I-POPU
autism NN I-POPU
. . O

METHODS NNP O
Thirty-one CD B-POPU
adults NNS I-POPU
( ( I-POPU
age NN I-POPU
[ VBZ I-POPU
mean+/-SD JJ I-POPU
] NNP I-POPU
, , I-POPU
28.1+/-7.3 JJ I-POPU
years NNS I-POPU
) ) I-POPU
with IN I-POPU
autistic JJ I-POPU
disorder NN I-POPU
( ( I-POPU
n=17 JJ I-POPU
) ) I-POPU
or CC I-POPU
pervasive JJ I-POPU
developmental JJ I-POPU
disorder NN I-POPU
not RB I-POPU
otherwise RB I-POPU
specified VBN I-POPU
( ( I-POPU
n=14 JJ I-POPU
) ) I-POPU
participated VBD I-POPU
in IN I-POPU
a DT I-POPU
12-week JJ I-POPU
double-blind NN I-POPU
, , I-POPU
placebo-controlled JJ I-POPU
trial NN I-POPU
of IN I-POPU
risperidone NN I-POPU
. . O

Patients NNS O
treated VBD O
with IN O
placebo NN O
subsequently RB O
received VBD O
a DT O
12-week JJ O
open-label JJ O
trial NN O
of IN O
risperidone NN B-INTV
. . O

RESULTS NNP O
For IN O
persons NNS O
completing VBG O
the DT O
study NN O
, , O
8 CD O
( ( O
57 CD O
% NN O
) ) O
of IN O
14 CD O
patients NNS O
treated VBN O
with IN O
risperidone NN B-INTV
were VBD O
categorized VBN O
as IN O
responders NNS O
( ( O
daily JJ O
dose VB O
[ JJ O
mean+/-SD JJ O
] NN O
, , O
2.9+/-1.4 JJ O
mg NN O
) ) O
compared VBN O
with IN O
none NN O
of IN O
16 CD O
in IN O
the DT O
placebo NN B-INTV
group NN O
( ( O
P NNP O
< NNP O
.002 NNP O
) ) O
. . O

Risperidone NN B-INTV
was VBD O
superior JJ O
to TO O
placebo VB B-INTV
in IN O
reducing VBG O
repetitive JJ B-OC
behavior NN I-OC
( ( O
P NNP O
< NNP O
.001 NNP O
) ) O
, , O
aggression NN B-OC
( ( O
P NNP O
< NNP O
.001 NNP O
) ) O
, , O
anxiety NN B-OC
or CC I-OC
nervousness NN I-OC
( ( I-OC
P NNP I-OC
< NNP I-OC
.02 NNP I-OC
) ) I-OC
, , I-OC
depression NN I-OC
( ( I-OC
P NNP I-OC
< NNP I-OC
.03 NNP I-OC
) ) I-OC
, , I-OC
irritability NN I-OC
( ( I-OC
P NNP I-OC
< NNP I-OC
.01 NNP I-OC
) ) I-OC
, , O
and CC O
the DT O
overall JJ B-OC
behavioral JJ I-OC
symptoms NNS I-OC
of IN I-OC
autism NN I-OC
( ( O
P NNP O
< NNP O
.02 NNP O
) ) O
. . O

Objective NNP O
, , O
measurable JJ O
change NN O
in IN O
social JJ B-OC
behavior NN I-OC
and CC I-OC
language NN I-OC
did VBD O
not RB O
occur VB O
. . O

Nine NNP O
( ( O
60 CD O
% NN O
) ) O
of IN O
15 CD O
patients NNS O
who WP O
received VBD O
treatment NN O
with IN O
open-label JJ O
risperidone NN O
following VBG O
the DT O
double-blind JJ O
placebo NN B-INTV
phase NN O
responded VBD O
. . O

Other JJ O
than IN O
mild JJ B-OC
, , I-OC
transient JJ I-OC
sedation NN I-OC
, , O
risperidone NN O
was VBD O
well RB O
tolerated VBN B-OC
, , O
with IN O
no DT O
evidence NN O
of IN O
extrapyramidal JJ B-OC
effects NNS I-OC
, , I-OC
cardiac JJ I-OC
events NNS I-OC
, , I-OC
or CC I-OC
seizures NNS I-OC
. . O

CONCLUSION NNP O
Risperidone NNP B-INTV
is VBZ O
more RBR O
effective JJ O
than IN O
placebo NN B-INTV
in IN O
the DT O
short-term JJ O
treatment NN O
of IN O
symptoms NNS O
of IN O
autism NN B-POPU
in IN I-POPU
adults NNS I-POPU
. . O

-DOCSTART- -X- O O

Behavioral JJ B-OC
changes NNS I-OC
in IN O
autistic JJ B-POPU
individuals NNS I-POPU
as IN O
a DT O
result NN O
of IN O
wearing VBG O
ambient JJ B-INTV
transitional JJ I-INTV
prism NN I-INTV
lenses NNS I-INTV
. . O

A DT O
double-blind JJ O
crossover NN O
design NN O
was VBD O
used VBN O
to TO O
assess VB O
the DT O
efficacy NN O
of IN O
wearing VBG B-INTV
ambient JJ I-INTV
lenses NNS I-INTV
to TO O
reduce VB O
the DT O
behavioral JJ O
symptoms NNS O
of IN O
autism NN O
. . O

Eighteen NNP B-POPU
autistic JJ I-POPU
individuals NNS I-POPU
, , I-POPU
ranging VBG I-POPU
in IN I-POPU
age NN I-POPU
from IN I-POPU
7 CD I-POPU
to TO I-POPU
18 CD I-POPU
years NNS I-POPU
, , O
participated VBD O
in IN O
the DT O
study NN O
. . O

Behavior NNP B-OC
, , I-OC
attention NN I-OC
, , I-OC
and CC I-OC
orientation NN I-OC
were VBD O
evaluated VBN O
at IN O
1 CD O
1/2 CD O
months NNS O
, , O
2 CD O
months NNS O
, , O
3 CD O
months NNS O
, , O
and CC O
4 CD O
months NNS O
. . O

Compared VBN O
to TO O
the DT O
placebo NN B-INTV
condition NN O
, , O
the DT O
results NNS O
showed VBD O
a DT O
decrease NN O
in IN O
behavior JJ B-OC
problems NNS I-OC
at IN O
the DT O
1 CD O
1/2 CD O
and CC O
2 CD O
month NN O
assessment NN O
periods NNS O
and CC O
a DT O
slight JJ O
loss NN O
of IN O
these DT O
benefits NNS O
at IN O
the DT O
3 CD O
and CC O
4 CD O
month NN O
assessment NN O
periods NNS O
. . O

These DT O
findings NNS O
support VBP O
the DT O
prediction NN O
that WDT O
ambient JJ B-INTV
lenses NNS I-INTV
, , O
worn VBN O
without IN O
engaging VBG O
in IN O
visual-motor NN O
exercises NNS O
, , O
have VBP O
positive JJ O
effects NNS O
on IN O
autistic JJ B-POPU
individuals NNS I-POPU
. . O

-DOCSTART- -X- O O

Treatment NN O
of IN O
children NNS B-POPU
with IN I-POPU
autism NN I-POPU
: : I-POPU
a DT O
randomized NN O
controlled VBN O
trial NN O
to TO O
evaluate VB O
a DT O
caregiver-based JJ B-INTV
intervention NN I-INTV
program NN I-INTV
in IN O
community NN B-POPU
day-care NN I-POPU
centers NNS I-POPU
. . O

This DT O
study NN O
reports VBZ O
on IN O
the DT O
results NNS O
of IN O
a DT O
randomized VBN O
controlled VBN O
trial NN O
that WDT O
evaluated VBD O
a DT O
caregiver-based JJ B-INTV
intervention NN I-INTV
program NN I-INTV
for IN O
children NNS B-POPU
with IN I-POPU
autism NN I-POPU
in IN I-POPU
community NN I-POPU
day-care NN I-POPU
centers NNS I-POPU
. . O

Thirty-five JJ B-POPU
preschool NN I-POPU
children NNS I-POPU
with IN I-POPU
a DT I-POPU
DSM NNP I-POPU
III-R NNP I-POPU
diagnosis NN I-POPU
of IN I-POPU
autism NN I-POPU
or CC I-POPU
pervasive JJ I-POPU
developmental JJ I-POPU
disorder NN I-POPU
were VBD O
randomized VBN O
to TO O
an DT O
experimental JJ O
or CC O
control NN O
group NN O
. . O

Children NNP O
in IN O
the DT O
experimental JJ O
group NN O
were VBD O
enrolled VBN O
in IN O
day NN O
care NN O
and CC O
their PRP$ O
parents NNS B-INTV
and CC I-INTV
child NN I-INTV
care NN I-INTV
workers NNS I-INTV
received VBD I-INTV
a DT I-INTV
12-week JJ I-INTV
intervention NN I-INTV
consisting NN I-INTV
of IN I-INTV
lectures NNS I-INTV
and CC I-INTV
on-site JJ I-INTV
consultations NNS I-INTV
to TO I-INTV
day-care JJ I-INTV
centers NNS I-INTV
. . O

In IN O
addition NN O
, , O
supportive JJ O
work NN O
was VBD O
undertaken VBN O
with IN O
families NNS O
. . O

Control NNP O
subjects VBZ O
received VBN O
day NN B-INTV
care VB I-INTV
alone RB I-INTV
. . O

In IN O
the DT O
experimental JJ O
group NN O
, , O
there EX O
were VBD O
greater JJR O
gains NNS O
in IN O
language NN B-OC
abilities NNS I-OC
, , O
significant JJ O
increases NNS O
in IN O
caregivers NNS B-OC
' POS I-OC
knowledge NN I-OC
about IN I-OC
autism NN I-OC
, , O
greater JJR O
perception NN B-OC
of IN I-OC
control NN I-OC
on IN I-OC
the DT I-OC
part NN I-OC
of IN I-OC
mothers NNS I-OC
, , O
and CC O
greater JJR O
parent NN B-OC
satisfaction NN I-OC
. . O

We PRP O
conclude VBP O
that IN O
this DT O
research NN O
design NN O
demonstrated VBD O
that IN O
the DT O
intervention NN O
was VBD O
significantly RB O
superior JJ O
to TO O
day NN O
care VB O
alone RB O
. . O

-DOCSTART- -X- O O

Randomized VBN O
trial NN O
of IN O
intensive JJ B-INTV
early JJ I-INTV
intervention NN I-INTV
for IN O
children NNS B-POPU
with IN I-POPU
pervasive JJ I-POPU
developmental JJ I-POPU
disorder NN I-POPU
. . O

Young NNP B-POPU
children NNS I-POPU
with IN I-POPU
pervasive JJ I-POPU
developmental JJ I-POPU
disorder NN I-POPU
were VBD O
randomly RB O
assigned VBN O
to TO O
intensive VB B-INTV
treatment NN I-INTV
or CC O
parent NN B-INTV
training NN I-INTV
. . O

The DT O
intensive JJ B-INTV
treatment NN I-INTV
group NN O
( ( B-POPU
7 CD I-POPU
with IN I-POPU
autism NN I-POPU
, , I-POPU
8 CD I-POPU
with IN I-POPU
pervasive JJ I-POPU
developmental JJ I-POPU
disorder NN I-POPU
not RB I-POPU
otherwise RB I-POPU
specified VBN I-POPU
-- : I-POPU
NOS NNP I-POPU
) ) I-POPU
averaged VBD O
24.52 CD O
hours NNS O
per IN O
week NN O
of IN O
individual JJ O
treatment NN O
for IN O
one CD O
year NN O
, , O
gradually RB O
reducing VBG O
hours NNS O
over IN O
the DT O
next JJ O
1 CD O
to TO O
2 CD O
years NNS O
. . O

The DT O
parent NN B-INTV
training NN I-INTV
group NN O
( ( B-POPU
7 CD I-POPU
with IN I-POPU
autism NN I-POPU
, , I-POPU
6 CD I-POPU
with IN I-POPU
pervasive JJ I-POPU
developmental JJ I-POPU
disorder NN I-POPU
NOS NNP I-POPU
) ) I-POPU
received VBD O
3 CD O
to TO O
9 CD O
months NNS O
of IN O
parent NN B-INTV
training NN I-INTV
. . O

The DT O
groups NNS O
appeared VBD O
similar JJ O
at IN O
intake NN O
on IN O
all DT O
measures NNS O
; : O
however RB O
, , O
at IN O
follow-up JJ O
the DT O
intensive JJ B-INTV
treatment NN I-INTV
group NN O
outperformed VBD O
the DT O
parent NN B-INTV
training VBG I-INTV
group NN O
on IN O
measures NNS O
of IN O
intelligence NN B-OC
, , I-OC
visual-spatial JJ I-OC
skills NNS I-OC
, , I-OC
language NN I-OC
, , I-OC
and CC I-OC
academics NNS I-OC
, , O
though IN O
not RB O
adaptive JJ B-OC
functioning NN I-OC
or CC O
behavior NN B-OC
problems NNS I-OC
. . O

Children NNP B-POPU
with IN I-POPU
pervasive JJ I-POPU
developmental JJ I-POPU
disorder NN I-POPU
NOS NNP I-POPU
may MD O
have VB O
gained VBN O
more JJR O
than IN O
those DT O
with IN O
autism NN B-POPU
. . O

-DOCSTART- -X- O O

Combined VBN B-INTV
descriptive JJ I-INTV
and CC I-INTV
explanatory JJ I-INTV
information NN I-INTV
improves VBZ O
peers NNS B-POPU
' POS I-POPU
perceptions NNS B-OC
of IN O
autism NN O
. . O

Authors NNS O
examined VBD O
the DT O
combined JJ O
effects NNS O
of IN O
descriptive JJ B-INTV
and CC I-INTV
explanatory JJ I-INTV
information NN I-INTV
on IN O
peers NNS B-POPU
' POS I-POPU
perceptions NNS B-OC
and CC I-OC
behavioral JJ I-OC
intentions NNS I-OC
toward IN O
an DT O
unfamiliar JJ O
child NN B-POPU
with IN I-POPU
autism NN I-POPU
. . O

Children NNP B-POPU
( ( I-POPU
N NNP I-POPU
= NNP I-POPU
576 CD I-POPU
; : I-POPU
M NNP I-POPU
age NN I-POPU
= VBD I-POPU
10.06 CD I-POPU
) ) I-POPU
were VBD O
randomly RB O
assigned VBN O
to TO O
view VB O
two CD O
videotapes NNS O
of IN O
a DT O
boy NN O
engaging VBG O
in IN O
typical JJ O
and CC O
autistic JJ O
behaviors NNS O
receiving VBG O
either RB O
descriptive JJ B-INTV
( ( I-INTV
AUT-D NNP I-INTV
) ) I-INTV
or CC O
descriptive JJ B-INTV
and CC I-INTV
explanatory JJ I-INTV
information NN I-INTV
( ( I-INTV
AUT-D NNP I-INTV
+ NNP I-INTV
E NNP I-INTV
) ) I-INTV
. . O

Children NNP O
responded VBD O
to TO O
measures NNS B-OC
of IN I-OC
attitudes NNS I-OC
( ( I-OC
Adjective NNP I-OC
Checklist NNP I-OC
) ) I-OC
and CC I-OC
behavioral JJ I-OC
intentions NNS I-OC
( ( I-OC
Shared NNP I-OC
Activities NNP I-OC
Questionnaire NNP I-OC
) ) I-OC
. . O

Children NNP O
rated VBD O
the DT O
typical JJ O
boy NN O
more RBR O
favorably RB O
than IN O
the DT O
boy NN O
showing VBG O
autistic JJ O
symptoms NNS O
. . O

When WRB O
compared VBN O
to TO O
descriptive VB B-INTV
information NN I-INTV
alone RB O
, , O
the DT O
combination NN B-INTV
of IN I-INTV
descriptive JJ I-INTV
and CC I-INTV
explanatory JJ I-INTV
information NN I-INTV
resulted VBD O
in IN O
improved JJ O
third- JJ O
and CC O
fourth-graders NNS O
' '' O
but CC O
not RB O
fifth-graders NNS O
' POS O
attitudes NNS O
toward IN O
the DT O
child NN O
with IN O
autism NN O
. . O

Combined VBN O
information NN O
improved VBN O
behavioral JJ B-OC
intentions NNS I-OC
across IN O
grades NNS O
; : O
however RB O
, , O
girls NNS O
( ( O
vs. FW O
boys NNS O
) ) O
were VBD O
more RBR O
responsive JJ O
to TO O
information NN O
as IN O
evidenced VBN O
by IN O
differences NNS O
in IN O
academic JJ B-OC
intentions NNS I-OC
. . O

The DT O
combination NN B-INTV
of IN I-INTV
descriptive JJ I-INTV
and CC I-INTV
explanatory JJ I-INTV
information NN I-INTV
about IN O
autism NN O
appears VBZ O
to TO O
have VB O
a DT O
positive JJ O
effect NN O
on IN O
children NNS B-POPU
's POS I-POPU
attitudes NNS B-OC
and CC I-OC
behavioral JJ I-OC
intentions NNS I-OC
. . O

Implications NNS O
of IN O
the DT O
findings NNS O
are VBP O
briefly RB O
discussed VBN O
as RB O
well RB O
as IN O
study NN O
limitations NNS O
and CC O
recommendations NNS O
for IN O
future JJ O
research NN O
. . O

-DOCSTART- -X- O O

Superior JJ O
visual JJ B-INTV
search NN I-INTV
in IN O
adults NNS B-POPU
with IN I-POPU
autism NN I-POPU
. . O

Recent JJ O
studies NNS O
have VBP O
suggested VBN O
that IN O
children NNS O
with IN O
autism NN O
perform NN O
better RBR O
than IN O
matched VBN O
controls NNS O
on IN O
visual JJ B-INTV
search NN I-INTV
tasks NNS B-OC
and CC O
that IN O
this DT O
stems VBZ O
from IN O
a DT O
superior JJ O
visual JJ O
discrimination NN O
ability NN O
. . O

This DT O
study NN O
assessed VBD O
whether IN O
these DT O
findings NNS O
generalize VBP O
from IN O
children NNS O
to TO O
adults NNS B-POPU
with IN I-POPU
autism NN I-POPU
. . O

Experiments NNS O
1 CD O
and CC O
2 CD O
showed VBD O
that IN O
, , O
like IN O
children NNS O
, , O
adults NNS B-POPU
with IN I-POPU
autism NN I-POPU
were VBD O
superior JJ O
to TO O
controls NNS O
at IN O
searching VBG B-OC
for IN I-OC
targets NNS I-OC
. . O

Experiment NN O
3 CD O
showed VBD O
that IN O
increases NNS O
in IN O
target-distractor JJ O
similarity NN O
slowed VBD O
the DT O
visual JJ B-OC
search NN I-OC
performance NN I-OC
of IN O
the DT O
control NN O
group NN O
significantly RB O
more RBR O
than IN O
that DT O
of IN O
the DT O
autism NN O
group NN O
, , O
suggesting VBG O
that IN O
the DT O
adults NNS B-POPU
with IN I-POPU
autism NN I-POPU
have VBP O
a DT O
superior JJ O
visual JJ B-OC
discrimination NN I-OC
ability NN I-OC
. . O

Thus RB O
, , O
these DT O
experiments NNS O
replicate VBP O
in IN O
adults NNS O
previous JJ O
findings NNS O
in IN O
children NNS O
with IN O
autism NN O
. . O

Superior NNP O
unique JJ B-OC
item NN I-OC
detection NN I-OC
in IN O
adults NNS B-POPU
with IN I-POPU
autism NN I-POPU
, , O
stemming VBG O
from IN O
enhanced VBN O
discrimination NN B-OC
, , O
is VBZ O
discussed VBN O
in IN O
the DT O
light NN O
of IN O
the DT O
possible JJ O
role NN O
of IN O
stimulus JJ O
processing NN O
disturbances NNS O
in IN O
the DT O
disorder NN O
in IN O
general JJ O
. . O

-DOCSTART- -X- O O

Intervention NN B-INTV
pilot NN O
for IN O
parents NNS B-POPU
of IN I-POPU
children NNS I-POPU
with IN I-POPU
autistic JJ I-POPU
spectrum NN I-POPU
disorder NN I-POPU
. . O

Parents NNS B-POPU
of IN I-POPU
children NNS I-POPU
who WP I-POPU
receive VBP I-POPU
the DT I-POPU
diagnosis NN I-POPU
of IN I-POPU
autistic JJ I-POPU
spectrum NN I-POPU
disorder NN I-POPU
( ( I-POPU
ASD NNP I-POPU
) ) I-POPU
experience NN O
a DT O
situational JJ O
crisis NN O
related VBN O
to TO O
receiving VBG O
the DT O
diagnosis NN O
, , O
which WDT O
causes VBZ O
feelings NNS O
of IN O
distress NN O
and CC O
urgency NN O
to TO O
access NN O
services NNS O
for IN O
the DT O
affected JJ O
child NN O
. . O

This DT O
paper NN O
describes VBZ O
a DT O
randomized JJ O
trial NN O
( ( O
n JJ O
= NNP O
31 CD O
) ) O
that WDT O
was VBD O
conducted VBN O
at IN O
a DT O
regional JJ O
diagnostic JJ O
center NN O
of IN O
a DT O
large JJ O
metropolitan JJ O
children NNS O
's POS O
hospital NN O
to TO O
( ( O
a DT O
) ) O
refine NN O
a DT O
nursing NN B-INTV
intervention NN I-INTV
designed VBN O
for IN O
parents NNS B-POPU
of IN I-POPU
children NNS I-POPU
with IN I-POPU
ASD NNP I-POPU
and CC O
( ( O
b NN O
) ) O
to TO O
identify VB O
methodological JJ O
revisions NNS O
for IN O
a DT O
larger JJR O
study NN O
. . O

A DT O
secondary JJ O
purpose NN O
was VBD O
to TO O
test VB O
the DT O
effects NNS B-OC
of IN O
a DT O
post-diagnosis JJ B-INTV
nursing NN I-INTV
intervention NN I-INTV
on IN O
parents NNS B-OC
' POS I-OC
reports NNS I-OC
of IN I-OC
stress NN I-OC
, , I-OC
impact NN I-OC
of IN I-OC
event NN I-OC
( ( I-OC
diagnosis NN I-OC
) ) I-OC
, , I-OC
and CC I-OC
use NN I-OC
of IN I-OC
services NNS I-OC
after IN O
a DT O
child NN O
is VBZ O
newly RB O
diagnosed VBN O
with IN O
ASD NNP O
. . O

The DT O
intervention NN O
consisted VBD O
of IN O
usual JJ B-INTV
care NN I-INTV
plus CC O
3 CD O
hours NNS O
contact NN B-INTV
with IN I-INTV
a DT I-INTV
pediatric JJ I-INTV
nurse NN I-INTV
practitioner NN I-INTV
( ( I-INTV
PNP NNP I-INTV
) ) I-INTV
for IN I-INTV
counseling NN I-INTV
, , I-INTV
instruction NN I-INTV
, , I-INTV
and CC I-INTV
assistance NN I-INTV
with IN I-INTV
implementation NN I-INTV
of IN I-INTV
the DT I-INTV
recommended VBN I-INTV
treatment NN I-INTV
plan NN I-INTV
. . O

The DT O
control NN O
group NN O
received VBD O
only RB O
the DT O
usual JJ B-INTV
care NN I-INTV
post-diagnosis NN O
, , O
which WDT O
consisted VBD O
of IN O
a DT O
1-hour JJ O
consultation NN B-INTV
session NN I-INTV
to TO I-INTV
receive VB I-INTV
the DT I-INTV
results NNS I-INTV
of IN I-INTV
diagnostic JJ I-INTV
tests NNS I-INTV
and CC I-INTV
a DT I-INTV
written VBN I-INTV
copy NN I-INTV
of IN I-INTV
the DT I-INTV
recommended VBN I-INTV
treatment NN I-INTV
plan NN I-INTV
provided VBN O
by IN O
a DT O
developmental JJ O
pediatrician JJ O
and/or NN O
PNP NNP O
. . O

Between NNP O
group NN O
differences NNS O
in IN O
measures NNS O
of IN O
" NNP B-OC
impact NN I-OC
of IN I-OC
event NN I-OC
" NN I-OC
and CC O
" NNP B-OC
perceived VBD I-OC
stress JJ I-OC
" NNS I-OC
were VBD O
not RB O
statistically RB O
significant JJ O
. . O

This DT O
was VBD O
attributed VBN O
to TO O
a DT O
small JJ O
sample NN O
size NN O
. . O

A NNP O
larger JJR O
study NN O
is VBZ O
feasible JJ O
and CC O
recommended VBD O
with IN O
an DT O
expanded JJ O
nursing NN B-INTV
intervention NN I-INTV
and CC O
a DT O
significantly RB O
larger JJR O
sample NN O
recruited VBD O
from IN O
an DT O
additional JJ O
recruitment NN O
site NN O
. . O

Nurses NNS O
working VBG O
with IN O
this DT O
special JJ O
population NN O
must MD O
recognize VB O
that IN O
parents NNS O
have VBP O
information NN O
and CC O
counseling NN O
needs NNS O
that WDT O
begin VBP O
after IN O
they PRP O
receive VBP O
the DT O
diagnosis NN O
of IN O
ASD NNP O
for IN O
their PRP$ O
child NN O
and CC O
can MD O
address VB O
these DT O
needs NNS O
with IN O
a DT O
standardized JJ O
nursing NN B-INTV
intervention NN I-INTV
. . O

-DOCSTART- -X- O O

Language NNP B-OC
outcome NN I-OC
in IN O
autism NN B-POPU
: : I-POPU
randomized JJ O
comparison NN O
of IN O
joint JJ B-INTV
attention NN I-INTV
and CC O
play NN B-INTV
interventions NNS I-INTV
. . O

This DT O
study NN O
reports VBZ O
results NNS O
of IN O
a DT O
randomized VBN O
controlled VBN O
trial NN O
aimed VBN O
at IN O
joint JJ B-INTV
attention NN I-INTV
( ( I-INTV
JA NNP I-INTV
) ) I-INTV
and CC O
symbolic JJ B-INTV
play NN I-INTV
( ( I-INTV
SP NNP I-INTV
) ) I-INTV
in IN O
preschool NN B-POPU
children NNS I-POPU
with IN I-POPU
autism NN I-POPU
, , O
with IN O
prediction NN O
to TO O
language NN B-OC
outcome RB I-OC
12 CD O
months NNS O
later RB O
. . O

Participants NNS B-POPU
were VBD I-POPU
58 CD I-POPU
children NNS I-POPU
( ( I-POPU
46 CD I-POPU
boys NNS I-POPU
) ) I-POPU
with IN I-POPU
autism NN I-POPU
between IN I-POPU
3 CD I-POPU
and CC I-POPU
4 CD I-POPU
years NNS I-POPU
of IN I-POPU
age NN I-POPU
. . O

Children NNP O
were VBD O
randomized VBN O
to TO O
a DT O
JA NNP B-INTV
intervention NN O
, , O
an DT O
SP NNP B-INTV
intervention NN O
, , O
or CC O
control NN O
group NN O
. . O

Interventions NNS O
were VBD O
conducted VBN O
30 CD O
min JJ O
daily JJ O
for IN O
5-6 JJ O
weeks NNS O
. . O

Assessments NNS O
of IN O
JA NNP B-INTV
skills NNS B-OC
, , I-OC
SP NNP B-INTV
skills NNS B-OC
, , I-OC
mother-child JJ I-OC
interactions NNS I-OC
, , I-OC
and CC I-OC
language NN I-OC
development NN I-OC
were VBD O
collected VBN O
at IN O
4 CD O
time NN O
points NNS O
: : O
pre- NN O
and CC O
postintervention NN O
and CC O
6 CD O
and CC O
12 CD O
months NNS O
postintervention NN O
by IN O
independent JJ O
testers NNS O
. . O

Results NNS O
indicate VBP O
that IN O
expressive JJ B-OC
language NN I-OC
gains NNS I-OC
were VBD O
greater JJR O
for IN O
both DT O
treatment NN O
groups NNS O
compared VBN O
with IN O
the DT O
control NN O
group NN O
, , O
and CC O
results NNS O
could MD O
not RB O
be VB O
explained VBN O
by IN O
differences NNS O
in IN O
other JJ O
interventions NNS O
in IN O
which WDT O
children NNS O
participated VBD O
. . O

For IN O
children NNS O
beginning VBG O
treatment NN O
with IN O
the DT O
lowest JJS O
language NN O
levels NNS O
, , O
the DT O
JA NNP B-INTV
intervention NN O
improved VBD O
language NN B-OC
outcome NN I-OC
significantly RB O
more RBR O
than IN O
did VBD O
the DT O
SP NNP B-INTV
or CC O
control VB O
interventions NNS O
. . O

These DT O
findings NNS O
suggest VBP O
clinically RB O
significant JJ O
benefits NNS O
of IN O
actively RB O
treating VBG O
JA NNP B-INTV
and CC O
SP NNP B-INTV
skills NNS O
in IN O
young JJ B-POPU
children NNS I-POPU
with IN I-POPU
autism NN I-POPU
. . O

-DOCSTART- -X- O O

[ JJ O
Effects NNS O
of IN O
auditory JJ B-INTV
integrative JJ I-INTV
training NN I-INTV
on IN O
autistic JJ B-POPU
children NNS I-POPU
] VBP I-POPU
. . O

OBJECTIVE NNP O
To TO O
explore VB O
the DT O
short-term JJ O
treatment NN O
effect NN B-OC
of IN O
the DT O
auditory JJ B-INTV
integrative JJ I-INTV
training NN I-INTV
on IN O
autistic JJ B-POPU
children NNS I-POPU
and CC O
provide VB O
them PRP O
with IN O
clinical JJ O
support NN O
for IN O
rehabilitative JJ O
treatment NN O
. . O

METHODS NNP O
A NNP O
total NN O
of IN O
81 CD B-POPU
cases NNS I-POPU
of IN I-POPU
autistic JJ I-POPU
children NNS I-POPU
were VBD I-POPU
selected VBN I-POPU
through IN O
the DT O
standard NN O
of IN O
DSM-4 NNP O
and CC O
clinical JJ O
case NN O
study NN O
was VBD O
used VBN O
. . O

They PRP O
were VBD O
divided VBN O
randomly RB O
into IN O
experimental JJ O
group NN O
and CC O
control VB O
one CD O
, , O
and CC O
respectively RB O
received VBD O
auditory JJ B-INTV
integrative JJ I-INTV
training NN I-INTV
and CC O
no DT O
training NN O
based VBN O
on IN O
the DT O
multiple JJ O
therapies NNS O
. . O

The DT O
patients NNS O
were VBD O
investigated VBN O
using VBG O
clinical JJ B-OC
manifestation NN I-OC
and CC I-OC
Autism NNP I-OC
Behavior NNP I-OC
Checklist NNP I-OC
( ( I-OC
ABC NNP I-OC
) ) I-OC
and CC I-OC
intelligence NN I-OC
quotient NN I-OC
( ( I-OC
IQ NNP I-OC
) ) I-OC
before IN O
and CC O
after IN O
six CD O
months NNS O
of IN O
treatment NN O
. . O

The DT O
effect NN O
was VBD O
evaluated VBN O
through IN O
the DT O
changes NNS B-OC
of IN I-OC
clinical JJ I-OC
manifestations NNS I-OC
and CC I-OC
scores NNS I-OC
of IN I-OC
ABC NNP I-OC
and CC I-OC
IQ NNP I-OC
. . O

The DT O
changes NNS B-OC
of IN I-OC
scores NNS I-OC
of IN I-OC
IQ NNP I-OC
were VBD I-OC
determined VBN I-OC
with IN I-OC
Gesell NNP I-OC
and CC I-OC
WPPSI NNP I-OC
or CC I-OC
WISC-R NNP I-OC
. . O

RESULTS NNP O
Compared VBD O
with IN O
40 CD O
patients NNS O
of IN O
the DT O
control NN O
group NN O
after IN O
the DT O
six CD O
months NNS O
of IN O
the DT O
auditory JJ B-INTV
integrative JJ I-INTV
training NN I-INTV
, , O
41 CD O
of IN O
the DT O
experimental JJ O
group NN O
had VBD O
greatly RB O
improved VBN O
in IN O
many JJ O
aspects NNS O
, , O
such JJ O
as IN O
the DT O
disorders NNS B-OC
of IN I-OC
their PRP$ I-OC
language NN I-OC
, , I-OC
social JJ I-OC
interactions NNS I-OC
and CC I-OC
typical JJ I-OC
behavior NN I-OC
symptoms NNS I-OC
while IN O
they PRP O
had VBD O
not RB O
changed VBN O
in IN O
their PRP$ O
abnormal JJ B-OC
behaviors NNS I-OC
. . O

The DT O
scores NNS B-OC
of IN I-OC
IQ NNP I-OC
or CC I-OC
DQ NNP I-OC
had VBD O
increased VBN O
and CC O
scores NNS B-OC
of IN I-OC
ABC NNP I-OC
had VBD O
dropped VBN O
. . O

The DT O
differences NNS O
between IN O
the DT O
two CD O
groups NNS O
were VBD O
greatly RB O
significant JJ O
in IN O
statistics NNS O
( ( O
P NNP O
< NNP O
0.01 CD O
) ) O
. . O

The DT O
decreasing VBG O
level NN O
of IN O
both DT O
ABC NNP B-OC
scores NNS I-OC
and CC O
the DT O
increasing VBG O
level NN O
of IN O
the DT O
IQ NNP B-OC
scores NNS I-OC
were VBD O
negatively RB O
correlated VBN O
with IN O
age NN O
, , O
and CC O
the DT O
decreasing VBG O
level NN O
of IN O
ABC NNP B-OC
scores NNS I-OC
was VBD O
in IN O
line NN O
regression NN O
( ( O
positive JJ O
correlation NN O
) ) O
with IN O
base NN O
IQ NNP O
. . O

CONCLUSION NNP O
The DT O
treatment NN O
of IN O
auditory JJ B-INTV
integrative JJ I-INTV
training NN I-INTV
( ( I-INTV
AIT NNP I-INTV
) ) I-INTV
could MD O
greatly RB O
improve VB O
on IN O
language NN B-OC
disorders NNS I-OC
, , I-OC
the DT I-OC
difficulties NNS I-OC
of IN I-OC
social JJ I-OC
interactions NNS I-OC
, , I-OC
typical JJ I-OC
behavior NN I-OC
symptoms NNS I-OC
and CC I-OC
developmental JJ I-OC
levels NNS I-OC
, , O
therefore IN O
it PRP O
is VBZ O
positive JJ O
to TO O
the DT O
autistic JJ B-POPU
children NNS I-POPU
in IN O
its PRP$ O
short-term JJ O
treatment NN O
effect NN B-OC
. . O

-DOCSTART- -X- O O

Randomized VBN O
controlled JJ O
trial NN O
of IN O
acupuncture NN B-INTV
versus NN O
sham JJ B-INTV
acupuncture NN I-INTV
in IN O
autism NN B-POPU
spectrum NN I-POPU
disorder NN I-POPU
. . O

OBJECTIVE IN O
We PRP O
aim VBP O
to TO O
study VB O
the DT O
efficacy NN B-OC
of IN O
acupuncture NN B-INTV
versus NN O
sham JJ B-INTV
acupuncture NN I-INTV
in IN O
children NNS B-POPU
with IN I-POPU
autism NN I-POPU
spectrum NN I-POPU
disorder NN I-POPU
. . O

METHODS VB O
A DT O
single-blind JJ O
randomized VBN O
control NN O
trial NN O
was VBD O
conducted VBN O
in IN O
50 CD B-POPU
children NNS I-POPU
. . O

These DT O
children NNS O
were VBD O
randomly RB O
assigned VBN O
to TO O
the DT O
treatment NN O
group NN O
with IN O
tongue JJ B-INTV
acupuncture NN I-INTV
( ( O
40 CD O
sessions NNS O
over IN O
8 CD O
weeks NNS O
) ) O
or CC O
the DT O
control NN O
group NN O
( ( B-INTV
sham JJ I-INTV
tongue NN I-INTV
acupuncture NN I-INTV
to TO O
nonacupoints NNS O
in IN O
the DT O
tongue NN O
) ) O
. . O

RESULTS NNP O
There EX O
was VBD O
improvement NN O
in IN O
both CC O
the DT O
treatment NN O
and CC O
control NN O
groups NNS O
in IN O
all DT O
assessed JJ O
measures NNS O
but CC O
more JJR O
so RB O
in IN O
the DT O
treatment NN O
than IN O
in IN O
the DT O
control NN O
group NN O
: : O
( ( O
1 CD O
) ) O
eye-hand NN B-OC
coordination NN I-OC
, , I-OC
performance NN I-OC
, , I-OC
and CC I-OC
practical JJ I-OC
reasoning NN I-OC
of IN I-OC
Griffiths NNP I-OC
Mental NNP I-OC
Developmental NNP I-OC
Scale NNP I-OC
; : I-OC
( ( I-OC
2 CD I-OC
) ) I-OC
sensory-motor NN I-OC
, , I-OC
social JJ I-OC
, , I-OC
affectual JJ I-OC
, , I-OC
language NN I-OC
, , I-OC
and CC I-OC
total JJ I-OC
score NN I-OC
of IN I-OC
Ritvo-Freeman NNP I-OC
Real NNP I-OC
Life NNP I-OC
Scale NNP I-OC
; : I-OC
( ( I-OC
3 CD I-OC
) ) I-OC
Comprehension NN I-OC
Language NNP I-OC
age NN I-OC
in IN I-OC
the DT I-OC
Reynell NNP I-OC
Language NNP I-OC
Developmental NNP I-OC
Scale NNP I-OC
; : I-OC
and CC I-OC
( ( I-OC
4 CD I-OC
) ) I-OC
Total NN I-OC
Score NNP I-OC
and CC I-OC
Mental NNP I-OC
Age NNP I-OC
in IN I-OC
Symbolic NNP I-OC
Play NNP I-OC
Test NNP I-OC
. . O

The DT O
only JJ O
statistically RB O
significant JJ O
improvement NN O
in IN O
the DT O
treatment NN O
as IN O
compared VBN O
to TO O
the DT O
control NN O
group NN O
was VBD O
seen VBN O
in IN O
self-care JJ B-OC
and CC I-OC
cognition NN I-OC
domains NNS I-OC
of IN I-OC
the DT I-OC
Functional NNP I-OC
Independence NNP I-OC
Measure NN I-OC
for IN I-OC
children NNS B-POPU
. . O

CONCLUSIONS NNP O
We PRP O
had VBD O
demonstrated VBN O
that IN O
a DT O
short JJ O
course NN O
of IN O
acupuncture NN B-INTV
had VBD O
efficacy NN B-OC
in IN O
improving VBG O
various JJ O
developmental JJ O
and CC O
behavioral JJ O
aspects NNS O
of IN O
children NNS B-POPU
with IN I-POPU
autism NN I-POPU
. . O

The DT O
long-term JJ O
efficacy NN B-OC
in IN O
functional JJ O
gain NN O
needs NNS O
to TO O
be VB O
further RB O
explored VBN O
. . O

-DOCSTART- -X- O O

Effects NNS O
of IN O
tryptophan JJ B-INTV
depletion NN I-INTV
in IN O
drug-free JJ B-POPU
adults NNS I-POPU
with IN I-POPU
autistic JJ I-POPU
disorder NN I-POPU
. . O

BACKGROUND IN O
The DT O
primary JJ O
objective NN O
of IN O
this DT O
study NN O
was VBD O
to TO O
investigate VB O
the DT O
behavioral JJ B-OC
and CC I-OC
biochemical JJ I-OC
responses NNS I-OC
to TO O
acute VB O
tryptophan JJ B-INTV
depletion NN I-INTV
in IN O
drug-free JJ B-POPU
adult NN I-POPU
patients NNS I-POPU
with IN I-POPU
autistic JJ I-POPU
disorder NN I-POPU
. . O

METHODS NNP O
Twenty NNP B-POPU
drug-free JJ I-POPU
adults NNS I-POPU
with IN I-POPU
autistic JJ I-POPU
disorder NN I-POPU
( ( I-POPU
16 CD I-POPU
men NNS I-POPU
and CC I-POPU
4 CD I-POPU
women NNS I-POPU
) ) I-POPU
( ( I-POPU
mean JJ I-POPU
[ NNP I-POPU
+/- NN I-POPU
SD NNP I-POPU
] NNP I-POPU
age NN I-POPU
, , I-POPU
30.5 CD I-POPU
+/- JJ I-POPU
8.5 CD I-POPU
years NNS I-POPU
) ) I-POPU
underwent JJ O
short-term JJ O
tryptophan NN B-INTV
depletion NN I-INTV
in IN O
a DT O
double-blind JJ O
, , O
placebo-controlled JJ O
, , O
randomized JJ O
crossover NN O
design NN O
. . O

Patients NNS O
received VBD O
a DT O
24-hour JJ O
, , O
low-tryptophan JJ B-INTV
diet NN I-INTV
followed VBD O
the DT O
next JJ O
morning NN O
by IN O
an DT O
amino NN B-INTV
acid NN I-INTV
drink NN I-INTV
. . O

Behavioral JJ B-OC
ratings NNS I-OC
were VBD O
obtained VBN O
on IN O
the DT O
morning NN O
of IN O
the DT O
amino NN B-INTV
acid NN I-INTV
drink NN I-INTV
( ( O
baseline NN O
) ) O
and CC O
180 CD O
, , O
300 CD O
, , O
and CC O
420 CD O
minutes NNS O
after IN O
the DT O
drink NN O
. . O

Plasma NNP B-OC
free JJ I-OC
and CC I-OC
total JJ I-OC
tryptophan NN I-OC
levels NNS I-OC
were VBD O
obtained VBN O
at IN O
baseline NN O
and CC O
5 CD O
hours NNS O
after IN O
the DT O
drink NN O
. . O

The DT O
active JJ O
and CC O
sham JJ O
testing NN O
sessions NNS O
were VBD O
separated VBN O
by IN O
7 CD O
days NNS O
. . O

RESULTS NNP O
Eleven NNP O
( ( O
65 CD O
% NN O
) ) O
of IN O
the DT O
17 CD O
patients NNS O
who WP O
completed VBD O
both DT O
test NN O
days NNS O
showed VBD O
a DT O
significant JJ O
global JJ O
worsening NN O
of IN O
behavioral JJ B-OC
symptoms NNS I-OC
with IN O
short-term JJ O
tryptophan NN B-INTV
depletion NN I-INTV
, , O
but CC O
none NN O
of IN O
the DT O
17 CD O
patients NNS O
showed VBD O
any DT O
significant JJ O
change NN O
in IN O
clinical JJ O
status NN O
from IN O
baseline NN O
after IN O
sham JJ B-INTV
depletion NN I-INTV
( ( O
P NNP O
= NNP O
.001 NNP O
) ) O
. . O

Tryptophan NNP B-INTV
depletion NN I-INTV
led VBD O
to TO O
a DT O
significant JJ O
increase NN O
in IN O
behaviors NNS B-OC
such JJ I-OC
as IN I-OC
whirling NN I-OC
, , I-OC
flapping NN I-OC
, , I-OC
pacing NN I-OC
, , I-OC
banging NN I-OC
and CC I-OC
hitting VBG I-OC
self NN I-OC
, , I-OC
rocking NN I-OC
, , I-OC
and CC I-OC
toe NN I-OC
walking NN I-OC
( ( O
P NNP O
< NNP O
.05 NNP O
) ) O
. . O

In IN O
addition NN O
, , O
patients NNS O
were VBD O
significantly RB O
less JJR O
calm JJ B-OC
and CC I-OC
happy JJ I-OC
and CC O
more RBR O
anxious JJ B-OC
. . O

No DT O
significant JJ O
change NN O
was VBD O
observed VBN O
in IN O
social JJ B-OC
relatedness NN I-OC
or CC I-OC
repetitive JJ I-OC
thoughts NNS I-OC
and CC I-OC
behavior NN I-OC
. . O

Plasma NNP B-OC
total JJ I-OC
and CC I-OC
free JJ I-OC
tryptophan NN I-OC
levels NNS I-OC
were VBD O
reduced VBN O
86 CD O
% NN O
and CC O
69 CD O
% NN O
, , O
respectively RB O
, , O
5 CD O
hours NNS O
after IN O
the DT O
tryptophan-deficient JJ B-INTV
amino NN I-INTV
acid NN I-INTV
drink NN I-INTV
. . O

Patients NNS O
who WP O
had VBD O
a DT O
significant JJ O
global JJ O
exacerbation NN O
of IN O
symptoms NNS B-OC
had VBD O
significantly RB O
higher JJR O
baseline NN O
plasma IN B-OC
total JJ I-OC
tryptophan NN I-OC
levels NNS I-OC
( ( O
P NNP O
< NNP O
.001 NNP O
) ) O
and CC O
Autism NNP B-OC
Behavior NNP I-OC
Checklist NNP I-OC
scores NNS I-OC
( ( O
P NNP O
= NNP O
.005 NNP O
) ) O
than IN O
did VBD O
patients NNS O
who WP O
showed VBD O
no DT O
significant JJ O
change NN O
in IN O
symptoms NNS B-OC
after IN O
tryptophan JJ B-INTV
depletion NN I-INTV
. . O

CONCLUSIONS VB O
The DT O
results NNS O
of IN O
this DT O
study NN O
are VBP O
consistent JJ O
with IN O
previous JJ O
research NN O
that WDT O
has VBZ O
implicated VBN O
a DT O
dysregulation NN O
in IN O
serotonin JJ O
function NN O
in IN O
some DT O
patients NNS B-POPU
with IN I-POPU
autism NN I-POPU
. . O

These DT O
data NNS O
suggest VBP O
that IN O
the DT O
short-term JJ O
reduction NN O
of IN O
serotonin NN O
precursor NN O
availability NN O
may MD O
exacerbate VB O
some DT O
symptoms NNS B-OC
characteristic JJ O
of IN O
autism NN O
in IN O
some DT O
patients NNS O
. . O

Continued JJ O
investigation NN O
into IN O
the DT O
role NN O
of IN O
serotonin NN O
in IN O
the DT O
pathogenesis NN O
and CC O
treatment NN O
of IN O
autistic JJ O
disorder NN O
is VBZ O
warranted VBN O
. . O

-DOCSTART- -X- O O

A DT O
double-blind JJ O
, , O
placebo-controlled JJ O
study NN O
of IN O
fluvoxamine NN B-INTV
in IN O
adults NNS B-POPU
with IN I-POPU
autistic JJ I-POPU
disorder NN I-POPU
. . O

BACKGROUND NNP O
Autistic NNP O
disorder NN O
is VBZ O
characterized VBN O
by IN O
a DT O
fundamental JJ O
disturbance NN O
in IN O
social JJ B-OC
interaction NN I-OC
, , I-OC
impairments NNS I-OC
in IN I-OC
communication NN I-OC
, , O
and CC O
a DT O
markedly RB O
restricted JJ B-OC
repertoire NN I-OC
of IN I-OC
activities NNS I-OC
and CC I-OC
interests NNS I-OC
. . O

Abnormalities NNS O
in IN O
the DT O
serotonin NN O
neurotransmitter NN O
system NN O
have VBP O
been VBN O
identified VBN O
in IN O
some DT O
persons NNS O
with IN O
autism NN O
. . O

No DT O
consistently RB O
effective JJ O
and CC O
safe JJ O
drugs NNS O
have VBP O
been VBN O
developed VBN O
for IN O
treating VBG O
the DT O
symptoms NNS B-OC
of IN O
autism NN O
. . O

METHODS NNP O
Thirty NNP B-POPU
adults NNS I-POPU
with IN I-POPU
autistic JJ I-POPU
disorder NN I-POPU
completed VBD O
a DT O
12-week JJ O
double-blind NN O
, , O
placebo-controlled JJ B-INTV
trial NN O
of IN O
the DT O
potent NN O
and CC O
selective JJ O
serotonin NN O
uptake JJ O
inhibitor NN O
fluvoxamine NN B-INTV
maleate NN I-INTV
. . O

Behavioral JJ B-OC
ratings NNS I-OC
were VBD O
obtained VBN O
at IN O
baseline NN O
and CC O
after IN O
4 CD O
, , O
8 CD O
, , O
and CC O
12 CD O
weeks NNS O
of IN O
treatment NN O
. . O

RESULTS NNP O
Eight NNP O
( ( O
53 CD O
% NN O
) ) O
of IN O
15 CD O
patients NNS O
in IN O
the DT O
fluvoxamine-treated JJ B-INTV
group NN O
were VBD O
categorized VBN O
as IN O
responders NNS O
compared VBN O
with IN O
none NN O
of IN O
15 CD O
in IN O
the DT O
placebo NN B-INTV
group NN O
( ( O
P NNP O
= NNP O
.001 NNP O
) ) O
. . O

Fluvoxamine NNP B-INTV
was VBD O
superior JJ O
to TO O
placebo VB B-INTV
in IN O
reducing VBG O
repetitive JJ B-OC
thoughts NNS I-OC
and CC I-OC
behavior NN I-OC
( ( O
P NNP O
< NNP O
.001 NNP O
) ) O
, , O
maladaptive JJ B-OC
behavior NN I-OC
( ( O
P NNP O
< NNP O
.001 NNP O
) ) O
, , O
and CC O
aggression NN B-OC
( ( O
P NNP O
< NNP O
.03 NNP O
) ) O
, , O
and CC O
in IN O
improving VBG O
some DT O
aspects NNS O
of IN O
social JJ B-OC
relatedness NN I-OC
( ( O
P NNP O
< NNP O
.04 NNP O
) ) O
, , O
especially RB O
language NN B-OC
usage NN I-OC
( ( O
P NNP O
< NNP O
.008 NNP O
) ) O
. . O

Treatment JJ B-OC
response NN I-OC
was VBD O
not RB O
correlated VBN O
with IN O
age NN B-OC
level NN I-OC
of IN I-OC
autistic JJ I-OC
behavior NN I-OC
, , O
or CC O
full-scale JJ B-OC
IQ NNP I-OC
. . O

Other JJ O
than IN O
mild JJ B-OC
sedation NN I-OC
and CC I-OC
nausea NN I-OC
in IN O
a DT O
few JJ O
patients NNS O
, , O
fluvoxamine NN B-INTV
was VBD O
well RB O
tolerated VBN O
. . O

No DT O
dyskinesias NN B-OC
, , I-OC
adverse JJ I-OC
cardiovascular JJ I-OC
events NNS I-OC
, , I-OC
or CC I-OC
seizures NNS I-OC
occurred VBD O
. . O

CONCLUSIONS NNP O
Fluvoxamine NNP B-INTV
is VBZ O
more RBR O
effective JJ B-OC
than IN O
placebo NN B-INTV
in IN O
the DT O
short-term JJ O
treatment NN O
of IN O
the DT O
symptoms NNS B-OC
of IN O
autistic JJ B-POPU
disorder NN I-POPU
in IN I-POPU
adults NNS I-POPU
. . O

Controlled JJ O
studies NNS O
of IN O
fluvoxamine NN B-INTV
and CC O
other JJ O
potent NN O
and CC O
selective JJ O
serotonin NN O
uptake JJ O
inhibitors NNS O
seem VBP O
warranted VBN O
in IN O
children NNS O
and CC O
adolescents NNS O
with IN O
autism NN O
. . O

